Psyllid ID: psy16889

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200---
Protein Sequence
AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Secondary Structure (PSIPRED)
cccccccccEEEEEccccccccHHHHHHHHHHHHHHcccccccccccccccccccccccccEEEEcccccccHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
EEEEcccccEEEEEEEccccccHHHHHHHHHHHHHHHHcccccEccccEEEcccccHHcccEEEEEEccHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccHHccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHH
Coil and Loop (DISEMBL)
avtdprdgrRVALKKLPNVFQSLVSSKRVFRELKMLCFfkhdnvlsaldilqpphldfFQEIYVITELLQSDLHKiivspqhltsdHIKVFLYQILRGLKYLHSARIlhrdikpgnllvnsNCILKICDFglarveepdpnkamtQEVVTQYYrapeilmgaRHYSAAVDVWSVGCIFAELLGRRIlfqaqspvqqlglitdl
Flexible Loop (DISEMBL)
avtdprdgrrvalkklpnvfqslvsSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDikpgnllvnSNCILKICDFGLARveepdpnkamTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFqaqspvqqlglitdl
Low Complexity Region (SEG)
AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Disordered region (IsUnstruct)
************LKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE******AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL******
Disordered Region (DISOPRED)
*V*D*RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Disordered Region (DISEMBL)
********RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Disordered Region (DISPRO)
AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	203	2.2.26 [Sep-21-2011]
D3ZSZ3	527	Serine/threonine-protein	yes	N/A	1.0	0.385	0.871	1e-104
O54949	527	Serine/threonine-protein	yes	N/A	1.0	0.385	0.871	1e-104
Q9UBE8	527	Serine/threonine-protein	yes	N/A	1.0	0.385	0.871	1e-104
E2QWQ2	527	Serine/threonine-protein	yes	N/A	1.0	0.385	0.871	1e-104
E1BMN8	534	Serine/threonine-protein	yes	N/A	1.0	0.380	0.871	1e-104
Q8QGV6	447	Serine/threonine-protein	N/A	N/A	1.0	0.454	0.862	1e-101
B1H3E1	454	Serine/threonine-protein	no	N/A	1.0	0.447	0.862	1e-101
Q9U9Y8	634	Serine/threonine kinase N	no	N/A	1.0	0.320	0.758	8e-88
A8XSC1	657	Serine/threonine kinase N	N/A	N/A	0.985	0.304	0.509	1e-60
P42525	529	Extracellular signal-regu	yes	N/A	0.995	0.381	0.5	8e-60

>sp|D3ZSZ3|NLK_RAT Serine/threonine-protein kinase NLK OS=Rattus norvegicus GN=Nlk PE=3 SV=1

 Score =  378 bits (970), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct: 154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct: 274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 334 LLGRRILFQAQSPIQQLDLITDL 356

Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.
Rattus norvegicus (taxid: 10116)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|O54949|NLK_MOUSE Serine/threonine-protein kinase NLK OS=Mus musculus GN=Nlk PE=1 SV=2

 Score =  378 bits (970), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct: 154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct: 274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 334 LLGRRILFQAQSPIQQLDLITDL 356

Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9UBE8|NLK_HUMAN Serine/threonine-protein kinase NLK OS=Homo sapiens GN=NLK PE=1 SV=2

 Score =  377 bits (969), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct: 154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct: 274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 334 LLGRRILFQAQSPIQQLDLITDL 356

Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|E2QWQ2|NLK_CANFA Serine/threonine-protein kinase NLK OS=Canis familiaris GN=NLK PE=3 SV=1

 Score =  377 bits (968), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct: 154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct: 274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 334 LLGRRILFQAQSPIQQLDLITDL 356

Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.

Canis familiaris (taxid: 9615)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|E1BMN8|NLK_BOVIN Serine/threonine-protein kinase NLK OS=Bos taurus GN=NLK PE=3 SV=2

 Score =  377 bits (967), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct: 161 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 220

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 221 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 280

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct: 281 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 340

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 341 LLGRRILFQAQSPIQQLDLITDL 363

Serine/threonine-protein kinase that regulates a number of transcription factors with key roles in cell fate determination. Positive effector of the non-canonical Wnt signaling pathway, acting downstream of WNT5A, MAP3K7/TAK1 and HIPK2. Activation of this pathway causes binding to and phosphorylation of the histone methyltransferase SETDB1. The NLK-SETDB1 complex subsequently interacts with PPARG, leading to methylation of PPARG target promoters at histone H3K9 and transcriptional silencing. The resulting loss of PPARG target gene transcription inhibits adipogenesis and promotes osteoblastogenesis in mesenchymal stem cells (MSCs). Negative regulator of the canonical Wnt/beta-catenin signaling pathway. Binds to and phosphorylates TCF7L2/TCF4 and LEF1, promoting the dissociation of the TCF7L2/LEF1/beta-catenin complex from DNA, as well as the ubiquitination and subsequent proteolysis of LEF1. Together these effects inhibit the transcriptional activation of canonical Wnt/beta-catenin target genes. Negative regulator of the Notch signaling pathway. Binds to and phosphorylates NOTCH1, thereby preventing the formation of a transcriptionally active ternary complex of NOTCH1, RBPJ/RBPSUH and MAML1. Negative regulator of the MYB family of transcription factors. Phosphorylation of MYB leads to its subsequent proteolysis while phosphorylation of MYBL1 and MYBL2 inhibits their interaction with the coactivator CREBBP. Other transcription factors may also be inhibited by direct phosphorylation of CREBBP itself. Acts downstream of IL6 and MAP3K7/TAK1 to phosphorylate STAT3, which is in turn required for activation of NLK by MAP3K7/TAK1.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q8QGV6|NLK2_XENLA Serine/threonine-protein kinase NLK2 OS=Xenopus laevis GN=nlk.2 PE=1 SV=1

 Score =  368 bits (945), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 175/203 (86%), Positives = 193/203 (95%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPP +D F+
Sbjct: 76  SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPQIDCFE 135

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITEL+Q+DLHK+IVSPQ L+SDHIKVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 136 EIYVITELMQTDLHKVIVSPQPLSSDHIKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 195

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHY +A+D+WSVGCIFAE
Sbjct: 196 SNCVLKICDFGLARVEELDESQHMTQEVVTQYYRAPEILMGSRHYRSAIDIWSVGCIFAE 255

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 256 LLGRRILFQAQSPIQQLDLITDL 278

Negatively regulates Wnt/beta-catenin-signaling during development. Plays a role together with sox11 in neural induction during early embryogenesis. Involved in TGFbeta-mediated mesoderm induction in early embryos, acting downstream of map3k7/tak1 to phosphorylate stat3.1. Augments the rnf138/narf-directed ubiquitination and degradation of tcf/lef by enhancing the association of rnf138/narf and tcf/lef. Phosphorylates mef2a to play a role in anterior neural development, including eye formation.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|B1H3E1|NLK2_XENTR Serine/threonine-protein kinase NLK2 OS=Xenopus tropicalis GN=nlk.2 PE=2 SV=1

 Score =  368 bits (945), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 175/203 (86%), Positives = 193/203 (95%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPP +D F+
Sbjct: 83  SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPQIDCFE 142

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITEL+Q+DLHK+IVSPQ L+SDHIKVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 143 EIYVITELMQTDLHKVIVSPQPLSSDHIKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 202

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHY +A+D+WSVGCIFAE
Sbjct: 203 SNCVLKICDFGLARVEELDESQHMTQEVVTQYYRAPEILMGSRHYRSAIDIWSVGCIFAE 262

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 263 LLGRRILFQAQSPIQQLDLITDL 285

Negatively regulates Wnt/beta-catenin-signaling during development. Plays a role together with sox11 in neural induction during early embryogenesis. Involved in TGFbeta-mediated mesoderm induction in early embryos, acting downstream of map3k7/tak1 to phosphorylate stat3. Augments the rnf138/narf-directed ubiquitination and degradation of tcf/lef by enhancing the association of rnf138/narf and tcf/lef. Phosphorylates mef2a to play a role in anterior neural development, including eye formation.

Xenopus tropicalis (taxid: 8364)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9U9Y8|NLK_CAEEL Serine/threonine kinase NLK OS=Caenorhabditis elegans GN=lit-1 PE=1 SV=1

 Score =  322 bits (826), Expect = 8e-88,   Method: Compositional matrix adjust.
 Identities = 154/203 (75%), Positives = 175/203 (86%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPR G+RVALKK+PNVFQ+L S KRVFRE+KML  F+HDNVLS LDILQP +  FFQ
Sbjct: 256 SVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 315

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+YV+TEL+QSDLHKIIVSPQ LT DH+KVF+YQILRGLKYLH+A ILHRDIKPGNLLVN
Sbjct: 316 ELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN 375

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNCILKICDFGLAR  +      MT EVVTQYYRAPE+LMGAR Y+ AVD+WSVGCIFAE
Sbjct: 376 SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 435

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LL R+ILFQA  P++QL +I DL
Sbjct: 436 LLQRKILFQAAGPIEQLQMIIDL 458

Has a role in the Wnt signaling pathway controlling the asymmetry of cell divisions during embryogenesis. Operates in the AB and EMS cell lineages influencing cell specification. Required for body wall muscle development, endoderm development, pop-1 asymmetry and T-cell division asymmetry. Lit-1/wrm-1 complex regulates pop-1 localization and is required for pop-1/par-5 interaction.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A8XSC1|NLK_CAEBR Serine/threonine kinase NLK OS=Caenorhabditis briggsae GN=lit-1 PE=3 SV=2

 Score =  232 bits (592), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 134/263 (50%), Positives = 159/263 (60%), Gaps = 63/263 (23%)

Query: 1   AVTDPRDGRRVALKKL---------------------------------------PNVFQ 21
           +VTDPR G+RVALKK+                                       P+ FQ
Sbjct: 224 SVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 283

Query: 22  SLVS--------SKRVFRELKMLCFFKHDNVLSALDIL-----------QPPHLDFFQEI 62
              S         +R+   +K +C F    VL  + +L               L+  +E 
Sbjct: 284 EFTSWHLTPSIHHQRLISHIKPICLF---FVLPLVSLLCAHMYVCMWWHGTALLEGRKET 340

Query: 63  --YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             YV+TEL+QSDLHKIIVSPQ LT DH+KVF+YQILRGLKYLH+A ILHRDIKPGNLLVN
Sbjct: 341 ITYVLTELMQSDLHKIIVSPQTLTIDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN 400

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNCILKICDFGLAR  +      MT EVVTQYYRAPE+LMGAR Y+ AVD+WSVGCIFAE
Sbjct: 401 SNCILKICDFGLARTWDSRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 460

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LL R+ILFQA  P++QL +I DL
Sbjct: 461 LLQRKILFQAAGPIEQLQMIIDL 483

Has a role in the Wnt signaling pathway controlling the asymmetry of cell divisions during embryogenesis. Operates in the AB and EMS cell lineages influencing cell specification. Required for body wall muscle development, endoderm development, pop-1 asymmetry and T-cell division asymmetry. Lit-1/wrm-1 complex regulates pop-1 localization and is required for pop-1/par-5 interaction.

Caenorhabditis briggsae (taxid: 6238)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|P42525|ERK1_DICDI Extracellular signal-regulated kinase 1 OS=Dictyostelium discoideum GN=erkA PE=2 SV=2

 Score =  229 bits (585), Expect = 8e-60,   Method: Compositional matrix adjust.
 Identities = 101/202 (50%), Positives = 149/202 (73%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +  D   G +VA+KK+   F +L  +KR  RE+ +L  FKH+N++S  DIL+P   + F+
Sbjct: 165 SAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHENLISIKDILKPNSKEQFE 224

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++Y+++EL+ +DLH+II SPQ L+ DH + F+YQ+LRGLK++HSA +LHRD+KP NLL+N
Sbjct: 225 DVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIHSANVLHRDLKPSNLLIN 284

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +C+LKICD GLARVE+      MT+ V T++YRAPE+++    Y+ A+D+WSVGCIFAE
Sbjct: 285 EDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVILSWNKYTKAIDIWSVGCIFAE 344

Query: 181 LLGRRILFQAQSPVQQLGLITD 202
           LLGR+ LFQ +  + Q+ LI +
Sbjct: 345 LLGRKPLFQGKDYIHQITLIIE 366

Kinase involved in a signal transduction pathway.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	203
157107527	417	serine/threonine kinase NLK [Aedes aegyp	1.0	0.486	0.955	1e-109
158294958	442	AGAP005898-PA [Anopheles gambiae str. PE	1.0	0.459	0.950	1e-109
170037489	377	serine/threonine kinase NLK [Culex quinq	1.0	0.538	0.950	1e-109
195016958	546	GH14986 [Drosophila grimshawi] gi|193897	1.0	0.371	0.940	1e-108
194751109	513	GF23805 [Drosophila ananassae] gi|190625	1.0	0.395	0.940	1e-108
345483126	413	PREDICTED: serine/threonine-protein kina	1.0	0.491	0.940	1e-108
532559	434	putative serine/threonine protein kinase	1.0	0.467	0.940	1e-108
195126687	556	GI13148 [Drosophila mojavensis] gi|19391	1.0	0.365	0.940	1e-108
532558	477	putative serine/threonine protein kinase	1.0	0.425	0.940	1e-108
24660555	430	nemo, isoform E [Drosophila melanogaster	1.0	0.472	0.940	1e-108

>gi|157107527|ref|XP_001649822.1| serine/threonine kinase NLK [Aedes aegypti] gi|108879565|gb|EAT43790.1| AAEL004797-PA [Aedes aegypti]

 Score =  400 bits (1029), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 194/203 (95%), Positives = 199/203 (98%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ
Sbjct: 9   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 68

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 69  EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 128

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD +K MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF E
Sbjct: 129 SNCVLKICDFGLARVEEPDQSKHMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFGE 188

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSPVQQL LIT+L
Sbjct: 189 LLGRRILFQAQSPVQQLELITEL 211

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|158294958|ref|XP_315928.3| AGAP005898-PA [Anopheles gambiae str. PEST] gi|157015807|gb|EAA11880.4| AGAP005898-PA [Anopheles gambiae str. PEST]

 Score =  399 bits (1026), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 193/203 (95%), Positives = 199/203 (98%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 68  AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 127

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 128 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 187

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD +K MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF E
Sbjct: 188 SNCVLKICDFGLARVEEPDQSKHMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFGE 247

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSPVQQL LIT+L
Sbjct: 248 LLGRRILFQAQSPVQQLELITEL 270

Source: Anopheles gambiae str. PEST

Species: Anopheles gambiae

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170037489|ref|XP_001846590.1| serine/threonine kinase NLK [Culex quinquefasciatus] gi|167880698|gb|EDS44081.1| serine/threonine kinase NLK [Culex quinquefasciatus]

 Score =  399 bits (1025), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 193/203 (95%), Positives = 199/203 (98%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 3   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 62

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 63  EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 122

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD +K MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF E
Sbjct: 123 SNCVLKICDFGLARVEEPDQSKHMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFGE 182

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSPVQQL LIT+L
Sbjct: 183 LLGRRILFQAQSPVQQLELITEL 205

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195016958|ref|XP_001984509.1| GH14986 [Drosophila grimshawi] gi|193897991|gb|EDV96857.1| GH14986 [Drosophila grimshawi]

 Score =  397 bits (1019), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 172 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 231

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 232 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 291

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 292 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 351

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 352 LLGRRILFQAQNPVQQLELITEL 374

Source: Drosophila grimshawi

Species: Drosophila grimshawi

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|194751109|ref|XP_001957869.1| GF23805 [Drosophila ananassae] gi|190625151|gb|EDV40675.1| GF23805 [Drosophila ananassae]

 Score =  396 bits (1018), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 139 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 198

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 199 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 258

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 259 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 318

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 319 LLGRRILFQAQNPVQQLELITEL 341

Source: Drosophila ananassae

Species: Drosophila ananassae

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345483126|ref|XP_003424747.1| PREDICTED: serine/threonine-protein kinase NLK-like [Nasonia vitripennis]

 Score =  395 bits (1016), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 197/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDG+RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ
Sbjct: 56  AVTDPRDGKRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 115

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL+SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 116 EIYVITELLQSDLHKIIVSPQHLSSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 175

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD NK MTQEVVTQYYRAPEILMGARHY+ AVD+WSVGCIF E
Sbjct: 176 SNCVLKICDFGLARVEEPDKNKHMTQEVVTQYYRAPEILMGARHYTNAVDIWSVGCIFGE 235

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LL RRILFQAQSPVQQL LIT+L
Sbjct: 236 LLRRRILFQAQSPVQQLELITEL 258

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|532559|gb|AAA21125.1| putative serine/threonine protein kinase [Drosophila melanogaster]

 Score =  395 bits (1016), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 56  AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 115

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 116 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 175

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 176 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 235

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 236 LLGRRILFQAQNPVQQLELITEL 258

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195126687|ref|XP_002007802.1| GI13148 [Drosophila mojavensis] gi|193919411|gb|EDW18278.1| GI13148 [Drosophila mojavensis]

 Score =  395 bits (1015), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 182 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 241

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 242 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 301

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 302 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 361

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 362 LLGRRILFQAQNPVQQLELITEL 384

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|532558|gb|AAA21124.1| putative serine/threonine protein kinase [Drosophila melanogaster]

 Score =  395 bits (1015), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 56  AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 115

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 116 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 175

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 176 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 235

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 236 LLGRRILFQAQNPVQQLELITEL 258

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|24660555|ref|NP_729316.1| nemo, isoform E [Drosophila melanogaster] gi|24660559|ref|NP_729317.1| nemo, isoform F [Drosophila melanogaster] gi|24660563|ref|NP_729318.1| nemo, isoform G [Drosophila melanogaster] gi|442630911|ref|NP_001261555.1| nemo, isoform H [Drosophila melanogaster] gi|195325861|ref|XP_002029649.1| GM25010 [Drosophila sechellia] gi|195492714|ref|XP_002094109.1| GE21651 [Drosophila yakuba] gi|195588595|ref|XP_002084043.1| GD14046 [Drosophila simulans] gi|23093969|gb|AAN12035.1| nemo, isoform E [Drosophila melanogaster] gi|23093970|gb|AAN12036.1| nemo, isoform F [Drosophila melanogaster] gi|23093971|gb|AAN12037.1| nemo, isoform G [Drosophila melanogaster] gi|194118592|gb|EDW40635.1| GM25010 [Drosophila sechellia] gi|194180210|gb|EDW93821.1| GE21651 [Drosophila yakuba] gi|194196052|gb|EDX09628.1| GD14046 [Drosophila simulans] gi|440215462|gb|AGB94250.1| nemo, isoform H [Drosophila melanogaster]

 Score =  395 bits (1015), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct: 56  AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 115

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct: 116 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 175

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct: 176 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 235

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQ+PVQQL LIT+L
Sbjct: 236 LLGRRILFQAQNPVQQLELITEL 258

Source: Drosophila melanogaster

Species: Drosophila melanogaster

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	203
FB|FBgn0011817	477	nmo "nemo" [Drosophila melanog	1.0	0.425	0.940	1.5e-99
UNIPROTKB|F1N862	462	NLK "Uncharacterized protein"	1.0	0.439	0.871	8.7e-95
UNIPROTKB|E1BMN8	534	NLK "Serine/threonine-protein	1.0	0.380	0.871	8.7e-95
UNIPROTKB|H2XJE9	527	NLK "Serine/threonine-protein	1.0	0.385	0.871	8.7e-95
UNIPROTKB|E2QWQ2	527	NLK "Serine/threonine-protein	1.0	0.385	0.871	8.7e-95
UNIPROTKB|H0YD75	475	NLK "Serine/threonine-protein	1.0	0.427	0.871	8.7e-95
UNIPROTKB|Q9UBE8	527	NLK "Serine/threonine-protein	1.0	0.385	0.871	8.7e-95
MGI|MGI:1201387	527	Nlk "nemo like kinase" [Mus mu	1.0	0.385	0.871	8.7e-95
RGD|1561602	527	Nlk "nemo like kinase" [Rattus	1.0	0.385	0.871	8.7e-95
ZFIN|ZDB-GENE-080320-1	533	nlk2 "nemo like kinase, type 2	1.0	0.380	0.871	8.7e-95

FB|FBgn0011817 nmo "nemo" [Drosophila melanogaster (taxid:7227)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 191/203 (94%), Positives = 198/203 (97%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH+NVLSALDILQPPHLDFFQ
Sbjct:    56 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHENVLSALDILQPPHLDFFQ 115

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYVITELLQSDLHKIIVSPQHL++DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN
Sbjct:   116 EIYVITELLQSDLHKIIVSPQHLSADHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 175

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEEPD  K MTQEVVTQYYRAPEILMGARHYS+AVDVWSVGCIF E
Sbjct:   176 SNCVLKICDFGLARVEEPDQAKHMTQEVVTQYYRAPEILMGARHYSSAVDVWSVGCIFGE 235

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQ+PVQQL LIT+L
Sbjct:   236 LLGRRILFQAQNPVQQLELITEL 258

GO:0048749 "compound eye development" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0016318 "ommatidial rotation" evidence=IGI;IMP

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0007476 "imaginal disc-derived wing morphogenesis" evidence=IMP

GO:0007474 "imaginal disc-derived wing vein specification" evidence=IMP

GO:0042332 "gravitaxis" evidence=IMP

GO:0001736 "establishment of planar polarity" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IGI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0008586 "imaginal disc-derived wing vein morphogenesis" evidence=IMP

GO:0045887 "positive regulation of synaptic growth at neuromuscular junction" evidence=IMP

UNIPROTKB|F1N862 NLK "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:    89 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 148

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   149 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 208

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   209 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 268

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   269 LLGRRILFQAQSPIQQLDLITDL 291

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0042169 "SH2 domain binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

UNIPROTKB|E1BMN8 NLK "Serine/threonine-protein kinase NLK" [Bos taurus (taxid:9913)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   161 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 220

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   221 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 280

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   281 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 340

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   341 LLGRRILFQAQSPIQQLDLITDL 363

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|H2XJE9 NLK "Serine/threonine-protein kinase NLK" [Bos taurus (taxid:9913)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   334 LLGRRILFQAQSPIQQLDLITDL 356

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042169 "SH2 domain binding" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

UNIPROTKB|E2QWQ2 NLK "Serine/threonine-protein kinase NLK" [Canis lupus familiaris (taxid:9615)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   334 LLGRRILFQAQSPIQQLDLITDL 356

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0042169 "SH2 domain binding" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0008134 "transcription factor binding" evidence=IEA

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

UNIPROTKB|H0YD75 NLK "Serine/threonine-protein kinase NLK" [Homo sapiens (taxid:9606)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   102 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 161

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   162 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 221

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   222 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 281

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   282 LLGRRILFQAQSPIQQLDLITDL 304

GO:0000287 "magnesium ion binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IEA

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA

GO:0042169 "SH2 domain binding" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

UNIPROTKB|Q9UBE8 NLK "Serine/threonine-protein kinase NLK" [Homo sapiens (taxid:9606)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   334 LLGRRILFQAQSPIQQLDLITDL 356

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0000287 "magnesium ion binding" evidence=ISS

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007243 "intracellular protein kinase cascade" evidence=ISS

GO:0006355 "regulation of transcription, DNA-dependent" evidence=ISS

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IMP

GO:0008134 "transcription factor binding" evidence=IPI

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0042169 "SH2 domain binding" evidence=ISS

GO:0018107 "peptidyl-threonine phosphorylation" evidence=ISS

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=ISS

GO:0004672 "protein kinase activity" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=IPI

MGI|MGI:1201387 Nlk "nemo like kinase" [Mus musculus (taxid:10090)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   334 LLGRRILFQAQSPIQQLDLITDL 356

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000287 "magnesium ion binding" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0004707 "MAP kinase activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=ISO

GO:0007243 "intracellular protein kinase cascade" evidence=IDA

GO:0008134 "transcription factor binding" evidence=ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

GO:0023014 "signal transduction by phosphorylation" evidence=IDA

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0031625 "ubiquitin protein ligase binding" evidence=ISO

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IDA

GO:0042169 "SH2 domain binding" evidence=IPI

GO:0042802 "identical protein binding" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0046872 "metal ion binding" evidence=IEA

RGD|1561602 Nlk "nemo like kinase" [Rattus norvegicus (taxid:10116)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   154 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 213

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   214 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 273

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   274 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 333

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   334 LLGRRILFQAQSPIQQLDLITDL 356

GO:0000287 "magnesium ion binding" evidence=IEA;ISO

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0004707 "MAP kinase activity" evidence=IEA;ISO

GO:0005524 "ATP binding" evidence=IEA;ISO

GO:0005634 "nucleus" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=IEA;ISO

GO:0007243 "intracellular protein kinase cascade" evidence=ISO

GO:0008134 "transcription factor binding" evidence=IEA;ISO

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IEA;ISO

GO:0023014 "signal transduction by phosphorylation" evidence=ISO

GO:0030178 "negative regulation of Wnt receptor signaling pathway" evidence=IEA;ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA;ISO

GO:0033136 "serine phosphorylation of STAT3 protein" evidence=IEA;ISO

GO:0042169 "SH2 domain binding" evidence=IEA;ISO

GO:0042802 "identical protein binding" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=IEA;ISO

ZFIN|ZDB-GENE-080320-1 nlk2 "nemo like kinase, type 2" [Danio rerio (taxid:7955)]

 Score = 943 (337.0 bits), Expect = 8.7e-95, P = 8.7e-95
 Identities = 177/203 (87%), Positives = 195/203 (96%)

Query:     1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D+F+
Sbjct:   160 SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDYFE 219

Query:    61 EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct:   220 EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 279

Query:   121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             SNC+LKICDFGLARVEE D ++ MTQEVVTQYYRAPEILMG+RHYS A+D+WSVGCIFAE
Sbjct:   280 SNCVLKICDFGLARVEELDESRHMTQEVVTQYYRAPEILMGSRHYSNAIDIWSVGCIFAE 339

Query:   181 LLGRRILFQAQSPVQQLGLITDL 203
             LLGRRILFQAQSP+QQL LITDL
Sbjct:   340 LLGRRILFQAQSPIQQLDLITDL 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0030177 "positive regulation of Wnt receptor signaling pathway" evidence=IMP

GO:0030901 "midbrain development" evidence=IMP

GO:0018107 "peptidyl-threonine phosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6Z437	MPK3_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.5408	0.9605	0.5270	yes	N/A
Q9LQQ9	MPK13_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.5172	0.9901	0.5537	yes	N/A
Q9UBE8	NLK_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.8719	1.0	0.3851	yes	N/A
O54949	NLK_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.8719	1.0	0.3851	yes	N/A
D3ZSZ3	NLK_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.8719	1.0	0.3851	yes	N/A
E2QWQ2	NLK_CANFA	2, ., 7, ., 1, 1, ., 2, 4	0.8719	1.0	0.3851	yes	N/A
E1BMN8	NLK_BOVIN	2, ., 7, ., 1, 1, ., 2, 4	0.8719	1.0	0.3801	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.824
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	203
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-159
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-118
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-92
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	7e-88
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-84
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-82
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-78
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-71
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-70
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-69
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-69
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-65
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-63
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-63
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-63
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-63
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-61
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-61
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-60
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-60
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-58
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-56
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-56
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-56
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-55
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-54
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-52
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-50
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-50
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-50
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-49
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-49
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-48
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-47
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-46
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-45
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-44
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-44
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-42
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-42
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-42
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-41
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-40
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-39
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-39
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-39
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-39
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-39
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-38
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-37
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-36
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-36
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-34
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-34
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-33
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-31
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-28
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-28
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-27
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-26
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-21
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-21
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-19
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-16
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-14
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-13
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-11
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-11
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-10
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-06
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	4e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-04

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  444 bits (1145), Expect = e-159
 Identities = 179/203 (88%), Positives = 196/203 (96%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +VTDPRDG+RVALKK+PNVFQ+LVS KRVFRELKMLCFFKHDNVLSALDILQPPH+D F+
Sbjct: 18  SVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE 77

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EIYV+TEL+QSDLHKIIVSPQ L+SDH+KVFLYQILRGLKYLHSA ILHRDIKPGNLLVN
Sbjct: 78  EIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN 137

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           SNC+LKICDFGLARVEEPD +K MTQEVVTQYYRAPEILMG+RHY++AVD+WSVGCIFAE
Sbjct: 138 SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGRRILFQAQSP+QQL LITDL
Sbjct: 198 LLGRRILFQAQSPIQQLDLITDL 220

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  338 bits (870), Expect = e-118
 Identities = 114/205 (55%), Positives = 160/205 (78%), Gaps = 2/205 (0%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +  D R GR+VA+KK+ NVF  L+ +KR+ RE+K+L   +H+N++  LDIL+PP  + F 
Sbjct: 18  SAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFN 77

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++Y++TEL+++DLHK+I SPQ LT DHI+ FLYQILRGLKYLHSA ++HRD+KP N+LVN
Sbjct: 78  DVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN 137

Query: 121 SNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           SNC LKICDFGLAR  +PD ++   +T+ VVT++YRAPE+L+ +  Y+ A+D+WSVGCIF
Sbjct: 138 SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF 197

Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AELL R+ LF  +  + QL LI ++
Sbjct: 198 AELLTRKPLFPGRDYIDQLNLIVEV 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  272 bits (698), Expect = 3e-92
 Identities = 106/203 (52%), Positives = 147/203 (72%), Gaps = 1/203 (0%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +  +     +VA+KK+ N F + + +KR  RE+K+L    H+NV++  DI+ PPH + F 
Sbjct: 23  SAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++Y++ EL+ +DLH+II S Q L+ DH + FLYQ+LRGLKY+HSA +LHRD+KP NLL+N
Sbjct: 83  DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN 142

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           +NC LKICDFGLAR    +    MT+ VVT++YRAPE+L+    Y+ A+DVWSVGCIFAE
Sbjct: 143 ANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           LLGR+ LF  +  V QL LIT+L
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITEL 224

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  261 bits (669), Expect = 7e-88
 Identities = 109/203 (53%), Positives = 150/203 (73%), Gaps = 4/203 (1%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D R G++VA+KK+P+ F     +KR  RELK+L  FKHDN+++  DIL+PP  DF +++Y
Sbjct: 26  DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF-KDVY 84

Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ +L++SDLH II S Q LT +HI+ FLYQ+LRGLKY+HSA ++HRD+KP NLLVN +C
Sbjct: 85  VVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC 144

Query: 124 ILKICDFGLAR--VEEPDPNKA-MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            L+I DFG+AR     P  +K  MT+ V T++YRAPE+L+    Y+ A+D+WSVGCIFAE
Sbjct: 145 ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           +LGRR LF  ++ V QL LI  +
Sbjct: 205 MLGRRQLFPGKNYVHQLKLILSV 227

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  251 bits (644), Expect = 7e-84
 Identities = 98/204 (48%), Positives = 137/204 (67%), Gaps = 6/204 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFF 59
           +  D + GR+VA+KKL   FQS + +KR +REL++L    H+NV+  LD+  P   L+ F
Sbjct: 33  SAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q++Y++T L+ +DL+ I+   Q L+ DHI+  +YQILRGLKY+HSA I+HRD+KP N+ V
Sbjct: 93  QDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV 151

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  +      MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 152 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 207

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           ELL  + LF     + QL  I +L
Sbjct: 208 ELLTGKTLFPGSDHIDQLKRIMNL 231

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  247 bits (634), Expect = 2e-82
 Identities = 102/204 (50%), Positives = 150/204 (73%), Gaps = 6/204 (2%)

Query: 3   TDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           T    G +VA+KK+ P  F+     +R  RE+K+L  FKH+N++  LDI++PP  + F +
Sbjct: 25  THKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +Y++ EL+++DL+K+I + QHL++DHI+ FLYQILRGLKY+HSA +LHRD+KP NLL+N+
Sbjct: 83  VYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 141

Query: 122 NCILKICDFGLARVEEP--DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           NC LKICDFGLAR+ +P  D    +T+ V T++YRAPEI++ ++ Y+ A+D+WSVGCI A
Sbjct: 142 NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E+L  R LF  +  + QL LI  +
Sbjct: 202 EMLSNRPLFPGKDYLHQLNLILGV 225

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  236 bits (604), Expect = 4e-78
 Identities = 103/200 (51%), Positives = 140/200 (70%), Gaps = 9/200 (4%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNV--LSALDILQPPHLDFFQEIY 63
           +   VA+KK+ NVF   + +KR  RELK+L  F+ H N+  L  +DI+ P     F E+Y
Sbjct: 26  EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP---GNFNELY 82

Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           +  EL+++DLH+II S Q LT  H + F+YQIL GLKY+HSA +LHRD+KPGNLLVN++C
Sbjct: 83  LYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC 142

Query: 124 ILKICDFGLARVEEPDPNKA---MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            LKICDFGLAR    +P +    MT+ V T++YRAPEI++  + Y+ A+DVWSVGCI AE
Sbjct: 143 ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE 202

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           LLGR+ +F+ +  V QL  I
Sbjct: 203 LLGRKPVFKGKDYVDQLNQI 222

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  219 bits (560), Expect = 2e-71
 Identities = 99/201 (49%), Positives = 137/201 (68%), Gaps = 9/201 (4%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
            D   G+ VA+KK+   F + V +KR +RELK+L   +H+N++S  DI   P     ++I
Sbjct: 30  RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LEDI 85

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y +TELL +DLH+++ S + L    I+ FLYQILRGLKY+HSA ++HRD+KP N+L+N N
Sbjct: 86  YFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C LKICDFGLAR+++P     MT  V T+YYRAPEI++  + Y   VD+WS GCIFAE+L
Sbjct: 145 CDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Query: 183 GRRILFQAQSPVQQLGLITDL 203
             + LF  +  V Q  +ITDL
Sbjct: 201 EGKPLFPGKDHVNQFSIITDL 221

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  217 bits (554), Expect = 1e-70
 Identities = 96/207 (46%), Positives = 142/207 (68%), Gaps = 5/207 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +  D   G +VA+KK+ +VF+ +  + R+ RE+K+L   +H +++    I+ PP    F+
Sbjct: 18  SAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFK 77

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +IYV+ EL++SDLH++I +   LT +H + FLYQ+LR LKY+H+A + HRD+KP N+L N
Sbjct: 78  DIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN 137

Query: 121 SNCILKICDFGLARVEEPDPNKAM--TQEVVTQYYRAPEILMGA--RHYSAAVDVWSVGC 176
           ++C LKICDFGLARV   D   A+  T  V T++YRAPE L G+    Y+ A+D+WS+GC
Sbjct: 138 ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGC 196

Query: 177 IFAELLGRRILFQAQSPVQQLGLITDL 203
           IFAE+L  + LF  ++ V QL LITDL
Sbjct: 197 IFAEVLTGKPLFPGKNVVHQLDLITDL 223

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  213 bits (545), Expect = 1e-69
 Identities = 89/198 (44%), Positives = 124/198 (62%), Gaps = 7/198 (3%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G  VA+KK+   F+S    K   RE+K+L    H N++  LD+ +        ++Y
Sbjct: 20  DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLY 74

Query: 64  VITELLQSDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           ++ E + +DL+K+I   Q  L    IK +LYQ+L+GL + HS  ILHRD+KP NLL+N+ 
Sbjct: 75  LVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +LK+ DFGLAR     P +  T  VVT++YRAPE+L+G + YS  VD+WSVGCIFAELL
Sbjct: 135 GVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193

Query: 183 GRRILFQAQSPVQQLGLI 200
            RR LF  +S + QL  I
Sbjct: 194 SRRPLFPGKSEIDQLFKI 211

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  212 bits (542), Expect = 2e-69
 Identities = 88/209 (42%), Positives = 122/209 (58%), Gaps = 21/209 (10%)

Query: 3   TDPRDGRRVALKKLPN------VFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPH 55
            D + G  VALKK+        +  + +      RE+ +L   KH N++  LD I     
Sbjct: 19  RDKKTGEIVALKKIRLDNEEEGIPSTAL------REISLLKELKHPNIVKLLDVIHTERK 72

Query: 56  LDFFQEIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
                 +Y++ E    DL K +   P  L+ + IK  +YQ+LRGL Y HS RILHRD+KP
Sbjct: 73  ------LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKP 126

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+L+N + +LK+ DFGLAR     P +  T EVVT +YRAPEIL+G++HYS AVD+WSV
Sbjct: 127 QNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSV 185

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLITDL 203
           GCIFAE++  + LF   S + QL  I  +
Sbjct: 186 GCIFAEMITGKPLFPGDSEIDQLFKIFQI 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  204 bits (520), Expect = 2e-65
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEI 62
           D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F ++
Sbjct: 38  DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 97

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL VN +
Sbjct: 98  YLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 157 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212

Query: 183 GRRILFQAQSPVQQLGLITDL 203
             R LF     + QL LI  L
Sbjct: 213 TGRTLFPGTDHIDQLKLILRL 233

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  196 bits (502), Expect = 1e-63
 Identities = 68/197 (34%), Positives = 108/197 (54%), Gaps = 10/197 (5%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D + G+ VA+K +          +R+ RE+K+L   KH N++   D+ +        +
Sbjct: 18  ARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNIVRLYDVFEDE-----DK 71

Query: 62  IYVITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y++ E     DL  ++     L+ D  + +L QIL  L+YLHS  I+HRD+KP N+L++
Sbjct: 72  LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD 131

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFGLAR    DP + +T  V T  Y APE+L+G + Y  AVD+WS+G I  E
Sbjct: 132 EDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYE 188

Query: 181 LLGRRILFQAQSPVQQL 197
           LL  +  F     + +L
Sbjct: 189 LLTGKPPFPGDDQLLEL 205

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  199 bits (508), Expect = 1e-63
 Identities = 93/201 (46%), Positives = 136/201 (67%), Gaps = 6/201 (2%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D R  ++VA+KKL   FQSL+ ++R +REL++L   KH+NV+  LD+  P   ++ F E+
Sbjct: 36  DTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I V  Q L+ +H++  +YQ+LRGLKY+HSA I+HRD+KP N+ VN +
Sbjct: 96  YLVTNLMGADLNNI-VKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 154

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C L+I DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 155 CELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Query: 183 GRRILFQAQSPVQQLGLITDL 203
             + LF     + QL  I ++
Sbjct: 211 KGKALFPGNDYIDQLKRIMEV 231

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  197 bits (504), Expect = 7e-63
 Identities = 81/203 (39%), Positives = 128/203 (63%), Gaps = 9/203 (4%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQE 61
            D R    VALKK+ + F++   ++R FRE+  L     H N++  L++++    +  ++
Sbjct: 27  IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDKD 83

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           IY++ E +++DLH +I +   L   H +  +YQ+L+ LKY+HS  ++HRD+KP N+L+NS
Sbjct: 84  IYLVFEYMETDLHAVIRA-NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS 142

Query: 122 NCILKICDFGLAR----VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +C +K+ DFGLAR    +EE   N  +T  V T++YRAPEIL+G+  Y+  VD+WSVGCI
Sbjct: 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
             E+L  + LF   S + QL  I
Sbjct: 203 LGEMLLGKPLFPGTSTLNQLEKI 225

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  196 bits (501), Expect = 7e-63
 Identities = 92/204 (45%), Positives = 121/204 (59%), Gaps = 14/204 (6%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKR-----VFRELKMLCFFKHDNVLSALDILQPPHLD 57
            D   GR VA+KK+         +K        RE+K+L   KH N++  LD+    H  
Sbjct: 20  RDKETGRIVAIKKIKL--GERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF--GHKS 75

Query: 58  FFQEIYVITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
               I ++ E +++DL K+I      LT   IK ++   LRGL+YLHS  ILHRD+KP N
Sbjct: 76  N---INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           LL+ S+ +LK+ DFGLAR     PN+ MT +VVT++YRAPE+L GARHY   VD+WSVGC
Sbjct: 133 LLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC 191

Query: 177 IFAELLGRRILFQAQSPVQQLGLI 200
           IFAELL R       S + QLG I
Sbjct: 192 IFAELLLRVPFLPGDSDIDQLGKI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  191 bits (488), Expect = 4e-61
 Identities = 79/204 (38%), Positives = 118/204 (57%), Gaps = 14/204 (6%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           + G  VALKK+      + + K  F     RE+K+L   +H N++   +I+         
Sbjct: 22  KTGELVALKKIR-----MENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG--- 73

Query: 61  EIYVITELLQSDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            IY++ E +  DL  ++ SP+   T   IK ++ Q+L GL+YLHS  ILHRDIK  N+L+
Sbjct: 74  SIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N++ +LK+ DFGLAR      +   T  V+T +YR PE+L+GA  Y   VD+WSVGCI A
Sbjct: 134 NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILA 193

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           EL   + +FQ  + ++QL  I +L
Sbjct: 194 ELFLGKPIFQGSTELEQLEKIFEL 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  192 bits (490), Expect = 7e-61
 Identities = 92/198 (46%), Positives = 131/198 (66%), Gaps = 7/198 (3%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEI 62
           D R G +VA+KKL   FQS + +KR +REL +L   +H+NV+  LD+       D FQ+ 
Sbjct: 36  DKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDF 95

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++   +Q+DL KI+     L+ D ++  +YQ+L GLKY+HSA I+HRD+KPGNL VN +
Sbjct: 96  YLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C LKI DFGLAR  + +    MT  VVT++YRAPE+++   HY+  VD+WSVGCI AE+L
Sbjct: 154 CELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Query: 183 GRRILFQAQSPVQQLGLI 200
             + LF+ +  + QL  I
Sbjct: 210 TGKTLFKGKDYLDQLTQI 227

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  190 bits (485), Expect = 4e-60
 Identities = 91/195 (46%), Positives = 132/195 (67%), Gaps = 6/195 (3%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D R G +VA+KKL   FQS + +KR +REL++L   KH+NV+  LD+  P   LD F + 
Sbjct: 36  DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++   + +DL K++   + L+ D I+  +YQ+L+GLKY+H+A I+HRD+KPGNL VN +
Sbjct: 96  YLVMPFMGTDLGKLM-KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED 154

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C LKI DFGLAR  + +    MT  VVT++YRAPE+++   HY+  VD+WSVGCI AE+L
Sbjct: 155 CELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Query: 183 GRRILFQAQSPVQQL 197
             + LF+    + QL
Sbjct: 211 TGKPLFKGHDHLDQL 225

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  191 bits (486), Expect = 5e-60
 Identities = 82/199 (41%), Positives = 124/199 (62%), Gaps = 10/199 (5%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVIT 66
           G+ VA+KKL   FQ++  +KR +REL ++    H N++  L++  P   L+ FQ++Y++ 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100

Query: 67  ELLQSDLHKIIVSPQHLTSDH--IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           EL+ ++L ++I     +  DH  +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C 
Sbjct: 101 ELMDANLCQVI----QMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 156

Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           LKI DFGLAR         MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  
Sbjct: 157 LKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRG 213

Query: 185 RILFQAQSPVQQLGLITDL 203
            +LF     + Q   I + 
Sbjct: 214 TVLFPGTDHIDQWNKIIEQ 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  185 bits (471), Expect = 2e-58
 Identities = 72/196 (36%), Positives = 116/196 (59%), Gaps = 6/196 (3%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+           +  RE+K L   +H  V+  LD+   PH        ++ E
Sbjct: 25  GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF--PHG---SGFVLVME 79

Query: 68  LLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            + SDL +++   +  L    +K ++  +L+G+ Y+H+  I+HRD+KP NLL++++ +LK
Sbjct: 80  YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLK 139

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGLAR+   +  +  + +V T++YRAPE+L GAR Y   VD+W+VGCIFAELL    
Sbjct: 140 IADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSP 199

Query: 187 LFQAQSPVQQLGLITD 202
           LF  ++ ++QL ++  
Sbjct: 200 LFPGENDIEQLAIVFR 215

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  183 bits (468), Expect = 2e-58
 Identities = 69/200 (34%), Positives = 106/200 (53%), Gaps = 7/200 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G+ VA+K L    +     +   RE+++L    H N++  +D  +         
Sbjct: 18  AKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDK-----DH 72

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y++ E  +  DL   +     L+ D  K    QILRGL+YLHS  I+HRD+KP N+L++
Sbjct: 73  LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLD 132

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N ++KI DFGLA+      + ++T  V T +Y APE+L+G   Y   VDVWS+G I  E
Sbjct: 133 ENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYE 191

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           LL  +  F  ++ + QL LI
Sbjct: 192 LLTGKPPFSGENILDQLQLI 211

Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  180 bits (459), Expect = 1e-56
 Identities = 88/206 (42%), Positives = 124/206 (60%), Gaps = 15/206 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDF 58
           D + G  VALKKL      +   K  F     RE+ +L   +H N+++  +++   +LD 
Sbjct: 26  DKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK 80

Query: 59  FQEIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              IY++ E ++ DL  ++    Q      +K  + Q+L G+ +LH   ILHRD+K  NL
Sbjct: 81  ---IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL 137

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           L+N+  ILKICDFGLAR E   P K  TQ VVT +YRAPE+L+GA+ YS A+D+WSVGCI
Sbjct: 138 LLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196

Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
           FAELL ++ LF  +S + QL  I  L
Sbjct: 197 FAELLTKKPLFPGKSEIDQLNKIFKL 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  179 bits (457), Expect = 1e-56
 Identities = 87/201 (43%), Positives = 120/201 (59%), Gaps = 18/201 (8%)

Query: 4   DPRDGRRVALKK--LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           D   G  VALKK  L    + + S+    RE+ +L    H N++  LD++   H +   +
Sbjct: 20  DKLTGEIVALKKIRLETEDEGVPST--AIREISLLKELNHPNIVRLLDVV---HSE--NK 72

Query: 62  IYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +Y++ E L  DL K +       L    IK +LYQ+L+G+ Y HS R+LHRD+KP NLL+
Sbjct: 73  LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132

Query: 120 NSNCILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +    LK+ DFGLAR   V    P +  T EVVT +YRAPEIL+G+R YS  VD+WS+GC
Sbjct: 133 DREGALKLADFGLARAFGV----PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGC 188

Query: 177 IFAELLGRRILFQAQSPVQQL 197
           IFAE++ RR LF   S + QL
Sbjct: 189 IFAEMVNRRPLFPGDSEIDQL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  178 bits (453), Expect = 7e-56
 Identities = 87/209 (41%), Positives = 120/209 (57%), Gaps = 12/209 (5%)

Query: 2   VTDPRDGRRVALKKL--PNVFQSLVSSKRVFRE---LKMLCFFKHDNVLSALDILQPPHL 56
             D   GR VALKK+  P   + +  S    RE   LK L  F+H N++  LD+   P  
Sbjct: 18  ARDLNTGRFVALKKVRVPLSEEGIPLS--TLREIALLKQLESFEHPNIVRLLDVCHGPRT 75

Query: 57  DFFQEIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           D   ++ ++ E +  DL   +       L  + IK  + Q+LRG+ +LHS RI+HRD+KP
Sbjct: 76  DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKP 135

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+LV S+  +KI DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSV
Sbjct: 136 QNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSV 192

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLITDL 203
           GCIFAEL  RR LF+  S   QL  I D+
Sbjct: 193 GCIFAELFRRRPLFRGTSEADQLDKIFDV 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  178 bits (454), Expect = 1e-55
 Identities = 84/218 (38%), Positives = 124/218 (56%), Gaps = 26/218 (11%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKR------VFRELKMLCFFKHDNVLSALDIL---QPPHL 56
           + GR VALKK+      L+ +++        RE+K+L   KH NV+  +D+         
Sbjct: 31  KTGRVVALKKI------LMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84

Query: 57  DFFQEIYVITELLQSDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
                +Y++T  +  DL  ++ +P   LT   IK ++ Q+L G+ YLH   ILHRDIK  
Sbjct: 85  RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAA 144

Query: 116 NLLVNSNCILKICDFGLARV-EEPDPN---------KAMTQEVVTQYYRAPEILMGARHY 165
           N+L+++  ILKI DFGLAR  + P PN         +  T  VVT++YR PE+L+G R Y
Sbjct: 145 NILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204

Query: 166 SAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           + AVD+W +GC+FAE+  RR + Q +S + QL LI  L
Sbjct: 205 TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  175 bits (445), Expect = 4e-54
 Identities = 76/211 (36%), Positives = 131/211 (62%), Gaps = 15/211 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF----- 58
           D    +RVA+KK+  V     S K   RE+K++    HDN++   ++L P   D      
Sbjct: 26  DSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83

Query: 59  ----FQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
                  +Y++ E +++DL  ++     L+ +H ++F+YQ+LRGLKY+HSA +LHRD+KP
Sbjct: 84  SLTELNSVYIVQEYMETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKP 142

Query: 115 GNLLVNS-NCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDV 171
            N+ +N+ + +LKI DFGLAR+ +P  +    +++ +VT++YR+P +L+   +Y+ A+D+
Sbjct: 143 ANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202

Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
           W+ GCIFAE+L  + LF     ++Q+ LI +
Sbjct: 203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  169 bits (430), Expect = 6e-52
 Identities = 85/227 (37%), Positives = 122/227 (53%), Gaps = 34/227 (14%)

Query: 4   DPRDGRRVALKKLPNV-FQSLVSSKR-----------VFRELKMLCFFKHDNVLSALDIL 51
           D   G+ VA+KK+  +   + V+  R             RELK++   KH+N++  +D+ 
Sbjct: 30  DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV- 88

Query: 52  QPPHLDFFQE--IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
                 + +   I ++ +++ SDL K++     LT   +K  L QIL GL  LH    +H
Sbjct: 89  ------YVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMH 142

Query: 110 RDIKPGNLLVNSNCILKICDFGLAR-------------VEEPDPNKAMTQEVVTQYYRAP 156
           RD+ P N+ +NS  I KI DFGLAR              E     + MT +VVT +YRAP
Sbjct: 143 RDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAP 202

Query: 157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           E+LMGA  Y  AVD+WSVGCIFAELL  + LF  ++ + QLG I +L
Sbjct: 203 ELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Length = 335

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  165 bits (419), Expect = 2e-50
 Identities = 82/210 (39%), Positives = 119/210 (56%), Gaps = 23/210 (10%)

Query: 4   DPRDGRRVALKK---------LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP 54
           D   G  VALKK         +P      +SS    RE+ +L   +H N++   +++   
Sbjct: 28  DTTSGEIVALKKVRMDNERDGIP------ISS---LREITLLLNLRHPNIVELKEVVVGK 78

Query: 55  HLDFFQEIYVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           HLD    I+++ E  + DL  ++ + P   +   +K  + Q+LRGL+YLH   I+HRD+K
Sbjct: 79  HLD---SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLK 135

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
             NLL+     LKI DFGLAR     P K MT +VVT +YRAPE+L+G   Y+ A+D+W+
Sbjct: 136 VSNLLLTDKGCLKIADFGLARTYGL-PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWA 194

Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           VGCI AELL  + L   +S ++QL LI  L
Sbjct: 195 VGCILAELLAHKPLLPGKSEIEQLDLIIQL 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  163 bits (415), Expect = 3e-50
 Identities = 80/196 (40%), Positives = 116/196 (59%), Gaps = 8/196 (4%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           +   G  VALKK+    ++        RE+ +L    H N++  LD++         ++Y
Sbjct: 21  NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY 75

Query: 64  VITELLQSDLHKI--IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++ E L  DL K         +    IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+
Sbjct: 76  LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 135

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE+
Sbjct: 136 EGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Query: 182 LGRRILFQAQSPVQQL 197
           + RR LF   S + QL
Sbjct: 195 VTRRALFPGDSEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  162 bits (412), Expect = 9e-50
 Identities = 77/170 (45%), Positives = 109/170 (64%), Gaps = 9/170 (5%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH--I 88
           RE+ +L   +H N++   D++   H +  + +Y++ E L  DL K + S      +   I
Sbjct: 50  REISLLKEMQHGNIVRLQDVV---HSE--KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI 104

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQE 147
           K +LYQILRG+ Y HS R+LHRD+KP NLL++     LK+ DFGLAR     P +  T E
Sbjct: 105 KTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHE 163

Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           VVT +YRAPEIL+G+RHYS  VD+WSVGCIFAE++ ++ LF   S + +L
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL 213

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  162 bits (411), Expect = 1e-49
 Identities = 79/198 (39%), Positives = 122/198 (61%), Gaps = 15/198 (7%)

Query: 6   RDGRRVALKK--LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL-QPPHLDFFQEI 62
           + G+ VA+KK  L +  + + S+    RE+ +L   +H N++   D+L Q   L      
Sbjct: 23  KTGQIVAMKKIRLESEEEGVPST--AIREISLLKELQHPNIVCLQDVLMQESRL------ 74

Query: 63  YVITELLQSDLHKI---IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Y+I E L  DL K    +   Q++ ++ +K +LYQIL+G+ + HS R+LHRD+KP NLL+
Sbjct: 75  YLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           ++  ++K+ DFGLAR     P +  T EVVT +YRAPE+L+G+  YS  VD+WS+G IFA
Sbjct: 135 DNKGVIKLADFGLARAFGI-PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFA 193

Query: 180 ELLGRRILFQAQSPVQQL 197
           E+  ++ LF   S + QL
Sbjct: 194 EMATKKPLFHGDSEIDQL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  162 bits (411), Expect = 7e-49
 Identities = 86/192 (44%), Positives = 124/192 (64%), Gaps = 10/192 (5%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVIT 66
           G  VA+KKL   FQ+   +KR +REL +L    H N++S L++  P   L+ FQ++Y++ 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 67  ELLQSDLHKIIVSPQHLTSDH--IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           EL+ ++L ++I    H+  DH  +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C 
Sbjct: 106 ELMDANLCQVI----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 161

Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           LKI DFGLAR      N  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  EL+  
Sbjct: 162 LKILDFGLARTAC--TNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKG 218

Query: 185 RILFQAQSPVQQ 196
            ++FQ    + Q
Sbjct: 219 SVIFQGTDHIDQ 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 1e-48
 Identities = 73/197 (37%), Positives = 114/197 (57%), Gaps = 12/197 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ---EIYV 64
           G  VA+KK           K   RE+K+L   +H+N+++  +         F+    +Y+
Sbjct: 26  GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE--------AFRRKGRLYL 77

Query: 65  ITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           + E ++  L +++  SP  L  D ++ +++Q+L+ + Y HS  I+HRDIKP N+LV+ + 
Sbjct: 78  VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG 137

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +LK+CDFG AR     P   +T  V T++YRAPE+L+G  +Y   VDVW++GCI AELL 
Sbjct: 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197

Query: 184 RRILFQAQSPVQQLGLI 200
              LF   S + QL LI
Sbjct: 198 GEPLFPGDSDIDQLYLI 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  158 bits (400), Expect = 3e-47
 Identities = 80/189 (42%), Positives = 120/189 (63%), Gaps = 6/189 (3%)

Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167

Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224

Query: 188 FQAQSPVQQ 196
           F     + Q
Sbjct: 225 FPGTDHIDQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  157 bits (397), Expect = 7e-47
 Identities = 82/189 (43%), Positives = 123/189 (65%), Gaps = 6/189 (3%)

Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 103 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160

Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 161 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 217

Query: 188 FQAQSPVQQ 196
           F  +  + Q
Sbjct: 218 FPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  150 bits (382), Expect = 5e-46
 Identities = 59/183 (32%), Positives = 99/183 (54%), Gaps = 10/183 (5%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D + G++VA+K +     S    + + RE+++L    H N++    + +         
Sbjct: 12  ARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NH 65

Query: 62  IYVITELLQS-DLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +Y++ E  +   L  ++      L+ D I   L QIL GL+YLHS  I+HRD+KP N+L+
Sbjct: 66  LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL 125

Query: 120 NSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           +S+   +K+ DFGL+++   D +  +   V T  Y APE+L+G  +YS   D+WS+G I 
Sbjct: 126 DSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVIL 184

Query: 179 AEL 181
            EL
Sbjct: 185 YEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  151 bits (384), Expect = 3e-45
 Identities = 74/209 (35%), Positives = 113/209 (54%), Gaps = 19/209 (9%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDI---LQPPHLDFF 59
            + VALKK+      + + K  F     RE+K+L   KH+NV++ ++I      P+  + 
Sbjct: 37  KQIVALKKV-----LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91

Query: 60  QEIYVITELLQSDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
              Y++ E  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K  N+L
Sbjct: 92  GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANIL 151

Query: 119 VNSNCILKICDFGLARV----EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           +  + ILK+ DFGLAR     +   PN+  T  VVT +YR PE+L+G R Y   +D+W  
Sbjct: 152 ITKDGILKLADFGLARAFSLSKNSKPNR-YTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLITDL 203
           GCI AE+  R  + Q  +   QL LI+ L
Sbjct: 211 GCIMAEMWTRSPIMQGNTEQHQLTLISQL 239

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 2e-44
 Identities = 77/200 (38%), Positives = 114/200 (57%), Gaps = 19/200 (9%)

Query: 4   DPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ-E 61
           + +DG+  A+KK   +  Q    S+   RE+ +L   KH+NV+S    L    L+     
Sbjct: 23  NGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS----LVEVFLEHADKS 78

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHI-----KVFLYQILRGLKYLHSARILHRDIKPGN 116
           +Y++ +  + DL +II   +      I     K  L+QIL G+ YLHS  +LHRD+KP N
Sbjct: 79  VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPAN 138

Query: 117 LLVNSNC----ILKICDFGLARVEEPDPNKAMTQE---VVTQYYRAPEILMGARHYSAAV 169
           +LV        ++KI D GLAR+    P K +      VVT +YRAPE+L+GARHY+ A+
Sbjct: 139 ILVMGEGPERGVVKIGDLGLARLFNA-PLKPLADLDPVVVTIWYRAPELLLGARHYTKAI 197

Query: 170 DVWSVGCIFAELLGRRILFQ 189
           D+W++GCIFAELL    +F+
Sbjct: 198 DIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  148 bits (376), Expect = 3e-44
 Identities = 78/201 (38%), Positives = 112/201 (55%), Gaps = 8/201 (3%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN-VLSALDILQPPHLDFFQEI 62
           D   G+ VALKK               RE+ +L        ++  LD+      +    +
Sbjct: 22  DKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81

Query: 63  YVITELLQSDLHKIIVS-----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           Y++ E L SDL K + S      + L +  IK F+YQ+L+G+ + H   ++HRD+KP NL
Sbjct: 82  YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNL 141

Query: 118 LVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           LV+    +LKI D GL R     P K+ T E+VT +YRAPE+L+G+ HYS  VD+WSVGC
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI-PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 177 IFAELLGRRILFQAQSPVQQL 197
           IFAE+  ++ LF   S +QQL
Sbjct: 201 IFAEMSRKQPLFPGDSELQQL 221

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  144 bits (365), Expect = 1e-42
 Identities = 71/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVIT 66
           G  VA+KK+   F S      + RE+K L     H N++   ++ +        E+Y + 
Sbjct: 24  GELVAIKKMKKKFYSWEECMNL-REVKSLRKLNEHPNIVKLKEVFRE-----NDELYFVF 77

Query: 67  ELLQSDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           E ++ +L++++     +  +   I+  +YQIL+GL ++H     HRD+KP NLLV+   +
Sbjct: 78  EYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV 137

Query: 125 LKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +KI DFGLAR +    P    T  V T++YRAPEIL+ +  YS+ VD+W++GCI AEL  
Sbjct: 138 VKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Query: 184 RRILFQAQSPVQQLGLIT 201
            R LF   S + QL  I 
Sbjct: 195 LRPLFPGSSEIDQLYKIC 212

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  144 bits (366), Expect = 1e-42
 Identities = 81/211 (38%), Positives = 121/211 (57%), Gaps = 16/211 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDIL--QPPHL 56
           D   G  VALKK+      L + K  F     RE+K+L    H N+++  +I+  +   L
Sbjct: 28  DKDTGELVALKKV-----RLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82

Query: 57  DFFQE---IYVITELLQSDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           DF ++    Y++ E +  DL  ++ S   H + DHIK F+ Q+L GL Y H    LHRDI
Sbjct: 83  DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDI 142

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           K  N+L+N+   +K+ DFGLAR+   + ++  T +V+T +YR PE+L+G   Y  A+DVW
Sbjct: 143 KCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVW 202

Query: 173 SVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           S GCI  EL  ++ +FQA   + QL LI+ L
Sbjct: 203 SCGCILGELFTKKPIFQANQELAQLELISRL 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 9e-42
 Identities = 69/172 (40%), Positives = 107/172 (62%), Gaps = 8/172 (4%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-PQHLTSDHIK 89
           RE  +L   KH N+++  DI+   H    + + ++ E L +DL + +      L+  +++
Sbjct: 52  REASLLKDLKHANIVTLHDII---HTK--KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVR 106

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +FL+Q+LRGL Y H  R+LHRD+KP NLL++    LK+ DFGLAR +   P+K  + EVV
Sbjct: 107 LFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PSKTYSNEVV 165

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ-QLGLI 200
           T +YR P++L+G+  YS ++D+W VGCIF E+   R LF   + V+ QL  I
Sbjct: 166 TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  140 bits (355), Expect = 3e-41
 Identities = 70/198 (35%), Positives = 110/198 (55%), Gaps = 13/198 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP---HLDF-FQEIY 63
           G+ VA+KK        V  K   RE++ML   KH N+++ +++ +     HL F + +  
Sbjct: 26  GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85

Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ EL   + +     P+ +    IK  ++Q L+ + + H    +HRD+KP N+L+    
Sbjct: 86  VLNEL---EKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG 137

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+CDFG AR+    P    T  V T++YRAPE+L+G   Y   VDVW++GC+FAELL 
Sbjct: 138 QIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Query: 184 RRILFQAQSPVQQLGLIT 201
            + L+  +S V QL LI 
Sbjct: 197 GQPLWPGKSDVDQLYLIR 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  138 bits (350), Expect = 2e-40
 Identities = 71/198 (35%), Positives = 114/198 (57%), Gaps = 13/198 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK        +  K   RE++ML   +H+N+++ +++ +       + +Y++ E
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLYLVFE 80

Query: 68  LLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
            +      DL K    P  L    ++ +L+QILRG+++ HS  I+HRDIKP N+LV+ + 
Sbjct: 81  FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG 137

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           ++K+CDFG AR     P +  T  V T++YRAPE+L+G   Y  AVD+W+VGC+  E+L 
Sbjct: 138 VVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196

Query: 184 RRILFQAQSPVQQLGLIT 201
              LF   S + QL  I 
Sbjct: 197 GEPLFPGDSDIDQLYHII 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  137 bits (346), Expect = 1e-39
 Identities = 74/174 (42%), Positives = 107/174 (61%), Gaps = 7/174 (4%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH-IK 89
           RE+ +L   KH N+++  DI+   H D  + + ++ E L  DL + +    ++ S H +K
Sbjct: 53  REVSLLKDLKHANIVTLHDIV---HTD--KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVK 107

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +FLYQILRGL Y H  ++LHRD+KP NLL+N    LK+ DFGLAR +   P K  + EVV
Sbjct: 108 IFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV 166

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           T +YR P++L+G+  YS  +D+W VGCIF E+   R LF   +   +L LI  L
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  136 bits (344), Expect = 1e-39
 Identities = 66/176 (37%), Positives = 104/176 (59%), Gaps = 9/176 (5%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS---PQHLTSDH 87
           RE+ ++   KH+N++   D++         ++ ++ E +  DL K + +      L  + 
Sbjct: 47  REISLMKELKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVRGALDPNT 101

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
           +K F YQ+L+G+ + H  R+LHRD+KP NLL+N    LK+ DFGLAR      N   + E
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNE 160

Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           VVT +YRAP++L+G+R YS ++D+WSVGCI AE++  R LF   +   QL  I  +
Sbjct: 161 VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  136 bits (344), Expect = 1e-39
 Identities = 77/198 (38%), Positives = 108/198 (54%), Gaps = 12/198 (6%)

Query: 7   DGRRVALKK--LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
               VALK+  L +  + + SS    RE+ +L   KH N++   D+L         ++ +
Sbjct: 24  THEIVALKRVRLDDDDEGVPSS--ALREICLLKELKHKNIVRLYDVLHSDK-----KLTL 76

Query: 65  ITELLQSDLHKIIVSPQHLTSDHI-KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           + E    DL K   S        I K F++Q+L+GL + HS  +LHRD+KP NLL+N N 
Sbjct: 77  VFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG 136

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL- 182
            LK+ DFGLAR     P +  + EVVT +YR P++L GA+ YS ++D+WS GCIFAEL  
Sbjct: 137 ELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 195

Query: 183 GRRILFQAQSPVQQLGLI 200
             R LF       QL  I
Sbjct: 196 AGRPLFPGNDVDDQLKRI 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  135 bits (341), Expect = 3e-39
 Identities = 71/174 (40%), Positives = 109/174 (62%), Gaps = 7/174 (4%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH-IK 89
           RE+ +L   KH N+++  DI+   H +  + + ++ E L SDL + + +  +L S H +K
Sbjct: 52  REVSLLKNLKHANIVTLHDII---HTE--RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVK 106

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +F++Q+LRGL Y H  +ILHRD+KP NLL+N    LK+ DFGLAR +   P K  + EVV
Sbjct: 107 IFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV 165

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           T +YR P++L+G+  YS  +D+W VGCI  E+   R +F   +  ++L LI  L
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  135 bits (341), Expect = 3e-39
 Identities = 83/205 (40%), Positives = 117/205 (57%), Gaps = 8/205 (3%)

Query: 4   DPRDGRRVALK--KLPNVFQSL-VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           DP  G  VALK  ++      L +S+ R    LK L  F H N++  +D+      D   
Sbjct: 21  DPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80

Query: 61  EIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           ++ ++ E +  DL   +  V P  L ++ IK  + Q LRGL +LH+  I+HRD+KP N+L
Sbjct: 81  KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 140

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V S   +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCIF
Sbjct: 141 VTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 197

Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AE+  R+ LF   S   QLG I DL
Sbjct: 198 AEMFRRKPLFCGNSEADQLGKIFDL 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  133 bits (335), Expect = 4e-38
 Identities = 69/171 (40%), Positives = 103/171 (60%), Gaps = 7/171 (4%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH-IK 89
           RE+ +L   KH N+++  DI+        + + ++ E L  DL + +    +  + H +K
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVK 107

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +FL+Q+LRGL Y H  ++LHRD+KP NLL+N    LK+ DFGLAR +   P K  + EVV
Sbjct: 108 LFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV 166

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           T +YR P+IL+G+  YS  +D+W VGCIF E+   R LF   +  +QL  I
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (332), Expect = 6e-38
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
            D   G  +A+K +     S    + + RE+++L   +H N++      +    +    +
Sbjct: 20  LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT---L 76

Query: 63  YVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            +  E      L S L K       L    I+ +  QIL GL YLHS  I+HRDIK  N+
Sbjct: 77  NIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGC 176
           LV+S+ ++K+ DFG A+          T  V  T Y+ APE++ G   Y  A D+WS+GC
Sbjct: 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGC 191

Query: 177 IFAELL-GRRILFQAQSPVQ 195
              E+  G+    +  +P+ 
Sbjct: 192 TVIEMATGKPPWSELGNPMA 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  129 bits (326), Expect = 6e-37
 Identities = 80/201 (39%), Positives = 120/201 (59%), Gaps = 8/201 (3%)

Query: 8   GRRVALKKLPNVFQSL---VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           GR VALK++          +S+ R    L+ L  F+H NV+   D+      D   ++ +
Sbjct: 27  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86

Query: 65  ITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           + E +  DL   +  V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+LV S+
Sbjct: 87  VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 146

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCIFAE+ 
Sbjct: 147 GQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMF 203

Query: 183 GRRILFQAQSPVQQLGLITDL 203
            R+ LF+  S V QLG I D+
Sbjct: 204 RRKPLFRGSSDVDQLGKILDV 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  128 bits (322), Expect = 3e-36
 Identities = 69/168 (41%), Positives = 102/168 (60%), Gaps = 6/168 (3%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE  +L   KH N++   DI+       F   Y+ T+L Q     +I  P  L   ++++
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQY----MIQHPGGLHPYNVRL 107

Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           F++Q+LRGL Y+H   ILHRD+KP NLL++    LK+ DFGLAR +   P++  + EVVT
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVT 166

Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV-QQL 197
            +YR P++L+GA  YS+A+D+W  GCIF E+L  +  F   S V +QL
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  127 bits (319), Expect = 7e-36
 Identities = 65/188 (34%), Positives = 112/188 (59%), Gaps = 7/188 (3%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+KK  +  ++    +   RELKML   K +N++   +  +        ++Y++ E ++
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLYLVFEYVE 83

Query: 71  SDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
            ++ +++   P  +  + ++ ++YQ+++ + + H   I+HRDIKP NLL++ N +LK+CD
Sbjct: 84  KNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCD 143

Query: 130 FGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQ 189
           FG AR      N   T+ V T++YR+PE+L+GA  Y  AVD+WSVGCI  EL   + LF 
Sbjct: 144 FGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFP 202

Query: 190 AQSPVQQL 197
            +S + QL
Sbjct: 203 GESEIDQL 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (310), Expect = 8e-35
 Identities = 54/184 (29%), Positives = 92/184 (50%), Gaps = 14/184 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
               R G+ VA+K +    +S    +++  E+++L   KH N++               E
Sbjct: 19  ARHKRTGKEVAIKVIK--LESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----E 71

Query: 62  IYVITELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++++ E     S    +  + Q LT   I     ++L+GL+YLHS  I+HRDIK  N+L+
Sbjct: 72  LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL 131

Query: 120 NSNCILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
            S+  +K+ DFGL+ ++ +      M   V T Y+ APE++ G + Y    D+WS+G   
Sbjct: 132 TSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVING-KPYDYKADIWSLGITA 187

Query: 179 AELL 182
            EL 
Sbjct: 188 IELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  122 bits (310), Expect = 1e-34
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V    DG+   LK++     S    +    E+K+L    H N++         + + F+E
Sbjct: 19  VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--------YYESFEE 70

Query: 62  ---IYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
              + ++ E      L   + K     +    + I  +  Q+   LKYLHS +ILHRDIK
Sbjct: 71  KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK 130

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           P N+ + SN ++K+ DFG+++V     + A T  V T YY +PE+      Y+   D+WS
Sbjct: 131 PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKP-YNYKSDIWS 188

Query: 174 VGCIFAELLGRRILFQAQSP 193
           +GC+  EL   +  F+ ++ 
Sbjct: 189 LGCVLYELCTLKHPFEGENL 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  122 bits (308), Expect = 4e-34
 Identities = 67/166 (40%), Positives = 96/166 (57%), Gaps = 7/166 (4%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIK 89
           RE  +L   KH N++   DI+           YV T+L Q  D H     P  L  +++K
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH-----PGGLHPENVK 106

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +FL+Q+LRGL Y+H   ILHRD+KP NLL++    LK+ DFGLAR +   P+   + EVV
Sbjct: 107 LFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV 165

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           T +YR P++L+G+  YS  +D+W VGCIF E++     F     +Q
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  119 bits (300), Expect = 4e-33
 Identities = 63/203 (31%), Positives = 112/203 (55%), Gaps = 15/203 (7%)

Query: 6   RDGRRVALKKLPNVFQSL--VSSKRVFRELKMLCFFKHDNVLSALDIL-QPPHLDFFQEI 62
           + G+  A+K +   F+SL  V++ R  + L+ L    H N+L  +++L           +
Sbjct: 22  KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLS--PHPNILRLIEVLFDRKT----GRL 75

Query: 63  YVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            ++ EL+  +L+++I    + L    +K ++YQ+L+ L ++H   I HRDIKP N+L+  
Sbjct: 76  ALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135

Query: 122 NCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           +  LK+ DFG  R +    P    T+ + T++YRAPE L+   +Y   +D+W+VGC+F E
Sbjct: 136 DI-LKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFE 191

Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           +L    LF   + + Q+  I D+
Sbjct: 192 ILSLFPLFPGTNELDQIAKIHDV 214

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  116 bits (292), Expect = 1e-31
 Identities = 76/203 (37%), Positives = 113/203 (55%), Gaps = 22/203 (10%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D +D +  ALK++     S+ +     RE+ +L   KH NV+ AL  +   H D  ++++
Sbjct: 24  DGKDEKEYALKQIEGTGISMSAC----REIALLRELKHPNVI-ALQKVFLSHSD--RKVW 76

Query: 64  VITELLQSDLHKIIV---------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           ++ +  + DL  II           P  L    +K  LYQIL G+ YLH+  +LHRD+KP
Sbjct: 77  LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKP 136

Query: 115 GNLLVNSNCI----LKICDFGLARV-EEP-DPNKAMTQEVVTQYYRAPEILMGARHYSAA 168
            N+LV         +KI D G AR+   P  P   +   VVT +YRAPE+L+GARHY+ A
Sbjct: 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 196

Query: 169 VDVWSVGCIFAELLGRRILFQAQ 191
           +D+W++GCIFAELL    +F  +
Sbjct: 197 IDIWAIGCIFAELLTSEPIFHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  116 bits (292), Expect = 1e-31
 Identities = 76/203 (37%), Positives = 112/203 (55%), Gaps = 22/203 (10%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D +D R  ALK++     S+ +     RE+ +L   KH NV+S   +    H D  ++++
Sbjct: 24  DGKDDRDYALKQIEGTGISMSAC----REIALLRELKHPNVISLQKVFLS-HAD--RKVW 76

Query: 64  VITELLQSDLHKIIV---------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           ++ +  + DL  II           P  L    +K  LYQIL G+ YLH+  +LHRD+KP
Sbjct: 77  LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 136

Query: 115 GNLLVNSNCI----LKICDFGLARV-EEP-DPNKAMTQEVVTQYYRAPEILMGARHYSAA 168
            N+LV         +KI D G AR+   P  P   +   VVT +YRAPE+L+GARHY+ A
Sbjct: 137 ANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA 196

Query: 169 VDVWSVGCIFAELLGRRILFQAQ 191
           +D+W++GCIFAELL    +F  +
Sbjct: 197 IDIWAIGCIFAELLTSEPIFHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  108 bits (269), Expect = 4e-28
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 9/201 (4%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSS-KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           V   RD + VALK L    +S     +R  RE+++L    H   +  L          + 
Sbjct: 16  VYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYL 75

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            +  +      DL K I     L+       L QIL  L+YLHS  I+HRDIKP N+L++
Sbjct: 76  VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD 135

Query: 121 SN-CILKICDFGLARV-----EEPDPNKAMTQEVVTQYYRAPEILMG--ARHYSAAVDVW 172
            +  ++K+ DFGLA++              +  V T  Y APE+L+G    + S++ D+W
Sbjct: 136 RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIW 195

Query: 173 SVGCIFAELLGRRILFQAQSP 193
           S+G    ELL     F+ +  
Sbjct: 196 SLGITLYELLTGLPPFEGEKN 216

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (264), Expect = 7e-28
 Identities = 61/186 (32%), Positives = 90/186 (48%), Gaps = 16/186 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V     G+  ALKK+ +V       K++ RELK L   +   V+         +  F++E
Sbjct: 20  VRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKC-------YGAFYKE 71

Query: 62  --IYVITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNL 117
             I ++ E +    L  ++     +    +     QIL+GL YLH+ R I+HRDIKP NL
Sbjct: 72  GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNL 131

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGC 176
           L+NS   +KI DFG+++V E           V T  Y +PE + G   YS A D+WS+G 
Sbjct: 132 LINSKGEVKIADFGISKVLE--NTLDQCNTFVGTVTYMSPERIQG-ESYSYAADIWSLGL 188

Query: 177 IFAELL 182
              E  
Sbjct: 189 TLLECA 194

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  105 bits (264), Expect = 7e-28
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 15/184 (8%)

Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G   A+K +            +V  E  +L   +   V+      Q         +Y++ 
Sbjct: 18  GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK-----NLYLVM 72

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           E L   DL  ++ +   L  D  ++++ +I+  L+YLHS  I+HRD+KP N+L++SN  L
Sbjct: 73  EYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132

Query: 126 KICDFGLARV-------EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           K+ DFGL++V          D  K   + V T  Y APE+++G + +S  VD WS+GCI 
Sbjct: 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCIL 191

Query: 179 AELL 182
            E L
Sbjct: 192 YEFL 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  104 bits (263), Expect = 8e-28
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 13/176 (7%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVITEL 68
           VA+K L     S    +   RE +++    H NV+  L +   + P        Y++ E 
Sbjct: 31  VAVKTLKED-ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPL-------YIVMEY 82

Query: 69  LQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           ++  DL   +   +  L+   +  F  QI RG++YL S   +HRD+   N LV  N ++K
Sbjct: 83  MEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK 142

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL+R    D         +   + APE L     +++  DVWS G +  E+ 
Sbjct: 143 ISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (262), Expect = 1e-27
 Identities = 54/196 (27%), Positives = 96/196 (48%), Gaps = 13/196 (6%)

Query: 7   DGRRVALKK---LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           DG   A+K+     +      + K++ +E+ +L   +H N++  L   +         +Y
Sbjct: 24  DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----DNLY 78

Query: 64  VITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +  EL+    L K++          I+++  QIL GL+YLH    +HRDIK  N+LV++N
Sbjct: 79  IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138

Query: 123 CILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++K+ DFG+A+ V E    K+      + Y+ APE++     Y  A D+WS+GC   E+
Sbjct: 139 GVVKLADFGMAKQVVEFSFAKSF---KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Query: 182 LGRRILFQAQSPVQQL 197
              +  +     V  +
Sbjct: 196 ATGKPPWSQLEGVAAV 211

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  103 bits (260), Expect = 2e-27
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 12/176 (6%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSAL-DILQPPHLDFFQEIYVITELL 69
           VA+K L     S    +   RE +++    H N++  L    +       + + ++ E +
Sbjct: 31  VAVKTLKED-ASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE------EPLMIVMEYM 83

Query: 70  QS-DLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
              DL   +   +   L+   +  F  QI RG++YL S   +HRD+   N LV  N ++K
Sbjct: 84  PGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVK 143

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL+R    D    +    +   + APE L     +++  DVWS G +  E+ 
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  103 bits (257), Expect = 5e-26
 Identities = 55/143 (38%), Positives = 84/143 (58%), Gaps = 15/143 (10%)

Query: 64  VITELLQSDLHKIIV----SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           V+ E +   +HK +     +   L    +K++ YQ+ R L Y+HS  I HRD+KP NLL+
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI 203

Query: 120 NSNC-ILKICDFGLARVEEPDPNKAMTQEVVT----QYYRAPEILMGARHYSAAVDVWSV 174
           + N   LK+CDFG A+      N    Q  V+    ++YRAPE+++GA +Y+  +D+WS+
Sbjct: 204 DPNTHTLKLCDFGSAK------NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSL 257

Query: 175 GCIFAELLGRRILFQAQSPVQQL 197
           GCI AE++    +F  QS V QL
Sbjct: 258 GCIIAEMILGYPIFSGQSSVDQL 280

Length = 440

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 99.6 bits (249), Expect = 1e-25
 Identities = 55/183 (30%), Positives = 95/183 (51%), Gaps = 14/183 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE-- 61
           +   G  VA+K++        + K + +E+ +L   KH N++         ++   +   
Sbjct: 21  NLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV--------KYIGSIETSD 72

Query: 62  -IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            +Y+I E  ++  L +II          + V++YQ+L+GL YLH   ++HRDIK  N+L 
Sbjct: 73  SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             + ++K+ DFG+A  +  D +K     V T Y+ APE++  +   S A D+WS+GC   
Sbjct: 133 TKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVI 190

Query: 180 ELL 182
           ELL
Sbjct: 191 ELL 193

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 97.7 bits (244), Expect = 6e-25
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 37/211 (17%)

Query: 6   RDGRRVALKKL------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDF 58
            DG+ +  K++          Q LVS   + RELK      H N++   D I+   +   
Sbjct: 23  SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK------HPNIVRYYDRIIDRSN--- 73

Query: 59  FQEIYVITELLQS-DLHKIIVSPQHLTSDH--------IKVFLYQILRGLKYLH-----S 104
            Q +Y++ E  +  DL ++I   Q    +          ++   Q+L  L   H      
Sbjct: 74  -QTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEEFIWRILT-QLLLALYECHNRSDPG 128

Query: 105 ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH 164
             +LHRD+KP N+ +++N  +K+ DFGLA++   D + A T  V T YY +PE L     
Sbjct: 129 NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYYMSPEQLNHMS- 186

Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           Y    D+WS+GC+  EL      F A++ +Q
Sbjct: 187 YDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.3 bits (240), Expect = 2e-24
 Identities = 56/186 (30%), Positives = 93/186 (50%), Gaps = 12/186 (6%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVI 65
            G  +A+K++        + K +  E+K+L   KH N++    + +    +  F E Y  
Sbjct: 24  TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME-YCS 82

Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
              L+  L    +  +H+    I+V+  Q+L GL YLHS  I+HRDIKP N+ ++ N ++
Sbjct: 83  GGTLEELLEHGRILDEHV----IRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVI 138

Query: 126 KICDFGLAR--VEEPDPNKAMTQEVV-TQYYRAPEILMGAR--HYSAAVDVWSVGCIFAE 180
           K+ DFG A              Q +  T  Y APE++ G +   +  A D+WS+GC+  E
Sbjct: 139 KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE 198

Query: 181 LL-GRR 185
           +  G+R
Sbjct: 199 MATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.0 bits (240), Expect = 2e-24
 Identities = 49/184 (26%), Positives = 76/184 (41%), Gaps = 34/184 (18%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVI 65
              +VA+K L          +    E  ++    H N++  L +  Q       + +Y++
Sbjct: 27  TETKVAVKTLKEGASE-EEREEFLEEASIMKKLSHPNIVRLLGVCTQG------EPLYIV 79

Query: 66  TELLQS-DLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           TE +   DL   +    + LT   +     QI +G++YL S   +HRD+   N LV  N 
Sbjct: 80  TEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENL 139

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDV 171
           ++KI DFGL+R    D            YYR            APE L     +++  DV
Sbjct: 140 VVKISDFGLSRDIYEDD-----------YYRKRGGGKLPIKWMAPESLK-DGKFTSKSDV 187

Query: 172 WSVG 175
           WS G
Sbjct: 188 WSFG 191

Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 2e-24
 Identities = 41/128 (32%), Positives = 72/128 (56%), Gaps = 6/128 (4%)

Query: 59  FQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ    +Y++ E     +L   +      + +  + +  +I+  L+YLHS  I++RD+KP
Sbjct: 62  FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+L++++  +K+ DFGLA+    + ++  T    T  Y APE+L+G   Y  AVD WS+
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTF-CGTPEYLAPEVLLGKG-YGKAVDWWSL 179

Query: 175 GCIFAELL 182
           G +  E+L
Sbjct: 180 GVLLYEML 187

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 95.0 bits (237), Expect = 5e-24
 Identities = 40/105 (38%), Positives = 60/105 (57%), Gaps = 4/105 (3%)

Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           SD+ KI      LT + I   LYQ L+GL+YLHS + +HRDIK GN+L+N     K+ DF
Sbjct: 86  SDIMKITNKT--LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADF 143

Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           G++     D        + T ++ APE++    + + A D+WS+G
Sbjct: 144 GVSGQLT-DTMAKRNTVIGTPFWMAPEVIQEIGYNNKA-DIWSLG 186

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 93.7 bits (233), Expect = 2e-23
 Identities = 48/168 (28%), Positives = 91/168 (54%), Gaps = 16/168 (9%)

Query: 32  ELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD---LHKIIV--SPQHLTSD 86
           E+ +L   +H N+++  +        F  +  ++ E+  ++   L+  IV    Q    +
Sbjct: 49  EIVILSLLQHPNIIAYYN-------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEE 101

Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
            +  +L+QI+  + Y+H A ILHRDIK  N+ +    ++K+ DFG++++   +   +M +
Sbjct: 102 MVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE--YSMAE 159

Query: 147 EVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
            VV T YY +PE+  G + Y+   D+W++GC+  ELL  +  F A +P
Sbjct: 160 TVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNP 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.9 bits (231), Expect = 3e-23
 Identities = 48/126 (38%), Positives = 72/126 (57%), Gaps = 8/126 (6%)

Query: 71  SDLHKIIVSPQH----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            DL K I   +     +    I     Q+LRGL+ LH  +ILHRD+K  N+L+ +N ++K
Sbjct: 84  GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVK 143

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I D G+++V +   N A TQ + T +Y APE+  G R YS   D+WS+GC+  E+     
Sbjct: 144 IGDLGISKVLK--KNMAKTQ-IGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAP 199

Query: 187 LFQAQS 192
            F+A+S
Sbjct: 200 PFEARS 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.4 bits (233), Expect = 4e-23
 Identities = 51/188 (27%), Positives = 96/188 (51%), Gaps = 24/188 (12%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD--ILQPPHLDFFQ 60
           TD   G+ VA+KK+    Q+    + +  E+ ++   KH N++   D  ++         
Sbjct: 39  TDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIVDYYDSYLVG-------D 88

Query: 61  EIYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           E++V+ E +      D+  I  +   +    I     ++L+GL+YLHS  ++HRDIK  N
Sbjct: 89  ELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN 146

Query: 117 LLVNSNCILKICDFGL-ARVEEPDPN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           +L++ +  +K+ DFG  A++ +      ++   V T Y+ APE ++  + Y   VD+WS+
Sbjct: 147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSV---VGTPYWMAPE-VIKRKDYGPKVDIWSL 202

Query: 175 GCIFAELL 182
           G +  E+ 
Sbjct: 203 GIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.4 bits (227), Expect = 1e-22
 Identities = 54/185 (29%), Positives = 94/185 (50%), Gaps = 12/185 (6%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFR---ELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           D   GR +A+K++P    S  + K V     E+++L   +H+ ++     L+       +
Sbjct: 23  DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----E 77

Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + +  E +    +   + +   LT    + +  QIL G++YLHS  I+HRDIK  N+L 
Sbjct: 78  TLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR 137

Query: 120 NSNCILKICDFGLA-RVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +S   +K+ DFG + R++    +    + V  T Y+ +PE++ G  +   A DVWSVGC 
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA-DVWSVGCT 196

Query: 178 FAELL 182
             E+L
Sbjct: 197 VVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.2 bits (227), Expect = 1e-22
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 24/170 (14%)

Query: 25  SSKRVFRELKMLCFFKHD---NVLSALDILQPPHLDFFQE---IYVITELLQS-DLHKII 77
           S + V  E ++L    H    N+  +           FQ+   +Y++ +LL   DL   +
Sbjct: 43  SVRNVLNERRILQELNHPFLVNLWYS-----------FQDEENMYLVVDLLLGGDLRYHL 91

Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEE 137
                 + + +K ++ +I+  L+YLHS  I+HRDIKP N+L++    + I DF +A    
Sbjct: 92  SQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151

Query: 138 PDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL-GRR 185
           PD    +T     T  Y APE+L   + YS AVD WS+G    E L G+R
Sbjct: 152 PD---TLTTSTSGTPGYMAPEVLC-RQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 90.6 bits (225), Expect = 3e-22
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 25/187 (13%)

Query: 7   DGRRVALKKLPNVFQSLVSSKR--VFRELKMLCFFKHDNVLSALDILQPPHLDFFQ--EI 62
           DGR VALKK+  +F+ + +  R    +E+ +L    H NV+  L         F +  E+
Sbjct: 26  DGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA-------SFIENNEL 77

Query: 63  YVITELLQS-DLHKIIVSPQHLTSDH-------IKVFLYQILRGLKYLHSARILHRDIKP 114
            ++ EL  + DL ++I   +H            I  +  Q+   L+++HS RI+HRDIKP
Sbjct: 78  NIVLELADAGDLSRMI---KHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKP 134

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+ + +  ++K+ D GL R        A +  V T YY +PE +     Y+   D+WS+
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHEN-GYNFKSDIWSL 192

Query: 175 GCIFAEL 181
           GC+  E+
Sbjct: 193 GCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 90.5 bits (225), Expect = 3e-22
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 17/183 (9%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--QEIYVI 65
             +VA+K++ ++ +   S   + +E++ +    H NV+         +  F    E++++
Sbjct: 26  NEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVKY-------YTSFVVGDELWLV 77

Query: 66  TELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
              L      D+ K       L    I   L ++L+GL+YLHS   +HRDIK GN+L+  
Sbjct: 78  MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137

Query: 122 NCILKICDFGL-ARVEEP--DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           +  +KI DFG+ A + +      K     V T  + APE++     Y    D+WS G   
Sbjct: 138 DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197

Query: 179 AEL 181
            EL
Sbjct: 198 IEL 200

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 90.2 bits (224), Expect = 4e-22
 Identities = 45/104 (43%), Positives = 66/104 (63%), Gaps = 9/104 (8%)

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR----VEEPDPNKA 143
           ++ F  Q+L GL YLHS  ILHRD+K  NLLV+++ I KI DFG+++    + + D N +
Sbjct: 110 VRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS 169

Query: 144 MTQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELL-GRR 185
           M   V   ++ APE++      YSA VD+WS+GC+  E+  GRR
Sbjct: 170 MQGSV---FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 89.5 bits (222), Expect = 7e-22
 Identities = 55/192 (28%), Positives = 94/192 (48%), Gaps = 16/192 (8%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF---QEIY 63
           D R  A+K++     +    +    E ++L       ++         + + F    ++ 
Sbjct: 24  DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR--------YYESFLDKGKLN 75

Query: 64  VITELLQS-DLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++ E  ++ DLHK++     + L  D +  F  QIL GL +LHS +ILHRDIK  NL ++
Sbjct: 76  IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           +   +KI D G+A++   + N A T  V T YY +PE L   + Y+   DVW++G +  E
Sbjct: 136 AYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYE 193

Query: 181 LLGRRILFQAQS 192
               +  F A +
Sbjct: 194 CCTGKHPFDANN 205

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 89.1 bits (221), Expect = 1e-21
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSAL-DILQPPHLDFF 59
           A  D     R+A+K++P   +     + +  E+ +  + KH N++  L    +      F
Sbjct: 26  AARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            E      L  S L +    P       I  +  QIL GLKYLH  +I+HRDIK  N+LV
Sbjct: 84  MEQVPGGSL--SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141

Query: 120 NS-NCILKICDFG----LARVEEPDPNKAMTQEVVTQYYRAPEIL-MGARHYSAAVDVWS 173
           N+ + ++KI DFG    LA +     N        T  Y APE++  G R Y A  D+WS
Sbjct: 142 NTYSGVVKISDFGTSKRLAGI-----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWS 196

Query: 174 VGCIFAEL-LGRRILFQAQSP 193
           +GC   E+  G+    +   P
Sbjct: 197 LGCTIVEMATGKPPFIELGEP 217

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 88.7 bits (221), Expect = 1e-21
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 26/183 (14%)

Query: 9   RRVALKKLPNVFQSLVSSKRV--FRELKMLCFFKHDNVLSALD--ILQPPHLDFFQEIYV 64
             VA+K L          +R    +E +++    H NV+  L     + P       +Y+
Sbjct: 24  TEVAVKTLKE---DASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-------LYL 73

Query: 65  ITE----------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           + E          L +S           L+   +  F  QI +G++YL S + +HRD+  
Sbjct: 74  VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAA 133

Query: 115 GNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
            N LV  + ++KI DFGL+R V + D  +  T   +   + APE L     +++  DVWS
Sbjct: 134 RNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWS 192

Query: 174 VGC 176
            G 
Sbjct: 193 FGV 195

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 3e-21
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 17/202 (8%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           ++   +   K      +    K++ REL++    K   ++                I + 
Sbjct: 23  KNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIA 79

Query: 66  TEL-----LQSDLHKIIVSPQHLTSDHI--KVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            E      L S ++K +        + +  K+    +L+GL YLHS +I+HRDIKP N+L
Sbjct: 80  MEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKI-AESVLKGLSYLHSRKIIHRDIKPSNIL 137

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           +     +K+CDFG++   E   + A T    T +Y APE + G + YS   DVWS+G   
Sbjct: 138 LTRKGQVKLCDFGVS--GELVNSLAGTF-TGTSFYMAPERIQG-KPYSITSDVWSLGLTL 193

Query: 179 AELLGRRILFQAQSPVQQLGLI 200
            E+   R  F  +     LG I
Sbjct: 194 LEVAQNRFPFPPEGE-PPLGPI 214

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 86.4 bits (214), Expect = 1e-20
 Identities = 44/133 (33%), Positives = 69/133 (51%), Gaps = 7/133 (5%)

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y++ E L   D   +I +   L  D  K ++ +++ G++ LH   I+HRDIKP NLL++
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               LK+ DFGL+R    +     T +     Y APE ++G        D WS+GC+  E
Sbjct: 132 QTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGD-DKMSDWWSLGCVIFE 185

Query: 181 LLGRRILFQAQSP 193
            L     F A++P
Sbjct: 186 FLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 6e-20
 Identities = 52/158 (32%), Positives = 87/158 (55%), Gaps = 12/158 (7%)

Query: 31  RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIK 89
           RE+ +L   +H+N++  L   L   HL+ F E YV    + + L+      + L    ++
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLE-YVPGGSVAALLNNYGAFEETL----VR 109

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-----NKAM 144
            F+ QIL+GL YLH+  I+HRDIK  N+LV++   +KI DFG+++  E +      N A 
Sbjct: 110 NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGAR 169

Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                + ++ APE++     Y+   D+WS+GC+  E+L
Sbjct: 170 PSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.8 bits (208), Expect = 8e-20
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 14/185 (7%)

Query: 2   VTDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           V      R  ALK +           + +F E ++L    H  ++         +  F  
Sbjct: 12  VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-------YRTFKD 64

Query: 61  E--IYVITEL-LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           +  IY++ E  L  +L  I+           + ++  ++   +YLH+  I++RD+KP NL
Sbjct: 65  KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL 124

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           L++SN  +K+ DFG A+  +    K  T    T  Y APEI++  + Y  +VD WS+G +
Sbjct: 125 LLDSNGYVKLVDFGFAKKLK-SGQKTWTF-CGTPEYVAPEIILN-KGYDFSVDYWSLGIL 181

Query: 178 FAELL 182
             ELL
Sbjct: 182 LYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 81.6 bits (202), Expect = 6e-19
 Identities = 55/156 (35%), Positives = 77/156 (49%), Gaps = 20/156 (12%)

Query: 44  VLSALDILQPPH----LDFFQ------EIYVITELLQS-DLHKIIVSPQHLTSDHI--KV 90
           +L  LDIL   +    + F+       +I +  E +    L KI+   Q    + I  K+
Sbjct: 46  ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI 105

Query: 91  FLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
               +L+GL YLH    I+HRD+KP N+LVNS   +K+CDFG++         A T  V 
Sbjct: 106 A-VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKT-FVG 161

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
           T  Y APE + G   YS   D+WS+G    EL  GR
Sbjct: 162 TSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.1 bits (203), Expect = 6e-19
 Identities = 58/206 (28%), Positives = 106/206 (51%), Gaps = 19/206 (9%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKR---VFRELKMLCFFKHDNVLSALDILQPPHLDFF 59
           TD   GR+VA+KK+      L   +R   +F E+ ++  ++H N++         +L   
Sbjct: 39  TDKSTGRQVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYS----SYL-VG 88

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            E++V+ E L+      IV+   +  + I      +L+ L +LH+  ++HRDIK  ++L+
Sbjct: 89  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL 148

Query: 120 NSNCILKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCI 177
            S+  +K+ DFG  A+V +  P +     V T Y+ APE++  +R  Y   VD+WS+G +
Sbjct: 149 TSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPYWMAPEVI--SRLPYGTEVDIWSLGIM 204

Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
             E++     +  + P+Q +  I D 
Sbjct: 205 VIEMVDGEPPYFNEPPLQAMKRIRDN 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 9e-19
 Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 17/187 (9%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDI-LQPPHLDF 58
                + G+ VA+K +  +       + +  E  +L  +  H N+ +     ++      
Sbjct: 24  KARHKKTGQLVAIKIMDIIEDE---EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80

Query: 59  FQEIYVITELLQ----SDLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
             +++++ EL      +DL K +    + L  + I   L + LRGL YLH  +++HRDIK
Sbjct: 81  DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK 140

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMG----ARHYSAA 168
             N+L+  N  +K+ DFG++   + D         + T Y+ APE++         Y A 
Sbjct: 141 GQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR 198

Query: 169 VDVWSVG 175
            DVWS+G
Sbjct: 199 SDVWSLG 205

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 2e-18
 Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 11/175 (6%)

Query: 31  RELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIK 89
           +E++++    H +++  L    +  H + F E ++    +   L K     + +  ++ +
Sbjct: 52  KEIRLMARLNHPHIIRMLGATCEDSHFNLFVE-WMAGGSVSHLLSKYGAFKEAVIINYTE 110

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKA---MT 145
               Q+LRGL YLH  +I+HRD+K  NLL++S    L+I DFG A         A     
Sbjct: 111 ----QLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG 166

Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           Q + T  + APE+L G   Y  + DVWSVGC+  E+   +  + A+     L LI
Sbjct: 167 QLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 2e-18
 Identities = 36/115 (31%), Positives = 66/115 (57%), Gaps = 1/115 (0%)

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            +++I E  +    + ++    +   +I V + ++L  LKY+H   ++HRDIK  N+LV 
Sbjct: 76  RLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT 135

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           +   +K+CDFG+A +   + +K  T  V T Y+ APE++   ++Y    D+WS+G
Sbjct: 136 NTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEGKYYDTKADIWSLG 189

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.2 bits (195), Expect = 4e-18
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 15/182 (8%)

Query: 15  KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYVITELLQSD- 72
           +LP    ++  S++   E  +L   KH N+++  +  +   HL      Y++ E      
Sbjct: 34  RLPKSSSAVEDSRK---EAVLLAKMKHPNIVAFKESFEADGHL------YIVMEYCDGGD 84

Query: 73  -LHKIIVSPQHL-TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
            + KI +    L   D I  +  Q+  G++++H  R+LHRDIK  N+ +  N  +K+ DF
Sbjct: 85  LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDF 144

Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           G AR+    P       V T YY  PEI      Y+   D+WS+GCI  EL   +  FQA
Sbjct: 145 GSARLLT-SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQA 202

Query: 191 QS 192
            S
Sbjct: 203 NS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 79.1 bits (195), Expect = 4e-18
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 16/195 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V    DG++  +K++     S    +   +E+ +L   KH N++         + + F+E
Sbjct: 19  VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ--------YQESFEE 70

Query: 62  ---IYVITELLQS-DLHKIIVSPQHL--TSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
              +Y++ +  +  DL+K I + + +    D I  +  QI   LK++H  +ILHRDIK  
Sbjct: 71  NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ 130

Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ +  +  +K+ DFG+ARV       A T  + T YY +PEI    R Y+   D+W++G
Sbjct: 131 NIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICEN-RPYNNKSDIWALG 188

Query: 176 CIFAELLGRRILFQA 190
           C+  E+   +  F+A
Sbjct: 189 CVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 79.7 bits (196), Expect = 5e-18
 Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 11/201 (5%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           T+   G++VA+KK+    +     + +F E+ ++  + H+NV+     +   +L    E+
Sbjct: 42  TEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHENVVD----MYNSYL-VGDEL 94

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V+ E L+      IV+   +  + I      +LR L YLH+  ++HRDIK  ++L+ S+
Sbjct: 95  WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154

Query: 123 CILKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             +K+ DFG  A+V +  P +     V T Y+ APE++     Y   VD+WS+G +  E+
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSL--VGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEM 211

Query: 182 LGRRILFQAQSPVQQLGLITD 202
           +     +  + P+Q +  I D
Sbjct: 212 IDGEPPYFNEPPLQAMRRIRD 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 6e-18
 Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 6/112 (5%)

Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
            DL K    P  L   +I   L ++L GL+YLH    +HRDIK  N+L++    +K+ DF
Sbjct: 87  LDLLK----PGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADF 142

Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           G++       +K  T  V T ++ APE++  +  Y    D+WS+G    EL 
Sbjct: 143 GVSGQLTSTMSKRNTF-VGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.0 bits (195), Expect = 7e-18
 Identities = 55/182 (30%), Positives = 88/182 (48%), Gaps = 11/182 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K L N            RE+++L    H+N++    + + P     + + +I E
Sbjct: 33  GEQVAVKSL-NHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---RSLRLIME 88

Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L S   +  +       +  ++ L+  QI +G+ YL S R +HRD+   N+LV S  ++
Sbjct: 89  YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLV 148

Query: 126 KICDFGLARVEEPDPNKAMTQ---EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGLA+V   D +    +   E    +Y APE L  ++  SA+ DVWS G    EL 
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Query: 183 GR 184
             
Sbjct: 207 TY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.1 bits (195), Expect = 8e-18
 Identities = 57/186 (30%), Positives = 85/186 (45%), Gaps = 12/186 (6%)

Query: 3   TDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D R    VA+KK+  +  QS    + + +E++ L   +H N +         H  +   
Sbjct: 35  RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            Y +     SD+ ++   P  L    I    +  L+GL YLHS   +HRDIK GN+L+  
Sbjct: 95  EYCLGS--ASDILEVHKKP--LQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE 150

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAAVDVWSVGCIFA 179
              +K+ DFG A +  P         V T Y+ APE++  M    Y   VDVWS+G    
Sbjct: 151 PGTVKLADFGSASLVSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205

Query: 180 ELLGRR 185
           EL  R+
Sbjct: 206 ELAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.4 bits (193), Expect = 1e-17
 Identities = 60/157 (38%), Positives = 81/157 (51%), Gaps = 22/157 (14%)

Query: 58  FFQE--IYVITELLQS---DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           FF E  I + TE +     D+++ I  P+H+    I V    +++GL YL S +ILHRD+
Sbjct: 68  FFVENRISICTEFMDGGSLDVYRKI--PEHVLG-RIAV---AVVKGLTYLWSLKILHRDV 121

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           KP N+LVN+   +K+CDFG++       N      V T  Y APE + G   Y    DVW
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISG-EQYGIHSDVW 177

Query: 173 SVGCIFAEL-LGRRILFQAQS------PVQQLGLITD 202
           S+G  F EL LGR    Q Q       P+Q L  I D
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD 214

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.3 bits (190), Expect = 3e-17
 Identities = 57/174 (32%), Positives = 88/174 (50%), Gaps = 14/174 (8%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH---LTSD 86
           +E+ +L   KH N+++     Q         ++++ E     DL K I + Q     + D
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENG-----RLFIVMEYCDGGDLMKRI-NRQRGVLFSED 101

Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMT 145
            I  +  QI  GLK++H  +ILHRDIK  N+ ++ N  + K+ DFG+AR        A T
Sbjct: 102 QILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL 199
             V T YY +PEI    R Y+   D+WS+GC+  EL   +  F+  + + QL L
Sbjct: 162 C-VGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.4 bits (190), Expect = 4e-17
 Identities = 59/199 (29%), Positives = 103/199 (51%), Gaps = 17/199 (8%)

Query: 8   GRRVALKKLPNVFQSLVSSKR---VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           GR+VA+K +      L   +R   +F E+ ++  ++H NV+     +   +L   +E++V
Sbjct: 46  GRQVAVKMM-----DLRKQQRRELLFNEVVIMRDYQHQNVVE----MYKSYL-VGEELWV 95

Query: 65  ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           + E LQ      IVS   L  + I      +L+ L YLHS  ++HRDIK  ++L+  +  
Sbjct: 96  LMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155

Query: 125 LKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +K+ DFG  A++ +  P +     V T Y+ APE++     Y   VD+WS+G +  E++ 
Sbjct: 156 VKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVI-SRTPYGTEVDIWSLGIMVIEMVD 212

Query: 184 RRILFQAQSPVQQLGLITD 202
               + + SPVQ +  + D
Sbjct: 213 GEPPYFSDSPVQAMKRLRD 231

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.4 bits (188), Expect = 6e-17
 Identities = 40/126 (31%), Positives = 66/126 (52%), Gaps = 9/126 (7%)

Query: 62  IYVITELLQ-SDLHKIIVS----PQHLTSDHIKVFLYQILRGLKYLH-SARILHRDIKPG 115
           +Y++ +L++ + L +   S     Q  T + I     Q++  L+YLH   RI+HRD+ P 
Sbjct: 84  LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143

Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+++  +  + I DFGLA+  +  P   +T  V T  Y  PEI+     Y    DVW+ G
Sbjct: 144 NIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFG 200

Query: 176 CIFAEL 181
           CI  ++
Sbjct: 201 CILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.9 bits (187), Expect = 8e-17
 Identities = 49/184 (26%), Positives = 88/184 (47%), Gaps = 16/184 (8%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLS--ALDILQPPHLDFFQEIY 63
           ++  RVA+K L +    L+  +   +E++ L   +H +++S  A+  +  P       +Y
Sbjct: 28  KNRVRVAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-------VY 78

Query: 64  VITELL-QSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +ITEL+ +  L   + SP  Q L    +     Q+  G+ YL     +HRD+   N+LV 
Sbjct: 79  IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            + + K+ DFGLAR+ + +     + + +   + APE       +S   DVWS G +  E
Sbjct: 139 EDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAA-SHGTFSTKSDVWSFGILLYE 196

Query: 181 LLGR 184
           +   
Sbjct: 197 MFTY 200

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 2e-16
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 24/166 (14%)

Query: 32  ELKMLCFFKHDNVLSALDILQPPHLDFFQE--IYVITELLQSD-LHKIIVSPQH-LTSDH 87
           E+ +L   KH N++   +        +F E  ++++ E      L  I++  +  LT   
Sbjct: 52  EIDILSECKHPNIVGLYEA-------YFYENKLWILIEFCDGGALDSIMLELERGLTEPQ 104

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
           I+    Q+L  L +LHS +++HRD+K GN+L+  +  +K+ DFG++       NK+  Q+
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSA-----KNKSTLQK 159

Query: 148 ----VVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAELLGRR 185
               + T Y+ APE++         Y    D+WS+G    EL    
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (183), Expect = 2e-16
 Identities = 60/190 (31%), Positives = 97/190 (51%), Gaps = 14/190 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFR---ELKMLCFFKHDNVLSALDILQPPH---LD 57
           D   GR +A+K++P    S  +SK V     E+++L   +HD ++     L+ P    L 
Sbjct: 23  DADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS 82

Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            F E Y+    ++  L     +   LT +  + +  QIL+G+ YLHS  I+HRDIK  N+
Sbjct: 83  IFVE-YMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI 137

Query: 118 LVNSNCILKICDFGLA-RVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVG 175
           L +S   +K+ DFG + R++    +    + V  T Y+ +PE++ G   Y    DVWSV 
Sbjct: 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVA 196

Query: 176 CIFAELLGRR 185
           C   E+L  +
Sbjct: 197 CTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.1 bits (185), Expect = 2e-16
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 2/107 (1%)

Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-V 135
               + LT   +  F YQ+ RG+++L S + +HRD+   N+LV  + ++KI DFGLAR +
Sbjct: 123 RPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182

Query: 136 EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              D  +  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.1 bits (184), Expect = 2e-16
 Identities = 60/185 (32%), Positives = 86/185 (46%), Gaps = 12/185 (6%)

Query: 4   DPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D R    VA+KK+  +  QS    + + +E+K L   KH N +         H  +    
Sbjct: 46  DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y +     SDL ++   P  L    I    +  L+GL YLHS  ++HRDIK GN+L+   
Sbjct: 106 YCLGS--ASDLLEVHKKP--LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAAVDVWSVGCIFAE 180
             +K+ DFG A +  P         V T Y+ APE++  M    Y   VDVWS+G    E
Sbjct: 162 GQVKLADFGSASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216

Query: 181 LLGRR 185
           L  R+
Sbjct: 217 LAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 4e-16
 Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 19/203 (9%)

Query: 3   TDPRDGRRVALKKLPNVFQS-----LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
            D   G+ VA+K++ N+ Q      +++   V RE K      H N+++ LD     +L 
Sbjct: 39  IDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENK------HPNIVNYLD----SYL- 86

Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              E++V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 146

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           L+  +  +K+ DFG      P+ +K  T  V T Y+ APE++   + Y   VD+WS+G +
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-RKAYGPKVDIWSLGIM 204

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
             E++     +  ++P++ L LI
Sbjct: 205 AIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 5e-16
 Identities = 37/97 (38%), Positives = 58/97 (59%), Gaps = 3/97 (3%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI+ GL++LH  RI++RD+KP N+L++ +  ++I D GLA VE     K +     T  Y
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKG-GKKIKGRAGTPGY 160

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
            APE+L G   Y  +VD +++GC   E++  R  F+ 
Sbjct: 161 MAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 7e-16
 Identities = 39/96 (40%), Positives = 56/96 (58%), Gaps = 3/96 (3%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI  G+ +LHS  I++RD+KP N+L++     ++ D GLA VE  D  K +TQ   T  Y
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKD-GKTITQRAGTNGY 160

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            APEIL     YS  VD +++GC   E++  R  F+
Sbjct: 161 MAPEILK-EEPYSYPVDWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.0 bits (182), Expect = 7e-16
 Identities = 39/94 (41%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 93  YQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ 151
             +LRGL YL     I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTR 162

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELL-GR 184
            Y +PE L G  HY+   D+WS+G    E+  GR
Sbjct: 163 SYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 73.6 bits (180), Expect = 7e-16
 Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 9/198 (4%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
            D   G+ VA+K++    Q     + +  E+ ++   K+ N+++ LD      L    E+
Sbjct: 39  IDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD----SFL-VGDEL 91

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V+ E L       +V+   +    I     + L+ L++LH+ +++HRDIK  N+L+  +
Sbjct: 92  FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFG      P+ +K  T  V T Y+ APE++   + Y   VD+WS+G +  E++
Sbjct: 152 GSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMV 209

Query: 183 GRRILFQAQSPVQQLGLI 200
                +  ++P++ L LI
Sbjct: 210 EGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.5 bits (180), Expect = 7e-16
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 14/190 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFR---ELKMLCFFKHDNVLSALDILQPPH---LD 57
           D   GR +A+K++    +S  +SK V     E+++L    H+ ++     L+ P    L 
Sbjct: 23  DADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS 82

Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            F E      +    +   + S   LT +  + +  QIL G+ YLHS  I+HRDIK  N+
Sbjct: 83  IFMEH-----MPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI 137

Query: 118 LVNSNCILKICDFGLARVEEPD--PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           L +S   +K+ DFG ++  +        M     T Y+ +PE++ G   Y    D+WSVG
Sbjct: 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVG 196

Query: 176 CIFAELLGRR 185
           C   E+L  +
Sbjct: 197 CTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.5 bits (180), Expect = 1e-15
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 12/185 (6%)

Query: 4   DPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D R+   VA+KK+  +  QS    + + +E++ L   +H N +         H  +    
Sbjct: 36  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y +     SDL ++   P  L    I    +  L+GL YLHS  ++HRD+K GN+L++  
Sbjct: 96  YCLGS--ASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAAVDVWSVGCIFAE 180
            ++K+ DFG A +  P         V T Y+ APE++  M    Y   VDVWS+G    E
Sbjct: 152 GLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206

Query: 181 LLGRR 185
           L  R+
Sbjct: 207 LAERK 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.2 bits (179), Expect = 1e-15
 Identities = 52/197 (26%), Positives = 102/197 (51%), Gaps = 9/197 (4%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 41  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 93

Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  + 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  +  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211

Query: 184 RRILFQAQSPVQQLGLI 200
               +  ++P++ L LI
Sbjct: 212 GEPPYLNENPLRALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.2 bits (179), Expect = 1e-15
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 9/197 (4%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA+K++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 40  DIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 92

Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L +LHS +++HRDIK  N+L+  + 
Sbjct: 93  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG 152

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  T  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 153 SVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVE 210

Query: 184 RRILFQAQSPVQQLGLI 200
               +  ++P++ L LI
Sbjct: 211 GEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 1e-15
 Identities = 37/103 (35%), Positives = 61/103 (59%), Gaps = 9/103 (8%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I  GL+ LH  RI++RD+KP N+L++    ++I D GLA VE P+  + +   V T  Y
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPE-GETIRGRVGTVGY 167

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
            APE++   R Y+ + D W +GC+  E++      + +SP +Q
Sbjct: 168 MAPEVVKNER-YTFSPDWWGLGCLIYEMI------EGKSPFRQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 1e-15
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 32  ELKMLCFFKHDNVLSALDILQPPHLDFFQEIY-VITELLQSDLHKIIV-SPQHLTSDHIK 89
           E  +L    H +V+   D L          I  ++     SDL+  +    + L  D   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTL------VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQAL 160

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQ 146
           +   QIL GL+YLH+ RI+HRD+K  N+ +N    + I D G A+     P     A T 
Sbjct: 161 IIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220

Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           E       APE+L   + Y++  D+WS G +  E+L
Sbjct: 221 ET-----NAPEVLARDK-YNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.5 bits (178), Expect = 2e-15
 Identities = 58/179 (32%), Positives = 88/179 (49%), Gaps = 12/179 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G  VA+KKL     S     R F RE+++L   +HDN++    +         + + ++ 
Sbjct: 33  GEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLVM 86

Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           E L     +  +       DH K+ LY  QI +G++YL S R +HRD+   N+LV S   
Sbjct: 87  EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR 146

Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 36/124 (29%), Positives = 63/124 (50%), Gaps = 20/124 (16%)

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-------- 139
            + +  +IL  L+YLHS  I+HRD+KP N+L++ +  +KI DFG A+V +P+        
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKG 163

Query: 140 -------PNKAMTQE----VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF 188
                    +   +     V T  Y +PE+L        + D+W++GCI  ++L  +  F
Sbjct: 164 DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPF 222

Query: 189 QAQS 192
           +  +
Sbjct: 223 RGSN 226

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.9 bits (176), Expect = 3e-15
 Identities = 38/93 (40%), Positives = 54/93 (58%), Gaps = 3/93 (3%)

Query: 92  LYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--VV 149
           L  I  G+KYL     +HRD+   N+LVNSN + K+ DFGL+RV E DP  A T     +
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +   R +++A DVWS G +  E++
Sbjct: 172 PIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-15
 Identities = 43/186 (23%), Positives = 77/186 (41%), Gaps = 33/186 (17%)

Query: 5   PRDGRR--VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            + G+   VA+K L    + + + K+ F RE  ++    H  ++  + + +   L    E
Sbjct: 18  MKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVME 75

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +          L K +   + +    +K   +Q+  G+ YL S   +HRD+   N+L+ +
Sbjct: 76  L-----APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN 130

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAV 169
               KI DFG++R      +          YYR            APE +   + +S+  
Sbjct: 131 RHQAKISDFGMSRALGAGSD----------YYRATTAGRWPLKWYAPECINYGK-FSSKS 179

Query: 170 DVWSVG 175
           DVWS G
Sbjct: 180 DVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.6 bits (175), Expect = 3e-15
 Identities = 51/182 (28%), Positives = 93/182 (51%), Gaps = 15/182 (8%)

Query: 7   DGRRVALKKLPNVFQSLVSSKR--VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           D + VALKK+  +F+ + +  R    +E+ +L    H NV+  LD     +     E+ +
Sbjct: 26  DRKPVALKKV-QIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----ELNI 79

Query: 65  ITELLQS-DLHKIIV----SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + EL  + DL ++I       + +    +  +  Q+   ++++HS R++HRDIKP N+ +
Sbjct: 80  VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            +  ++K+ D GL R        A +  V T YY +PE +     Y+   D+WS+GC+  
Sbjct: 140 TATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH-ENGYNFKSDIWSLGCLLY 197

Query: 180 EL 181
           E+
Sbjct: 198 EM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 3e-15
 Identities = 54/189 (28%), Positives = 92/189 (48%), Gaps = 9/189 (4%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
            DG++  +KKL     S    K   +E ++L   KH N+++  +  +         +Y++
Sbjct: 23  TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIV 78

Query: 66  TELLQS-DLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
               +  DL+  +     + L  + +  +  QI   L+YLH   ILHRD+K  N+ +   
Sbjct: 79  MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT 138

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            I+K+ D G+ARV E   + A T  + T YY +PE L   + Y+   DVW++GC   E+ 
Sbjct: 139 NIIKVGDLGIARVLENQCDMASTL-IGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMA 196

Query: 183 GRRILFQAQ 191
             +  F A+
Sbjct: 197 TLKHAFNAK 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 72.0 bits (176), Expect = 4e-15
 Identities = 52/159 (32%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHI 88
           + +E+K L   KH N +         H  +    Y +     SDL ++   P  L    I
Sbjct: 68  IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS--ASDLLEVHKKP--LQEVEI 123

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
               +  L+GL YLHS  ++HRDIK GN+L+     +K+ DFG A    P         V
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----ANSFV 178

Query: 149 VTQYYRAPEIL--MGARHYSAAVDVWSVGCIFAELLGRR 185
            T Y+ APE++  M    Y   VDVWS+G    EL  R+
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 7/103 (6%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
                   + +  Q++  L+YLHS  I++RD+KP NLL++S+  +KI DFG A+  +   
Sbjct: 96  GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154

Query: 141 NKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               T  +  T  Y APEI++  + Y  AVD W++G +  E+L
Sbjct: 155 ----TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.1 bits (171), Expect = 1e-14
 Identities = 52/184 (28%), Positives = 92/184 (50%), Gaps = 19/184 (10%)

Query: 7   DGRRVALKKLPNVFQSLVSSKR--VFRELKMLCFFKHDNVLSALDILQPPHLDFFQ--EI 62
           DG  VALKK+  +F  + +  R    +E+ +L    H NV+         +  F +  E+
Sbjct: 26  DGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-------YASFIEDNEL 77

Query: 63  YVITELLQS-DLHKII----VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            ++ EL  + DL ++I       + +    +  +  Q+   L+++HS R++HRDIKP N+
Sbjct: 78  NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 137

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            + +  ++K+ D GL R        A +  V T YY +PE +     Y+   D+WS+GC+
Sbjct: 138 FITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH-ENGYNFKSDIWSLGCL 195

Query: 178 FAEL 181
             E+
Sbjct: 196 LYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 1e-14
 Identities = 62/185 (33%), Positives = 90/185 (48%), Gaps = 21/185 (11%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR  ALK +    +  V  +++ RE+++L    H NV+   D+      D   EI V+ E
Sbjct: 99  GRLYALKVIYGNHEDTVR-RQICREIEILRDVNHPNVVKCHDMF-----DHNGEIQVLLE 152

Query: 68  LL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +    L    ++ +   +D       QIL G+ YLH   I+HRDIKP NLL+NS   +K
Sbjct: 153 FMDGGSLEGTHIADEQFLAD----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVK 208

Query: 127 ICDFGLARV--EEPDPNKAMTQEVVTQYYRAPEI----LMGARHYSAAVDVWSVGCIFAE 180
           I DFG++R+  +  DP       V T  Y +PE     L    +   A D+WS+G    E
Sbjct: 209 IADFGVSRILAQTMDP---CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Query: 181 L-LGR 184
             LGR
Sbjct: 266 FYLGR 270

Length = 353

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.1 bits (171), Expect = 2e-14
 Identities = 52/196 (26%), Positives = 101/196 (51%), Gaps = 11/196 (5%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK+    +     + +F E+ ++  ++H+NV+   +     +L    E++V+ E
Sbjct: 45  GKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN----SYL-VGDELWVVME 97

Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  +K+
Sbjct: 98  FLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157

Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++    
Sbjct: 158 SDFGFCAQVSKEVPRRKSL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214

Query: 187 LFQAQSPVQQLGLITD 202
            +  + P++ + +I D
Sbjct: 215 PYFNEPPLKAMKMIRD 230

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 70.5 bits (172), Expect = 2e-14
 Identities = 41/92 (44%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +LRGL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 112 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 168

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    EL +GR
Sbjct: 169 MSPERLQGT-HYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 2e-14
 Identities = 38/114 (33%), Positives = 65/114 (57%), Gaps = 7/114 (6%)

Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           Q DL+K     + LT + +  + +Q+ +G+++L S + +HRD+   N+L++ N ++KICD
Sbjct: 168 QEDLYK-----KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICD 222

Query: 130 FGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           FGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.7 bits (170), Expect = 2e-14
 Identities = 40/106 (37%), Positives = 57/106 (53%), Gaps = 2/106 (1%)

Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V  + +T   +    YQ+ RG++YL S + +HRD+   N+LV  N ++KI DFGLAR V 
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             D  K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 233

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.8 bits (168), Expect = 3e-14
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 39  FKHDNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSPQ-HLTSDHIKVFLYQIL 96
           F H N++    ++       F+   +ITE +++  L K +       +S  +   L  I 
Sbjct: 63  FSHHNIIRLEGVVTK-----FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIA 117

Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--VVTQYYR 154
            G+KYL     +HRD+   N+LVNSN   K+ DFGL+RV E DP    T     +   + 
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177

Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           APE +   R +++A DVWS G +  E++
Sbjct: 178 APEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 3e-14
 Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 30/183 (16%)

Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           VALK++  ++   L   + V  E  +L   K + ++  L   Q       + +Y+  E +
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYLYLAMEYV 83

Query: 70  QS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
              D   ++ +   L+ DH + ++ ++   +  LH    +HRD+KP N L++++  +K+ 
Sbjct: 84  PGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLT 143

Query: 129 DFGLAR---------VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           DFGL++         V  PD             Y APE+L G + Y   VD WS+GC+  
Sbjct: 144 DFGLSKGIVTYANSVVGSPD-------------YMAPEVLRG-KGYDFTVDYWSLGCMLY 189

Query: 180 ELL 182
           E L
Sbjct: 190 EFL 192

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 68.5 bits (167), Expect = 4e-14
 Identities = 45/140 (32%), Positives = 71/140 (50%), Gaps = 2/140 (1%)

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L   +I   L +IL+GL YLHS R +HRDIK  N+L++
Sbjct: 76  KLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 135

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               +K+ DFG+A  +  D        V T ++ APE++  +  Y    D+WS+G    E
Sbjct: 136 EQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIE 193

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           L           P++ L LI
Sbjct: 194 LAKGEPPNSDLHPMRVLFLI 213

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 68.1 bits (167), Expect = 5e-14
 Identities = 43/130 (33%), Positives = 59/130 (45%), Gaps = 18/130 (13%)

Query: 62  IYVITEL---------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           IY++TE          L+S   K +  PQ +          QI  G+ YL S   +HRD+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLESRNYIHRDL 129

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDV 171
              N+LV  N + KI DFGLAR+ E D   A         + APE    G   ++   DV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG--RFTIKSDV 187

Query: 172 WSVGCIFAEL 181
           WS G +  E+
Sbjct: 188 WSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 68.6 bits (167), Expect = 5e-14
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 2/121 (1%)

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L    I   L +IL+GL YLHS + +HRDIK  N+L++
Sbjct: 76  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 135

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFG+A  +  D        V T ++ APE++  +  Y +  D+WS+G    E
Sbjct: 136 EHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIE 193

Query: 181 L 181
           L
Sbjct: 194 L 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.3 bits (167), Expect = 5e-14
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 37/171 (21%)

Query: 27  KRVFRELKML--C-----------FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD- 72
           K++ REL+++  C           F   +N+   ++ +    LD    IY     +  + 
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD---RIYKKGGPIPVEI 104

Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFG 131
           L KI V+               ++ GL YL++  RI+HRDIKP N+LVNS   +K+CDFG
Sbjct: 105 LGKIAVA---------------VVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFG 149

Query: 132 LARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              V     N      V T  Y +PE + G + Y+   DVWS+G    EL 
Sbjct: 150 ---VSGELINSIADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELA 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 68.0 bits (166), Expect = 7e-14
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 22/187 (11%)

Query: 8   GRRVALKKL----PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEI 62
           G+ +A+K++     NV  +    +++  E+ +L   KH N++  L   L    +  F E 
Sbjct: 24  GQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME- 82

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V    + S L++    P+ +   + K    QIL G+ YLH+  ++HRDIK  N+++  N
Sbjct: 83  FVPGGSISSILNRFGPLPEPVFCKYTK----QILDGVAYLHNNCVVHRDIKGNNVMLMPN 138

Query: 123 CILKICDFGLAR--------VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            I+K+ DFG AR            +  K+M     T Y+ APE++     Y    D+WS+
Sbjct: 139 GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG---TPYWMAPEVI-NESGYGRKSDIWSI 194

Query: 175 GCIFAEL 181
           GC   E+
Sbjct: 195 GCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.8 bits (165), Expect = 7e-14
 Identities = 37/105 (35%), Positives = 56/105 (53%), Gaps = 3/105 (2%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP--DP 140
           LT    + +  QIL G+ YLHS  I+HRDIK  N+L +S   +K+ DFG ++  +     
Sbjct: 103 LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162

Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRR 185
              +     T Y+ +PE++ G   Y    DVWS+GC   E+L  +
Sbjct: 163 GTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 67.7 bits (165), Expect = 8e-14
 Identities = 38/99 (38%), Positives = 60/99 (60%), Gaps = 3/99 (3%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           L+ + +  +  Q+L G+ Y+H  RILHRD+K  N+ + +N +LKI DFG++R+     + 
Sbjct: 103 LSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDL 161

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           A T    T YY +PE L   + Y +  D+WS+GCI  E+
Sbjct: 162 ATTF-TGTPYYMSPEAL-KHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.6 bits (165), Expect = 8e-14
 Identities = 40/111 (36%), Positives = 65/111 (58%), Gaps = 4/111 (3%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPN 141
           L  D I  F  QIL  L ++H+  ILHRD+K  N+L++ +  ++KI DFG+++      +
Sbjct: 98  LDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKS 156

Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           KA T  V T  Y +PE+  G + Y+   D+W++GC+  EL   +  F+A +
Sbjct: 157 KAYTV-VGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 2/91 (2%)

Query: 93  YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQ 151
           YQ+ RG++YL S R +HRD+   N+LV  + ++KI DFGLAR V + D  K  +   +  
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            + APE L   R Y+   DVWS G +  E+ 
Sbjct: 201 KWMAPEALFD-RVYTHQSDVWSFGILMWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 1e-13
 Identities = 33/96 (34%), Positives = 58/96 (60%), Gaps = 1/96 (1%)

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
           D  K ++ +++  L++LH   I++RD+KP N+L+++   + +CDFGL++    D NK   
Sbjct: 96  DRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTN 154

Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
               T  Y APE+L+  + Y+  VD WS+G +  E+
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 67.3 bits (164), Expect = 2e-13
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 2/106 (1%)

Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V  + L+   +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR + 
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             D  K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 2e-13
 Identities = 47/152 (30%), Positives = 79/152 (51%), Gaps = 17/152 (11%)

Query: 59  FQE--IYVITELLQSDLHK----IIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRD 111
           F+E  +++  E++ + L K    +      +  D +      I++ L+YLHS   ++HRD
Sbjct: 70  FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD 129

Query: 112 IKPGNLLVNSNCILKICDFGLA--RVEEPDPNKAMTQEVVTQYYRAPEIL---MGARHYS 166
           +KP N+L+N N  +K+CDFG++   V+    + A T +   + Y APE +   +  + Y 
Sbjct: 130 VKPSNVLINRNGQVKLCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQKGYD 185

Query: 167 AAVDVWSVGCIFAEL-LGRRILFQAQSPVQQL 197
              DVWS+G    EL  GR      ++P QQL
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 67.4 bits (164), Expect = 2e-13
 Identities = 37/91 (40%), Positives = 52/91 (57%), Gaps = 2/91 (2%)

Query: 93  YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQ 151
           YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR V   D  K  T   +  
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            + APE L   R Y+   DVWS G +  E+ 
Sbjct: 201 KWMAPEALFD-RVYTHQSDVWSFGVLLWEIF 230

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.0 bits (163), Expect = 2e-13
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 168

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 169 MSPERLQGT-HYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 3e-13
 Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 6/146 (4%)

Query: 59  FQ---EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ   ++Y+I + L+  DL   +      T + +K +L ++   L +LHS  I++RD+KP
Sbjct: 67  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKP 126

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+L++    +K+ DFGL++ E  D  K       T  Y APE++   R ++ + D WS 
Sbjct: 127 ENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSF 184

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLI 200
           G +  E+L   + FQ +   + + +I
Sbjct: 185 GVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 66.6 bits (162), Expect = 3e-13
 Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 9/103 (8%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I  GL+ LH  RI++RD+KP N+L++ +  ++I D GLA V  P+  + +   V T  Y
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPE-GQTIKGRVGTVGY 167

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
            APE++   R Y+ + D W++GC+  E++        QSP QQ
Sbjct: 168 MAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 36/117 (30%), Positives = 58/117 (49%), Gaps = 8/117 (6%)

Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
            D++++   P  L+   I     + L+GL YLH    +HRDIK  N+L+  +  +K+ DF
Sbjct: 88  QDIYQVTRGP--LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH--YSAAVDVWSVG--CI-FAELL 182
           G++        K  +  + T Y+ APE+    R   Y    D+W++G   I  AEL 
Sbjct: 146 GVSAQLTATIAKRKSF-IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.2 bits (161), Expect = 3e-13
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 38/202 (18%)

Query: 2   VTDPRDGRRVALKKLP-------------NVFQSLVSSKRVFRELKMLCFFKHDNVLSAL 48
           VT+ +DG   A+K L              N+ QSL +   V +   M  F+K D ++   
Sbjct: 41  VTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM--FYKADKLVGG- 97

Query: 49  DILQPPHLDFFQEIYVITELLQ----SDLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLH 103
                       +++++ EL      ++L K +++  Q L    I   LY  L GL++LH
Sbjct: 98  ------------QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145

Query: 104 SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR 163
           + RI+HRD+K  N+L+ +   +K+ DFG++  +           V T ++ APE++   +
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204

Query: 164 H----YSAAVDVWSVGCIFAEL 181
                Y A  DVWS+G    EL
Sbjct: 205 QYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 4e-13
 Identities = 43/130 (33%), Positives = 63/130 (48%), Gaps = 10/130 (7%)

Query: 62  IYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           IY++TEL     L   L     + + L    +     Q+  G+ YL +   +HRD+   N
Sbjct: 76  IYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARN 133

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV  N I K+ DFGLARV + D  +A         + APE  +  R +S   DVWS G 
Sbjct: 134 VLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGI 192

Query: 177 IFAELL--GR 184
           +  E++  GR
Sbjct: 193 LLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 65.6 bits (160), Expect = 6e-13
 Identities = 35/89 (39%), Positives = 54/89 (60%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I+ GL++LH   I++RD+K  N+L++ +  +KI DFG+ +       KA T    T  Y
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDY 162

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APEIL G + Y+ +VD WS G +  E+L
Sbjct: 163 IAPEILKGQK-YNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 6e-13
 Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 13/107 (12%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q L  L YLH  +I+HRD+K GN+L   +  +K+ DFG++       N 
Sbjct: 100 LTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNT 154

Query: 143 AMTQE----VVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAEL 181
              Q     + T Y+ APE++M      R Y    DVWS+G    E+
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 6e-13
 Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 33/169 (19%)

Query: 59  FQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ+   +Y++ E +   DL  +++       +  + ++ +++  L  +H    +HRDIKP
Sbjct: 70  FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKP 129

Query: 115 GNLLVNSNCILKICDFGLA-------------------------RVEEPDPNKAMTQ--- 146
            N+L++++  +K+ DFGL                           V   D  +   +   
Sbjct: 130 DNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189

Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
            V T  Y APE+L G   Y    D WS+G I  E+L     F + +  +
Sbjct: 190 TVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 65.2 bits (159), Expect = 7e-13
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 1/88 (1%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
            +   ++YL S   +HRD+   N LV  + ++K+ DFGLAR    D   +         +
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKW 167

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL 181
             PE+   +R +S+  DVWS G +  E+
Sbjct: 168 APPEVFDYSR-FSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 65.2 bits (159), Expect = 8e-13
 Identities = 37/114 (32%), Positives = 62/114 (54%), Gaps = 15/114 (13%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV------- 135
           L  D  +++  + +  L+YLH+  I+HRD+KP NLL+ S   +K+ DFGL+++       
Sbjct: 98  LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157

Query: 136 ------EEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                  E D  + + ++V  T  Y APE+++  + Y   VD W++G I  E L
Sbjct: 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 65.1 bits (158), Expect = 8e-13
 Identities = 37/107 (34%), Positives = 57/107 (53%), Gaps = 13/107 (12%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q+L  L+YLHS +I+HRD+K GN+L+  +  +K+ DFG++       N 
Sbjct: 107 LTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNV 161

Query: 143 AMTQE----VVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
              Q     + T Y+ APE++M        Y    D+WS+G    E+
Sbjct: 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 65.3 bits (159), Expect = 1e-12
 Identities = 37/110 (33%), Positives = 60/110 (54%), Gaps = 22/110 (20%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR--VEEPD- 139
           LT + +  + +Q+ RG+++L S + +HRD+   N+L++ N ++KICDFGLAR   ++PD 
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229

Query: 140 --------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
                   P K M          APE +   + Y+   DVWS G +  E+
Sbjct: 230 VRKGDARLPLKWM----------APESIFD-KVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 64.5 bits (157), Expect = 1e-12
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 24/166 (14%)

Query: 40  KHDNVLSALDILQ----PPHLDF----FQE--IYVITELLQS-DLHKII---VSPQHLTS 85
           K + ++  LDIL     P  +DF    F E  +Y+  E + +  L K+    V+ + +  
Sbjct: 42  KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPE 101

Query: 86  DHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM 144
           D ++   Y +++GLK+L     I+HRD+KP N+LVN N  +K+CDFG++        K  
Sbjct: 102 DVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT- 160

Query: 145 TQEVVTQYYRAPEIL-----MGARHYSAAVDVWSVGCIFAEL-LGR 184
              +  Q Y APE +          Y+   DVWS+G    E+ LGR
Sbjct: 161 --NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 64.2 bits (156), Expect = 1e-12
 Identities = 45/184 (24%), Positives = 87/184 (47%), Gaps = 30/184 (16%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G++VA+K +    +  V+++    E  ++    H N++  L ++          +Y++ E
Sbjct: 29  GQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI------LHNGLYIVME 78

Query: 68  L---------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           L         L++    ++   Q L       F   +  G++YL S +++HRD+   N+L
Sbjct: 79  LMSKGNLVNFLRTRGRALVSVIQLLQ------FSLDVAEGMEYLESKKLVHRDLAARNIL 132

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V+ + + K+ DFGLARV     +  +    +   + APE L   + +S+  DVWS G + 
Sbjct: 133 VSEDGVAKVSDFGLARVG----SMGVDNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLL 187

Query: 179 AELL 182
            E+ 
Sbjct: 188 WEVF 191

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 64.6 bits (157), Expect = 1e-12
 Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 16/188 (8%)

Query: 4   DPR---DGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF 59
           DP     G +VA+K L P    + ++   + +E+++L    H+N++    I      D  
Sbjct: 26  DPEGDNTGEQVAVKSLKPESGGNHIAD--LKKEIEILRNLYHENIVKYKGICTE---DGG 80

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFL---YQILRGLKYLHSARILHRDIKPGN 116
             I +I E L S   K  + P++    ++K  L    QI +G+ YL S + +HRD+   N
Sbjct: 81  NGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 139

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSV 174
           +LV S   +KI DFGL +  E D      ++ +    ++ APE L+ ++ Y A+ DVWS 
Sbjct: 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS-DVWSF 198

Query: 175 GCIFAELL 182
           G    ELL
Sbjct: 199 GVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.6 bits (157), Expect = 2e-12
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 2/101 (1%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT + +  + +Q+ RG+++L S + +HRD+   N+L++ N ++KICDFGLAR    DP+ 
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 230

Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                  +   + APE +   + Y+   DVWS G +  E+ 
Sbjct: 231 VRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIF 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.9 bits (155), Expect = 2e-12
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 32  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 82

Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 83  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 136

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 137 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 195

Query: 181 L 181
           L
Sbjct: 196 L 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 2e-12
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 2/95 (2%)

Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
            I   L +IL+GL YLHS + +HRDIK  N+L++    +K+ DFG+A  +  D       
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNT 160

Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            V T ++ APE++  +  Y +  D+WS+G    EL
Sbjct: 161 FVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 2e-12
 Identities = 53/160 (33%), Positives = 76/160 (47%), Gaps = 21/160 (13%)

Query: 32  ELKMLCFF-KHDNV---LSALDILQPPHLDFFQEIYVITEL-LQSDLHKIIVSPQH--LT 84
           ELK++     H+N+   L A  I  P        I VITE     DL   +   +   LT
Sbjct: 88  ELKIMSHLGNHENIVNLLGACTIGGP--------ILVITEYCCYGDLLNFLRRKRESFLT 139

Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--- 141
            + +  F YQ+ +G+ +L S   +HRD+   N+L+    I+KICDFGLAR    D N   
Sbjct: 140 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVV 199

Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K   +  V   + APE +     Y+   DVWS G +  E+
Sbjct: 200 KGNARLPVK--WMAPESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.7 bits (155), Expect = 3e-12
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 1/103 (0%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           +H T   ++V++ +I+  L +LH   I++RDIK  N+L++S   + + DFGL++    + 
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Query: 141 NKAMTQEVVTQYYRAPEILM-GARHYSAAVDVWSVGCIFAELL 182
            +       T  Y APE++  G+  +  AVD WS+G +  ELL
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 63.3 bits (154), Expect = 3e-12
 Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 29/190 (15%)

Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITEL 68
              A+K L N    L   ++  +E  ++  F H NVLS L I  P        + V+  +
Sbjct: 24  IHCAVKSL-NRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE---GSPLVVLPYM 79

Query: 69  LQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
              DL   I S  H  T   +  F  Q+ +G++YL S + +HRD+   N +++ +  +K+
Sbjct: 80  KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKV 139

Query: 128 CDFGLAR---------VEEPD----PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            DFGLAR         V        P K M  E +               ++   DVWS 
Sbjct: 140 ADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-----------KFTTKSDVWSF 188

Query: 175 GCIFAELLGR 184
           G +  EL+ R
Sbjct: 189 GVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 3e-12
 Identities = 35/89 (39%), Positives = 56/89 (62%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I+ GL++LHS  I++RD+K  N++++ +  +KI DFG+ +      N+A T    T  Y
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDY 162

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APEIL G + Y+ +VD WS G +  E+L
Sbjct: 163 IAPEILQGLK-YTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.4 bits (154), Expect = 4e-12
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 20/116 (17%)

Query: 80  PQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA----- 133
           P+H L    + +F  QI  G+ YLHS   +HRD+   N+L++++ ++KI DFGLA     
Sbjct: 100 PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159

Query: 134 -----RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
                RV E   +          ++ A E L   +   A+ DVWS G    ELL  
Sbjct: 160 GHEYYRVREDGDSPV--------FWYAVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 4e-12
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 13/178 (7%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           +VA+K L       +  +   +E +++   +HD ++    ++        + IY++TE +
Sbjct: 32  KVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYIVTEFM 82

Query: 70  -QSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +  L   +     ++L    +     QI  G+ Y+     +HRD++  N+LV  N + K
Sbjct: 83  GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCK 142

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           I DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  EL+ +
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.9 bits (153), Expect = 4e-12
 Identities = 36/98 (36%), Positives = 59/98 (60%), Gaps = 2/98 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI+ GL++LH  RI++RD+KP N+L++++  ++I D GLA VE  D          T  +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGF 163

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            APE+L G   Y  +VD +++G    E++  R  F+A+
Sbjct: 164 MAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRAR 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 4e-12
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 2/92 (2%)

Query: 92  LYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVVT 150
           L  I  G+KYL     +HRD+   N+LVNSN + K+ DFGL+R  E+ +         + 
Sbjct: 112 LRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIP 171

Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             + APE +   R +++A DVWS G +  E++
Sbjct: 172 IRWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.3 bits (154), Expect = 4e-12
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 2/108 (1%)

Query: 84  TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA 143
           + D  + +  +I+  L YLHS  +++RD+K  NL+++ +  +KI DFGL +    D    
Sbjct: 93  SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151

Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
           M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q
Sbjct: 152 MKTFCGTPEYLAPEVL-EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.2 bits (153), Expect = 4e-12
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            + D  + +  +I+  L YLHS +I++RD+K  NL+++ +  +KI DFGL +    D   
Sbjct: 92  FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-A 150

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.1 bits (153), Expect = 4e-12
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 4/102 (3%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPN 141
           LT   +  F +QI RG++YL   +++HRD+   N+LV     +KI DFGL+R V E D  
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 142 KAMTQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELL 182
              ++  +   + A E L    H Y+   DVWS G +  E++
Sbjct: 184 VKRSKGRIPVKWMAIESL--FDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.3 bits (151), Expect = 5e-12
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 8/155 (5%)

Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIVSPQHLTS 85
           +   E ++L  + H N++  + +         Q IY++ EL+     L  +      L +
Sbjct: 38  KFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKT 92

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
             +  F      G+ YL S   +HRD+   N LV  N +LKI DFG++R E+     +  
Sbjct: 93  KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152

Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            + +   + APE L   R YS+  DVWS G +  E
Sbjct: 153 LKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 62.4 bits (152), Expect = 6e-12
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 11/129 (8%)

Query: 60  QEIYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
             ++++ EL     L+S L     +   L    + ++ YQ+   L YL S R +HRDI  
Sbjct: 79  NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAA 135

Query: 115 GNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
            N+LV+S   +K+ DFGL+R +E+    KA   ++  ++  APE +   R +++A DVW 
Sbjct: 136 RNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-APESI-NFRRFTSASDVWM 193

Query: 174 VGCIFAELL 182
            G    E+L
Sbjct: 194 FGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 6e-12
 Identities = 37/110 (33%), Positives = 57/110 (51%), Gaps = 3/110 (2%)

Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+T  +I   ++Q+  G+KYL     +HRD+   N+L+ +    KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE  M    +S+  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWYAPEC-MNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.7 bits (152), Expect = 7e-12
 Identities = 37/109 (33%), Positives = 58/109 (53%), Gaps = 2/109 (1%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 150

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 62.2 bits (151), Expect = 7e-12
 Identities = 45/197 (22%), Positives = 92/197 (46%), Gaps = 16/197 (8%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVITE 67
           +VA+K    + +  +S +    E K++    H  +  L  +   Q P       +Y++TE
Sbjct: 30  KVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-------LYIVTE 79

Query: 68  LLQSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +++   L+ +      L+ D +      +  G++YL     +HRD+   N LV+S  ++
Sbjct: 80  FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVV 139

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR- 184
           K+ DFG+ R    D   + +       +  PE+   ++ YS+  DVWS G +  E+    
Sbjct: 140 KVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEG 198

Query: 185 RILFQAQSPVQQLGLIT 201
           ++ F+ +S  + + +I+
Sbjct: 199 KMPFEKKSNYEVVEMIS 215

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.2 bits (151), Expect = 7e-12
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 9/125 (7%)

Query: 62  IYVITELLQSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           IY++TE + +   L+ +    +      +      +  G+ YL S + +HRD+   N LV
Sbjct: 74  IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGC 176
           +    +K+ DFGL+R    D     T  V +++   +  PE+L+ ++ +S+  DVW+ G 
Sbjct: 134 DDQGCVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGV 189

Query: 177 IFAEL 181
           +  E+
Sbjct: 190 LMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 8e-12
 Identities = 33/94 (35%), Positives = 57/94 (60%), Gaps = 2/94 (2%)

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  ++L  L+ LH   +++RD+KP N+L++    + +CDFGL ++   D +K  T   
Sbjct: 96  RFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-C 154

Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T  Y APE+L+G   Y+ AVD W++G +  E+L
Sbjct: 155 GTPEYLAPELLLG-HGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 9e-12
 Identities = 36/98 (36%), Positives = 56/98 (57%), Gaps = 4/98 (4%)

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
           D    +L +I   L++LH   I++RD+KP N+L+++   +K+ DFGL +  E      +T
Sbjct: 100 DTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVT 157

Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                T  Y APEILM + H   AVD WS+G +  ++L
Sbjct: 158 HTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDML 194

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.5 bits (152), Expect = 9e-12
 Identities = 35/112 (31%), Positives = 51/112 (45%), Gaps = 3/112 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++  L  +HS   +HRD+KP N+L++ +  LK+ DFG     + +        V T  Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY 209

Query: 154 RAPEILMGARH---YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
            +PE+L        Y    D WSVG    E+L     F A S V     I D
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 1e-11
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 26/183 (14%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           +VA+K L       +S +    E  ++   +HD ++    ++        + IY+ITE  
Sbjct: 32  KVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIITEYM 83

Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+SD    ++ P+ +       F  QI  G+ Y+     +HRD++  N+LV+
Sbjct: 84  AKGSLLDFLKSDEGGKVLLPKLID------FSAQIAEGMAYIERKNYIHRDLRAANVLVS 137

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDVWSVGCIFA 179
            + + KI DFGLARV E +   A         + APE I  G+  ++   DVWS G +  
Sbjct: 138 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLY 195

Query: 180 ELL 182
           E++
Sbjct: 196 EIV 198

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 33/102 (32%), Positives = 57/102 (55%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
            + + D ++ +  +I+  L++LH   I++RDIK  N+L++S   + + DFGL++    + 
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159

Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +       T  Y APEI+ G   +  AVD WS+G +  ELL
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 61.6 bits (149), Expect = 1e-11
 Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 13/178 (7%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           +VA+K L       +S +    E +++   +HD ++    ++        + IY++TE +
Sbjct: 32  KVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYIVTEYM 82

Query: 70  QSDLHKIIVSP---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                   +     + L   ++     Q+  G+ Y+     +HRD++  N+LV    + K
Sbjct: 83  SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCK 142

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           I DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  EL+ +
Sbjct: 143 IADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.9 bits (150), Expect = 1e-11
 Identities = 36/126 (28%), Positives = 69/126 (54%), Gaps = 11/126 (8%)

Query: 72  DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
           DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 132 LA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           LA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +LL      + 
Sbjct: 143 LACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL------RG 192

Query: 191 QSPVQQ 196
            SP +Q
Sbjct: 193 HSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 1e-11
 Identities = 53/185 (28%), Positives = 88/185 (47%), Gaps = 23/185 (12%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITEL-- 68
           VA+K L     S  ++K +  E  ++    H +V+  L I          ++ +IT+L  
Sbjct: 39  VAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS------SQVQLITQLMP 91

Query: 69  LQSDL-----HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           L   L     HK  +  Q+L +     +  QI +G+ YL   R++HRD+   N+LV +  
Sbjct: 92  LGCLLDYVRNHKDNIGSQYLLN-----WCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ 146

Query: 124 ILKICDFGLARVEEPDPNKAMTQE-VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +KI DFGLA++ + D  +   +   V   + A E ++  R Y+   DVWS G    EL+
Sbjct: 147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELM 205

Query: 183 --GRR 185
             G +
Sbjct: 206 TFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 62.3 bits (151), Expect = 1e-11
 Identities = 38/132 (28%), Positives = 66/132 (50%), Gaps = 24/132 (18%)

Query: 87  HIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSN----------------CILKICD 129
           H+   ++Q    L Y H+   ++H D+KP N+L+ ++                C ++ICD
Sbjct: 232 HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 130 FGLARVEEPDPNKAMTQEVVTQYYRAPEILMG-ARHYSAAVDVWSVGCIFAELLGRRILF 188
            G       D   + T  V T++YR+PE+++G    YS   D+WS+GCI  EL   ++L+
Sbjct: 292 LGGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLY 345

Query: 189 QAQSPVQQLGLI 200
                ++ L L+
Sbjct: 346 DTHDNLEHLHLM 357

Length = 467

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 17/212 (8%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI--LQPPHLDF 58
           AV   +   R+   K+ N ++ L       +  +  CF +  NVL   D   +   H  F
Sbjct: 18  AVVKMKHTERIYAMKILNKWEML-------KRAETACFREERNVLVNGDCQWITTLHYAF 70

Query: 59  FQEIY---VITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
             E Y   V+   +  DL  ++      L  D  + ++ +++  +  +H    +HRDIKP
Sbjct: 71  QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKP 130

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM----GARHYSAAVD 170
            N+L++ N  +++ DFG       D     +  V T  Y +PEIL     G   Y    D
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190

Query: 171 VWSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
            WS+G    E+L     F A+S V+  G I +
Sbjct: 191 WWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 62.1 bits (150), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 51/210 (24%)

Query: 23  LVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITEL-----LQSDLHKI 76
           LV    V RELK      H N++  +D  L   +    Q++Y++ E      L  ++ K 
Sbjct: 59  LVIEVNVMRELK------HKNIVRYIDRFLNKAN----QKLYILMEFCDAGDLSRNIQKC 108

Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHS-------ARILHRDIKPGNLLV---------- 119
                 +    I     Q+L  L Y H+        R+LHRD+KP N+ +          
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168

Query: 120 -------NSNCILKICDFGLAR---VEEPDPNKAMTQEVV-TQYYRAPEILMG-ARHYSA 167
                  N   I KI DFGL++   +E      +M    V T YY +PE+L+   + Y  
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIE------SMAHSCVGTPYYWSPELLLHETKSYDD 222

Query: 168 AVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
             D+W++GCI  EL   +  F   +   QL
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKANNFSQL 252

Length = 1021

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 2e-11
 Identities = 36/127 (28%), Positives = 69/127 (54%), Gaps = 11/127 (8%)

Query: 72  DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
           DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 132 LA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           LA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +LL      + 
Sbjct: 143 LACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL------RG 192

Query: 191 QSPVQQL 197
            SP +Q 
Sbjct: 193 HSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.6 bits (149), Expect = 2e-11
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 2/94 (2%)

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I   L YLHS  I++RD+KP N+L++S   + + DFGL + E  + N   +   
Sbjct: 99  RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC 157

Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T  Y APE+L   + Y   VD W +G +  E+L
Sbjct: 158 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 2e-11
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 1/107 (0%)

Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE 136
           +   +      ++++  +I+  L++LH   I++RDIK  N+L++SN  + + DFGL++  
Sbjct: 96  LSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155

Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELL 182
             D  +       T  Y AP+I+ G    +  AVD WS+G +  ELL
Sbjct: 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 11/157 (7%)

Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-QHLTS 85
           +  +E ++L  + H N++  + +           IY++ EL+Q  D    + +    L  
Sbjct: 39  KFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELVQGGDFLTFLRTEGPRLKV 93

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
             +   +     G++YL S   +HRD+   N LV    +LKI DFG++R EE D   A T
Sbjct: 94  KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST 152

Query: 146 --QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
              + +   + APE L   R YS+  DVWS G +  E
Sbjct: 153 GGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 61.6 bits (149), Expect = 3e-11
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 18/206 (8%)

Query: 5   PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           P+  R +A K++    ++   + ++  E+  L    H+N+L   +IL+          Y+
Sbjct: 190 PKCERLIA-KRVKAGSRA---AIQLENEILALGRLNHENILKIEEILRSE-----ANTYM 240

Query: 65  ITELLQSDLHKIIVSPQHLTSD-----HIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           IT+    DL+  +        D       +  + Q+L  ++Y+H  +++HRDIK  N+ +
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  + + DFG A   E +        V T    +PEIL G   Y    D+WS G I  
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILL 359

Query: 180 ELLGRRIL---FQAQSPVQQLGLITD 202
           ++L             P +QL  I D
Sbjct: 360 DMLSHDFCPIGDGGGKPGKQLLKIID 385

Length = 501

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 60.7 bits (147), Expect = 3e-11
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 5/95 (5%)

Query: 92  LYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEV-- 148
           L  I  G+KYL     +HRD+   N+LVNSN + K+ DFGL+R  E D  +   T  +  
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 149 -VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +   + APE +   R +++A DVWS G +  E++
Sbjct: 172 KIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.0 bits (148), Expect = 3e-11
 Identities = 33/89 (37%), Positives = 51/89 (57%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I   L YLHS  I++RD+KP N+L++S   + + DFGL + E  + +K  +    T  Y
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEY 162

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE+L   + Y   VD W +G +  E+L
Sbjct: 163 LAPEVLR-KQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.1 bits (148), Expect = 3e-11
 Identities = 36/90 (40%), Positives = 57/90 (63%), Gaps = 4/90 (4%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           +I+ GL++LHS  I++RD+K  N+L++++  +KI DFG+ +  E     A T     T  
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPD 161

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           Y APEIL+G + Y+ +VD WS G +  E+L
Sbjct: 162 YIAPEILLGQK-YNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-11
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 5/89 (5%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I+  L+YLHS  I++RD+KP N+L++    +K+ DFG A+ +  D    +     T  Y
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTLCG---TPEY 164

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE++    H + AVD W++G +  E+L
Sbjct: 165 LAPEVIQSKGH-NKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 60.8 bits (147), Expect = 3e-11
 Identities = 36/100 (36%), Positives = 59/100 (59%), Gaps = 9/100 (9%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +IL GL+ LH    ++RD+KP N+L++    ++I D GLA V+ P+  +++   V T  Y
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPE-GESIRGRVGTVGY 167

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
            APE+L   R Y+ + D W +GC+  E++      + QSP
Sbjct: 168 MAPEVLNNQR-YTLSPDYWGLGCLIYEMI------EGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 3e-11
 Identities = 27/90 (30%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL + + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           + APE L     ++   DVWS G +  E+ 
Sbjct: 187 WMAPESLKDGV-FTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 60.5 bits (147), Expect = 3e-11
 Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 41/205 (20%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDIL---QPPHLDF-FQEIYVI 65
           VA+K L     +   +++ F RE ++L  F+H+N++    +     PP + F + E   +
Sbjct: 38  VAVKTLKET--ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL 95

Query: 66  TELLQSD------LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + L+S       L         LT   +     QI  G+ YL S   +HRD+   N LV
Sbjct: 96  NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEV-VTQYYR------------APEILMGARHYS 166
             + ++KI DFG            M+++V  T YYR             PE +M  R ++
Sbjct: 156 GYDLVVKIGDFG------------MSRDVYTTDYYRVGGHTMLPIRWMPPESIM-YRKFT 202

Query: 167 AAVDVWSVGCIFAELL--GRRILFQ 189
              DVWS G +  E+   G++  + 
Sbjct: 203 TESDVWSFGVVLWEIFTYGKQPWYG 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.1 bits (146), Expect = 4e-11
 Identities = 49/188 (26%), Positives = 86/188 (45%), Gaps = 30/188 (15%)

Query: 8   GRRVALKKLPNV---FQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIY 63
           G++VA+K L +     Q+ ++   V   L+      H N++  L + LQ         +Y
Sbjct: 29  GQKVAVKCLKDDSTAAQAFLAEASVMTTLR------HPNLVQLLGVVLQGNP------LY 76

Query: 64  VITELL-QSDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++TE + +  L   + S     +T      F   +  G++YL     +HRD+   N+LV+
Sbjct: 77  IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS 136

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH--YSAAVDVWSVGCIF 178
            + + K+ DFGLA+    + ++      +   + APE L   R   +S   DVWS G + 
Sbjct: 137 EDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEAL---REKKFSTKSDVWSFGILL 189

Query: 179 AEL--LGR 184
            E+   GR
Sbjct: 190 WEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 61.2 bits (148), Expect = 4e-11
 Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 2/94 (2%)

Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           +  YQI+  L  +HS +++HRD+K  N+ +    I+K+ DFG ++      +  +     
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 150 -TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T YY APE+    R YS   D+WS+G I  ELL
Sbjct: 233 GTPYYLAPELWERKR-YSKKADMWSLGVILYELL 265

Length = 478

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.8 bits (147), Expect = 4e-11
 Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 2/101 (1%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT+  +  F YQ+ RG+++L S   +HRD+   N+L+    I+KICDFGLAR    D N 
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293

Query: 143 -AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +     +   + APE +     Y+   DVWS G +  E+ 
Sbjct: 294 VSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIF 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.1 bits (146), Expect = 4e-11
 Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 21/174 (12%)

Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L  +    ++      +E  ++    H+N++    + L  P       + ++TEL
Sbjct: 26  VAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLIRLYGVVLTHP-------LMMVTEL 76

Query: 69  -----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                L   L K   +  H     +  +  QI  G++YL S R +HRD+   N+L+ S+ 
Sbjct: 77  APLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD 134

Query: 124 ILKICDFGLAR-VEEPDPNKAMT-QEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
            +KI DFGL R + + + +  M     V   + APE L   R +S A DVW  G
Sbjct: 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR-TRTFSHASDVWMFG 187

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.4 bits (146), Expect = 5e-11
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 27/196 (13%)

Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHD----NVLSA--------LDIL 51
           +DG R+  A+K++   + S    +    EL++LC   H     N+L A        L I 
Sbjct: 30  KDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88

Query: 52  QPPH---LDFFQEIYVITELLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSAR 106
             PH   LDF ++    + +L++D    I   +   L+S  +  F   + RG+ YL   +
Sbjct: 89  YAPHGNLLDFLRK----SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
            +HRD+   N+LV  N + KI DFGL+R +E    K M +  V   + A E L     Y+
Sbjct: 145 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMAIESL-NYSVYT 201

Query: 167 AAVDVWSVGCIFAELL 182
              DVWS G +  E++
Sbjct: 202 TNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.5 bits (146), Expect = 5e-11
 Identities = 39/126 (30%), Positives = 65/126 (51%), Gaps = 2/126 (1%)

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +VI  +   DL   +   + L  +H + +  +I   L YLH   I++RD+K  N+L++S 
Sbjct: 73  FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ D+G+ + E   P    +    T  Y APEIL G   Y  +VD W++G +  E++
Sbjct: 133 GHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMM 190

Query: 183 GRRILF 188
             R  F
Sbjct: 191 AGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.3 bits (146), Expect = 6e-11
 Identities = 32/90 (35%), Positives = 54/90 (60%), Gaps = 2/90 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           Q+L  + ++HS  ++HRDIK  N+L+ SN ++K+ DFG +++     +  + +    T Y
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           Y APEI    + YS   D++S+G +  ELL
Sbjct: 211 YVAPEIWR-RKPYSKKADMFSLGVLLYELL 239

Length = 496

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 60.1 bits (145), Expect = 7e-11
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 11/203 (5%)

Query: 11  VALKKLPNVFQSLVSSK-RVFRELKMLCFFKHDNVLSALDILQPPHLDF-FQE---IYVI 65
           V LK    VF   + +K  + +  +  CF +  +VL   D      L + FQ+   +Y++
Sbjct: 20  VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79

Query: 66  TEL-LQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
            +  +  DL  ++      L  D  + +L +++  +  +H    +HRDIKP N+L++ N 
Sbjct: 80  MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 139

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM----GARHYSAAVDVWSVGCIFA 179
            +++ DFG       D     +  V T  Y +PEIL     G   Y    D WS+G    
Sbjct: 140 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199

Query: 180 ELLGRRILFQAQSPVQQLGLITD 202
           E+L     F A+S V+  G I +
Sbjct: 200 EMLYGETPFYAESLVETYGKIMN 222

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 8e-11
 Identities = 42/139 (30%), Positives = 63/139 (45%), Gaps = 17/139 (12%)

Query: 49  DILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARIL 108
           D  +      + +  V +E+L+ D  ++ +  + L S     F YQ+ +G+ +L S   +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED--ELALDTEDLLS-----FSYQVAKGMSFLASKNCI 236

Query: 109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH---- 164
           HRD+   N+L+    I KICDFGLAR    D N      VV    R P   M        
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIRNDSNY-----VVKGNARLPVKWMAPESIFNC 291

Query: 165 -YSAAVDVWSVGCIFAELL 182
            Y+   DVWS G +  E+ 
Sbjct: 292 VYTFESDVWSYGILLWEIF 310

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.8 bits (145), Expect = 8e-11
 Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 7/112 (6%)

Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKA 143
           +D  K +  +++   +YLHS  I++RD+KP NLL+++   +K+ DFG A +V +      
Sbjct: 117 NDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC 176

Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
            T E     Y APE++    H   AVD W++G +  E +     F   +P +
Sbjct: 177 GTPE-----YLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 59.1 bits (143), Expect = 8e-11
 Identities = 48/182 (26%), Positives = 80/182 (43%), Gaps = 18/182 (9%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIY 63
           +    VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y
Sbjct: 29  KYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FY 78

Query: 64  VITELL-QSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLV 119
           +ITE +   +L   +        + + V LY   QI   ++YL     +HRD+   N LV
Sbjct: 79  IITEFMTYGNLLDYLRECNRQEVNAV-VLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             N ++K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  
Sbjct: 138 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLW 196

Query: 180 EL 181
           E+
Sbjct: 197 EI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 9e-11
 Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 4/123 (3%)

Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            L  D  + +L +++  +  +H    +HRDIKP N+L++ N  +++ DFG       D  
Sbjct: 98  RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157

Query: 142 KAMTQEVVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
                 V T  Y +PEIL     G   Y    D WS+G    E+L     F A+S V+  
Sbjct: 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217

Query: 198 GLI 200
           G I
Sbjct: 218 GKI 220

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.2 bits (143), Expect = 1e-10
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 9/99 (9%)

Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE 157
           GL+ L   RI++RD+KP N+L++    ++I D GLA V+ P+  + +   V T  Y APE
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPE-GETVRGRVGTVGYMAPE 171

Query: 158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
           ++   + Y+ + D W +GC+  E++      Q QSP ++
Sbjct: 172 VINNEK-YTFSPDWWGLGCLIYEMI------QGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 59.6 bits (144), Expect = 1e-10
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 15/169 (8%)

Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY---VITELLQSDLHKIIVSPQHLTS 85
           VF E K+L +  H   ++        +  F  E Y   V+  ++  +    +   +   +
Sbjct: 78  VFSERKILNYINHPFCVNL-------YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN 130

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
           D    +  QI+   +YL S  I++RD+KP NLL++ +  +K+ DFG A+V +    +  T
Sbjct: 131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYT 187

Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV 194
               T  Y APEIL+   H  AA D W++G    E+L     F A  P+
Sbjct: 188 L-CGTPEYIAPEILLNVGHGKAA-DWWTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 58.9 bits (142), Expect = 1e-10
 Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 32/195 (16%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           +VA+K +     +    +    E   +  F H NV+  + + LQ    + +    VI   
Sbjct: 28  KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPF 87

Query: 69  LQ-SDLHKIIV------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++  DLH  ++       PQ+L +  +  F+  I  G++YL S   +HRD+   N ++N 
Sbjct: 88  MKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147

Query: 122 NCILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEIL-----------MGARHYSAAV 169
           N  + + DFGL+ ++   D            YYR   I            +  R Y+   
Sbjct: 148 NMNVCVADFGLSKKIYNGD------------YYRQGRIAKMPVKWIAIESLADRVYTTKS 195

Query: 170 DVWSVGCIFAELLGR 184
           DVWS G    E+  R
Sbjct: 196 DVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)

Query: 4   DPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF---- 58
           DP   RRVALKK+  ++ ++ +  KR  RE K+     H  ++    I       +    
Sbjct: 23  DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP 82

Query: 59  FQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFL---YQILRGLKYLHSARILHRDIKPG 115
           + E Y +  LL+S   K  +S +      +  FL   ++I   ++Y+HS  +LHRD+KP 
Sbjct: 83  YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPD 142

Query: 116 NLLVNSNCILKICDFGLARVEE-----------PDPN---KAMT---QEVVTQYYRAPEI 158
           N+L+     + I D+G A  ++            + N    +MT   + V T  Y APE 
Sbjct: 143 NILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202

Query: 159 LMGARHYSAAVDVWSVGCIFAELL 182
           L+G    S + D++++G I  ++L
Sbjct: 203 LLGVPA-SESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 59.5 bits (144), Expect = 1e-10
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 12/101 (11%)

Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           F  Q+ +G+ +L S   +HRD+   N+L+    + KICDFGLAR    D N      VV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-----VVK 271

Query: 151 QYYRAPEILMGARH-----YSAAVDVWSVGCIFAEL--LGR 184
              R P   M         Y+   DVWS G +  E+  LG+
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGK 312

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.9 bits (143), Expect = 1e-10
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 10/100 (10%)

Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           ++ GL+YLH  +I++RD+K  NLL+++   +KI DFGL + E        +    T  + 
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEFL 168

Query: 155 APEILMGARHYSAAVDVWSVGC-IFAELLGRRILFQAQSP 193
           APE+L     Y+ AVD W +G  I+  L+G       +SP
Sbjct: 169 APEVLTETS-YTRAVDWWGLGVLIYEMLVG-------ESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 40/127 (31%), Positives = 65/127 (51%), Gaps = 6/127 (4%)

Query: 60  QEIYVITELLQS-DLHKIIVSPQHLTSDHIKV--FLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +    L   + S +       K+  F  QI  G+ ++     +HRD++  N
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAAN 132

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDVWSVG 175
           +LV+++ + KI DFGLARV E +   A         + APE I  G+  ++   DVWS G
Sbjct: 133 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS--FTIKSDVWSFG 190

Query: 176 CIFAELL 182
            +  E++
Sbjct: 191 ILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 4/99 (4%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           +I+ GL++LH   I++RD+K  N+L++S   +KI DFG+ +  E       T     T  
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPD 161

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
           Y APEIL     Y  AVD W++G +  E+L  +  F+  
Sbjct: 162 YIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 32/206 (15%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           +D   VA+K L +   +L + K   RE ++L   +H++++    +      D    I V 
Sbjct: 33  KDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVC----GDGDPLIMVF 86

Query: 66  TELLQSDLHK----------IIVSPQHLTSD---------HIKVFLYQILRGLKYLHSAR 106
             +   DL+K          I+V  Q   +          HI     QI  G+ YL S  
Sbjct: 87  EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS---QIASGMVYLASQH 143

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHY 165
            +HRD+   N LV +N ++KI DFG++R V   D  +     ++   +  PE +M  R +
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKF 202

Query: 166 SAAVDVWSVGCIFAELL--GRRILFQ 189
           +   DVWS G I  E+   G++  FQ
Sbjct: 203 TTESDVWSFGVILWEIFTYGKQPWFQ 228

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 58.5 bits (141), Expect = 2e-10
 Identities = 39/137 (28%), Positives = 65/137 (47%), Gaps = 7/137 (5%)

Query: 49  DILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARIL 108
           DI    +   + + Y+ +   ++    +I     L+   +  F YQ+  G+++L S   +
Sbjct: 203 DIESSNYESPYDQ-YLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261

Query: 109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYRAPEILMGARHY 165
           HRD+   N+L+    ++KICDFGLAR    D N   K  T   +   + APE +     Y
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST--FLPLKWMAPESIFNNL-Y 318

Query: 166 SAAVDVWSVGCIFAELL 182
           +   DVWS G +  E+ 
Sbjct: 319 TTLSDVWSFGILLWEIF 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 57.9 bits (140), Expect = 2e-10
 Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 24/139 (17%)

Query: 60  QEIYVITELLQS----DLHKIIVSPQHLTSDHIKVFLY-------QILRGLKYLHSARIL 108
           + IY+ITE +++    D  K        T + IK+ +        QI  G+ ++     +
Sbjct: 73  EPIYIITEYMENGSLVDFLK--------TPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124

Query: 109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSA 167
           HRD++  N+LV+     KI DFGLAR+ E +   A         + APE I  G   ++ 
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--FTI 182

Query: 168 AVDVWSVGCIFAELL--GR 184
             DVWS G +  E++  GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 57.3 bits (138), Expect = 3e-10
 Identities = 28/84 (33%), Positives = 46/84 (54%), Gaps = 1/84 (1%)

Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE 157
           G+ YL S+ ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + +PE
Sbjct: 112 GMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE 171

Query: 158 ILMGARHYSAAVDVWSVGCIFAEL 181
           +   ++ YS+  DVWS G +  E+
Sbjct: 172 VFSFSK-YSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 57.4 bits (139), Expect = 3e-10
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 27/176 (15%)

Query: 22  SLVSSKRVFRELKMLCFFKHDNVLSALDIL----QPPHLDF-FQEIYVITELLQSDLHKI 76
           S +    + +E  +L    H N+L  L +     +PP + + +     +   LQ      
Sbjct: 48  SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGE 107

Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE 136
             +PQ L++  +     QI  G+ YLH   ++H+DI   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 137 EPD-----------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            P            P K M          A E L+  + YS+A DVWS G +  EL
Sbjct: 168 FPMDYHCLGDNENRPVKWM----------ALESLVN-KEYSSASDVWSFGVLLWEL 212

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 2/108 (1%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + L  +H + +  +I   L +LH   I++RD+K  N+L++++  +K+ D+G+ + E   P
Sbjct: 91  RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGP 149

Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF 188
               +    T  Y APEIL G   Y  +VD W++G +  E++  R  F
Sbjct: 150 GDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 5/103 (4%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           L  D I     +ILRGL +LH+ +++HRDIK  N+L+  N  +K+ DFG++   +    +
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177

Query: 143 AMTQEVVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
             T  + T Y+ APE++    +    Y    D+WS+G    E+
Sbjct: 178 RNTF-IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 57.7 bits (139), Expect = 4e-10
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 92  FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 150

Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.1 bits (138), Expect = 5e-10
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 93  YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQ 151
            QI  G++YL S   +HRD+   N LV     +KI DFGL+R +   D  +  ++ ++  
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            +  PE ++  + ++   D+WS G +  E+
Sbjct: 191 RWMPPEAILYGK-FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 57.4 bits (139), Expect = 5e-10
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 7/93 (7%)

Query: 93  YQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMTQEVVT 150
              ++ L YL    +I+HRD+KP N+L++ N  +K+CDFG++ ++ +   + A T++   
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGC 170

Query: 151 QYYRAPEILM--GARHYSAAVDVWSVGCIFAEL 181
           + Y APE +       Y    DVWS+G    E+
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.4 bits (138), Expect = 5e-10
 Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 4/113 (3%)

Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEP 138
           P  LT   +     QI  G+ YL S   +HRD+   N LV  N ++KI DFG++R V   
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173

Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           D  +     ++   +  PE +M  R ++   DVWS+G +  E+   G++  +Q
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.1 bits (138), Expect = 6e-10
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I  GL +LHS  I++RD+K  N+++++   +KI DFG+ + E     K       T  Y
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDY 167

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APEI+   + Y  +VD W+ G +  E+L
Sbjct: 168 IAPEIIA-YQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 56.9 bits (137), Expect = 6e-10
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 14/165 (8%)

Query: 25  SSKRVFRELK--MLCF--FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS 79
           S ++ F+E+   ML      H  ++  L I     L    ++  +  LL     H+  + 
Sbjct: 48  SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLD 107

Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD 139
           PQ L +     +  QI +G+ YL   R++HR++   N+L+ S+ I++I DFG+A +  PD
Sbjct: 108 PQRLLN-----WCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 140 PNKAMTQEVVT--QYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K    E  T  ++     IL G   Y+   DVWS G    E++
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 7e-10
 Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 5/115 (4%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
              D  + +L +++  +  +H    +HRDIKP N+L++    +K+ DFG A     +   
Sbjct: 99  FDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAV-----DVWSVGCIFAELLGRRILFQAQS 192
                V T  Y APE+L               D WS+G I  E++  R  F   +
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 7e-10
 Identities = 33/86 (38%), Positives = 47/86 (54%), Gaps = 6/86 (6%)

Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD---PNKAMTQEVVTQYYR 154
           G++YL S   +HRD+   N LV  N +LKI DFG++R EE      +  + Q  +   + 
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WT 162

Query: 155 APEILMGARHYSAAVDVWSVGCIFAE 180
           APE L   R Y++  DVWS G +  E
Sbjct: 163 APEALNYGR-YTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.8 bits (137), Expect = 7e-10
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 2/106 (1%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           L  +H + +  +I   L +LH   I++RD+K  N+L+++   +K+ D+G+ + E   P  
Sbjct: 93  LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGD 151

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF 188
             +    T  Y APEIL G   Y  +VD W++G +  E++  R  F
Sbjct: 152 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 56.6 bits (136), Expect = 8e-10
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 16/167 (9%)

Query: 27  KRVFRELKMLCFFKHDNVLS----ALDILQPPHLDFFQEIYVITELLQ----SDLHKIIV 78
           + + +E+ ML  + H   ++    A     PP +D   +++++ E       +DL K   
Sbjct: 47  EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD--DQLWLVMEFCGAGSVTDLIKN-T 103

Query: 79  SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP 138
               L  + I     +ILRGL +LH  +++HRDIK  N+L+  N  +K+ DFG++   + 
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163

Query: 139 DPNKAMTQEVVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
              +  T  + T Y+ APE++    +    Y    D+WS+G    E+
Sbjct: 164 TVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.6 bits (136), Expect = 9e-10
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 25/195 (12%)

Query: 6   RDGRRV-ALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALD-----------ILQ 52
           +DG ++ A  K+   F S    +    EL++LC    H N+++ L            I  
Sbjct: 25  KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84

Query: 53  PPH---LDFFQEIYVITELLQSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARI 107
            P+   LDF ++    + +L++D    K   +   LTS  +  F   +  G++YL   + 
Sbjct: 85  APYGNLLDFLRK----SRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQF 140

Query: 108 LHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA 167
           +HRD+   N+LV  N   KI DFGL+R EE    K M +  V   + A E L     Y+ 
Sbjct: 141 IHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR--WMAIESL-NYSVYTT 197

Query: 168 AVDVWSVGCIFAELL 182
             DVWS G +  E++
Sbjct: 198 KSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 1e-09
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           ++   + YLHS  I++RD+KP N+L++S   + + DFGL + E  +P +  +    T  Y
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEY 162

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE+L     Y   VD W +G +  E+L
Sbjct: 163 LAPEVLR-KEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 42/165 (25%)

Query: 59  FQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ+   +Y+I E L   D+  +++     T +  + ++ + +  +  +H    +HRDIKP
Sbjct: 70  FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKP 129

Query: 115 GNLLVNSNCILKICDFGL------------ARV---EEPDPNKAMTQE------------ 147
            NLL+++   +K+ DFGL             R+     P        +            
Sbjct: 130 DNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWK 189

Query: 148 ----------VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                     V T  Y APE+ +    Y+   D WS+G I  E+L
Sbjct: 190 RNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 2/94 (2%)

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I   L YLHS  I++RD+KP N+L++S   + + DFGL + E    +   T   
Sbjct: 99  RFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFC 157

Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T  Y APE++   + Y   VD W +G +  E+L
Sbjct: 158 GTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.6 bits (134), Expect = 2e-09
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           Q+  G+ YL   + +HRD+   N LV  N ++KI DFGL+R +   D  KA   + +   
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +  PE +   R Y+   DVW+ G +  E+
Sbjct: 198 WMPPESIFYNR-YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 32/128 (25%), Positives = 59/128 (46%), Gaps = 29/128 (22%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL---------- 132
           L+ +  + +  ++L  L+YLH   I++RD+KP N+L++ +  + + DF L          
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 133 ----ARVEEPDPN-KAMTQEVV-------------TQYYRAPEILMGARHYSAAVDVWSV 174
                R      +  ++  E               T+ Y APE++ G  H  +AVD W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTL 218

Query: 175 GCIFAELL 182
           G +  E+L
Sbjct: 219 GILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 37/117 (31%), Positives = 55/117 (47%), Gaps = 3/117 (2%)

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           K +  +++  L  +HS  ++HRD+KP N+L++ +  LK+ DFG     +          V
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204

Query: 149 VTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
            T  Y +PE+L    G  +Y    D WSVG    E+L     F A S V     I D
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 40/130 (30%), Positives = 70/130 (53%), Gaps = 15/130 (11%)

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHI--KVFLYQILRGLKYL---HSARILHRDIKPG 115
           ++++  EL+ + L K++   Q    + I  K+    I++ L YL   H   ++HRD+KP 
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKM-TVAIVKALHYLKEKHG--VIHRDVKPS 144

Query: 116 NLLVNSNCILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEIL---MGARHYSAAVDV 171
           N+L++++  +K+CDFG++ R+ +   +KA T+      Y APE +        Y    DV
Sbjct: 145 NILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADV 201

Query: 172 WSVGCIFAEL 181
           WS+G    EL
Sbjct: 202 WSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 2e-09
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           QI  G+KYL S   +HRD+   N LV  N  +KI DFG++R +   D  +   + V+   
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 153 YRAPE-ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + + E IL+G   ++ A DVW+ G    E+L        + P  QL
Sbjct: 198 WMSWESILLG--KFTTASDVWAFGVTLWEILT----LCKEQPYSQL 237

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.0 bits (132), Expect = 2e-09
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 4/113 (3%)

Query: 73  LHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
           L+K +   +  +T  ++   ++Q+  G+KYL     +HRD+   N+L+ +    KI DFG
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFG 140

Query: 132 LARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           L++    D +  KA +       + APE +   R +S+  DVWS G    E  
Sbjct: 141 LSKALGADDSYYKARSAGKWPLKWYAPECIN-FRKFSSRSDVWSYGITMWEAF 192

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 2e-09
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 7/112 (6%)

Query: 72  DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDF 130
           DL  ++     L+   +K  + Q++  L  LH   I+H DIK  N+L + +   + +CD+
Sbjct: 95  DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154

Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL ++           +    Y+ +PE + G  +Y  + D W+VG +  ELL
Sbjct: 155 GLCKII----GTPSCYDGTLDYF-SPEKIKG-HNYDVSFDWWAVGVLTYELL 200

Length = 267

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           + L+GL YLHS   +HRDIK  N+L+  N  +K+ DFG+A        K  +  + T Y+
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF-IGTPYW 172

Query: 154 RAPEILMGARH--YSAAVDVWSVGCIFAEL 181
            APE+    ++  Y+   D+W+VG    EL
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 4/91 (4%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQ 151
           QI +G+ YL   R++HRD+   N+LV S   +KI DFGLAR+ + D  +  A   +V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +     IL   R ++   DVWS G    EL+
Sbjct: 177 WMALESILH--RRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.0 bits (132), Expect = 3e-09
 Identities = 47/189 (24%), Positives = 88/189 (46%), Gaps = 12/189 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V + ++G + A+K L  +       +  +  LK L    H NV+    +     +    +
Sbjct: 37  VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKFYGMYYKKDVKNGDQ 94

Query: 62  IYVITELLQ----SDLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           ++++ EL      +DL K  +   + +    I   L++ L GL++LH  + +HRD+K  N
Sbjct: 95  LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNN 154

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH----YSAAVDVW 172
           +L+ +   +K+ DFG++  +           V T ++ APE++   +     Y A  DVW
Sbjct: 155 ILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213

Query: 173 SVGCIFAEL 181
           S+G    EL
Sbjct: 214 SLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.1 bits (132), Expect = 3e-09
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           L+   I     + L+GL YLHS   +HRDIK  N+L+  N  +K+ DFG++   +     
Sbjct: 103 LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI 160

Query: 143 AMTQEVV-TQYYRAPEILMGARH--YSAAVDVWSVGCIFAEL 181
           A  +  + T Y+ APE+    R   Y+   D+W+VG    EL
Sbjct: 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.8 bits (132), Expect = 3e-09
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 20/163 (12%)

Query: 31  RELKMLCFFKHDNVLSALDILQ--PPHLDFFQEIYVITE----------LLQSDLHKIIV 78
           REL M     H NV+  L + +   PH       Y+I E          L  +      +
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPH-------YMILEYTDLGDLKQFLRATKSKDEKL 109

Query: 79  SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP 138
            P  L++        QI  G+ +L +AR +HRD+   N LV+S   +K+    L++    
Sbjct: 110 KPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
                +   ++   + APE +     +S   DVWS G +  E+
Sbjct: 170 SEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 3/109 (2%)

Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +++  L  +HS   +HRD+KP N+L++ +  LK+ DFG       +        V
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204

Query: 149 VTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV 194
            T  Y +PE+L    G  +Y    D WSVG    E+L     F A S V
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 8e-09
 Identities = 38/105 (36%), Positives = 52/105 (49%), Gaps = 20/105 (19%)

Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY- 153
           +LR ++YLH  RI+HRDIK  N+ +N    + + DFG A     D N         +YY 
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA-------NKYYG 242

Query: 154 -------RAPEILMGARH-YSAAVDVWSVGCIFAEL-LGRRILFQ 189
                   APE+L  AR  Y  AVD+WS G +  E+      LF+
Sbjct: 243 WAGTIATNAPELL--ARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285

Length = 391

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.4 bits (128), Expect = 1e-08
 Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 8/106 (7%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           QI  G+KYL S   +HRD+   N LV  N  +KI DFG++R +   D  +   + V+   
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 153 YRAPE-ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + A E ILMG   ++ A DVW+ G    E+L   +L + Q P  +L
Sbjct: 206 WMAWECILMG--KFTTASDVWAFGVTLWEIL---MLCKEQ-PYGEL 245

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 24/168 (14%)

Query: 32  ELKMLCFFKHD----NVLSALD--------ILQPPH---LDFFQEIYVITELLQSD--LH 74
           EL++LC   H     N+L A +        I   PH   LDF ++    + +L++D    
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK----SRVLETDPAFA 100

Query: 75  KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR 134
               +   L+S  +  F   + RG+ YL   + +HRD+   N+LV  N + KI DFGL+R
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Query: 135 VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +E    K M +  V   + A E L     Y+   DVWS G +  E++
Sbjct: 161 GQEVYVKKTMGRLPVR--WMAIESL-NYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 2/92 (2%)

Query: 99  LKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI 158
           L +LH   +++RD+K  N+L+++    K+ DFG+ + E        T    T  Y APEI
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEI 167

Query: 159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           L     Y  +VD W++G +  E++  +  F+A
Sbjct: 168 LQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 2/99 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I   L +LH   I++RD+K  N+L++     K+ DFG+ + E     K  +    T  Y
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDY 162

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
            APEIL     Y  +VD W++G +  E+L     F+A++
Sbjct: 163 IAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 44/137 (32%), Positives = 64/137 (46%), Gaps = 30/137 (21%)

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLY-----QILRGLKYLHSARILHRDIKPGN 116
           I ++T+L+    H  ++   H   D+I   L      QI +G+ YL   R++HRD+   N
Sbjct: 83  IQLVTQLMP---HGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN 139

Query: 117 LLVNSNCILKICDFGLARVEEPD-----------PNKAMTQEVVTQYYRAPEILMGARHY 165
           +LV S   +KI DFGLAR+ E D           P K M  E +  +Y         R +
Sbjct: 140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI--HY---------RKF 188

Query: 166 SAAVDVWSVGCIFAELL 182
           +   DVWS G    EL+
Sbjct: 189 THQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.7 bits (126), Expect = 2e-08
 Identities = 44/150 (29%), Positives = 72/150 (48%), Gaps = 14/150 (9%)

Query: 52  QPPHL----DFFQ---EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLH 103
           +PP L      FQ    +Y + E +   DL   I         H   +  +I  GL +LH
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 104 SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMG 161
           S  I++RD+K  N++++S   +KI DFG+ +    D    +T +    T  Y APEI+  
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCGTPDYIAPEII-A 174

Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            + Y  +VD W+ G +  E+L  +  F+ +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 52.8 bits (126), Expect = 2e-08
 Identities = 25/46 (54%), Positives = 31/46 (67%)

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA 133
           IK  + Q+L GL+ LH   I+HRDIKP NLLV  +  +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.5 bits (126), Expect = 3e-08
 Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 44/158 (27%)

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA------------ 133
           D  + ++ ++   ++ +H    +HRDIKP N+L++ +  +K+ DFGL             
Sbjct: 101 DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 134 ---------------RVEEPDPNKAMTQE---------------VVTQYYRAPEILMGAR 163
                             E D  +    E               V T  Y APE+L+   
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RT 219

Query: 164 HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ-QLGLI 200
            Y+   D WSVG I  E+L  +  F A +P + QL +I
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI 257

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 4e-08
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 39/173 (22%)

Query: 59  FQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ+   +Y+I E L   D+  +++    LT +  + ++ + +  +  +H    +HRDIKP
Sbjct: 70  FQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKP 129

Query: 115 GNLLVNSNCILKICDFGLA-------RVE-----------------EPDPNKAMT----- 145
            NLL++S   +K+ DFGL        R E                      KA T     
Sbjct: 130 DNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNR 189

Query: 146 -----QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
                  V T  Y APE+ M    Y+   D WS+G I  E+L     F +++P
Sbjct: 190 RQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.5 bits (123), Expect = 4e-08
 Identities = 45/181 (24%), Positives = 86/181 (47%), Gaps = 24/181 (13%)

Query: 8   GRRVALKKLPN--VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           G +VA+K + N    Q+ ++   V  +L+      H N++  L ++    ++    +Y++
Sbjct: 29  GNKVAVKCIKNDATAQAFLAEASVMTQLR------HSNLVQLLGVI----VEEKGGLYIV 78

Query: 66  TELL-QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           TE + +  L   + S     L  D +  F   +   ++YL +   +HRD+   N+LV+ +
Sbjct: 79  TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED 138

Query: 123 CILKICDFGLARVEEPDPNKAMTQEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            + K+ DFGL +        + TQ+   +   + APE L   + +S   DVWS G +  E
Sbjct: 139 NVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWE 191

Query: 181 L 181
           +
Sbjct: 192 I 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 51.5 bits (123), Expect = 5e-08
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 2/106 (1%)

Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V+P  LT   +     QI  G+ YL S   +HRD+   N LV    ++KI DFG++R + 
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             D  +   + ++   +  PE ++  R ++   D+WS G +  E+ 
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 4/100 (4%)

Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-- 142
           S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   D  +  
Sbjct: 108 SQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 168 AEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 6e-08
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 36/169 (21%)

Query: 60  QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           + +Y+I E L   D+  +++    L+ +  + ++ + +  +  +H    +HRDIKP NLL
Sbjct: 74  RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133

Query: 119 VNSNCILKICDFGLA-------RVE-------EPDPN----------KAMT--------- 145
           +++   +K+ DFGL        R E        P  +          KA T         
Sbjct: 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLA 193

Query: 146 -QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
              V T  Y APE+ M    Y+   D WS+G I  E+L     F +++P
Sbjct: 194 YSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.0 bits (122), Expect = 7e-08
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 27/190 (14%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVIT 66
           RVA+K L     +    K+ F +E  ++  F H N++  L +  L  P        Y+I 
Sbjct: 28  RVAVKTLRK--GATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-------QYIIM 78

Query: 67  ELLQS--------DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           EL++         D       P  LT   +      + +G  YL     +HRD+   N L
Sbjct: 79  ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCL 138

Query: 119 VNSNC-----ILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           V+        ++KI DFGLAR + + D  +   + ++   + APE L+  + ++   DVW
Sbjct: 139 VSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVW 197

Query: 173 SVGCIFAELL 182
           S G +  E+L
Sbjct: 198 SFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.7 bits (121), Expect = 8e-08
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 22/168 (13%)

Query: 30  FRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE----------LLQSDLHKIIVS 79
            +E+K++   K+ N++  L +           + +ITE          L Q ++      
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 80  PQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-V 135
             ++ S  I   LY   QI  G+KYL S   +HRD+   N LV ++  +KI DFG++R +
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 136 EEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDVWSVGCIFAELL 182
              D  +   + V+   + A E IL+G   ++ A DVW+ G    E+ 
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMF 225

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 50.0 bits (119), Expect = 1e-07
 Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 31/193 (16%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDIL---QPPHLDFFQEIYVIT 66
           VA+K L +  ++    +  F+   M+    +H N++  L ++   QP  + F       +
Sbjct: 38  VAIKTLKD--KAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF-------S 88

Query: 67  ELLQSDLHKIIV--SPQH---LTSDHIKV--------FLY---QILRGLKYLHSARILHR 110
               SDLH+ +V  SP      T D   V        F++   QI  G+++L S  ++H+
Sbjct: 89  YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHK 148

Query: 111 DIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAV 169
           D+   N+LV     +KI D GL R V   D  K M   ++   + +PE +M  + +S   
Sbjct: 149 DLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDS 207

Query: 170 DVWSVGCIFAELL 182
           D+WS G +  E+ 
Sbjct: 208 DIWSYGVVLWEVF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 9/116 (7%)

Query: 70  QSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
           +SDL+  + +  + L    +     Q+L  + Y+H   I+HRDIK  N+LVN    + + 
Sbjct: 243 RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLG 302

Query: 129 DFG---LARVEEPDP-NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           DFG    AR     P +  +   V T    APE+L G   Y+ +VD+WS G +  E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTN---APEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.7 bits (119), Expect = 2e-07
 Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 23/188 (12%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF---QEIYV 64
              VA+KK+     S    K + +E+      +H N+L        P++  F    E+YV
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYVTSFIVDSELYV 76

Query: 65  ITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++ L+      DL K    P+ L    I   L  +L  L Y+HS   +HR +K  ++L++
Sbjct: 77  VSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS 135

Query: 121 SNCILKICDFGLAR--VEEPDPNKAM----TQEVVTQYYRAPEILMGARH-YSAAVDVWS 173
            +  + +     +   ++     + +       V    + +PE+L      Y+   D++S
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195

Query: 174 VGCIFAEL 181
           VG    EL
Sbjct: 196 VGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 49.6 bits (118), Expect = 2e-07
 Identities = 32/104 (30%), Positives = 54/104 (51%), Gaps = 14/104 (13%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQY- 152
           +I  GL +LH   I++RD+K  N++++S   +KI DFG+ +       + M   V T+  
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGVTTRTF 161

Query: 153 -----YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
                Y APEI+   + Y  +VD W+ G +  E+L  +  F  +
Sbjct: 162 CGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 42/120 (35%), Positives = 60/120 (50%), Gaps = 20/120 (16%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLAR----VEEPDPNKA-MT 145
           Q+L  L   H+  I+HRD+KP N++V+   +    K+ DFG+      V + D      T
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT 146

Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAE-LLGRR---------ILFQAQSPV 194
            EV+ T  Y APE L G    +   D+++ G IF E L G+R         IL+Q  SPV
Sbjct: 147 TEVLGTPTYCAPEQLRG-EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPV 205

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 49.4 bits (118), Expect = 2e-07
 Identities = 40/174 (22%), Positives = 72/174 (41%), Gaps = 35/174 (20%)

Query: 39  FKHDNVLSALDI-LQPPHLDFFQEIYVITELLQ-SDLHKIIVS------PQHLTSDHIKV 90
           F H NV+  + +  +   L    +  VI   ++  DLH  ++       P+ L    +  
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           F+  I  G++YL +   +HRD+   N ++  +  + + DFGL++       K  + +   
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK-------KIYSGD--- 167

Query: 151 QYYRAPEIL-----------MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
            YYR   I            +  R Y++  DVW+ G    E+  R      Q+P
Sbjct: 168 -YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-----GQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 31/174 (17%)

Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL-QSDLHKIIV--SPQH---LT 84
           +E  ++    H N++  L ++        Q + ++ E L Q DLH+ ++  SP      +
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110

Query: 85  SD---------------HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           SD               HI +   QI  G++YL S   +H+D+   N+L+     +KI D
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAI---QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISD 167

Query: 130 FGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            GL+R +   D  +   + ++   +  PE +M  + +S+  D+WS G +  E+ 
Sbjct: 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIF 220

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 18/37 (48%), Positives = 28/37 (75%)

Query: 99  LKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV 135
           L YLH   I+HRD+KP N+L+++   +K+ DFGL++V
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.2 bits (117), Expect = 3e-07
 Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 52/190 (27%)

Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           +F   Y+    + S L ++ V P+ L     + ++ ++   ++ +H    +HRDIKP N+
Sbjct: 77  YFVMDYIPGGDMMSLLIRMEVFPEVLA----RFYIAELTLAIESVHKMGFIHRDIKPDNI 132

Query: 118 LVNSNCILKICDFGLA------------------RVEEPDPN---------------KAM 144
           L++ +  +K+ DFGL                   R +  +P+               K +
Sbjct: 133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192

Query: 145 TQEVVTQYYR-------------APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            Q    Q+ R             APE+L+  + Y+   D WSVG I  E+L  +  F A 
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251

Query: 192 SPVQ-QLGLI 200
           +P + QL +I
Sbjct: 252 TPTETQLKVI 261

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.3 bits (115), Expect = 4e-07
 Identities = 29/108 (26%), Positives = 51/108 (47%), Gaps = 5/108 (4%)

Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
           ++  + +K +  +++  L  LH   I+ RD+ P N+L++    +++  F      E    
Sbjct: 81  NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED--- 137

Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            +   E V   Y APE+  G    + A D WS+G I  ELL  + L +
Sbjct: 138 -SCDGEAVENMYCAPEV-GGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 5e-07
 Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 46/198 (23%)

Query: 11  VALKKL-PNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITE 67
           VA+K L P+      +++  F +E+K+L      N+   L +    P L       +I E
Sbjct: 49  VAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL------CMIME 99

Query: 68  LLQ-SDLHKIIVSPQHLTSDHI--------KVFLY---QILRGLKYLHSARILHRDIKPG 115
            ++  DL++ +      TS              LY   QI  G++YL S   +HRD+   
Sbjct: 100 YMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159

Query: 116 NLLVNSNCILKICDFGLAR---------VE--EPDPNKAMTQEVVTQYYRAPEILMGARH 164
           N LV  N  +KI DFG++R         V+   P P + M  E          +L+G   
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE---------SVLLG--K 208

Query: 165 YSAAVDVWSVGCIFAELL 182
           ++   DVW+ G    E+L
Sbjct: 209 FTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 47.3 bits (112), Expect = 1e-06
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 7/105 (6%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL++ + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + +PE L     ++   DVWS G +  E     I   A+ P Q +
Sbjct: 187 WMSPESLKDGV-FTTYSDVWSFGVVLWE-----IATLAEQPYQGM 225

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 42/179 (23%), Positives = 73/179 (40%), Gaps = 47/179 (26%)

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V+  +   D+  +++       D  + ++ ++   ++ +H    +HRDIKP N+L++ +
Sbjct: 78  FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137

Query: 123 CILKICDFGLA-------------------------RVEEPDPN-------------KAM 144
             +K+ DFGL                            E  DP              +A 
Sbjct: 138 GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA 197

Query: 145 TQE--------VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
            Q         V T  Y APE+L+    Y+   D WSVG I  E+L  +  F AQ+P++
Sbjct: 198 RQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE 255

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL++ + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + APE L     ++ + D+WS G +  E     I   A+ P Q L
Sbjct: 187 WMAPESLKDGV-FTTSSDMWSFGVVLWE-----ITSLAEQPYQGL 225

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.8 bits (111), Expect = 2e-06
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 51/174 (29%)

Query: 59  FQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ+   +Y+I E L   DL  +++     + D  + ++ + +  ++ +H    +HRDIKP
Sbjct: 70  FQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKP 129

Query: 115 GNLLVNSNCILKICDFGLA-------------RVEEPDPNKAMTQE-------------- 147
            N+L++    +K+ DFGL+             ++ +   NK                   
Sbjct: 130 DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMS 189

Query: 148 -------------------VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                              V T  Y APEI +  + Y    D WS+G I  E L
Sbjct: 190 SKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECL 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 33/108 (30%), Positives = 50/108 (46%), Gaps = 17/108 (15%)

Query: 95  ILRGLKYLHSARILHRDIKPGNLLVN--SNCILKICDFGLARVEEPDPNK------AMTQ 146
           +L  L YLH   I+HRD+K  N+ ++   N +L   DFG A   +  P+       + T 
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTL 251

Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSP 193
           E       +PE L+    Y A  D+WS G +  E+  + + LF  Q  
Sbjct: 252 ET-----NSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293

Length = 392

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 43.4 bits (102), Expect = 2e-05
 Identities = 44/186 (23%), Positives = 77/186 (41%), Gaps = 10/186 (5%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVI 65
            ++VA+K L     S    +   RE   +  F H NV  L  + +           + ++
Sbjct: 27  FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86

Query: 66  TELLQSDLHKIIV------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             +   DLH  ++       P  L    +  F+  I  G++YL S   +HRD+   N ++
Sbjct: 87  PFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML 146

Query: 120 NSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           N N  + + DFGL++ +   D  +      +   + A E L     Y+   DVW+ G   
Sbjct: 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESL-ADNVYTTHSDVWAFGVTM 205

Query: 179 AELLGR 184
            E++ R
Sbjct: 206 WEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.4 bits (102), Expect = 3e-05
 Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            L +  +   L  +  G+KYL     +H+ +    +LVNS+ + KI  F   R++E D +
Sbjct: 103 QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQE-DKS 159

Query: 142 KAMTQEVVTQ---YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +A+   +  +    + APE +    H+S+A DVWS G +  E++
Sbjct: 160 EAIYTTMSGKSPVLWAAPEAIQ-YHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 34/127 (26%), Positives = 58/127 (45%), Gaps = 11/127 (8%)

Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR----V 135
           P+ ++   I   L+  LRGL YLH    +HR+IK  ++L++ + ++ +   GL+     V
Sbjct: 95  PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLV 152

Query: 136 EEPDPNKAMTQ----EVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELLGRRILFQA 190
                 K +            + +PE+L    + Y+   D++SVG    EL   R+ FQ 
Sbjct: 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Query: 191 QSPVQQL 197
               Q L
Sbjct: 213 MLRTQML 219

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 29/107 (27%)

Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNKAMTQEVVTQ 151
           + +G KYL     +HRDI   N L+       + KI DFG+AR    D  +A        
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRA-------S 173

Query: 152 YYR------------APEILMGARHYSAAVDVWSVGCIFAEL--LGR 184
           YYR             PE  +    +++  DVWS G +  E+  LG 
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGY 219

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 20/47 (42%), Positives = 28/47 (59%), Gaps = 1/47 (2%)

Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLA 133
           I+  + QIL  L  LHS  I+HRD+KP N++ +  +   KI D G A
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 4e-04
 Identities = 21/61 (34%), Positives = 32/61 (52%), Gaps = 4/61 (6%)

Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
             +I    + L    IK  +  +L  L+Y+H   I H DIKP N++V+ N    I D+G+
Sbjct: 117 FKRIKCKNKKL----IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGI 172

Query: 133 A 133
           A
Sbjct: 173 A 173

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 38.7 bits (90), Expect = 8e-04
 Identities = 27/96 (28%), Positives = 43/96 (44%), Gaps = 9/96 (9%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP-DPNKAMTQEVVTQY 152
           ++  GL +LH A  +H D+   N  + ++  +KI D+GLA  + P D         V   
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167

Query: 153 YRAPEILMGARHYSAAV-------DVWSVGCIFAEL 181
           + APE L+  R             ++WS+G    EL
Sbjct: 168 WLAPE-LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	203
KOG0595|consensus	429		100.0
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0615|consensus	475		100.0
KOG0593|consensus	396		100.0
KOG0591|consensus	375		100.0
KOG0581|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0600|consensus	560		100.0
KOG0592|consensus	604		100.0
KOG0588|consensus	786		100.0
KOG0660|consensus	359		100.0
KOG0663|consensus	419		100.0
KOG0597|consensus	808		100.0
KOG0583|consensus	370		100.0
KOG0659|consensus	318		100.0
KOG0661|consensus	538		100.0
KOG0605|consensus	550		100.0
KOG0611|consensus	668		100.0
KOG0594|consensus	323		100.0
KOG0658|consensus	364		100.0
KOG0192|consensus	362		100.0
KOG0599|consensus	411		100.0
KOG0694|consensus	694		100.0
KOG0664|consensus	449		100.0
KOG0578|consensus	550		100.0
KOG0585|consensus	576		100.0
KOG4717|consensus	864		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0667|consensus	586		100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0033|consensus	355		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0198|consensus	313		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0582|consensus	516		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0610|consensus	459		100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589|consensus	426		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0197|consensus	468		100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0586|consensus	596		100.0
KOG0580|consensus	281		100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032|consensus	382		100.0
KOG0201|consensus	467		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4250|consensus	732		100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0690|consensus	516		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0614|consensus	732		100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0604|consensus	400		100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0662|consensus	292		100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0612|consensus	1317		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG1187|consensus	361		100.0
KOG4721|consensus	904		100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0584|consensus	632		100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0983|consensus	391		100.0
KOG0607|consensus	463		100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0574|consensus	502		100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1026|consensus	774		100.0
KOG0696|consensus	683		100.0
KOG0984|consensus	282		100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4236|consensus	888		100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0577|consensus	948		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0986|consensus	591		100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG1989|consensus	738		100.0
KOG0665|consensus	369		100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0194|consensus	474		100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0668|consensus	338		100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4279|consensus	1226		100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095|consensus	1025		100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0603|consensus	612		100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0669|consensus	376		100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
KOG0666|consensus	438		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG2345|consensus	302		100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4645|consensus	1509		100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG1006|consensus	361		100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0608|consensus	1034		100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.98
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
KOG1094|consensus	807		99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.98
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.98
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.98
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.98
KOG0579|consensus	1187		99.98
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.98
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.98
KOG1152|consensus	772		99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
KOG0196|consensus	996		99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
KOG0695|consensus	593		99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
KOG0596|consensus	677		99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
KOG1035|consensus	1351		99.97
KOG4257|consensus	974		99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0671|consensus	415		99.97
KOG0199|consensus	1039		99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG4278|consensus	1157		99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
KOG0670|consensus	752		99.96
KOG0587|consensus	953		99.96
KOG1151|consensus	775		99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.96
KOG0200|consensus	609		99.95
KOG1025|consensus	1177		99.95
KOG2052|consensus	513		99.95
KOG1027|consensus	903		99.95
KOG1290|consensus	590		99.95
KOG3653|consensus	534		99.95
KOG1345|consensus	378		99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
KOG1165|consensus	449		99.92
KOG1167|consensus	418		99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1024|consensus	563		99.9
KOG0576|consensus	829		99.9
KOG1163|consensus	341		99.9
KOG1164|consensus	322		99.9
KOG1240|consensus	1431		99.89
KOG0590|consensus	601		99.88
PRK09188	365	serine/threonine protein kinase; Provisional	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG0603|consensus	612		99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG1166|consensus	974		99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0195|consensus	448		99.77
PRK10345	210	hypothetical protein; Provisional	99.76
KOG4158|consensus	598		99.75
KOG0606|consensus	1205		99.74
KOG1033|consensus	516		99.73
smart00090	237	RIO RIO-like kinase.	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.64
KOG1023|consensus	484		99.63
KOG0590|consensus	601		99.61
KOG1243|consensus	690		99.61
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.55
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.54
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
KOG0601|consensus	524		99.42
KOG1266|consensus	458		99.38
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.33
KOG3087|consensus	229		99.32
KOG3741|consensus	655		99.32
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.32
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.22
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.21
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.19
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
KOG0606|consensus	1205		99.13
KOG0601|consensus	524		99.07
PRK09902	216	hypothetical protein; Provisional	99.06
COG4248	637	Uncharacterized protein with protein kinase and he	99.05
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.99
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.71
KOG2137|consensus	700		98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.44
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.23
KOG1035|consensus	1351		98.16
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.15
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.09
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.96
PLN02876	822	acyl-CoA dehydrogenase	97.78
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.77
KOG0576|consensus	829		97.71
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.51
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.49
KOG1826|consensus	2724		97.31
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.31
KOG2270|consensus	520		97.18
KOG1235|consensus	538		97.08
KOG2268|consensus	465		96.9
PRK12396	409	5-methylribose kinase; Reviewed	96.68
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.68
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.56
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.41
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.39
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	96.24
PRK05231	319	homoserine kinase; Provisional	96.2
PF01636	239	APH: Phosphotransferase enzyme family This family	96.15
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.14
PRK10271	188	thiK thiamine kinase; Provisional	95.99
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.89
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.79
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.78
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.65
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	95.65
PLN02236	344	choline kinase	95.38
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.33
KOG1093|consensus	725		95.29
COG2334	331	Putative homoserine kinase type II (protein kinase	95.0
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.55
PRK11768	325	serine/threonine protein kinase; Provisional	94.41
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	94.3
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.14
PRK06148	1013	hypothetical protein; Provisional	93.55
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	93.2
PRK06149	972	hypothetical protein; Provisional	93.14
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	92.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	92.72

>KOG0595|consensus

Probab=100.00  E-value=1.6e-48  Score=289.45  Aligned_cols=191  Identities=31%  Similarity=0.527  Sum_probs=173.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +++++++..||||.+......+...+.+..|+.+|+.++|||||.++++..++     ..+|+|||||. |+|.+++.+.
T Consensus        29 g~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~  103 (429)
T KOG0595|consen   29 GRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRR  103 (429)
T ss_pred             eEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHc
Confidence            56889999999999977666778888999999999999999999999999998     68899999999 6999999999


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC------CeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN------CILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      +.++|..++.++.|++.|+++||+++|+||||||+||+++.+      ..+|+.|||+++...  +..-..+.+|++.|+
T Consensus       104 ~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~--~~~~a~tlcGSplYM  181 (429)
T KOG0595|consen  104 GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ--PGSMAETLCGSPLYM  181 (429)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC--chhHHHHhhCCcccc
Confidence            999999999999999999999999999999999999999864      468999999998554  344446679999999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |||++.. ++|+.++|+||+|+++|++++|++||...+..+.+..+
T Consensus       182 APEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  182 APEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             CHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            9999987 56999999999999999999999999999988887654

>KOG0575|consensus

Probab=100.00  E-value=4.9e-48  Score=299.04  Aligned_cols=194  Identities=34%  Similarity=0.521  Sum_probs=176.1

Q ss_pred             CcCCCCCcEEEEEeccCc-cchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNV-FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      ++|..+|+.||+|+++.. .....+.+.+.+|+++.++++|||||+++++|+|.     .++|+|.|+|. ++|...++.
T Consensus        37 ~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Kr  111 (592)
T KOG0575|consen   37 ARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKR  111 (592)
T ss_pred             EEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHh
Confidence            567899999999999653 34667889999999999999999999999999999     89999999999 799999998


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .++++|.+++.++.||+.||.|||+++|+|||||..|++++.+.++|++|||+|+...... ....+.+|||-|.|||++
T Consensus       112 rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-Erk~TlCGTPNYIAPEVl  190 (592)
T KOG0575|consen  112 RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-ERKKTLCGTPNYIAPEVL  190 (592)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-cccceecCCCcccChhHh
Confidence            8999999999999999999999999999999999999999999999999999998655443 344555999999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .. ...+..+||||+||++|.||.|++||+..+-.+.+.+|..
T Consensus       191 ~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~  232 (592)
T KOG0575|consen  191 NK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL  232 (592)
T ss_pred             cc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh
Confidence            97 4479999999999999999999999999999999888763

>KOG0598|consensus

Probab=100.00  E-value=3.6e-47  Score=279.30  Aligned_cols=194  Identities=28%  Similarity=0.451  Sum_probs=173.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |+.+.+|+.||+|+++.... .....+..++|..++..++||+|++++..|++.     ..+|+|+||+.| +|...+..
T Consensus        44 Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~  118 (357)
T KOG0598|consen   44 VRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQR  118 (357)
T ss_pred             EEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHh
Confidence            56678999999999965433 334677889999999999999999999999999     789999999985 99999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.|+|..++.++.+|+.||.|||++||+|||+||+|||+|..|.++|+|||++...... .....+.+||+.|+|||++
T Consensus       119 eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~~t~tfcGT~eYmAPEil  197 (357)
T KOG0598|consen  119 EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GDATRTFCGTPEYMAPEIL  197 (357)
T ss_pred             cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC-CCccccccCCccccChHHH
Confidence            999999999999999999999999999999999999999999999999999999843332 3344456999999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .+ +.|+..+|+||||+++|+|++|.+||.+.+.....+.|.+
T Consensus       198 ~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~  239 (357)
T KOG0598|consen  198 LG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK  239 (357)
T ss_pred             hc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc
Confidence            98 4689999999999999999999999999998888888764

>KOG0615|consensus

Probab=100.00  E-value=3.8e-47  Score=282.37  Aligned_cols=193  Identities=32%  Similarity=0.538  Sum_probs=163.7

Q ss_pred             CcCCCCCcEEEEEeccCccchh-----hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL-----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   75 (203)
                      |.+++||+.||||+++......     .......+|+++|++++|||||++++++..+     ...|+||||++ |+|.+
T Consensus       191 a~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd  265 (475)
T KOG0615|consen  191 AYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-----DSSYMVLEYVEGGELFD  265 (475)
T ss_pred             EEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-----CceEEEEEEecCccHHH
Confidence            5678999999999995432211     1223457899999999999999999999998     67799999998 59999


Q ss_pred             HHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         76 IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN---CILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      .+..++.+.+..-..++.|++.|+.|||++||+||||||+||++..+   -.+|+.|||++...+  ...-+.+.+||+.
T Consensus       266 ~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g--~~sfm~TlCGTps  343 (475)
T KOG0615|consen  266 KVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSG--EGSFMKTLCGTPS  343 (475)
T ss_pred             HHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccc--cceehhhhcCCcc
Confidence            99999999999999999999999999999999999999999999865   678999999998654  4556677899999


Q ss_pred             cccceeeeccc--CCCcchhHHHHHHHHHHHHhCCcccCCCChHH-Hhhhhh
Q psy16889        153 YRAPEILMGAR--HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ-QLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-~~~~i~  201 (203)
                      |.|||++.+..  .+..+.|+||+||++|-+|+|.+||.+..... ..+||.
T Consensus       344 YvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~  395 (475)
T KOG0615|consen  344 YVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQIL  395 (475)
T ss_pred             ccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHh
Confidence            99999998743  23457899999999999999999998875433 556654

>KOG0593|consensus

Probab=100.00  E-value=5.4e-46  Score=267.02  Aligned_cols=196  Identities=34%  Similarity=0.654  Sum_probs=176.8

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +|+++.||+.||||.+-.+..++.-..-.++|++++++++|+|+|.++.+|...     ...++|.|||+-++++.++..
T Consensus        20 KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~   94 (396)
T KOG0593|consen   20 KCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERY   94 (396)
T ss_pred             EeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhc
Confidence            489999999999999977655666566677999999999999999999999988     678899999998888888754


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..++++.+..++.|++.|+.|||+++++||||||+||+++..|.+||||||.++.... +....+....|-.|.|||.+
T Consensus        95 p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~YTDYVATRWYRaPELL  173 (396)
T KOG0593|consen   95 PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNYTDYVATRWYRAPELL  173 (396)
T ss_pred             cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-CcchhhhhhhhhhccChhhh
Confidence             4599999999999999999999999999999999999999999999999999986543 56667777788999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .++-.|+.+.||||+||++.||++|++.|++.++-+++..|..
T Consensus       174 vGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k  216 (396)
T KOG0593|consen  174 VGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK  216 (396)
T ss_pred             cccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence            9987899999999999999999999999999999999987753

>KOG0591|consensus

Probab=100.00  E-value=2.8e-45  Score=261.01  Aligned_cols=195  Identities=27%  Similarity=0.448  Sum_probs=166.6

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhh-hccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +|.+..+|+.+|.|.++-..-+....+.+..|+.+|++++||||+++++ .+..+.    ..+++|||+|+ |+|...+.
T Consensus        37 kv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~----evlnivmE~c~~GDLsqmIk  112 (375)
T KOG0591|consen   37 KVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN----EVLNIVMELCDAGDLSQMIK  112 (375)
T ss_pred             EeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc----hhhHHHHHhhcccCHHHHHH
Confidence            3677899999999999755556667788999999999999999999998 343331    56899999998 68766654


Q ss_pred             ----CCCCCChHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCC
Q psy16889         79 ----SPQHLTSDHIKVFLYQILRGLKYLHS--AR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT  150 (203)
Q Consensus        79 ----~~~~~~~~~~~~~~~qi~~~l~~lh~--~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  150 (203)
                          .+..++|..+|+++.|++.||..||.  .+  +.||||||.||+++.+|.+||+|||+++....... ......||
T Consensus       113 ~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t-fA~S~VGT  191 (375)
T KOG0591|consen  113 HFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT-FAHSLVGT  191 (375)
T ss_pred             HHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH-HHHhhcCC
Confidence                35679999999999999999999998  44  99999999999999999999999999987665433 33556899


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |.|++||.+.+ ..|+++|||||+||++|||+.-++||.+.+-.++..+|.
T Consensus       192 PyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~  241 (375)
T KOG0591|consen  192 PYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE  241 (375)
T ss_pred             CcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH
Confidence            99999999998 559999999999999999999999999997777666664

>KOG0581|consensus

Probab=100.00  E-value=3.2e-45  Score=269.23  Aligned_cols=192  Identities=31%  Similarity=0.456  Sum_probs=169.5

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhH-HHHHHHhhhH-HhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ-EIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~-~~~lv~e~~~-~~l~~~~~   78 (203)
                      +|+|+.|++.+|+|.+... ........+.+|+++++..+||+||.+|+.|..+     . .++++||||+ |+|...+.
T Consensus        97 kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~-----~~~isI~mEYMDgGSLd~~~k  170 (364)
T KOG0581|consen   97 KVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSN-----GEEISICMEYMDGGSLDDILK  170 (364)
T ss_pred             EEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC-----CceEEeehhhcCCCCHHHHHh
Confidence            3789999999999999432 4556677899999999999999999999999998     4 3789999999 59999888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .-+.++|..+..++.+++++|.|||+ .+|+||||||+|++++..|.+||+|||.+......   ...+..||..|+|||
T Consensus       171 ~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPE  247 (364)
T KOG0581|consen  171 RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTSAYMSPE  247 (364)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccccccChh
Confidence            88999999999999999999999995 99999999999999999999999999999744322   446668899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCC-----ChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ-----SPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-----~~~~~~~~i~~  202 (203)
                      .+.+ ..|+.++||||||++++|+++|+.||...     ...+++..|..
T Consensus       248 Ri~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  248 RISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD  296 (364)
T ss_pred             hhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence            9998 56999999999999999999999999885     67777777753

>KOG0616|consensus

Probab=100.00  E-value=4.4e-45  Score=261.33  Aligned_cols=191  Identities=27%  Similarity=0.449  Sum_probs=173.1

Q ss_pred             CcCCCCCcEEEEEeccCc-cchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNV-FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|..||+|++... .-...+.++...|-.+|+...||+++++++.+.+.     ..+|+||||.+ |.|.+++.+
T Consensus        63 Vr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk  137 (355)
T KOG0616|consen   63 VREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRK  137 (355)
T ss_pred             EEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHh
Confidence            578899999999999543 23556778888999999999999999999999998     78999999998 599999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .++|++..++.++.|++.|++|||+.+|++||+||+|||+|.+|-+|++|||.+......    .-+.+|||.|+|||.+
T Consensus       138 ~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~TlCGTPeYLAPEii  213 (355)
T KOG0616|consen  138 SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TWTLCGTPEYLAPEII  213 (355)
T ss_pred             cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc----EEEecCCccccChHHh
Confidence            999999999999999999999999999999999999999999999999999999754322    3455899999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .. +.++.++|+||||+++|||+.|.+||...++..+.++|.+
T Consensus       214 ~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~  255 (355)
T KOG0616|consen  214 QS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE  255 (355)
T ss_pred             hc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence            98 6699999999999999999999999999999999998864

>KOG0600|consensus

Probab=100.00  E-value=7.4e-45  Score=276.04  Aligned_cols=200  Identities=40%  Similarity=0.646  Sum_probs=181.8

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +|+|..+|+.||+|.++-............+|+.+|++++||||+++.+...+...   ..+|+|+|||+-+|.-.+...
T Consensus       135 kAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~---~siYlVFeYMdhDL~GLl~~p  211 (560)
T KOG0600|consen  135 KARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS---GSIYLVFEYMDHDLSGLLSSP  211 (560)
T ss_pred             EeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC---ceEEEEEecccchhhhhhcCC
Confidence            47899999999999997655555666677799999999999999999999877632   467899999999988887764


Q ss_pred             C-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 Q-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      + .|++.++..+++|++.+|+|||++|+.|||||.+|||+|.+|.+||.|||+++++.......++...-|..|.|||.+
T Consensus       212 ~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELL  291 (560)
T KOG0600|consen  212 GVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELL  291 (560)
T ss_pred             CcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHh
Confidence            3 699999999999999999999999999999999999999999999999999998887777778888889999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      .+...|++..|+||.||++.||+.|++.|++.+.-+++..|.++
T Consensus       292 LG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfkl  335 (560)
T KOG0600|consen  292 LGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKL  335 (560)
T ss_pred             cCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHH
Confidence            99888999999999999999999999999999999999998764

>KOG0592|consensus

Probab=100.00  E-value=4.4e-45  Score=279.38  Aligned_cols=196  Identities=28%  Similarity=0.450  Sum_probs=172.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhh-hhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLV-SSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |+++.+++.||||++.....-.+ ....+..|-+.|.+| .||+|++++.-|+|+     ..+|+|+||++ |+|++++.
T Consensus        92 A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~  166 (604)
T KOG0592|consen   92 AREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIK  166 (604)
T ss_pred             eeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHH
Confidence            78899999999999955433323 344566788899999 999999999999999     78999999998 79999999


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC------------Cccc
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK------------AMTQ  146 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~------------~~~~  146 (203)
                      +.+.|++...+.++.||+.||+|||++||+||||||+|||++.++.++|.|||.+.........            ....
T Consensus       167 K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~S  246 (604)
T KOG0592|consen  167 KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSS  246 (604)
T ss_pred             HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccc
Confidence            9999999999999999999999999999999999999999999999999999998754432211            1134


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      ..||..|++||++.. +..++.+|||+|||++|.|+.|++||.+.+..-+.+.|+++
T Consensus       247 FVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l  302 (604)
T KOG0592|consen  247 FVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL  302 (604)
T ss_pred             eeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence            688999999999988 56899999999999999999999999999999999999864

>KOG0588|consensus

Probab=100.00  E-value=8.4e-45  Score=283.43  Aligned_cols=193  Identities=30%  Similarity=0.473  Sum_probs=177.0

Q ss_pred             CcCCCCCcEEEEEeccCc-cchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNV-FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++.+||+..|||+++.. ..+......+.+|+.+|+-+.|||+++++++|.++     ..+|+|.||+. |.|++++..
T Consensus        31 akh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~-----~~lylvlEyv~gGELFdylv~  105 (786)
T KOG0588|consen   31 AKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK-----QHLYLVLEYVPGGELFDYLVR  105 (786)
T ss_pred             hhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccC-----ceEEEEEEecCCchhHHHHHh
Confidence            578899999999999664 44666677899999999999999999999999999     78999999998 699999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +|++++.++.+++.||+.++.|||..+|+|||+||+|++++..++||+.|||++.  ...++....+.+|++.|.+||++
T Consensus       106 kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAs--Le~~gklLeTSCGSPHYA~PEIV  183 (786)
T KOG0588|consen  106 KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMAS--LEVPGKLLETSCGSPHYAAPEIV  183 (786)
T ss_pred             hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceee--cccCCccccccCCCcccCCchhh
Confidence            9999999999999999999999999999999999999999999999999999997  34556777888999999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+..+.+.++||||.|+++|.||+|+.||++.+-..++.++.
T Consensus       184 ~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~  225 (786)
T KOG0588|consen  184 SGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ  225 (786)
T ss_pred             cCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            998777999999999999999999999999988888777654

>KOG0660|consensus

Probab=100.00  E-value=1e-43  Score=260.36  Aligned_cols=203  Identities=51%  Similarity=0.916  Sum_probs=183.4

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +|.++.+|+.||||.+.+.+.......+..+|+.+++.++|+||+.+.+++..+..+....+|+|+|+|+.+|...+..+
T Consensus        40 sA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~  119 (359)
T KOG0660|consen   40 SAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQ  119 (359)
T ss_pred             EEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcC
Confidence            46789999999999999888888888999999999999999999999999987555445778999999999999999998


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++++.+..++.|++.||+|+|+.|++|||+||+|++++.+..+|++|||+++..... ....++....|-.|.|||..
T Consensus       120 ~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll  199 (359)
T KOG0660|consen  120 QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELL  199 (359)
T ss_pred             ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHH
Confidence            88999999999999999999999999999999999999999999999999999865432 22344566668889999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      .....|+...||||.||++.||++|++-|++.+--++++.|.++
T Consensus       200 l~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~  243 (359)
T KOG0660|consen  200 LNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL  243 (359)
T ss_pred             hccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence            88788999999999999999999999999999999999998764

>KOG0663|consensus

Probab=100.00  E-value=3.5e-43  Score=255.39  Aligned_cols=199  Identities=41%  Similarity=0.649  Sum_probs=178.4

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      .++|++|++.||+|.++.......-.-...+|+.++.+.+|||||.+..+......   ..+|+||||++-+|...+.+-
T Consensus        94 Rakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~iy~VMe~~EhDLksl~d~m  170 (419)
T KOG0663|consen   94 RAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKIYIVMEYVEHDLKSLMETM  170 (419)
T ss_pred             EeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ceeeeeHHHHHhhHHHHHHhc
Confidence            37899999999999997654444444456789999999999999999999887665   458999999999999988864


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ++|+..++..++.|+++|++|||++.|+|||||++|++++..|-+|++|||+++.++.+ .++++...-|..|.|||.+
T Consensus       171 ~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELL  249 (419)
T KOG0663|consen  171 KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELL  249 (419)
T ss_pred             cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-cccCcceEEEeeecCHHHh
Confidence             58999999999999999999999999999999999999999999999999999987755 5666777789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      .+.+.|+.+.|+||+||++.|++++++-|++.+..+++.+|..+
T Consensus       250 LG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l  293 (419)
T KOG0663|consen  250 LGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL  293 (419)
T ss_pred             cCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence            99999999999999999999999999999999999999998753

>KOG0597|consensus

Probab=100.00  E-value=1.6e-43  Score=272.41  Aligned_cols=194  Identities=32%  Similarity=0.518  Sum_probs=178.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      .+.+.+++.||+|.+.+..+...+...+.+|+++++.++||||+.+++.|+..     ...++|+||+.|+|++++...+
T Consensus        21 grrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-----~~~~vVte~a~g~L~~il~~d~   95 (808)
T KOG0597|consen   21 GRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-----AHLWVVTEYAVGDLFTILEQDG   95 (808)
T ss_pred             cccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-----ceEEEEehhhhhhHHHHHHhcc
Confidence            46788999999999988878888888999999999999999999999999998     7889999999999999999999


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .++|+.+..++.++.+||.|||+.+|.|||+||.||+++..|.+|++|||+++..... ....+...|||.|+|||++.+
T Consensus        96 ~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vltsikGtPlYmAPElv~e  174 (808)
T KOG0597|consen   96 KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLTSIKGTPLYMAPELVEE  174 (808)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ceeeeeccCcccccCHHHHcC
Confidence            9999999999999999999999999999999999999999999999999999865543 334455688999999999997


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                       ++|+..+|+|||||++||+.+|++||-..+-.++.+.|.+
T Consensus       175 -~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~  214 (808)
T KOG0597|consen  175 -QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILK  214 (808)
T ss_pred             -CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhc
Confidence             7799999999999999999999999999998888888753

>KOG0583|consensus

Probab=100.00  E-value=1.7e-43  Score=271.53  Aligned_cols=194  Identities=30%  Similarity=0.502  Sum_probs=168.6

Q ss_pred             CcCCCCCcEEEEEeccCccch---hhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS---LVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   76 (203)
                      +.+..+|+.||+|++......   ....+.+.+|+.+++.++ ||||+++++++...     ..+|+||||+.| +|+++
T Consensus        36 a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~  110 (370)
T KOG0583|consen   36 AKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDY  110 (370)
T ss_pred             eeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-----CeEEEEEEecCCccHHHH
Confidence            467889999999987553111   133456778999999998 99999999999998     568999999985 99999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      +...++++|.+++.++.|+++|++|||++||+||||||+|++++.+ +++|++|||++.... .........+|++.|.|
T Consensus       111 i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~a  189 (370)
T KOG0583|consen  111 IVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAA  189 (370)
T ss_pred             HHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-CCCCcccCCCCCcccCC
Confidence            9999999999999999999999999999999999999999999998 999999999998543 34456667799999999


Q ss_pred             ceeeeccc-CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGAR-HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||++.+.. ..+.++|+||+|+++|.|++|..||...+.......|.
T Consensus       190 PEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~  236 (370)
T KOG0583|consen  190 PEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR  236 (370)
T ss_pred             HHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence            99999866 44689999999999999999999999988777776654

>KOG0659|consensus

Probab=100.00  E-value=2.9e-42  Score=243.58  Aligned_cols=195  Identities=41%  Similarity=0.672  Sum_probs=173.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      ++|.++|+.||||.++.....+.-.....+|+..++.++|+||+.+.++|.+.     ..+-+|.||++.+|...++.. 
T Consensus        21 a~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~   95 (318)
T KOG0659|consen   21 ARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKN   95 (318)
T ss_pred             EEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----CceEEEEEeccccHHHHhcccc
Confidence            67999999999999976544544456688999999999999999999999988     667899999999999988864 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      -.++..++..++.+++++++|||++.|.||||||.|++++.+|.+|+.|||+++.+....... +...-|-.|.|||.+.
T Consensus        96 i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-~~~V~TRWYRAPELLf  174 (318)
T KOG0659|consen   96 IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-THQVVTRWYRAPELLF  174 (318)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-ccceeeeeccChHHhc
Confidence            569999999999999999999999999999999999999999999999999999766543332 3225577899999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+.|+...|+||.||++.||+-|.+.|++.++-+++..|..
T Consensus       175 Gsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~  216 (318)
T KOG0659|consen  175 GSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR  216 (318)
T ss_pred             cchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence            999999999999999999999999999999999999988864

>KOG0661|consensus

Probab=100.00  E-value=6.1e-42  Score=258.61  Aligned_cols=195  Identities=34%  Similarity=0.619  Sum_probs=171.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      |..+++|+.||||.++..+.+-++ -.=.+|+..|++++ ||||+++.+++.+++    ..+|+|||||+.+|.+.+.. 
T Consensus        29 a~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R  103 (538)
T KOG0661|consen   29 AKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDR  103 (538)
T ss_pred             eeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhc
Confidence            567899999999999775544222 22347999999998 999999999999984    27899999999999999885 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +..|+++.++.|+.||+++|+++|++|+.|||+||+||++..+..+||+|||+++....  ..+.+....|-.|.|||++
T Consensus       104 ~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S--kpPYTeYVSTRWYRAPEvL  181 (538)
T KOG0661|consen  104 NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS--KPPYTEYVSTRWYRAPEVL  181 (538)
T ss_pred             CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc--CCCcchhhhcccccchHHh
Confidence            46699999999999999999999999999999999999999888999999999985443  3455666778889999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      .....|+.+.|+|++||+++|+.+-++.|+|.+..+++.+|-+|
T Consensus       182 Lrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V  225 (538)
T KOG0661|consen  182 LRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV  225 (538)
T ss_pred             hhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence            98888999999999999999999999999999999999988654

>KOG0605|consensus

Probab=100.00  E-value=3.2e-42  Score=263.39  Aligned_cols=195  Identities=27%  Similarity=0.438  Sum_probs=171.0

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+-+.||+.||+|+++.+. ....+.+.+..|=++|..-.+|.||+++..|++.     .++|+||||++ |++...+.+
T Consensus       160 arKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~  234 (550)
T KOG0605|consen  160 ARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMR  234 (550)
T ss_pred             EEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHh
Confidence            4567899999999996643 3667788899999999999999999999999999     89999999998 599999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCC--------------------C
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP--------------------D  139 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~--------------------~  139 (203)
                      .+.+++++++.++.+++.|++.+|+.|++||||||+|+++|..|.+||+|||++.....                    .
T Consensus       235 ~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~  314 (550)
T KOG0605|consen  235 KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAK  314 (550)
T ss_pred             cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCC
Confidence            99999999999999999999999999999999999999999999999999999852111                    0


Q ss_pred             CCC-C-----c--------------------ccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        140 PNK-A-----M--------------------TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       140 ~~~-~-----~--------------------~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      +.. .     .                    ....|||.|+|||++.+.+ |+...|+|||||++||||.|-+||.+.++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp  393 (550)
T KOG0605|consen  315 PSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETP  393 (550)
T ss_pred             CccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence            000 0     0                    1127899999999999954 99999999999999999999999999999


Q ss_pred             HHHhhhhhc
Q psy16889        194 VQQLGLITD  202 (203)
Q Consensus       194 ~~~~~~i~~  202 (203)
                      .+...+|.+
T Consensus       394 ~~T~rkI~n  402 (550)
T KOG0605|consen  394 QETYRKIVN  402 (550)
T ss_pred             HHHHHHHHH
Confidence            999988864

>KOG0611|consensus

Probab=100.00  E-value=4.5e-42  Score=256.00  Aligned_cols=194  Identities=24%  Similarity=0.449  Sum_probs=174.4

Q ss_pred             CcCCCCCcEEEEEeccCc-cchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNV-FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++...|+.||||.++.. ..+..+...+++|+++|+.++||||+.++.+|+..     ..+.+||||.. |+|.+++..
T Consensus        72 A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSe  146 (668)
T KOG0611|consen   72 AYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISE  146 (668)
T ss_pred             hhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHH
Confidence            567789999999999553 34666777899999999999999999999999988     67889999998 699999999


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.++|.+++.++.||.+|+.|||+++++|||||.+||++|.++++|+.|||++..+..  ..-..+.+|++.|.+||.+
T Consensus       147 r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~--~kfLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  147 RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD--KKFLQTFCGSPLYASPEIV  224 (668)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc--ccHHHHhcCCcccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999986543  3344667899999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .+..+-++..|-||||+++|.+..|..||++.+-..++.||..
T Consensus       225 NG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~  267 (668)
T KOG0611|consen  225 NGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR  267 (668)
T ss_pred             CCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc
Confidence            9976668999999999999999999999999988888888763

>KOG0594|consensus

Probab=100.00  E-value=5.4e-42  Score=251.42  Aligned_cols=202  Identities=43%  Similarity=0.687  Sum_probs=174.2

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCC-ccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN-VLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +++++.+|+.||+|.++.............+|+.+++.++|+| |+++++++.+... ......++|+||+..+|..++.
T Consensus        29 kar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd  108 (323)
T KOG0594|consen   29 KARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMD  108 (323)
T ss_pred             EEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHH
Confidence            3678899999999999765444445566789999999999999 9999999887631 1112678999999999999988


Q ss_pred             CCC----CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         79 SPQ----HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ~~~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      ..+    .++...++.++.||+.||+|||+++|+||||||+|+++++.|.+|++|||+++...- +....+...+|..|.
T Consensus       109 ~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i-p~~~yt~evvTlWYR  187 (323)
T KOG0594|consen  109 SLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI-PMRTYTPEVVTLWYR  187 (323)
T ss_pred             hccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC-CcccccccEEEeecc
Confidence            644    588889999999999999999999999999999999999999999999999985442 344456668899999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      |||++.+...|+...|+||+||++.||+++++.|.+.+..+++..|.++
T Consensus       188 aPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  188 APEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             CHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            9999999878999999999999999999999999999999999888653

>KOG0658|consensus

Probab=100.00  E-value=2.6e-41  Score=248.20  Aligned_cols=192  Identities=36%  Similarity=0.610  Sum_probs=163.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh----C
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV----S   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~   79 (203)
                      -.++++.||||..-..      ...--+|+++|+.+.||||+++..+|.........+..+|+||++.+|.+.+.    .
T Consensus        45 ~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~  118 (364)
T KOG0658|consen   45 LRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRA  118 (364)
T ss_pred             EcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhc
Confidence            3466899999988321      11223699999999999999999998776655446888999999999988877    3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      +..++.-+++-+..||++|+.|||+.||+||||||+|+++|.+ |.+||||||.|.....  ..+......|-.|.|||.
T Consensus       119 ~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~--~epniSYicSRyYRaPEL  196 (364)
T KOG0658|consen  119 NQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK--GEPNISYICSRYYRAPEL  196 (364)
T ss_pred             CCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc--CCCceeEEEeccccCHHH
Confidence            6789999999999999999999999999999999999999955 9999999999985443  233345566888999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      +.+...|+.+.||||.||++.||+-|++-|++.+..+++..|.++
T Consensus       197 ifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~  241 (364)
T KOG0658|consen  197 IFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV  241 (364)
T ss_pred             HcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence            999999999999999999999999999999999999999988763

>KOG0192|consensus

Probab=100.00  E-value=3.7e-41  Score=256.74  Aligned_cols=189  Identities=32%  Similarity=0.457  Sum_probs=162.2

Q ss_pred             CCcE-EEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCC
Q psy16889          7 DGRR-VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQH   82 (203)
Q Consensus         7 ~~~~-~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~   82 (203)
                      .|.. ||+|++.....+....+.+.+|+.++++++||||+++++++..+..    ..++||||++ |+|.+++..  ...
T Consensus        63 ~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~~iVtEy~~~GsL~~~l~~~~~~~  138 (362)
T KOG0192|consen   63 RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SLCIVTEYMPGGSLSVLLHKKRKRK  138 (362)
T ss_pred             CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ceEEEEEeCCCCcHHHHHhhcccCC
Confidence            4666 9999997655555557789999999999999999999999998831    5789999998 688888876  678


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ++...+..++.+|+.|+.|||+++ |+||||||+|++++.++ .+|++|||+++...... ..++...||..|+|||++.
T Consensus       139 l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~  217 (362)
T KOG0192|consen  139 LPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLR  217 (362)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCCCCCccccChhhhc
Confidence            999999999999999999999999 99999999999999997 99999999998544322 3344468899999999999


Q ss_pred             cc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +. ..++.++|+||||+++|||+||+.||.+..+.+....+
T Consensus       218 ~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v  258 (362)
T KOG0192|consen  218 GEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV  258 (362)
T ss_pred             CCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            52 56999999999999999999999999998875555443

>KOG0599|consensus

Probab=100.00  E-value=1e-40  Score=237.30  Aligned_cols=193  Identities=25%  Similarity=0.445  Sum_probs=165.6

Q ss_pred             CcCCCCCcEEEEEeccCcc--c----hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhH
Q psy16889          2 VTDPRDGRRVALKKLPNVF--Q----SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~--~----~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l   73 (203)
                      |.++.+|+.+++|++....  .    ...-.+.-.+|+.+++++ .||+|+++.++++.+     ...++|.|.++ |.|
T Consensus        36 ci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~-----sF~FlVFdl~prGEL  110 (411)
T KOG0599|consen   36 CIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD-----AFVFLVFDLMPRGEL  110 (411)
T ss_pred             hhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-----chhhhhhhhcccchH
Confidence            6788999999999983211  1    222244566799999999 899999999999998     78899999998 899


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .+++...-.++|++.+.+++|++.+++|||.++|+|||+||+||+++++.+++++|||.+...  .++......+|||+|
T Consensus       111 FDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l--~~GekLrelCGTPgY  188 (411)
T KOG0599|consen  111 FDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL--EPGEKLRELCGTPGY  188 (411)
T ss_pred             HHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc--CCchhHHHhcCCCcc
Confidence            999998888999999999999999999999999999999999999999999999999999843  456667778999999


Q ss_pred             ccceeeec-----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMG-----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +|||.+.-     ...|+...|.|++|+++|.++.|.+||.....--.+.+|+
T Consensus       189 LAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im  241 (411)
T KOG0599|consen  189 LAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM  241 (411)
T ss_pred             cChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH
Confidence            99998753     2347889999999999999999999998866555555554

>KOG0694|consensus

Probab=100.00  E-value=1.7e-41  Score=265.92  Aligned_cols=193  Identities=20%  Similarity=0.343  Sum_probs=169.5

Q ss_pred             cCCCCCcEEEEEeccC-ccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          3 TDPRDGRRVALKKLPN-VFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~-~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      -.+.+++.||||.++. ......+.+..+.|-+++... +||++++++.+|+++     .++|+||||+.|+-...+...
T Consensus       388 e~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~-----~~l~fvmey~~Ggdm~~~~~~  462 (694)
T KOG0694|consen  388 ELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK-----EHLFFVMEYVAGGDLMHHIHT  462 (694)
T ss_pred             EEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC-----CeEEEEEEecCCCcEEEEEec
Confidence            3567899999999955 445777889999999988888 699999999999999     789999999986334444455


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.|++..++.++.+++.||+|||++||+|||||.+||++|.+|.+||+|||++...- .......+.+|||.|+|||++.
T Consensus       463 ~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~~g~~TsTfCGTpey~aPEil~  541 (694)
T KOG0694|consen  463 DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-GQGDRTSTFCGTPEFLAPEVLT  541 (694)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC-CCCCccccccCChhhcChhhhc
Confidence            789999999999999999999999999999999999999999999999999997422 2344556779999999999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      + ..|+.+.|+||||+++|+||.|++||.+++.+++...|++
T Consensus       542 e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~  582 (694)
T KOG0694|consen  542 E-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN  582 (694)
T ss_pred             c-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence            8 5699999999999999999999999999999999988864

>KOG0664|consensus

Probab=100.00  E-value=1.6e-41  Score=241.84  Aligned_cols=203  Identities=76%  Similarity=1.212  Sum_probs=192.3

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +++|+.+|+.|++|.+++.+.+......+.+|+.++..++|.|+++.+++.+....++...+|+++|.+..+|+..+...
T Consensus        71 sVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSP  150 (449)
T KOG0664|consen   71 SVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSP  150 (449)
T ss_pred             eccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccC
Confidence            57899999999999999988888888999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      .+++...+.-++.||+++|+|||+.+|.||||||.|.+++.+-.+|+||||+++.........++...-|..|.|||.+.
T Consensus       151 Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLM  230 (449)
T KOG0664|consen  151 QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLM  230 (449)
T ss_pred             CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhh
Confidence            99999999999999999999999999999999999999999999999999999977766666777667788899999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      +.++|+...||||.||++.|++.++..|+..++.++++.|.+|
T Consensus       231 GaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdL  273 (449)
T KOG0664|consen  231 GARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDL  273 (449)
T ss_pred             cchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999864

>KOG0578|consensus

Probab=100.00  E-value=3.3e-41  Score=259.30  Aligned_cols=190  Identities=27%  Similarity=0.491  Sum_probs=166.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |+...+++.||||.+...  .....+.+..|+.+|+..+|+|||++++.+...     ..+|+||||++| +|.+ +...
T Consensus       292 A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWVVMEym~ggsLTD-vVt~  363 (550)
T KOG0578|consen  292 ARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWVVMEYMEGGSLTD-VVTK  363 (550)
T ss_pred             eeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEEEEeecCCCchhh-hhhc
Confidence            567889999999999553  334457788999999999999999999998877     578999999995 6555 4555


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++|.++..++.+++.||+|||.+||+|||||.+||+++.+|.+||+|||++........ ......||+.|+|||++.
T Consensus       364 ~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvt  442 (550)
T KOG0578|consen  364 TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRSTMVGTPYWMAPEVVT  442 (550)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccccccCCCCccchhhhh
Confidence            6799999999999999999999999999999999999999999999999999987665544 445558999999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      . +.|+++.||||||+++.||+-|++||-.+++-..+..|.
T Consensus       443 r-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa  482 (550)
T KOG0578|consen  443 R-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA  482 (550)
T ss_pred             h-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence            8 569999999999999999999999999888888887775

>KOG0585|consensus

Probab=100.00  E-value=2.2e-41  Score=255.73  Aligned_cols=198  Identities=29%  Similarity=0.481  Sum_probs=165.6

Q ss_pred             CcCCCCCcEEEEEeccCccch------------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS------------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL   69 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~   69 (203)
                      |+|..+|+.||||+++.....            ....+...+|+.++++++|||||+++.+.-++..   ..+|+|+|||
T Consensus       116 ar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s---~~~YlVley~  192 (576)
T KOG0585|consen  116 ARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPES---DKLYLVLEYC  192 (576)
T ss_pred             EeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCccc---CceEEEEEec
Confidence            578899999999999543211            1124688899999999999999999999988866   5789999999


Q ss_pred             HHhHHHHHhCCCC-CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC----CCCCc
Q psy16889         70 QSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD----PNKAM  144 (203)
Q Consensus        70 ~~~l~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~  144 (203)
                      ...-..+....++ +++++++.++..+..+|+|||.+||+||||||+|++++.+|.+|++|||.+......    .....
T Consensus       193 s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L  272 (576)
T KOG0585|consen  193 SKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQL  272 (576)
T ss_pred             cCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHH
Confidence            9544445555555 999999999999999999999999999999999999999999999999998754222    12233


Q ss_pred             ccccCCcccccceeeeccc---CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        145 TQEVVTQYYRAPEILMGAR---HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~~---~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ....|||-|+|||...+..   ..+.+.||||+|++||+++.|+.||-++...++...|++
T Consensus       273 ~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn  333 (576)
T KOG0585|consen  273 SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN  333 (576)
T ss_pred             hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence            4468899999999887632   246789999999999999999999999999999988875

>KOG4717|consensus

Probab=100.00  E-value=5.8e-41  Score=256.46  Aligned_cols=194  Identities=29%  Similarity=0.516  Sum_probs=176.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |++..+|+.||||++.....+......+++|++.|+-.+|||||++|.+.-.+     ..+|+++|... |+|++++.++
T Consensus        37 ArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TKlyLiLELGD~GDl~DyImKH  111 (864)
T KOG4717|consen   37 ARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TKLYLILELGDGGDLFDYIMKH  111 (864)
T ss_pred             hhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ceEEEEEEecCCchHHHHHHhh
Confidence            56788999999999987777777888999999999999999999999999877     67899999887 5999999876


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ..++|+.+.+++.||+.|+.|||+..+|||||||+|+.+- +-|-+||.|||++..+  .+....++.+|+..|.|||.
T Consensus       112 e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf--~PG~kL~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  112 EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF--QPGKKLTTSCGSLAYSAPEI  189 (864)
T ss_pred             hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC--CCcchhhcccchhhccCchh
Confidence             4599999999999999999999999999999999999775 6689999999999754  45677788899999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+..+..++.||||||+++|.+.+|++||++.++.+.+.+|++
T Consensus       190 LLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD  233 (864)
T KOG4717|consen  190 LLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD  233 (864)
T ss_pred             hhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence            99988778899999999999999999999999999999999875

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.5e-40  Score=257.06  Aligned_cols=200  Identities=89%  Similarity=1.388  Sum_probs=170.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.||+|.+............+.+|+++++.++|+||+++++++...........|+++||+.++|...+...+
T Consensus        19 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   98 (372)
T cd07853          19 VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ   98 (372)
T ss_pred             EEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCC
Confidence            45778999999999865444444556788999999999999999999999877533323678999999999999888888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...............++..|+|||.+.+
T Consensus        99 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~  178 (372)
T cd07853          99 PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG  178 (372)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC
Confidence            89999999999999999999999999999999999999999999999999987544333333344466888999999887


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ...++.++|+|||||++|+|++|+.||.+.++.+.+..|.
T Consensus       179 ~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  218 (372)
T cd07853         179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT  218 (372)
T ss_pred             CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            6668899999999999999999999999988887776664

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0667|consensus

Probab=100.00  E-value=2.8e-40  Score=258.14  Aligned_cols=190  Identities=31%  Similarity=0.551  Sum_probs=164.4

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-C-----CCccchhhhccCCCcchhHHHHHHHhhhHHhHH
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-H-----DNVLSALDILQPPHLDFFQEIYVITELLQSDLH   74 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~   74 (203)
                      +|+|.+||+.||||++++.   +.-......|+.+|..++ |     -|+|+++++|...     .+.|+|.|.++.+|.
T Consensus       204 k~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-----~HlciVfELL~~NLY  275 (586)
T KOG0667|consen  204 KAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-----NHLCIVFELLSTNLY  275 (586)
T ss_pred             EEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----cceeeeehhhhhhHH
Confidence            4789999999999999763   223344556888888886 3     3799999999988     899999999999999


Q ss_pred             HHHhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCC
Q psy16889         75 KIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVT  150 (203)
Q Consensus        75 ~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  150 (203)
                      ++++.+  ..++...++.++.||+.||.+||+.+|+|+||||+|||+..  ...+|++|||.+.......    .....+
T Consensus       276 ellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v----ytYiQS  351 (586)
T KOG0667|consen  276 ELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV----YTYIQS  351 (586)
T ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc----eeeeec
Confidence            999865  34999999999999999999999999999999999999974  4589999999998544322    255668


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      ..|.|||++.+ .+|+.+.|+|||||++.||++|.+.|++.+..+++..|+++
T Consensus       352 RfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  352 RFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEV  403 (586)
T ss_pred             cccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHH
Confidence            88999999999 56999999999999999999999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-40  Score=254.46  Aligned_cols=197  Identities=45%  Similarity=0.842  Sum_probs=161.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +++..+|+.||||.++...........+.+|+++++.++||||+++++++..........+|++|||++++|.+.+....
T Consensus        19 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~   98 (338)
T cd07859          19 AIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND   98 (338)
T ss_pred             EEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcc
Confidence            46788999999999865433444456788999999999999999999988654332223578999999999999988888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC--CCCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP--NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~aPe~~  159 (203)
                      .++++.+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.......  ........+++.|+|||++
T Consensus        99 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  178 (338)
T cd07859          99 DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC  178 (338)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHH
Confidence            89999999999999999999999999999999999999999999999999987432211  1122344678899999987


Q ss_pred             ecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        160 MGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       160 ~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      .+. ..++.++|+||||+++|+|++|++||.+.+....+.
T Consensus       179 ~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~  218 (338)
T cd07859         179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD  218 (338)
T ss_pred             hccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence            652 457889999999999999999999998877655443

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0033|consensus

Probab=100.00  E-value=2.4e-41  Score=237.09  Aligned_cols=193  Identities=28%  Similarity=0.377  Sum_probs=172.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.|++|+++....+....+.+.+|+++-+.++||||+++.+.....     .+.|+|.|++.| +|...+...
T Consensus        30 c~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R  104 (355)
T KOG0033|consen   30 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAR  104 (355)
T ss_pred             HHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHH
Confidence            56789999999999976656666889999999999999999999999999888     678899999985 888777777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ..++|..+...+.||+++|.|||.++|+|||+||+|+++-   +..-+||+|||++...+  .........|+|.|+|||
T Consensus       105 ~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPE  182 (355)
T KOG0033|consen  105 EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPE  182 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccCCCcccCHH
Confidence            8899999999999999999999999999999999999995   44578999999998554  455667778999999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.. .+|+.++|+|+-|+++|-+|.|.+||.+.+...+.++|+.
T Consensus       183 vvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~  226 (355)
T KOG0033|consen  183 VLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA  226 (355)
T ss_pred             Hhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence            9998 5599999999999999999999999999999999998864

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.4e-40  Score=254.92  Aligned_cols=194  Identities=25%  Similarity=0.375  Sum_probs=163.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++... ........+..|..++++++|++|+++++.+.+.     ..+|+||||++ |+|.+.+..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   94 (363)
T cd05628          20 VQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMK   94 (363)
T ss_pred             EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHh
Confidence            4577889999999995432 1233446778899999999999999999999887     57889999997 589999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------------------  141 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------------  141 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........                  
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (363)
T cd05628          95 KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ  174 (363)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccccccccccccccc
Confidence            88899999999999999999999999999999999999999999999999999864321100                  


Q ss_pred             ----------------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        142 ----------------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       142 ----------------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                                      .......||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~  249 (363)
T cd05628         175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVM  249 (363)
T ss_pred             ccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                            00123468999999999987 458899999999999999999999999988877776664

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0198|consensus

Probab=100.00  E-value=2.8e-40  Score=245.51  Aligned_cols=184  Identities=28%  Similarity=0.449  Sum_probs=153.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+.++|+..|||.....  +....+.+.+|+.++++++|||||++++.......   ..+++.|||+. |+|.+.+...
T Consensus        36 ~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i~mEy~~~GsL~~~~~~~  110 (313)
T KOG0198|consen   36 ATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNIFMEYAPGGSLSDLIKRY  110 (313)
T ss_pred             EEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEeeeeccCCCcHHHHHHHc
Confidence            346677999999998654  22226779999999999999999999997444421   25789999998 5999998876


Q ss_pred             C-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCC--CCCCCcccccCCcccccc
Q psy16889         81 Q-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEP--DPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~aP  156 (203)
                      + .++|..++.+..|++++|+|||++|++|+||||+||+++. ++.+||.|||.+.....  ..........||+.|+||
T Consensus       111 g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maP  190 (313)
T KOG0198|consen  111 GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAP  190 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCc
Confidence            6 7999999999999999999999999999999999999999 79999999999875553  222334456889999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      |++.......+.+|||||||++.||+||++||..
T Consensus       191 Evi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  191 EVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             hhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            9999633334699999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-40  Score=246.57  Aligned_cols=190  Identities=24%  Similarity=0.339  Sum_probs=161.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.     ..++++|||+. ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   94 (291)
T cd05612          20 VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRN   94 (291)
T ss_pred             EEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHH
Confidence            46778899999999854221 223456688899999999999999999998877     57789999998 589999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.||++||++|++||||+|+||+++.++.++++|||.+......    .....|++.|+|||++
T Consensus        95 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~  170 (291)
T cd05612          95 SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVI  170 (291)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----cccccCChhhcCHHHH
Confidence            888999999999999999999999999999999999999999999999999998744321    1233578899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+..+.|.
T Consensus       171 ~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~  211 (291)
T cd05612         171 QS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL  211 (291)
T ss_pred             cC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            87 457899999999999999999999999988777666553

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-39  Score=244.74  Aligned_cols=193  Identities=36%  Similarity=0.628  Sum_probs=160.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +.+..+++.||+|.++... .......+.+|++++++++||||+++++++.+.     ...++++||++++|.+.+... 
T Consensus        24 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~   97 (288)
T cd07871          24 GRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCG   97 (288)
T ss_pred             EEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcC
Confidence            4567889999999986432 222345677899999999999999999999877     567899999999998887654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||++|++||||||+||+++.++.++++|||.+...... ........+++.|+|||.+.
T Consensus        98 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  176 (288)
T cd07871          98 NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLL  176 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-CccccCceecccccChHHhc
Confidence            45899999999999999999999999999999999999999999999999998643322 22223346688899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||+|+++|+|++|++||.+.+..+.+..+.
T Consensus       177 ~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~  217 (288)
T cd07871         177 GSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF  217 (288)
T ss_pred             CCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            65668999999999999999999999999888777665553

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6e-40  Score=250.47  Aligned_cols=192  Identities=26%  Similarity=0.388  Sum_probs=161.5

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++.... .......+.+|++++++++||||+++++++..+     ...+++|||+. ++|.+.+..
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   88 (323)
T cd05571          14 VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHH
Confidence            46778999999999864322 333455677899999999999999999999887     56789999998 588888888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||++
T Consensus        89 ~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~~  167 (323)
T cd05571          89 ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcccceecCccccChhhh
Confidence            888999999999999999999999999999999999999999999999999998642211 2223344679999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+|||||++|+|++|+.||...+.......+
T Consensus       168 ~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~  207 (323)
T cd05571         168 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (323)
T ss_pred             cC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence            87 45899999999999999999999999887766655544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.3e-40  Score=250.01  Aligned_cols=190  Identities=24%  Similarity=0.383  Sum_probs=162.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||+|++.... ......+.+.+|+.++++++||||+++++++.++     ...+++|||+. ++|.+.+..
T Consensus        37 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  111 (329)
T PTZ00263         37 AKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRK  111 (329)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHH
Confidence            4567889999999985422 1233456788999999999999999999999887     56789999997 589999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.++++.+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......    .....|++.|+|||++
T Consensus       112 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~  187 (329)
T PTZ00263        112 AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEVI  187 (329)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCChhhcCHHHH
Confidence            888999999999999999999999999999999999999999999999999998754322    1234678899999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.++.+....|.
T Consensus       188 ~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  228 (329)
T PTZ00263        188 QS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL  228 (329)
T ss_pred             cC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence            87 457899999999999999999999999888777666553

>KOG0582|consensus

Probab=100.00  E-value=3.1e-39  Score=242.43  Aligned_cols=191  Identities=25%  Similarity=0.388  Sum_probs=161.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+-+-+++.||||++.....+. +.+.+.+|+..++.++||||++++-+|..+     ..+|+||.+|. |++++.+...
T Consensus        45 A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~  118 (516)
T KOG0582|consen   45 ARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTY  118 (516)
T ss_pred             eeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHH
Confidence            4566788999999997654443 378899999999999999999999999988     78999999998 6888887742


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--Cc-ccccCCccccc
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AM-TQEVVTQYYRA  155 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~-~~~~~~~~~~a  155 (203)
                        ..++|..+..+++++++||.|||++|.+|||+|+.||+++.+|.++|.|||.+.........  .. ....|+++|+|
T Consensus       119 ~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmA  198 (516)
T KOG0582|consen  119 YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMA  198 (516)
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccC
Confidence              34999999999999999999999999999999999999999999999999987744332211  11 44588999999


Q ss_pred             ceeeec-ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        156 PEILMG-ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       156 Pe~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ||++.. ...|+.++||||||++..|+..|..||....+-..+-
T Consensus       199 PEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl  242 (516)
T KOG0582|consen  199 PEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL  242 (516)
T ss_pred             hHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence            999543 3458999999999999999999999999988766553

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-39  Score=241.79  Aligned_cols=193  Identities=34%  Similarity=0.650  Sum_probs=161.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~   80 (203)
                      |+++.+++.|++|++..........+.+.+|+++++.++||||+++++++..+     ...++||||+++++.+.+. ..
T Consensus        20 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   94 (287)
T cd07848          20 CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMP   94 (287)
T ss_pred             EEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcC
Confidence            46778999999999965444445566788999999999999999999999877     5678999999976655554 44


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++++.++.++.|++.||++||+.+++|+||||+||+++.++.++++|||.+...............+++.|+|||++.
T Consensus        95 ~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (287)
T cd07848          95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL  174 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHc
Confidence            67999999999999999999999999999999999999999999999999998754433333333446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|++||.+.+..+.+..+
T Consensus       175 ~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~  213 (287)
T cd07848         175 G-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI  213 (287)
T ss_pred             C-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7 44789999999999999999999999987766555443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=246.72  Aligned_cols=192  Identities=23%  Similarity=0.410  Sum_probs=161.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++... ........+.+|+.++++++||||+++++++.++     ...+++|||+. ++|.+++..
T Consensus        12 ~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~   86 (312)
T cd05585          12 VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQR   86 (312)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHh
Confidence            4677889999999985432 2334456778899999999999999999998877     56789999998 589898888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||++...... ........|++.|+|||++
T Consensus        87 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~  165 (312)
T cd05585          87 EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELL  165 (312)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccccCCcccCCHHHH
Confidence            888999999999999999999999999999999999999999999999999998743222 1222344678999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       166 ~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~  205 (312)
T cd05585         166 LG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI  205 (312)
T ss_pred             cC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence            87 45899999999999999999999999988776665554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.2e-39  Score=246.46  Aligned_cols=192  Identities=27%  Similarity=0.392  Sum_probs=160.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||+|++..... .......+.+|+++++.++||||+++++++..+     ...++||||++ ++|...+..
T Consensus        14 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~   88 (323)
T cd05595          14 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSR   88 (323)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHH
Confidence            45778999999999964322 233455677899999999999999999999877     56789999998 588888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||++
T Consensus        89 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~  167 (323)
T cd05595          89 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccCCcCcCCcccc
Confidence            788999999999999999999999999999999999999999999999999988642221 2222344678999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++|+.||...+.......+
T Consensus       168 ~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~  207 (323)
T cd05595         168 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI  207 (323)
T ss_pred             cC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            77 45899999999999999999999999888776665554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=253.94  Aligned_cols=194  Identities=26%  Similarity=0.366  Sum_probs=160.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||++..... .....+.+.+|++++++++||||+++++++.++     ...|+||||+. ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   94 (377)
T cd05629          20 VQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIK   94 (377)
T ss_pred             EEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHh
Confidence            45778999999999854221 233456678899999999999999999999887     67899999997 589998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-------------C----
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-------------K----  142 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------------~----  142 (203)
                      .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||++........             .    
T Consensus        95 ~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (377)
T cd05629          95 YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID  174 (377)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccc
Confidence            88899999999999999999999999999999999999999999999999998853211000             0    


Q ss_pred             -----------------------------CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        143 -----------------------------AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       143 -----------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                                                   ......||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||...+.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (377)
T cd05629         175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMFECLIGWPPFCSENS  253 (377)
T ss_pred             cccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence                                         0012357889999999877 5589999999999999999999999998887


Q ss_pred             HHHhhhhh
Q psy16889        194 VQQLGLIT  201 (203)
Q Consensus       194 ~~~~~~i~  201 (203)
                      .+.+..|.
T Consensus       254 ~~~~~~i~  261 (377)
T cd05629         254 HETYRKII  261 (377)
T ss_pred             HHHHHHHH
Confidence            76665553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=251.28  Aligned_cols=193  Identities=25%  Similarity=0.383  Sum_probs=161.3

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||++.... ........+.+|+++++.++||||+++++++.++     ..++++|||+. ++|.+++..
T Consensus        20 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~   94 (364)
T cd05599          20 VQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMK   94 (364)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHH
Confidence            4677899999999995431 2233455678899999999999999999999887     67889999997 589998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-----------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-----------------  142 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-----------------  142 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||++.........                 
T Consensus        95 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (364)
T cd05599          95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF  174 (364)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccccccccccccccccc
Confidence            888999999999999999999999999999999999999999999999999988643211100                 


Q ss_pred             --------------------CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        143 --------------------AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 --------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                                          ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.++.+....+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i  251 (364)
T cd05599         175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKI  251 (364)
T ss_pred             ccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHH
Confidence                                0112357899999999877 45899999999999999999999999988877666554

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.6e-39  Score=246.62  Aligned_cols=192  Identities=27%  Similarity=0.405  Sum_probs=161.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|++..... .......+.+|+++++.++||||+++.+++.+.     ...++||||+. ++|...+..
T Consensus        14 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~   88 (328)
T cd05593          14 VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSR   88 (328)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHh
Confidence            46778999999999964322 333456778899999999999999999999877     56789999998 588888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.++..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...... ........|++.|+|||++
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~  167 (328)
T cd05593          89 ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVL  167 (328)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCCcCccChhhh
Confidence            788999999999999999999999999999999999999999999999999998642221 1222334678999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       168 ~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~  207 (328)
T cd05593         168 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  207 (328)
T ss_pred             cC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence            87 45799999999999999999999999887776665554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0610|consensus

Probab=100.00  E-value=1.9e-38  Score=236.22  Aligned_cols=193  Identities=24%  Similarity=0.327  Sum_probs=161.3

Q ss_pred             cCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          3 TDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      ..+.++..+|+|++.+.. .+.....+...|-++|+.++||.++.+|..++.+     .+.|++||||. |+|+...++ 
T Consensus        97 ~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQ  171 (459)
T KOG0610|consen   97 ELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQ  171 (459)
T ss_pred             EecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-----ceeEEEEecCCCccHHHHHhhC
Confidence            456677999999995532 2344455667799999999999999999999998     78899999998 588887765 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-------------------
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-------------------  139 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-------------------  139 (203)
                       .+.|+++.++.++.+++.||+|||..|||+|||||+|||+.++|.+-|+||.++......                   
T Consensus       172 p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~  251 (459)
T KOG0610|consen  172 PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCR  251 (459)
T ss_pred             CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccc
Confidence             456999999999999999999999999999999999999999999999999976421100                   


Q ss_pred             -------------CCC-----------------------CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh
Q psy16889        140 -------------PNK-----------------------AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG  183 (203)
Q Consensus       140 -------------~~~-----------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~  183 (203)
                                   ..+                       ....-.||..|+|||++.+.+ .+.+.|+|+||+++|||+.
T Consensus       252 ~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLy  330 (459)
T KOG0610|consen  252 SRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLY  330 (459)
T ss_pred             cccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHh
Confidence                         000                       111226788899999999966 6999999999999999999


Q ss_pred             CCcccCCCChHHHhhhhh
Q psy16889        184 RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       184 g~~pf~~~~~~~~~~~i~  201 (203)
                      |..||.+.++.+.+.+|+
T Consensus       331 G~TPFKG~~~~~Tl~NIv  348 (459)
T KOG0610|consen  331 GTTPFKGSNNKETLRNIV  348 (459)
T ss_pred             CCCCcCCCCchhhHHHHh
Confidence            999999999999988875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.9e-39  Score=251.09  Aligned_cols=193  Identities=23%  Similarity=0.335  Sum_probs=160.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++..+|+.||+|+++... ......+.+.+|+++++.++|+||+++++++.++     ..+++||||++ |+|.+++..
T Consensus        20 ~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   94 (381)
T cd05626          20 ACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIR   94 (381)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHh
Confidence            4678899999999996432 2334456788999999999999999999999887     56889999997 589998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------------------  141 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------------  141 (203)
                      .+.+++..+..++.|++.||++||+.|++||||||+||+++.++.++|+|||++........                  
T Consensus        95 ~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (381)
T cd05626          95 MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPS  174 (381)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcc
Confidence            88899999999999999999999999999999999999999999999999998753210000                  


Q ss_pred             ----------------------------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        142 ----------------------------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       142 ----------------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                                                  .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         175 DLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             cccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence                                        00112368899999999887 4588999999999999999999999988776


Q ss_pred             HHHhhhh
Q psy16889        194 VQQLGLI  200 (203)
Q Consensus       194 ~~~~~~i  200 (203)
                      .+....|
T Consensus       254 ~~~~~~i  260 (381)
T cd05626         254 TETQLKV  260 (381)
T ss_pred             HHHHHHH
Confidence            6655444

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-39  Score=247.59  Aligned_cols=189  Identities=26%  Similarity=0.468  Sum_probs=161.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++..+|+.||+|+++.... .......+..|+++++.++||||+++++++.+.     ...+++|||+. ++|.+++..
T Consensus        20 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~   94 (333)
T cd05600          20 AKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNN   94 (333)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHH
Confidence            46778899999999964322 223455678899999999999999999999877     56789999997 589998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.+|.+||++|++||||||+||+++.++.++|+|||++.....    ......|++.|+|||++
T Consensus        95 ~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~  170 (333)
T cd05600          95 LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVL  170 (333)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCCcccCccccChhHh
Confidence            78899999999999999999999999999999999999999999999999999874432    22344678999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+. .++.++|+||||+++|+|++|..||.+.+..+....+
T Consensus       171 ~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i  210 (333)
T cd05600         171 RGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL  210 (333)
T ss_pred             cCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence            874 6899999999999999999999999988877665544

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589|consensus

Probab=100.00  E-value=2.5e-39  Score=246.60  Aligned_cols=195  Identities=28%  Similarity=0.461  Sum_probs=172.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      ++++.+++.+++|.+.....+...+.....|+.++++++||||+.+.+.|..++    ..++++|+||+| ++.+.+.. 
T Consensus        23 vrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l~Ivm~Y~eGg~l~~~i~~~   98 (426)
T KOG0589|consen   23 VRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLLCIVMEYCEGGDLAQLIKEQ   98 (426)
T ss_pred             hhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceEEEEEeecCCCCHHHHHHHH
Confidence            578889999999999777667777778889999999999999999999999884    238899999995 77777664 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       +..|+|+.+..|+.|++.|+.|||+++|+|||||+.||+++.++.++|.|||++....... .......||+.|++||.
T Consensus        99 k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEi  177 (426)
T KOG0589|consen   99 KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEI  177 (426)
T ss_pred             hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-hhhheecCCCcccCHHH
Confidence             3569999999999999999999999999999999999999999999999999998665543 23355588999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+ .+|+.++|||||||++|||++-+++|.+.+...+..+|.+
T Consensus       178 l~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~  220 (426)
T KOG0589|consen  178 LSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR  220 (426)
T ss_pred             hCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh
Confidence            988 6799999999999999999999999999999988888753

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-38  Score=241.57  Aligned_cols=184  Identities=36%  Similarity=0.646  Sum_probs=154.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      |.+..+|+.||+|+++... .......+.+|+.+++.++||||+++++++.++     ...++||||++++|.+.+.. .
T Consensus        24 ~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   97 (303)
T cd07869          24 GKSKVNGKLVALKVIRLQE-EEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHP   97 (303)
T ss_pred             EEECCCCCEEEEEEecccc-ccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCC
Confidence            4567789999999986432 222334567899999999999999999999877     56789999999999888765 3


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.++++.+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+...... ........+++.|+|||++.
T Consensus        98 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  176 (303)
T cd07869          98 GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLL  176 (303)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccCCCCcccCCCCChHHHc
Confidence            67999999999999999999999999999999999999999999999999998643322 22233446688999999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +...++.++|+||||+++|+|++|+.||.+..
T Consensus       177 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  208 (303)
T cd07869         177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK  208 (303)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            65567889999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.5e-39  Score=251.47  Aligned_cols=193  Identities=23%  Similarity=0.342  Sum_probs=159.7

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++..+++.||+|++.... ........+.+|++++++++|+||+++++++.++     ...++||||++ |+|.+.+..
T Consensus        20 a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   94 (382)
T cd05625          20 ARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIR   94 (382)
T ss_pred             EEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHh
Confidence            4677899999999985421 1233456788899999999999999999999887     57889999998 589888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------------------  141 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------------  141 (203)
                      .+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++........                  
T Consensus        95 ~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (382)
T cd05625          95 MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS  174 (382)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccccccccccccccccc
Confidence            78899999999999999999999999999999999999999999999999998742210000                  


Q ss_pred             ----------------------------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        142 ----------------------------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       142 ----------------------------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                                                  .......||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             ccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence                                        00112357889999999987 4589999999999999999999999998877


Q ss_pred             HHHhhhh
Q psy16889        194 VQQLGLI  200 (203)
Q Consensus       194 ~~~~~~i  200 (203)
                      .+....+
T Consensus       254 ~~~~~~i  260 (382)
T cd05625         254 LETQMKV  260 (382)
T ss_pred             HHHHHHH
Confidence            6655544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=248.52  Aligned_cols=194  Identities=24%  Similarity=0.388  Sum_probs=164.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||+++.... .......+..|+++++.++|+||+++++++.++     ...++||||+. ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   94 (350)
T cd05573          20 VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIR   94 (350)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHH
Confidence            56778999999999964322 224456788899999999999999999999887     57889999997 589998887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-------------------  140 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------------------  140 (203)
                      .+.+++..++.++.|++.||++||+.|++||||||+||+++.++.++|+|||.+.......                   
T Consensus        95 ~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (350)
T cd05573          95 KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL  174 (350)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccccccccccccccccc
Confidence            7889999999999999999999999999999999999999999999999999987543322                   


Q ss_pred             ---------CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        141 ---------NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       141 ---------~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                               ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..+....|.
T Consensus       175 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~  243 (350)
T cd05573         175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKII  243 (350)
T ss_pred             ccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHh
Confidence                     112234467899999999987 468999999999999999999999999888776666554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0197|consensus

Probab=100.00  E-value=4.1e-39  Score=246.55  Aligned_cols=183  Identities=28%  Similarity=0.474  Sum_probs=160.6

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCCChH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHLTSD   86 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~   86 (203)
                      .|++|.+...   .-..+.+.+|+++|++|+|++||++++++..+     .-+||||||+. |+|.+++..  .+.++..
T Consensus       232 ~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~  303 (468)
T KOG0197|consen  232 KVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNLP  303 (468)
T ss_pred             cccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccchH
Confidence            7889988543   22345677999999999999999999999987     46789999998 799999986  5679999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCC
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS  166 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~  166 (203)
                      +...++.||+++++||+++++|||||-..|||++++..+|++|||+++..............-+..|.|||.+... .++
T Consensus       304 ~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS  382 (468)
T KOG0197|consen  304 QLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG-KFS  382 (468)
T ss_pred             HHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC-Ccc
Confidence            9999999999999999999999999999999999999999999999996555555555555556779999999884 499


Q ss_pred             cchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        167 AAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       167 ~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+||+||||++|||++| |+.||.+.+..+.++++.
T Consensus       383 ~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le  418 (468)
T KOG0197|consen  383 SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE  418 (468)
T ss_pred             cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence            99999999999999998 899999999999998875

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-38  Score=243.04  Aligned_cols=193  Identities=24%  Similarity=0.358  Sum_probs=161.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||||+++... ......+.+..|..+++.+ +||||+++++++.+.     ..+++||||++ ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~   88 (320)
T cd05590          14 ARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQ   88 (320)
T ss_pred             EEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHH
Confidence            4677889999999986432 1233455677788888876 799999999999887     56789999998 58988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ....+++..+..++.|++.||++||+++++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        89 ~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (320)
T cd05590          89 KSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEI  167 (320)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccccCccccCHHH
Confidence            7788999999999999999999999999999999999999999999999999998643221 222234467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       168 ~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  209 (320)
T cd05590         168 LQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  209 (320)
T ss_pred             HcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            887 457899999999999999999999999988877776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.8e-39  Score=251.57  Aligned_cols=193  Identities=23%  Similarity=0.350  Sum_probs=159.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|++..... .......+.+|+++++.++|+||+++++.+.++     ..++++|||+. ++|.+++..
T Consensus        20 a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~   94 (376)
T cd05598          20 VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIR   94 (376)
T ss_pred             EEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHh
Confidence            46778899999999854221 223456678899999999999999999999887     57889999997 589999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-------------------  140 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------------------  140 (203)
                      .+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++.......                   
T Consensus        95 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (376)
T cd05598          95 LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS  174 (376)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccccccccccccccccc
Confidence            8889999999999999999999999999999999999999999999999999874221000                   


Q ss_pred             -----------------------CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        141 -----------------------NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       141 -----------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                                             ........|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.++.+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~  253 (376)
T cd05598         175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQ  253 (376)
T ss_pred             ccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHH
Confidence                                   000112367899999999987 45899999999999999999999999988876665


Q ss_pred             hhh
Q psy16889        198 GLI  200 (203)
Q Consensus       198 ~~i  200 (203)
                      ..+
T Consensus       254 ~~i  256 (376)
T cd05598         254 LKV  256 (376)
T ss_pred             HHH
Confidence            544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-39  Score=249.80  Aligned_cols=194  Identities=25%  Similarity=0.367  Sum_probs=160.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.||+|++.... ........+.+|..+++.++||||+++++++.++     ...++||||+. |+|.+++..
T Consensus        62 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~  136 (370)
T cd05621          62 VRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN  136 (370)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh
Confidence            4577889999999985421 1223345677899999999999999999999887     57889999997 588887754


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..+..++.|++.||++||+++++||||||+||+++.++.++|+|||.+...............||+.|+|||++
T Consensus       137 -~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         137 -YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHH
Confidence             4689999999999999999999999999999999999999999999999999875433322233455789999999998


Q ss_pred             ecc---cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGA---RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+.   ..++.++|+||||+++|+|++|+.||.+.+....+..|.
T Consensus       216 ~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~  260 (370)
T cd05621         216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             hccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            753   236789999999999999999999999888777666654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-38  Score=241.85  Aligned_cols=189  Identities=26%  Similarity=0.375  Sum_probs=158.1

Q ss_pred             CCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          5 PRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      ..+|+.||+|++.....  .......+..|+++++.++||||+++++++.++     ...|++|||+. ++|.+.+...+
T Consensus        21 ~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~   95 (323)
T cd05584          21 ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREG   95 (323)
T ss_pred             CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcC
Confidence            46889999999854321  223345677899999999999999999999887     56789999998 48989888888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||++.+
T Consensus        96 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~  174 (323)
T cd05584          96 IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVTHTFCGTIEYMAPEILMR  174 (323)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcccccCCCccccChhhccC
Confidence            8999999999999999999999999999999999999999999999999998632221 122233467899999999987


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                       ..++.++|+||||+++|+|++|+.||.+......+..+
T Consensus       175 -~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~  212 (323)
T cd05584         175 -SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI  212 (323)
T ss_pred             -CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence             44789999999999999999999999988776666554

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9e-39  Score=248.02  Aligned_cols=194  Identities=24%  Similarity=0.364  Sum_probs=160.0

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+++.||+|+++... ........+.+|..+++.++||||+++++++.++     ...+++|||++ ++|.+.+..
T Consensus        62 ~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~  136 (371)
T cd05622          62 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN  136 (371)
T ss_pred             EEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh
Confidence            5678899999999985421 1223345577899999999999999999999877     57889999997 578777654


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..+..++.|++.||++||+++++||||||+||+++.++.++|+|||.+...............||+.|+|||++
T Consensus       137 -~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         137 -YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL  215 (371)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHH
Confidence             4589999999999999999999999999999999999999999999999999875443322233445689999999998


Q ss_pred             eccc---CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGAR---HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~---~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+..   .++.++|+||||+++|+|++|+.||.+.+.......|.
T Consensus       216 ~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  260 (371)
T cd05622         216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (371)
T ss_pred             hccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7532   36889999999999999999999999988776666654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-39  Score=245.72  Aligned_cols=191  Identities=26%  Similarity=0.406  Sum_probs=161.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      +..+|+.|++|++............+..|++++++++||||+++++++.++     ...|+||||+. ++|.+.+.....
T Consensus        20 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~   94 (318)
T cd05582          20 GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVM   94 (318)
T ss_pred             cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCC
Confidence            457899999999965433333455677899999999999999999999887     56789999997 589888887788


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....... .......|++.|+|||.+.+ 
T Consensus        95 l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-  172 (318)
T cd05582          95 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNR-  172 (318)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcC-
Confidence            9999999999999999999999999999999999999999999999999987433221 22233467889999999887 


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ..++.++|+||||+++|+|++|+.||.+.+..+.+.+|.
T Consensus       173 ~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~  211 (318)
T cd05582         173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL  211 (318)
T ss_pred             CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH
Confidence            457899999999999999999999999888777766553

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.3e-39  Score=248.64  Aligned_cols=194  Identities=24%  Similarity=0.379  Sum_probs=162.3

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||+|+++... ........+..|..++..++|++|+++++.+.+.     ..+++||||++ ++|.+.+..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   94 (360)
T cd05627          20 VQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMK   94 (360)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHh
Confidence            4577899999999985422 2333456778899999999999999999999887     57889999998 589998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------------------
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------------------  141 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------------------  141 (203)
                      .+.+++..+..++.|++.+|++||++|++||||||+||+++.++.++|+|||++........                  
T Consensus        95 ~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (360)
T cd05627          95 KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ  174 (360)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccc
Confidence            88899999999999999999999999999999999999999999999999998763321100                  


Q ss_pred             ----------------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        142 ----------------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       142 ----------------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                                      .......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.++.+....|.
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~  249 (360)
T cd05627         175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVM  249 (360)
T ss_pred             ccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHH
Confidence                            00113367899999999887 458999999999999999999999999988877766554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.3e-39  Score=245.56  Aligned_cols=184  Identities=26%  Similarity=0.385  Sum_probs=156.6

Q ss_pred             CcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCCh
Q psy16889          8 GRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~   85 (203)
                      +..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+.     ..++++|||+. |+|.+++...+.+++
T Consensus        56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~  130 (340)
T PTZ00426         56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPN  130 (340)
T ss_pred             CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCH
Confidence            4689999985422 1233456788899999999999999999999887     56789999997 589999888888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCC
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHY  165 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~  165 (203)
                      ..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....    ......|++.|+|||++.+ ..+
T Consensus       131 ~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~-~~~  205 (340)
T PTZ00426        131 DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT----RTYTLCGTPEYIAPEILLN-VGH  205 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC----CcceecCChhhcCHHHHhC-CCC
Confidence            99999999999999999999999999999999999999999999999875432    1233467889999999987 457


Q ss_pred             CcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        166 SAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       166 ~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.++|+||||+++|+|++|..||.+.++....+.|.
T Consensus       206 ~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~  241 (340)
T PTZ00426        206 GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL  241 (340)
T ss_pred             CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            899999999999999999999999888766665553

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.5e-38  Score=242.65  Aligned_cols=193  Identities=21%  Similarity=0.312  Sum_probs=161.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+|+.||+|+++... ......+.+..|.++++.+ +||||+++++++.++     ...++||||++ ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~   88 (321)
T cd05591          14 AELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQ   88 (321)
T ss_pred             EEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHH
Confidence            4567889999999985432 1233445677788888866 899999999999887     56789999998 58888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ....+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (321)
T cd05591          89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFCGTPDYIAPEI  167 (321)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC-CccccccccCccccCHHH
Confidence            7788999999999999999999999999999999999999999999999999998643222 222334467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+.++.|.
T Consensus       168 ~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~  209 (321)
T cd05591         168 LQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL  209 (321)
T ss_pred             HcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            877 458999999999999999999999999988877776654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0586|consensus

Probab=100.00  E-value=4.7e-39  Score=249.51  Aligned_cols=187  Identities=23%  Similarity=0.436  Sum_probs=170.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      ++++.+|..||||++..........+.+.+|+++++.++||||++++++...+     ..+|+||||+. |.+++++.++
T Consensus        75 a~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~  149 (596)
T KOG0586|consen   75 ARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKH  149 (596)
T ss_pred             eEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhc
Confidence            46788999999999987777777778899999999999999999999999988     78999999998 6999999999


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+.+.+++..+.|+.+|++|||+++++|||||++|++++.+.++||+|||++..+.  ......+.+|++.|.|||++.
T Consensus       150 gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lqt~cgsppyAaPEl~~  227 (596)
T KOG0586|consen  150 GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQTFCGSPPYAAPELFN  227 (596)
T ss_pred             ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--ccccccccCCCCCccChHhhc
Confidence            999999999999999999999999999999999999999999999999999998665  344456668899999999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      +.++.++..|+||+|+++|.|+.|..||.+..-.+
T Consensus       228 g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~  262 (596)
T KOG0586|consen  228 GKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE  262 (596)
T ss_pred             CcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence            98878999999999999999999999999875443

>KOG0580|consensus

Probab=100.00  E-value=3.6e-39  Score=224.78  Aligned_cols=193  Identities=28%  Similarity=0.395  Sum_probs=168.8

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-   78 (203)
                      ++.++++--||+|++-.+.. .......+.+|+++.+.++||||+++|++|.|+     ..+|+++||.. |++...+. 
T Consensus        41 arekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~  115 (281)
T KOG0580|consen   41 AREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQE  115 (281)
T ss_pred             eeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHh
Confidence            45678899999999944333 333445678999999999999999999999999     78999999998 78988888 


Q ss_pred             -CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         79 -SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        79 -~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                       ..+.+++.....++.|++.|+.|||..+++||||||+|++++..+.+|+.|||.+....   .....+.+||..|++||
T Consensus       116 ~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~kR~tlcgt~dyl~pE  192 (281)
T KOG0580|consen  116 GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SNKRKTLCGTLDYLPPE  192 (281)
T ss_pred             cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CCCceeeecccccCCHh
Confidence             56779999999999999999999999999999999999999999999999999986432   34445568899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      ...+ ..++...|+|++|++.||++.|.+||...+..+..+.|.++
T Consensus       193 mv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~  237 (281)
T KOG0580|consen  193 MVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV  237 (281)
T ss_pred             hcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence            9988 55799999999999999999999999999988888888753

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-38  Score=247.27  Aligned_cols=194  Identities=23%  Similarity=0.356  Sum_probs=160.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.++     ...++||||++ |+|.+.+..
T Consensus        62 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~  136 (370)
T cd05596          62 VRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN  136 (370)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh
Confidence            45778999999999854221 223345577899999999999999999999887     57889999997 578877654


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...............|++.|+|||++
T Consensus       137 -~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (370)
T cd05596         137 -YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             -cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHh
Confidence             4689999999999999999999999999999999999999999999999999875433322233445689999999988


Q ss_pred             ecc---cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGA---RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+.   ..++.++|+|||||++|+|++|+.||.+.+....+..|.
T Consensus       216 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  260 (370)
T cd05596         216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  260 (370)
T ss_pred             ccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence            653   237889999999999999999999999988777666654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.9e-39  Score=244.55  Aligned_cols=192  Identities=26%  Similarity=0.390  Sum_probs=160.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|++..... .......+..|+++++.++||||+++.+++.++     ...++||||++ ++|...+..
T Consensus        14 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~   88 (325)
T cd05594          14 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSR   88 (325)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHh
Confidence            45778999999999964322 233455677899999999999999999998887     56789999998 588888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+...... ........|++.|+|||+
T Consensus        89 ~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (325)
T cd05594          89 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEV  167 (325)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-CcccccccCCcccCCHHH
Confidence            7889999999999999999999997 79999999999999999999999999998642221 122233467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+.......+
T Consensus       168 ~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i  208 (325)
T cd05594         168 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI  208 (325)
T ss_pred             Hcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence            877 45899999999999999999999999887776655544

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.3e-38  Score=240.18  Aligned_cols=192  Identities=24%  Similarity=0.372  Sum_probs=157.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+++.||+|+++.... .....+....|..++... +||||+++++++..+     ...++||||++ ++|...+.
T Consensus        14 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~   88 (316)
T cd05592          14 AELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHH
Confidence            45678899999999864322 223344455666666654 899999999998877     56789999997 58888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++....... .......|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~  167 (316)
T cd05592          89 SSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEI  167 (316)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccCCccccCHHH
Confidence            77889999999999999999999999999999999999999999999999999986432221 22234467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|
T Consensus       168 ~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i  208 (316)
T cd05592         168 LKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI  208 (316)
T ss_pred             HcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            987 45889999999999999999999999988877666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-38  Score=245.71  Aligned_cols=175  Identities=23%  Similarity=0.303  Sum_probs=150.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |+|..+++.||+|...        ...+.+|++++++++||||+++++++..+     ...++++|++.++|..++....
T Consensus       111 ~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~  177 (391)
T PHA03212        111 CIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKR  177 (391)
T ss_pred             EEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcC
Confidence            5788999999999753        23467899999999999999999998876     5678899999999998888778


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++.+++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...............||+.|+|||++.+
T Consensus       178 ~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~  257 (391)
T PHA03212        178 NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR  257 (391)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC
Confidence            89999999999999999999999999999999999999999999999999986433222233344578999999999987


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                       ..++.++|+||||+++|+|++|+.||-+
T Consensus       258 -~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        258 -DPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence             4589999999999999999999977643

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.4e-38  Score=241.66  Aligned_cols=193  Identities=24%  Similarity=0.374  Sum_probs=157.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHH-HHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+|+.||+|++..... .......+..|.. +++.++||||+++++++.+.     ...+++|||+. ++|..++.
T Consensus        14 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~   88 (323)
T cd05575          14 AKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQ   88 (323)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHH
Confidence            46778999999999854321 2223334444444 56788999999999998877     56789999998 48888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (323)
T cd05575          89 RERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEV  167 (323)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccccCChhhcChhh
Confidence            8888999999999999999999999999999999999999999999999999988642221 222334467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||...+..+....|.
T Consensus       168 ~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~  209 (323)
T cd05575         168 LRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL  209 (323)
T ss_pred             hcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence            887 558999999999999999999999999887777665553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-37  Score=241.02  Aligned_cols=192  Identities=44%  Similarity=0.763  Sum_probs=157.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.||+|.+............+.+|+.+++.++||||+++++++...... ....+|++|||+++++...+.  
T Consensus        40 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--  117 (359)
T cd07876          40 AFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH--  117 (359)
T ss_pred             EEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh--
Confidence            46778999999999965544445566788999999999999999999988654321 113468999999988877664  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....  ........+++.|+|||++.
T Consensus       118 ~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~  195 (359)
T cd07876         118 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVIL  195 (359)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc--CccCCCCcccCCCCCchhcc
Confidence            3588999999999999999999999999999999999999999999999999864322  12223446688899999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+.
T Consensus       196 ~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~  232 (359)
T cd07876         196 G-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN  232 (359)
T ss_pred             C-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            7 458899999999999999999999999877655443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=241.67  Aligned_cols=194  Identities=25%  Similarity=0.345  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||+|++.... ......+.+.+|..+++.++|+||+++++++.++     ..+++||||+. ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~   94 (331)
T cd05597          20 VKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHH
Confidence            4567889999999985421 2233445678899999999999999999999887     67889999997 589888865


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..+..++.|++.+|++||+++++||||||+||+++.++.++|+|||.+...............|++.|+|||+
T Consensus        95 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05597          95 FEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI  174 (331)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHH
Confidence             4679999999999999999999999999999999999999999999999999986543322222233467899999999


Q ss_pred             eec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +..    ...++.++|+||||+++|+|++|+.||.+.+..+....|
T Consensus       175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05597         175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             HhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            863    234678999999999999999999999888766665544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.4e-39  Score=244.87  Aligned_cols=195  Identities=23%  Similarity=0.330  Sum_probs=161.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||+|+++.... .......+.+|..+++.++|+||+++++++.+.     ...++||||++ ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   94 (330)
T cd05601          20 VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNR   94 (330)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHH
Confidence            46778999999999965322 233456678899999999999999999998877     56789999997 588888876


Q ss_pred             C-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 P-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      . +.+++..+..++.|++.+|++||+++++||||||+||+++.++.++|+|||.+...............+++.|+|||+
T Consensus        95 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~  174 (330)
T cd05601          95 YEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV  174 (330)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHH
Confidence            5 679999999999999999999999999999999999999999999999999987544332222233467889999999


Q ss_pred             eec-----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMG-----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +..     ...++.++|+||||+++|+|++|+.||.+.+....+..|.
T Consensus       175 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  222 (330)
T cd05601         175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM  222 (330)
T ss_pred             hccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence            863     2457889999999999999999999998887766665553

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=6.8e-38  Score=239.15  Aligned_cols=193  Identities=22%  Similarity=0.307  Sum_probs=159.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||+|+++.... .....+.+..|..+++.+. |++|+++.+++.+.     ..+|+||||++ ++|.+++.
T Consensus        19 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~   93 (323)
T cd05615          19 AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQ   93 (323)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHH
Confidence            46778999999999864322 2334456777888888885 57788898888877     56789999997 58988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        94 ~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  172 (323)
T cd05615          94 QVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFCGTPDYIAPEI  172 (323)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-CccccCccCCccccCHHH
Confidence            8788999999999999999999999999999999999999999999999999998643222 112233457889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+.......|.
T Consensus       173 ~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (323)
T cd05615         173 IAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (323)
T ss_pred             HcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            877 558899999999999999999999999988777666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.2e-38  Score=240.17  Aligned_cols=192  Identities=23%  Similarity=0.352  Sum_probs=156.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHH-HHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFREL-KMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+|+.|++|++..... .......+..|. .+++.++||||+++++++.+.     ...+++|||++ ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~   88 (321)
T cd05603          14 AKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQ   88 (321)
T ss_pred             EEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHH
Confidence            46778899999999854321 222333445554 467888999999999998877     56789999998 48888887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ....+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...... ........|++.|+|||.
T Consensus        89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (321)
T cd05603          89 RERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFCGTPEYLAPEV  167 (321)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccccccCCcccCCHHH
Confidence            7788999999999999999999999999999999999999999999999999998643222 122234467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||...+.......|
T Consensus       168 ~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i  208 (321)
T cd05603         168 LRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI  208 (321)
T ss_pred             hcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence            877 45889999999999999999999999988766665554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.8e-38  Score=235.12  Aligned_cols=196  Identities=39%  Similarity=0.640  Sum_probs=155.3

Q ss_pred             cCC-CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          3 TDP-RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         3 ~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      .+. .+|+.||+|.++.............+|++.++.+   +||||+++++++..........+++++|+++++|.+++.
T Consensus        21 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~  100 (290)
T cd07862          21 RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD  100 (290)
T ss_pred             EEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHH
Confidence            443 3578899999865433333334555677766665   699999999987543222114578999999998888876


Q ss_pred             C--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 S--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .  ...+++..+..++.|++.||++||++|++||||||+||+++.++.++++|||.+......  .......+++.|+||
T Consensus       101 ~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aP  178 (290)
T cd07862         101 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP  178 (290)
T ss_pred             hCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC--cccccccccccccCh
Confidence            4  345899999999999999999999999999999999999999999999999998754322  223344678899999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |.+.+ ..++.++|+||||+++|+|++|++||.+.+..+.+..|.
T Consensus       179 E~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~  222 (290)
T cd07862         179 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  222 (290)
T ss_pred             HHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            99876 458899999999999999999999999988887777664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.2e-38  Score=238.85  Aligned_cols=193  Identities=23%  Similarity=0.313  Sum_probs=159.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCC-CccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHD-NVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+++.||||++..... .....+.+..|.++++.++|+ +|+++++++.+.     ...|+||||+. ++|.+.+.
T Consensus        19 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~   93 (324)
T cd05587          19 AERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQ   93 (324)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHH
Confidence            45678899999999864321 234456677899999999665 588888888776     56789999997 58988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        94 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  172 (324)
T cd05587          94 QVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTRTFCGTPDYIAPEI  172 (324)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCceeeecCCccccChhh
Confidence            8788999999999999999999999999999999999999999999999999988632211 122233467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||+|+++|+|++|+.||.+.+..+.+..|.
T Consensus       173 ~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~  214 (324)
T cd05587         173 IAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM  214 (324)
T ss_pred             hcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987 558899999999999999999999999888777766554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0032|consensus

Probab=100.00  E-value=8.1e-38  Score=240.26  Aligned_cols=192  Identities=34%  Similarity=0.534  Sum_probs=168.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |+++.+|+.+|+|+++.... +..+.+.+.+|+++|+++. ||||+.+.+++.+.     ..+++|||++. |+|.+.+.
T Consensus        54 ~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~  128 (382)
T KOG0032|consen   54 CREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIV  128 (382)
T ss_pred             EEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHH
Confidence            67788999999999955332 3335678999999999997 99999999999999     67899999998 59998887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC----CeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN----CILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .. .++|..+..++.|++.+++|||+.|++|||+||+|+++...    +.++++|||++.....  .......+||+.|+
T Consensus       129 ~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~  205 (382)
T KOG0032|consen  129 KK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYV  205 (382)
T ss_pred             Hc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceEeeecCCcccc
Confidence            76 49999999999999999999999999999999999999633    4799999999986655  45566779999999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      |||++.. ..|+...|+||+|+++|.|++|.+||.+.+......+|..
T Consensus       206 APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~  252 (382)
T KOG0032|consen  206 APEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR  252 (382)
T ss_pred             CchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence            9999987 5589999999999999999999999999998888777653

>KOG0201|consensus

Probab=100.00  E-value=5.3e-38  Score=235.28  Aligned_cols=189  Identities=25%  Similarity=0.380  Sum_probs=166.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.|.++++.||+|++... .....++.+.+|+..+.+++++||.++|+.+..+     ..++++||||. |++.+.+...
T Consensus        32 ~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~  105 (467)
T KOG0201|consen   32 AIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSG  105 (467)
T ss_pred             eeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccC
Confidence            578999999999999654 4445677889999999999999999999999888     78999999999 5888888887


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+.|.++.-++++++.|+.|+|.++.+|||||+.||++...|.++++|||.+.......... .+..||+.|+|||++.
T Consensus       106 ~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  106 NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIK  184 (467)
T ss_pred             CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-ccccccccccchhhhc
Confidence            778999999999999999999999999999999999999999999999999987544433333 6678999999999999


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      + ..|+.++||||||++.+||++|++|+.+..+...+.
T Consensus       185 ~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf  221 (467)
T KOG0201|consen  185 Q-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF  221 (467)
T ss_pred             c-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence            6 559999999999999999999999999877644443

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.1e-37  Score=236.60  Aligned_cols=193  Identities=37%  Similarity=0.638  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +++..+++.|++|.++... .......+.+|++++++++|+||+++++++..+     ...+++|||++++|.+.+... 
T Consensus        25 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   98 (309)
T cd07872          25 GRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCG   98 (309)
T ss_pred             EEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcC
Confidence            4577889999999986432 222334567899999999999999999999877     567899999999888887653 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||++|++||||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  177 (309)
T cd07872          99 NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLL  177 (309)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cccccccccccccCCHHHh
Confidence            458999999999999999999999999999999999999999999999999986433221 2223335688899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|++||.+.+..+.+..+.
T Consensus       178 ~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  218 (309)
T cd07872         178 GSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF  218 (309)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            65668899999999999999999999999887766655543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.2e-38  Score=238.37  Aligned_cols=192  Identities=24%  Similarity=0.345  Sum_probs=158.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||+|+++.... .....+....|..++... +||+|+++++++.+.     ..+|+||||+. ++|...+.
T Consensus        14 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~   88 (316)
T cd05620          14 AELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQ   88 (316)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHH
Confidence            45778999999999964321 123345566777777755 999999999999887     57889999998 58888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (316)
T cd05620          89 DKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEI  167 (316)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceeccCCCcCccCHHH
Confidence            7788999999999999999999999999999999999999999999999999988632211 122334467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       168 ~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~  208 (316)
T cd05620         168 LQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI  208 (316)
T ss_pred             HcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            987 45899999999999999999999999988877666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3e-37  Score=238.47  Aligned_cols=193  Identities=42%  Similarity=0.758  Sum_probs=158.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+++.|++|.+............+.+|+.+++.++||||+++++++...... .....+++|||+++++...+.. 
T Consensus        36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-  114 (355)
T cd07874          36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM-  114 (355)
T ss_pred             EEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh-
Confidence            46778899999999976544555566788899999999999999999988654321 1235689999999888877653 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       .+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++......  .......++..|+|||++.
T Consensus       115 -~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~  191 (355)
T cd07874         115 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL  191 (355)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc--cccCCccccCCccCHHHHc
Confidence             5889999999999999999999999999999999999999999999999999743322  2223446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+..
T Consensus       192 ~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  229 (355)
T cd07874         192 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            7 4588999999999999999999999998776555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.9e-38  Score=240.17  Aligned_cols=193  Identities=23%  Similarity=0.352  Sum_probs=156.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHH-HHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFREL-KMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      |.+..+++.||+|++..... .......+..|. .+++.++|+||+++++++.+.     ...+++|||+.+ +|.+.+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~   88 (325)
T cd05602          14 ARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQ   88 (325)
T ss_pred             EEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHH
Confidence            46778899999999854221 112223344443 456788999999999999877     567899999985 8888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~gt~~y~aPE~  167 (325)
T cd05602          89 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFCGTPEYLAPEV  167 (325)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcccccCCccccCHHH
Confidence            8788999999999999999999999999999999999999999999999999998643221 122334467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       168 ~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  209 (325)
T cd05602         168 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  209 (325)
T ss_pred             HcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            987 558899999999999999999999999888777666553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-37  Score=240.95  Aligned_cols=195  Identities=41%  Similarity=0.755  Sum_probs=160.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+++.||||++............+.+|+.+++.++||||+++++++..... .....+|+||||+++++...+.. 
T Consensus        43 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-  121 (364)
T cd07875          43 AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-  121 (364)
T ss_pred             EEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh-
Confidence            4677889999999997654445556678899999999999999999998765432 11134689999999988877653 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       .+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++......  .......++..|+|||++.
T Consensus       122 -~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~  198 (364)
T cd07875         122 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL  198 (364)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--CcccCCcccCCcCCHHHHh
Confidence             5889999999999999999999999999999999999999999999999999754322  2223346788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       199 ~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  238 (364)
T cd07875         199 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  238 (364)
T ss_pred             C-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7 458999999999999999999999999988776665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.1e-38  Score=239.09  Aligned_cols=193  Identities=24%  Similarity=0.326  Sum_probs=159.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+++.||+|+++.... .....+....|..++..+ +|++|+++++++.+.     ...++||||++ ++|...+.
T Consensus        19 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~   93 (323)
T cd05616          19 AERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQ   93 (323)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHH
Confidence            45678899999999864322 223344566777777777 688999999998877     56789999997 58988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        94 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~  172 (323)
T cd05616          94 QVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEI  172 (323)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-CCccccCCCChhhcCHHH
Confidence            7788999999999999999999999999999999999999999999999999998643221 122234467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       173 ~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~  214 (323)
T cd05616         173 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  214 (323)
T ss_pred             hcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987 558999999999999999999999999988877776654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-38  Score=241.09  Aligned_cols=193  Identities=24%  Similarity=0.376  Sum_probs=157.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHH-HHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+|+.||+|++..... .......+..|.. +++.++||||+++++++..+     ...+++|||+. ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~   88 (325)
T cd05604          14 AKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQ   88 (325)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHH
Confidence            46778999999999854321 2223344555544 56778999999999998877     56789999998 48888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (325)
T cd05604          89 RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEV  167 (325)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccccCChhhCCHHH
Confidence            8788999999999999999999999999999999999999999999999999998642211 222234467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus       168 ~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~  209 (325)
T cd05604         168 IRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL  209 (325)
T ss_pred             HcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence            887 457899999999999999999999999887776665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.7e-38  Score=238.44  Aligned_cols=191  Identities=23%  Similarity=0.339  Sum_probs=154.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHH---hhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKML---CFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   76 (203)
                      +.+..+|+.||||+++.... .....+.+..|.+++   +.++||||+++++++.+.     ...|+||||+.+ +|...
T Consensus        18 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~   92 (324)
T cd05589          18 AEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMH   92 (324)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----CEEEEEEcCCCCCcHHHH
Confidence            45678899999999964321 223345566666554   566899999999999877     567899999985 77666


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...... ........|++.|+||
T Consensus        93 ~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g~~~y~aP  170 (324)
T cd05589          93 IH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRTSTFCGTPEFLAP  170 (324)
T ss_pred             hh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCcccccccCccccCH
Confidence            54 467999999999999999999999999999999999999999999999999988642221 2222344678999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       171 E~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i  213 (324)
T cd05589         171 EVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI  213 (324)
T ss_pred             hHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99887 45789999999999999999999999988877666554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.4e-37  Score=237.17  Aligned_cols=194  Identities=47%  Similarity=0.845  Sum_probs=159.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+++.||||.+............+.+|++++++++|+||+++++++...... .....++++++++++|.+.+. .
T Consensus        34 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-~  112 (343)
T cd07878          34 AYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-C  112 (343)
T ss_pred             EEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh-c
Confidence            46778999999999965444444556677899999999999999999988654321 123467889998888877664 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....    ......+++.|+|||++.
T Consensus       113 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWYRAPEIML  188 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC----CcCCccccccccCchHhc
Confidence            5699999999999999999999999999999999999999999999999999875332    223346788999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       189 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  228 (343)
T cd07878         189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI  228 (343)
T ss_pred             CCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            7556889999999999999999999999987766655544

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.7e-38  Score=240.47  Aligned_cols=183  Identities=23%  Similarity=0.324  Sum_probs=152.9

Q ss_pred             CCCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          4 DPRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +..+|+.||+|++.....  .....+.+..|.++++.+ +|++|+++++++..+     ...+++|||+. ++|.+.+..
T Consensus        24 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~   98 (332)
T cd05614          24 GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQ   98 (332)
T ss_pred             cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHH
Confidence            456899999999854221  223345677899999999 599999999998877     56789999998 589898888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.++++++..++.|++.||++||++|++||||||+||+++.++.++|+|||++...............|++.|+|||++
T Consensus        99 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~  178 (332)
T cd05614          99 RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII  178 (332)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHh
Confidence            78899999999999999999999999999999999999999999999999999875433322233344678999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+...++.++|+||||+++|+|++|+.||...
T Consensus       179 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             cCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            87555788999999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.7e-37  Score=232.20  Aligned_cols=196  Identities=38%  Similarity=0.610  Sum_probs=155.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      |.++.+|+.|++|.++.............+|++.++.+   +||||+++++++..........+++++|++.++|.+++.
T Consensus        19 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   98 (288)
T cd07863          19 ARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLD   98 (288)
T ss_pred             EEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHH
Confidence            56788999999999865332222233455666666655   799999999988754332224578999999998888876


Q ss_pred             CC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 SP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      ..  ..++++.+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......  .......++..|+||
T Consensus        99 ~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aP  176 (288)
T cd07863          99 KVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--MALTPVVVTLWYRAP  176 (288)
T ss_pred             hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc--ccCCCccccccccCc
Confidence            43  45899999999999999999999999999999999999999999999999998754322  122334568889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |++.+ ..++.++|+||||+++|+|++|++||.+....+.+..|
T Consensus       177 E~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~  219 (288)
T cd07863         177 EVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI  219 (288)
T ss_pred             hHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHH
Confidence            99877 45899999999999999999999999888776666554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.9e-37  Score=245.26  Aligned_cols=192  Identities=33%  Similarity=0.536  Sum_probs=153.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc---hhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD---FFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +++..+++.||||.+...      .....+|+.+++.++||||+++++++......   ....++++|||+++++.+.+.
T Consensus        85 ~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~  158 (440)
T PTZ00036         85 AICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMK  158 (440)
T ss_pred             EEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHH
Confidence            456788999999988431      12345799999999999999998876543211   012456899999987766653


Q ss_pred             ----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         79 ----SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        79 ----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                          ....+++..++.++.|++.||+|||+++++||||||+||+++.++ .++|+|||++......  .......+++.|
T Consensus       159 ~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~--~~~~~~~~t~~y  236 (440)
T PTZ00036        159 HYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG--QRSVSYICSRFY  236 (440)
T ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC--CCcccCCCCcCc
Confidence                456799999999999999999999999999999999999999664 6999999999744322  222334668889


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +|||++.+...++.++|+|||||++|+|++|.+||.+.+..+.+.+|.
T Consensus       237 ~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             cCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999998775668999999999999999999999999988777766554

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-37  Score=236.68  Aligned_cols=193  Identities=24%  Similarity=0.342  Sum_probs=159.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+++.||+|+++... ........+..|.++++.+ +||||+++++++.+.     ..++++|||+. ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~   88 (318)
T cd05570          14 AELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQ   88 (318)
T ss_pred             EEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHH
Confidence            4567889999999996432 1233455677888888888 799999999999877     56789999997 58888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||.+...... ........+++.|+|||+
T Consensus        89 ~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g~~~y~aPE~  167 (318)
T cd05570          89 RSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFCGTPDYIAPEI  167 (318)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccceecCccccCHHH
Confidence            7788999999999999999999999999999999999999999999999999988642221 122233457889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       168 ~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~  209 (318)
T cd05570         168 LSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL  209 (318)
T ss_pred             hcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            987 458899999999999999999999999887776665543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.6e-37  Score=233.34  Aligned_cols=184  Identities=22%  Similarity=0.348  Sum_probs=152.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||+|.+..... .......+.+|+.++++++|++++++.+++.++     ...++++||+. ++|...+..
T Consensus        19 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~   93 (285)
T cd05631          19 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             EEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHh
Confidence            45678999999999854322 223344577899999999999999999998877     56789999998 577766543


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ...+++..+..++.|++.||++||+.+++||||||+||+++.++.++++|||.+.....  ........|+..|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~g~~~y~aPE  171 (285)
T cd05631          94 MGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GETVRGRVGTVGYMAPE  171 (285)
T ss_pred             hCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CCeecCCCCCCCccCHh
Confidence              34689999999999999999999999999999999999999999999999999875322  12223446789999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+...
T Consensus       172 ~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~  206 (285)
T cd05631         172 VINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE  206 (285)
T ss_pred             hhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence            9987 4589999999999999999999999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=241.60  Aligned_cols=193  Identities=25%  Similarity=0.395  Sum_probs=157.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      +.+..+|+.||||++.... ...........|..++...   +||+|+++++++.++     ..++++|||+. ++|...
T Consensus        12 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~   86 (330)
T cd05586          12 VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWH   86 (330)
T ss_pred             EEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEEcCCCCChHHHH
Confidence            4678899999999985421 1222333445566666655   799999999999887     56789999997 588888


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +...+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|++.|+||
T Consensus        87 l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~gt~~y~aP  165 (330)
T cd05586          87 LQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTFCGTTEYLAP  165 (330)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCccCCccccCH
Confidence            888888999999999999999999999999999999999999999999999999998643222 2223344678999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |++.+...++.++|+||||+++|+|++|+.||.+....+.+..|
T Consensus       166 E~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i  209 (330)
T cd05586         166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI  209 (330)
T ss_pred             HHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence            99876555789999999999999999999999988777666554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.2e-37  Score=230.73  Aligned_cols=192  Identities=36%  Similarity=0.593  Sum_probs=157.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      |++..+|+.+++|.++...........+.+|++.+++++|+|++++++++.+.     ...++++||++++|.+++.. .
T Consensus        19 ~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   93 (284)
T cd07839          19 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCN   93 (284)
T ss_pred             EEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcC
Confidence            46778999999999865433333445677899999999999999999999887     57789999999988887764 5


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..++.++.|++.||.+||+++++|+||+|+||+++.++.++++|||.+...... ........++..|+|||.+.
T Consensus        94 ~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  172 (284)
T cd07839          94 GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF  172 (284)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-CCCcCCCccccCCcChHHHh
Confidence            67999999999999999999999999999999999999999999999999998754322 12223345678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcc-cCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRIL-FQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~  199 (203)
                      +...++.++|+||||+++|+|++|+.| |.+.+..+.+..
T Consensus       173 ~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~  212 (284)
T cd07839         173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR  212 (284)
T ss_pred             CCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence            755578999999999999999998777 555555444443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.2e-37  Score=235.70  Aligned_cols=192  Identities=25%  Similarity=0.370  Sum_probs=157.6

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+++.||||+++.... ..........|..+++.. +||||+++++++.+.     ..++++|||+. ++|...+.
T Consensus        14 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~   88 (316)
T cd05619          14 AELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQ   88 (316)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            45778899999999865321 122344566677777764 999999999999887     56789999997 58988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ....+++.++..++.|++.||+|||+++++||||||+||+++.++.++++|||.+...... ........|++.|+|||+
T Consensus        89 ~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (316)
T cd05619          89 SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEI  167 (316)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCceeeecCCccccCHHH
Confidence            7778999999999999999999999999999999999999999999999999998642221 112233467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||+|+++|+|++|+.||.+.+..+.+..+
T Consensus       168 ~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i  208 (316)
T cd05619         168 LLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI  208 (316)
T ss_pred             HcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            887 45899999999999999999999999988776666544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.2e-38  Score=239.77  Aligned_cols=194  Identities=24%  Similarity=0.340  Sum_probs=159.5

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.||+|++.... ........+.+|..+++.++|++|+++++++.++     ...|+||||+. |+|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~   94 (331)
T cd05624          20 VKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSK   94 (331)
T ss_pred             EEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHH
Confidence            4567889999999985421 2233445577899999999999999999999877     57789999997 589888876


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       .+.+++..+..++.|++.+|++||+++++||||||+||+++.++.++|+|||++...............|++.|+|||+
T Consensus        95 ~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~  174 (331)
T cd05624          95 FEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI  174 (331)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHH
Confidence             4679999999999999999999999999999999999999999999999999987543322222233467899999998


Q ss_pred             eecc----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+.    +.++.++|+||||+++|+|++|+.||.+.+..+....|
T Consensus       175 ~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i  220 (331)
T cd05624         175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI  220 (331)
T ss_pred             HhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHH
Confidence            8642    34688999999999999999999999888776666554

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-37  Score=238.53  Aligned_cols=195  Identities=24%  Similarity=0.340  Sum_probs=159.7

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.++.+++.+++|++.... ........+.+|..++..++|++|+++++++.+.     ...++||||+. |+|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~   94 (332)
T cd05623          20 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSK   94 (332)
T ss_pred             EEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHH
Confidence            3567788999999985421 2223344577899999999999999999999877     56789999997 689988875


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..+..++.|++.++++||+++++||||||+||+++.++.++|+|||.+...............|++.|+|||+
T Consensus        95 ~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~  174 (332)
T cd05623          95 FEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI  174 (332)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHH
Confidence             4679999999999999999999999999999999999999999999999999986433222222233467999999998


Q ss_pred             eec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +..    ...++.++|+||||+++|+|++|+.||...+..+.+..|.
T Consensus       175 ~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~  221 (332)
T cd05623         175 LQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  221 (332)
T ss_pred             HhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence            862    2457889999999999999999999999888777666553

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.4e-37  Score=238.08  Aligned_cols=182  Identities=24%  Similarity=0.392  Sum_probs=153.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+|+.||+|+++.... .......+..|..+++.+ +||||+++++++.+.     ..++++|||++ ++|..++.
T Consensus        14 ~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~   88 (329)
T cd05588          14 VELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQ   88 (329)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHH
Confidence            45778999999999965322 233445677899999888 799999999999887     56789999998 58888887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||++..... .........|++.|+|||+
T Consensus        89 ~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~gt~~y~aPE~  167 (329)
T cd05588          89 RQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTFCGTPNYIAPEI  167 (329)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccccccCCccccCHHH
Confidence            778899999999999999999999999999999999999999999999999999863221 1222334567899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||..
T Consensus       168 ~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         168 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             HcC-CCCCCccceechHHHHHHHHHCCCCccc
Confidence            987 5588999999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-37  Score=244.30  Aligned_cols=190  Identities=26%  Similarity=0.398  Sum_probs=156.1

Q ss_pred             cCCCC-CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh--
Q psy16889          3 TDPRD-GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV--   78 (203)
Q Consensus         3 ~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--   78 (203)
                      .+..+ ++.|++|.+..  ........+..|+.+++.++||||+++++++..+     ...++||||+. |+|.+.+.  
T Consensus        87 ~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  159 (478)
T PTZ00267         87 TRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQR  159 (478)
T ss_pred             EEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHH
Confidence            34445 77889997743  2333445677899999999999999999999887     56789999997 58876653  


Q ss_pred             --CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccccc
Q psy16889         79 --SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRA  155 (203)
Q Consensus        79 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~a  155 (203)
                        ...++++.++..++.|++.+|.+||+++++||||||+||+++.++.++|+|||++........ .......||+.|+|
T Consensus       160 ~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~a  239 (478)
T PTZ00267        160 LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLA  239 (478)
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccC
Confidence              346799999999999999999999999999999999999999999999999999975433221 12234467999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+
T Consensus       240 PE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~  283 (478)
T PTZ00267        240 PELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV  283 (478)
T ss_pred             HhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999887 45899999999999999999999999988777666554

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-36  Score=228.59  Aligned_cols=190  Identities=39%  Similarity=0.683  Sum_probs=156.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS--   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--   79 (203)
                      +.+..+|+.|++|.++...........+.+|+.++++++|||++++++++.++     ...++++||+.++|.+++..  
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~   93 (285)
T cd07861          19 GRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLP   93 (285)
T ss_pred             EEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCC
Confidence            45677899999999865433333446678899999999999999999999876     56789999999888877653  


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..++.++.|++.||++||+++++|+||+|+||+++.++.++|+|||.+...... ........+++.|+|||.
T Consensus        94 ~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~  172 (285)
T cd07861          94 KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-VRVYTHEVVTLWYRAPEV  172 (285)
T ss_pred             CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-cccccCCcccccccChHH
Confidence             256999999999999999999999999999999999999999999999999998743322 222233355788999998


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      +.+...++.++|+||||+++|+|++|++||.+....+.+
T Consensus       173 ~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~  211 (285)
T cd07861         173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL  211 (285)
T ss_pred             hcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            876555788999999999999999999999887654433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4250|consensus

Probab=100.00  E-value=2.7e-37  Score=243.09  Aligned_cols=185  Identities=30%  Similarity=0.462  Sum_probs=157.2

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +++++|+.||||.++.. .+...++...+|++++++++|+|||+++++=.+... .......++||||. |+|...+...
T Consensus        33 rnketG~~vAvK~~~~~-~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~P  111 (732)
T KOG4250|consen   33 RNKETGRLVAVKTFNKE-SSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSP  111 (732)
T ss_pred             cccccccchhHHhhhhh-cccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCc
Confidence            57899999999999764 356678889999999999999999999998665541 11134678999998 5999998864


Q ss_pred             ---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCe--EEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         81 ---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCI--LKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        81 ---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~--~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                         ..++|.+++.++..+..|+.+||++||+||||||.||++-  .+|+  .||+|||.++...  .........||..|
T Consensus       112 EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~--d~s~~~S~vGT~~Y  189 (732)
T KOG4250|consen  112 ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD--DNSLFTSLVGTEEY  189 (732)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC--CCCeeeeecCchhh
Confidence               3499999999999999999999999999999999999985  3343  5999999998443  34467778999999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ++||.....+.|+...|.||||+++|+++||..||--
T Consensus       190 LhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  190 LHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             cChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            9999998657799999999999999999999999954

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.5e-36  Score=226.59  Aligned_cols=194  Identities=37%  Similarity=0.675  Sum_probs=162.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      |.+..+|+.|++|++............+.+|+.++++++|||++++++++.+.     ...++|+||++++|.+.+.. .
T Consensus        19 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~   93 (286)
T cd07832          19 AKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEE   93 (286)
T ss_pred             EEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcC
Confidence            45677899999999966544444556788999999999999999999999886     56789999997789888754 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.+++.++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07832          94 RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY  173 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeee
Confidence            67999999999999999999999999999999999999999999999999998755433322333446788899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+.++.++|+||+|+++|++++|++||.+..+...+..+
T Consensus       174 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~  213 (286)
T cd07832         174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV  213 (286)
T ss_pred             ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHH
Confidence            7666789999999999999999999999887765555443

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.9e-37  Score=228.71  Aligned_cols=184  Identities=24%  Similarity=0.352  Sum_probs=151.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-   78 (203)
                      +.+..+|+.|++|.+..... .....+.+..|+++++.++|+||+++.+++...     ...+++|||++ ++|...+. 
T Consensus        12 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~   86 (280)
T cd05608          12 CQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYN   86 (280)
T ss_pred             EEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHh
Confidence            45778999999999854322 222335667899999999999999999988877     56789999998 47766552 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++++|||.+....... .......+++.|+|
T Consensus        87 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~g~~~y~a  165 (280)
T cd05608          87 VDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKGYAGTPGFMA  165 (280)
T ss_pred             ccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccccCCCcCccC
Confidence               34569999999999999999999999999999999999999999999999999986433222 12233467889999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus       166 PE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~  201 (280)
T cd05608         166 PELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARG  201 (280)
T ss_pred             HHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence            999987 457899999999999999999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-36  Score=228.02  Aligned_cols=188  Identities=19%  Similarity=0.270  Sum_probs=155.9

Q ss_pred             CCCcEEEEEeccCccchh-hhhHHHHHHHHHHhhcCCCCccchhhhccC--CCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          6 RDGRRVALKKLPNVFQSL-VSSKRVFRELKMLCFFKHDNVLSALDILQP--PHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      .+|+.||||.++...... ...+.+.+|++++++++||||+++++++.+  +..   ...+++|||+. |+|.+++...+
T Consensus        41 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~---~~~~lv~Ey~~~g~L~~~l~~~~  117 (283)
T PHA02988         41 FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL---PRLSLILEYCTRGYLREVLDKEK  117 (283)
T ss_pred             ECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC---CceEEEEEeCCCCcHHHHHhhCC
Confidence            478899999996543322 224667899999999999999999999876  221   45689999999 58999988878


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      .+++.....++.|++.++.+||+ .+++||||+|+||+++.++.++++|||.+.......    ....++..|+|||++.
T Consensus       118 ~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~  193 (283)
T PHA02988        118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLN  193 (283)
T ss_pred             CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhh
Confidence            89999999999999999999998 499999999999999999999999999987433221    2335678899999987


Q ss_pred             cc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +. ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       194 ~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i  234 (283)
T PHA02988        194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI  234 (283)
T ss_pred             hccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            52 45899999999999999999999999988877766655

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-36  Score=230.10  Aligned_cols=192  Identities=37%  Similarity=0.645  Sum_probs=158.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +++..+++.|++|.++.... ......+.+|+..++.++||||+++++++..+     ...++++||++++|.+++.. .
T Consensus        25 ~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~   98 (301)
T cd07873          25 GRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCG   98 (301)
T ss_pred             EEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcC
Confidence            45678899999999864322 22334567899999999999999999999877     56789999999999888765 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||.+.
T Consensus        99 ~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  177 (301)
T cd07873          99 NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTLWYRPPDILL  177 (301)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-CcccccceeecccCcHHHh
Confidence            568999999999999999999999999999999999999999999999999986433221 2222335578899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|+|++|++||.+.+..+.+..+
T Consensus       178 ~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~  217 (301)
T cd07873         178 GSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI  217 (301)
T ss_pred             CCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            6556788999999999999999999999988766555433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-37  Score=236.14  Aligned_cols=181  Identities=24%  Similarity=0.382  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+++.||+|++..... .......+..|..++.++ +||||+++++++.++     ..++++|||+. ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~   88 (329)
T cd05618          14 VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQ   88 (329)
T ss_pred             EEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHH
Confidence            46778999999999965322 233445677888888777 899999999999887     56789999998 58888887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...... ........|++.|+|||+
T Consensus        89 ~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (329)
T cd05618          89 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEI  167 (329)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccccCCccccCHHH
Confidence            7788999999999999999999999999999999999999999999999999998642221 222234467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.
T Consensus       168 ~~~-~~~~~~~DiwslG~il~el~~g~~Pf~  197 (329)
T cd05618         168 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFD  197 (329)
T ss_pred             HcC-CCCCCccceecccHHHHHHhhCCCCCc
Confidence            987 457899999999999999999999995

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-36  Score=224.86  Aligned_cols=192  Identities=41%  Similarity=0.700  Sum_probs=158.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS--   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--   79 (203)
                      +.+..+|+.|+||.++...........+.+|++.+++++||||+++++++.+.     ...++++||+.++|..++..  
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~   93 (284)
T cd07860          19 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASP   93 (284)
T ss_pred             EEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCC
Confidence            45677899999999865444444456788999999999999999999999876     56789999998888887754  


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.|++|||+.+++|+||+|+||+++.++.++++|||.+...... ........++..|+|||.+
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~  172 (284)
T cd07860          94 LSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL  172 (284)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-ccccccccccccccCCeEE
Confidence            456899999999999999999999999999999999999999999999999998644322 1222233457789999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      .+...++.++|+||||+++|++++|+.||.+.+..+.+.+
T Consensus       173 ~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~  212 (284)
T cd07860         173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR  212 (284)
T ss_pred             ecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            8756568899999999999999999999988776554433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0690|consensus

Probab=100.00  E-value=8.6e-38  Score=227.40  Aligned_cols=192  Identities=26%  Similarity=0.377  Sum_probs=168.8

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+.+.+|+.||+|+++... ......+.-..|.+.++..+||.+..+...|+.+     ..+++||||.. |.|.-.+..
T Consensus       187 ~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsr  261 (516)
T KOG0690|consen  187 CREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSR  261 (516)
T ss_pred             EeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhh
Confidence            5678999999999996643 3555667778899999999999999999999998     78899999998 488888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...|+|...+.+-.+|..||.|||+++|++||+|.+|.++|.+|.+|+.|||++... -.........+|||.|+|||++
T Consensus       262 er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~~g~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  262 ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IKYGDTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-ccccceeccccCChhhcCchhh
Confidence            788999999999999999999999999999999999999999999999999999742 2345566777999999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .. ..|+...|+|.+|+++|||++|+.||...+-..+...|
T Consensus       341 eD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI  380 (516)
T KOG0690|consen  341 ED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI  380 (516)
T ss_pred             cc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence            88 56999999999999999999999999987766665555

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6e-37  Score=234.31  Aligned_cols=182  Identities=22%  Similarity=0.369  Sum_probs=153.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+++.||+|+++.... .....+.+..|..++.++ +||+|+++++++.+.     ..+++||||+. ++|...+.
T Consensus        14 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~   88 (327)
T cd05617          14 VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQ   88 (327)
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            45678899999999965322 234456678899988888 799999999999877     56789999997 58888887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........|++.|+|||+
T Consensus        89 ~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~  167 (327)
T cd05617          89 RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEI  167 (327)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecccCCcccCCHHH
Confidence            7788999999999999999999999999999999999999999999999999988642221 222234467899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||..
T Consensus       168 ~~~-~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         168 LRG-EEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             HCC-CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence            987 5589999999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-36  Score=232.31  Aligned_cols=183  Identities=28%  Similarity=0.499  Sum_probs=146.5

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      ..+++.||||+++.. ........+.+|+.+++.+ +||||+++++++....    ..++++|||++ |+|.+++...  
T Consensus        34 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~  108 (338)
T cd05102          34 KSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKRE  108 (338)
T ss_pred             cccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcch
Confidence            456788999998643 2333456788999999999 8999999999876543    34678999998 5887776532  


Q ss_pred             ------------------------------------------------------------CCCChHHHHHHHHHHHHHHH
Q psy16889         81 ------------------------------------------------------------QHLTSDHIKVFLYQILRGLK  100 (203)
Q Consensus        81 ------------------------------------------------------------~~~~~~~~~~~~~qi~~~l~  100 (203)
                                                                                  .++++.++..++.|++.||+
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~  188 (338)
T cd05102         109 FFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME  188 (338)
T ss_pred             hcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHH
Confidence                                                                        34788899999999999999


Q ss_pred             HHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeeecccCCCcchhHHHHHHHHH
Q psy16889        101 YLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA  179 (203)
Q Consensus       101 ~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~  179 (203)
                      |||+++++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++|+||||+++|
T Consensus       189 ~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~  267 (338)
T cd05102         189 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLW  267 (338)
T ss_pred             HHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc-CCCCcccCHHHHHHHHH
Confidence            99999999999999999999999999999999874322211 11122234577999999877 45899999999999999


Q ss_pred             HHHh-CCcccCCCCh
Q psy16889        180 ELLG-RRILFQAQSP  193 (203)
Q Consensus       180 ~ll~-g~~pf~~~~~  193 (203)
                      +|++ |..||.+...
T Consensus       268 el~~~g~~pf~~~~~  282 (338)
T cd05102         268 EIFSLGASPYPGVQI  282 (338)
T ss_pred             HHHhCCCCCCCCCCc
Confidence            9997 9999987553

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.9e-36  Score=230.50  Aligned_cols=196  Identities=54%  Similarity=0.971  Sum_probs=161.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.++.+|+.|++|++............+.+|+.++++++||||+++++++....... ...++++||++++|.+++...+
T Consensus        24 ~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-~~~~lv~e~~~~~l~~~~~~~~  102 (334)
T cd07855          24 AIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF-KDVYVVMDLMESDLHHIIHSDQ  102 (334)
T ss_pred             EEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC-ceEEEEEehhhhhHHHHhccCC
Confidence            467788999999998654444445567788999999999999999999886543221 4578999999999999988778


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCccccccee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAPEI  158 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPe~  158 (203)
                      .+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++++|||.+.........   ......++..|.|||.
T Consensus       103 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (334)
T cd07855         103 PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL  182 (334)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHH
Confidence            8999999999999999999999999999999999999999999999999998643322211   1223466888999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      +.+...++.++|+||||+++|+|++|++||.+.+..+.+.
T Consensus       183 ~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~  222 (334)
T cd07855         183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK  222 (334)
T ss_pred             hcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH
Confidence            8765557899999999999999999999998876554443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.7e-36  Score=231.10  Aligned_cols=185  Identities=28%  Similarity=0.435  Sum_probs=156.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|..+++|.+.... .....+.+.+|++++++++||||+++++++.++     ...+++|||+.+ +|.+++...
T Consensus        24 ~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   97 (331)
T cd06649          24 VQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEA   97 (331)
T ss_pred             EEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHc
Confidence            4677889999999986532 233456788999999999999999999998877     467899999984 899888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..+..++.|++.++.|||++ +++|+||||+||+++.++.++|+|||.+......   ......+++.|+|||++
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g~~~y~aPE~~  174 (331)
T cd06649          98 KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL  174 (331)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccccCCCCcCcCCHhHh
Confidence            8899999999999999999999986 5999999999999999999999999998643221   22334578899999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      .+ ..++.++|+||||+++|+|++|+.||......+.
T Consensus       175 ~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~  210 (331)
T cd06649         175 QG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL  210 (331)
T ss_pred             cC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            87 4589999999999999999999999987665443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=223.12  Aligned_cols=190  Identities=26%  Similarity=0.439  Sum_probs=156.9

Q ss_pred             CcCCCCCcEEEEEeccCccch---hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS---LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      +.+..+|+.+++|.++.....   ......+.+|++++++++||||+++++++.++     ...++++|++. ++|.+.+
T Consensus        21 ~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~   95 (263)
T cd06625          21 CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQL   95 (263)
T ss_pred             EEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHH
Confidence            456788999999998643222   22345678899999999999999999999887     57789999997 4888888


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCc--ccccCCccccc
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM--TQEVVTQYYRA  155 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~a  155 (203)
                      ...+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+...........  ....++..|+|
T Consensus        96 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  175 (263)
T cd06625          96 KAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS  175 (263)
T ss_pred             HHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccC
Confidence            8778899999999999999999999999999999999999999999999999999864432211111  23345778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ||.+.+. .++.++|+||||+++|++++|+.||...+.....
T Consensus       176 PE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  216 (263)
T cd06625         176 PEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI  216 (263)
T ss_pred             cceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHHHH
Confidence            9999874 4889999999999999999999999876655443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0614|consensus

Probab=100.00  E-value=1.1e-36  Score=232.31  Aligned_cols=185  Identities=26%  Similarity=0.424  Sum_probs=164.9

Q ss_pred             EEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCChHH
Q psy16889         10 RVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~   87 (203)
                      -+|+|+++.... ...+.+++..|-++|...+.|.|+++|.-|.++     .++|+.||-|- |.++..+...+.|.+..
T Consensus       447 ~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~t  521 (732)
T KOG0614|consen  447 TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYT  521 (732)
T ss_pred             HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccch
Confidence            478888854332 445677889999999999999999999999999     89999999986 69999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCc
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA  167 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~  167 (203)
                      .+.++..+.+|++|||++||++|||||+|++++.+|-+||.|||.+.....  ....-+.+|||.|.|||.+.+.+ .+.
T Consensus       522 arF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--g~KTwTFcGTpEYVAPEIILnKG-HD~  598 (732)
T KOG0614|consen  522 ARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--GRKTWTFCGTPEYVAPEIILNKG-HDR  598 (732)
T ss_pred             hhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc--CCceeeecCCcccccchhhhccC-cch
Confidence            999999999999999999999999999999999999999999999985543  33344568999999999999854 689


Q ss_pred             chhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        168 AVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       168 ~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.|.||||+++|||++|++||.+.++-..++.|.+
T Consensus       599 avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk  633 (732)
T KOG0614|consen  599 AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK  633 (732)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence            99999999999999999999999999988888763

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.7e-36  Score=229.00  Aligned_cols=182  Identities=40%  Similarity=0.696  Sum_probs=147.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC----
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS----   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----   79 (203)
                      +..+++.|++|.+...    .....+.+|+++++.++||||+++++++.....   ...++++||++++|...+..    
T Consensus        24 ~~~~~~~~aiK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~   96 (317)
T cd07868          24 DGKDDRDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRAS   96 (317)
T ss_pred             cCCCCceEEEEEECCC----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEEEeccCCCHHHHHHhcccc
Confidence            3457889999998543    123456789999999999999999998865432   35678999999888777642    


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCeEEEeecCccccCCCCCC--CCccccc
Q psy16889         80 -----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV----NSNCILKICDFGLARVEEPDPN--KAMTQEV  148 (203)
Q Consensus        80 -----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  148 (203)
                           ...+++..++.++.|++.||+|||++|++||||||+||++    +.++.++++|||.+........  .......
T Consensus        97 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  176 (317)
T cd07868          97 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV  176 (317)
T ss_pred             cccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcc
Confidence                 1258999999999999999999999999999999999999    4567899999999975443221  1223456


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +++.|+|||++.+...++.++|+||+|+++|+|++|++||....
T Consensus       177 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            78899999999876668899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.4e-36  Score=225.32  Aligned_cols=192  Identities=33%  Similarity=0.628  Sum_probs=156.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhH-HHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDL-HKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~   80 (203)
                      +.+..+|+.|++|.+............+.+|++++++++|+|++++++++...     ...++++||+++++ .......
T Consensus        20 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~   94 (286)
T cd07847          20 CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNP   94 (286)
T ss_pred             EEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCC
Confidence            45677899999999865433333445678899999999999999999999877     56789999999654 4444455


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+........ ......++..|.|||.+.
T Consensus        95 ~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~  173 (286)
T cd07847          95 RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLV  173 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCcccccccCCHHHHh
Confidence            6799999999999999999999999999999999999999999999999999875433221 222334577899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +...++.++|+||||+++|+|++|++||.+.++.+.+..
T Consensus       174 ~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~  212 (286)
T cd07847         174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL  212 (286)
T ss_pred             CCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            655578899999999999999999999998876655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0604|consensus

Probab=100.00  E-value=2.5e-37  Score=222.23  Aligned_cols=179  Identities=30%  Similarity=0.469  Sum_probs=151.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.||+.||+|++.+       ....++|++.--+. .|||||++++++...... ..++.+|||.++ |+|++.+..
T Consensus        81 C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~-rkcLLiVmE~meGGeLfsriq~  152 (400)
T KOG0604|consen   81 CVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQG-RKCLLIVMECMEGGELFSRIQD  152 (400)
T ss_pred             EEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC-ceeeEeeeecccchHHHHHHHH
Confidence            67899999999999853       35567788765444 899999999998765332 357889999998 599999987


Q ss_pred             CCC--CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 PQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 ~~~--~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      ++.  |+|.++..|++||..|+.|||+.+|.||||||+|++..   .+..+||+|||++.....  .....+++.|+.|.
T Consensus       153 ~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYv  230 (400)
T KOG0604|consen  153 RGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYV  230 (400)
T ss_pred             cccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC--CccccCCccccccc
Confidence            654  99999999999999999999999999999999999997   456789999999985433  34455667799999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |||++... .|+.+.|+||+|+++|-||+|-+||..+
T Consensus       231 aPevlg~e-KydkscdmwSlgVimYIlLCGyPPFYS~  266 (400)
T KOG0604|consen  231 APEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_pred             CHHHhCch-hcCCCCCccchhHHHHHhhcCCCccccc
Confidence            99999874 4899999999999999999999999764

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=223.38  Aligned_cols=192  Identities=43%  Similarity=0.718  Sum_probs=158.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.++.+|+.|++|+++...........+.+|++.++.++|+|++++++++.+.     ...++++||++++|.+++....
T Consensus        18 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~   92 (283)
T cd07835          18 ARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSP   92 (283)
T ss_pred             EEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCC
Confidence            45677999999999865433333445678899999999999999999999877     5778999999888888877654


Q ss_pred             --CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         82 --HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 --~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                        .+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+...... ........++..|+|||++
T Consensus        93 ~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~~~~~~aPE~~  171 (283)
T cd07835          93 LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL  171 (283)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-ccccCccccccCCCCCcee
Confidence              7999999999999999999999999999999999999999999999999998643322 1122223457789999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      .+...++.++|+||||+++|+|++|++||...++...+..
T Consensus       172 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  211 (283)
T cd07835         172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR  211 (283)
T ss_pred             ecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            7755578899999999999999999999988776554433

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0662|consensus

Probab=100.00  E-value=7.8e-36  Score=200.95  Aligned_cols=196  Identities=38%  Similarity=0.608  Sum_probs=174.6

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      ++++..+++.||+|..+....+........+|+-+++.++|.||++++++...+     ..+.+|.|+|..+|..++.. 
T Consensus        20 karn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdsl   94 (292)
T KOG0662|consen   20 KARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSL   94 (292)
T ss_pred             ecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhc
Confidence            367899999999999977655666667788999999999999999999998877     56789999999999998874 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ++.+..+.++.++.|+++++.++|+.++.|||+||.|.+++.+|.+|+.|||+++.++ .+........-|..|.+|.++
T Consensus        95 ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafg-ipvrcysaevvtlwyrppdvl  173 (292)
T KOG0662|consen   95 NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAEVVTLWYRPPDVL  173 (292)
T ss_pred             CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcC-CceEeeeceeeeeeccCccee
Confidence            6889999999999999999999999999999999999999999999999999998654 334555555668899999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHH-hCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .+.+-|+++.|+||-||++.|+. .|++.|++++..+++..|..
T Consensus       174 fgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~  217 (292)
T KOG0662|consen  174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_pred             eeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH
Confidence            99888999999999999999999 47888999999999998864

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-36  Score=228.12  Aligned_cols=196  Identities=39%  Similarity=0.671  Sum_probs=160.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.+..+|+.|++|.+..............+|+.++++++|+|++++++++.+...   ...++++||++++|.+.+.. .
T Consensus        26 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~  102 (309)
T cd07845          26 ARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---DSIFLVMEYCEQDLASLLDNMP  102 (309)
T ss_pred             EEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---CeEEEEEecCCCCHHHHHHhcc
Confidence            4567889999999986433332333456689999999999999999999876532   34689999999888877764 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus       103 ~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  181 (309)
T cd07845         103 TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLL  181 (309)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCCCcccccccccChhhhc
Confidence            679999999999999999999999999999999999999999999999999987544322 2223334467799999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|++||.+.++.+.+..+.
T Consensus       182 ~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~  222 (309)
T cd07845         182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII  222 (309)
T ss_pred             CCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            75667899999999999999999999999988877776554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-36  Score=230.41  Aligned_cols=196  Identities=52%  Similarity=0.951  Sum_probs=161.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.|+||.+............+.+|+.+++.++|+||+++++++...........++++||++++|.+++...+
T Consensus        24 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~  103 (337)
T cd07858          24 AKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQ  103 (337)
T ss_pred             EEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCC
Confidence            46778999999999865433444455677899999999999999999988765432223478999999999999988888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.+
T Consensus       104 ~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  182 (337)
T cd07858         104 TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLN  182 (337)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-ccccccccccCccChHHHhc
Confidence            89999999999999999999999999999999999999999999999999987543221 22233356788999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ...++.++|+||||+++|+|++|++||.+.+......
T Consensus       183 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  219 (337)
T cd07858         183 CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK  219 (337)
T ss_pred             CCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence            4458899999999999999999999998776544433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.6e-36  Score=222.09  Aligned_cols=190  Identities=21%  Similarity=0.329  Sum_probs=153.5

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQH   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~   82 (203)
                      ...+..|++|.++... +......+.+|+..+++++||||+++++++..+     ...++||||+++ +|.+++.. .+.
T Consensus        30 ~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  103 (266)
T cd05064          30 SKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQ  103 (266)
T ss_pred             CCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCC
Confidence            3567789999996542 233456788999999999999999999998876     568899999985 77777765 357


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..++.++.|++.|+++||+++++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+ 
T Consensus       104 l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  182 (266)
T cd05064         104 LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-  182 (266)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-
Confidence            9999999999999999999999999999999999999999999999999876432211111112233567999998876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..++.++|+||||+++|++++ |+.||.+.+..+.+..+.
T Consensus       183 ~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05064         183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE  222 (266)
T ss_pred             CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence            558999999999999999875 999999888777666543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-35  Score=226.66  Aligned_cols=200  Identities=57%  Similarity=1.035  Sum_probs=167.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |.+..+|+.|++|.+............+.+|+..++.++|+||+++.+++.+.........|+++||++++|.+.+....
T Consensus        19 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~   98 (330)
T cd07834          19 AVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ   98 (330)
T ss_pred             EEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCC
Confidence            45667899999999976544455567788999999999999999999998877422223678999999999999888877


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+........  .......++..|+|||.+
T Consensus        99 ~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  178 (330)
T cd07834          99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL  178 (330)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceee
Confidence            999999999999999999999999999999999999999999999999999885443321  122334567789999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+...++.++|+||||+++|+|++|++||.+....+.+..+.
T Consensus       179 ~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~  220 (330)
T cd07834         179 LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIV  220 (330)
T ss_pred             ecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            885468999999999999999999999999888766655543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-36  Score=235.92  Aligned_cols=176  Identities=21%  Similarity=0.335  Sum_probs=149.6

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL   83 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   83 (203)
                      +..+++.|++|.+...       ....+|++++++++||||+++++++...     ...+++||++.++|.+++...+.+
T Consensus       115 ~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l  182 (392)
T PHA03207        115 GDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPL  182 (392)
T ss_pred             CCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCC
Confidence            3456788999987532       2345799999999999999999998876     567789999999999988777889


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeeecc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      ++.+++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........ .......|++.|+|||++.+ 
T Consensus       183 ~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  261 (392)
T PHA03207        183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-  261 (392)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-
Confidence            9999999999999999999999999999999999999999999999999874433222 22234467899999999987 


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        163 RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ..++.++|+||||+++|+|++|+.||.+..
T Consensus       262 ~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            458999999999999999999999997654

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.3e-36  Score=238.99  Aligned_cols=198  Identities=23%  Similarity=0.315  Sum_probs=160.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc---hhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD---FFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      +.+..+|+.||||++.....+......+.+|+..+..++|+|++++...+...+..   ....+++++||+. |+|.+.+
T Consensus        51 a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l  130 (496)
T PTZ00283         51 AKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI  130 (496)
T ss_pred             EEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHH
Confidence            45778999999999965544555667788999999999999999998876543221   1123578999998 5888877


Q ss_pred             hC----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcc
Q psy16889         78 VS----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQY  152 (203)
Q Consensus        78 ~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~  152 (203)
                      ..    ...+++..+..++.|++.+|.|||+++++||||||+||+++.++.++|+|||++....... ........|++.
T Consensus       131 ~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~  210 (496)
T PTZ00283        131 KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY  210 (496)
T ss_pred             HHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcc
Confidence            53    3569999999999999999999999999999999999999999999999999987543221 122234467899


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       211 Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~  257 (496)
T PTZ00283        211 YVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT  257 (496)
T ss_pred             eeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999987 45899999999999999999999999988776666544

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.6e-36  Score=225.12  Aligned_cols=193  Identities=46%  Similarity=0.732  Sum_probs=159.6

Q ss_pred             CcCCCCCcEEEEEeccCccch---hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS---LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +.+..+|+.|++|.++.....   ......+..|++.+++++|+||+++++++.++     ...++|+||+.++|.+++.
T Consensus        19 ~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~   93 (298)
T cd07841          19 ARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIK   93 (298)
T ss_pred             EEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----CEEEEEEcccCCCHHHHHh
Confidence            356778999999999654322   22345567899999999999999999999886     5678999999779999887


Q ss_pred             CCC-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         79 SPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        79 ~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ... .+++..+..++.|+++||.+||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|.|||
T Consensus        94 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE  172 (298)
T cd07841          94 DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQVVTRWYRAPE  172 (298)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccccccccceeeeCHH
Confidence            765 79999999999999999999999999999999999999999999999999987543322 2223334577899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+...++.++|+||||+++|++++|.+||.+..+.+.+..+
T Consensus       173 ~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~  215 (298)
T cd07841         173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI  215 (298)
T ss_pred             HHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence            8866556789999999999999999999999887766655444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-36  Score=225.37  Aligned_cols=186  Identities=24%  Similarity=0.353  Sum_probs=152.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||+|++..... .......+.+|+.+++.++|+||+++++.+.++     ...+++|||+. ++|.+.+..
T Consensus        19 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05605          19 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYN   93 (285)
T ss_pred             EEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHh
Confidence            45677899999999854322 222334567899999999999999999998877     56789999998 578766643


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ...+++..+..++.|++.++++||+.+++|+||+|+||++++++.++++|||.+......  .......++..|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE  171 (285)
T cd05605          94 MGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ETIRGRVGTVGYMAPE  171 (285)
T ss_pred             cCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--CccccccCCCCccCcH
Confidence              346999999999999999999999999999999999999999999999999998753321  1222346788999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      ++.+ ..++.++|+||+|+++|++++|+.||.+.....
T Consensus       172 ~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~  208 (285)
T cd05605         172 VVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV  208 (285)
T ss_pred             HhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhh
Confidence            9876 458899999999999999999999998865533

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0612|consensus

Probab=100.00  E-value=5e-37  Score=251.53  Aligned_cols=196  Identities=25%  Similarity=0.371  Sum_probs=173.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+++-||+|+++.-. ......+.|.+|=.+|..-+.+=|+.+...|+|+     .++|+||||+. |+|...+.+
T Consensus        94 Vr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk  168 (1317)
T KOG0612|consen   94 VRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSK  168 (1317)
T ss_pred             EEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-----cceEEEEecccCchHHHHHhh
Confidence            5678999999999996511 1234556788888899888988999999999999     89999999998 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++++..++.++.+|..||..+|+.|+|||||||+||++|..|.++|.|||.+-.........+....|||.|.|||++
T Consensus       169 ~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvL  248 (1317)
T KOG0612|consen  169 FDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVL  248 (1317)
T ss_pred             cCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHH
Confidence            88999999999999999999999999999999999999999999999999999987665656667777999999999998


Q ss_pred             ecc----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ...    ..|++..|+||+|+++|||+.|..||...+-.+.+..|++
T Consensus       249 qs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~  295 (1317)
T KOG0612|consen  249 QSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN  295 (1317)
T ss_pred             HhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence            642    4589999999999999999999999999999999988875

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.4e-36  Score=224.75  Aligned_cols=189  Identities=29%  Similarity=0.457  Sum_probs=160.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.|++|.++.... .....+.+.+|++++++++||||+++++++.+.     ..++++|||+. ++|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~   94 (290)
T cd05580          20 VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRK   94 (290)
T ss_pred             EEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHH
Confidence            45677899999999854322 233456788999999999999999999999877     56789999995 699999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+......    .....+++.|.|||.+
T Consensus        95 ~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~  170 (290)
T cd05580          95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEII  170 (290)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCCCCCCccccChhhh
Confidence            888999999999999999999999999999999999999999999999999998754332    2233568889999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ...+.++|+||||+++|+|++|+.||.........+++
T Consensus       171 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  210 (290)
T cd05580         171 LS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI  210 (290)
T ss_pred             cC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            76 45788999999999999999999999887766555544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.8e-36  Score=220.26  Aligned_cols=192  Identities=27%  Similarity=0.406  Sum_probs=160.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.+..+|+.|++|.+............+.+|+++++.++|||++++++++.++     ...++++||+. ++|.+++.. 
T Consensus        19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   93 (256)
T cd08529          19 VVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQ   93 (256)
T ss_pred             EEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHh
Confidence            45677899999999865444556677888999999999999999999999877     56789999997 588888765 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... .......+++.|.|||+
T Consensus        94 ~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~  172 (256)
T cd08529          94 RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTIVGTPYYLSPEL  172 (256)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-chhhccccCccccCHHH
Confidence             3579999999999999999999999999999999999999999999999999887543322 12233356788999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ..+ ..++.++|+||||+++++|++|+.||...+..+....+
T Consensus       173 ~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  213 (256)
T cd08529         173 CED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI  213 (256)
T ss_pred             hcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            887 45789999999999999999999999888766655443

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG1187|consensus

Probab=100.00  E-value=2.5e-36  Score=231.47  Aligned_cols=178  Identities=26%  Similarity=0.389  Sum_probs=148.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--C
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--H   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~   82 (203)
                      .+|..||||.+.......  ...|..|++++.+++|||+++++++|.+.+.    ...+|.||+. |+|.+++....  +
T Consensus        97 ~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~LVYEym~nGsL~d~L~~~~~~~  170 (361)
T KOG1187|consen   97 SDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLLVYEYMPNGSLEDHLHGKKGEP  170 (361)
T ss_pred             CCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEEEEEccCCCCHHHHhCCCCCCC
Confidence            456899999885532221  3449999999999999999999999998731    4679999998 79999987654  8


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccc-cCCccccccee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSAR---ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE-VVTQYYRAPEI  158 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-~~~~~~~aPe~  158 (203)
                      +++..+.+|+.++|+||+|||+..   |+|||||++||++|.+.+.|++|||++...... ....... .||..|++||+
T Consensus       171 L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy  249 (361)
T KOG1187|consen  171 LDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEY  249 (361)
T ss_pred             CCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhh
Confidence            999999999999999999999754   999999999999999999999999999643321 2221222 78999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ... +..+.++|+||||++++|++||+.|....
T Consensus       250 ~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  250 AST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             hcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            987 55899999999999999999999888754

>KOG4721|consensus

Probab=100.00  E-value=3.5e-37  Score=237.98  Aligned_cols=172  Identities=25%  Similarity=0.401  Sum_probs=151.1

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLT   84 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~   84 (203)
                      ..++.||||.++.         .-..++.=|++|+|+||+.+.++|...     .+++|+||||. |.|...++....++
T Consensus       145 l~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~~it  210 (904)
T KOG4721|consen  145 LHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGRPIT  210 (904)
T ss_pred             ccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCC-----ceeEEeeeccccccHHHHHhccCccC
Confidence            4567788887642         223467789999999999999999998     78999999998 79999999999999


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      ......|.++|+.++.|||.+.|+|||||.-||++..+..+|++|||.++.....  ..+....||..|+|||++.+ ++
T Consensus       211 p~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrn-eP  287 (904)
T KOG4721|consen  211 PSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRN-EP  287 (904)
T ss_pred             HHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhc-CC
Confidence            9999999999999999999999999999999999999999999999999865443  33345588999999999998 67


Q ss_pred             CCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        165 YSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      -+.+.||||||++|||||||+.||..-+..
T Consensus       288 csEKVDIwSfGVVLWEmLT~EiPYkdVdss  317 (904)
T KOG4721|consen  288 CSEKVDIWSFGVVLWEMLTGEIPYKDVDSS  317 (904)
T ss_pred             cccccceehhHHHHHHHHhcCCCccccchh
Confidence            899999999999999999999999875443

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.4e-36  Score=223.40  Aligned_cols=182  Identities=27%  Similarity=0.368  Sum_probs=149.6

Q ss_pred             CcCCCCCcEEEEEeccCccch-hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS-LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.++.+|+.|++|.+...... ......+..|++++++++||||+++.+++.++     ...+++|||+. ++|.+.+..
T Consensus        12 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~   86 (277)
T cd05607          12 VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYN   86 (277)
T ss_pred             EEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHh
Confidence            456788999999998542221 22234456799999999999999999998877     56789999997 478776653


Q ss_pred             C--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 P--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .  ..+++..+..++.|++.|+++||+.|++||||+|+||+++.++.++++|||.+......  .......++..|+|||
T Consensus        87 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE  164 (277)
T cd05607          87 VGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAGTNGYMAPE  164 (277)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCCCCCccCHH
Confidence            3  35889999999999999999999999999999999999999999999999998754322  2223346788999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ++.+. .++.++|+||||+++|+|++|+.||...
T Consensus       165 ~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         165 ILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             HHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence            98874 4899999999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.2e-35  Score=217.68  Aligned_cols=190  Identities=24%  Similarity=0.380  Sum_probs=155.5

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      .+.+++.+++|+++.........+.+..|+.+++.++|+||+++++++..+      ..++++||++ ++|.+++...+.
T Consensus        18 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~   91 (257)
T cd05116          18 MKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE------SWMLVMELAELGPLNKFLQKNKH   91 (257)
T ss_pred             cCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC------CcEEEEecCCCCcHHHHHHhcCC
Confidence            456789999999865544445567788999999999999999999987543      3578999998 578888877778


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~  160 (203)
                      ++++.+..++.|++.+++++|++|++|+||+|+||+++.++.++++|||.+.........  ......++..|+|||.+.
T Consensus        92 ~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05116          92 VTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN  171 (257)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence            999999999999999999999999999999999999999999999999998754332211  112223356799999886


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      . ..++.++|+||||+++|++++ |+.||......+..+.+
T Consensus       172 ~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i  211 (257)
T cd05116         172 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI  211 (257)
T ss_pred             c-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            5 457889999999999999998 99999887776665554

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0193|consensus

Probab=100.00  E-value=2.9e-36  Score=233.78  Aligned_cols=185  Identities=25%  Similarity=0.346  Sum_probs=158.3

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~   86 (203)
                      ..||||+++-...+++..+.|+.|+..+++-+|.||+=+.+++-.+     .. .+|+.+|+| +|..++.. ...|...
T Consensus       415 GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p-----~~-AIiTqwCeGsSLY~hlHv~etkfdm~  488 (678)
T KOG0193|consen  415 GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP-----PL-AIITQWCEGSSLYTHLHVQETKFDMN  488 (678)
T ss_pred             cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC-----ce-eeeehhccCchhhhhccchhhhhhHH
Confidence            3599999988777888999999999999999999999999999877     34 899999997 78877763 4679999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCC-CCCCCcccccCCcccccceeeec--cc
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP-DPNKAMTQEVVTQYYRAPEILMG--AR  163 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~aPe~~~~--~~  163 (203)
                      ..+.|+.|++.++.|||.++|+|+|||..||++.+++++||.|||++..... .........-|...|+|||+++.  ..
T Consensus       489 ~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~n  568 (678)
T KOG0193|consen  489 TTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDN  568 (678)
T ss_pred             HHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccC
Confidence            9999999999999999999999999999999999999999999999874332 22234445566788999999874  24


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +|++++|+||||+++|||++|..||....+.+++-+
T Consensus       569 PfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifm  604 (678)
T KOG0193|consen  569 PFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFM  604 (678)
T ss_pred             CCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEE
Confidence            689999999999999999999999997766665533

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7e-36  Score=238.31  Aligned_cols=188  Identities=23%  Similarity=0.432  Sum_probs=150.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC------CCccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH------DNVLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |.+..+++.||||+++...   ........|+++++.++|      .+++++++++....    ..+++++++++++|.+
T Consensus       148 a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~  220 (467)
T PTZ00284        148 AWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET----GHMCIVMPKYGPCLLD  220 (467)
T ss_pred             EEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC----ceEEEEEeccCCCHHH
Confidence            4567889999999985421   122334456666666644      45888888887653    3567899999889999


Q ss_pred             HHhCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCC----------------eEEEeecCccccCCC
Q psy16889         76 IIVSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNC----------------ILKICDFGLARVEEP  138 (203)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~----------------~~~l~d~~~~~~~~~  138 (203)
                      ++...+.+++..+..++.|++.||+|||+ .||+||||||+||+++.++                .+||+|||.+.... 
T Consensus       221 ~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-  299 (467)
T PTZ00284        221 WIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-  299 (467)
T ss_pred             HHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-
Confidence            98888889999999999999999999998 5999999999999998665                49999999875322 


Q ss_pred             CCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       139 ~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                         .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.
T Consensus       300 ---~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        300 ---HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             ---cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence               22234567899999999987 458999999999999999999999999988777666553

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-35  Score=228.91  Aligned_cols=194  Identities=42%  Similarity=0.783  Sum_probs=158.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+............+.+|+.++++++|+||+++++++..... ......++++||+.++|.+.+...
T Consensus        35 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~  114 (353)
T cd07850          35 AYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD  114 (353)
T ss_pred             EEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc
Confidence            4677899999999986544444455677789999999999999999998765432 111356899999999888877653


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                        +++..+..++.|++.||++||++|++|+||||+||+++.++.++++|||.+.......  ......++..|+|||.+.
T Consensus       115 --l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~  190 (353)
T cd07850         115 --LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVIL  190 (353)
T ss_pred             --CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC--CCCCCcccccccCHHHHh
Confidence              8999999999999999999999999999999999999999999999999997543221  123335678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|+.||...+.......+
T Consensus       191 ~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~  229 (353)
T cd07850         191 G-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI  229 (353)
T ss_pred             C-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            7 55899999999999999999999999887765554443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-35  Score=223.39  Aligned_cols=192  Identities=42%  Similarity=0.697  Sum_probs=156.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.|++|.+............+.+|++.+++++|+||+++++++.++     ..+++|+||+++++.+.+....
T Consensus        21 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   95 (294)
T PLN00009         21 ARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSP   95 (294)
T ss_pred             EEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCC
Confidence            45677899999999865433333445678899999999999999999999877     5788999999988888876543


Q ss_pred             --CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         82 --HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        82 --~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                        .+++..++.++.|++.||++||+++++|+||+|+||+++. ++.++++|||.+...... ........+++.|+|||.
T Consensus        96 ~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~  174 (294)
T PLN00009         96 DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHEVVTLWYRAPEI  174 (294)
T ss_pred             CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-ccccccCceeecccCHHH
Confidence              3688889999999999999999999999999999999985 567999999998744322 122233355778999998


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +.+...++.++|+||||+++|++++|++||......+.+.+
T Consensus       175 ~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~  215 (294)
T PLN00009        175 LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK  215 (294)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            87656678999999999999999999999988766555544

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.7e-35  Score=222.99  Aligned_cols=195  Identities=42%  Similarity=0.693  Sum_probs=159.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      |.+..+|+.+++|.++...........+.+|++++++++||||+++++++.....   ...++++||++++|.+.+... 
T Consensus        24 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~~  100 (293)
T cd07843          24 ARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMK  100 (293)
T ss_pred             EEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC---CcEEEEehhcCcCHHHHHHhcc
Confidence            4567789999999996543333333456789999999999999999998765532   467899999998888887653 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++++++..++.|++.||++||+++++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||.+.
T Consensus       101 ~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  179 (293)
T cd07843         101 QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-KPYTQLVVTLWYRAPELLL  179 (293)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-cccccccccccccCchhhc
Confidence            459999999999999999999999999999999999999999999999999887544322 2223345678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|+|++|.+||......+.+..+
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~  219 (293)
T cd07843         180 GAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI  219 (293)
T ss_pred             CCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            7555788999999999999999999999987766555443

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=220.26  Aligned_cols=196  Identities=39%  Similarity=0.653  Sum_probs=162.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +.+..+|+.+++|.+............+.+|++++++++|+|++++++++.+.+.   ...++++||++++|.+.+... 
T Consensus        18 ~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~   94 (287)
T cd07840          18 ARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPE   94 (287)
T ss_pred             EEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCC---CcEEEEeccccccHHHHHhccC
Confidence            3566789999999997654333444567889999999999999999999876631   357899999998888887764 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..++.++.|++.|+++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.
T Consensus        95 ~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  174 (287)
T cd07840          95 VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL  174 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeE
Confidence            67999999999999999999999999999999999999999999999999998755444322333445577899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|++++|+.||......+.+..+
T Consensus       175 ~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~  214 (287)
T cd07840         175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI  214 (287)
T ss_pred             ccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            6556789999999999999999999999887766655544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.6e-35  Score=228.12  Aligned_cols=183  Identities=28%  Similarity=0.414  Sum_probs=146.5

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      ..+++.||+|+++.... ....+.+.+|+++++.+ +|+||+++++++...     ...+++|||+. |+|.+++...  
T Consensus        65 ~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~  138 (374)
T cd05106          65 EDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAE  138 (374)
T ss_pred             ccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhh
Confidence            34556899999965422 23456788999999999 899999999999887     56789999998 5887766421  


Q ss_pred             --------------------------------------------------------------------CCCChHHHHHHH
Q psy16889         81 --------------------------------------------------------------------QHLTSDHIKVFL   92 (203)
Q Consensus        81 --------------------------------------------------------------------~~~~~~~~~~~~   92 (203)
                                                                                          .++++..+..++
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  218 (374)
T cd05106         139 TFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFS  218 (374)
T ss_pred             hhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHH
Confidence                                                                                247888999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeecccCCCcchhH
Q psy16889         93 YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGARHYSAAVDV  171 (203)
Q Consensus        93 ~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~~Di  171 (203)
                      .|++.||+|||++|++||||||+||+++.++.++|+|||++......... ......++..|+|||++.+ ..++.++|+
T Consensus       219 ~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv  297 (374)
T cd05106         219 SQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDV  297 (374)
T ss_pred             HHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccH
Confidence            99999999999999999999999999999999999999998743322111 1112233567999999876 458999999


Q ss_pred             HHHHHHHHHHHh-CCcccCCCChH
Q psy16889        172 WSVGCIFAELLG-RRILFQAQSPV  194 (203)
Q Consensus       172 ~slG~~l~~ll~-g~~pf~~~~~~  194 (203)
                      ||||+++|+|++ |+.||......
T Consensus       298 wSlGvil~ellt~G~~Pf~~~~~~  321 (374)
T cd05106         298 WSYGILLWEIFSLGKSPYPGILVN  321 (374)
T ss_pred             HHHHHHHHHHHhCCCCCCcccccc
Confidence            999999999997 99999776543

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.6e-35  Score=225.43  Aligned_cols=194  Identities=40%  Similarity=0.735  Sum_probs=158.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.+++|.+............+.+|+.+++++ +|+||+++++++.....   ...++++||++++|..++...
T Consensus        26 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~  102 (337)
T cd07852          26 AIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDIYLVFEYMETDLHAVIRAN  102 (337)
T ss_pred             EEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceEEEEecccccCHHHHHhcC
Confidence            45677899999998854434444556677899999999 99999999998865432   356899999999998887765


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC----CCcccccCCcccccc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN----KAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~aP  156 (203)
                       .+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+........    .......++..|+||
T Consensus       103 -~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         103 -ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence             789999999999999999999999999999999999999999999999998874433221    122233567889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |.+.+...++.++|+||||+++|+|++|+.||.+..+.+....
T Consensus       182 E~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~  224 (337)
T cd07852         182 EILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK  224 (337)
T ss_pred             eeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9887656678899999999999999999999988776655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=223.12  Aligned_cols=184  Identities=37%  Similarity=0.668  Sum_probs=152.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.++.+|+.|++|.+...... .....+.+|++++++++|+||+++++++.++     ...++|+||+.++|.+++.. .
T Consensus        24 ~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~   97 (291)
T cd07844          24 GRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCG   97 (291)
T ss_pred             EEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCC
Confidence            456778999999998643222 2234566899999999999999999999877     57789999999999888764 3


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|.|||.+.
T Consensus        98 ~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  176 (291)
T cd07844          98 GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTLWYRPPDVLL  176 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccccccccccCCcHHhh
Confidence            568999999999999999999999999999999999999999999999999986433221 1122224577899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +...++.++|+||+|+++|+|++|+.||.+..
T Consensus       177 ~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence            65557889999999999999999999997665

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0584|consensus

Probab=100.00  E-value=1.8e-36  Score=235.68  Aligned_cols=192  Identities=31%  Similarity=0.440  Sum_probs=162.2

Q ss_pred             CcCCCCCcEEEEEecc--CccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLP--NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~--~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.|..+|..||--.++  ....++...+++..|+.+|+.|+||||++++++|.+...   ...-+|+|.+. |+|..+..
T Consensus        59 a~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~k  135 (632)
T KOG0584|consen   59 AFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRK  135 (632)
T ss_pred             ccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHH
Confidence            4567777777765542  233466677999999999999999999999999998754   45678999997 89999999


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      +.+.++...+..|++||+++|.|||++.  |+|||||.+||+++ ..|.+|++|+|+++.......+   ...|||.|+|
T Consensus       136 k~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak---svIGTPEFMA  212 (632)
T KOG0584|consen  136 KHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK---SVIGTPEFMA  212 (632)
T ss_pred             HhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc---eeccCccccC
Confidence            9999999999999999999999999986  99999999999998 5699999999999865543332   2588999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC-hHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS-PVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~i~  201 (203)
                      ||....  .|+...||||||+.++||+|+.+||.+.. +.++++++.
T Consensus       213 PEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~  257 (632)
T KOG0584|consen  213 PEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT  257 (632)
T ss_pred             hHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence            998874  58999999999999999999999998865 555555543

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-35  Score=220.83  Aligned_cols=190  Identities=35%  Similarity=0.704  Sum_probs=155.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHh-HHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+..........+.+.+|+++++.++||||+++++++.++     ...++++||+.+. +.......
T Consensus        20 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   94 (286)
T cd07846          20 CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYP   94 (286)
T ss_pred             EEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhcc
Confidence            45667899999999865433333455678899999999999999999999877     5678999999964 44444455


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  173 (286)
T cd07846          95 NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVATRWYRAPELLV  173 (286)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCcccceeeccCcHHhc
Confidence            569999999999999999999999999999999999999999999999999987533322 2223345677899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      +...++.++|+||||+++|++++|++||...+..+..
T Consensus       174 ~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~  210 (286)
T cd07846         174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL  210 (286)
T ss_pred             cccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence            6555788999999999999999999999877654443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-35  Score=225.98  Aligned_cols=189  Identities=19%  Similarity=0.281  Sum_probs=151.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.++.+|+.||+|.+..........+.+.+|+++++.++||||+++++++..+     ...++|+||+. ++|.+++.. 
T Consensus        19 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   93 (327)
T cd08227          19 ARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTH   93 (327)
T ss_pred             EeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhh
Confidence            46788999999999965444444456777899999999999999999999887     56789999998 578877754 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-C-----CcccccCCcc
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-K-----AMTQEVVTQY  152 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~-----~~~~~~~~~~  152 (203)
                       ...+++..+..++.|++.||+|||+++++|+||||+||+++.++.+++.||+.......... .     ......++..
T Consensus        94 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (327)
T cd08227          94 FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP  173 (327)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceec
Confidence             34589999999999999999999999999999999999999999999999986532211100 0     0111234667


Q ss_pred             cccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        153 YRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       153 ~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      |+|||++.+. ..++.++|+||||+++|++++|+.||.......
T Consensus       174 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  217 (327)
T cd08227         174 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  217 (327)
T ss_pred             ccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence            9999998753 357899999999999999999999998765443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-36  Score=222.10  Aligned_cols=185  Identities=32%  Similarity=0.550  Sum_probs=158.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.++.+++.||+|++..............+|+..+++++||||+++++++.+.     ...++++|++.+ +|.+++...
T Consensus        18 ~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~   92 (260)
T PF00069_consen   18 AKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKN   92 (260)
T ss_dssp             EEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHH
T ss_pred             EEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----cccccccccccccccccccccc
Confidence            56788999999999976655544444556699999999999999999999886     566799999997 899988877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+... ...........++..|.|||+..
T Consensus        93 ~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~~y~aPE~~~  171 (260)
T PF00069_consen   93 KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNPFVGTPEYMAPEVLQ  171 (260)
T ss_dssp             SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSSSSSSGGGSCHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccc
Confidence            88999999999999999999999999999999999999999999999999998743 22233444556788999999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ....++.++|+||||+++++|++|..||....
T Consensus       172 ~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~  203 (260)
T PF00069_consen  172 QGKKYTRKSDIWSLGIILYELLTGKLPFEESN  203 (260)
T ss_dssp             TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred             cccccccccccccccccccccccccccccccc
Confidence            33568999999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.1e-35  Score=221.46  Aligned_cols=192  Identities=36%  Similarity=0.647  Sum_probs=158.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +.+..+|+.|++|.++... .....+.+.+|++++++++|+|++++++++.+.     ...++++||++++|.+++... 
T Consensus        19 ~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   92 (284)
T cd07836          19 GRNRTTGEIVALKEIHLDA-EEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHG   92 (284)
T ss_pred             EEECCCCeEEEEEEecccc-cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcC
Confidence            4567889999999986532 223345677899999999999999999999887     567899999999888877643 


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                        ..++++.+..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|++||.
T Consensus        93 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~  171 (284)
T cd07836          93 VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSNEVVTLWYRAPDV  171 (284)
T ss_pred             CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-cccccccccccccChHH
Confidence              468999999999999999999999999999999999999999999999999987433221 12223345778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+...++.++|+||||+++|++++|++||.+.+..+.+..+
T Consensus       172 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~  213 (284)
T cd07836         172 LLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI  213 (284)
T ss_pred             hcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            876556788999999999999999999999887766555443

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0983|consensus

Probab=100.00  E-value=1.2e-34  Score=206.33  Aligned_cols=193  Identities=21%  Similarity=0.392  Sum_probs=158.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~   79 (203)
                      ++.+.+|...|||.++.. .+.++..++...++++.+- ..|+||+++++|-.+     ..+++.||.+..-....+. .
T Consensus       111 ~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkri  184 (391)
T KOG0983|consen  111 MRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRI  184 (391)
T ss_pred             EEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHh
Confidence            567789999999999765 3444556677777766665 599999999999988     6788999998865544444 3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .++++|.-+-++...+.+||.||-+ .+++|||+||+||++|..|++|+||||.+-+.-  ...+.+...|.+.|+|||.
T Consensus       185 k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSkAhtrsAGC~~YMaPER  262 (391)
T KOG0983|consen  185 KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSKAHTRSAGCAAYMAPER  262 (391)
T ss_pred             cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee--cccccccccCCccccCccc
Confidence            4679999999999999999999985 589999999999999999999999999987433  3445566688999999999


Q ss_pred             eecc--cCCCcchhHHHHHHHHHHHHhCCcccCCC-ChHHHhhhhhc
Q psy16889        159 LMGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQ-SPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~i~~  202 (203)
                      +...  ..|+.++|+||||++++||.||+.||.+. .+++.+..|.+
T Consensus       263 idp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln  309 (391)
T KOG0983|consen  263 IDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN  309 (391)
T ss_pred             cCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence            8753  34788999999999999999999999886 47777777653

>KOG0607|consensus

Probab=100.00  E-value=4.4e-36  Score=217.76  Aligned_cols=184  Identities=27%  Similarity=0.448  Sum_probs=155.9

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +|++.++|..||||++..  .....+.++.+|++++.+. .|+||+.++++|+++     ...|+|+|-+. |.|+..+.
T Consensus        96 tcv~i~t~~EYAVKiidK--q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~  168 (463)
T KOG0607|consen   96 TCVSIQTGKEYAVKIIDK--QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQ  168 (463)
T ss_pred             eeeeeccchhhhhhhhhc--CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ceEEEEEecccCchHHHHHH
Confidence            477899999999999954  2445677899999999998 899999999999998     77899999998 59999999


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCC------CCCCCcccccC
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEP------DPNKAMTQEVV  149 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~------~~~~~~~~~~~  149 (203)
                      .+..|+|.++..+++.|+.||.+||.+||.|||+||+||+-....   -+|++||.+..-...      .......++.|
T Consensus       169 ~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvG  248 (463)
T KOG0607|consen  169 KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVG  248 (463)
T ss_pred             HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCccc
Confidence            999999999999999999999999999999999999999987554   479999987652221      12223346688


Q ss_pred             Ccccccceeeec----ccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        150 TQYYRAPEILMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       150 ~~~~~aPe~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +..|+|||+..-    .-.|+.+.|.||||+++|=||+|-+||.+.
T Consensus       249 SAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  249 SAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             chhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            889999998642    234788999999999999999999999774

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=225.60  Aligned_cols=194  Identities=50%  Similarity=0.953  Sum_probs=155.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.|++|.+... ........+.+|+.++++++|+||+++++++...........++++|++++++.+.+.. .
T Consensus        24 ~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~  101 (336)
T cd07849          24 ATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-Q  101 (336)
T ss_pred             EEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc-C
Confidence            457789999999998532 22234456778999999999999999999876554322245689999999988877644 5


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||++........  .......++..|+|||.+
T Consensus       102 ~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (336)
T cd07849         102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM  181 (336)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHh
Confidence            699999999999999999999999999999999999999999999999999874332211  112234568889999987


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+...++.++|+||||+++|+|++|++||.+......+
T Consensus       182 ~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~  219 (336)
T cd07849         182 LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL  219 (336)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            66556889999999999999999999999876654443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.8e-35  Score=223.27  Aligned_cols=198  Identities=34%  Similarity=0.595  Sum_probs=157.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc---hhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD---FFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +.+..+|+.|+||.+..............+|++++++++||||+++++++......   .....++++||+++++.+.+.
T Consensus        31 ~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~  110 (310)
T cd07865          31 ARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS  110 (310)
T ss_pred             EEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHH
Confidence            45677899999999854333333334566899999999999999999987655321   113458999999988888776


Q ss_pred             CC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcccc
Q psy16889         79 SP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYR  154 (203)
Q Consensus        79 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~  154 (203)
                      .. ..+++.+++.++.|++.||++||++|++|+||+|+||+++.++.++++|||.+.........   ......++..|+
T Consensus       111 ~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~  190 (310)
T cd07865         111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR  190 (310)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcccc
Confidence            54 46999999999999999999999999999999999999999999999999998754332211   122335577899


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |||.+.+...++.++|+||||+++|+|++|.+||.+.++...+..
T Consensus       191 aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~  235 (310)
T cd07865         191 PPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL  235 (310)
T ss_pred             CcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999887755578899999999999999999999988876655443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.1e-35  Score=217.78  Aligned_cols=190  Identities=24%  Similarity=0.363  Sum_probs=154.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.+..+++.+++|.+...   ......+.+|++.++.++|+||+++++++...     ...++++||++ ++|.+++.. 
T Consensus        25 ~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   96 (263)
T cd05052          25 GVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC   96 (263)
T ss_pred             EEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhC
Confidence            345678999999998642   23345688899999999999999999998876     56789999997 588888764 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..++.++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+................+..|+|||.
T Consensus        97 ~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~  176 (263)
T cd05052          97 NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  176 (263)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHH
Confidence             3458999999999999999999999999999999999999999999999999987544322222222233567999998


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       177 ~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~  218 (263)
T cd05052         177 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  218 (263)
T ss_pred             hcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            876 457899999999999999998 99999887766655443

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=220.84  Aligned_cols=191  Identities=37%  Similarity=0.709  Sum_probs=159.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH-hCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII-VSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~~~   80 (203)
                      +.+..+++.|++|.++...........+.+|++++++++|+||+++++++.++     ...++++||+++++.+.+ ...
T Consensus        20 ~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~   94 (288)
T cd07833          20 CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASP   94 (288)
T ss_pred             EEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcC
Confidence            45677899999999865444455567889999999999999999999999876     567899999997655544 455


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.++..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+...............++..|+|||++.
T Consensus        95 ~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  174 (288)
T cd07833          95 GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLV  174 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhc
Confidence            67999999999999999999999999999999999999999999999999998755443322333445678899999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      +...++.++|+||||+++|++++|++||.+....+.+
T Consensus       175 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~  211 (288)
T cd07833         175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL  211 (288)
T ss_pred             CCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            7546889999999999999999999999877655443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-35  Score=226.36  Aligned_cols=185  Identities=26%  Similarity=0.425  Sum_probs=155.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|..+++|++.... .......+.+|++++++++|+||+++++++.++     ..++++|||+. ++|.+++...
T Consensus        24 ~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   97 (333)
T cd06650          24 VSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKA   97 (333)
T ss_pred             EEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHc
Confidence            4567789999999986532 233456788999999999999999999999887     56789999997 5999988887


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..+..++.|++.++.|||+. +++|+||||+||+++.++.++++|||++......   ......++..|+|||++
T Consensus        98 ~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~  174 (333)
T cd06650          98 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL  174 (333)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCccccCHHHh
Confidence            8899999999999999999999975 7999999999999999999999999998643221   12233568889999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      .+ ..++.++|+||||+++|++++|+.||......+.
T Consensus       175 ~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~  210 (333)
T cd06650         175 QG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL  210 (333)
T ss_pred             cC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence            87 4588999999999999999999999987654433

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-35  Score=224.79  Aligned_cols=182  Identities=38%  Similarity=0.693  Sum_probs=146.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC----
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS----   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----   79 (203)
                      +..+++.|++|.+...    .....+.+|+++++.++||||+++++++.....   ...++++||++++|.+.+..    
T Consensus        24 ~~~~~~~~a~k~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~   96 (317)
T cd07867          24 DGKDEKEYALKQIEGT----GISMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWLLFDYAEHDLWHIIKFHRAS   96 (317)
T ss_pred             CCCccceEEEEEecCC----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEEEEeeeCCcHHHHHHhhhcc
Confidence            3457789999998543    223457789999999999999999998855432   45678999999888777642    


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCeEEEeecCccccCCCCCC--CCccccc
Q psy16889         80 -----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV----NSNCILKICDFGLARVEEPDPN--KAMTQEV  148 (203)
Q Consensus        80 -----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  148 (203)
                           ...+++..++.++.|++.||++||+++++||||||+||++    +.++.++|+|||.+........  .......
T Consensus        97 ~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  176 (317)
T cd07867          97 KANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV  176 (317)
T ss_pred             ccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcce
Confidence                 2358899999999999999999999999999999999999    4567899999999975443221  1223446


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +++.|+|||.+.+...++.++|+||||+++|+|++|++||....
T Consensus       177 ~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            68889999998775668899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0574|consensus

Probab=100.00  E-value=1e-36  Score=219.87  Aligned_cols=181  Identities=25%  Similarity=0.469  Sum_probs=159.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~   79 (203)
                      |.++++|..+|||..+-.    .+.+.+.+|+.++++...+++|++|+.+..+     ..+++|||||+ |+..+.++ +
T Consensus        52 AIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R  122 (502)
T KOG0574|consen   52 AIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRAR  122 (502)
T ss_pred             HHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHh
Confidence            678999999999999643    4678899999999999999999999988877     56899999999 78888877 5


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +++++|+++..+++..+++|+|||....+|||||..||+++.+|..||.|||.+-..... .....+..||+.|+|||++
T Consensus       123 ~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  123 RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAKRNTVIGTPFWMAPEVI  201 (502)
T ss_pred             cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh-HHhhCccccCcccccHHHH
Confidence            688999999999999999999999999999999999999999999999999998643322 3345667999999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ..-+ |+..+||||||++..||.-|++||..--+
T Consensus       202 ~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHP  234 (502)
T KOG0574|consen  202 EEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHP  234 (502)
T ss_pred             HHhc-cchhhhHhhhcchhhhhhcCCCCcccccc
Confidence            8744 89999999999999999999999977543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6e-35  Score=216.00  Aligned_cols=192  Identities=27%  Similarity=0.441  Sum_probs=156.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.++.+++.|++|.+..........+.+.+|++.+++++|+|++++.+.+...+    ..+++++||++ ++|.+++.. 
T Consensus        19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~   94 (257)
T cd08223          19 VRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQ   94 (257)
T ss_pred             EEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHh
Confidence            456778999999998654444455667888999999999999999998775432    35679999997 588887764 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||+
T Consensus        95 ~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~y~aPE~  173 (257)
T cd08223          95 KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMASTLIGTPYYMSPEL  173 (257)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-CccccccCCcCccChhH
Confidence             3568999999999999999999999999999999999999999999999999987543222 22233456788999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      ..+ ..++.++|+||||++++++++|+.||...+.......
T Consensus       174 ~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  213 (257)
T cd08223         174 FSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR  213 (257)
T ss_pred             hcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            887 4578899999999999999999999988765554433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.4e-35  Score=215.03  Aligned_cols=191  Identities=26%  Similarity=0.395  Sum_probs=152.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.+..+|+.+++|.+.... .......+.+|++++++++||||+++++++.+.     ...++++||+. ++|.+++.. 
T Consensus        14 ~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   87 (252)
T cd05084          14 GRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTE   87 (252)
T ss_pred             EEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhC
Confidence            4567789999999885432 233446788999999999999999999999877     56789999997 488888765 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC-cccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA-MTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPe~  158 (203)
                      .+.+++..++.++.|++.+|.|||+++++|+||+|+||+++.++.++++|||.+.......... ......+..|+|||.
T Consensus        88 ~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  167 (252)
T cd05084          88 GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA  167 (252)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchh
Confidence            3468999999999999999999999999999999999999999999999999986432211111 111122456999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      +.+ ..++.++|+||||+++|++++ |..||...........
T Consensus       168 ~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~  208 (252)
T cd05084         168 LNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA  208 (252)
T ss_pred             hcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH
Confidence            877 447899999999999999997 8999987666554433

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.1e-35  Score=216.85  Aligned_cols=192  Identities=26%  Similarity=0.478  Sum_probs=162.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.+++|.+.....+......+.+|++++++++|+||+++++++.+.     ...++++||+. ++|.+.+...
T Consensus        19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~   93 (256)
T cd08221          19 YRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQ   93 (256)
T ss_pred             EEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhc
Confidence            35678899999999865544555667788999999999999999999999887     56788999998 5888888654


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                        ..+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+........ ......+++.|.|||.
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~  172 (256)
T cd08221          94 KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPEL  172 (256)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-cccccCCCccccCHhh
Confidence              5689999999999999999999999999999999999999999999999999875433221 2234467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ..+. .++.++|+||||+++|+|++|+.||......+....+
T Consensus       173 ~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~  213 (256)
T cd08221         173 CQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI  213 (256)
T ss_pred             cCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            8874 4788999999999999999999999887776666554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.5e-35  Score=221.07  Aligned_cols=199  Identities=37%  Similarity=0.631  Sum_probs=159.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-----hhHHHHHHHhhhHHhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-----FFQEIYVITELLQSDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-----~~~~~~lv~e~~~~~l~~~   76 (203)
                      +.++.+|+.|++|.++...........+.+|+++++.++|||++++++++.+....     .....++++||+++++...
T Consensus        26 ~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~  105 (302)
T cd07864          26 ARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGL  105 (302)
T ss_pred             EEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHH
Confidence            35667899999999965433334445677899999999999999999988765310     0125789999999888777


Q ss_pred             HhCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         77 IVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        77 ~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      +... ..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|
T Consensus       106 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~  185 (302)
T cd07864         106 LESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP  185 (302)
T ss_pred             HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccC
Confidence            7653 569999999999999999999999999999999999999999999999999987544332222233344677999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ||.+.+...++.++|+||||++++++++|++||...+..+.+..+
T Consensus       186 PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~  230 (302)
T cd07864         186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELI  230 (302)
T ss_pred             hHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            998876555788999999999999999999999887766655444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=214.35  Aligned_cols=185  Identities=26%  Similarity=0.436  Sum_probs=151.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~   83 (203)
                      +++.|++|.++...   ...+.+.+|++.+++++|+||+++++++...     ...++++|++. ++|.+++...  ..+
T Consensus        29 ~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~  100 (261)
T cd05068          29 NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRAL  100 (261)
T ss_pred             CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCC
Confidence            45789999986432   2345688899999999999999999988776     56789999995 6898888654  369


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+................+..|+|||...+ .
T Consensus       101 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  179 (261)
T cd05068         101 KLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-N  179 (261)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-C
Confidence            999999999999999999999999999999999999999999999999987554322222222222457999998876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|++++ |+.||.+......+..+
T Consensus       180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  217 (261)
T cd05068         180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV  217 (261)
T ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            57899999999999999998 99999988877666554

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-34  Score=224.83  Aligned_cols=183  Identities=28%  Similarity=0.445  Sum_probs=147.1

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   80 (203)
                      +..++..||||+++... .....+.+.+|+++++.+ +||||+++++++.+.     ...+++|||+. |+|.+++... 
T Consensus        61 ~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~  134 (375)
T cd05104          61 KSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKR  134 (375)
T ss_pred             cCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhcc
Confidence            45677889999986432 223456788999999999 899999999999887     56789999998 5887776431 


Q ss_pred             --------------------------------------------------------------------------CCCChH
Q psy16889         81 --------------------------------------------------------------------------QHLTSD   86 (203)
Q Consensus        81 --------------------------------------------------------------------------~~~~~~   86 (203)
                                                                                                ..++++
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  214 (375)
T cd05104         135 DSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTE  214 (375)
T ss_pred             cccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHH
Confidence                                                                                      247888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC-cccccCCcccccceeeecccCC
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA-MTQEVVTQYYRAPEILMGARHY  165 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~aPe~~~~~~~~  165 (203)
                      .+..++.|++.||+|||+++++||||||+||+++.++.++++|||++.......... .....++..|+|||++.+ ..+
T Consensus       215 ~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  293 (375)
T cd05104         215 DLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVY  293 (375)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCC
Confidence            999999999999999999999999999999999999999999999987443222111 112233557999999977 458


Q ss_pred             CcchhHHHHHHHHHHHHh-CCcccCCCCh
Q psy16889        166 SAAVDVWSVGCIFAELLG-RRILFQAQSP  193 (203)
Q Consensus       166 ~~~~Di~slG~~l~~ll~-g~~pf~~~~~  193 (203)
                      +.++|+||||+++|+|++ |..||.....
T Consensus       294 ~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         294 TFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             CCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence            999999999999999997 8999977543

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1026|consensus

Probab=100.00  E-value=5.1e-36  Score=240.23  Aligned_cols=188  Identities=26%  Similarity=0.442  Sum_probs=164.5

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----   80 (203)
                      +...||||.++.. .+....+.|++|++++..++|||||++++++..+     .-+++|.||+. |||.+++...     
T Consensus       515 ~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~  588 (774)
T KOG1026|consen  515 DEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKAD  588 (774)
T ss_pred             cceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccc
Confidence            4456999999764 3444678899999999999999999999999998     66889999998 8999998632     


Q ss_pred             ---------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc-cCCCCCCCCcccccCC
Q psy16889         81 ---------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVT  150 (203)
Q Consensus        81 ---------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~-~~~~~~~~~~~~~~~~  150 (203)
                               ++++..+.+.++.||+.+++||-++..|||||-..|+++.++..+|++|||+++ .+.....+.....+..
T Consensus       589 ~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lP  668 (774)
T KOG1026|consen  589 KLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLP  668 (774)
T ss_pred             cccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceee
Confidence                     238889999999999999999999999999999999999999999999999998 4555555555455668


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+|+|||.+..+ .++..|||||+|+++||+++ |+.||.+.++.+.++.|.
T Consensus       669 IRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  669 IRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            899999999984 49999999999999999997 999999999999998875

>KOG0696|consensus

Probab=100.00  E-value=9.8e-36  Score=222.71  Aligned_cols=192  Identities=23%  Similarity=0.321  Sum_probs=168.1

Q ss_pred             CCCCCcEEEEEeccC-ccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          4 DPRDGRRVALKKLPN-VFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~-~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      .+-+.+.||||+++. ...++.+.+.-+-|-++|.-. +.|.++++.++|+..     ..+|+||||+. |+|-..++.-
T Consensus       370 rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm-----DRLyFVMEyvnGGDLMyhiQQ~  444 (683)
T KOG0696|consen  370 RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQV  444 (683)
T ss_pred             ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh-----hheeeEEEEecCchhhhHHHHh
Confidence            456778899999954 444666777777888888777 778899999999988     78999999998 5999999988


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.|.|..+..++.+|+-+|=+||++||++||||.+|+|++.+|.+|+.|||++...- -......+.+|||.|+|||.+.
T Consensus       445 GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~~TTkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  445 GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDGVTTKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-cCCcceeeecCCCcccccceEE
Confidence            999999999999999999999999999999999999999999999999999997322 2233445568999999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      - ++|+.+.|+||+|+++|||+.|++||.+.+..++.+.|.+
T Consensus       524 Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e  564 (683)
T KOG0696|consen  524 Y-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME  564 (683)
T ss_pred             e-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            7 7799999999999999999999999999999999998875

>KOG0984|consensus

Probab=100.00  E-value=5.7e-35  Score=200.20  Aligned_cols=193  Identities=26%  Similarity=0.456  Sum_probs=157.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHH-hhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHH----
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKI----   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~----   76 (203)
                      .++..+|.-.|+|.++....+..+ .++..|+++. +...+|+++.+++.+.+.     ..+++.||.+..+|..+    
T Consensus        65 mrh~~sg~imAvKri~~tvn~q~q-~r~L~dldi~~r~~~CPf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v  138 (282)
T KOG0984|consen   65 MRHIQSGTIMAVKRIRATVNSQEQ-KRLLMDLDIIMRTVDCPFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKV  138 (282)
T ss_pred             eeeccCCeEEEEeeehhhcChHHH-HHHHHhhhhhccCCCCCeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHH
Confidence            468899999999999765444443 4455566654 444899999999988877     66889999998766433    


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      +..++.++|..+-+++..+..|+.+||++ .++|||+||+||+++.+|++|+||||.+-.....  .+.+...|.-.|+|
T Consensus       139 ~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS--iAkt~daGCkpYma  216 (282)
T KOG0984|consen  139 LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS--IAKTMDAGCKPYMA  216 (282)
T ss_pred             HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhh--hHHHHhcCCCccCC
Confidence            45678899999999999999999999965 8999999999999999999999999998643322  23333466777999


Q ss_pred             ceeeecc---cCCCcchhHHHHHHHHHHHHhCCcccCCC-ChHHHhhhhhc
Q psy16889        156 PEILMGA---RHYSAAVDVWSVGCIFAELLGRRILFQAQ-SPVQQLGLITD  202 (203)
Q Consensus       156 Pe~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~i~~  202 (203)
                      ||.+...   +.|+.++|+||||+++.||.+++.||..+ ++++++.++++
T Consensus       217 PEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  217 PERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9988642   35889999999999999999999999886 59999998875

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=218.14  Aligned_cols=193  Identities=45%  Similarity=0.754  Sum_probs=162.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.+..+|+.+++|.++...........+.+|++.+++++|+||+++++++.++     ...++++||+++++.+.+.. .
T Consensus        18 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~   92 (283)
T cd05118          18 ARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQ   92 (283)
T ss_pred             EEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhc
Confidence            45678899999999866544444566788899999999999999999999887     56789999999988888775 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|.|||.+.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~  171 (283)
T cd05118          93 RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLL  171 (283)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHh
Confidence            679999999999999999999999999999999999999999999999999887544332 1222335677899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|++++|+.||.+.+..+.+..+
T Consensus       172 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~  211 (283)
T cd05118         172 GDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI  211 (283)
T ss_pred             cCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7546889999999999999999999999888776655443

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.9e-35  Score=223.66  Aligned_cols=194  Identities=43%  Similarity=0.675  Sum_probs=159.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhh------------hHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVS------------SKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL   69 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~   69 (203)
                      +.+..+|+.|+||.+.........            ...+.+|+++++.++|+||+++++++...     ...+++||++
T Consensus        28 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~  102 (335)
T PTZ00024         28 AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-----DFINLVMDIM  102 (335)
T ss_pred             EEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC-----CcEEEEEecc
Confidence            456788999999998543222100            12467899999999999999999998877     5678999999


Q ss_pred             HHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC---------
Q psy16889         70 QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP---------  140 (203)
Q Consensus        70 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---------  140 (203)
                      .++|.+.+.....++++.+..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+.......         
T Consensus       103 ~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  182 (335)
T PTZ00024        103 ASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE  182 (335)
T ss_pred             ccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccc
Confidence            99999998887889999999999999999999999999999999999999999999999999887543110         


Q ss_pred             ----CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        141 ----NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       141 ----~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                          ........++..|.|||.+.+...++.++|+||||+++|++++|.+||.+..+.+.+..|
T Consensus       183 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                111122345778999999887555789999999999999999999999988877666544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-35  Score=226.35  Aligned_cols=179  Identities=31%  Similarity=0.442  Sum_probs=145.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|+||++.... .......+.+|+++++.++|+||+++++++.++     ..+++++||+.+ +|..    .
T Consensus        93 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~----~  162 (353)
T PLN00034         93 VIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEG----T  162 (353)
T ss_pred             EEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeEEEEEecCCCCcccc----c
Confidence            4567789999999985432 233456788999999999999999999999877     567899999985 5533    2


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ...++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........|+..|+|||.+.
T Consensus       163 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~  241 (353)
T PLN00034        163 HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDPCNSSVGTIAYMSPERIN  241 (353)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-cccccccccCccccCccccc
Confidence            34678888999999999999999999999999999999999999999999998754322 12223446788999999875


Q ss_pred             cc----cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GA----RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ..    ...+.++|+||||+++|+|++|+.||...
T Consensus       242 ~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  276 (353)
T PLN00034        242 TDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG  276 (353)
T ss_pred             cccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence            32    23456899999999999999999999743

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=8.2e-35  Score=219.42  Aligned_cols=197  Identities=39%  Similarity=0.629  Sum_probs=156.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.|++|..+...........+.+|+.+++.+ +|+||+++++++...........|+++||++++|.+++.. 
T Consensus        20 ~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   99 (295)
T cd07837          20 ARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN   99 (295)
T ss_pred             EEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHh
Confidence            45678899999999865433333446678899999999 5699999999887653211123689999999888877653 


Q ss_pred             ----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 ----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 ----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                          ...+++..++.++.|++.+|++||+++++|+||+|+||+++. ++.++++|||.+....... .......+++.|.
T Consensus       100 ~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~  178 (295)
T cd07837         100 GRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV-KSYTHEIVTLWYR  178 (295)
T ss_pred             cccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc-cccCCcccccCCC
Confidence                245899999999999999999999999999999999999998 8899999999887443221 1222334577899


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |||.+.+...++.++|+||||+++|+|++|..||.+.++.+.+..
T Consensus       179 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~  223 (295)
T cd07837         179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH  223 (295)
T ss_pred             ChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            999887656678999999999999999999999988776555443

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7e-35  Score=220.83  Aligned_cols=187  Identities=25%  Similarity=0.366  Sum_probs=148.3

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .++..||+|.+.... .......+.+|++++++++||||+++++++.+.     ...+++|||+. ++|.+++...    
T Consensus        44 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (304)
T cd05096          44 GRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDD  117 (304)
T ss_pred             CcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccc
Confidence            345579999986532 233456788999999999999999999999877     56789999997 5887776432    


Q ss_pred             ---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCc
Q psy16889         81 ---------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAM  144 (203)
Q Consensus        81 ---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~  144 (203)
                                     ..+++..+..++.|++.||++||+.|++|+||||+||+++.++.++|+|||.+........ ...
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~  197 (304)
T cd05096         118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ  197 (304)
T ss_pred             cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEec
Confidence                           2367788999999999999999999999999999999999999999999999874332211 111


Q ss_pred             ccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh--CCcccCCCChHHHhhh
Q psy16889        145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG--RRILFQAQSPVQQLGL  199 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~~~~~~~~~~~  199 (203)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++  +..||.+.+..+.+..
T Consensus       198 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~  253 (304)
T cd05096         198 GRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN  253 (304)
T ss_pred             CcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHH
Confidence            22234677999999876 458999999999999999986  6788987766655443

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-35  Score=216.18  Aligned_cols=188  Identities=24%  Similarity=0.347  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+++.+++|.+....  ......+.+|++++++++||||+++++++.+.     ..++++|||+++ +|.+++...
T Consensus        22 ~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~   94 (262)
T cd06613          22 ARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVT   94 (262)
T ss_pred             eEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhh
Confidence            4566788999999996532  22557788999999999999999999998776     567899999985 777777655


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..+..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+...... ........++..|+|||.+
T Consensus        95 ~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~y~~Pe~~  173 (262)
T cd06613          95 RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IAKRKSFIGTPYWMAPEVA  173 (262)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh-hhccccccCCccccCchhh
Confidence             78999999999999999999999999999999999999999999999999988743322 1122333567789999998


Q ss_pred             ecc--cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+.  ..++.++|+||||+++|+|++|++||.+.++....
T Consensus       174 ~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~  213 (262)
T cd06613         174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL  213 (262)
T ss_pred             cccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            763  25788999999999999999999999887654443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=9.8e-35  Score=215.91  Aligned_cols=192  Identities=26%  Similarity=0.427  Sum_probs=154.6

Q ss_pred             CcCCCCCcEEEEEeccCccc---hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ---SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      +.+..+|+.|++|.+.....   .......+.+|++++++++||||+++++++.++..   ..+++++||++ ++|.+++
T Consensus        21 ~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~l   97 (265)
T cd06652          21 CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---RTLSIFMEHMPGGSIKDQL   97 (265)
T ss_pred             EEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---ceEEEEEEecCCCcHHHHH
Confidence            35678899999998843211   22345678889999999999999999998876532   34568999997 5898888


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCccccc
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~a  155 (203)
                      ...+.+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+........  .......++..|+|
T Consensus        98 ~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (265)
T cd06652          98 KSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS  177 (265)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccC
Confidence            7777799999999999999999999999999999999999999999999999998874332111  11223346778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ||++.+ ..++.++|+||||+++|++++|+.||.........
T Consensus       178 PE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  218 (265)
T cd06652         178 PEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI  218 (265)
T ss_pred             hhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH
Confidence            999877 45789999999999999999999999876544433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4236|consensus

Probab=100.00  E-value=2.2e-36  Score=231.95  Aligned_cols=183  Identities=30%  Similarity=0.504  Sum_probs=161.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS--   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--   79 (203)
                      ..++++|+.||||++....-.......++.|+.+++++.||+||.+---|+..     ..+++|||-+.|+.++-+..  
T Consensus       583 g~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsE  657 (888)
T KOG4236|consen  583 GKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSE  657 (888)
T ss_pred             ceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhh
Confidence            35789999999999977666666678899999999999999999999999988     67899999999988877663  


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .+++++..-..++.||+.||.|||.+||+|+||||+|+++..   ..++||||||.++.+......  ....||+.|+||
T Consensus       658 kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR--rsVVGTPAYLaP  735 (888)
T KOG4236|consen  658 KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR--RSVVGTPAYLAP  735 (888)
T ss_pred             cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh--hhhcCCccccCH
Confidence            578999999999999999999999999999999999999963   458999999999977655433  344789999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.+ +.|+.+.|+||.|+++|--|+|..||.+..
T Consensus       736 EVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE  770 (888)
T KOG4236|consen  736 EVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE  770 (888)
T ss_pred             HHHhh-ccccccccceeeeEEEEEEecccccCCCcc
Confidence            99998 558999999999999999999999998753

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-34  Score=215.09  Aligned_cols=191  Identities=27%  Similarity=0.419  Sum_probs=159.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |++..+++.+++|++..... .......+.+|+.+++.++||||+++++.+.++     ...++++||+. ++|.+++..
T Consensus        12 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   86 (262)
T cd05572          12 VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRD   86 (262)
T ss_pred             EEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhh
Confidence            46677899999999964322 334456788999999999999999999998877     57889999987 589998887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.+|+++|+++++|+||+|+||+++.++.++++|||.+.......  ......+++.|++||.+
T Consensus        87 ~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~  164 (262)
T cd05572          87 RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEII  164 (262)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCcCccChhHh
Confidence            7789999999999999999999999999999999999999999999999999987543321  22233567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCC--hHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQS--PVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~i  200 (203)
                      .+ ..++.++|+||+|+++|++++|..||....  +...+..+
T Consensus       165 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  206 (262)
T cd05572         165 LN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI  206 (262)
T ss_pred             cC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence            76 457899999999999999999999998776  54444443

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0577|consensus

Probab=100.00  E-value=1.1e-34  Score=225.01  Aligned_cols=189  Identities=28%  Similarity=0.433  Sum_probs=159.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~   79 (203)
                      |+|..+.+.||||.++-+.. +.+..+.+.+|+..+++++|||++.+.++|..+     ...|+|||||-|+-.+.+. .
T Consensus        45 Ard~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVh  119 (948)
T KOG0577|consen   45 ARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVH  119 (948)
T ss_pred             eeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHH
Confidence            57899999999999966544 444556789999999999999999999999888     7899999999986666555 3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++.+-++..|..+.+.+|+|||+.+.+|||||..||++++.|.+||.|||.+...     .+.....|||.|+|||++
T Consensus       120 kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~-----~PAnsFvGTPywMAPEVI  194 (948)
T KOG0577|consen  120 KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM-----APANSFVGTPYWMAPEVI  194 (948)
T ss_pred             hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-----CchhcccCCccccchhHh
Confidence            468999999999999999999999999999999999999999999999999998743     333556889999999998


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ..  .+.|+-+.||||||++..|+.-.++|+=.-+.-..+.-|
T Consensus       195 LAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI  237 (948)
T KOG0577|consen  195 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  237 (948)
T ss_pred             eeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH
Confidence            63  356899999999999999999999995444444444333

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.6e-34  Score=217.36  Aligned_cols=188  Identities=26%  Similarity=0.408  Sum_probs=152.4

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--   81 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--   81 (203)
                      ..++..+++|.+...  .......+.+|++++++++|+||+++++++...     ..+++++||+. ++|.+++...+  
T Consensus        32 ~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  104 (288)
T cd05093          32 EQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPD  104 (288)
T ss_pred             CCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCc
Confidence            345677899988543  233456788999999999999999999998876     57889999998 58888775432  


Q ss_pred             -----------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccC
Q psy16889         82 -----------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVV  149 (203)
Q Consensus        82 -----------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  149 (203)
                                 .+++..+..++.|++.+|++||++|++||||||+||+++.++.++++|||.+........ .......+
T Consensus       105 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  184 (288)
T cd05093         105 AVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML  184 (288)
T ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCc
Confidence                       489999999999999999999999999999999999999999999999999874332211 11222334


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+.+..+
T Consensus       185 ~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i  235 (288)
T cd05093         185 PIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  235 (288)
T ss_pred             cccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            667999999877 458899999999999999998 99999887776655544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.2e-35  Score=217.18  Aligned_cols=184  Identities=25%  Similarity=0.344  Sum_probs=152.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+++.|++|.++..  .......+.+|+.+++.++||||+++++++...     ..+++++||++ ++|.+.+...
T Consensus        28 ~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~  100 (267)
T cd06645          28 ARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVT  100 (267)
T ss_pred             EEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhc
Confidence            456788999999998643  222345677899999999999999999998776     56789999998 4888888888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+...... ........++..|+|||++.
T Consensus       101 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  179 (267)
T cd06645         101 GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccccccccCcccccChhhhc
Confidence            88999999999999999999999999999999999999999999999999998643322 12223346788899999874


Q ss_pred             c--ccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        161 G--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       161 ~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .  ...++.++|+||||+++|+|++|+.||....+
T Consensus       180 ~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~  214 (267)
T cd06645         180 VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP  214 (267)
T ss_pred             cccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc
Confidence            2  24478899999999999999999999866543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.2e-35  Score=218.59  Aligned_cols=186  Identities=22%  Similarity=0.353  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +.+..+|+.+|+|.+..... .......+.+|++++++++|++++++.+.+.++     ...++++||+.+ +|...+..
T Consensus        19 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   93 (285)
T cd05632          19 CQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYN   93 (285)
T ss_pred             EEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHH
Confidence            45677899999999854322 223345577899999999999999999988877     567899999984 77766643


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++++|||.+......  .......++..|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~g~~~~~aPE  171 (285)
T cd05632          94 MGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYMAPE  171 (285)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--CcccCCCCCcCccChH
Confidence              346999999999999999999999999999999999999999999999999988643221  1223346788999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      .+.+ ..++.++|+||||+++|++++|..||.+.....
T Consensus       172 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~  208 (285)
T cd05632         172 VLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV  208 (285)
T ss_pred             HhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9876 458899999999999999999999998876543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-34  Score=215.46  Aligned_cols=190  Identities=26%  Similarity=0.464  Sum_probs=155.1

Q ss_pred             CcCCCCCcEEEEEeccCccch-------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS-------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l   73 (203)
                      +.+..+++.+++|.+......       ....+.+.+|+.++++++||||+++++++...     ...++++||+++ +|
T Consensus        19 a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L   93 (267)
T cd06628          19 GMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-----DHLNIFLEYVPGGSV   93 (267)
T ss_pred             EEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CccEEEEEecCCCCH
Confidence            456678999999988543221       12235678899999999999999999998877     577899999974 88


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-----CCCccccc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-----NKAMTQEV  148 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~  148 (203)
                      .+++...+.+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+.......     ........
T Consensus        94 ~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  173 (267)
T cd06628          94 AALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ  173 (267)
T ss_pred             HHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccC
Confidence            8888877889999999999999999999999999999999999999999999999999887543211     11112234


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ++..|+|||.+.+ ..++.++|+||||+++|++++|+.||.+.+....+
T Consensus       174 ~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  221 (267)
T cd06628         174 GSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI  221 (267)
T ss_pred             CCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH
Confidence            6778999999877 44788999999999999999999999876554443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-34  Score=216.65  Aligned_cols=188  Identities=23%  Similarity=0.398  Sum_probs=152.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----   80 (203)
                      ++..|++|.+... ........+.+|++.++.++||||+++++++.+.     ...++++||+. ++|.+++...     
T Consensus        34 ~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~  107 (283)
T cd05048          34 SATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSD  107 (283)
T ss_pred             ceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcc
Confidence            4477999998643 2233456688999999999999999999998876     45678999997 5888887643     


Q ss_pred             -----------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCccccc
Q psy16889         81 -----------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEV  148 (203)
Q Consensus        81 -----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~  148 (203)
                                 ..+++.++..++.|++.||.+||+++++|+||||+||+++.++.++|+|||.+....... ........
T Consensus       108 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~  187 (283)
T cd05048         108 VGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL  187 (283)
T ss_pred             cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCc
Confidence                       458889999999999999999999999999999999999999999999999987432221 11223334


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      +++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+.+..+....|.
T Consensus       188 ~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             ccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            5778999998876 458999999999999999998 999999887777666553

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-34  Score=217.82  Aligned_cols=184  Identities=36%  Similarity=0.644  Sum_probs=150.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.+..+|+.|++|.++... .......+.+|++.++.++|+||+++.+++.++     ...++++||+.+++.+.+.. .
T Consensus        24 ~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   97 (291)
T cd07870          24 GISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHP   97 (291)
T ss_pred             EEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCC
Confidence            3567789999999985432 222234567899999999999999999998876     46778999999888777654 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...... ........+++.|+|||.+.
T Consensus        98 ~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  176 (291)
T cd07870          98 GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLL  176 (291)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-CCCCCCccccccccCCceee
Confidence            56889999999999999999999999999999999999999999999999988643322 11223334578899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +...++.++|+||||+++|++++|+.||.+.+
T Consensus       177 ~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         177 GATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            65557889999999999999999999997654

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.9e-34  Score=213.39  Aligned_cols=187  Identities=23%  Similarity=0.436  Sum_probs=152.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      +++..+++|.+...   ....+.+.+|+++++.++||||+++++++...     ...+++|||++ ++|.+++.. .+.+
T Consensus        26 ~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~   97 (256)
T cd05114          26 RAQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKL   97 (256)
T ss_pred             ccCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCC
Confidence            34567999987532   12345678899999999999999999998877     56789999997 588888764 4568


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+ .
T Consensus        98 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  176 (256)
T cd05114          98 SKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-S  176 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-C
Confidence            999999999999999999999999999999999999999999999999887543222222222234567999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|++++ |+.||...+..+.+..+.
T Consensus       177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~  215 (256)
T cd05114         177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS  215 (256)
T ss_pred             ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            58899999999999999999 899999888777766654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-34  Score=215.39  Aligned_cols=188  Identities=27%  Similarity=0.399  Sum_probs=152.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .+++.|++|.+.... .....+.+.+|+++++.++|+||+++++++...     ...+++|||+. ++|.+++...    
T Consensus        33 ~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  106 (280)
T cd05049          33 NDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDA  106 (280)
T ss_pred             CCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCch
Confidence            557889999986532 223456788999999999999999999999887     56789999997 5888877543    


Q ss_pred             ----------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccC
Q psy16889         81 ----------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVV  149 (203)
Q Consensus        81 ----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~  149 (203)
                                ..+++..+..++.|++.++++||++|++|+||+|+||+++.++.++++|||.+........ .......+
T Consensus       107 ~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~  186 (280)
T cd05049         107 AFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML  186 (280)
T ss_pred             hhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcc
Confidence                      3488999999999999999999999999999999999999999999999999864322111 11122234


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       187 ~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05049         187 PIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI  237 (280)
T ss_pred             cceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            677999999887 458999999999999999998 99999887766665544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=9.2e-35  Score=219.05  Aligned_cols=188  Identities=27%  Similarity=0.511  Sum_probs=154.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+++.|+||.+...  .....+.+.+|+..++.++|+|++++++.+...     ...++++||+++ +|.+++. .
T Consensus        41 ~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~  112 (292)
T cd06658          41 ATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVT-H  112 (292)
T ss_pred             EEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHh-c
Confidence            356678999999998542  233456688999999999999999999998877     567899999985 6666654 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+....... .......++..|+|||...
T Consensus       113 ~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  191 (292)
T cd06658         113 TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVIS  191 (292)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCccccCHHHHc
Confidence            568999999999999999999999999999999999999999999999999886433221 2223345688899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      + ..++.++|+||||+++|++++|+.||...++.+.+..
T Consensus       192 ~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  229 (292)
T cd06658         192 R-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR  229 (292)
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            6 4578999999999999999999999988776554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=213.99  Aligned_cols=188  Identities=26%  Similarity=0.429  Sum_probs=157.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----   80 (203)
                      ++..+++|.++...... ..+.+.+|++.++.++|+|++++++++.+.     ..+++++||+. ++|.+++...     
T Consensus        22 ~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~   95 (262)
T cd00192          22 KTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVFP   95 (262)
T ss_pred             CCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhcccccc
Confidence            38899999997653333 567888999999999999999999999885     67889999995 6898888764     


Q ss_pred             ----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccccc
Q psy16889         81 ----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRA  155 (203)
Q Consensus        81 ----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~a  155 (203)
                          ..+++.+++.++.|++.|+++||+++++|+||+|+||+++.++.++++|||.+........ .......++..|.|
T Consensus        96 ~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  175 (262)
T cd00192          96 SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMA  175 (262)
T ss_pred             ccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccC
Confidence                7799999999999999999999999999999999999999999999999999975443221 12233345778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ||.+.+. .++.++|+||||+++|++++ |..||......+..+.+.
T Consensus       176 PE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  221 (262)
T cd00192         176 PESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR  221 (262)
T ss_pred             HHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            9988774 58899999999999999998 699999887776666553

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.6e-35  Score=217.02  Aligned_cols=185  Identities=25%  Similarity=0.326  Sum_probs=152.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.|++|++...  .......+.+|+..+++++||||+++++++..+     ..+++++||++ ++|.+.+...
T Consensus        28 ~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~  100 (267)
T cd06646          28 ARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVT  100 (267)
T ss_pred             EEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhc
Confidence            456778999999998543  222345677899999999999999999998876     46788999998 4888888777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.++++||+.+++|+|++|+||+++.++.++++|||.+...... ........++..|+|||.+.
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~  179 (267)
T cd06646         101 GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IAKRKSFIGTPYWMAPEVAA  179 (267)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc-ccccCccccCccccCHhHcc
Confidence            88999999999999999999999999999999999999999999999999998744322 12223345678899999875


Q ss_pred             c--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        161 G--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       161 ~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      .  ...++.++|+||+|+++|+|++|+.||....+.
T Consensus       180 ~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~  215 (267)
T cd06646         180 VEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM  215 (267)
T ss_pred             cccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence            3  234678999999999999999999998665443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.9e-35  Score=215.29  Aligned_cols=184  Identities=29%  Similarity=0.454  Sum_probs=156.5

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.|++|.+..... .....+.+.+|++.+++++||||+++++.+.++     ...++++||+.+ +|.+.+..
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   93 (258)
T cd05578          19 VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQ   93 (258)
T ss_pred             EEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHh
Confidence            45678899999999964322 224567788999999999999999999999877     567899999975 88888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++++.+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+.......  ......++..|.|||.+
T Consensus        94 ~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~  171 (258)
T cd05578          94 KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL  171 (258)
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccccCCChhhcCHHHH
Confidence            7789999999999999999999999999999999999999999999999999987543322  22334567789999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+. .++.++|+||||+++|++++|+.||...+.
T Consensus       172 ~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  204 (258)
T cd05578         172 CRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSR  204 (258)
T ss_pred             ccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence            774 478999999999999999999999988763

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.6e-34  Score=218.92  Aligned_cols=193  Identities=27%  Similarity=0.445  Sum_probs=158.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +.+..+++.|++|.++.... .......+.+|+++++.++||||+++++.+..+     ..+++++||++| +|.+++..
T Consensus        20 ~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~   94 (305)
T cd05609          20 VRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKN   94 (305)
T ss_pred             EEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHH
Confidence            45678899999999854322 233456778899999999999999999998877     567899999985 88888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--------------Ccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--------------AMT  145 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~  145 (203)
                      .+.+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+.........              ...
T Consensus        95 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (305)
T cd05609          95 IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK  174 (305)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhcccc
Confidence            788999999999999999999999999999999999999999999999999987632111000              111


Q ss_pred             cccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       146 ~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ...++..|+|||.+.+ ..++.++|+||||+++|++++|..||.+..+.+.+..+
T Consensus       175 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~  228 (305)
T cd05609         175 QVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV  228 (305)
T ss_pred             CCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            2345778999999876 45789999999999999999999999988777666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9.2e-35  Score=240.90  Aligned_cols=186  Identities=26%  Similarity=0.403  Sum_probs=150.5

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +++..+|+.||+|+++.... .....+.+.+|++++++++||||+++++++.++     ...+++|||++| +|.+.+..
T Consensus        21 A~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s   95 (932)
T PRK13184         21 AYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKS   95 (932)
T ss_pred             EEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHH
Confidence            46788999999999864322 233456788999999999999999999999877     567899999984 77776642


Q ss_pred             -----------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-------
Q psy16889         80 -----------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-------  141 (203)
Q Consensus        80 -----------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------  141 (203)
                                 ....+...+..++.|++.||++||++|++||||||+||+++.++.++++|||.+........       
T Consensus        96 ~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~  175 (932)
T PRK13184         96 VWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDV  175 (932)
T ss_pred             hhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceeccccccccccccc
Confidence                       12356678889999999999999999999999999999999999999999999875421100       


Q ss_pred             ----------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        142 ----------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       142 ----------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                                .......||+.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....
T Consensus       176 ~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        176 DERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             ccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence                      01112357999999999887 4579999999999999999999999977543

>KOG0986|consensus

Probab=100.00  E-value=3.2e-36  Score=226.86  Aligned_cols=184  Identities=25%  Similarity=0.368  Sum_probs=157.1

Q ss_pred             CCcCCCCCcEEEEEeccCccchhh-hhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLV-SSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +|.-+.||+.||+|.+........ .......|-.++++.+.++||.+-..|+..     ..+++|+..|+ |+|..++-
T Consensus       203 acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk-----d~LClVLtlMNGGDLkfHiy  277 (591)
T KOG0986|consen  203 ACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK-----DALCLVLTLMNGGDLKFHIY  277 (591)
T ss_pred             EEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC-----CceEEEEEeecCCceeEEee
Confidence            355678999999999844333222 334466788999999999999999999998     67899999998 58887776


Q ss_pred             CCC--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 SPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +.+  .|+++.+..++.+|+.+|++||+.+||+||+||+||++|+.|.++++|+|++..+..  ......+.||.+|+||
T Consensus       278 n~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~--g~~~~~rvGT~GYMAP  355 (591)
T KOG0986|consen  278 NHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE--GKPIRGRVGTVGYMAP  355 (591)
T ss_pred             ccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC--CCccccccCcccccCH
Confidence            654  699999999999999999999999999999999999999999999999999985443  4444556899999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.+.. |+.+.|+|||||++|+|+.|+.||....
T Consensus       356 Evl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  356 EVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             HHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhh
Confidence            9999855 9999999999999999999999997654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=214.13  Aligned_cols=193  Identities=44%  Similarity=0.726  Sum_probs=161.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +.+..+|+.|++|.+..........+.+..|++.+++++|+|++++++++.+.     ...++++|+++++|.+++... 
T Consensus        18 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~   92 (282)
T cd07829          18 ARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRP   92 (282)
T ss_pred             eeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhc
Confidence            45677899999999976543344456778899999999999999999999887     678899999999999988765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus        93 ~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~  171 (282)
T cd07829          93 GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHEVVTLWYRAPEILL  171 (282)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCccccCcCcCChHHhc
Confidence            579999999999999999999999999999999999999999999999999887443221 1222334467799999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|++++|++||.+....+.+..+
T Consensus       172 ~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  211 (282)
T cd07829         172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI  211 (282)
T ss_pred             CCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            7546889999999999999999999999888766555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=216.48  Aligned_cols=189  Identities=24%  Similarity=0.409  Sum_probs=154.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+++.+++|.+...  .....+.+..|++++++++|+|++++++++..+     ...+++|||+++ +|.+++.. 
T Consensus        24 ~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   96 (280)
T cd06611          24 AQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLEL   96 (280)
T ss_pred             EEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHh
Confidence            345678999999998542  333456788899999999999999999999877     567899999985 78777765 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+...... ........+++.|++||.+
T Consensus        97 ~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~y~~PE~~  175 (280)
T cd06611          97 ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQKRDTFIGTPYWMAPEVV  175 (280)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc-ccccceeecchhhcCHHHH
Confidence            457999999999999999999999999999999999999999999999999987643322 2222334568889999987


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ..    ...++.++|+||||+++|+|++|++||.+.+....+.
T Consensus       176 ~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~  218 (280)
T cd06611         176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL  218 (280)
T ss_pred             hhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH
Confidence            52    2346789999999999999999999998876655443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.9e-35  Score=242.10  Aligned_cols=190  Identities=27%  Similarity=0.453  Sum_probs=152.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |.+..+++.|++|.+............+..|+.++++++||||++++++|.+...   ..+|+||||+. ++|.+++.. 
T Consensus        32 Akdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~~lyIVMEY~~gGSL~~lL~k~  108 (1021)
T PTZ00266         32 VKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKC  108 (1021)
T ss_pred             EEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---CEEEEEEeCCCCCcHHHHHHHH
Confidence            4677889999999986554455556778899999999999999999998865432   35789999998 588877653 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEecC-----------------CCeEEEeecCc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSA-------RILHRDIKPGNLLVNS-----------------NCILKICDFGL  132 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~-------~i~H~di~~~nil~~~-----------------~~~~~l~d~~~  132 (203)
                         .+.+++..++.|+.||+.||+|||+.       +|+|+||||+||+++.                 .+.++|+|||+
T Consensus       109 ~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGl  188 (1021)
T PTZ00266        109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL  188 (1021)
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCc
Confidence               36799999999999999999999984       4999999999999964                 23489999999


Q ss_pred             cccCCCCCCCCcccccCCcccccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        133 ARVEEPDPNKAMTQEVVTQYYRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      +.......  ......+++.|+|||++.+. ..++.++|||||||++|+|++|+.||........
T Consensus       189 Ar~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        189 SKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             cccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence            87543221  22334678999999988642 4578999999999999999999999987654433

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.3e-34  Score=215.98  Aligned_cols=188  Identities=25%  Similarity=0.428  Sum_probs=152.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+|+.+++|.+...  .....+.+.+|+..++.++|+|++++++++..+     ...+++|||+++ +|...+.. 
T Consensus        31 ~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~  103 (292)
T cd06644          31 AKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLEL  103 (292)
T ss_pred             EEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhh
Confidence            356678999999998642  334456788899999999999999999998776     567899999985 56555543 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+...... ........++..|+|||.+
T Consensus       104 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~  182 (292)
T cd06644         104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQRRDSFIGTPYWMAPEVV  182 (292)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc-ccccceecCCccccCceee
Confidence            466999999999999999999999999999999999999999999999999988643222 1222334567889999998


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+    ...++.++|+||||+++|+|++|+.||...++....
T Consensus       183 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  224 (292)
T cd06644         183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL  224 (292)
T ss_pred             ccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH
Confidence            53    234678899999999999999999999876654443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-34  Score=215.46  Aligned_cols=192  Identities=32%  Similarity=0.594  Sum_probs=154.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+++.|++|.++....+... ....+|+..++++ +|+|++++++++.++..   ...++++||+++++.+.+.. 
T Consensus        18 ~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~   93 (282)
T cd07831          18 AQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLALVFELMDMNLYELIKGR   93 (282)
T ss_pred             EEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEEEEEecCCccHHHHHHhc
Confidence            356778999999998654333222 3345788888888 49999999999887632   34688999999988888775 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.+|++||+.+++|+||+|+||+++. +.++++|||.+.......  ......++..|+|||.+
T Consensus        94 ~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~  170 (282)
T cd07831          94 KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--PYTEYISTRWYRAPECL  170 (282)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC--CcCCCCCCcccCChhHh
Confidence            457999999999999999999999999999999999999999 999999999987543221  11223457889999987


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ...+.++.++|+||||+++|+|++|.+||.+.+..+.+..+
T Consensus       171 ~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~  211 (282)
T cd07831         171 LTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI  211 (282)
T ss_pred             hcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence            65455788999999999999999999999887766554443

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG1989|consensus

Probab=100.00  E-value=4.8e-35  Score=235.18  Aligned_cols=190  Identities=24%  Similarity=0.432  Sum_probs=150.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCC-cch-hHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPH-LDF-FQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~-~~~-~~~~~lv~e~~~-~~l~~~~   77 (203)
                      |.+...|..||+|++-..  +....+.+.+|+++|++| .|+|||.+++...... ... .-.+++.||||. |+|.+++
T Consensus        56 a~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~m  133 (738)
T KOG1989|consen   56 AQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFM  133 (738)
T ss_pred             EEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHH
Confidence            445666799999998432  556778899999999999 5999999999432221 211 134679999999 6999998


Q ss_pred             hC--CCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCc--------c
Q psy16889         78 VS--PQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM--------T  145 (203)
Q Consensus        78 ~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~--------~  145 (203)
                      ..  ...|+|.++++|+.++++|+.+||.+.  |+|||||-+|+|++.+|++||||||.++-.........        .
T Consensus       134 n~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI  213 (738)
T KOG1989|consen  134 NTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEI  213 (738)
T ss_pred             HHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHH
Confidence            74  355999999999999999999999988  99999999999999999999999999873332221110        1


Q ss_pred             cccCCcccccceeeec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        146 QEVVTQYYRAPEILMG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       146 ~~~~~~~~~aPe~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ..--|+.|.|||.+.-  +...+.++|||+|||+||-|+....||.+...
T Consensus       214 ~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  214 EKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             HhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            1123888999998752  35689999999999999999999999988643

>KOG0665|consensus

Probab=100.00  E-value=3.7e-34  Score=207.26  Aligned_cols=197  Identities=46%  Similarity=0.800  Sum_probs=171.7

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVS   79 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~   79 (203)
                      +|.|.-++++|++|.....+.......+..+|..++..++|+|+++++.+|...... .....|+|||++..+|...+. 
T Consensus        34 ~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~-  112 (369)
T KOG0665|consen   34 AAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL-  112 (369)
T ss_pred             ecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH-
Confidence            366788999999999977666666667788999999999999999999998765433 345689999999999998876 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       -.+.-+.+..++.|++.|++++|+.||+||||||+||++..+..+|+.|||++......  ..++....+-.|.|||++
T Consensus       113 -~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevi  189 (369)
T KOG0665|consen  113 -MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVI  189 (369)
T ss_pred             -HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cccCchhheeeccCchhe
Confidence             45778899999999999999999999999999999999999999999999999854332  566777778889999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .+.+ +....||||+||++.||++|...|++...-++..+|.+
T Consensus       190 l~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~  231 (369)
T KOG0665|consen  190 LGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIE  231 (369)
T ss_pred             eccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHH
Confidence            9976 89999999999999999999999999998888887765

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-34  Score=220.53  Aligned_cols=197  Identities=51%  Similarity=0.854  Sum_probs=156.8

Q ss_pred             cCCCC--CcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC
Q psy16889          3 TDPRD--GRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS   79 (203)
Q Consensus         3 ~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   79 (203)
                      .+..+  +..||+|.++...........+.+|+++++++ +|+||+++++........ ...+++++++++++|.+.+..
T Consensus        20 ~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~-~~~~~~~~e~~~~~L~~~l~~   98 (332)
T cd07857          20 RNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN-FNELYLYEELMEADLHQIIRS   98 (332)
T ss_pred             EeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc-CCcEEEEEecccCCHHHHHhc
Confidence            44555  88999999865433333455678899999999 699999999864332111 134678889999899999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aP  156 (203)
                      ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........   ......++..|+||
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aP  178 (332)
T cd07857          99 GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP  178 (332)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCc
Confidence            888999999999999999999999999999999999999999999999999998754322111   12233568889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |...+...++.++|+||+|+++|++++|++||.+.+..+.+.++
T Consensus       179 E~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~  222 (332)
T cd07857         179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQI  222 (332)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHH
Confidence            98876556789999999999999999999999887765555443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.6e-35  Score=218.50  Aligned_cols=183  Identities=25%  Similarity=0.373  Sum_probs=150.8

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.|++|.+..... .......+..|+.++++++|++++++++.+.+.     ...+++|||+. ++|.+.+..
T Consensus        19 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~   93 (285)
T cd05630          19 CQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYH   93 (285)
T ss_pred             EEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHH
Confidence            45778999999999854322 222334567899999999999999999998877     56789999997 578777643


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||.+......  .......++..|+|||
T Consensus        94 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~g~~~y~aPE  171 (285)
T cd05630          94 MGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPE  171 (285)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC--ccccCCCCCccccChH
Confidence              245999999999999999999999999999999999999999999999999988643221  1223346788999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+.+ ..++.++|+||+|+++|+|++|+.||....
T Consensus       172 ~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~  205 (285)
T cd05630         172 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK  205 (285)
T ss_pred             HHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence            9977 458999999999999999999999998653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-34  Score=220.55  Aligned_cols=193  Identities=51%  Similarity=0.886  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.||+|++.....+....+.+.+|++++++++|+||+++++++...... .....++++++++++|.+.+.. 
T Consensus        36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-  114 (345)
T cd07877          36 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-  114 (345)
T ss_pred             EEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-
Confidence            45678899999999865444444456778899999999999999999987644211 1124578888888888776654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..++.++.|++.|+++||+++++|+||+|+||+++.++.++++|||.+.....    ......++..|+|||.+.
T Consensus       115 ~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~  190 (345)
T cd07877         115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIML  190 (345)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc----cccccccCCCccCHHHHh
Confidence            4699999999999999999999999999999999999999999999999999874322    223335677899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +...++.++|+||||+++|++++|++||........+..
T Consensus       191 ~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  229 (345)
T cd07877         191 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  229 (345)
T ss_pred             CccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            655678899999999999999999999987766555443

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.8e-35  Score=219.64  Aligned_cols=188  Identities=29%  Similarity=0.495  Sum_probs=154.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+...  .....+.+.+|+..++.++|||++++++++..+     ...++++||+++ +|...+ ..
T Consensus        40 ~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~-~~  111 (297)
T cd06659          40 AREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIV-SQ  111 (297)
T ss_pred             EEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHH-hh
Confidence            456778999999998542  223345678899999999999999999998877     567899999985 666654 44


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+.
T Consensus       112 ~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  190 (297)
T cd06659         112 TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVIS  190 (297)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCccccCHHHHc
Confidence            668999999999999999999999999999999999999999999999999886433221 2223345688899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      + ..++.++|+||||+++|+|++|+.||....+.+.+..
T Consensus       191 ~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  228 (297)
T cd06659         191 R-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR  228 (297)
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            7 4578999999999999999999999987766555444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=214.10  Aligned_cols=193  Identities=26%  Similarity=0.443  Sum_probs=155.6

Q ss_pred             CcCCCCCcEEEEEeccCcc---chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVF---QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      +.+..+|+.|++|.+....   ........+.+|++.+++++|+||+++++++.+...   ..+++++||+. ++|.+.+
T Consensus        21 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~   97 (264)
T cd06653          21 CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---KKLSIFVEYMPGGSIKDQL   97 (264)
T ss_pred             EEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---CEEEEEEEeCCCCcHHHHH
Confidence            4567889999999874321   123345678889999999999999999998866532   34568899997 4888888


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCccccc
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~a  155 (203)
                      ...+.+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........  .......++..|.|
T Consensus        98 ~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (264)
T cd06653          98 KAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS  177 (264)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccC
Confidence            7777899999999999999999999999999999999999999999999999999875432111  11123356788999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ||.+.+ ..++.++|+||||+++|++++|+.||..........
T Consensus       178 PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  219 (264)
T cd06653         178 PEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF  219 (264)
T ss_pred             HhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence            999887 447899999999999999999999998765544443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-34  Score=218.39  Aligned_cols=199  Identities=40%  Similarity=0.676  Sum_probs=156.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc---hhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD---FFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +.+..+|+.+++|.+..............+|++.++.++|+||+++++++.+....   ....+++++||+.+++...+.
T Consensus        27 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~  106 (311)
T cd07866          27 ARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE  106 (311)
T ss_pred             EEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHh
Confidence            45678899999999854333333334567899999999999999999987654321   013457899999988877766


Q ss_pred             C-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC----------Ccccc
Q psy16889         79 S-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK----------AMTQE  147 (203)
Q Consensus        79 ~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~  147 (203)
                      . ...+++..+..++.|++++|++||++|++|+||+|+||+++.++.++++|||++.........          .....
T Consensus       107 ~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (311)
T cd07866         107 NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL  186 (311)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccc
Confidence            4 457999999999999999999999999999999999999999999999999998744322211          11222


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+++.|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+....+
T Consensus       187 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         187 VVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             eeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            45677999998876556789999999999999999999999887766655544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-34  Score=217.65  Aligned_cols=186  Identities=25%  Similarity=0.494  Sum_probs=153.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +++..+|+.|++|.+...  .....+.+.+|+..++.++|+|++++++++...     ..+++++||+.+ +|...+.. 
T Consensus        38 ~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-  109 (296)
T cd06655          38 AIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-  109 (296)
T ss_pred             EEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-
Confidence            356789999999998543  223346678899999999999999999998876     567899999985 67666544 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.++..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.
T Consensus       110 ~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~  188 (296)
T cd06655         110 TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVT  188 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCCcCCCccccCcchhc
Confidence            5689999999999999999999999999999999999999999999999998864332221 122335678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      + ..++.++|+||||+++|++++|+.||...++...+
T Consensus       189 ~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~  224 (296)
T cd06655         189 R-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL  224 (296)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            6 45789999999999999999999999887765444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-34  Score=212.33  Aligned_cols=185  Identities=22%  Similarity=0.376  Sum_probs=149.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~   84 (203)
                      +++.+++|.+....   ...+.+.+|++++++++|+||+++++++...     ...++++||++ ++|.+++.. .+.++
T Consensus        27 ~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~   98 (256)
T cd05059          27 GKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLG   98 (256)
T ss_pred             CCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCC
Confidence            46679999985322   2334677899999999999999999998777     56789999997 588888764 45789


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+ ..
T Consensus        99 ~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~  177 (256)
T cd05059          99 TEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY-SR  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhcc-CC
Confidence            99999999999999999999999999999999999999999999999887543222222222223457999999887 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++|++++ |+.||...++.+....+
T Consensus       178 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05059         178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV  214 (256)
T ss_pred             CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence            7899999999999999998 89999887766655544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.5e-34  Score=213.23  Aligned_cols=193  Identities=31%  Similarity=0.478  Sum_probs=159.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.+++|.+.... ......+.+.+|++.+++++|+|++++++.+...     ...++++|++. ++|.+.+..
T Consensus        12 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   86 (265)
T cd05579          12 AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLEN   86 (265)
T ss_pred             EEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHH
Confidence            4566789999999985432 2334566788999999999999999999998776     56789999997 488888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-------CCcccccCCcc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-------KAMTQEVVTQY  152 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~  152 (203)
                      .+.+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||++........       .......++..
T Consensus        87 ~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (265)
T cd05579          87 VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD  166 (265)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCcc
Confidence            77899999999999999999999999999999999999999999999999998874332211       12223345778


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |++||...+.. .+.++|+||||+++|++++|..||......+....+
T Consensus       167 ~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~  213 (265)
T cd05579         167 YIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI  213 (265)
T ss_pred             ccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            99999987744 788999999999999999999999887766655444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.2e-34  Score=215.31  Aligned_cols=187  Identities=26%  Similarity=0.416  Sum_probs=151.6

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .++..+++|.+...  .......+.+|++.+++++|+||+++++++...     ...+++|||++ ++|.+++...    
T Consensus        33 ~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  105 (291)
T cd05094          33 KDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDA  105 (291)
T ss_pred             CcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCccc
Confidence            45667889988542  233345688999999999999999999999876     56789999997 5888887543    


Q ss_pred             ------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccc
Q psy16889         81 ------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQE  147 (203)
Q Consensus        81 ------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  147 (203)
                                  +.+++..++.++.|++.++++||+++++|+||+|+||+++.++.++++|||.+........ ......
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~  185 (291)
T cd05094         106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT  185 (291)
T ss_pred             ccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCC
Confidence                        3489999999999999999999999999999999999999999999999999874332221 112233


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+.++.+
T Consensus       186 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         186 MLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            45677999998877 457899999999999999998 99999887776655544

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-34  Score=211.33  Aligned_cols=186  Identities=22%  Similarity=0.372  Sum_probs=149.3

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      .++..|++|++... ......+.+.+|+.++++++|+||+++++++..+      ..++++||++ ++|.+++.. ...+
T Consensus        20 ~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~   92 (257)
T cd05115          20 KKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE------ALMLVMEMASGGPLNKFLSGKKDEI   92 (257)
T ss_pred             CCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC------CeEEEEEeCCCCCHHHHHHhCCCCC
Confidence            45667999998653 2334456788999999999999999999987543      4578999997 588887764 4679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeec
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~  161 (203)
                      ++..+..++.|++.++++||++|++|+||+|+||+++.++.++++|||.+.........  ......++..|+|||.+.+
T Consensus        93 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  172 (257)
T cd05115          93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF  172 (257)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc
Confidence            99999999999999999999999999999999999999999999999998743322211  1122223567999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                       +.++.++|+||||+++|++++ |+.||.+....+....
T Consensus       173 -~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~  210 (257)
T cd05115         173 -RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF  210 (257)
T ss_pred             -CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH
Confidence             457899999999999999996 9999988776655543

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.2e-34  Score=215.01  Aligned_cols=191  Identities=26%  Similarity=0.436  Sum_probs=153.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..++..+++|.+...  .....+.+.+|+++++.++|+|++++++++...     ...++++||+++ +|...+.. 
T Consensus        24 ~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~   96 (282)
T cd06643          24 AQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLEL   96 (282)
T ss_pred             EEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhc
Confidence            356678889999998542  233456788899999999999999999998876     467899999985 66665543 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+...... ........++..|+|||++
T Consensus        97 ~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~  175 (282)
T cd06643          97 ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVV  175 (282)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-ccccccccccccccCHhhc
Confidence            467999999999999999999999999999999999999999999999999998643322 1222333568889999987


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ..    ...++.++|+||+|+++|+|++|++||...++.+....+
T Consensus       176 ~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~  220 (282)
T cd06643         176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI  220 (282)
T ss_pred             cccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence            42    244678999999999999999999999887766554443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-34  Score=213.99  Aligned_cols=190  Identities=22%  Similarity=0.393  Sum_probs=152.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+++.+++|.+... ........+.+|+++++.++||||+++++++...     ...+++|||+. ++|.+++...  
T Consensus        30 ~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  103 (283)
T cd05090          30 GMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSP  103 (283)
T ss_pred             CCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCC
Confidence            4457789999999643 2233446788899999999999999999998877     56789999998 5888876421  


Q ss_pred             ---------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCc
Q psy16889         81 ---------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAM  144 (203)
Q Consensus        81 ---------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  144 (203)
                                     ..+++..+..++.|++.++++||+++++|+||+|+||+++.++.++++|||++....... ....
T Consensus       104 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  183 (283)
T cd05090         104 HSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQ  183 (283)
T ss_pred             CCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecc
Confidence                           247889999999999999999999999999999999999999999999999987543221 1112


Q ss_pred             ccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ....++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.++.+.+..+
T Consensus       184 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         184 PKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             cCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            22234567999999876 447899999999999999998 99999887766555443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.7e-34  Score=211.44  Aligned_cols=193  Identities=20%  Similarity=0.331  Sum_probs=152.2

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhH-HhHHHHHhC-----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQ-SDLHKIIVS-----   79 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~-----   79 (203)
                      ++..|++|.++....+....+.+.+|++.++.++|+||+++++++..... ......++++||+. ++|...+..     
T Consensus        26 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~  105 (273)
T cd05035          26 SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG  105 (273)
T ss_pred             CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccC
Confidence            55889999997654455556778899999999999999999998765432 11134788999988 577766532     


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccce
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe  157 (203)
                       ...+++..+..++.|++.||++||+++++|+||||+||+++.++.++++|||.+......... .......+..|.+||
T Consensus       106 ~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  185 (273)
T cd05035         106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE  185 (273)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHh
Confidence             246899999999999999999999999999999999999999999999999998744322111 111223356799999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+ ..++.++|+||||+++|++++ |..||.+..+.+.++.+
T Consensus       186 ~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05035         186 SLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL  228 (273)
T ss_pred             hccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            8876 558899999999999999998 89999888776665544

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-34  Score=211.98  Aligned_cols=187  Identities=26%  Similarity=0.437  Sum_probs=152.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~   82 (203)
                      .++..|++|.+...   ....+.+.+|+.++++++|+||+++++++.+.     ...++++||+. ++|.+++..  ...
T Consensus        28 ~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~   99 (261)
T cd05072          28 NNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGK   99 (261)
T ss_pred             cCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCC
Confidence            35667999987542   22356788999999999999999999998776     56789999997 588888754  356


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+ 
T Consensus       100 ~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  178 (261)
T cd05072         100 VLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-  178 (261)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-
Confidence            8999999999999999999999999999999999999999999999999997544322222223334567999999876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..++.++|+||||+++|+|++ |..||......+....+.
T Consensus       179 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05072         179 GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ  218 (261)
T ss_pred             CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            457889999999999999998 999998877766665543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.4e-34  Score=213.90  Aligned_cols=191  Identities=28%  Similarity=0.422  Sum_probs=157.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.+..+++.+++|.++... .....+.+..|+.+++.++|+|++++.+++.++     ..+++++||++ ++|.+.+.. 
T Consensus        19 ~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   92 (255)
T cd08219          19 VQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQ   92 (255)
T ss_pred             EEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhc
Confidence            4567789999999985432 234556788899999999999999999999877     56789999997 588877653 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...++++.+..++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+...... ........+++.|+|||+
T Consensus        93 ~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~aPE~  171 (255)
T cd08219          93 RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYACTYVGTPYYVPPEI  171 (255)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-ccccccccCCccccCHHH
Confidence             356899999999999999999999999999999999999999999999999998744322 222233456788999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++|..||...+.......+
T Consensus       172 ~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~  212 (255)
T cd08219         172 WEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV  212 (255)
T ss_pred             Hcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH
Confidence            877 44789999999999999999999999887766554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=215.10  Aligned_cols=188  Identities=23%  Similarity=0.350  Sum_probs=156.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+.... .......+.+|+++++.++|+|++++.+++.++     ...++++|++.+ +|.+++...
T Consensus        20 ~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~   93 (274)
T cd06609          20 AIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG   93 (274)
T ss_pred             EEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc
Confidence            4567789999999986432 234456678899999999999999999998877     567899999985 888877654


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       ++++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus        94 -~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  171 (274)
T cd06609          94 -KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPFWMAPEVIK  171 (274)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCccccChhhhc
Confidence             89999999999999999999999999999999999999999999999999987544332 2223345677899999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      +.. ++.++|+||||+++|++++|+.||...++.....
T Consensus       172 ~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~  208 (274)
T cd06609         172 QSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF  208 (274)
T ss_pred             cCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence            744 8999999999999999999999998766544433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.6e-34  Score=216.63  Aligned_cols=180  Identities=26%  Similarity=0.387  Sum_probs=145.6

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCChHH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~   87 (203)
                      .|++|.++.. ......+.+.+|+.+++.++||||+++++++...      ..+++++|+. |+|.+++... ..+++..
T Consensus        38 ~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~  110 (316)
T cd05108          38 PVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQY  110 (316)
T ss_pred             eEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhccccCCHHH
Confidence            4899998643 2334456788899999999999999999988765      2457888887 6888888764 5689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeecccCCC
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGARHYS  166 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~  166 (203)
                      +..++.|++.||+|||+++++||||||+||+++.++.++|+|||.+......... .......+..|++||.+.+ ..++
T Consensus       111 ~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~  189 (316)
T cd05108         111 LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYT  189 (316)
T ss_pred             HHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCC
Confidence            9999999999999999999999999999999999999999999999754332211 1122233567999999876 4589


Q ss_pred             cchhHHHHHHHHHHHHh-CCcccCCCChHHHh
Q psy16889        167 AAVDVWSVGCIFAELLG-RRILFQAQSPVQQL  197 (203)
Q Consensus       167 ~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  197 (203)
                      .++|+||||+++|++++ |+.||.+....+..
T Consensus       190 ~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~  221 (316)
T cd05108         190 HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS  221 (316)
T ss_pred             chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999997 99999887665543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-34  Score=220.75  Aligned_cols=194  Identities=49%  Similarity=0.885  Sum_probs=158.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+++.|++|.+.....+......+.+|+.++++++|+|++++.+++..... ......++++|+++++|.+.+.. 
T Consensus        34 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-  112 (343)
T cd07851          34 AFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-  112 (343)
T ss_pred             EEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-
Confidence            4567789999999986543344455667789999999999999999998866532 11234789999998888887765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+......    .....++..|.|||.+.
T Consensus       113 ~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~  188 (343)
T cd07851         113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIML  188 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc----ccCCcccccccCHHHHh
Confidence            56999999999999999999999999999999999999999999999999998754322    22335577899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +...++.++|+||||+++|++++|+.||.+....+.+..+
T Consensus       189 ~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i  228 (343)
T cd07851         189 NWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI  228 (343)
T ss_pred             CCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            6445788999999999999999999999888776665554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.4e-34  Score=213.27  Aligned_cols=188  Identities=24%  Similarity=0.367  Sum_probs=149.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .+++.|++|.+... ........+.+|+.+++.++|+||+++++++.+.     ...++++||++ ++|.+++...    
T Consensus        34 ~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~  107 (277)
T cd05062          34 EPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEM  107 (277)
T ss_pred             CceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccc
Confidence            45678999998543 2223445678899999999999999999998777     56789999988 5888777542    


Q ss_pred             ------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccc
Q psy16889         81 ------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYY  153 (203)
Q Consensus        81 ------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  153 (203)
                            ..++...+..++.|++.++++||+.+++|+||||+||+++.++.++++|||.+........ .......++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (277)
T cd05062         108 ENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (277)
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhh
Confidence                  2357788999999999999999999999999999999999999999999999864332211 111222446679


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +|||.+.+ ..++.++|+||||+++|++++ |..||.+....+.+..+
T Consensus       188 ~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         188 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             cChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999876 458999999999999999998 79999888776666544

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-34  Score=217.95  Aligned_cols=193  Identities=24%  Similarity=0.390  Sum_probs=156.4

Q ss_pred             CcCCCCCcEEEEEeccCccch-hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS-LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.|++|.+...... ......+..|++.++.++|+||+++++.+.+.     ...++++||+.+ +|.+++..
T Consensus        20 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   94 (316)
T cd05574          20 VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQR   94 (316)
T ss_pred             EEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHh
Confidence            456678999999999653222 23456788899999999999999999998876     567899999974 88887764


Q ss_pred             C--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---------------
Q psy16889         80 P--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---------------  142 (203)
Q Consensus        80 ~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------------  142 (203)
                      .  ..+++..+..++.|++.+|++||+.|++|+||||+||+++.++.++++|||.+.........               
T Consensus        95 ~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (316)
T cd05574          95 QPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN  174 (316)
T ss_pred             CCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccccccccccccccccc
Confidence            3  56999999999999999999999999999999999999999999999999987643221110               


Q ss_pred             -------------CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        143 -------------AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 -------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                                   ......|+..|+|||...+. .++.++|+||||+++|++++|+.||.+.+....+..+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~  244 (316)
T cd05574         175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI  244 (316)
T ss_pred             ccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHH
Confidence                         01122467789999998874 4789999999999999999999999887766555443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.6e-34  Score=213.02  Aligned_cols=192  Identities=24%  Similarity=0.412  Sum_probs=154.3

Q ss_pred             CcCCCCCcEEEEEeccCccc---hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ---SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      +.+..+|+.|++|.+.....   .......+.+|+.++++++||||+++++++.+...   ...++++||+. ++|.+.+
T Consensus        21 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~l~~e~~~~~~L~~~l   97 (266)
T cd06651          21 CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---KTLTIFMEYMPGGSVKDQL   97 (266)
T ss_pred             EEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---CEEEEEEeCCCCCcHHHHH
Confidence            45678899999998854322   22334568889999999999999999998865432   34578999997 4888888


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC--CCCcccccCCccccc
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP--NKAMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~a  155 (203)
                      ...+.+++..++.++.|++.++++||+++++|+||+|+||+++.++.++++|||.+.......  ........++..|+|
T Consensus        98 ~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a  177 (266)
T cd06651          98 KAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS  177 (266)
T ss_pred             HHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccC
Confidence            877789999999999999999999999999999999999999999999999999886432211  111122346778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ||.+.+ ..++.++|+||+|+++|++++|+.||.........
T Consensus       178 PE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~  218 (266)
T cd06651         178 PEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI  218 (266)
T ss_pred             HHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH
Confidence            999877 55889999999999999999999999876544433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0194|consensus

Probab=100.00  E-value=4e-35  Score=227.40  Aligned_cols=183  Identities=25%  Similarity=0.358  Sum_probs=159.6

Q ss_pred             EEEEeccC-ccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-CCChHH
Q psy16889         11 VALKKLPN-VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-HLTSDH   87 (203)
Q Consensus        11 ~~vK~~~~-~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~   87 (203)
                      ||+|.... ..........+++|++++++++||||++++++..+.     .-+++|||+|. |+|.+++...+ .++..+
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~e  263 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLE  263 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHH
Confidence            89999975 335777888999999999999999999999999988     67899999998 59999999876 599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCc
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA  167 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~  167 (203)
                      ...++.+.+.+++|||+++++||||-..|++++.++.+|++|||+++... ..........-+..|+|||.+... .+++
T Consensus       264 k~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-~~~~~~~~~klPirWLAPEtl~~~-~~s~  341 (474)
T KOG0194|consen  264 KLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-QYVMKKFLKKLPIRWLAPETLNTG-IFSF  341 (474)
T ss_pred             HHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc-ceeeccccccCcceecChhhhccC-cccc
Confidence            99999999999999999999999999999999999999999999987443 111111122346789999999884 7999


Q ss_pred             chhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        168 AVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       168 ~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++||||||+++||+++ |..||.+....+..+.|
T Consensus       342 kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI  375 (474)
T KOG0194|consen  342 KTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI  375 (474)
T ss_pred             ccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence            9999999999999998 78899999999988887

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-35  Score=216.21  Aligned_cols=191  Identities=25%  Similarity=0.418  Sum_probs=153.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +...+..|+||.++.. ......+.+.+|++.+++++||||+++++++...     ...++|+||+. |+|.+++...  
T Consensus        24 ~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~   97 (259)
T PF07714_consen   24 DNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNK   97 (259)
T ss_dssp             TTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCT
T ss_pred             cCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-----cccccccccccccccccccccccc
Confidence            4567788999999553 3344578899999999999999999999999865     34678999998 6899988865  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..+..++.|++.||.|||+++++|++|+++||+++.++.+||+|||.+...... .............|.|||.+
T Consensus        98 ~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~  177 (259)
T PF07714_consen   98 EPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVL  177 (259)
T ss_dssp             TTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            77999999999999999999999999999999999999999999999999998754221 11222233456779999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+.. ++.++||||||+++||+++ |+.||......+....+.
T Consensus       178 ~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~  219 (259)
T PF07714_consen  178 KDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK  219 (259)
T ss_dssp             HHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH
T ss_pred             cccc-cccccccccccccccccccccccccccccccccccccc
Confidence            8744 7999999999999999999 789999988877766653

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-34  Score=211.40  Aligned_cols=185  Identities=21%  Similarity=0.398  Sum_probs=149.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~   84 (203)
                      .+..+++|.+....   ...+.+.+|+..+++++||||+++++++...     ...+++|||+. ++|.+++.. ...++
T Consensus        27 ~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~   98 (256)
T cd05113          27 GQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQ   98 (256)
T ss_pred             CCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCC
Confidence            34569999885432   2235688999999999999999999998776     45789999997 578888765 34689


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..++.++.|++.|+++||+.+++|+||+|+||+++.++.++++|||.+...............++..|.+||...+ ..
T Consensus        99 ~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~  177 (256)
T cd05113          99 PSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY-SK  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc-Cc
Confidence            99999999999999999999999999999999999999999999999887443322222222234567999999876 44


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++|+|++ |..||......+....+
T Consensus       178 ~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05113         178 FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV  214 (256)
T ss_pred             ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            7899999999999999998 99999887766555444

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.7e-33  Score=213.52  Aligned_cols=184  Identities=29%  Similarity=0.444  Sum_probs=151.9

Q ss_pred             cCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          3 TDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      .+..+|+.|++|.+.... ........+.+|+++++.++|||++++.+++.++     ...++++||+.+++.+.+.. .
T Consensus        35 ~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~  109 (307)
T cd06607          35 RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHK  109 (307)
T ss_pred             EEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHcc
Confidence            456789999999985432 2333445688999999999999999999999877     45779999999888777653 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++++|||.+......     ....++..|+|||++.
T Consensus       110 ~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~  184 (307)
T cd06607         110 KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVGTPYWMAPEVIL  184 (307)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccCCccccCceeee
Confidence            67999999999999999999999999999999999999999999999999988643221     2235677899999885


Q ss_pred             c--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        161 G--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       161 ~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      +  ...++.++|+||||+++|++++|+.||.+......
T Consensus       185 ~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~  222 (307)
T cd06607         185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA  222 (307)
T ss_pred             ccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence            3  24578899999999999999999999987655443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-34  Score=214.38  Aligned_cols=186  Identities=25%  Similarity=0.347  Sum_probs=153.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.++... .....+.+.+|++++++++|+||+++++++..+     ...++|+||+++ +|.+.+.. 
T Consensus        23 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-   95 (277)
T cd06642          23 GIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-   95 (277)
T ss_pred             EEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-
Confidence            3467789999999986432 223456788999999999999999999999877     567899999985 77776644 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus        96 ~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  174 (277)
T cd06642          96 GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIK  174 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhcccCcccccCHHHhC
Confidence            578999999999999999999999999999999999999999999999999987543221 1222335677899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      + ..++.++|+||||+++|++++|+.||....+...
T Consensus       175 ~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~  209 (277)
T cd06642         175 Q-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV  209 (277)
T ss_pred             c-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH
Confidence            7 4578999999999999999999999976554443

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-34  Score=211.94  Aligned_cols=190  Identities=23%  Similarity=0.360  Sum_probs=149.4

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCC-cchhHHHHHHHhhhH-HhHHHHHh------CCC
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITELLQ-SDLHKIIV------SPQ   81 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~~~~~lv~e~~~-~~l~~~~~------~~~   81 (203)
                      .+++|.++....+....+.+.+|++.++.++|+||+++++++.... .......++++||+. ++|.+++.      ...
T Consensus        28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  107 (272)
T cd05075          28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ  107 (272)
T ss_pred             eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence            6899998765445566778889999999999999999998764322 111135678899997 57877653      224


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~  160 (203)
                      .+++..+..++.|++.||+|||+++++|+||||+||+++.++.++++|||.+........ .......+++.|++||...
T Consensus       108 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  187 (272)
T cd05075         108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLA  187 (272)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHcc
Confidence            589999999999999999999999999999999999999999999999999875432211 1112223466799999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|++++ |+.||.+....+....+
T Consensus       188 ~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  227 (272)
T cd05075         188 D-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL  227 (272)
T ss_pred             C-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            7 458999999999999999998 89999887766655544

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.5e-34  Score=216.82  Aligned_cols=184  Identities=27%  Similarity=0.435  Sum_probs=153.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|..+++|.+.... .......+.+|++++++++||||+++++++.++     ..+++++||++ ++|.+++...
T Consensus        20 ~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~   93 (308)
T cd06615          20 VLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKA   93 (308)
T ss_pred             EEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhc
Confidence            3566788999999986432 233445688899999999999999999999887     56789999998 4899998877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++++|||.+......   ......++..|+|||..
T Consensus        94 ~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~  170 (308)
T cd06615          94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERL  170 (308)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---ccccCCCCcCccChhHh
Confidence            889999999999999999999997 58999999999999999999999999988643221   12334567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      .+ ..++.++|+||||+++|++++|+.||...+..+
T Consensus       171 ~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~  205 (308)
T cd06615         171 QG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE  205 (308)
T ss_pred             cC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhh
Confidence            76 457899999999999999999999997655433

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-34  Score=218.56  Aligned_cols=184  Identities=29%  Similarity=0.485  Sum_probs=145.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-   80 (203)
                      +..+++.|++|+++... .......+.+|+++++++ +|+||+++++++...+    ..+++++||+.+ +|.+.+... 
T Consensus        33 ~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~  107 (337)
T cd05054          33 KSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKR  107 (337)
T ss_pred             cccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhcc
Confidence            34567899999986542 223445677899999999 8999999999876553    356788999984 777665421 


Q ss_pred             ------------------------------------------------------------CCCChHHHHHHHHHHHHHHH
Q psy16889         81 ------------------------------------------------------------QHLTSDHIKVFLYQILRGLK  100 (203)
Q Consensus        81 ------------------------------------------------------------~~~~~~~~~~~~~qi~~~l~  100 (203)
                                                                                  .++++..+..++.|++.+|+
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~  187 (337)
T cd05054         108 ECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGME  187 (337)
T ss_pred             ccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHH
Confidence                                                                        26889999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeeecccCCCcchhHHHHHHHHH
Q psy16889        101 YLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA  179 (203)
Q Consensus       101 ~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~  179 (203)
                      |||+++++||||||+||+++.++.++|+|||++........ .......++..|+|||++.+ ..++.++|+|||||++|
T Consensus       188 ~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~  266 (337)
T cd05054         188 FLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLW  266 (337)
T ss_pred             HHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC-CCCCccccHHHHHHHHH
Confidence            99999999999999999999999999999999975432221 11222344567999999887 45899999999999999


Q ss_pred             HHHh-CCcccCCCCh
Q psy16889        180 ELLG-RRILFQAQSP  193 (203)
Q Consensus       180 ~ll~-g~~pf~~~~~  193 (203)
                      ++++ |..||.+...
T Consensus       267 el~t~g~~p~~~~~~  281 (337)
T cd05054         267 EIFSLGASPYPGVQI  281 (337)
T ss_pred             HHHHcCCCCCCCCCc
Confidence            9997 9999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-34  Score=217.17  Aligned_cols=185  Identities=25%  Similarity=0.476  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +++..+|+.+++|.+....  ....+.+.+|+.+++.++|+|++++++.+.++     ...++|+||+.+ +|.+++.. 
T Consensus        39 ~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-  110 (296)
T cd06654          39 AMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-  110 (296)
T ss_pred             EEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-
Confidence            3567889999999985432  22346688999999999999999999998876     567899999984 78877654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....... .......+++.|+|||.+.
T Consensus       111 ~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  189 (296)
T cd06654         111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVT  189 (296)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc-cccCcccCCccccCHHHHc
Confidence            568999999999999999999999999999999999999999999999999886433221 1122335678899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      + ..++.++|+||||+++|++++|+.||....+...
T Consensus       190 ~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~  224 (296)
T cd06654         190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA  224 (296)
T ss_pred             C-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence            6 4578999999999999999999999987765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.8e-34  Score=218.75  Aligned_cols=192  Identities=47%  Similarity=0.825  Sum_probs=153.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +++..+|+.|++|.+............+.+|+++++.++|+||+++++++...... ....+++++||+..++.....  
T Consensus        34 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--  111 (342)
T cd07879          34 AIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--  111 (342)
T ss_pred             EEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc--
Confidence            45678899999999865433333445678899999999999999999988654321 112357899998877766542  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++++.+..++.|++.|+++||+.+++||||+|+||+++.++.++++|||.+.....    ......++..|+|||.+.
T Consensus       112 ~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~  187 (342)
T cd07879         112 HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL  187 (342)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----CCCCceeeecccChhhhc
Confidence            4689999999999999999999999999999999999999999999999999864322    122335577899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+....+..
T Consensus       188 ~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~  226 (342)
T cd07879         188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  226 (342)
T ss_pred             CccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            645578899999999999999999999998775554443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.1e-34  Score=215.49  Aligned_cols=184  Identities=26%  Similarity=0.383  Sum_probs=151.8

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.|++|.+..... .......+..|++++++++|||++++++++...     ...++++||++ ++|.+++..
T Consensus        12 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   86 (277)
T cd05577          12 CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYN   86 (277)
T ss_pred             EEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHH
Confidence            45678899999999854322 222344567899999999999999999998776     56789999998 588888765


Q ss_pred             CC--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .+  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+.....  ........++..|.+||
T Consensus        87 ~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~y~~PE  164 (277)
T cd05577          87 VGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAGTPGYMAPE  164 (277)
T ss_pred             cCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccCCCCcCCHH
Confidence            44  799999999999999999999999999999999999999999999999998864332  22222335577899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ...+.. ++.++|+||||+++|++++|+.||.....
T Consensus       165 ~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~  199 (277)
T cd05577         165 VLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKE  199 (277)
T ss_pred             HhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence            987744 88999999999999999999999977543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-34  Score=209.89  Aligned_cols=186  Identities=22%  Similarity=0.349  Sum_probs=151.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCCh
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLTS   85 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~   85 (203)
                      ++..+++|.+...... ...+.+.+|+++++.++|+|++++++++..+      ..++++||+. ++|.+++...+.+++
T Consensus        22 ~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~   94 (257)
T cd05060          22 KEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKGE------PLMLVMELAPLGPLLKYLKKRREIPV   94 (257)
T ss_pred             CcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC------ceEEEEEeCCCCcHHHHHHhCCCCCH
Confidence            3478999999654332 3456788899999999999999999987643      4579999987 589999887778999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC--cccccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+..........  .....++..|.|||.+.+ .
T Consensus        95 ~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  173 (257)
T cd05060          95 SDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-G  173 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-C
Confidence            9999999999999999999999999999999999999999999999987443322111  111122457999998876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|++++ |.+||...+..+....+
T Consensus       174 ~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~  211 (257)
T cd05060         174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML  211 (257)
T ss_pred             CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            58899999999999999998 99999887776665544

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-33  Score=208.02  Aligned_cols=187  Identities=26%  Similarity=0.416  Sum_probs=150.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      .++..+++|.+.... .......+.+|++.++.++||||+++++++...     ...+++|||++ ++|.+++.. ...+
T Consensus        17 ~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   90 (250)
T cd05085          17 KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDEL   90 (250)
T ss_pred             cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCC
Confidence            467889999986542 223344678899999999999999999998877     56789999997 588887764 3568


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.++.++|++|++|+||+|+||+++.++.++++|||.+...............++..|+|||++.+ .
T Consensus        91 ~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  169 (250)
T cd05085          91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-G  169 (250)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-C
Confidence            999999999999999999999999999999999999999999999999986433222111122233567999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      .++.++|+||||+++|++++ |..||.+.........
T Consensus       170 ~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~  206 (250)
T cd05085         170 RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ  206 (250)
T ss_pred             CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            57889999999999999998 9999988766555443

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.5e-34  Score=212.55  Aligned_cols=185  Identities=27%  Similarity=0.461  Sum_probs=152.0

Q ss_pred             CcCCCCCcEEEEEeccCccc----hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ----SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   76 (203)
                      +.+..+|+.+++|.++....    .......+.+|++.+++++|+|++++++++.+.     ...++++||+.+ +|.+.
T Consensus        19 ~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~   93 (268)
T cd06630          19 ARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----SHFNLFVEWMAGGSVSHL   93 (268)
T ss_pred             EEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----CeEEEEEeccCCCcHHHH
Confidence            35678999999999854321    122346788999999999999999999999887     567899999985 88888


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCC---CcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNK---AMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~  152 (203)
                      +...+++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++|||.+.........   ......++..
T Consensus        94 l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  173 (268)
T cd06630          94 LSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA  173 (268)
T ss_pred             HHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccc
Confidence            87778899999999999999999999999999999999999998765 6999999998754332111   1122356778


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |.|||.+.+ ..++.++|+||||++++++++|+.||....
T Consensus       174 ~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~  212 (268)
T cd06630         174 FMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEK  212 (268)
T ss_pred             eeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            999999876 457899999999999999999999997544

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.9e-34  Score=210.28  Aligned_cols=193  Identities=28%  Similarity=0.452  Sum_probs=158.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |.+..+|+.|++|.++.........+.+..|++.++.++|+|++++++++.....   ...++++||++ ++|.+++.. 
T Consensus        19 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~e~~~~~~L~~~l~~~   95 (265)
T cd08217          19 VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYIVMEYCEGGDLAQLIQKC   95 (265)
T ss_pred             eeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEEEehhccCCCHHHHHHHH
Confidence            4677899999999987654555666778899999999999999999997765432   35679999997 477777653 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLH-----SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh-----~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                         ..+++++.++.++.|++.+|.+||     +.+++|+||+|+||+++.++.++++|||.+........ ......+++
T Consensus        96 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~  174 (265)
T cd08217          96 KKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTP  174 (265)
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc-cccccccCC
Confidence               467999999999999999999999     89999999999999999999999999999875433221 123345688


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      .|+|||.+.+ ..++.++|+||||++++++++|+.||......+..+.
T Consensus       175 ~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  221 (265)
T cd08217         175 YYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK  221 (265)
T ss_pred             CccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH
Confidence            8999999887 4478899999999999999999999988765544443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.5e-34  Score=216.05  Aligned_cols=187  Identities=21%  Similarity=0.313  Sum_probs=152.7

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--   79 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--   79 (203)
                      .+..+|+.||+|+++....+......+.+|++.++.++|+||+++++++.++     ...++++||++ +++.+++..  
T Consensus        20 ~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~   94 (314)
T cd08216          20 KHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHF   94 (314)
T ss_pred             EecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhc
Confidence            4566899999999976434555667899999999999999999999999877     56789999998 577777764  


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------CCcccccCCccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------KAMTQEVVTQYY  153 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~  153 (203)
                      ...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++||+.+........      .......++..|
T Consensus        95 ~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  174 (314)
T cd08216          95 PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW  174 (314)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccc
Confidence            34689999999999999999999999999999999999999999999999998753321111      111222446679


Q ss_pred             ccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        154 RAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       154 ~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      +|||.+... ..++.++|+||+|+++|+|++|+.||......
T Consensus       175 ~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~  216 (314)
T cd08216         175 LSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT  216 (314)
T ss_pred             cCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998753 34788999999999999999999999876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.5e-34  Score=212.35  Aligned_cols=188  Identities=22%  Similarity=0.304  Sum_probs=146.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ---   81 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---   81 (203)
                      .....+++|.+... ........+.+|++.++.++|+||+++++.+.+.     ...+++|||+. ++|.+++....   
T Consensus        20 ~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~   93 (269)
T cd05042          20 MSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMV   93 (269)
T ss_pred             CCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccc
Confidence            34567888987543 2233345678899999999999999999998877     56789999998 58888876432   


Q ss_pred             --CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccccccee
Q psy16889         82 --HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        82 --~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~  158 (203)
                        ..++..+..++.|++.|++|||+++++||||||+||+++.++.++++|||.+........ .......++..|+|||+
T Consensus        94 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05042          94 AQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             cccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHH
Confidence              256788899999999999999999999999999999999999999999999864322111 11122344667999998


Q ss_pred             eec------ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        159 LMG------ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       159 ~~~------~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      ...      ...++.++|+||||+++|+|++ |+.||....+.+.+..
T Consensus       174 ~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  221 (269)
T cd05042         174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ  221 (269)
T ss_pred             HhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            643      2346789999999999999998 7899988776665544

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.3e-34  Score=210.50  Aligned_cols=189  Identities=27%  Similarity=0.454  Sum_probs=156.3

Q ss_pred             CcCCCCCcEEEEEeccCcc---chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVF---QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   77 (203)
                      +.+..+|+.|++|.+....   ........+..|++.++.++|+|++++++++.+.     ..+++++||+++ +|.+++
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~   93 (258)
T cd06632          19 GLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLL   93 (258)
T ss_pred             EEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----CeEEEEEEecCCCcHHHHH
Confidence            3456789999999985422   1233456788999999999999999999998877     567899999974 888888


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ...+.+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+.......  ......++..|++||
T Consensus        94 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe  171 (258)
T cd06632          94 KKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPE  171 (258)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--cccccCCCcceeCHH
Confidence            877789999999999999999999999999999999999999999999999999887543222  223445688899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+.....++.++|+||||+++|++++|+.||......+..
T Consensus       172 ~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~  211 (258)
T cd06632         172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV  211 (258)
T ss_pred             HhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH
Confidence            8876433789999999999999999999999876644433

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0668|consensus

Probab=100.00  E-value=3e-33  Score=194.79  Aligned_cols=188  Identities=30%  Similarity=0.601  Sum_probs=157.0

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      ++..+++.++||+++..     ....+.+|+.+++.+. +|||++++++..++..   ..+.++.|+... +.....   
T Consensus        58 ~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly---  126 (338)
T KOG0668|consen   58 INITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLY---  126 (338)
T ss_pred             cccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc---cCchhHhhhhccccHHHHh---
Confidence            45678899999998653     4567899999999995 9999999999998865   578899999984 444433   


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.++..+++.++.|+++||.|||+.||.|||+||+|+|++. .-.++|+|+|++.++.+.  .....+..+-.|.-||.+
T Consensus       127 ~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~--~eYnVRVASRyfKGPELL  204 (338)
T KOG0668|consen  127 PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG--KEYNVRVASRYFKGPELL  204 (338)
T ss_pred             hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--ceeeeeeehhhcCCchhe
Confidence            45888999999999999999999999999999999999994 568999999999876543  233333445668889999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcc-cCCCChHHHhhhhhcC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRIL-FQAQSPVQQLGLITDL  203 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i~~~  203 (203)
                      ..-+.|+.+.|+|||||++..|+..+-| |.+.++.+++-.|++|
T Consensus       205 Vdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakV  249 (338)
T KOG0668|consen  205 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKV  249 (338)
T ss_pred             eechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHH
Confidence            8878899999999999999999987555 7999999999988764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-33  Score=215.64  Aligned_cols=184  Identities=51%  Similarity=0.927  Sum_probs=152.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.|++|++............+.+|+++++.++|||++++.+++....    ...++++|+++++|.+.+.. .
T Consensus        29 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~  103 (328)
T cd07856          29 ARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-R  103 (328)
T ss_pred             EEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-C
Confidence            457789999999988544334445567888999999999999999999886543    34578999998888776654 5


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++++|++||+.+++|+||+|+||+++.++.++++|||.+.....    ......++..|+|||.+.+
T Consensus       104 ~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~  179 (328)
T cd07856         104 PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QMTGYVSTRYYRAPEIMLT  179 (328)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----CcCCCcccccccCceeeec
Confidence            688999999999999999999999999999999999999999999999999874322    1122345778999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      ...++.++|+||||+++|++++|++||......
T Consensus       180 ~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~  212 (328)
T cd07856         180 WQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV  212 (328)
T ss_pred             cCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            456889999999999999999999999876653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.7e-34  Score=217.31  Aligned_cols=191  Identities=21%  Similarity=0.340  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.||+|+...........+.+.+|+.+++.++||||+++++++..+     ...++++||+.+ ++.+++...
T Consensus        19 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~   93 (328)
T cd08226          19 ARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTY   93 (328)
T ss_pred             EEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhh
Confidence            46788999999999865444445567788999999999999999999999887     567899999984 777776643


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC------cccccCCcc
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA------MTQEVVTQY  152 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~  152 (203)
                        ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+++.||+.+..........      .....++..
T Consensus        94 ~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (328)
T cd08226          94 FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP  173 (328)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccC
Confidence              358999999999999999999999999999999999999999999999997543221110000      011123556


Q ss_pred             cccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        153 YRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       153 ~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      |+|||++.+. ..++.++|+||||+++|++++|+.||........+
T Consensus       174 y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~  219 (328)
T cd08226         174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML  219 (328)
T ss_pred             ccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence            9999998764 34688999999999999999999999887654443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-34  Score=227.87  Aligned_cols=173  Identities=27%  Similarity=0.333  Sum_probs=144.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      +.+..+++.|+||...        .....+|++++++++|+||+++++++..+     ...++++|++.++|..++... 
T Consensus       188 a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~  254 (461)
T PHA03211        188 SSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARL  254 (461)
T ss_pred             EEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcC
Confidence            4577788999999642        23356899999999999999999998776     456788999988888887653 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++.+++.++.|++.+|.|||++|++||||||+||+++.++.++|+|||++......... ......||..|+|||++
T Consensus       255 ~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~  334 (461)
T PHA03211        255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVL  334 (461)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHH
Confidence            56999999999999999999999999999999999999999999999999998754322111 12234678999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCccc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILF  188 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf  188 (203)
                      .+ ..++.++|+||||+++|+|++|..|+
T Consensus       335 ~~-~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        335 AG-DPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cC-CCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            87 45899999999999999999887553

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.1e-34  Score=212.61  Aligned_cols=189  Identities=24%  Similarity=0.359  Sum_probs=150.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-----   79 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----   79 (203)
                      .+++.|++|+++... .....+.+.+|+.+++.++||||+++++++.+.     ...++++||+. ++|.+++..     
T Consensus        33 ~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~  106 (283)
T cd05091          33 EQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHS  106 (283)
T ss_pred             CceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCc
Confidence            456889999996432 223456688899999999999999999998877     45678888887 467766531     


Q ss_pred             -----------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccc
Q psy16889         80 -----------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQE  147 (203)
Q Consensus        80 -----------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  147 (203)
                                 ...+++..+..++.|++.||+++|+.|++||||||+||++++++.++++|||++........ ......
T Consensus       107 ~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  186 (283)
T cd05091         107 DVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS  186 (283)
T ss_pred             cccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCc
Confidence                       23588889999999999999999999999999999999999999999999998874332211 112233


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+.+..+.
T Consensus       187 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         187 LLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             cCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            44678999999876 447899999999999999998 899999888777776654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=8.6e-34  Score=210.51  Aligned_cols=185  Identities=28%  Similarity=0.481  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+++.|++|.++...........+..|+++++.++|+||++++++....     ..+++++||+. ++|.+++...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   93 (264)
T cd06626          19 AVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHG   93 (264)
T ss_pred             EEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhc
Confidence            34567899999999966544445677899999999999999999999988766     56789999998 5888888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcc---cccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT---QEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~---~~~~~~~~~aPe  157 (203)
                      +.+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+............   ...++..|+|||
T Consensus        94 ~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE  173 (264)
T cd06626          94 RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE  173 (264)
T ss_pred             CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChh
Confidence            77999999999999999999999999999999999999999999999999998754433222111   345677899999


Q ss_pred             eeeccc--CCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        158 ILMGAR--HYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       158 ~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ++.+..  ..+.++|+||||++++++++|+.||...
T Consensus       174 ~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             hccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence            987633  2688999999999999999999999765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-33  Score=208.94  Aligned_cols=189  Identities=30%  Similarity=0.447  Sum_probs=158.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+|+.+++|.+............+.+|++.+++++|+||+++.+++.+.     ...++++||+++ +|.+++.. 
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~   93 (256)
T cd08530          19 VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKR   93 (256)
T ss_pred             EEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHH
Confidence            35677899999999976544555667788999999999999999999999887     567899999974 78777654 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                         ...++++.+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+......   ......++..|.+|
T Consensus        94 ~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~~~~P  170 (256)
T cd08530          94 KKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAP  170 (256)
T ss_pred             HhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---CcccccCCccccCH
Confidence               456899999999999999999999999999999999999999999999999998754433   22233567889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |...+ ..++.++|+||||+++|++++|+.||...+..+....
T Consensus       171 e~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~  212 (256)
T cd08530         171 EVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK  212 (256)
T ss_pred             HHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99876 5578899999999999999999999988776554433

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.9e-34  Score=218.11  Aligned_cols=195  Identities=38%  Similarity=0.777  Sum_probs=154.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchh---------HHHHHHHhhhHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF---------QEIYVITELLQSD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~---------~~~~lv~e~~~~~   72 (203)
                      +.+..+|+.|++|.+...  .......+.+|++++++++||||+++++++........         ...++++||++++
T Consensus        24 ~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  101 (342)
T cd07854          24 AVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD  101 (342)
T ss_pred             EEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccccc
Confidence            467789999999998543  22445668889999999999999999998776542211         2467899999988


Q ss_pred             HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCC--CcccccC
Q psy16889         73 LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNK--AMTQEVV  149 (203)
Q Consensus        73 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~  149 (203)
                      |.+.+.. +.+++..++.++.|++.|+++||+.|++|+||+|+||+++ .++.++++|||.+.........  ......+
T Consensus       102 L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  180 (342)
T cd07854         102 LANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV  180 (342)
T ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccc
Confidence            8877654 5699999999999999999999999999999999999997 4567899999998643322111  1122345


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +..|.|||.+.+...++.++|+||||+++|+|++|+.||.+..+.+....
T Consensus       181 ~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~  230 (342)
T cd07854         181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL  230 (342)
T ss_pred             cccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            77899999876655678899999999999999999999987766555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-34  Score=220.70  Aligned_cols=173  Identities=29%  Similarity=0.406  Sum_probs=143.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.+..+++.|++|+...        .....|+.++++++|+||+++++++...     ...++++|++.++|.+++.. .
T Consensus        85 ~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~  151 (357)
T PHA03209         85 ATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRS  151 (357)
T ss_pred             EEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhcc
Confidence            45667888999998532        1234689999999999999999999877     56778999999999888764 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......  .......|+..|+|||++.
T Consensus       152 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~  229 (357)
T PHA03209        152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--PAFLGLAGTVETNAPEVLA  229 (357)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC--cccccccccccccCCeecC
Confidence            67999999999999999999999999999999999999999999999999998743221  1223346788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCc-ccCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRI-LFQA  190 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~-pf~~  190 (203)
                      + ..++.++|+||||+++|+|+++.. +|..
T Consensus       230 ~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        230 R-DKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            7 458999999999999999998544 4443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=217.65  Aligned_cols=193  Identities=46%  Similarity=0.826  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.|+||.+............+.+|+++++.++|+||+++++++...... .....++++++++++|..++.. 
T Consensus        34 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-  112 (343)
T cd07880          34 ALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-  112 (343)
T ss_pred             EEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-
Confidence            45678899999999854433344455678999999999999999999988765321 1123578999998788777654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+......    .....+++.|++||.+.
T Consensus       113 ~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~  188 (343)
T cd07880         113 EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVIL  188 (343)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHh
Confidence            57999999999999999999999999999999999999999999999999998743321    12234577899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +...++.++|+||||+++|++++|+.||.+......+..
T Consensus       189 ~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            644578899999999999999999999988765544433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-34  Score=217.30  Aligned_cols=188  Identities=38%  Similarity=0.667  Sum_probs=151.4

Q ss_pred             cCCC--CCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC
Q psy16889          3 TDPR--DGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS   79 (203)
Q Consensus         3 ~~~~--~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   79 (203)
                      .+..  +|+.||+|.+.... ......+.+.+|+.++++++||||+++++++.+...   ..+++|+||+++++.+.+..
T Consensus        20 ~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~   96 (316)
T cd07842          20 KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKF   96 (316)
T ss_pred             EecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---ceEEEEEeCCCcCHHHHHHh
Confidence            3445  78999999996532 122334567789999999999999999999987643   35689999998777665532


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC----CCeEEEeecCccccCCCCCC--CCccccc
Q psy16889         80 -----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS----NCILKICDFGLARVEEPDPN--KAMTQEV  148 (203)
Q Consensus        80 -----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~~~~~~~~--~~~~~~~  148 (203)
                           ...+++..++.++.|++.++++||+.+++|+||+|+||+++.    ++.++++|||.+........  .......
T Consensus        97 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  176 (316)
T cd07842          97 HRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV  176 (316)
T ss_pred             hccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCcc
Confidence                 236899999999999999999999999999999999999998    89999999999875433222  1223335


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ++..|+|||.+.+...++.++|+||||+++++|++|++||.+...
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             ccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            678899999887756678999999999999999999999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-33  Score=211.64  Aligned_cols=188  Identities=23%  Similarity=0.403  Sum_probs=151.1

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC---
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP---   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---   80 (203)
                      ..++..+++|.+...  .....+.+.+|++.++.++|+||+++++++.+.     ...++++||+. ++|.+++...   
T Consensus        32 ~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~  104 (280)
T cd05092          32 EQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPD  104 (280)
T ss_pred             CCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcc
Confidence            456778999988643  334456788999999999999999999998877     56789999997 5888777543   


Q ss_pred             ------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccc
Q psy16889         81 ------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQE  147 (203)
Q Consensus        81 ------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  147 (203)
                                  ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+........ ......
T Consensus       105 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~  184 (280)
T cd05092         105 AKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT  184 (280)
T ss_pred             hhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCc
Confidence                        2488999999999999999999999999999999999999999999999999864322211 111222


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .+++.|+|||.+.+ ..++.++|+||||+++|+|++ |.+||......+.+..+
T Consensus       185 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         185 MLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             cccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            34677999998877 457899999999999999998 99999877666555443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4279|consensus

Probab=100.00  E-value=6.1e-35  Score=230.20  Aligned_cols=185  Identities=30%  Similarity=0.470  Sum_probs=158.9

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-   78 (203)
                      |++|..++...|||.++.  ......+.+.+|+.+-++++|.|||++++.+..+     ++.-+-||-.+ |+|.+.++ 
T Consensus       593 A~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrs  665 (1226)
T KOG4279|consen  593 AARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRS  665 (1226)
T ss_pred             eeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHh
Confidence            578999999999999965  4556677899999999999999999999998887     44556678777 58888887 


Q ss_pred             CCCCC--ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 SPQHL--TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ~~~~~--~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      .+|++  +|..+-.+-+||+++|+|||++.|||||||-+|++++ -.|.+|++|||.+...... .....+..||..|+|
T Consensus       666 kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFTGTLQYMA  744 (1226)
T KOG4279|consen  666 KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFTGTLQYMA  744 (1226)
T ss_pred             ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccC-CccccccccchhhhC
Confidence            46888  9999999999999999999999999999999999998 5689999999999754332 344456688999999


Q ss_pred             ceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        156 PEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       156 Pe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ||++..+ +.|+.++|||||||++.||.||++||-+...
T Consensus       745 PEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs  783 (1226)
T KOG4279|consen  745 PEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS  783 (1226)
T ss_pred             hHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence            9999753 4589999999999999999999999977643

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=206.88  Aligned_cols=192  Identities=26%  Similarity=0.432  Sum_probs=159.8

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.+++|.+..... .....+.+..|++++++++|+|++++++.+.++     ...++++|++. ++|.+++..
T Consensus        12 ~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~   86 (250)
T cd05123          12 VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSK   86 (250)
T ss_pred             EEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHh
Confidence            34566899999999855322 223556788899999999999999999999877     67889999995 699999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.++.++|+.+++|+||+|+||+++.++.++++|||.+....... .......++..|.+||..
T Consensus        87 ~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~  165 (250)
T cd05123          87 EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVL  165 (250)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCccccChHHh
Confidence            7789999999999999999999999999999999999999999999999999987543321 223344567789999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ...+.++|+||||+++|++++|+.||...........+
T Consensus       166 ~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~  205 (250)
T cd05123         166 LG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI  205 (250)
T ss_pred             CC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            77 44788999999999999999999999887765554443

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.5e-33  Score=212.86  Aligned_cols=188  Identities=27%  Similarity=0.397  Sum_probs=147.9

Q ss_pred             CCCCCc--EEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          4 DPRDGR--RVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         4 ~~~~~~--~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +..+|.  .+++|.++.. ......+.+.+|++.++++ +||||+++++++...     ..+++++||+. ++|.+++..
T Consensus        23 ~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   96 (297)
T cd05089          23 IKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRK   96 (297)
T ss_pred             ecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----CcceEEEEecCCCcHHHHHHh
Confidence            344554  4688887532 2333456788899999999 799999999998876     56889999987 588888754


Q ss_pred             C----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC
Q psy16889         80 P----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA  143 (203)
Q Consensus        80 ~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  143 (203)
                      .                +.+++..++.++.|++.|+++||+.|++|+||||+||+++.++.++++|||++......  ..
T Consensus        97 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~  174 (297)
T cd05089          97 SRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--VK  174 (297)
T ss_pred             ccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccce--ec
Confidence            2                24889999999999999999999999999999999999999999999999998632211  11


Q ss_pred             cccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       144 ~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ......+..|+|||...+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       175 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~  231 (297)
T cd05089         175 KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL  231 (297)
T ss_pred             cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            111122456999998876 458899999999999999997 99999887766655443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG1095|consensus

Probab=100.00  E-value=3.8e-34  Score=236.58  Aligned_cols=184  Identities=24%  Similarity=0.425  Sum_probs=157.9

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-------
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-------   80 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------   80 (203)
                      -.|+||.++.. .+......|.+|..+|+.++||||+++++++.+.     ..+++++|||. |+|+.+++..       
T Consensus       723 ~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~  796 (1025)
T KOG1095|consen  723 IQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQP  796 (1025)
T ss_pred             eEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCCC
Confidence            35899998654 4566778899999999999999999999999987     67889999998 6999999854       


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcccc-CCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~-~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++..+++.++.+++++.+||++++.|||||...|+|++....+|+.|||+++. +................|+|||.+
T Consensus       797 ~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl  876 (1025)
T KOG1095|consen  797 SNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESL  876 (1025)
T ss_pred             CCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHH
Confidence            3499999999999999999999999999999999999999999999999999983 332222222222445689999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      .. ..++.++||||||+++||++| |..||++.++.+++..
T Consensus       877 ~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~  916 (1025)
T KOG1095|consen  877 KD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD  916 (1025)
T ss_pred             hh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence            97 669999999999999999998 8999999999888763

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1e-33  Score=211.92  Aligned_cols=182  Identities=23%  Similarity=0.384  Sum_probs=146.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhh-hHHHHHH---HHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVS-SKRVFRE---LKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      +.+..+|+.||+|++......... ......|   ...++...||+|+++.+++...     ...++++||+. ++|..+
T Consensus        13 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~   87 (278)
T cd05606          13 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYH   87 (278)
T ss_pred             EEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEEEecCCCCcHHHH
Confidence            456778999999998543222111 1223333   3344556899999999999877     56788999998 588888


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +...+.+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+.......   .....++..|+||
T Consensus        88 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aP  164 (278)
T cd05606          88 LSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAP  164 (278)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCcCCCcCCcCc
Confidence            8777889999999999999999999999999999999999999999999999999986433221   1233578889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |.+.+...++.++|+||+|+++|+|++|+.||...
T Consensus       165 E~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             HHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            99876445789999999999999999999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-34  Score=212.74  Aligned_cols=187  Identities=24%  Similarity=0.425  Sum_probs=154.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC---CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK---HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   77 (203)
                      +.+..+|+.|++|.++.. ......+.+.+|+.++++++   |||++++++++.+.     ...++++||+.+ +|.+++
T Consensus        20 ~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~   93 (277)
T cd06917          20 GKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLM   93 (277)
T ss_pred             EEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHH
Confidence            456788999999998643 22334566778999999986   99999999998776     567899999975 787776


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .. +.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|+|||
T Consensus        94 ~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE  171 (277)
T cd06917          94 KA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPE  171 (277)
T ss_pred             Hc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-cccccccCCcceeCHH
Confidence            55 479999999999999999999999999999999999999999999999999987544332 2233346788899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      .+.+...++.++|+||||+++|+|++|..||.+......
T Consensus       172 ~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~  210 (277)
T cd06917         172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA  210 (277)
T ss_pred             HhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence            887656678899999999999999999999987665443

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=210.55  Aligned_cols=190  Identities=36%  Similarity=0.623  Sum_probs=156.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+++.|+||.+...... .......+|+..+++++ |+|++++++++.++     ...+++|||++++|.+.+...
T Consensus        18 ~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~   91 (283)
T cd07830          18 ARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDR   91 (283)
T ss_pred             EEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhc
Confidence            345678899999998653222 22334557899999998 99999999999886     577899999988998887765


Q ss_pred             C--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 Q--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 ~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .  .+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+......  .......++..|+|||.
T Consensus        92 ~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~aPE~  169 (283)
T cd07830          92 KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTDYVSTRWYRAPEI  169 (283)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCcCCCCCcccccCcee
Confidence            4  7899999999999999999999999999999999999999999999999998744322  12233356778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +.+...++.++|+||||++++++++|++||...+..+.+..
T Consensus       170 ~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~  210 (283)
T cd07830         170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK  210 (283)
T ss_pred             eecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence            87656678999999999999999999999988776555443

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.6e-33  Score=211.17  Aligned_cols=181  Identities=26%  Similarity=0.451  Sum_probs=144.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHH-HHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV--   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--   78 (203)
                      +.++.+|+.||+|.++........ ..+..|.. .++..+|||++++++++..+     ...++++||++++|.+.+.  
T Consensus        20 ~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~   93 (283)
T cd06617          20 MRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKV   93 (283)
T ss_pred             EEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHh
Confidence            467789999999998654333332 33444555 46667999999999999876     5678999999987766554  


Q ss_pred             --CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 --SPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 --~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                        ....+++..++.++.|++.++++||++ +++|+||+|+||+++.++.++++|||.+......  .......++..|+|
T Consensus        94 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~a  171 (283)
T cd06617          94 YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VAKTIDAGCKPYMA  171 (283)
T ss_pred             ccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--cccccccCCccccC
Confidence              235699999999999999999999997 9999999999999999999999999998743321  12222356778999


Q ss_pred             ceeeecc---cCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        156 PEILMGA---RHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       156 Pe~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ||.+.+.   ..++.++|+||||+++|+|++|+.||..
T Consensus       172 PE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             hhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence            9988642   3367899999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2e-33  Score=208.61  Aligned_cols=182  Identities=25%  Similarity=0.438  Sum_probs=147.4

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCCCh
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHLTS   85 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~   85 (203)
                      ..|++|+++....   ..+.+.+|+++++.++|+||+++++++...      ..++++||++ ++|.+++..  ...+++
T Consensus        31 ~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (262)
T cd05071          31 TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGEMGKYLRL  101 (262)
T ss_pred             ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECCC------CcEEEEEcCCCCcHHHHHhhccccCCCH
Confidence            4699999864322   235678899999999999999999887543      3579999998 588888864  245899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCC
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHY  165 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~  165 (203)
                      ..+..++.|++.+|+++|+.+++|+||+|+||+++.++.++|+|||.+...............++..|+|||...+ ..+
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~  180 (262)
T cd05071         102 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRF  180 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCC
Confidence            9999999999999999999999999999999999999999999999987543332222223344667999998876 457


Q ss_pred             CcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        166 SAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       166 ~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.++|+||||+++|++++ |..||.+..+.+.+..+
T Consensus       181 ~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~  216 (262)
T cd05071         181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV  216 (262)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence            999999999999999999 89999887776665544

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-33  Score=208.88  Aligned_cols=183  Identities=25%  Similarity=0.461  Sum_probs=152.9

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-C
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-P   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~   80 (203)
                      .+..+++.+++|.++..    ...+.+.+|++.+++++|+|++++++++.+.     ...++++|++++ +|.+.+.. .
T Consensus        23 ~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~   93 (256)
T cd06612          23 IHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITN   93 (256)
T ss_pred             EEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCc
Confidence            45567899999998543    1256788999999999999999999999887     567899999985 88887764 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~  172 (256)
T cd06612          94 KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-AKRNTVIGTPFWMAPEVIQ  172 (256)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc-cccccccCCccccCHHHHh
Confidence            678999999999999999999999999999999999999999999999999987543322 1223334678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      + ..++.++|+||||+++|+|++|+.||....+...
T Consensus       173 ~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~  207 (256)
T cd06612         173 E-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA  207 (256)
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence            7 4578999999999999999999999987655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-33  Score=212.46  Aligned_cols=188  Identities=27%  Similarity=0.503  Sum_probs=154.4

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      .+..+++.+++|.+...  .....+.+.+|+.+++.++|+|++++++++...     ...++++||+. ++|.+++.. +
T Consensus        39 ~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~  110 (285)
T cd06648          39 TDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-T  110 (285)
T ss_pred             EECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-C
Confidence            45678999999988532  223345678899999999999999999998876     56789999997 488887766 6


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++.++..++.|++.++++||++|++||||+|+||+++.++.++++|||.+....... .......++..|+|||...+
T Consensus       111 ~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~  189 (285)
T cd06648         111 RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISR  189 (285)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccccccCCccccCHHHhcC
Confidence            79999999999999999999999999999999999999999999999999876433221 12233456888999999876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                       ..++.++|+||+|+++|++++|+.||...++...+..+
T Consensus       190 -~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~  227 (285)
T cd06648         190 -LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI  227 (285)
T ss_pred             -CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH
Confidence             45789999999999999999999999877665554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.6e-34  Score=210.37  Aligned_cols=192  Identities=28%  Similarity=0.458  Sum_probs=157.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+............+.+|++++++++|+||+++.+++...     ...++++||+. ++|.+.+...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   93 (256)
T cd08218          19 VKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQ   93 (256)
T ss_pred             EEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhc
Confidence            35667899999999865433444556788999999999999999999998877     56789999997 4888877643


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                        ..+++.++..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........ ......+++.|.|||+
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~  172 (256)
T cd08218          94 RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEI  172 (256)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-hhhhccCCccccCHHH
Confidence              3589999999999999999999999999999999999999999999999998875432211 1122346778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ..+ ...+.++|+||||++++++++|+.||......+....+
T Consensus       173 ~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~  213 (256)
T cd08218         173 CEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI  213 (256)
T ss_pred             hCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH
Confidence            877 44788999999999999999999999877766655443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.7e-33  Score=208.76  Aligned_cols=184  Identities=26%  Similarity=0.442  Sum_probs=152.3

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC--CCCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS--PQHLT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~   84 (203)
                      ++.+++|.+...  .......+..|+.+++.++|+||+++++++.+.     ...++++||+.+ +|.+++..  ...++
T Consensus        30 ~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~  102 (261)
T cd05148          30 RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLP  102 (261)
T ss_pred             CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCC
Confidence            788999998643  222455688899999999999999999998877     567899999985 89888875  34689


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.|+++||++|++|+||+|+||+++.++.++++|||.+......... .....++..|.+||...+ ..
T Consensus       103 ~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~-~~  180 (261)
T cd05148         103 VASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL-SSDKKIPYKWTAPEAASH-GT  180 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc-ccCCCCceEecCHHHHcc-CC
Confidence            9999999999999999999999999999999999999999999999998754322211 123334567999998876 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++|++++ |+.||...+..+.+..+
T Consensus       181 ~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~  217 (261)
T cd05148         181 FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI  217 (261)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            8899999999999999998 89999888776665554

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-33  Score=209.95  Aligned_cols=183  Identities=32%  Similarity=0.466  Sum_probs=156.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.|++|++...... .....+..|++.++.++|+|++++++++..+     ..+++++||++ ++|.+++...
T Consensus        20 ~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   93 (264)
T cd06623          20 VRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKV   93 (264)
T ss_pred             EEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHc
Confidence            456778999999998654322 4456788999999999999999999999887     56789999999 6899988877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..+..++.|++.++++||+ .+++|+||+|+||+++.++.++++|||.+........ ......++..|.|||..
T Consensus        94 ~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~~pE~~  172 (264)
T cd06623          94 GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERI  172 (264)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-cccceeecccccCHhhh
Confidence            889999999999999999999999 9999999999999999999999999998875433222 22234567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+ ..++.++|+||||+++|++++|+.||....
T Consensus       173 ~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         173 QG-ESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             CC-CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            77 468899999999999999999999998774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=211.23  Aligned_cols=195  Identities=42%  Similarity=0.648  Sum_probs=154.7

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS   79 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   79 (203)
                      .+..+|+.|++|.++...........+.+|+.+++++   +|+|++++++++.+.+......+++++|++.++|.+++..
T Consensus        19 ~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~   98 (287)
T cd07838          19 RDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK   98 (287)
T ss_pred             EECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHH
Confidence            4566899999999965433333334566677766665   6999999999988764322234789999999888887764


Q ss_pred             C--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 P--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .  ..+++..++.++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+.......  ......++..|+|||
T Consensus        99 ~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE  176 (287)
T cd07838          99 CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVVTLWYRAPE  176 (287)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc--ccccccccccccChH
Confidence            3  358999999999999999999999999999999999999999999999999987543221  112224577899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..+
T Consensus       177 ~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~  218 (287)
T cd07838         177 VLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI  218 (287)
T ss_pred             Hhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence            9987 44789999999999999999999999988877666554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.1e-34  Score=214.68  Aligned_cols=188  Identities=26%  Similarity=0.411  Sum_probs=147.4

Q ss_pred             cCCCCCcE--EEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          3 TDPRDGRR--VALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         3 ~~~~~~~~--~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      .+..+|..  +++|.++.. .+......+.+|+++++++ +|+||+++++++.+.     ..+++++||++ ++|.+++.
T Consensus        27 ~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~  100 (303)
T cd05088          27 RIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLR  100 (303)
T ss_pred             EEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHH
Confidence            44556654  577766432 2233456778899999999 899999999999877     57899999997 58888775


Q ss_pred             CC----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC
Q psy16889         79 SP----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK  142 (203)
Q Consensus        79 ~~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  142 (203)
                      ..                +.+++.+++.++.|++.|+++||++|++||||+|+||+++.++.++++|||++......  .
T Consensus       101 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~  178 (303)
T cd05088         101 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--V  178 (303)
T ss_pred             hcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh--h
Confidence            32                25889999999999999999999999999999999999999999999999998632211  1


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      .......+..|+|||.+.+ ..++.++|+||||+++|++++ |..||...+..+..+.
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         179 KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             hcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            1111223557999998876 457899999999999999998 9999987665554443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-33  Score=211.94  Aligned_cols=190  Identities=23%  Similarity=0.339  Sum_probs=153.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-   81 (203)
                      +...+..|++|.+.... .....+.+.+|++++++++||||+++++++..+     ...++++|++. ++|.+++.... 
T Consensus        42 ~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  115 (296)
T cd05051          42 NADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVA  115 (296)
T ss_pred             ccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhccc
Confidence            34456779999986432 234567788999999999999999999999877     56789999997 58888776544 


Q ss_pred             ----------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCC
Q psy16889         82 ----------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVT  150 (203)
Q Consensus        82 ----------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~  150 (203)
                                .+++..++.++.|++.||++||+.+++|+||||+||+++.++.++++|||.+........ .......++
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  195 (296)
T cd05051         116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLP  195 (296)
T ss_pred             ccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCC
Confidence                      689999999999999999999999999999999999999999999999999874332211 112233446


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHh--CCcccCCCChHHHhhhh
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLG--RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~~~~~~~~~~~i  200 (203)
                      ..|+|||.+.+ ..++.++|+||||+++|++++  +..||...+..+.+..+
T Consensus       196 ~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~  246 (296)
T cd05051         196 IRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA  246 (296)
T ss_pred             ceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHH
Confidence            78999998876 448999999999999999997  78899877666655443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=209.00  Aligned_cols=188  Identities=29%  Similarity=0.393  Sum_probs=151.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHH-HhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKM-LCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.+..+|+.|++|.++.... .......+..|... ....+|+|++++++++...     ..+++++||++ ++|.+.+.
T Consensus        15 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~   89 (260)
T cd05611          15 AKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIK   89 (260)
T ss_pred             EEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHH
Confidence            45677899999999864322 12222333444443 4455999999999999876     56789999997 48888887


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||.+.....     .....++..|.+||.
T Consensus        90 ~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~  164 (260)
T cd05611          90 TLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTPDYLAPET  164 (260)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCCCcCccChhh
Confidence            778899999999999999999999999999999999999999999999999998864322     122346778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +.+.. ++.++|+||||+++|++++|..||...+..+....+
T Consensus       165 ~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  205 (260)
T cd05611         165 ILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI  205 (260)
T ss_pred             hcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            88744 789999999999999999999999887766554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0603|consensus

Probab=100.00  E-value=3.8e-34  Score=223.33  Aligned_cols=182  Identities=27%  Similarity=0.462  Sum_probs=148.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhh-cCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCF-FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..++..+++|++...      .....+|..++.. -+|||++++.+++.+.     ...|+|||.+.| .+.+.+..
T Consensus       341 ~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~  409 (612)
T KOG0603|consen  341 CESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRS  409 (612)
T ss_pred             eeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecCC-----ceeeeeehhccccHHHHHHHh
Confidence            457788889999998653      1122345544444 4999999999999988     788999999985 66666666


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe-cCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV-NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.++ .++..|+.+|+.|+.+||++|++|||+||+||++ +..+.++|+|||.+......    +...+-|..|.|||+
T Consensus       410 ~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEv  484 (612)
T KOG0603|consen  410 KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDTPALTLQYVAPEV  484 (612)
T ss_pred             cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcccchhhcccChhh
Confidence            66566 8888999999999999999999999999999999 58999999999998743322    344466888999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChH-HHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV-QQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~i  200 (203)
                      +.. +.|+.++||||||++||+||+|+.||...... +++.+|
T Consensus       485 l~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i  526 (612)
T KOG0603|consen  485 LAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI  526 (612)
T ss_pred             hcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh
Confidence            996 66999999999999999999999999887655 555554

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-33  Score=219.08  Aligned_cols=180  Identities=29%  Similarity=0.468  Sum_probs=144.6

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP---   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---   80 (203)
                      .++..||||+++.. ......+.+.+|+++++++. ||||+++++++.+.     ...+++|||+. |+|.+++...   
T Consensus        65 ~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~  138 (400)
T cd05105          65 QPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDN  138 (400)
T ss_pred             CCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhh
Confidence            44567999999643 23334567889999999995 99999999999877     56789999997 5777665321   


Q ss_pred             --------------------------------------------------------------------------------
Q psy16889         81 --------------------------------------------------------------------------------   80 (203)
Q Consensus        81 --------------------------------------------------------------------------------   80 (203)
                                                                                                      
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (400)
T cd05105         139 FLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSN  218 (400)
T ss_pred             hhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcc
Confidence                                                                                            


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                   ..+++..+..++.|++.|++|||+.+++|+||||+||+++.++.++++|||++........ .....
T Consensus       219 ~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~  298 (400)
T cd05105         219 DSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS  298 (400)
T ss_pred             hhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCC
Confidence                         2478888999999999999999999999999999999999999999999999874332211 12222


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCC
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQS  192 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  192 (203)
                      ..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||....
T Consensus       299 ~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~  344 (400)
T cd05105         299 TFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMI  344 (400)
T ss_pred             cCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence            345677999999877 457899999999999999997 999997654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-33  Score=208.09  Aligned_cols=191  Identities=26%  Similarity=0.428  Sum_probs=156.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+++.+++|.+.....+......+.+|++.+++++|||++++++.+...     ...++++||+++ +|.+++...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   93 (256)
T cd08220          19 CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKR   93 (256)
T ss_pred             EEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHh
Confidence            45677899999999966544555567788999999999999999999988766     567899999974 888887653


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ..+++..+..++.|++.++++||++|++|+||+|+||+++.+ +.++++|||.+.......  ......++..|+|||
T Consensus        94 ~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~aPE  171 (256)
T cd08220          94 CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KAYTVVGTPCYISPE  171 (256)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cccccccCCcccCch
Confidence              458999999999999999999999999999999999999855 467999999987543321  222335678899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+ ..++.++|+||||+++|++++|+.||...+.......+
T Consensus       172 ~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  213 (256)
T cd08220         172 LCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI  213 (256)
T ss_pred             hccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH
Confidence            9887 44788999999999999999999999887665554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=209.92  Aligned_cols=188  Identities=24%  Similarity=0.363  Sum_probs=151.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .++..|++|.+... ........+.+|+.+++.++|+||+++++++...     ...++++||++ ++|.+++...    
T Consensus        34 ~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~  107 (277)
T cd05032          34 EPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEA  107 (277)
T ss_pred             CcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccch
Confidence            45688999998543 2233445678899999999999999999998877     56789999997 5888877532    


Q ss_pred             ------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccc
Q psy16889         81 ------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYY  153 (203)
Q Consensus        81 ------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  153 (203)
                            ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++++|||.+........ .......++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (277)
T cd05032         108 ENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (277)
T ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccc
Confidence                  2478889999999999999999999999999999999999999999999999864332211 122233456789


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .|||.+.+ ..++.++|+||||+++|++++ |+.||.+.+..+..+.+
T Consensus       188 ~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         188 MAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             cCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            99998876 447899999999999999998 99999888777665544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=7e-34  Score=211.45  Aligned_cols=183  Identities=28%  Similarity=0.480  Sum_probs=149.5

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-   78 (203)
                      +++..+|+.|+||.++... ........+.+|+++++.++|||++++++++.+.     ...++++||+++ +|.+.+. 
T Consensus        21 ~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08228          21 ATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKY   95 (267)
T ss_pred             EEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHH
Confidence            4567789999999875422 2334455678899999999999999999998876     466789999984 7766654 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....++++.+..++.|++.|+.+||+++++|+||+|+||+++.++.++++|||.+....... .......+++.|+|
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~a  174 (267)
T cd08228          96 FKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMS  174 (267)
T ss_pred             hhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-HHHhcCCCCccccC
Confidence               23558999999999999999999999999999999999999999999999999887543221 11223356778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ||.+.+ ..++.++|+||||+++|++++|+.||...
T Consensus       175 PE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         175 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             hhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            999877 45789999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.8e-34  Score=215.17  Aligned_cols=183  Identities=26%  Similarity=0.480  Sum_probs=151.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+...  .....+.+.+|+.+++.++|+|++++++++..+     ...++++||+++ +|.+++.. 
T Consensus        38 ~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-  109 (297)
T cd06656          38 AIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-  109 (297)
T ss_pred             EEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-
Confidence            356788999999998543  223346678899999999999999999999877     567899999984 77776644 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... .......+++.|.|||.+.
T Consensus       110 ~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  188 (297)
T cd06656         110 TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVT  188 (297)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-cCcCcccCCccccCHHHHc
Confidence            568999999999999999999999999999999999999999999999999886433221 1122335678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      + ..++.++|+||||+++|++++|..||...++.
T Consensus       189 ~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~  221 (297)
T cd06656         189 R-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL  221 (297)
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            7 55789999999999999999999999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-33  Score=211.65  Aligned_cols=182  Identities=26%  Similarity=0.370  Sum_probs=145.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   82 (203)
                      ...+++.|++|.++... .......+.+|++.++.++||||+++++++.....   ...+++|||+.+ +|.+++.. ..
T Consensus        29 ~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~~-~~  103 (283)
T cd05080          29 NDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG---KGLQLIMEYVPLGSLRDYLPK-HK  103 (283)
T ss_pred             cCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---ceEEEEecCCCCCCHHHHHHH-cC
Confidence            44678899999986532 22345677889999999999999999998765432   346799999984 77777654 45


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~  160 (203)
                      +++.+++.++.|++.++++||+++++|+||||+||+++.++.++++|||.+.........  ......++..|+|||...
T Consensus       104 l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         104 LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            999999999999999999999999999999999999999999999999998754332211  112223456699999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      + ..++.++|+||||+++|+|++|..||...
T Consensus       184 ~-~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         184 E-NKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             c-cCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            6 45789999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0669|consensus

Probab=100.00  E-value=4.6e-34  Score=201.38  Aligned_cols=202  Identities=34%  Similarity=0.605  Sum_probs=169.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc---chhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL---DFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      |+++++|+.|++|+.--......-.....+|+.+++.++|+|++.++.++.....   ......|+|+++|+-+|.-.+.
T Consensus        36 Ar~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLs  115 (376)
T KOG0669|consen   36 ARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLS  115 (376)
T ss_pred             HhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhc
Confidence            6788999999999873322233334556789999999999999999998764322   2234589999999999888877


Q ss_pred             CC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC---CCcccccCCcccc
Q psy16889         79 SP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYR  154 (203)
Q Consensus        79 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~  154 (203)
                      .. -.++..++..+++++..+|.|+|+..|+|||+|+.|++++.+|.+++.|||+++.......   ...+.+.-|..|.
T Consensus       116 n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYr  195 (376)
T KOG0669|consen  116 NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYR  195 (376)
T ss_pred             CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecC
Confidence            65 6799999999999999999999999999999999999999999999999999975443322   2345556688999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      +||.+.+.+.|+++.|+|+-||++.+|+|+++.+++++...++..|..|
T Consensus       196 ppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L  244 (376)
T KOG0669|consen  196 PPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL  244 (376)
T ss_pred             CHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence            9999999999999999999999999999999999999999999888653

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-33  Score=208.69  Aligned_cols=186  Identities=27%  Similarity=0.443  Sum_probs=152.1

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~   83 (203)
                      ++..++||.+....   ...+.+.+|+..+++++|+|++++++++.+.     ...++++|++. ++|.+++...  ..+
T Consensus        29 ~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~  100 (261)
T cd05034          29 GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKL  100 (261)
T ss_pred             CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCC
Confidence            45779999986422   2345688999999999999999999998776     45789999997 4888888654  468


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.|+.+||+++++|+||+|+||+++.++.++++|||.+................+..|.|||.+.+ .
T Consensus       101 ~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~  179 (261)
T cd05034         101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-G  179 (261)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-C
Confidence            999999999999999999999999999999999999999999999999987543322222222233567999998886 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|++++ |+.||.+......+..+.
T Consensus       180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  218 (261)
T cd05034         180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE  218 (261)
T ss_pred             CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            57899999999999999998 999998887776666553

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-33  Score=208.80  Aligned_cols=186  Identities=28%  Similarity=0.445  Sum_probs=150.6

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~   86 (203)
                      ..+++|.+.... .....+.+..|++++++++|+|++++.+++.+.     ...+++|||+++ +|.+++.. .+.+++.
T Consensus        34 ~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  107 (268)
T cd05063          34 VAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSY  107 (268)
T ss_pred             eEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHH
Confidence            379999985432 233456788999999999999999999999877     567899999984 78777764 4678999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcc--cccCCcccccceeeecccC
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT--QEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~aPe~~~~~~~  164 (203)
                      .+..++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+............  ....+..|+|||++.+ ..
T Consensus       108 ~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~  186 (268)
T cd05063         108 QLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY-RK  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhc-CC
Confidence            99999999999999999999999999999999999999999999998744332221111  1122446999998876 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|++++ |+.||...+..+....|.
T Consensus       187 ~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~  224 (268)
T cd05063         187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN  224 (268)
T ss_pred             cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence            7899999999999999997 999998887777666654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-33  Score=210.37  Aligned_cols=185  Identities=25%  Similarity=0.426  Sum_probs=150.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+... ........+.+|++++++++|+||+++++.+..+     ...++++||+++ +|..++...
T Consensus        20 ~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   93 (286)
T cd06622          20 VLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGG   93 (286)
T ss_pred             EEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhc
Confidence            456678999999988643 2333446788999999999999999999998877     567899999985 777766542


Q ss_pred             ---CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         81 ---QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ---~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                         +.+++..+..++.|++.++.+||+ .+++|+||+|+||+++.++.++++|||.+......   ......++..|+||
T Consensus        94 ~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aP  170 (286)
T cd06622          94 VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAP  170 (286)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---ccccCCCccCccCc
Confidence               479999999999999999999997 59999999999999999999999999988643221   12223457789999


Q ss_pred             eeeeccc-----CCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        157 EILMGAR-----HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       157 e~~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      |.+.+..     .++.++|+||||+++|++++|+.||.......
T Consensus       171 E~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  214 (286)
T cd06622         171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN  214 (286)
T ss_pred             chhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence            9886432     25789999999999999999999997654433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-33  Score=207.61  Aligned_cols=188  Identities=26%  Similarity=0.409  Sum_probs=152.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~   84 (203)
                      +...|++|.++... .......+.+|+..+++++||||+++++++...     ...++++|++.+ +|.+++.. .+.++
T Consensus        31 ~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~  104 (266)
T cd05033          31 KEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFT  104 (266)
T ss_pred             CcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCC
Confidence            45679999986432 333456688899999999999999999998776     567899999974 88888765 45799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeeccc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      +..+..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+.+ .
T Consensus       105 ~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~  183 (266)
T cd05033         105 VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-R  183 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-C
Confidence            9999999999999999999999999999999999999999999999999855421111 1112233567999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|++++ |..||......+....+.
T Consensus       184 ~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  222 (266)
T cd05033         184 KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE  222 (266)
T ss_pred             CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            57899999999999999997 999998877666655543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-33  Score=206.69  Aligned_cols=186  Identities=26%  Similarity=0.420  Sum_probs=152.7

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC--CC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH--LT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~   84 (203)
                      +..+++|.+... ........+.+|++.++.++|+||+++++++.+.     ...++++|++. ++|.+++.....  ++
T Consensus        28 ~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~~  101 (258)
T smart00219       28 EVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKELS  101 (258)
T ss_pred             CceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccCC
Confidence            488999999543 2222566788999999999999999999999887     56789999997 488888765443  99


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+...............++..|++||...+ ..
T Consensus       102 ~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~  180 (258)
T smart00219      102 LSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GK  180 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhcc-CC
Confidence            99999999999999999999999999999999999999999999999987544332222112235678999998865 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++++|++ |.+||...+..+..+.+
T Consensus       181 ~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~  217 (258)
T smart00219      181 FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL  217 (258)
T ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7899999999999999998 89999887766665544

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-33  Score=210.46  Aligned_cols=187  Identities=22%  Similarity=0.394  Sum_probs=148.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ----   81 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----   81 (203)
                      ++..|++|.++.. ........+..|+.+++.++|+||+++++++.+.     ...++++||+. ++|.+++....    
T Consensus        35 ~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~  108 (277)
T cd05036          35 VELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPE  108 (277)
T ss_pred             CceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCC
Confidence            6778999988543 2233345688899999999999999999988776     45679999997 58888876432    


Q ss_pred             ---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCCCCCC-CcccccCCcccc
Q psy16889         82 ---HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNK-AMTQEVVTQYYR  154 (203)
Q Consensus        82 ---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~  154 (203)
                         .+++..+..++.|++.++++||+++++|+||+|+||+++.++   .++++|||.+......... .......+..|+
T Consensus       109 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  188 (277)
T cd05036         109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM  188 (277)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhC
Confidence               489999999999999999999999999999999999998654   5899999998754222111 111222345799


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      |||++.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+
T Consensus       189 aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~  234 (277)
T cd05036         189 PPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV  234 (277)
T ss_pred             CHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999876 458999999999999999996 99999987766665544

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-33  Score=211.44  Aligned_cols=188  Identities=25%  Similarity=0.355  Sum_probs=155.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+++.|++|.+... ........+.+|+.+++.++|+|++++++++.++     ...++++||+++ +|.+++.. 
T Consensus        23 ~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-   95 (277)
T cd06640          23 GIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-   95 (277)
T ss_pred             EEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-
Confidence            356778999999998643 2233456788899999999999999999999887     568899999985 78877654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +++++..+..++.|++.+++++|+.+++|+||+|+||+++.++.++++|||.+....... .......++..|.|||.+.
T Consensus        96 ~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~apE~~~  174 (277)
T cd06640          96 GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQ  174 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccccccCcccccCHhHhc
Confidence            568999999999999999999999999999999999999999999999999986443222 1222335677899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      + ..++.++|+||||+++|+|++|+.||....+.....
T Consensus       175 ~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06640         175 Q-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF  211 (277)
T ss_pred             c-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence            6 447899999999999999999999998766554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-33  Score=211.80  Aligned_cols=188  Identities=28%  Similarity=0.457  Sum_probs=151.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP---   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---   80 (203)
                      .++..+++|.+... ........+.+|+..++.+ +||||+++++++...     ...++++||+. ++|.+++...   
T Consensus        45 ~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  118 (304)
T cd05101          45 KEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPP  118 (304)
T ss_pred             CcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCc
Confidence            34567999998643 2234456788999999999 899999999999877     56789999998 5888887642   


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-Cccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~  146 (203)
                                   ..++..++..++.|++.||+|||++|++|+||||+||+++.++.++++|||.+......... ....
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~  198 (304)
T cd05101         119 GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN  198 (304)
T ss_pred             ccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccC
Confidence                         24778889999999999999999999999999999999999999999999998754332211 1122


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++..|+|||++.+ ..++.++|+||||+++|++++ |..||.+.+..+....+
T Consensus       199 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  252 (304)
T cd05101         199 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  252 (304)
T ss_pred             CCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            234567999999877 457899999999999999998 88999888777766554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.6e-34  Score=212.43  Aligned_cols=175  Identities=29%  Similarity=0.464  Sum_probs=146.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+++.|++|.+.... .......+.+|++++++++||||+++++.+...     ...++++||+++ +|..+    
T Consensus        20 ~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----   89 (279)
T cd06619          20 AYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----   89 (279)
T ss_pred             EEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----
Confidence            4577899999999986432 233445688999999999999999999998877     456789999986 44332    


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+......   ......++..|+|||.+.
T Consensus        90 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~  166 (279)
T cd06619          90 RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERIS  166 (279)
T ss_pred             hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCCCChhhcCceeec
Confidence            35789999999999999999999999999999999999999999999999998743322   223346688899999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      + ..++.++|+||||+++|+|++|+.||..
T Consensus       167 ~-~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         167 G-EQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             C-CCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            7 4588999999999999999999999965

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-33  Score=208.53  Aligned_cols=185  Identities=25%  Similarity=0.392  Sum_probs=151.9

Q ss_pred             CCCcEEEEEeccCccc----hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          6 RDGRRVALKKLPNVFQ----SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      .+|+.+++|.+.....    .......+.+|++.+++++|+||+++.+++.+.     ...++++||+.+ +|.+++...
T Consensus        22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   96 (265)
T cd06631          22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRF   96 (265)
T ss_pred             cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhc
Confidence            4788899998854221    223345688899999999999999999999877     577899999974 888888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-----CCCCcccccCCccccc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-----PNKAMTQEVVTQYYRA  155 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~~a  155 (203)
                      +++++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+......     .........++..|.|
T Consensus        97 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (265)
T cd06631          97 GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA  176 (265)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccC
Confidence            88999999999999999999999999999999999999999999999999988643211     1111223356788999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      ||.+.+ ..++.++|+||||+++|++++|..||...+....
T Consensus       177 pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~  216 (265)
T cd06631         177 PEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA  216 (265)
T ss_pred             hhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHH
Confidence            999877 4478999999999999999999999987654443

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-33  Score=208.59  Aligned_cols=188  Identities=26%  Similarity=0.435  Sum_probs=152.6

Q ss_pred             CcCCCCCcEEEEEeccCccch--------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-Hh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS--------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~--------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   72 (203)
                      +.+..+|+.+++|.+......        ....+.+.+|+..++.++|+|++++++++...     ...++++||+. ++
T Consensus        20 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~   94 (272)
T cd06629          20 ALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-----EYLSIFLEYVPGGS   94 (272)
T ss_pred             EeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-----CceEEEEecCCCCc
Confidence            346678999999988432111        11234677899999999999999999998776     56789999997 58


Q ss_pred             HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCc
Q psy16889         73 LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQ  151 (203)
Q Consensus        73 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~  151 (203)
                      |.+.+...+.+++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........ .......++.
T Consensus        95 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T cd06629          95 IGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV  174 (272)
T ss_pred             HHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCc
Confidence            888888778899999999999999999999999999999999999999999999999999874332211 1123335677


Q ss_pred             ccccceeeeccc-CCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        152 YYRAPEILMGAR-HYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       152 ~~~aPe~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      .|.|||.+.... .++.++|+||||+++|++++|..||......
T Consensus       175 ~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~  218 (272)
T cd06629         175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI  218 (272)
T ss_pred             cccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH
Confidence            899999887643 4788999999999999999999999765543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0666|consensus

Probab=100.00  E-value=3.1e-34  Score=207.47  Aligned_cols=179  Identities=40%  Similarity=0.682  Sum_probs=154.4

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-----CCCC
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-----PQHL   83 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~~~   83 (203)
                      +.+|+|.++.+.....-.....+|+.+++.++|||++.+..++-..+    ..++++.||.+-+|+..+.-     ...+
T Consensus        54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d----~~v~l~fdYAEhDL~~II~fHr~~~~~~l  129 (438)
T KOG0666|consen   54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD----KKVWLLFDYAEHDLWHIIKFHRASKAKQL  129 (438)
T ss_pred             hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC----ceEEEEehhhhhhHHHHHHHhccchhccC
Confidence            37999999776565566677889999999999999999999998743    57889999999999888753     2459


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC----CeEEEeecCccccCCCCCCC--CcccccCCcccccce
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN----CILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPE  157 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe  157 (203)
                      +...+..++.||+.++.|||++-+.||||||.||++..+    |.+|+.|+|+++.+..+...  ......-|..|.|||
T Consensus       130 p~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  130 PRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             CHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            999999999999999999999999999999999999866    89999999999976654332  223345588899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+.+.++|+++.|+|++||++.||+|.++.|.+.
T Consensus       210 LLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  210 LLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             HhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999999999999999999999999999774

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-33  Score=209.95  Aligned_cols=184  Identities=28%  Similarity=0.471  Sum_probs=150.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-   78 (203)
                      +.+..+|+.++||.+.... ........+.+|+++++.++|+||+++++++..+     ...++++|++.+ +|.+++. 
T Consensus        21 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~   95 (267)
T cd08229          21 ATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             EeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHH
Confidence            4567789999999885432 2333456788999999999999999999999877     567799999984 7777664 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+....... .......++..|+|
T Consensus        96 ~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~a  174 (267)
T cd08229          96 FKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMS  174 (267)
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-cccccccCCcCccC
Confidence               24568999999999999999999999999999999999999999999999999887543222 11223356788999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ||...+ ..++.++|+||||+++|+|++|..||.+..
T Consensus       175 pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  210 (267)
T cd08229         175 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDK  210 (267)
T ss_pred             HHHhcC-CCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence            999877 447889999999999999999999996543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-33  Score=209.00  Aligned_cols=189  Identities=25%  Similarity=0.405  Sum_probs=148.1

Q ss_pred             cCCCCCc--EEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          3 TDPRDGR--RVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         3 ~~~~~~~--~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      .+..+|.  .+++|.++.. ......+.+..|++.++++ +||||+++++++...     ..++++|||+. ++|.+++.
T Consensus        15 ~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~   88 (270)
T cd05047          15 RIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLR   88 (270)
T ss_pred             EEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHH
Confidence            3445555  4688887532 2233456788899999999 899999999999877     56789999997 58888875


Q ss_pred             CC----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC
Q psy16889         79 SP----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK  142 (203)
Q Consensus        79 ~~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  142 (203)
                      ..                ..++++++..++.|++.|+++||+.+++|+||+|+||+++.++.++++|||++......  .
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~--~  166 (270)
T cd05047          89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--V  166 (270)
T ss_pred             hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchh--h
Confidence            42                24789999999999999999999999999999999999999999999999988532211  1


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .......+..|.|||++.. ..++.++|+||||+++|+|++ |+.||.+.+..+..+.+
T Consensus       167 ~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  224 (270)
T cd05047         167 KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  224 (270)
T ss_pred             hccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence            1111223556999998876 458899999999999999997 99999877665555443

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.1e-33  Score=207.33  Aligned_cols=185  Identities=24%  Similarity=0.423  Sum_probs=150.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~   82 (203)
                      .+++.|++|.+....   ...+.+.+|+.++++++|+|++++++++.+.      ..++++|++. ++|.+.+..  ...
T Consensus        28 ~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05067          28 NGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPEGIK   98 (260)
T ss_pred             CCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEccC------CcEEEEEcCCCCCHHHHHHhcCCCC
Confidence            467889999986432   2345788899999999999999999987443      4689999997 588887754  346


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++.++..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.. 
T Consensus        99 ~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-  177 (260)
T cd05067          99 LTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-
Confidence            8999999999999999999999999999999999999999999999999987544222222223334567999998876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++.++|+||||+++|++++ |++||.+.+..+....+
T Consensus       178 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  216 (260)
T cd05067         178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL  216 (260)
T ss_pred             CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence            457899999999999999998 99999888776665544

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG2345|consensus

Probab=100.00  E-value=6e-34  Score=199.76  Aligned_cols=186  Identities=26%  Similarity=0.351  Sum_probs=151.0

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--   79 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--   79 (203)
                      .+..+++.||+|.+...  +.++.+..++|++..++++|||+++++++...+..+.....|++.+|.. |+|.+.+..  
T Consensus        41 ~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k  118 (302)
T KOG2345|consen   41 KGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLK  118 (302)
T ss_pred             cccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHh
Confidence            35678999999999653  3567788999999999999999999999876665444456889999987 788887753  


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--------Ccccc
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--------AMTQE  147 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~  147 (203)
                        +..++|.+++.|+.++++||++||+..  +.|+||||.||++...+.+++.|||.++...-....        .....
T Consensus       119 ~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e  198 (302)
T KOG2345|consen  119 IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEE  198 (302)
T ss_pred             hcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHH
Confidence              347999999999999999999999998  999999999999999999999999998632211000        11122


Q ss_pred             cCCcccccceeeecc--cCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        148 VVTQYYRAPEILMGA--RHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ..|..|.|||.+.-.  ...+.++|||||||++|.|+.|..||..
T Consensus       199 ~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~  243 (302)
T KOG2345|consen  199 RCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER  243 (302)
T ss_pred             hCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence            347789999988642  3467899999999999999999999954

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-33  Score=206.40  Aligned_cols=189  Identities=26%  Similarity=0.400  Sum_probs=151.7

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~   81 (203)
                      +.. |+.|++|.+...... ...+.+..|++++++++|+||+++++++.+.     ...++++|++. ++|.+++.. ..
T Consensus        16 ~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~   88 (251)
T cd05041          16 LKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKN   88 (251)
T ss_pred             EeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCC
Confidence            344 899999998654332 3556788999999999999999999998877     56789999997 588888754 45


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCc-ccccCCcccccceeee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM-TQEVVTQYYRAPEILM  160 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPe~~~  160 (203)
                      .+++..+..++.+++.++++||+++++|+||+|+||+++.++.++++|||.+........... .....+..|.|||.+.
T Consensus        89 ~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  168 (251)
T cd05041          89 RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN  168 (251)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhc
Confidence            689999999999999999999999999999999999999999999999999874332111111 1112245699999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|++++ |..||...........+
T Consensus       169 ~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~  208 (251)
T cd05041         169 Y-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI  208 (251)
T ss_pred             c-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence            6 458999999999999999998 89999887655544433

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.2e-33  Score=211.32  Aligned_cols=193  Identities=27%  Similarity=0.407  Sum_probs=151.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-   78 (203)
                      +.+..+|+.+++|.+....   .....+.+|+.+++++ +|||++++++++...+.......++++||+++ +|.+.+. 
T Consensus        41 ~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~  117 (291)
T cd06639          41 VTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG  117 (291)
T ss_pred             EEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHH
Confidence            4567889999999985421   2234567889999998 89999999999875432212357899999974 7776654 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....+++..++.++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+........ ......++..|+|
T Consensus       118 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~a  196 (291)
T cd06639         118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMA  196 (291)
T ss_pred             hhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc-cccCccCCccccC
Confidence               346799999999999999999999999999999999999999999999999999874432221 1123356788999


Q ss_pred             ceeeeccc----CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        156 PEILMGAR----HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       156 Pe~~~~~~----~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ||.+....    .++.++|+||||+++|+|++|++||....+...+.
T Consensus       197 PE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~  243 (291)
T cd06639         197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF  243 (291)
T ss_pred             hhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence            99876432    25789999999999999999999998876554443

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.8e-33  Score=212.54  Aligned_cols=188  Identities=29%  Similarity=0.438  Sum_probs=153.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.+++|.++... ........+..|++.+++++|+|++++++++.++     ...++++||+.|++.+.+.. 
T Consensus        44 ~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~  118 (317)
T cd06635          44 ARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVH  118 (317)
T ss_pred             EEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHh
Confidence            3566789999999985432 2333445688899999999999999999998877     45689999999888777653 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++++.++..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+.....     .....++..|+|||.+
T Consensus       119 ~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~y~aPE~~  193 (317)
T cd06635         119 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTPYWMAPEVI  193 (317)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCccccChhhh
Confidence            56699999999999999999999999999999999999999999999999998864322     1233567789999987


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      ..  .+.++.++|+||||+++|+|++|+.||........+..
T Consensus       194 ~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  235 (317)
T cd06635         194 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  235 (317)
T ss_pred             hcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            42  24578899999999999999999999977665544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.4e-33  Score=207.30  Aligned_cols=187  Identities=28%  Similarity=0.453  Sum_probs=151.0

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~   85 (203)
                      +..+++|.+..... ......+..|+..+++++||||+++++++.++     ...+++|||++ ++|.+++... +.+++
T Consensus        32 ~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~  105 (267)
T cd05066          32 EIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFTV  105 (267)
T ss_pred             ceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCCH
Confidence            44799999864322 23456788899999999999999999998776     56789999997 5888887653 56899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcc--cccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT--QEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~--~~~~~~~~~aPe~~~~~~  163 (203)
                      .++..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+............  ...++..|++||.+.+ .
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~  184 (267)
T cd05066         106 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY-R  184 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc-C
Confidence            999999999999999999999999999999999999999999999998754432221111  1122457999999977 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|++++ |..||.+....+....+.
T Consensus       185 ~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~  223 (267)
T cd05066         185 KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE  223 (267)
T ss_pred             ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh
Confidence            58999999999999999886 999998877666555543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.1e-33  Score=206.69  Aligned_cols=186  Identities=24%  Similarity=0.436  Sum_probs=149.6

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~   82 (203)
                      .++..+++|.+.....   ..+.+.+|+.++++++|++++++++++...      ..+++|||+. ++|.+.+..  ...
T Consensus        28 ~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05070          28 NGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKDGEGRA   98 (260)
T ss_pred             cCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECCC------CcEEEEEecCCCcHHHHHHhcCCCC
Confidence            3567799999864322   335688999999999999999999987543      3579999997 488888764  345


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||...+ 
T Consensus        99 ~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  177 (260)
T cd05070          99 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-  177 (260)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-
Confidence            8999999999999999999999999999999999999999999999999987543322222222234567999998876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..++.++|+||||+++|++++ |.+||.+....+....+.
T Consensus       178 ~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~  217 (260)
T cd05070         178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE  217 (260)
T ss_pred             CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            457899999999999999999 899998877766665553

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4645|consensus

Probab=100.00  E-value=2.8e-34  Score=238.15  Aligned_cols=194  Identities=25%  Similarity=0.401  Sum_probs=160.5

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +|.+..+|+-.|+|.+............+.+|..++..++|||+++++++=.+.     ..+++-||||.| +|.+.+..
T Consensus      1253 tavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~IFMEyC~~GsLa~ll~~ 1327 (1509)
T KOG4645|consen 1253 TAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVYIFMEYCEGGSLASLLEH 1327 (1509)
T ss_pred             EeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHHHHHHHHhccCcHHHHHHh
Confidence            467899999999999855433455667788999999999999999999998887     788999999994 77777666


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC---CCCcccccCCcccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~aP  156 (203)
                      .+-.+|-....+-.|++.++.|||+.|||||||||.||+++.+|.+|++|||.+.......   ........||+-|+||
T Consensus      1328 gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAP 1407 (1509)
T KOG4645|consen 1328 GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAP 1407 (1509)
T ss_pred             cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCc
Confidence            6667777777788999999999999999999999999999999999999999997554432   1122355789999999


Q ss_pred             eeeeccc--CCCcchhHHHHHHHHHHHHhCCcccCCCC-hHHHhhh
Q psy16889        157 EILMGAR--HYSAAVDVWSVGCIFAELLGRRILFQAQS-PVQQLGL  199 (203)
Q Consensus       157 e~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~-~~~~~~~  199 (203)
                      |++.+.+  ....+.|||||||++.||+||+.||...+ .+.++..
T Consensus      1408 Evit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~ 1453 (1509)
T KOG4645|consen 1408 EVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH 1453 (1509)
T ss_pred             hhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH
Confidence            9998743  34678999999999999999999998754 5555543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-33  Score=211.48  Aligned_cols=182  Identities=23%  Similarity=0.381  Sum_probs=145.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhh-hHHHHHHHHH---HhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVS-SKRVFRELKM---LCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~-~~~~~~e~~~---l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      +.+..+|+.+++|.+......... .....+|...   +...+|++++.+++++..+     ...+++|||+. ++|.++
T Consensus        13 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   87 (279)
T cd05633          13 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYH   87 (279)
T ss_pred             EEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHH
Confidence            456788999999998543222121 2223344433   3334799999999988876     46789999998 588888


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +...+.+++..+..++.|++.||++||+++++|+||+|+||+++.++.++++|||.+......   ......++..|+||
T Consensus        88 i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~y~aP  164 (279)
T cd05633          88 LSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP  164 (279)
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccCcCCCcCccCH
Confidence            887788999999999999999999999999999999999999999999999999998643322   11233578899999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |...+...++.++|+||+|+++|++++|+.||...
T Consensus       165 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            98865455789999999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.9e-33  Score=207.56  Aligned_cols=180  Identities=22%  Similarity=0.378  Sum_probs=143.3

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCChHH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~   87 (203)
                      .+++|.+... ........+..|+..+++++||||+++++++...      ..++++|++. ++|.+++.. .+.+++..
T Consensus        38 ~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~------~~~~i~e~~~~gsL~~~l~~~~~~~~~~~  110 (279)
T cd05111          38 PVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA------SLQLVTQLSPLGSLLDHVRQHRDSLDPQR  110 (279)
T ss_pred             EEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC------ccEEEEEeCCCCcHHHHHHhcccCCCHHH
Confidence            4777877432 2223345677788889999999999999987543      3567888887 699988864 46799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeecccCCC
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGARHYS  166 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~  166 (203)
                      +..++.|++.+++|||+++++|+||||+||+++.++.++++|||.+......... ......++..|++||.+.+ ..++
T Consensus       111 ~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~  189 (279)
T cd05111         111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYT  189 (279)
T ss_pred             HHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcC
Confidence            9999999999999999999999999999999999999999999998754322211 1223345667999999876 4589


Q ss_pred             cchhHHHHHHHHHHHHh-CCcccCCCChHHHh
Q psy16889        167 AAVDVWSVGCIFAELLG-RRILFQAQSPVQQL  197 (203)
Q Consensus       167 ~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  197 (203)
                      .++|+||||+++|++++ |..||.+..+....
T Consensus       190 ~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~  221 (279)
T cd05111         190 HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP  221 (279)
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            99999999999999998 99999887665543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.8e-33  Score=211.18  Aligned_cols=183  Identities=28%  Similarity=0.433  Sum_probs=148.4

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      ..++..+++|.++... .....+.+.+|+++++++ +|+||+++++++...     ...++++||+. ++|.+++...  
T Consensus        62 ~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~  135 (302)
T cd05055          62 SDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRE  135 (302)
T ss_pred             CCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCC
Confidence            4566789999986532 223456788999999999 899999999998877     56789999998 5888887643  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++.++..++.|++.++++||+++++|+||+|+||+++.++.++++|||.+......... ......++..|+|||.+
T Consensus       136 ~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  215 (302)
T cd05055         136 SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI  215 (302)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhh
Confidence            33899999999999999999999999999999999999999999999999998744322211 11122346679999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPV  194 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~  194 (203)
                      .+ ..++.++|+||||+++|++++ |..||......
T Consensus       216 ~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~  250 (302)
T cd05055         216 FN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD  250 (302)
T ss_pred             cc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence            77 447899999999999999998 99999776543

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.1e-33  Score=212.08  Aligned_cols=187  Identities=27%  Similarity=0.446  Sum_probs=149.4

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      ++..+++|.+... ........+..|+++++.+ +|+||+++++++...     ...++++||++ ++|.+++...    
T Consensus        49 ~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  122 (307)
T cd05098          49 RVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPG  122 (307)
T ss_pred             ccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcc
Confidence            4467999998643 2233456688899999999 899999999999877     56789999998 5888887643    


Q ss_pred             ------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-Ccccc
Q psy16889         81 ------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQE  147 (203)
Q Consensus        81 ------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~  147 (203)
                                  ..+++.++..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+......... .....
T Consensus       123 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~  202 (307)
T cd05098         123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG  202 (307)
T ss_pred             cccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccC
Confidence                        24888999999999999999999999999999999999999999999999998744322111 11122


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       203 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         203 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            23467999998877 457899999999999999998 89999887766655443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-33  Score=209.75  Aligned_cols=189  Identities=26%  Similarity=0.412  Sum_probs=154.6

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-   80 (203)
                      .+..+|..+++|++....... ....+.+|++.++.++|+|++++++.+...     ...++++|++.+ +|.+.+... 
T Consensus        21 ~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~   94 (267)
T cd06610          21 ICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSY   94 (267)
T ss_pred             EEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhc
Confidence            445688999999986543332 567788999999999999999999988776     567899999974 787777643 


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCccccc
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRA  155 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~a  155 (203)
                        ..+++..+..++.|++.++++||++|++|+||+|+||++++++.++++|||.+.........   ......++..|++
T Consensus        95 ~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~  174 (267)
T cd06610          95 PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA  174 (267)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcC
Confidence              46899999999999999999999999999999999999999999999999988754432222   1122346778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ||.+.....++.++|+||||+++|+|++|+.||.+.++...+
T Consensus       175 Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~  216 (267)
T cd06610         175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL  216 (267)
T ss_pred             hHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence            999877546789999999999999999999999876654433

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.3e-33  Score=205.65  Aligned_cols=184  Identities=27%  Similarity=0.376  Sum_probs=150.8

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CCCCh
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QHLTS   85 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~   85 (203)
                      ..|++|.++..... ...+.+..|++.+++++|+||+++++++.+      ...++++||+. ++|.+++...  ..+++
T Consensus        24 ~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~   96 (257)
T cd05040          24 IPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLI   96 (257)
T ss_pred             eEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCcH
Confidence            36999999664333 556778899999999999999999998876      24578999997 6898888764  36899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ..++.++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+.........  ......++..|+|||.+.+ .
T Consensus        97 ~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~  175 (257)
T cd05040          97 STLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-R  175 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-c
Confidence            999999999999999999999999999999999999999999999998754332111  1122345677999998876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|+|++ |+.||...+..+.+..+
T Consensus       176 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  213 (257)
T cd05040         176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI  213 (257)
T ss_pred             CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            57899999999999999998 99999887776665544

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6e-33  Score=206.77  Aligned_cols=188  Identities=22%  Similarity=0.277  Sum_probs=146.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..++..+++|.++... .......+.+|+..+++++||||+++++++.+.     ...+++|||++ ++|.+++...  
T Consensus        18 ~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~   91 (269)
T cd05087          18 SGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRK   91 (269)
T ss_pred             CCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhh
Confidence            34566789999886542 223345678899999999999999999998876     45789999998 5888877532  


Q ss_pred             ---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccc
Q psy16889         81 ---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aP  156 (203)
                         ...++..+..++.|++.++++||+.+++|+||||+||+++.++.++++|||.+........ .......++..|+||
T Consensus        92 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  171 (269)
T cd05087          92 AELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP  171 (269)
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCH
Confidence               2456778889999999999999999999999999999999999999999999864322211 111233456789999


Q ss_pred             eeeeccc------CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHh
Q psy16889        157 EILMGAR------HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQL  197 (203)
Q Consensus       157 e~~~~~~------~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  197 (203)
                      |++.+..      .++.++|+||||+++|++++ |+.||....+.+..
T Consensus       172 E~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  219 (269)
T cd05087         172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL  219 (269)
T ss_pred             hHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence            9886421      24779999999999999996 99999877655543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-33  Score=206.13  Aligned_cols=189  Identities=29%  Similarity=0.503  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|.+..........+.+.+|++++++++|+|++++.+++.++     ...++++|++++ +|.+.+...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~   93 (254)
T cd06627          19 GLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKF   93 (254)
T ss_pred             EEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhc
Confidence            34667889999999976544445667899999999999999999999998776     567789999985 888888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........ ......++..|.+||...
T Consensus        94 ~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~  172 (254)
T cd06627          94 GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPYWMAPEVIE  172 (254)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cccccccchhhcCHhhhc
Confidence            8899999999999999999999999999999999999999999999999999875443322 123345678899999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      +.. ++.++|+||+|+++|++++|..||...++...+
T Consensus       173 ~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~  208 (254)
T cd06627         173 MSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL  208 (254)
T ss_pred             CCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            744 789999999999999999999999876654443

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.1e-33  Score=211.58  Aligned_cols=188  Identities=27%  Similarity=0.456  Sum_probs=150.1

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP---   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---   80 (203)
                      ..+..+++|.+.... .......+..|+++++++ +||||+++++++.+.     ..+++++||+. ++|.+++...   
T Consensus        42 ~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~  115 (314)
T cd05099          42 DQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPP  115 (314)
T ss_pred             CcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCC
Confidence            345679999986432 234456788899999999 699999999998876     56789999997 5888887542   


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                   +.+++.++..++.|++.||++||++|++|+||+|+||+++.++.++++|||.+........ .....
T Consensus       116 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  195 (314)
T cd05099         116 GPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN  195 (314)
T ss_pred             cccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEcccccccccccccccccccc
Confidence                         3488899999999999999999999999999999999999999999999999974432211 11112


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.+....+....+
T Consensus       196 ~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~  249 (314)
T cd05099         196 GRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL  249 (314)
T ss_pred             CCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            223457999999876 558899999999999999998 89999887766655543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.6e-33  Score=207.93  Aligned_cols=188  Identities=24%  Similarity=0.348  Sum_probs=152.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ---   81 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---   81 (203)
                      .+.+.+++|.+... ......+.+.+|++++++++|+|++++++++.+.     ...++++||++ ++|.+++....   
T Consensus        33 ~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~  106 (275)
T cd05046          33 GGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKD  106 (275)
T ss_pred             CCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhccccc
Confidence            45677999988542 2222456788999999999999999999998876     56789999998 58888887544   


Q ss_pred             ------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         82 ------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        82 ------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                            .+++..+..++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+...............++..|+|
T Consensus       107 ~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~  186 (275)
T cd05046         107 EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA  186 (275)
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecC
Confidence                  69999999999999999999999999999999999999999999999999886433222223333345677999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ||.+.+ ..++.++|+||||+++|++++ |..||........+..+
T Consensus       187 PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~  231 (275)
T cd05046         187 PEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL  231 (275)
T ss_pred             hhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH
Confidence            998876 447889999999999999998 88999876665555443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3e-33  Score=209.16  Aligned_cols=193  Identities=26%  Similarity=0.443  Sum_probs=158.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+|+.|++|++.... ........+.+|.+++++++ |+||+++++++.++     ...+++||++. ++|.+.+.
T Consensus        20 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~   94 (280)
T cd05581          20 AKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIR   94 (280)
T ss_pred             EEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHH
Confidence            4566789999999985422 22333456778999999998 99999999999877     56789999995 69999988


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-----------------
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-----------------  141 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----------------  141 (203)
                      ..+.+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+........                 
T Consensus        95 ~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (280)
T cd05581          95 KYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK  174 (280)
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccc
Confidence            888899999999999999999999999999999999999999999999999999875443321                 


Q ss_pred             --CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        142 --KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       142 --~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                        .......++..|.|||+..+ ..++.++|+||||++++++++|+.||...+.....+.+
T Consensus       175 ~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (280)
T cd05581         175 NRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI  234 (280)
T ss_pred             cccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence              12223355778999998876 44788999999999999999999999987755544443

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-33  Score=205.68  Aligned_cols=183  Identities=25%  Similarity=0.444  Sum_probs=147.5

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC--CCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP--QHLT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~   84 (203)
                      +..+++|.+....   ...+.+.+|++++++++|+|++++++++...      ..+++|||+.+ +|.+++...  ..++
T Consensus        30 ~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~~~  100 (260)
T cd05069          30 TTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEE------PIYIVTEFMGKGSLLDFLKEGDGKYLK  100 (260)
T ss_pred             CceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCC------CcEEEEEcCCCCCHHHHHhhCCCCCCC
Confidence            3468999875421   2345678899999999999999999887543      35799999984 898888643  3589


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.||.+||+.|++|+||+|+||++++++.++++|||.+...............++..|+|||...+ ..
T Consensus       101 ~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~  179 (260)
T cd05069         101 LPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR  179 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CC
Confidence            99999999999999999999999999999999999999999999999987543322222222334667999998876 44


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++|++++ |+.||.+..+.+...++
T Consensus       180 ~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  216 (260)
T cd05069         180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV  216 (260)
T ss_pred             cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            7899999999999999999 99999887776665554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.2e-33  Score=207.59  Aligned_cols=185  Identities=27%  Similarity=0.459  Sum_probs=149.1

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~   86 (203)
                      ..|+||.+.... .......+..|+..+++++||||+++.+++.++     ...++++||+++ +|.+++.. .+.+++.
T Consensus        33 ~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  106 (269)
T cd05065          33 IFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTVI  106 (269)
T ss_pred             eeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCHH
Confidence            469999986532 334456788999999999999999999998777     567899999985 78887764 4568999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC-ccccc---CCcccccceeeecc
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA-MTQEV---VTQYYRAPEILMGA  162 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~---~~~~~~aPe~~~~~  162 (203)
                      +++.++.|++.|+++||++|++|+||+|+||+++.++.++++|||.+.......... .....   .+..|+|||.+.+ 
T Consensus       107 ~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-  185 (269)
T cd05065         107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-  185 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-
Confidence            999999999999999999999999999999999999999999999886443222111 11111   1346999999876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++.++|+||||+++|++++ |..||...+..+....+
T Consensus       186 ~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i  224 (269)
T cd05065         186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI  224 (269)
T ss_pred             CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            457899999999999999886 99999887776665554

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-33  Score=208.32  Aligned_cols=181  Identities=26%  Similarity=0.368  Sum_probs=144.8

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCChHH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~   87 (203)
                      .|++|.++.. ........+.+|..+++.++|+||+++++++...      ..++++++++ |+|.+.+.. .+.+++..
T Consensus        38 ~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~  110 (279)
T cd05109          38 PVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRENKDRIGSQD  110 (279)
T ss_pred             EEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhhccCCCCHHH
Confidence            5899998643 2333456688899999999999999999988654      2457888887 688888765 45699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeecccCCC
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGARHYS  166 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~  166 (203)
                      +..++.|++.||+|||+++++|+||||+||+++.++.++|+|||.+......... ......++..|+|||...+ ..++
T Consensus       111 ~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~  189 (279)
T cd05109         111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH-RRFT  189 (279)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc-CCCC
Confidence            9999999999999999999999999999999999999999999998754322211 1122233567999999876 4588


Q ss_pred             cchhHHHHHHHHHHHHh-CCcccCCCChHHHhh
Q psy16889        167 AAVDVWSVGCIFAELLG-RRILFQAQSPVQQLG  198 (203)
Q Consensus       167 ~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~  198 (203)
                      .++|+||||+++|++++ |..||......+...
T Consensus       190 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~  222 (279)
T cd05109         190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD  222 (279)
T ss_pred             chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999999998 999998766554443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-33  Score=210.02  Aligned_cols=180  Identities=29%  Similarity=0.487  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.++.+++.+++|.+..... ......+.+|++.++.++||||+++++.+..+     ..+++++|+++ ++|.+.+...
T Consensus        20 ~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   93 (265)
T cd06605          20 VLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEV   93 (265)
T ss_pred             EEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHc
Confidence            45677899999999865432 24456788899999999999999999998887     56789999999 5888888765


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ..+++..+..++.|++.+++++|+ .+++|+||+|+||+++.++.++++|||.+.........   ...++..|+|||.
T Consensus        94 ~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~y~~PE~  170 (265)
T cd06605          94 QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPER  170 (265)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh---cccCChhccCHHH
Confidence             789999999999999999999999 99999999999999999999999999988643322111   1456778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +.+ ..++.++|+||||+++|++++|+.||...
T Consensus       171 ~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         171 IQG-NDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             HcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            877 45889999999999999999999999664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8e-33  Score=206.18  Aligned_cols=185  Identities=26%  Similarity=0.411  Sum_probs=149.3

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~   85 (203)
                      ...+++|...... .....+.+.+|+..+++++|+||+++++++.++      ..++++||+. ++|.+++... ..+++
T Consensus        34 ~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~  106 (270)
T cd05056          34 KIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------PVWIVMELAPLGELRSYLQVNKYSLDL  106 (270)
T ss_pred             CcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------CcEEEEEcCCCCcHHHHHHhCCCCCCH
Confidence            4568999885432 234556788999999999999999999988765      3468999997 5898888753 45899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCC
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHY  165 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~  165 (203)
                      ..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.. ..+
T Consensus       107 ~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  185 (270)
T cd05056         107 ASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRF  185 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCC
Confidence            9999999999999999999999999999999999999999999999987543332222222233567999998876 457


Q ss_pred             CcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        166 SAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       166 ~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.++|+||||+++|++++ |..||.+.+..+.+..+
T Consensus       186 ~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  221 (270)
T cd05056         186 TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI  221 (270)
T ss_pred             CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            899999999999999986 99999888766655444

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.2e-33  Score=207.79  Aligned_cols=183  Identities=30%  Similarity=0.491  Sum_probs=150.4

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.|++|.++... ......+.+.+|++++++++|++++++++++.+.     ...++++||++ ++|...+..
T Consensus        21 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   95 (267)
T cd08224          21 AICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKH   95 (267)
T ss_pred             EEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHH
Confidence            4566789999999885422 2333466788999999999999999999999877     45689999998 488777642


Q ss_pred             ----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         80 ----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        80 ----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                          ...++++.+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|.|
T Consensus        96 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~a  174 (267)
T cd08224          96 FKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMS  174 (267)
T ss_pred             hcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-cccceecCCccccC
Confidence                3558999999999999999999999999999999999999999999999999886433221 12223356778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ||.+.+ ..++.++|+||||+++|++++|+.||...
T Consensus       175 pE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         175 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             HHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            998876 45789999999999999999999999554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.6e-33  Score=210.07  Aligned_cols=182  Identities=24%  Similarity=0.342  Sum_probs=149.7

Q ss_pred             CCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          5 PRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      ..+|+.|++|+++....  .....+.+..|+++++++ +|++|+++++++..+     ...++++||+. ++|.+++...
T Consensus        25 ~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   99 (290)
T cd05613          25 HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQR   99 (290)
T ss_pred             CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHc
Confidence            35899999999864321  222345677899999999 699999999998877     56778999998 4899988877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+...............++..|++||.+.
T Consensus       100 ~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (290)
T cd05613         100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR  179 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhcc
Confidence            88999999999999999999999999999999999999999999999999998754332222223345678899999987


Q ss_pred             cc-cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GA-RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .. ..++.++|+||||+++|++++|+.||...
T Consensus       180 ~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  211 (290)
T cd05613         180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVD  211 (290)
T ss_pred             CCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence            53 23678899999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.8e-33  Score=210.24  Aligned_cols=188  Identities=27%  Similarity=0.475  Sum_probs=150.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS----   79 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----   79 (203)
                      ..+..+++|.+.... .......+.+|+++++++ +|+||+++++++..+     ..++++|||+. ++|..++..    
T Consensus        40 ~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~  113 (293)
T cd05053          40 NETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPP  113 (293)
T ss_pred             CCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCC
Confidence            345679999986532 233445688899999999 899999999998877     56789999987 588877742    


Q ss_pred             ------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         80 ------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        80 ------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                  .+.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||.+........ .....
T Consensus       114 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  193 (293)
T cd05053         114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN  193 (293)
T ss_pred             ccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCC
Confidence                        34689999999999999999999999999999999999999999999999999875432211 11222


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++..|+|||+..+ ..++.++|+||||+++|++++ |..||.+....+....+
T Consensus       194 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  247 (293)
T cd05053         194 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  247 (293)
T ss_pred             CCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            234567999998876 457899999999999999997 99999887766655443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.9e-33  Score=208.59  Aligned_cols=187  Identities=25%  Similarity=0.396  Sum_probs=148.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC------
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS------   79 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------   79 (203)
                      .+..+++|.+.... .....+.+.+|+..++.++||||+++++.+...     ...++++||+. ++|.+++..      
T Consensus        29 ~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  102 (290)
T cd05045          29 GYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGP  102 (290)
T ss_pred             cceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccc
Confidence            44678899886432 223456788999999999999999999998876     45788999998 577776542      


Q ss_pred             ------------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC
Q psy16889         80 ------------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        80 ------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~  141 (203)
                                        ...+++..++.++.|++.+|++||+.+++||||+|+||+++.++.++++|||.+........
T Consensus       103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~  182 (290)
T cd05045         103 SYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS  182 (290)
T ss_pred             cccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccc
Confidence                              13478899999999999999999999999999999999999999999999999874322211


Q ss_pred             -CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        142 -KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       142 -~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                       .......++..|+|||...+ ..++.++|+||||+++|+|++ |..||.+..+....+.+
T Consensus       183 ~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~  242 (290)
T cd05045         183 YVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL  242 (290)
T ss_pred             hhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence             11222234567999998876 458899999999999999998 99999888776655543

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3e-33  Score=210.82  Aligned_cols=186  Identities=25%  Similarity=0.475  Sum_probs=152.1

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   81 (203)
                      .+..+|+.|++|.+...  .......+.+|+..++.++|+|++++++++..+     ...++++||+++ +|.+.+ ..+
T Consensus        40 ~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~-~~~  111 (292)
T cd06657          40 TVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIV-THT  111 (292)
T ss_pred             EEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEecCCCCcHHHHH-hcC
Confidence            45678999999998532  223456688899999999999999999999877     567899999985 666654 445


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+.+
T Consensus       112 ~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~  190 (292)
T cd06657         112 RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISR  190 (292)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCccccCHHHhcC
Confidence            68999999999999999999999999999999999999999999999999876433221 12233356788999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                       ..++.++|+||+|+++|++++|..||......+.+.
T Consensus       191 -~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~  226 (292)
T cd06657         191 -LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  226 (292)
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence             457899999999999999999999998776554433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.2e-33  Score=206.97  Aligned_cols=177  Identities=19%  Similarity=0.268  Sum_probs=142.1

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~   84 (203)
                      ....|++|.+...  .......+.+|+.+++.++||||+++++++..+     ...++||||+++ +|..++.. .+.++
T Consensus        43 ~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~  115 (274)
T cd05076          43 RELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVP  115 (274)
T ss_pred             eeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCC
Confidence            3456899988543  222345677899999999999999999999877     567899999985 67776654 56799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-------eEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-------ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +..+..++.|++.||+|||+++++||||||+||+++..+       .++++|||.+......     ....++..|+|||
T Consensus       116 ~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe  190 (274)
T cd05076         116 VAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPE  190 (274)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-----cccccCCcccCch
Confidence            999999999999999999999999999999999997543       4799999987532211     1224567799999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHH-hCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~~~  195 (203)
                      .+.+...++.++|+||||+++|+++ +|+.||....+.+
T Consensus       191 ~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         191 CVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            8876566899999999999999985 7999998776544

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=208.81  Aligned_cols=194  Identities=25%  Similarity=0.410  Sum_probs=152.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCc-chhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHL-DFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      +.++.+++.+++|++....   ...+.+.+|+++++++ +|+||+++++++..... .....+++++||+.+ +|.+.+.
T Consensus        25 ~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~  101 (275)
T cd06608          25 ARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK  101 (275)
T ss_pred             EEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHH
Confidence            4566788999999986432   2345688999999999 79999999999876532 111356899999985 6766654


Q ss_pred             C----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         79 S----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .    +..+++..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+...... ........++..|+
T Consensus       102 ~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~y~  180 (275)
T cd06608         102 GLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST-LGRRNTFIGTPYWM  180 (275)
T ss_pred             HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc-hhhhcCcccccccc
Confidence            3    467999999999999999999999999999999999999999999999999988643322 22223345688899


Q ss_pred             cceeeecc----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        155 APEILMGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       155 aPe~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |||.+...    ..++.++|+||||+++|++++|+.||....+...+.+
T Consensus       181 aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  229 (275)
T cd06608         181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK  229 (275)
T ss_pred             CHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH
Confidence            99987542    3467889999999999999999999987654444433

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.4e-33  Score=210.59  Aligned_cols=187  Identities=27%  Similarity=0.419  Sum_probs=153.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.|++|.+..... .......+.+|++.++.++|+|++++++++.+.     ...++++||+.+++.+.+.. 
T Consensus        40 ~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~  114 (313)
T cd06633          40 ATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVH  114 (313)
T ss_pred             EEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhc
Confidence            35667899999999854322 333445678899999999999999999999887     56789999999888877764 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++++.++..++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+....     ......++..|+|||++
T Consensus       115 ~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~~~~~~~~y~aPE~~  189 (313)
T cd06633         115 KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMAPEVI  189 (313)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CCCCccccccccChhhc
Confidence            4679999999999999999999999999999999999999999999999999886322     12234567889999998


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      ..  ...++.++|+||||+++|+|++|..||...+....+.
T Consensus       190 ~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~  230 (313)
T cd06633         190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY  230 (313)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            52  2457889999999999999999999998766554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-33  Score=204.46  Aligned_cols=180  Identities=24%  Similarity=0.443  Sum_probs=150.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--CC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--HL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~   83 (203)
                      .|+.|++|.+.....   ....+.+|+.+++.++|+|++++++++.+.     ...++++|+++ ++|.+++....  .+
T Consensus        28 ~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~   99 (256)
T cd05039          28 RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVI   99 (256)
T ss_pred             cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCC
Confidence            578899999965322   456788999999999999999999998875     56789999998 58988887554  79


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.++.+||+++++|+||+|+||+++.++.++++|||.+........    ....+..|.|||.+.. .
T Consensus       100 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~-~  174 (256)
T cd05039         100 TLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALRE-K  174 (256)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc----cCCCcccccCchhhcC-C
Confidence            9999999999999999999999999999999999999999999999999875422111    2233556999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      .++.++|+||||+++|++++ |..||......+....
T Consensus       175 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~  211 (256)
T cd05039         175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH  211 (256)
T ss_pred             cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            57889999999999999997 9999988776655443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=226.75  Aligned_cols=158  Identities=27%  Similarity=0.424  Sum_probs=131.5

Q ss_pred             hhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-----CCCChHHHHHHHHHHHHHH
Q psy16889         25 SSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-----QHLTSDHIKVFLYQILRGL   99 (203)
Q Consensus        25 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l   99 (203)
                      ....+.+|++++++++|+||+++++++.+.     ...|++++++.+++..++...     .......+..++.|++.||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL  280 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAV  280 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999887     456788888888777765432     2345677889999999999


Q ss_pred             HHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHH
Q psy16889        100 KYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA  179 (203)
Q Consensus       100 ~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~  179 (203)
                      +|||++|++||||||+||+++.++.++|+|||++...............|+..|+|||++.+ ..++.++|||||||++|
T Consensus       281 ~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~  359 (501)
T PHA03210        281 EYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILL  359 (501)
T ss_pred             HHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHH
Confidence            99999999999999999999999999999999997554333333334567999999999987 45899999999999999


Q ss_pred             HHHhCCccc
Q psy16889        180 ELLGRRILF  188 (203)
Q Consensus       180 ~ll~g~~pf  188 (203)
                      +|++|+.++
T Consensus       360 ell~~~~~p  368 (501)
T PHA03210        360 DMLSHDFCP  368 (501)
T ss_pred             HHHHCCCCC
Confidence            999987543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-33  Score=209.84  Aligned_cols=188  Identities=29%  Similarity=0.508  Sum_probs=156.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+++.|++|.+.....   ..+.+.+|++.++.++|+|++++++++...     ...++++||++ ++|.+++...
T Consensus        38 ~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  109 (286)
T cd06614          38 ATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQN  109 (286)
T ss_pred             EEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHh
Confidence            34566789999999864322   456788899999999999999999998877     56789999999 6899888876


Q ss_pred             C-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 Q-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      . .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... .......++..|++||.+
T Consensus       110 ~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~  188 (286)
T cd06614         110 FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGTPYWMAPEVI  188 (286)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hhhccccCCcccCCHhHh
Confidence            5 89999999999999999999999999999999999999999999999999876433221 122233457789999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      .+ ..++.++|+||||+++|++++|+.||...++......
T Consensus       189 ~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~  227 (286)
T cd06614         189 KR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL  227 (286)
T ss_pred             cC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            76 4578999999999999999999999988776554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-33  Score=205.92  Aligned_cols=191  Identities=28%  Similarity=0.482  Sum_probs=159.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+++.|++|++............+.+|++.++.++|+|++++.+.+.+.     ...++++|++++ +|.+.+.. 
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   93 (258)
T cd08215          19 VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQ   93 (258)
T ss_pred             EEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHh
Confidence            45667899999999976544456667788999999999999999999998877     567789999985 88887765 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                         ...+++..+..++.+++.++.+||++|++|+||+|+||+++.++.++++|||.+....... .......+++.|+||
T Consensus        94 ~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~p  172 (258)
T cd08215          94 KKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSP  172 (258)
T ss_pred             hccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ceecceeeeecccCh
Confidence               3679999999999999999999999999999999999999999999999999987544332 122334668889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |...+ ..++.++|+||+|++++++++|+.||......+....
T Consensus       173 e~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~  214 (258)
T cd08215         173 ELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK  214 (258)
T ss_pred             hHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH
Confidence            98876 4578999999999999999999999988766555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.4e-33  Score=210.03  Aligned_cols=183  Identities=22%  Similarity=0.404  Sum_probs=146.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHH---HH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHK---II   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~---~~   77 (203)
                      +.+..+|+.+++|.+...... .....+.+|+..+.++. |+||+++++++..+     ...++++|++.+++.+   .+
T Consensus        23 ~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~   96 (288)
T cd06616          23 MLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYV   96 (288)
T ss_pred             EEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHH
Confidence            457788999999998643222 34556788999999995 99999999988776     4566888888754433   22


Q ss_pred             h--CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         78 V--SPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        78 ~--~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .  ..+.+++..+..++.|++.++++||+. +++||||+|+||+++.++.++++|||++.......  ......++..|+
T Consensus        97 ~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~  174 (288)
T cd06616          97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPYM  174 (288)
T ss_pred             HHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC--ccccccCccCcc
Confidence            2  346799999999999999999999975 99999999999999999999999999986433221  112235677899


Q ss_pred             cceeeecc--cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        155 APEILMGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       155 aPe~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |||.+.+.  ..++.++|+||||+++|++++|+.||....
T Consensus       175 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             CHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            99998775  358899999999999999999999997654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG1006|consensus

Probab=100.00  E-value=2.3e-34  Score=204.04  Aligned_cols=191  Identities=23%  Similarity=0.386  Sum_probs=150.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHH-HHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH---
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII---   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---   77 (203)
                      ..++.+|+..|||.++......+ ..++..|.+ .++.-+.||||++++....+     ..-|+.||.|.-++..+.   
T Consensus        83 M~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~v  156 (361)
T KOG1006|consen   83 MLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRV  156 (361)
T ss_pred             hhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHH
Confidence            46889999999999966544333 345556666 45555899999999998777     456889999986553332   


Q ss_pred             --hCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         78 --VSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        78 --~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                        ..+..++|+-+-.+......||.||-+ ..|+|||+||+||+++..|.+||||||.+-....  ..+.+...|...|+
T Consensus       157 y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiAkT~daGCrpYm  234 (361)
T KOG1006|consen  157 YSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIAKTVDAGCRPYM  234 (361)
T ss_pred             HHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH--HHHhhhccCCcccc
Confidence              234679999999999999999999985 5899999999999999999999999999863322  33445556777899


Q ss_pred             cceeeecccC-CCcchhHHHHHHHHHHHHhCCcccCCCCh-HHHhhhh
Q psy16889        155 APEILMGARH-YSAAVDVWSVGCIFAELLGRRILFQAQSP-VQQLGLI  200 (203)
Q Consensus       155 aPe~~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~i  200 (203)
                      |||.+..... |+.+||+||||+++||+.||+.|+.+++. .+++.++
T Consensus       235 APERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~V  282 (361)
T KOG1006|consen  235 APERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQV  282 (361)
T ss_pred             ChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHH
Confidence            9999986544 88999999999999999999999999764 4444444

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-32  Score=206.91  Aligned_cols=188  Identities=24%  Similarity=0.367  Sum_probs=149.0

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .++..|++|.+.... .......+.+|+..++.++|+||+++++++.++     ...+++|||+. ++|.+++...    
T Consensus        34 ~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~  107 (288)
T cd05061          34 EAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEA  107 (288)
T ss_pred             CcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhcccc
Confidence            345689999986432 223344677899999999999999999998877     56789999997 5888887532    


Q ss_pred             ------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccc
Q psy16889         81 ------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYY  153 (203)
Q Consensus        81 ------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  153 (203)
                            ...+...+..++.|++.||.+||+++++|+||||+||+++.++.++++|||.++....... .......++..|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y  187 (288)
T cd05061         108 ENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  187 (288)
T ss_pred             ccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccc
Confidence                  2356678899999999999999999999999999999999999999999999874332211 111222345679


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +|||.+.+ ..++.++|+||||+++|++++ |+.||.+....+.+..+
T Consensus       188 ~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         188 MAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             cCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999876 457899999999999999998 79999887776665544

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6e-33  Score=205.35  Aligned_cols=182  Identities=23%  Similarity=0.447  Sum_probs=147.0

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~   82 (203)
                      ..|+.+++|.++..    ...+.+.+|+.++++++|++++++++++...+    ...++++||++ ++|.+++...  ..
T Consensus        27 ~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~   98 (256)
T cd05082          27 YRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSV   98 (256)
T ss_pred             EcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCC
Confidence            35788999988542    23456889999999999999999998754432    35689999998 5888887653  34


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..+..++.|++.+|++||++|++|+||+|+||+++.++.++++|||.+.......    .....+..|+|||+..+ 
T Consensus        99 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~-  173 (256)
T cd05082          99 LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-  173 (256)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----CCCccceeecCHHHHcc-
Confidence            8999999999999999999999999999999999999999999999999887432221    12233567999998876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++.++|+||||+++|+|++ |+.||......+....+
T Consensus       174 ~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~  212 (256)
T cd05082         174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  212 (256)
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            457899999999999999997 99999887665554443

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-32  Score=204.93  Aligned_cols=174  Identities=21%  Similarity=0.264  Sum_probs=140.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~   85 (203)
                      ...+++|.+...  .......+.+|+.+++.++||||+++++++.++     ...++++||+++ +|..++.. .+.+++
T Consensus        32 ~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~  104 (262)
T cd05077          32 EIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLTT  104 (262)
T ss_pred             ceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCCH
Confidence            446889987543  223345677899999999999999999998876     456799999985 66666553 466999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe-------EEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI-------LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+..++.|++.|++|||+++++|+||+|+||+++.++.       ++++|||.+......     ....++..|+|||.
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~  179 (262)
T cd05077         105 PWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPEC  179 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-----ccccccccccChhh
Confidence            999999999999999999999999999999999986654       899999988643221     22345677999998


Q ss_pred             eecccCCCcchhHHHHHHHHHHHH-hCCcccCCCCh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSP  193 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~~~  193 (203)
                      +.....++.++|+||||+++|+|+ +|..||.....
T Consensus       180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~  215 (262)
T cd05077         180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL  215 (262)
T ss_pred             hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence            875566889999999999999997 68999877554

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-32  Score=207.24  Aligned_cols=184  Identities=24%  Similarity=0.385  Sum_probs=146.4

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-------
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-------   80 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-------   80 (203)
                      ..|++|.++.. ......+.+.+|++.+++++|+|++++++++...     ...+++|||+. ++|.+++...       
T Consensus        45 ~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  118 (295)
T cd05097          45 VLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFT  118 (295)
T ss_pred             eEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhcccccccc
Confidence            35899998643 2333456788999999999999999999999877     56789999998 4787776432       


Q ss_pred             -----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccc
Q psy16889         81 -----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYR  154 (203)
Q Consensus        81 -----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~  154 (203)
                           ..+++..+..++.|++.|+++||+++++|+||+|+||+++.++.++++|||.+........ .......++..|+
T Consensus       119 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~  198 (295)
T cd05097         119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWM  198 (295)
T ss_pred             ccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeec
Confidence                 2478889999999999999999999999999999999999999999999999874322211 1112223356799


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHh--CCcccCCCChHHHhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLG--RRILFQAQSPVQQLGL  199 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~~~~~~~~~~~  199 (203)
                      |||...+ ..++.++|+||||+++|+|++  +..||...+..+.+..
T Consensus       199 aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~  244 (295)
T cd05097         199 AWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN  244 (295)
T ss_pred             Chhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence            9998876 448999999999999999987  7789987766555443

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.3e-32  Score=206.99  Aligned_cols=185  Identities=25%  Similarity=0.375  Sum_probs=145.9

Q ss_pred             CCCCCc----EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          4 DPRDGR----RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         4 ~~~~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +..+|+    .+++|.+.... .......+.+|+.+++.++||||+++++++..+      ..++++|++. |+|.+.+.
T Consensus        28 ~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~  100 (303)
T cd05110          28 WVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVH  100 (303)
T ss_pred             EecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHH
Confidence            344554    57888885432 223344678899999999999999999988654      2457889988 68888876


Q ss_pred             CC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccc
Q psy16889         79 SP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aP  156 (203)
                      .. ..+++..+..++.|++.+|+|||+++++|+||||+||+++.++.++++|||.+......... ......++..|++|
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (303)
T cd05110         101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL  180 (303)
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCH
Confidence            54 46899999999999999999999999999999999999999999999999999754322211 12223346679999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHH
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQ  196 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  196 (203)
                      |.+.+ ..++.++|+||||+++|++++ |+.||.+....+.
T Consensus       181 E~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~  220 (303)
T cd05110         181 ECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI  220 (303)
T ss_pred             HHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99876 558899999999999999997 9999987665443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.9e-33  Score=205.26  Aligned_cols=191  Identities=28%  Similarity=0.449  Sum_probs=154.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.++.+|..+++|.+.....+....+.+.+|+++++.++|+|++++++.+.+.     ...++++||+. ++|.+++...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   93 (257)
T cd08225          19 AKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQ   93 (257)
T ss_pred             EEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhc
Confidence            45677899999999865433334556788999999999999999999998877     56789999997 4888877643


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ..+++..+..++.|++.++.+||+.+++|+||+|+||+++.++ .++++|||.+....... .......+++.|.|||
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape  172 (257)
T cd08225          94 RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPE  172 (257)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccccccCCCccccCHH
Confidence              3589999999999999999999999999999999999999875 46999999887543222 1222335678899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +..+ ..++.++|+||||++++++++|+.||...+..+....
T Consensus       173 ~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  213 (257)
T cd08225         173 ICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK  213 (257)
T ss_pred             HHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            8876 4478999999999999999999999987765554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-32  Score=207.22  Aligned_cols=189  Identities=23%  Similarity=0.355  Sum_probs=150.0

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC---
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP---   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---   80 (203)
                      ..+++.+++|.+.... +......+.+|+..+++++|||++++++++.+.     ...++++||++ ++|.+++...   
T Consensus        32 ~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  105 (288)
T cd05050          32 YEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPR  105 (288)
T ss_pred             CCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCcc
Confidence            3578899999986432 223345688899999999999999999998876     56789999998 4888877532   


Q ss_pred             -------------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC
Q psy16889         81 -------------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        81 -------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~  141 (203)
                                         ..+++..++.++.|++.+|++||+++++|+||+|+||+++.++.++++|||.+........
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  185 (288)
T cd05050         106 AQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY  185 (288)
T ss_pred             ccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc
Confidence                               2478889999999999999999999999999999999999999999999998864322211


Q ss_pred             -CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        142 -KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       142 -~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                       ........+..|+|||...+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       186 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~  245 (288)
T cd05050         186 YKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV  245 (288)
T ss_pred             ccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             11122233567999998876 458999999999999999997 88899777666655443

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.2e-33  Score=203.25  Aligned_cols=186  Identities=30%  Similarity=0.508  Sum_probs=155.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.+++|+++....  .....+.+|++.+++++|++++++.+++..+     ...++++||++ ++|.+.+...
T Consensus        19 ~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~   91 (253)
T cd05122          19 ARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKST   91 (253)
T ss_pred             EEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhc
Confidence            34567899999999965322  3556788999999999999999999998877     56788999999 5888887665


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+........  .....++..|++||.+
T Consensus        92 ~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~  169 (253)
T cd05122          92 NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVI  169 (253)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccceecCCcccCHHHH
Confidence             6799999999999999999999999999999999999999999999999999875443321  2344567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+. ..+.++|+||||+++|++++|+.||...+....+
T Consensus       170 ~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  206 (253)
T cd05122         170 NGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKAL  206 (253)
T ss_pred             cCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence            774 4788999999999999999999999887544433

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.2e-33  Score=206.87  Aligned_cols=190  Identities=23%  Similarity=0.366  Sum_probs=150.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcch-hHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDF-FQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      +.+..+++.|++|++....   .....+..|+..++++ +|+|++++.+++....... ....++++||++ ++|.+.+.
T Consensus        25 ~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~  101 (272)
T cd06637          25 GRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK  101 (272)
T ss_pred             EEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHH
Confidence            3567789999999985432   2345677899999998 7999999999886543211 134679999998 48888776


Q ss_pred             CC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 SP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      ..  ..+++..+..++.|++.+++|||+++++|+||+|+||+++.++.++++|||++...... ........++..|+||
T Consensus       102 ~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~g~~~y~aP  180 (272)
T cd06637         102 NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT-VGRRNTFIGTPYWMAP  180 (272)
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccc-cccCCcccccccccCH
Confidence            53  46899999999999999999999999999999999999999999999999998743322 1223344678889999


Q ss_pred             eeeec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        157 EILMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       157 e~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      |++.+    ...++.++|+||+|+++|+|++|+.||....+..
T Consensus       181 E~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~  223 (272)
T cd06637         181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  223 (272)
T ss_pred             hHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            98863    2347889999999999999999999997655443

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.1e-33  Score=205.94  Aligned_cols=187  Identities=27%  Similarity=0.429  Sum_probs=148.4

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC------
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS------   79 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------   79 (203)
                      .++.+++|.+... ........+.+|++.++.++||||+++++++.++     ...++++||+. ++|.+++..      
T Consensus        25 ~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~   98 (269)
T cd05044          25 GPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERF   98 (269)
T ss_pred             cceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhccc
Confidence            3467999988543 2223456788899999999999999999998877     46789999987 588877753      


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-----eEEEeecCccccCCCCCC-CCcccccCCcc
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-----ILKICDFGLARVEEPDPN-KAMTQEVVTQY  152 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~  152 (203)
                       ...+++.++..++.|++.+++|||+.+++|+||+|+||+++.++     .++++|||.+........ .......++..
T Consensus        99 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  178 (269)
T cd05044          99 GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR  178 (269)
T ss_pred             CCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCcc
Confidence             23478899999999999999999999999999999999999877     899999999864322211 11122244677


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      |+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus       179 y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~  226 (269)
T cd05044         179 WMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV  226 (269)
T ss_pred             ccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence            999999877 457999999999999999998 99999887766655443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.8e-32  Score=203.30  Aligned_cols=185  Identities=25%  Similarity=0.428  Sum_probs=149.3

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~   82 (203)
                      .++..+++|.+...   ....+.+.+|+++++.++|+|++++++++...      ..++++||++ ++|.+++..  ...
T Consensus        28 ~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~~~~~~~~~   98 (260)
T cd05073          28 NKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE------PIYIITEFMAKGSLLDFLKSDEGSK   98 (260)
T ss_pred             cCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCC------CeEEEEEeCCCCcHHHHHHhCCccc
Confidence            34567999987542   22346788899999999999999999988763      3578999997 589888865  345


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.+...............++..|.|||.+.. 
T Consensus        99 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-  177 (260)
T cd05073          99 QPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-  177 (260)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-
Confidence            8888999999999999999999999999999999999999999999999887543322222222334567999999876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++.++|+||||+++|++++ |..||.+.+..+....+
T Consensus       178 ~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~  216 (260)
T cd05073         178 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL  216 (260)
T ss_pred             CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            457889999999999999998 99999988776665543

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.3e-33  Score=203.56  Aligned_cols=173  Identities=23%  Similarity=0.315  Sum_probs=143.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+|+.+|+.|++|.++...       ....|...+....|||++++++++.+.     ...+++|||+. ++|.+++...
T Consensus        12 ~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576          12 VMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             EEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHh
Confidence            6788999999999996431       123344555566899999999999877     56789999998 5898888777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.+|++||+++++|+||||+||+++.++.++++|||.+......    .....++..|+|||...
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccCCcccC
Confidence            78999999999999999999999999999999999999999999999999987543321    12224466799999886


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      + ..++.++|+||+|+++|++++|+.|+...
T Consensus       156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~  185 (237)
T cd05576         156 I-SEETEACDWWSLGAILFELLTGKTLVECH  185 (237)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence            6 44788999999999999999999887643

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-32  Score=204.82  Aligned_cols=183  Identities=27%  Similarity=0.414  Sum_probs=147.8

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCChHH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~   87 (203)
                      .+++|..+.. ........+.+|+..+++++|+|++++++++...      ..++++||+. ++|.+++.. ...+++..
T Consensus        38 ~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~  110 (279)
T cd05057          38 PVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLSS------QVQLITQLMPLGCLLDYVRNHKDNIGSQY  110 (279)
T ss_pred             EEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC------ceEEEEecCCCCcHHHHHHhccCCCCHHH
Confidence            6899988543 2234556788999999999999999999988753      4678999987 588888775 45699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeecccCCC
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMGARHYS  166 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~  166 (203)
                      +..++.|++.|+++||+++++|+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.. ..++
T Consensus       111 ~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~  189 (279)
T cd05057         111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYT  189 (279)
T ss_pred             HHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcC
Confidence            9999999999999999999999999999999999999999999998754322211 1111222457999998865 4578


Q ss_pred             cchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        167 AAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       167 ~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++|+||||+++|++++ |+.||.+....+..+.+
T Consensus       190 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  224 (279)
T cd05057         190 HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL  224 (279)
T ss_pred             chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            99999999999999998 99999988776655444

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-32  Score=204.12  Aligned_cols=195  Identities=22%  Similarity=0.346  Sum_probs=149.9

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhH-HhHHHHHhC---
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQ-SDLHKIIVS---   79 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~-~~l~~~~~~---   79 (203)
                      ..+|+.++||++..........+.+.+|++.++.++||||+++++++...... .....+++++|+. ++|..++..   
T Consensus        24 ~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  103 (273)
T cd05074          24 DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI  103 (273)
T ss_pred             CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence            45688999999976544555667788999999999999999999987654321 1123456777776 577665431   


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccccc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRA  155 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~a  155 (203)
                         ...+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+........ .......+++.|.+
T Consensus       104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  183 (273)
T cd05074         104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA  183 (273)
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcC
Confidence               12478999999999999999999999999999999999999999999999998874432211 11122234567999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ||...+ ..++.++|+||||+++|++++ |++||.+....+....+
T Consensus       184 pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~  228 (273)
T cd05074         184 LESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL  228 (273)
T ss_pred             HhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            998876 457889999999999999998 89999887766555443

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-32  Score=202.58  Aligned_cols=185  Identities=22%  Similarity=0.415  Sum_probs=149.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~   84 (203)
                      +++.+++|.+....   ...+.+.+|++.+++++||+++++++++...     ...++++||+.+ +|.+++.. .+.++
T Consensus        27 ~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~   98 (256)
T cd05112          27 EKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFS   98 (256)
T ss_pred             CCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCC
Confidence            46789999885432   2235688899999999999999999998777     567899999984 78877765 35689


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      ++.++.++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+...............++..|+|||.+.+ ..
T Consensus        99 ~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~  177 (256)
T cd05112          99 QETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SK  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CC
Confidence            99999999999999999999999999999999999999999999999887443222222222234567999998876 44


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++.++|+||||+++|++++ |..||.........+.+
T Consensus       178 ~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  214 (256)
T cd05112         178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI  214 (256)
T ss_pred             cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            7899999999999999998 99999887766655543

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8e-33  Score=208.61  Aligned_cols=184  Identities=26%  Similarity=0.491  Sum_probs=151.3

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      .+..+++.|++|.+...  .....+.+.+|+.+++.++|||++++++++..+     ...++++||+. ++|.+++.. .
T Consensus        39 ~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~  110 (293)
T cd06647          39 IDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-T  110 (293)
T ss_pred             EEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-c
Confidence            45678899999998532  223346688899999999999999999998877     56789999997 488877654 4


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++.++..++.|++.++.+||++|++|+||+|+||+++.++.++++|||.+....... .......+++.|++||.+..
T Consensus       111 ~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~  189 (293)
T cd06647         111 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVTR  189 (293)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-cccccccCChhhcCchhhcc
Confidence            58899999999999999999999999999999999999999999999999876433222 22233356778999999876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                       ..++.++|+||||+++|++++|+.||...+....
T Consensus       190 -~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~  223 (293)
T cd06647         190 -KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA  223 (293)
T ss_pred             -CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence             4578999999999999999999999987655433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0608|consensus

Probab=100.00  E-value=7.5e-34  Score=222.00  Aligned_cols=191  Identities=23%  Similarity=0.352  Sum_probs=159.2

Q ss_pred             CCCCCcEEEEEeccC-ccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          4 DPRDGRRVALKKLPN-VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~-~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      -..|...||+|.++. ......+......|-++|.....+-||++|..|+|.     ..+|+||+|+. |++-..+...+
T Consensus       650 KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmg  724 (1034)
T KOG0608|consen  650 KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMG  724 (1034)
T ss_pred             ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhc
Confidence            345567788888843 234556677888899999999999999999999999     78999999998 59999888889


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCC-CCCC-----------C-------
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEE-PDPN-----------K-------  142 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~-~~~~-----------~-------  142 (203)
                      -|.|..++.++.++.+|+++.|..|.+||||||+|||+|.+|.|||.|||+++-+. ....           .       
T Consensus       725 IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e  804 (1034)
T KOG0608|consen  725 IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPE  804 (1034)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchh
Confidence            99999999999999999999999999999999999999999999999999986211 0000           0       


Q ss_pred             ----------------------CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        143 ----------------------AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 ----------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                                            ..-...||+.|+|||++...+ ++...|+||.|++||||+.|++||-...+-+....|
T Consensus       805 ~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv  883 (1034)
T KOG0608|consen  805 WADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKV  883 (1034)
T ss_pred             hccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence                                  001227899999999999854 889999999999999999999999887766554444

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-32  Score=209.54  Aligned_cols=186  Identities=27%  Similarity=0.443  Sum_probs=149.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-----
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-----   80 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----   80 (203)
                      +..+++|.+... ........+.+|+++++++ +|+||+++++++...     ...++++||++ ++|.+++...     
T Consensus        44 ~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~  117 (334)
T cd05100          44 PVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGM  117 (334)
T ss_pred             ceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCccc
Confidence            346899988643 2334456788999999999 899999999999877     56789999997 5888887542     


Q ss_pred             -----------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-Cccccc
Q psy16889         81 -----------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEV  148 (203)
Q Consensus        81 -----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~  148 (203)
                                 ..++..++..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.++........ ......
T Consensus       118 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  197 (334)
T cd05100         118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR  197 (334)
T ss_pred             ccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCC
Confidence                       23778889999999999999999999999999999999999999999999998744322111 112223


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++..|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       198 ~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         198 LPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             cCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            3457999999877 457899999999999999998 89999988777766554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.6e-32  Score=202.53  Aligned_cols=187  Identities=18%  Similarity=0.268  Sum_probs=144.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----C
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----Q   81 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~   81 (203)
                      ....+++|.+... ......+.+.+|+..++.++||||+++++.+.+.     ...+++|||+. ++|.+++...    .
T Consensus        21 ~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~   94 (268)
T cd05086          21 GVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRR   94 (268)
T ss_pred             CcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhcccc
Confidence            3445677776432 2233456788999999999999999999998876     56789999998 5888887642    3


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceeee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++..+..++.|++.||+|||+.+++|+||||+||+++.++.++++|||.+....... ........++..|+|||+..
T Consensus        95 ~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  174 (268)
T cd05086          95 NSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG  174 (268)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcc
Confidence            46777888999999999999999999999999999999999999999999875322111 11122335677899999875


Q ss_pred             cc------cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        161 GA------RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       161 ~~------~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      ..      ..++.++|+||||+++|+|++ |..||...+..+.+..
T Consensus       175 ~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~  220 (268)
T cd05086         175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNH  220 (268)
T ss_pred             cccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            31      235678999999999999996 5789987776655543

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-32  Score=205.03  Aligned_cols=183  Identities=30%  Similarity=0.471  Sum_probs=149.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..++..|++|.+...  .....+.+.+|+.+++.++|+||+++++++..+     ...++++||+. ++|.+++...
T Consensus        27 ~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   99 (268)
T cd06624          27 ARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSK   99 (268)
T ss_pred             eEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHh
Confidence            356778899999988643  223456788999999999999999999998877     56789999997 5888887653


Q ss_pred             -CCC--ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         81 -QHL--TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 -~~~--~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                       ..+  ++..+..++.|++.++++||+++++|+||+|+||+++. ++.++++|||.+...... ........++..|+||
T Consensus       100 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~~aP  178 (268)
T cd06624         100 WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI-NPCTETFTGTLQYMAP  178 (268)
T ss_pred             cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC-CCccccCCCCccccCh
Confidence             455  88899999999999999999999999999999999986 679999999988644322 1222233567889999


Q ss_pred             eeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |.+.+. ..++.++|+||||+++|++++|+.||....
T Consensus       179 E~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~  215 (268)
T cd06624         179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG  215 (268)
T ss_pred             hhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence            988653 347889999999999999999999997643

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.5e-32  Score=206.19  Aligned_cols=180  Identities=27%  Similarity=0.369  Sum_probs=146.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-C
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-Q   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~   81 (203)
                      +..+++.|++|.++... .......+.+|++++++++|||++++.+++.+.+.   ...++++||++ ++|.+++... .
T Consensus        29 ~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~g~~L~~~l~~~~~  104 (284)
T cd05079          29 GDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPRNKN  104 (284)
T ss_pred             CCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---CceEEEEEccCCCCHHHHHHhccC
Confidence            46789999999986432 23345678899999999999999999998876532   35689999997 5888887643 4


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++.++..++.|++.+|++||++|++|+||+|+||+++.++.++++|||.+.........  ......++..|.|||.+
T Consensus       105 ~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~  184 (284)
T cd05079         105 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL  184 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHh
Confidence            6899999999999999999999999999999999999999999999999998754332211  11223446679999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCccc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILF  188 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf  188 (203)
                      .+ ..++.++|+||||+++|+++++..|+
T Consensus       185 ~~-~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         185 IQ-SKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             cc-CCCCccccchhhhhhhhhhhcCCCCC
Confidence            76 45789999999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.2e-32  Score=205.22  Aligned_cols=180  Identities=28%  Similarity=0.436  Sum_probs=144.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~   81 (203)
                      +..+|+.|++|.+...  .......+.+|++++++++||||+++.+++...+.   ..+++++||+. ++|.+++.. ..
T Consensus        29 ~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  103 (284)
T cd05081          29 QDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRE  103 (284)
T ss_pred             cCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC---CceEEEEEecCCCCHHHHHHhcCc
Confidence            5678999999998653  23345678899999999999999999997654432   35689999997 589888764 35


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..+..++.|++.||++||++|++|+||||+||+++.++.++++|||.+.........  ......++..|+|||..
T Consensus       104 ~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  183 (284)
T cd05081         104 RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL  183 (284)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHh
Confidence            6899999999999999999999999999999999999999999999999998754322111  11112234469999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                      .+ ..++.++|+||||+++|++++|..|+.
T Consensus       184 ~~-~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         184 TE-SKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cc-CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence            76 457899999999999999999877654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=2.2e-32  Score=206.40  Aligned_cols=185  Identities=24%  Similarity=0.389  Sum_probs=147.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ---   81 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---   81 (203)
                      .++..+++|.+... ........+.+|++.++.++|+||+++++++.++     ...++++||+. ++|.+++....   
T Consensus        44 ~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (296)
T cd05095          44 NQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQE  117 (296)
T ss_pred             CceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCccc
Confidence            34567999998643 2333456788999999999999999999999877     56789999997 58888876432   


Q ss_pred             --------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcc
Q psy16889         82 --------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQY  152 (203)
Q Consensus        82 --------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~  152 (203)
                              .+++..+..++.|++.|+++||+.|++|+||||+||+++.++.++++|||.+......... ......++..
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  197 (296)
T cd05095         118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR  197 (296)
T ss_pred             ccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccc
Confidence                    3677889999999999999999999999999999999999999999999998743322111 1122233567


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHh--CCcccCCCChHHHh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLG--RRILFQAQSPVQQL  197 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~--g~~pf~~~~~~~~~  197 (203)
                      |++||...+ ..++.++|+||||+++|+|++  |..||...+..+.+
T Consensus       198 ~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~  243 (296)
T cd05095         198 WMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI  243 (296)
T ss_pred             cCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence            999998766 458999999999999999998  78999876655544

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.98  E-value=3.7e-32  Score=201.68  Aligned_cols=187  Identities=26%  Similarity=0.380  Sum_probs=145.1

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~   84 (203)
                      ++..+++|.+... ......+.+.+|+.+++.++|||++++++++....    ...++++||+. ++|.+++... ...+
T Consensus        22 ~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~   96 (262)
T cd05058          22 QKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPT   96 (262)
T ss_pred             ceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCC
Confidence            4567999988532 23344567888999999999999999999765432    34678999988 5888887653 4567


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC---CCcccccCCcccccceeeec
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~  161 (203)
                      +..+..++.|++.||++||+.+++|+||+|+||+++.++.++++|||.+........   .......++..|+|||...+
T Consensus        97 ~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  176 (262)
T cd05058          97 VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT  176 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhcc
Confidence            888899999999999999999999999999999999999999999999864322111   11122234667999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                       ..++.++|+||||+++|+|++ |.+||...+..+....
T Consensus       177 -~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~  214 (262)
T cd05058         177 -QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY  214 (262)
T ss_pred             -CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence             458899999999999999999 5777877665554443

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=1.4e-32  Score=206.47  Aligned_cols=191  Identities=23%  Similarity=0.384  Sum_probs=148.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-   78 (203)
                      |.+..+|+.+++|++....   ...+.+..|+.+++.+ +|+||+++++++..........++++|||+++ +|.+.+. 
T Consensus        37 ~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  113 (286)
T cd06638          37 VLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG  113 (286)
T ss_pred             EEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHH
Confidence            4567889999999875421   1234577899999999 79999999998743221111467899999974 7766543 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|+|
T Consensus       114 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~a  192 (286)
T cd06638         114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMA  192 (286)
T ss_pred             hhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC-CccccccCCCcccC
Confidence               34568999999999999999999999999999999999999999999999999987543221 12233357888999


Q ss_pred             ceeeecc----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        156 PEILMGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       156 Pe~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      ||.+...    ..++.++|+||+|+++|+|++|+.||....+...
T Consensus       193 PE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~  237 (286)
T cd06638         193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA  237 (286)
T ss_pred             hhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence            9987532    3468899999999999999999999987655443

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1094|consensus

Probab=99.98  E-value=2.3e-32  Score=211.72  Aligned_cols=186  Identities=25%  Similarity=0.385  Sum_probs=156.5

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC--C
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH--L   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~   83 (203)
                      .+..||||+++.. .....+..|.+|+++|.+++||||+.++++|..+     ..+++++||++ |+|.+++..+..  .
T Consensus       561 g~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePicmI~EYmEnGDLnqFl~aheapt~  634 (807)
T KOG1094|consen  561 GPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPLCMITEYMENGDLNQFLSAHELPTA  634 (807)
T ss_pred             CceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----CchHHHHHHHhcCcHHHHHHhccCccc
Confidence            3578999999653 4445567899999999999999999999999888     67899999999 799999987633  3


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc-cCCCCCCCCcccccCCcccccceeeecc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~-~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      .-..-..+++||+.+++||.+.++||||+.+.|++++.++++|++|||+++ .+.............+.+|+|+|.+..+
T Consensus       635 ~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg  714 (807)
T KOG1094|consen  635 ETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG  714 (807)
T ss_pred             ccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc
Confidence            444556799999999999999999999999999999999999999999998 3444444443444557789999999874


Q ss_pred             cCCCcchhHHHHHHHHHHHH--hCCcccCCCChHHHhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELL--GRRILFQAQSPVQQLGL  199 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll--~g~~pf~~~~~~~~~~~  199 (203)
                       .++.++|+|++|+++||++  +.+.||....+++..++
T Consensus       715 -kFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven  752 (807)
T KOG1094|consen  715 -KFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN  752 (807)
T ss_pred             -cccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence             4999999999999999986  57999999888877654

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=1.2e-32  Score=206.81  Aligned_cols=182  Identities=27%  Similarity=0.414  Sum_probs=152.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|++... ........+.+|+++++.++||||+++++++.+.     ..+++++||+++ +|..++...
T Consensus        24 ~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~   97 (284)
T cd06620          24 VKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKG   97 (284)
T ss_pred             EEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhc
Confidence            356678999999988543 2233456788999999999999999999999887     567899999984 787877777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..+..++.+++.++.+||+ .+++|+||+|+||+++.++.++++|||++......   ......++..|+|||++
T Consensus        98 ~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---~~~~~~~~~~~~aPE~~  174 (284)
T cd06620          98 GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERI  174 (284)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---ccCccccCcccCCHHHH
Confidence            789999999999999999999997 58999999999999999999999999987633211   11234568889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+ ..++.++|+||||+++|++++|+.||....+
T Consensus       175 ~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~  207 (284)
T cd06620         175 QG-GKYTVKSDVWSLGISIIELALGKFPFAFSNI  207 (284)
T ss_pred             cc-CCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence            76 4578999999999999999999999986554

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=1.7e-32  Score=208.15  Aligned_cols=186  Identities=28%  Similarity=0.457  Sum_probs=151.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~   79 (203)
                      ++++.+++.+++|.+.... ........+.+|+++++.++|+|++++.+++..+     ...++|+||+.+++.+.+. .
T Consensus        34 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~  108 (308)
T cd06634          34 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVH  108 (308)
T ss_pred             EEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHc
Confidence            3567789999999985421 2333445677899999999999999999998876     5678999999988877664 3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++++.++..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+......     ....++..|+|||.+
T Consensus       109 ~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~  183 (308)
T cd06634         109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVI  183 (308)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCccccCHHHH
Confidence            456899999999999999999999999999999999999999999999999988643321     223457789999987


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+  ...++.++|+||||+++|++++|..||......+.+
T Consensus       184 ~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  223 (308)
T cd06634         184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (308)
T ss_pred             hhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence            52  234688999999999999999999998776554443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.98  E-value=1.6e-32  Score=205.36  Aligned_cols=187  Identities=26%  Similarity=0.375  Sum_probs=153.2

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   81 (203)
                      .+..+++.|++|++.... .......+.+|+..+++++||||+++++++..+     ...++++||+++ +|.+++.. .
T Consensus        24 ~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~   96 (277)
T cd06641          24 IDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-G   96 (277)
T ss_pred             EECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-C
Confidence            466789999999985432 223446788899999999999999999999877     567899999985 77776654 5


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .++++.+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+...... ........++..|+|||.+.+
T Consensus        97 ~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~  175 (277)
T cd06641          97 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWMAPEVIKQ  175 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-hhhhccccCCccccChhhhcc
Confidence            6899999999999999999999999999999999999999999999999988643322 112233356778999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                       ..++.++|+||||+++|++++|..||....+.....
T Consensus       176 -~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  211 (277)
T cd06641         176 -SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF  211 (277)
T ss_pred             -CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence             457889999999999999999999998766554443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.98  E-value=2.9e-32  Score=204.13  Aligned_cols=188  Identities=23%  Similarity=0.358  Sum_probs=149.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----   80 (203)
                      ++..|++|.+... ......+.+.+|+..++.++|+|++++++++....    ...+++++++. ++|.+++...     
T Consensus        34 ~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~  108 (280)
T cd05043          34 KEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEA  108 (280)
T ss_pred             ceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhcccccc
Confidence            4688999988643 34445677889999999999999999999876542    34678888887 5887776532     


Q ss_pred             ---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccc
Q psy16889         81 ---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aP  156 (203)
                         ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++++|||+++........ ......++..|+||
T Consensus       109 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~ap  188 (280)
T cd05043         109 NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL  188 (280)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCH
Confidence               45899999999999999999999999999999999999999999999999998754332211 11222345679999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      |++.+ ..++.++|+||||+++|++++ |+.||...++.+....+
T Consensus       189 E~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  232 (280)
T cd05043         189 ESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL  232 (280)
T ss_pred             HHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence            99876 457899999999999999998 99999887766655433

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=2.6e-32  Score=205.23  Aligned_cols=182  Identities=27%  Similarity=0.414  Sum_probs=148.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV--   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~--   78 (203)
                      +.+..+++.+++|.+.... .......+.+|++.+++++||||+++++++.+...   ..+++++||+++ +|.+++.  
T Consensus        20 ~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~   95 (287)
T cd06621          20 CRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIAMEYCEGGSLDSIYKKV   95 (287)
T ss_pred             EEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEEEEEEecCCCCHHHHHHHH
Confidence            4566789999999986432 22345678899999999999999999998865432   356899999974 7766543  


Q ss_pred             --CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 --SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                        ....+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++++|||.+........   ....++..|++|
T Consensus        96 ~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~~p  172 (287)
T cd06621          96 KKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAP  172 (287)
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc---ccccCCccccCH
Confidence              345689999999999999999999999999999999999999999999999999864322111   123457789999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       173 E~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         173 ERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             HHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            98876 45789999999999999999999999865

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.98  E-value=5e-32  Score=211.70  Aligned_cols=185  Identities=27%  Similarity=0.438  Sum_probs=147.5

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   80 (203)
                      +..+++.||+|+++... .....+.+.+|++++.++. ||||+++++++..+     ...++|+||+. |+|.+++... 
T Consensus        63 ~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~  136 (401)
T cd05107          63 HSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG-----GPIYIITEYCRYGDLVDYLHRNK  136 (401)
T ss_pred             CCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-----CCcEEEEeccCCCcHHHHHHhcc
Confidence            34567889999996542 2233456889999999996 99999999999887     56789999998 5887776432 


Q ss_pred             --------------------------------------------------------------------------------
Q psy16889         81 --------------------------------------------------------------------------------   80 (203)
Q Consensus        81 --------------------------------------------------------------------------------   80 (203)
                                                                                                      
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (401)
T cd05107         137 HTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQY  216 (401)
T ss_pred             ccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhh
Confidence                                                                                            


Q ss_pred             -----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-C
Q psy16889         81 -----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-K  142 (203)
Q Consensus        81 -----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  142 (203)
                                       ..+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++++|||++........ .
T Consensus       217 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~  296 (401)
T cd05107         217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYI  296 (401)
T ss_pred             hcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccc
Confidence                             2367778899999999999999999999999999999999999999999999874322211 1


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHH
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQ  195 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~  195 (203)
                      ......++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||......+
T Consensus       297 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~  349 (401)
T cd05107         297 SKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE  349 (401)
T ss_pred             cCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence            1222345678999999877 457899999999999999998 899997755443

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0579|consensus

Probab=99.98  E-value=3.2e-33  Score=218.84  Aligned_cols=192  Identities=24%  Similarity=0.427  Sum_probs=161.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHh-HHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~-~   79 (203)
                      |.++.++-..|-|++..  .+.+..+.+.-|+++|....||+|+++++.|...     ..+++..|||+|. ....+. -
T Consensus        51 A~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL  123 (1187)
T KOG0579|consen   51 AVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLEL  123 (1187)
T ss_pred             hhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHh
Confidence            45667777777787733  4556778888999999999999999999988777     6789999999964 444433 3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++.++..++.|++.||.|||+++|+|||||..||+++.+|.++|.|||.+.... ..........|||.|+|||+.
T Consensus       124 ~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkRDsFIGTPYWMAPEVv  202 (1187)
T KOG0579|consen  124 GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKRDSFIGTPYWMAPEVV  202 (1187)
T ss_pred             ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-hHHhhhccccCCcccccchhe
Confidence            5679999999999999999999999999999999999999999999999999986432 233455667899999999987


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .-    .++|++++||||||+++.+|..+++|-...++.-.+-.|.
T Consensus       203 mCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKia  248 (1187)
T KOG0579|consen  203 MCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA  248 (1187)
T ss_pred             eeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHh
Confidence            53    4679999999999999999999999999988877776664

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=1.7e-32  Score=203.23  Aligned_cols=176  Identities=18%  Similarity=0.233  Sum_probs=142.3

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~   85 (203)
                      ..++++|.+...  .....+.+.+|+.+++.++|||++++++++..+     ...+++|||++ ++|.+++... ..+++
T Consensus        27 ~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~   99 (258)
T cd05078          27 KTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINI   99 (258)
T ss_pred             cchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCH
Confidence            345888887432  233456788899999999999999999998876     45789999998 5888888654 45899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe--------EEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--------LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ..+..++.|++.++++||+.+++|+||||+||+++.++.        ++++|||.+......     ....++..|+|||
T Consensus       100 ~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE  174 (258)
T cd05078         100 SWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPE  174 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc-----hhccccCCccCch
Confidence            999999999999999999999999999999999986654        699999988643221     2234577899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~  195 (203)
                      ++.+...++.++|+||||+++|++++| ..||....+..
T Consensus       175 ~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~  213 (258)
T cd05078         175 CIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK  213 (258)
T ss_pred             hccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH
Confidence            998755678999999999999999998 57776665543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.98  E-value=5e-32  Score=200.21  Aligned_cols=181  Identities=25%  Similarity=0.479  Sum_probs=148.0

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--C
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--Q   81 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~   81 (203)
                      ..+++.|++|.++..    ...+.+.+|+.+++.++|||++++++++..+      ..++++||+. ++|.+++...  .
T Consensus        26 ~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~   95 (254)
T cd05083          26 EYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIVMELMSKGNLVNFLRTRGRA   95 (254)
T ss_pred             ccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEEEECCCCCCHHHHHHhcCcC
Confidence            357888999998542    2345688899999999999999999988655      2478999998 5898887653  3


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      .+++..+..++.|++.++.+||+.|++||||+|+||+++.++.++++|||.+......    ......+..|.|||.+.+
T Consensus        96 ~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~  171 (254)
T cd05083          96 LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVKWTAPEALKH  171 (254)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CCCCCCCceecCHHHhcc
Confidence            5899999999999999999999999999999999999999999999999988643221    112233567999998876


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                       ..++.++|+||||+++|+|++ |+.||...+..+....+
T Consensus       172 -~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  210 (254)
T cd05083         172 -KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV  210 (254)
T ss_pred             -CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence             457899999999999999997 99999888776655443

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=6.9e-32  Score=207.69  Aligned_cols=183  Identities=29%  Similarity=0.500  Sum_probs=144.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   80 (203)
                      +..+++.||||+++... .......+.+|+.+++++ +|+||+++++++...+    ...+++|||++ |+|.+++... 
T Consensus        33 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~  107 (343)
T cd05103          33 KTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKR  107 (343)
T ss_pred             ccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcC
Confidence            45678999999996432 223345688899999999 7899999999876543    35678999998 5787776431 


Q ss_pred             ------------------------------------------------------------------CCCChHHHHHHHHH
Q psy16889         81 ------------------------------------------------------------------QHLTSDHIKVFLYQ   94 (203)
Q Consensus        81 ------------------------------------------------------------------~~~~~~~~~~~~~q   94 (203)
                                                                                        ..++...+..++.|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  187 (343)
T cd05103         108 GEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQ  187 (343)
T ss_pred             CccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHH
Confidence                                                                              23678888999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeeecccCCCcchhHHH
Q psy16889         95 ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWS  173 (203)
Q Consensus        95 i~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~s  173 (203)
                      +++||+|||+++++|+||||+||+++.++.++++|||.+........ .......++..|+|||.+.+ ..++.++|+||
T Consensus       188 i~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s  266 (343)
T cd05103         188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS  266 (343)
T ss_pred             HHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC-CCCCchhhHHH
Confidence            99999999999999999999999999999999999999874322211 11122234567999999876 45889999999


Q ss_pred             HHHHHHHHHh-CCcccCCCC
Q psy16889        174 VGCIFAELLG-RRILFQAQS  192 (203)
Q Consensus       174 lG~~l~~ll~-g~~pf~~~~  192 (203)
                      ||+++|++++ |..||....
T Consensus       267 lG~~l~el~~~g~~p~~~~~  286 (343)
T cd05103         267 FGVLLWEIFSLGASPYPGVK  286 (343)
T ss_pred             HHHHHHHHHHCCCCCCCCcc
Confidence            9999999996 999997754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.98  E-value=2.6e-32  Score=204.60  Aligned_cols=192  Identities=23%  Similarity=0.377  Sum_probs=149.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCc-chhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHL-DFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      +.+..+++.+++|++...   ......+..|+.+++++ +|+|++++++++..... ......+++|||+++ +|.+.+.
T Consensus        35 ~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~  111 (282)
T cd06636          35 GRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK  111 (282)
T ss_pred             EEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHH
Confidence            456778999999998542   22345677889989988 79999999998854311 011457899999985 7877765


Q ss_pred             C--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 S--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .  ...+++..+..++.|++.+++|||+.+++|+||+|+||+++.++.++++|||.+....... .......++..|+||
T Consensus       112 ~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aP  190 (282)
T cd06636         112 NTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAP  190 (282)
T ss_pred             HccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCCCcccccccccCH
Confidence            4  3458899999999999999999999999999999999999999999999999986433221 122334568889999


Q ss_pred             eeeec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        157 EILMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       157 e~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      |.+..    ...++.++|+||||+++|+|++|..||....+....
T Consensus       191 E~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             hhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            98753    234778999999999999999999999776554433

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG1152|consensus

Probab=99.98  E-value=1.5e-33  Score=217.97  Aligned_cols=181  Identities=27%  Similarity=0.428  Sum_probs=156.7

Q ss_pred             CcCCCCCcEEEEEeccCccc--hhh----hhHHHHHHHHHHhhcC---CCCccchhhhccCCCcchhHHHHHHHhhhH-H
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ--SLV----SSKRVFRELKMLCFFK---HDNVLSALDILQPPHLDFFQEIYVITELLQ-S   71 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~--~~~----~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~   71 (203)
                      |+++++...|+||.+..++.  +.+    ..-.+-.|+++|..++   |+||++++++|+++     .++|++||.-+ |
T Consensus       580 ai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd-----d~yyl~te~hg~g  654 (772)
T KOG1152|consen  580 AIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD-----DYYYLETEVHGEG  654 (772)
T ss_pred             eeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-----CeeEEEecCCCCC
Confidence            67888999999999955321  111    1223556999999996   99999999999999     78899999877 3


Q ss_pred             -hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCC
Q psy16889         72 -DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT  150 (203)
Q Consensus        72 -~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  150 (203)
                       +|.+++..++.++|.++..|++|++.+++.||++||+|||||-+|+.++.+|-+||+|||.+......+   .....||
T Consensus       655 IDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgp---fd~f~gt  731 (772)
T KOG1152|consen  655 IDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP---FDVFVGT  731 (772)
T ss_pred             cchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcCCC---cceeeee
Confidence             899999999999999999999999999999999999999999999999999999999999987554333   3445779


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ..|.|||++.+.++.+...|||+||+++|.+...+.||..
T Consensus       732 v~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  732 VDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9999999999988788999999999999999999999864

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=3.5e-32  Score=204.56  Aligned_cols=183  Identities=24%  Similarity=0.347  Sum_probs=148.7

Q ss_pred             CCCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          4 DPRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +..+++.|+||+++....  .......+..|+++++++ +||+|+++.+.+..+     ...++|+||+. ++|.+++..
T Consensus        24 ~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~   98 (288)
T cd05583          24 GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQ   98 (288)
T ss_pred             cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhh
Confidence            346788999999864321  222345677899999999 699999999998776     45679999998 488888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++++|||.+...............++..|++||..
T Consensus        99 ~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  178 (288)
T cd05583          99 REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHh
Confidence            77899999999999999999999999999999999999999999999999998875433222222233567889999988


Q ss_pred             eccc-CCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        160 MGAR-HYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       160 ~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+.. ..+.++|+||||+++|+|++|..||...
T Consensus       179 ~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~  211 (288)
T cd05583         179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD  211 (288)
T ss_pred             cCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence            6632 3678999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=2.6e-32  Score=203.21  Aligned_cols=173  Identities=21%  Similarity=0.346  Sum_probs=141.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.++.+|+.+++|.+.......       .|......+ +|+|++++++.+..+     ...+++|||++ ++|.+++..
T Consensus        35 ~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~  102 (267)
T PHA03390         35 LKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKK  102 (267)
T ss_pred             EEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHh
Confidence            4567889999999985421111       122222222 799999999999887     56889999997 599998887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ...++++++..++.|+++++++||+.+++|+||+|+||+++.++ .++++|||.+......     ....++..|+|||+
T Consensus       103 ~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~  177 (267)
T PHA03390        103 EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEK  177 (267)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCCCcccChhh
Confidence            77899999999999999999999999999999999999999888 9999999988744322     12356788999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +.+ ..++.++|+||+|+++|++++|+.||....
T Consensus       178 ~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        178 IKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             hcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            977 457899999999999999999999997654

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=4.5e-32  Score=200.33  Aligned_cols=187  Identities=28%  Similarity=0.442  Sum_probs=156.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.|++|++..........+.+.+|++.+++++|+||+++++.+.+...   ..+++++|+++ ++|.+++...
T Consensus        19 ~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~   95 (260)
T cd06606          19 ALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEK---NTLNIFLEYVSGGSLSSLLKKF   95 (260)
T ss_pred             EEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCC---CeEEEEEEecCCCcHHHHHHHc
Confidence            3566789999999996544444567788899999999999999999998876531   34678999995 6888888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..+..++.|++.++++||+.+++|+||+|+||+++.++.++++|||.+......... ......++..|.+||..
T Consensus        96 ~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606          96 GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhh
Confidence            78999999999999999999999999999999999999999999999999998754433221 12334567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+. ..+.++|+||||++++++++|..||....
T Consensus       176 ~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         176 RGE-EYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             cCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            774 47899999999999999999999998765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=7.1e-32  Score=203.67  Aligned_cols=182  Identities=23%  Similarity=0.421  Sum_probs=143.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.|+||.++..... .....+..|+..+.+. .|+||+++++++.+.     ...++++||+++.+.+.... 
T Consensus        34 ~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~  107 (296)
T cd06618          34 MRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRI  107 (296)
T ss_pred             EEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHh
Confidence            345567999999999654222 2334455666666666 599999999999877     56788999998776666554 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.+++..+..++.|++.+++|||+ .+++|+||+|+||+++.++.++|+|||.+.......  ......++..|+|||.
T Consensus       108 ~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~  185 (296)
T cd06618         108 QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPER  185 (296)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--cccCCCCCccccCHhh
Confidence            4579999999999999999999997 599999999999999999999999999986433221  1222345778999999


Q ss_pred             eecc---cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        159 LMGA---RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       159 ~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +.+.   ..++.++|+||||+++|+|++|+.||...
T Consensus       186 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         186 IDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             cCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            8753   23678999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0196|consensus

Probab=99.97  E-value=3e-33  Score=222.40  Aligned_cols=189  Identities=28%  Similarity=0.431  Sum_probs=165.4

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~   84 (203)
                      .-..||||.++.. -...++..|..|+.+|-+++||||+++-++....     .-+.+++|||+ |+|..+++. .+.|+
T Consensus       656 re~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGqft  729 (996)
T KOG0196|consen  656 REITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQFT  729 (996)
T ss_pred             cceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCceE
Confidence            3456999999754 4556677899999999999999999999999887     56789999999 799998874 47799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccC--Ccccccceeeecc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGA  162 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~--~~~~~aPe~~~~~  162 (203)
                      .-++..++..|+.+++||-+.|+|||||-..|||++.+-.+|++|||+++.....+....++..|  ..+|.|||.+.- 
T Consensus       730 viQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-  808 (996)
T KOG0196|consen  730 VIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-  808 (996)
T ss_pred             eehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhh-
Confidence            99999999999999999999999999999999999999999999999999776666454444433  568999999988 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhhc
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.++.+||+||+|+++||.++ |+.||.+.++.+.++.|.+
T Consensus       809 RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~  849 (996)
T KOG0196|consen  809 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ  849 (996)
T ss_pred             cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh
Confidence            559999999999999999885 9999999999999988753

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=6.6e-32  Score=199.88  Aligned_cols=171  Identities=19%  Similarity=0.266  Sum_probs=139.2

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-CCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-HLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~   86 (203)
                      ..+++|.+....   .....+.+|+.+++.++||||+++++++...      ..++++||+. ++|.+++...+ .+++.
T Consensus        31 ~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~  101 (259)
T cd05037          31 VSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVRD------ENIMVEEYVKFGPLDVFLHREKNNVSLH  101 (259)
T ss_pred             eeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEecC------CcEEEEEcCCCCcHHHHHHhhccCCCHH
Confidence            457778764321   1156788899999999999999999988662      2468999998 58888877655 79999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-------eEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-------ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+..++.|++.+|++||++|++|+||||+||+++.++       .++++|||.+.....     .....++..|+|||++
T Consensus       102 ~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~  176 (259)
T cd05037         102 WKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECI  176 (259)
T ss_pred             HHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc-----ccccccCCCccChhhh
Confidence            9999999999999999999999999999999999877       799999999874332     1222445679999998


Q ss_pred             ecc-cCCCcchhHHHHHHHHHHHHh-CCcccCCCCh
Q psy16889        160 MGA-RHYSAAVDVWSVGCIFAELLG-RRILFQAQSP  193 (203)
Q Consensus       160 ~~~-~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~  193 (203)
                      .+. ..++.++|+||||+++|++++ |..||...+.
T Consensus       177 ~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~  212 (259)
T cd05037         177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS  212 (259)
T ss_pred             cCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence            774 357899999999999999998 6888877643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0695|consensus

Probab=99.97  E-value=1.2e-32  Score=201.77  Aligned_cols=182  Identities=23%  Similarity=0.381  Sum_probs=158.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |+.++|.+.||+|+++... ..+++++....|-....+. +||.++-+..+|+.+     ..+++|.||.+ |+|--.+.
T Consensus       269 ~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte-----srlffvieyv~ggdlmfhmq  343 (593)
T KOG0695|consen  269 VRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQ  343 (593)
T ss_pred             eehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc-----ceEEEEEEEecCcceeeehh
Confidence            5678899999999996543 3555666666676666666 899999999999998     78889999998 58888888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ....++|+.++.+..+|+.||.|||++||++||+|.+|++++..|.+||.|+|++... ..+....++.+|||.|.|||.
T Consensus       344 rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~-l~~gd~tstfcgtpnyiapei  422 (593)
T KOG0695|consen  344 RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-LGPGDTTSTFCGTPNYIAPEI  422 (593)
T ss_pred             hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC-CCCCcccccccCCCcccchhh
Confidence            8888999999999999999999999999999999999999999999999999999743 344555667799999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +.+ ..|+.+.|+|+||++++||+.|+.||.-
T Consensus       423 lrg-eeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  423 LRG-EEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             hcc-cccCceehHHHHHHHHHHHHcCCCCcce
Confidence            998 5599999999999999999999999953

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.1e-31  Score=201.28  Aligned_cols=182  Identities=29%  Similarity=0.451  Sum_probs=148.0

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-C
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-H   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~   82 (203)
                      ..+++.+++|.++..... ...+.+.+|++.++.++|+||+++++++...+.   ...++++||+. ++|.+++.... .
T Consensus        30 ~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~l~~~~~~  105 (284)
T cd05038          30 DNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQ  105 (284)
T ss_pred             CCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC---CceEEEEecCCCCCHHHHHHhCccc
Confidence            456889999999654333 345678899999999999999999998876432   46789999997 58888886543 6


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~  160 (203)
                      +++..+..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+........  .......++..|.+||...
T Consensus       106 ~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         106 INLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            99999999999999999999999999999999999999999999999999875442211  1111223355699999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      + ..++.++|+||||+++++|++|..||...
T Consensus       186 ~-~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         186 T-SKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             c-CCCCcccchHHHhhhhheeeccCCCcccc
Confidence            6 45789999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0596|consensus

Probab=99.97  E-value=2.8e-32  Score=209.87  Aligned_cols=178  Identities=28%  Similarity=0.404  Sum_probs=147.3

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCC-CChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH-LTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~   86 (203)
                      .-|++|.+.....+......+..|+..|.+| .|.+|+.++++=..+     .++|+|||+.+-+|..++..... .+..
T Consensus       386 ~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~  460 (677)
T KOG0596|consen  386 QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDPDW  460 (677)
T ss_pred             cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCchH
Confidence            4566666655556777788999999999999 789999999987776     68999999888899999987654 4446


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccceeeeccc--
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEILMGAR--  163 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~~--  163 (203)
                      .++.+..||+.|+.+.|+.||||.||||.|+++-. |.+||+|||.+...... .......-.||+.|++||.+....  
T Consensus       461 ~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~  539 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS  539 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence            88889999999999999999999999999999865 59999999999754433 233445568999999999886432  


Q ss_pred             --------CCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        164 --------HYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       164 --------~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                              ..++++|||||||++|+|+.|++||..-.
T Consensus       540 ~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~  576 (677)
T KOG0596|consen  540 RENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII  576 (677)
T ss_pred             ccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence                    14679999999999999999999998754

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.8e-31  Score=198.75  Aligned_cols=184  Identities=26%  Similarity=0.474  Sum_probs=147.5

Q ss_pred             CCcEEEEEeccCcc--------chhhhhHHHHHHHHHHhh-cCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHH
Q psy16889          7 DGRRVALKKLPNVF--------QSLVSSKRVFRELKMLCF-FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKI   76 (203)
Q Consensus         7 ~~~~~~vK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   76 (203)
                      +++.+++|.+....        ........+..|+..+++ ++|+||+++++++.++     ...++++||+.+ +|.+.
T Consensus        25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~   99 (269)
T cd08528          25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEH   99 (269)
T ss_pred             CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-----CeEEEEEecCCCCcHHHH
Confidence            67889999884321        222344556778887765 6999999999998877     567899999874 66655


Q ss_pred             Hh----CCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         77 IV----SPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        77 ~~----~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      +.    ....+++..++.++.|++.++.+||+ .+++|+||+|+||+++.++.++++|||.+.......  ......++.
T Consensus       100 l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~  177 (269)
T cd08528         100 FNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES--KLTSVVGTI  177 (269)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc--ccccccCcc
Confidence            42    34579999999999999999999996 789999999999999999999999999987543322  333446688


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG  198 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~  198 (203)
                      .|.+||.+.+ ..++.++|+||||+++|++++|+.||..........
T Consensus       178 ~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~  223 (269)
T cd08528         178 LYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT  223 (269)
T ss_pred             cCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence            8999999987 457999999999999999999999998776554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1035|consensus

Probab=99.97  E-value=1.5e-31  Score=220.89  Aligned_cols=186  Identities=32%  Similarity=0.490  Sum_probs=149.2

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccC---------------------------
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP---------------------------   53 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------------------------   53 (203)
                      +|+++-+|+.||||.++... +...-..+.+|+..+.+++|||||+++..|..                           
T Consensus       497 kVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~  575 (1351)
T KOG1035|consen  497 KVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNG  575 (1351)
T ss_pred             EEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCccc
Confidence            37899999999999998764 56666789999999999999999999931100                           


Q ss_pred             --------------------------------------C---------Ccch----------------------------
Q psy16889         54 --------------------------------------P---------HLDF----------------------------   58 (203)
Q Consensus        54 --------------------------------------~---------~~~~----------------------------   58 (203)
                                                            +         +.++                            
T Consensus       576 ~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~  655 (1351)
T KOG1035|consen  576 VDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKT  655 (1351)
T ss_pred             ceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhcccc
Confidence                                                  0         0000                            


Q ss_pred             ------------hHHHHHHHhhhHHhHHHHHhCCCCCC--hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe
Q psy16889         59 ------------FQEIYVITELLQSDLHKIIVSPQHLT--SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI  124 (203)
Q Consensus        59 ------------~~~~~lv~e~~~~~l~~~~~~~~~~~--~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~  124 (203)
                                  ..++|+-||||+.++++++.....+.  ....++++.||++||.|+|++|++||||||.||+++.++.
T Consensus       656 ~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~  735 (1351)
T KOG1035|consen  656 ENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS  735 (1351)
T ss_pred             CCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC
Confidence                        02357889999988777776655554  8889999999999999999999999999999999999999


Q ss_pred             EEEeecCccccCC-----------------CCCCCCcccccCCcccccceeeeccc--CCCcchhHHHHHHHHHHHHhCC
Q psy16889        125 LKICDFGLARVEE-----------------PDPNKAMTQEVVTQYYRAPEILMGAR--HYSAAVDVWSVGCIFAELLGRR  185 (203)
Q Consensus       125 ~~l~d~~~~~~~~-----------------~~~~~~~~~~~~~~~~~aPe~~~~~~--~~~~~~Di~slG~~l~~ll~g~  185 (203)
                      +||+|||+++...                 .......+...||..|+|||++.+..  .|+.+.|+||||++++||+.  
T Consensus       736 VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y--  813 (1351)
T KOG1035|consen  736 VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY--  813 (1351)
T ss_pred             eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc--
Confidence            9999999987511                 11122446678899999999998865  69999999999999999984  


Q ss_pred             cccCC
Q psy16889        186 ILFQA  190 (203)
Q Consensus       186 ~pf~~  190 (203)
                       ||+.
T Consensus       814 -PF~T  817 (1351)
T KOG1035|consen  814 -PFGT  817 (1351)
T ss_pred             -cCCc
Confidence             3554

>KOG4257|consensus

Probab=99.97  E-value=1.3e-31  Score=209.11  Aligned_cols=183  Identities=27%  Similarity=0.443  Sum_probs=157.5

Q ss_pred             EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCCChHH
Q psy16889         10 RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHLTSDH   87 (203)
Q Consensus        10 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~   87 (203)
                      -||||..+.. ..+.+.+.|..|+.++++++||||+++++++.+.      -.++|||.+. |.|..+++.+ ..++...
T Consensus       420 aVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~WivmEL~~~GELr~yLq~nk~sL~l~t  492 (974)
T KOG4257|consen  420 AVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PMWIVMELAPLGELREYLQQNKDSLPLRT  492 (974)
T ss_pred             eeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ceeEEEecccchhHHHHHHhccccchHHH
Confidence            3889998764 3445689999999999999999999999999887      4689999998 8999999864 5699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCc
Q psy16889         88 IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA  167 (203)
Q Consensus        88 ~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~  167 (203)
                      +..++.||+.|+.|||+.+.|||||-..||++..+.-+||.|||+++.......-..+....+.-|+|||.+.- +.++.
T Consensus       493 L~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTt  571 (974)
T KOG4257|consen  493 LTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTT  571 (974)
T ss_pred             HHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccch-hcccc
Confidence            99999999999999999999999999999999999999999999999776655444444445667999999987 44999


Q ss_pred             chhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        168 AVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       168 ~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ++|+|.||+.+||+++ |.-||.+-.+.+.+..|
T Consensus       572 ASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i  605 (974)
T KOG4257|consen  572 ASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI  605 (974)
T ss_pred             hhhHHHHHHHHHHHHHhcCCccccccccceEEEe
Confidence            9999999999999985 89999987766655433

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.1e-31  Score=200.99  Aligned_cols=159  Identities=20%  Similarity=0.220  Sum_probs=124.4

Q ss_pred             HHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecC
Q psy16889         32 ELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRD  111 (203)
Q Consensus        32 e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~d  111 (203)
                      +...+..+.|++++++++++....... ...+++++++..++.+.+......++..+..++.|++.++++||+++++|||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD  151 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCRM-YYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGD  151 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCCc-eEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            344556678999999998765443211 1235667776666666665555578899999999999999999999999999


Q ss_pred             CCCCcEEecCCCeEEEeecCccccCCCCC------CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCC
Q psy16889        112 IKPGNLLVNSNCILKICDFGLARVEEPDP------NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRR  185 (203)
Q Consensus       112 i~~~nil~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~  185 (203)
                      |||+||+++.++.++++|||++.......      ........||+.|+|||+..+ ..++.++|+||||+++|+|++|+
T Consensus       152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~  230 (294)
T PHA02882        152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIK  230 (294)
T ss_pred             CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999999999999999999987543211      111223357899999999887 55899999999999999999999


Q ss_pred             cccCCCC
Q psy16889        186 ILFQAQS  192 (203)
Q Consensus       186 ~pf~~~~  192 (203)
                      .||.+.+
T Consensus       231 ~P~~~~~  237 (294)
T PHA02882        231 LPWKGFG  237 (294)
T ss_pred             CCCCccc
Confidence            9998773

>KOG0671|consensus

Probab=99.97  E-value=3e-32  Score=201.39  Aligned_cols=187  Identities=30%  Similarity=0.513  Sum_probs=154.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc--CCCC----ccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF--KHDN----VLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~----i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |+|.+++..||||++++.   ....+..+-|++.++++  +.|+    ++.+.++|...     ...++|.|.++-++.+
T Consensus       108 c~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-----ghiCivfellG~S~~d  179 (415)
T KOG0671|consen  108 CWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-----GHICIVFELLGLSTFD  179 (415)
T ss_pred             EeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-----CceEEEEeccChhHHH
Confidence            578888999999999753   23445666789999999  2332    66776777666     7889999999999999


Q ss_pred             HHhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--------------------CCeEEEeecCcc
Q psy16889         76 IIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--------------------NCILKICDFGLA  133 (203)
Q Consensus        76 ~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--------------------~~~~~l~d~~~~  133 (203)
                      ++..+  .+++...++.++.|+++++++||+.+++|.||||+||++..                    +..++++|||.+
T Consensus       180 Flk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsA  259 (415)
T KOG0671|consen  180 FLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSA  259 (415)
T ss_pred             HhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCc
Confidence            99875  46999999999999999999999999999999999999832                    235899999999


Q ss_pred             ccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        134 RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +......    .....|-.|.|||++.+- .++.+.|+||+||+|+|+.+|...|++..+.+.+++|.
T Consensus       260 tf~~e~h----s~iVsTRHYRAPEViLgL-GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMe  322 (415)
T KOG0671|consen  260 TFDHEHH----STIVSTRHYRAPEVILGL-GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMME  322 (415)
T ss_pred             ceeccCc----ceeeeccccCCchheecc-CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHH
Confidence            8654332    344557889999999994 49999999999999999999999999999888776653

>KOG0199|consensus

Probab=99.97  E-value=1.2e-30  Score=205.98  Aligned_cols=184  Identities=27%  Similarity=0.371  Sum_probs=156.1

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCCCh
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHLTS   85 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~   85 (203)
                      ..||||+++...... ....|.+|+..|.+++|+|++++|++..+.      -..+|+|.+. |+|++.+.+  ...|-.
T Consensus       139 V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~q------p~mMV~ELaplGSLldrLrka~~~~llv  211 (1039)
T KOG0199|consen  139 VNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQ------PAMMVFELAPLGSLLDRLRKAKKAILLV  211 (1039)
T ss_pred             EeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccc------hhhHHhhhcccchHHHHHhhccccceeH
Confidence            359999996643333 567899999999999999999999999875      4679999998 799998876  456999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC-c-ccccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA-M-TQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-~-~~~~~~~~~~aPe~~~~~~  163 (203)
                      ..+..++.||+.|+.||..+++||||+-..|+++-....+|++|||+.+......... + ....-..-|+|||.+.. .
T Consensus       212 ~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~  290 (1039)
T KOG0199|consen  212 SRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH-R  290 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc-c
Confidence            9999999999999999999999999999999999999999999999998554433221 1 12222456999999987 5


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+|++|+++|||++ |+-||.+....+++++|
T Consensus       291 kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i  328 (1039)
T KOG0199|consen  291 KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI  328 (1039)
T ss_pred             cccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc
Confidence            59999999999999999997 79999999999999876

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.6e-30  Score=190.16  Aligned_cols=180  Identities=36%  Similarity=0.632  Sum_probs=152.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.+++|++........ ...+.+|++.+++++|+|++++.+.+...     ...++++|++++ +|.+++...
T Consensus         8 ~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~   81 (244)
T smart00220        8 ARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKR   81 (244)
T ss_pred             EEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhc
Confidence            34556899999999965322221 57888999999999999999999998876     467789999986 898888776


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.+++.++.+||+.+++|+||+|+||+++.++.++++|||.+.......  ......++..|++||...
T Consensus        82 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       82 GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCHHHHc
Confidence            669999999999999999999999999999999999999999999999999987544322  223345677899999887


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      + ..++.++|+||||++++++++|..||..
T Consensus       160 ~-~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      160 G-KGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             c-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            6 4478899999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.7e-30  Score=187.19  Aligned_cols=193  Identities=32%  Similarity=0.555  Sum_probs=156.4

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   81 (203)
                      .+..+++.+++|.+...... ...+.+.+|++.++.++|+|++++++.+...     ...++++|++.+ +|.+.+....
T Consensus        19 ~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~   92 (225)
T smart00221       19 RDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKG   92 (225)
T ss_pred             EEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcc
Confidence            44567899999999653222 2466788999999999999999999988776     567789999986 8888887665


Q ss_pred             C-CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         82 H-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        82 ~-~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      . +++..+..++.+++.++.+||+.+++|+|++|+|++++.++.++++|||.+...............++..|++||...
T Consensus        93 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  172 (225)
T smart00221       93 GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL  172 (225)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc
Confidence            5 899999999999999999999999999999999999999999999999988754433211223345577899999884


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCC--CChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQA--QSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~--~~~~~~~~~i~  201 (203)
                      ....++.++|+|+||++++++++|+.||..  +......+.|.
T Consensus       173 ~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~  215 (225)
T smart00221      173 GGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS  215 (225)
T ss_pred             CCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence            335577899999999999999999999987  33445555553

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4278|consensus

Probab=99.97  E-value=1.6e-30  Score=203.44  Aligned_cols=183  Identities=26%  Similarity=0.402  Sum_probs=155.6

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCCCh
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHLTS   85 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~   85 (203)
                      --||||.++.   +.-..+.|..|+.+|+.++|||+|+++++|..+     .-.|+++|||. |+|++++..  ...++.
T Consensus       293 lTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~a  364 (1157)
T KOG4278|consen  293 LTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLRECNRSEVPA  364 (1157)
T ss_pred             eeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHhchhhcch
Confidence            3477887742   333567899999999999999999999999988     66789999998 799999984  355888


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCC
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHY  165 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~  165 (203)
                      -.+++++.||.+|++||..++.+||||-..|+++.++.-+|+.|||+++..............-..-|.|||-+.- ..+
T Consensus       365 vvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtF  443 (1157)
T KOG4278|consen  365 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTF  443 (1157)
T ss_pred             hHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccc-ccc
Confidence            8889999999999999999999999999999999999999999999999766555554444444667999999987 458


Q ss_pred             CcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        166 SAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       166 ~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.++|+|+||++|||+.| |..||++-+..+.+..+
T Consensus       444 SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LL  479 (1157)
T KOG4278|consen  444 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLL  479 (1157)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHH
Confidence            999999999999999997 89999998876665543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=6.1e-30  Score=211.24  Aligned_cols=128  Identities=23%  Similarity=0.373  Sum_probs=111.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||||+++... ........+..|+.+++.++|+||+++++++...     ..+|+||||+. ++|.+++..
T Consensus        23 a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~   97 (669)
T cd05610          23 GRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHI   97 (669)
T ss_pred             EEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHh
Confidence            4567789999999986432 2333446788899999999999999999988776     56789999996 589888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .+.+++..++.++.|++.||+|||+.+|+||||||+||+++.++.++|+|||++.
T Consensus        98 ~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          98 YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            7789999999999999999999999999999999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=1.2e-29  Score=188.08  Aligned_cols=189  Identities=26%  Similarity=0.421  Sum_probs=145.2

Q ss_pred             cCCCCCcEEEEEeccCcc---chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          3 TDPRDGRRVALKKLPNVF---QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      .+..++..+++|..+...   ...........|+.+++.++||||+++++.+.+.     ...++++||+.+ +|.+.+.
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~   94 (260)
T cd08222          20 KDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLE   94 (260)
T ss_pred             EecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHH
Confidence            344555556666654321   1223344566789999999999999999999877     567899999984 6666553


Q ss_pred             ----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         79 ----SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                          ....+++.++..++.|++.++.+||+.|++|+||+|+||+++. +.++++|||.+....... .......+++.|.
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~  172 (260)
T cd08222          95 ELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC-DLATTFTGTPYYM  172 (260)
T ss_pred             HHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc-ccccCCCCCcCcc
Confidence                3467999999999999999999999999999999999999975 579999999886543221 1222335677899


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |||...+ ..++.++|+||||+++|++++|..||...........
T Consensus       173 ~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~  216 (260)
T cd08222         173 SPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR  216 (260)
T ss_pred             CHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            9998866 4478899999999999999999999987665544433

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0670|consensus

Probab=99.96  E-value=9.5e-31  Score=200.54  Aligned_cols=190  Identities=33%  Similarity=0.545  Sum_probs=158.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC------CCccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH------DNVLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |.|...|..||||++.+.....   ..=..|+++|++|+.      -|+++++..|...     .++|+|+|.+.-+|.+
T Consensus       451 a~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-----nHLClVFE~LslNLRe  522 (752)
T KOG0670|consen  451 ARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-----NHLCLVFEPLSLNLRE  522 (752)
T ss_pred             ccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-----ceeEEEehhhhchHHH
Confidence            6788889999999996531111   122468999999953      2799999999888     8999999999988988


Q ss_pred             HHhCCC---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         76 IIVSPQ---HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        76 ~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      .+...|   .+....++.++.|++.||..|-..|++|.||||+|||+++. ..+||||||.+........   ++..-+-
T Consensus       523 vLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei---tPYLVSR  599 (752)
T KOG0670|consen  523 VLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI---TPYLVSR  599 (752)
T ss_pred             HHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc---cHHHHHH
Confidence            887644   38899999999999999999999999999999999999965 4679999999976554433   3334467


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhcC
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL  203 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~~  203 (203)
                      .|.|||.+.+ -+|+...|+||.||+|||+-||+..|++.++.+.+...++|
T Consensus       600 FYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  600 FYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             hccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            7999999999 56999999999999999999999999999999999877764

>KOG0587|consensus

Probab=99.96  E-value=2.2e-29  Score=202.53  Aligned_cols=191  Identities=23%  Similarity=0.369  Sum_probs=155.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      ++++++|+..|+|+.....   ...+.++.|.++++.. .|||++.+++++.-.+...-+.+|+|||||+ |+..+.+..
T Consensus        38 ~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn  114 (953)
T KOG0587|consen   38 GRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKN  114 (953)
T ss_pred             EeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhh
Confidence            5678899999999985432   2235677788999888 8999999999876554444478999999999 566666543


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                        ...+.|+.+..|+..++.++.+||.+.++|||||-.||++++++.+||+|||.+...... .....+..||+.|+|||
T Consensus       115 ~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPE  193 (953)
T KOG0587|consen  115 TKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPE  193 (953)
T ss_pred             hcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecc-cccccCcCCCcccccce
Confidence              567999999999999999999999999999999999999999999999999999744333 23345558999999999


Q ss_pred             eeeccc----CCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        158 ILMGAR----HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       158 ~~~~~~----~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      ++.-.+    .|+..+|+||||++..||.-|.+|+-..=+.-.
T Consensus       194 Viac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra  236 (953)
T KOG0587|consen  194 VIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA  236 (953)
T ss_pred             eeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence            997643    367789999999999999999999866544333

>KOG1151|consensus

Probab=99.96  E-value=4.2e-29  Score=188.90  Aligned_cols=189  Identities=28%  Similarity=0.397  Sum_probs=153.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhh----hhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLV----SSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   75 (203)
                      |.|...++.||||+-..... .++    ......+|.++-+.+.||.||++|++|.-+.    ...+-|+|||+| +|.-
T Consensus       482 AFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDF  557 (775)
T KOG1151|consen  482 AFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDF  557 (775)
T ss_pred             hcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc----ccceeeeeecCCCchhH
Confidence            67888999999998743222 111    2345678999999999999999999997664    356789999997 7888


Q ss_pred             HHhCCCCCChHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCC------Cc
Q psy16889         76 IIVSPQHLTSDHIKVFLYQILRGLKYLHSA--RILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNK------AM  144 (203)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~--~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~------~~  144 (203)
                      ++..+..++|.+++.|+-||..||.||.+.  -|+|-||||.||++.   .-|.+|+.|||++.........      ..
T Consensus       558 YLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLT  637 (775)
T KOG1151|consen  558 YLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELT  637 (775)
T ss_pred             HHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeee
Confidence            888888999999999999999999999976  599999999999995   4578999999999855443322      22


Q ss_pred             ccccCCcccccceeeecc---cCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        145 TQEVVTQYYRAPEILMGA---RHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~---~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      ....||..|++||.+.-.   ...+.+.|+||+|+++|.++.|+-||..+...
T Consensus       638 SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  638 SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            344778899999987643   23678999999999999999999999987543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.96  E-value=4.5e-29  Score=214.56  Aligned_cols=168  Identities=18%  Similarity=0.335  Sum_probs=135.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.||||.+.....      ...+|++.+++++||||+++++++.++     ...++||||++ |+|.+++.  
T Consensus       709 ~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~--  775 (968)
T PLN00113        709 GKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR--  775 (968)
T ss_pred             EEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh--
Confidence            34567899999999854211      123468889999999999999999877     45789999998 58888874  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLH---SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                       .+++..+..++.|++.|++|||   +.+++||||||+||+++.++..++. ++......     ......+++.|+|||
T Consensus       776 -~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-----~~~~~~~t~~y~aPE  848 (968)
T PLN00113        776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSAYVAPE  848 (968)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----cCCCccccccccCcc
Confidence             3889999999999999999999   6699999999999999988777665 44433211     111225678899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ++.+ ..++.++||||||+++|||++|+.||..
T Consensus       849 ~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        849 TRET-KDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             cccC-CCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence            9887 5589999999999999999999999854

>KOG0200|consensus

Probab=99.95  E-value=1.4e-28  Score=200.79  Aligned_cols=184  Identities=30%  Similarity=0.454  Sum_probs=153.5

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC----
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ----   81 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----   81 (203)
                      ...||||.++..... .+.+.+..|+++++.+ +|+||+.+++++...     ..+++++||+. |+|..++....    
T Consensus       328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~  401 (609)
T KOG0200|consen  328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTES  401 (609)
T ss_pred             eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhcccccc
Confidence            557999999776444 6778899999999999 799999999999885     67889999998 79999887544    


Q ss_pred             ------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC--cccc
Q psy16889         82 ------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA--MTQE  147 (203)
Q Consensus        82 ------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~  147 (203)
                                  .++..++..++.||+.+++||++..++|||+-..||++..+..+|++|||+++.........  ....
T Consensus       402 ~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~  481 (609)
T KOG0200|consen  402 IDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAG  481 (609)
T ss_pred             ccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCC
Confidence                        48899999999999999999999999999999999999999999999999998433322221  1111


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCC-hHHHhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQS-PVQQLG  198 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~-~~~~~~  198 (203)
                      .....|+|||.+.. ..++.++|+||+|+++||++| |..||.+.. ..+.++
T Consensus       482 ~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~  533 (609)
T KOG0200|consen  482 TLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE  533 (609)
T ss_pred             ccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH
Confidence            13556999999998 669999999999999999997 899999855 444444

>KOG1025|consensus

Probab=99.95  E-value=7.3e-28  Score=193.06  Aligned_cols=184  Identities=28%  Similarity=0.406  Sum_probs=153.8

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~   85 (203)
                      +.+|++|++... .+......+.+|+-.|.+++|||++++++++..+      .+-+|++|++ |.|.++++. +..+-.
T Consensus       725 KipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr~~igs  797 (1177)
T KOG1025|consen  725 KIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHRDNIGS  797 (1177)
T ss_pred             cceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhhccccH
Confidence            457889988543 4555667899999999999999999999999887      3789999999 799999874 577999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcc-cccCCcccccceeeecccC
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+.|..||++++.|||+++++||||-..|+++.....+|+.|||++............ .....+.|+|-|.+.. ..
T Consensus       798 q~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~  876 (1177)
T KOG1025|consen  798 QDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RK  876 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cC
Confidence            999999999999999999999999999999999999999999999999854433222211 1122456999998887 55


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      ++.++|+||+|+++||++| |..|+.+.+..++-..
T Consensus       877 ~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl  912 (1177)
T KOG1025|consen  877 YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL  912 (1177)
T ss_pred             CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH
Confidence            8999999999999999997 9999999877766544

>KOG2052|consensus

Probab=99.95  E-value=3.6e-28  Score=183.03  Aligned_cols=171  Identities=26%  Similarity=0.410  Sum_probs=137.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc--CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF--KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      --|+.||||++..     .+...+.+|.++.+..  +|+||+.+++.-..+... -..+++|++|.+ |+|.+++.. ..
T Consensus       232 wrGe~VAVKiF~s-----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs-~TQLwLvTdYHe~GSL~DyL~r-~t  304 (513)
T KOG2052|consen  232 WRGEDVAVKIFSS-----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS-WTQLWLVTDYHEHGSLYDYLNR-NT  304 (513)
T ss_pred             ccCCceEEEEecc-----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc-eEEEEEeeecccCCcHHHHHhh-cc
Confidence            4589999999953     3445677777777655  999999999875433322 246899999998 899999988 67


Q ss_pred             CChHHHHHHHHHHHHHHHHHHh-----C---CceecCCCCCcEEecCCCeEEEeecCccccCCCC---CCCCcccccCCc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHS-----A---RILHRDIKPGNLLVNSNCILKICDFGLARVEEPD---PNKAMTQEVVTQ  151 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~-----~---~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~  151 (203)
                      ++.+...+++..++++|++||.     +   .|.|||||..||++..++...+.|+|++-.....   .........||-
T Consensus       305 v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTK  384 (513)
T KOG2052|consen  305 VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTK  384 (513)
T ss_pred             CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCcccee
Confidence            9999999999999999999994     3   4999999999999999999999999999754433   233556779999


Q ss_pred             ccccceeeeccc---CC--CcchhHHHHHHHHHHHHh
Q psy16889        152 YYRAPEILMGAR---HY--SAAVDVWSVGCIFAELLG  183 (203)
Q Consensus       152 ~~~aPe~~~~~~---~~--~~~~Di~slG~~l~~ll~  183 (203)
                      +|+|||++...-   .+  -..+||||||.++||++.
T Consensus       385 RYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  385 RYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             eccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence            999999997632   11  136899999999999863

>KOG1027|consensus

Probab=99.95  E-value=3.8e-29  Score=200.26  Aligned_cols=176  Identities=32%  Similarity=0.417  Sum_probs=142.0

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCC--
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH--   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~--   82 (203)
                      ..|+.||||.+-.     +......+|+..++.- .||||++++..=.+.     ...|+..|.|.-+|.+++.....  
T Consensus       531 ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~  600 (903)
T KOG1027|consen  531 YEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDV  600 (903)
T ss_pred             eCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccch
Confidence            4688999998843     2344567899988888 899999999887777     67889999999999999876311  


Q ss_pred             --CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---C--CeEEEeecCccccCCCCCC--CCcccccCCccc
Q psy16889         83 --LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---N--CILKICDFGLARVEEPDPN--KAMTQEVVTQYY  153 (203)
Q Consensus        83 --~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~--~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~  153 (203)
                        ......+.++.|+++||++||+.+|+||||||.||+++.   +  ..++|+|||++........  .......||.+|
T Consensus       601 ~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW  680 (903)
T KOG1027|consen  601 EMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGW  680 (903)
T ss_pred             hhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccc
Confidence              122456788999999999999999999999999999975   2  4679999999985443322  234566789999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCC
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQS  192 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~  192 (203)
                      .|||.+.... -+.+.|||||||++|+.++| ..||...-
T Consensus       681 ~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~  719 (903)
T KOG1027|consen  681 QAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSL  719 (903)
T ss_pred             cCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchH
Confidence            9999998855 46799999999999999985 99998753

>KOG1290|consensus

Probab=99.95  E-value=2.4e-27  Score=180.46  Aligned_cols=114  Identities=30%  Similarity=0.438  Sum_probs=97.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-----CC---CccchhhhccCCCcchhHHHHHHHhhhHHhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-----HD---NVLSALDILQPPHLDFFQEIYVITELLQSDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~---~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l   73 (203)
                      |+|.++.+.||+|+.+.   .....+....|+.+|++++     ++   .||++++.|...+... .++++|+|+++.+|
T Consensus        97 awDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnL  172 (590)
T KOG1290|consen   97 AWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG-QHVCMVFEVLGDNL  172 (590)
T ss_pred             EeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC-cEEEEEehhhhhHH
Confidence            67899999999999854   2344567788999999982     32   5999999998776554 58999999999999


Q ss_pred             HHHHhCC--CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEe
Q psy16889         74 HKIIVSP--QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLV  119 (203)
Q Consensus        74 ~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~  119 (203)
                      +.++...  ..++...++.|+.|++.+|.|||+ .||+|.||||+|||+
T Consensus       173 LklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  173 LKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence            9998853  459999999999999999999995 599999999999998

>KOG3653|consensus

Probab=99.95  E-value=1.5e-27  Score=180.85  Aligned_cols=175  Identities=29%  Similarity=0.412  Sum_probs=140.0

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc--CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF--KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      -+++.||||+++.     .+.+.+..|-++.+..  +|+||++++..-.....+ ...+++|++|.+ |+|.+++.. ..
T Consensus       231 L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLVt~fh~kGsL~dyL~~-nt  303 (534)
T KOG3653|consen  231 LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLVTEFHPKGSLCDYLKA-NT  303 (534)
T ss_pred             ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEEeeeccCCcHHHHHHh-cc
Confidence            4678999999965     4556677777766655  899999999876554433 256889999998 799999876 45


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSA---------RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQY  152 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~---------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~  152 (203)
                      +++.+..+++..++.+|+|||+-         .|+|||||..||++..++...|+|||++........ .....-.||.+
T Consensus       304 isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~R  383 (534)
T KOG3653|consen  304 ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRR  383 (534)
T ss_pred             ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhh
Confidence            89999999999999999999952         599999999999999999999999999986553222 22233588999


Q ss_pred             cccceeeecccCCC-----cchhHHHHHHHHHHHHhCCcc
Q psy16889        153 YRAPEILMGARHYS-----AAVDVWSVGCIFAELLGRRIL  187 (203)
Q Consensus       153 ~~aPe~~~~~~~~~-----~~~Di~slG~~l~~ll~g~~p  187 (203)
                      |+|||++.+.-.+.     .+.|+||+|.++||++++-.-
T Consensus       384 YMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~  423 (534)
T KOG3653|consen  384 YMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTD  423 (534)
T ss_pred             hcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccc
Confidence            99999998753333     368999999999999986443

>KOG1345|consensus

Probab=99.95  E-value=1.3e-28  Score=175.47  Aligned_cols=178  Identities=23%  Similarity=0.428  Sum_probs=139.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.++..+++|-++..   ......+.+|...=-.| .|.||+.-|++.....    +.+.+++||++ |+|.+-+..
T Consensus        43 ~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~YvF~qE~aP~gdL~snv~~  115 (378)
T KOG1345|consen   43 AEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYVFVQEFAPRGDLRSNVEA  115 (378)
T ss_pred             eeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEEEeeccCccchhhhhcCc
Confidence            568899999999999754   34456678887755555 6889999998754433    46678999999 899988776


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .| +.|..-..++.|+++|+.|+|+.++||||||.+||++-  +..++||||||..+..+..- .   .......|.+||
T Consensus       116 ~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-~---~~~~~~~y~~pe  190 (378)
T KOG1345|consen  116 AG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-K---YLEYVNNYHAPE  190 (378)
T ss_pred             cc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-h---hhhhhcccCCcH
Confidence            43 78888999999999999999999999999999999985  34589999999997543221 1   112244588888


Q ss_pred             eeecc----cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        158 ILMGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       158 ~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +....    -...+.+|+|.||+++|.++||.+||+..
T Consensus       191 ~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka  228 (378)
T KOG1345|consen  191 LCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA  228 (378)
T ss_pred             HHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence            76532    12467899999999999999999999864

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.1e-27  Score=201.83  Aligned_cols=156  Identities=21%  Similarity=0.200  Sum_probs=116.5

Q ss_pred             HHhhcCC-CCccchhhhccCCCcchh--HHHHHHHhhhHHhHHHHHhC-CCCCChHHHHHHHHHHHHHHHHHHhCCceec
Q psy16889         35 MLCFFKH-DNVLSALDILQPPHLDFF--QEIYVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHR  110 (203)
Q Consensus        35 ~l~~l~~-~~i~~~~~~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  110 (203)
                      ..+.++| +||+++++++.....+..  .....++|+++++|.+++.. ...+++.++..++.||+.||+|||++||+||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         25 GSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             ccchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            3455566 688888888743332221  35778899998999999975 3569999999999999999999999999999


Q ss_pred             CCCCCcEEecCCCeE-------------------EEeecCccccCCCCCC---------------CCcccccCCcccccc
Q psy16889        111 DIKPGNLLVNSNCIL-------------------KICDFGLARVEEPDPN---------------KAMTQEVVTQYYRAP  156 (203)
Q Consensus       111 di~~~nil~~~~~~~-------------------~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~~aP  156 (203)
                      ||||+||+++..+.+                   +++|||+++.......               .......+|+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            999999999655544                   4555555432110000               001113467889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |++.+ ..++.++|||||||++|||++|.+|+...
T Consensus       185 E~~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~  218 (793)
T PLN00181        185 EEDNG-SSSNCASDVYRLGVLLFELFCPVSSREEK  218 (793)
T ss_pred             hhhcc-CCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence            99887 45899999999999999999999987653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=6.5e-26  Score=162.09  Aligned_cols=172  Identities=35%  Similarity=0.622  Sum_probs=142.0

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   80 (203)
                      .+..+|+.+++|++....... ..+.+.+|++.++.++|++++++++++...     ...++++|+++ ++|.+++... 
T Consensus        13 ~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~   86 (215)
T cd00180          13 RDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENE   86 (215)
T ss_pred             EecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhcc
Confidence            445579999999996532221 356788999999999999999999999887     56778999999 6888887765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..++.+.+..++.+++.++++||+.+++|+||+|.||+++. ++.++++||+.+........ ......+...|.+||..
T Consensus        87 ~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~  165 (215)
T cd00180          87 GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVL  165 (215)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCCCCccChhHh
Confidence            57999999999999999999999999999999999999999 89999999999875433221 12333557779999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAEL  181 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~l  181 (203)
                      ......+.++|+|++|++++++
T Consensus       166 ~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         166 LGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cccCCCCchhhhHHHHHHHHHH
Confidence            7743578899999999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=3.3e-26  Score=185.33  Aligned_cols=130  Identities=26%  Similarity=0.363  Sum_probs=96.0

Q ss_pred             HHHHHHHhhhH-HhHHHHHhCCC--------------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy16889         60 QEIYVITELLQ-SDLHKIIVSPQ--------------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL  118 (203)
Q Consensus        60 ~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil  118 (203)
                      ...++++||++ ++|.+++....                    ...+..+..++.|++.+|+|||+++|+||||||+||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            35678888877 46666654321                    1224456789999999999999999999999999999


Q ss_pred             ecC-CCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc---------------------CCCcchhHHHHHH
Q psy16889        119 VNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR---------------------HYSAAVDVWSVGC  176 (203)
Q Consensus       119 ~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~---------------------~~~~~~Di~slG~  176 (203)
                      ++. ++.+|++|||++...............+++.|+|||.+....                     .++.++|+|||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            985 579999999999754333233334456788999999654211                     1234569999999


Q ss_pred             HHHHHHhCCcccC
Q psy16889        177 IFAELLGRRILFQ  189 (203)
Q Consensus       177 ~l~~ll~g~~pf~  189 (203)
                      ++|+|+++..|+.
T Consensus       368 iL~el~~~~~~~~  380 (566)
T PLN03225        368 IFLQMAFPNLRSD  380 (566)
T ss_pred             HHHHHHhCcCCCc
Confidence            9999999776654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=3.2e-25  Score=176.15  Aligned_cols=186  Identities=25%  Similarity=0.294  Sum_probs=126.1

Q ss_pred             CCCCcEEEEEeccCccch------------hhhhHHHHHHHHHHhhcCCCCc-----cchhhhccCCCcch---hHHHHH
Q psy16889          5 PRDGRRVALKKLPNVFQS------------LVSSKRVFRELKMLCFFKHDNV-----LSALDILQPPHLDF---FQEIYV   64 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~---~~~~~l   64 (203)
                      ...++.||||.+......            ....+....|+..+.+++|.++     +++++++.....+.   ....++
T Consensus       183 ~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~L  262 (507)
T PLN03224        183 EQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWL  262 (507)
T ss_pred             cccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEE
Confidence            456778999998542111            0111233346667777766543     56666654321110   124678


Q ss_pred             HHhhhH-HhHHHHHhCC------------------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe
Q psy16889         65 ITELLQ-SDLHKIIVSP------------------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV  119 (203)
Q Consensus        65 v~e~~~-~~l~~~~~~~------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~  119 (203)
                      |+||++ ++|.+++...                        ..+++..++.++.|++.+|.++|+.+++||||||+||++
T Consensus       263 V~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl  342 (507)
T PLN03224        263 VWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV  342 (507)
T ss_pred             EEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE
Confidence            999987 4776665421                        124567788999999999999999999999999999999


Q ss_pred             cCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC-------------------C--CcchhHHHHHHHH
Q psy16889        120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH-------------------Y--SAAVDVWSVGCIF  178 (203)
Q Consensus       120 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~-------------------~--~~~~Di~slG~~l  178 (203)
                      +.++.++++|||++...............+++.|.+||.+.....                   +  ....|+||+|+++
T Consensus       343 ~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil  422 (507)
T PLN03224        343 TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL  422 (507)
T ss_pred             CCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence            999999999999986433222212222234788999998764211                   1  1246999999999


Q ss_pred             HHHHhCCc-ccCC
Q psy16889        179 AELLGRRI-LFQA  190 (203)
Q Consensus       179 ~~ll~g~~-pf~~  190 (203)
                      |+|+++.. ||..
T Consensus       423 ~em~~~~l~p~~~  435 (507)
T PLN03224        423 MQMCVPELRPVAN  435 (507)
T ss_pred             HHHHhCCCCCccc
Confidence            99999875 6754

>KOG1165|consensus

Probab=99.92  E-value=1.4e-24  Score=158.86  Aligned_cols=179  Identities=20%  Similarity=0.314  Sum_probs=149.1

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~   81 (203)
                      +..++++||||.-+..    .....+..|.+..+.| ..++|+.++.+.+..     .+-.+|+|.++.+|.+.+. ...
T Consensus        49 Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~NiLVidLLGPSLEDLFD~CgR  119 (449)
T KOG1165|consen   49 NLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNILVIDLLGPSLEDLFDLCGR  119 (449)
T ss_pred             ccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeecccc-----chhhhhhhhhCcCHHHHHHHhcC
Confidence            4578999999997543    2345688899999999 778999999888877     6788999999976666555 344


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----CCeEEEeecCccccCCCCCCC------CcccccCC
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-----NCILKICDFGLARVEEPDPNK------AMTQEVVT  150 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~~------~~~~~~~~  150 (203)
                      .|+.+++..++.|++.-++++|++++++|||||+|+++..     ...+.++|||++..+..+..+      ......||
T Consensus       120 ~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGT  199 (449)
T KOG1165|consen  120 RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGT  199 (449)
T ss_pred             cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccc
Confidence            7999999999999999999999999999999999999964     346899999999876654333      23455789


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+|++-....+ ++-+.+.|+-|||-++++.|.|..||++..
T Consensus       200 ARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  200 ARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             eeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            99999998888 446899999999999999999999998864

>KOG1167|consensus

Probab=99.92  E-value=1.6e-25  Score=167.61  Aligned_cols=183  Identities=31%  Similarity=0.501  Sum_probs=145.5

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~   84 (203)
                      .++.|++|.+...    ....++..|++.+..+ .+.||+++.+++..+     +.+.+|+||++- ...++..   .++
T Consensus        63 ~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~~---~l~  130 (418)
T KOG1167|consen   63 KRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLYR---SLS  130 (418)
T ss_pred             ccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC-----CeeEEEecccCccCHHHHHh---cCC
Confidence            6788999998543    2345688999999999 789999999999988     678899999983 5555443   367


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCC---------------CC--------
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEP---------------DP--------  140 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~---------------~~--------  140 (203)
                      ..++..+++.++.||+++|.+||+||||||+|++.+ ..+.-.|+|||++.....               .+        
T Consensus       131 ~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~  210 (418)
T KOG1167|consen  131 LAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHC  210 (418)
T ss_pred             HHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccc
Confidence            899999999999999999999999999999999998 457788999999861000               00        


Q ss_pred             --------------------CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCccc-CCCChHHHhhh
Q psy16889        141 --------------------NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF-QAQSPVQQLGL  199 (203)
Q Consensus       141 --------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~  199 (203)
                                          ......+.||++|.|||++..-..-+++.|+||-|+++..+++++.|| ....+.+.+..
T Consensus       211 ~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~e  290 (418)
T KOG1167|consen  211 QSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAE  290 (418)
T ss_pred             cccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHH
Confidence                                001123478999999999987666688999999999999999999995 55556666655


Q ss_pred             hh
Q psy16889        200 IT  201 (203)
Q Consensus       200 i~  201 (203)
                      |+
T Consensus       291 i~  292 (418)
T KOG1167|consen  291 IA  292 (418)
T ss_pred             HH
Confidence            54

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.9e-24  Score=150.36  Aligned_cols=107  Identities=29%  Similarity=0.514  Sum_probs=91.3

Q ss_pred             HhHHHHHhC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccC
Q psy16889         71 SDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV  149 (203)
Q Consensus        71 ~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  149 (203)
                      |+|.+++.. ...+++.+++.++.|++.||+|||+++      ||+||+++.++.+++  ||.+......      ...+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCC
Confidence            467777765 456999999999999999999999998      999999999999998  9988754322      1256


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ++.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus        67 ~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~  108 (176)
T smart00750       67 DPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEER  108 (176)
T ss_pred             cccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence            889999999987 558999999999999999999999997654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024|consensus

Probab=99.90  E-value=1.1e-24  Score=162.46  Aligned_cols=188  Identities=21%  Similarity=0.330  Sum_probs=148.1

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-----C--
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-----S--   79 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~--   79 (203)
                      .+.|.+|..+.. .+.-+...+..|.-.+..+.|||+.++.++.....    ..++++..+.+ |+|..++.     .  
T Consensus       314 ~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~  388 (563)
T KOG1024|consen  314 CQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPS  388 (563)
T ss_pred             HHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCc
Confidence            344566666432 45556777888988899999999999999876543    35556666666 78888776     1  


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccc-cCCcccccce
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE-VVTQYYRAPE  157 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~-~~~~~~~aPe  157 (203)
                       ...++-.++..++.|++.|+++||+.+++|.||-..|+++++.-++|++|-.+++...+......... -.+..|++||
T Consensus       389 ~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE  468 (563)
T KOG1024|consen  389 YAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE  468 (563)
T ss_pred             cccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence             13477778888999999999999999999999999999999999999999988875444433332222 2255799999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+.+ ..|+..+|+||||+++|||+| |+.|+.+-+|++.-..+.
T Consensus       469 al~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  469 ALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             HHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9988 569999999999999999997 899999999988765543

>KOG0576|consensus

Probab=99.90  E-value=7.5e-26  Score=177.94  Aligned_cols=189  Identities=25%  Similarity=0.344  Sum_probs=157.5

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +++|+.+++..|+|+++..  ...+..-+.+|+-+++..+||||+.+++.+.-.     ..+++.||||+| +|.+.-.-
T Consensus        33 KaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~-----dklwicMEycgggslQdiy~~  105 (829)
T KOG0576|consen   33 KARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----DKLWICMEYCGGGSLQDIYHV  105 (829)
T ss_pred             hhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhh-----cCcEEEEEecCCCcccceeee
Confidence            4789999999999999653  333455677899999999999999999988877     568899999994 78887777


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .++++|-++...+++.+.+++|||++|.+|||||-.||++++.|.+++.|||.+..+... ..+.....||+.|+|||+-
T Consensus       106 TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i~KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  106 TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-IAKRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh-hhhhhcccCCccccchhHH
Confidence            789999999999999999999999999999999999999999999999999998754433 3344566899999999986


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .-  ...|....|+|++|+...|+.--++|--..-+...+
T Consensus       185 averkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l  224 (829)
T KOG0576|consen  185 AVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL  224 (829)
T ss_pred             HHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence            42  234788999999999999998888885443333333

>KOG1163|consensus

Probab=99.90  E-value=4.4e-24  Score=150.14  Aligned_cols=183  Identities=20%  Similarity=0.262  Sum_probs=146.7

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~   80 (203)
                      .+..+|+.||||.-+..    ..-..+..|..+.+.++ ..+|+.+..+....     .+-.+||+.++.+|.+.+. ..
T Consensus        35 ~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~ynvlVMdLLGPsLEdLfnfC~  105 (341)
T KOG1163|consen   35 ISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DYNVLVMDLLGPSLEDLFNFCS  105 (341)
T ss_pred             eeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhcccc-----ccceeeeeccCccHHHHHHHHh
Confidence            46789999999997432    22345677889999995 56788888888777     5677999999987777665 34


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCC------CCcccccCCc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPN------KAMTQEVVTQ  151 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~  151 (203)
                      ..|+..+++.++-|++.-++|+|.++.+||||||+|+++.   .-..+.++|||++..+.....      .......||.
T Consensus       106 R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTa  185 (341)
T KOG1163|consen  106 RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTA  185 (341)
T ss_pred             hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceee
Confidence            5799999999999999999999999999999999999986   345789999999986554322      2234457788


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      +|.+-....+.. -+...|+-|+|.+++++..|..||++.....
T Consensus       186 RYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  186 RYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             eehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            999888777633 5889999999999999999999999965443

>KOG1164|consensus

Probab=99.90  E-value=1.1e-23  Score=160.68  Aligned_cols=184  Identities=23%  Similarity=0.248  Sum_probs=143.0

Q ss_pred             cCCCC-CcEEEEEeccCccchhhhhHHHHHHHHHHhhcC----CCCccchhhhcc-CCCcchhHHHHHHHhhhHHhHHHH
Q psy16889          3 TDPRD-GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK----HDNVLSALDILQ-PPHLDFFQEIYVITELLQSDLHKI   76 (203)
Q Consensus         3 ~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~~-~~~~~~~~~~~lv~e~~~~~l~~~   76 (203)
                      .+..+ .+.+|+|..........  ..+..|..++..+.    .++++.+++... .+     .+.++||+.++.+|.+.
T Consensus        38 ~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl  110 (322)
T KOG1164|consen   38 SDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDL  110 (322)
T ss_pred             EecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----ceeEEEEeccCccHHHH
Confidence            34444 36788888754322221  25677888888886    358888988884 44     56788999999999987


Q ss_pred             HhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-----CeEEEeecCccc--cCCCCCC------
Q psy16889         77 IVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-----CILKICDFGLAR--VEEPDPN------  141 (203)
Q Consensus        77 ~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-----~~~~l~d~~~~~--~~~~~~~------  141 (203)
                      ....  +.++..++..++.|++.+|+++|+.|++||||||+|+++...     ..+.++|||+++  .+.....      
T Consensus       111 ~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~  190 (322)
T KOG1164|consen  111 RKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPP  190 (322)
T ss_pred             HHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccC
Confidence            7533  679999999999999999999999999999999999999854     468999999998  3222211      


Q ss_pred             CC-cccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        142 KA-MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       142 ~~-~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      .. .....||..|.++....+ ...+.+.|+||++.++.+++.|..||.+....
T Consensus       191 r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  191 RPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             CCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            11 223458999999999888 55799999999999999999999999776643

>KOG1240|consensus

Probab=99.89  E-value=3.2e-22  Score=165.22  Aligned_cols=178  Identities=25%  Similarity=0.355  Sum_probs=135.7

Q ss_pred             CCCcEEEEEeccCc--cchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCC
Q psy16889          6 RDGRRVALKKLPNV--FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   83 (203)
                      .....|+||++-+.  ..+.....+..+|++ .+..++||++++.-+...+     ...|+|.+|...+|.+.+..++.+
T Consensus        44 ~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL  117 (1431)
T KOG1240|consen   44 DREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFL  117 (1431)
T ss_pred             CCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHH
Confidence            33445999999332  223333333334444 5556999999999887776     678999999999999999999999


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC------cccccCCcccccce
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA------MTQEVVTQYYRAPE  157 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~~~aPe  157 (203)
                      ..-+.+-|+.|+++||..+|+.|++|||||.+||+++.-+++.|.||-.....-.+...+      ..+...-.+|.|||
T Consensus       118 ~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPE  197 (1431)
T KOG1240|consen  118 VLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPE  197 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChH
Confidence            999999999999999999999999999999999999999999999997654211111111      11223355699999


Q ss_pred             eeeccc---------C-CCcchhHHHHHHHHHHHHh-CCcccC
Q psy16889        158 ILMGAR---------H-YSAAVDVWSVGCIFAELLG-RRILFQ  189 (203)
Q Consensus       158 ~~~~~~---------~-~~~~~Di~slG~~l~~ll~-g~~pf~  189 (203)
                      .+....         . .+++-||||+||++.|+++ |++||.
T Consensus       198 RFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  198 RFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             hhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence            875411         1 4678899999999999997 799993

>KOG0590|consensus

Probab=99.88  E-value=2.4e-23  Score=168.76  Aligned_cols=161  Identities=36%  Similarity=0.483  Sum_probs=137.3

Q ss_pred             HHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCce
Q psy16889         29 VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARIL  108 (203)
Q Consensus        29 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~  108 (203)
                      +..|+-+-..++|+|++.....+.+.+.     .+-.||||+++|...+...+.++..++..+++|++.+++|+|+.|+.
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~-----~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Gia  442 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDG-----ILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLA  442 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhccc-----chhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCce
Confidence            5567777788899999888888877643     22339999999999998888999999999999999999999999999


Q ss_pred             ecCCCCCcEEecCCCeEEEeecCccccCCCCCC---CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCC
Q psy16889        109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRR  185 (203)
Q Consensus       109 H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~  185 (203)
                      |||+||+|++++.+|.+|++|||.+.....+..   .......|+..|+|||++.+.+......|+||.|+++..|.+|+
T Consensus       443 hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~  522 (601)
T KOG0590|consen  443 HRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR  522 (601)
T ss_pred             eccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence            999999999999999999999999875544333   34456678889999999998665566889999999999999999


Q ss_pred             cccCCCChH
Q psy16889        186 ILFQAQSPV  194 (203)
Q Consensus       186 ~pf~~~~~~  194 (203)
                      .||......
T Consensus       523 ~~Wk~a~~~  531 (601)
T KOG0590|consen  523 FPWKVAKKS  531 (601)
T ss_pred             Ccccccccc
Confidence            999776544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=5.1e-22  Score=152.03  Aligned_cols=144  Identities=20%  Similarity=0.203  Sum_probs=103.4

Q ss_pred             CcCCC-CCcEEEEEeccCcc---chhhhhHHHHHHHHHHhhcCCCCccc-hhhhccCCCcchhHHHHHHHhhhHH-hHHH
Q psy16889          2 VTDPR-DGRRVALKKLPNVF---QSLVSSKRVFRELKMLCFFKHDNVLS-ALDILQPPHLDFFQEIYVITELLQS-DLHK   75 (203)
Q Consensus         2 ~~~~~-~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~   75 (203)
                      |++.. +|+.+|||+.....   ......+.+.+|++++++++|+|+++ +++.         ...|++|||+.| +|. 
T Consensus        37 a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---------~~~~LVmE~~~G~~L~-  106 (365)
T PRK09188         37 GYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---------GKDGLVRGWTEGVPLH-  106 (365)
T ss_pred             EEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---------CCcEEEEEccCCCCHH-
Confidence            33444 67778999864221   12234566889999999999999885 4331         235799999986 554 


Q ss_pred             HHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEecCCCeEEEeecCccccCCCCCCCC-------cccc
Q psy16889         76 IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI-KPGNLLVNSNCILKICDFGLARVEEPDPNKA-------MTQE  147 (203)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~  147 (203)
                      .....   .   ...++.|++.+|.+||++|++|||| ||+||+++.++.++|+|||++..........       ....
T Consensus       107 ~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~  180 (365)
T PRK09188        107 LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHL  180 (365)
T ss_pred             HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhh
Confidence            22211   1   2467899999999999999999999 9999999999999999999998544322111       1234


Q ss_pred             cCCcccccceeeec
Q psy16889        148 VVTQYYRAPEILMG  161 (203)
Q Consensus       148 ~~~~~~~aPe~~~~  161 (203)
                      .+++.|.+||.+..
T Consensus       181 ~~~~~~~~pe~~~~  194 (365)
T PRK09188        181 LKHKRTYAPDALTP  194 (365)
T ss_pred             hccCccCCcccCCh
Confidence            55777899998765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=5.1e-21  Score=145.40  Aligned_cols=180  Identities=33%  Similarity=0.540  Sum_probs=146.5

Q ss_pred             cEEEEEeccCccchhh-hhHHHHHHHHHHhhcCCC-CccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC---C
Q psy16889          9 RRVALKKLPNVFQSLV-SSKRVFRELKMLCFFKHD-NVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ---H   82 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~   82 (203)
                      ..+++|.+........ ....+.+|...++.+.|+ +++++.+.+...     ...+++++++.+ ++.+......   .
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~   97 (384)
T COG0515          23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGP   97 (384)
T ss_pred             cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccC
Confidence            5678888865444332 567788999999999888 799999999555     336788999885 6666665554   7


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCC-----CcccccCCcccccc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNK-----AMTQEVVTQYYRAP  156 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~aP  156 (203)
                      +++.....++.|++.+++++|+.+++|||+||+||+++..+ .++++|||.+.........     ......++..|.+|
T Consensus        98 ~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515          98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCH
Confidence            99999999999999999999999999999999999999888 7999999998743332221     34566789999999


Q ss_pred             eeeecc--cCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        157 EILMGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       157 e~~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      |.+.+.  ...+...|+||+|++++++++|..||.....
T Consensus       178 e~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~  216 (384)
T COG0515         178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN  216 (384)
T ss_pred             HHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            999873  4578999999999999999999999877663

>KOG0603|consensus

Probab=99.85  E-value=3.4e-22  Score=156.84  Aligned_cols=175  Identities=26%  Similarity=0.350  Sum_probs=146.5

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      .....|.-+++|.................|-.++...+ ||.++++...++.+     ...++++++..| ++...+...
T Consensus        17 ~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~   91 (612)
T KOG0603|consen   17 GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKE   91 (612)
T ss_pred             ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHhhhhcccchhhhccccC
Confidence            34567778888888554332223335556777788885 99999999999988     678899999985 888888888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+.+.....+..+++.+++.+|+.+++|+|+|++||+++.+|.+++.|||.+...-.....     +|+..|+|||++.
T Consensus        92 ~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----cgt~eymApEI~~  166 (612)
T KOG0603|consen   92 VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN  166 (612)
T ss_pred             CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh
Confidence            88999999999999999999999999999999999999999999999999999743322111     7799999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +   ....+|.||+|++.++++||..||.+
T Consensus       167 g---h~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  167 G---HLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             c---cCCcccchhhhhhHHHHhhCCCCCch
Confidence            4   57889999999999999999999998

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=8.4e-22  Score=139.17  Aligned_cols=125  Identities=17%  Similarity=0.219  Sum_probs=92.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhh------------------------hHHHHHHHHHHhhcCCCCccchhhhccCCCcc
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVS------------------------SKRVFRELKMLCFFKHDNVLSALDILQPPHLD   57 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   57 (203)
                      |.+. +|++||||+++....+...                        ......|++.+.++.++++.....+...    
T Consensus        16 a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~----   90 (190)
T cd05147          16 ATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK----   90 (190)
T ss_pred             EECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec----
Confidence            3454 8999999999654221111                        1123459999999988877433332211    


Q ss_pred             hhHHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         58 FFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYL-HSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        58 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                         ..++||||++| ++.......+.++++++..++.|++.+|.++ |+.|++||||||+||+++ ++.++++|||.+..
T Consensus        91 ---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~  166 (190)
T cd05147          91 ---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVE  166 (190)
T ss_pred             ---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence               12699999996 3433334456799999999999999999999 799999999999999998 47899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=6.4e-22  Score=141.81  Aligned_cols=152  Identities=18%  Similarity=0.228  Sum_probs=108.5

Q ss_pred             CCcEEEEEeccCccchhhh-hHH------HHHHHHHHhhcCCCCccchhhhccCCCcc---hhHHHHHHHhhhHH-hHHH
Q psy16889          7 DGRRVALKKLPNVFQSLVS-SKR------VFRELKMLCFFKHDNVLSALDILQPPHLD---FFQEIYVITELLQS-DLHK   75 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~-~~~------~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~~-~l~~   75 (203)
                      ++..+++|++......... .+.      +.+|++.+.++.|++|..+.+++.+....   +....+++|||++| +|.+
T Consensus        53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~  132 (232)
T PRK10359         53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND  132 (232)
T ss_pred             CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence            4668999999654332222 222      57899999999999999999886654211   11346789999997 6766


Q ss_pred             HHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         76 IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        76 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      ..    .+++    ....+++.++..+|+.|++|||++|+|++++.+| ++++|||........  .....         
T Consensus       133 ~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~--~a~d~---------  192 (232)
T PRK10359        133 MP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQR--KAKDR---------  192 (232)
T ss_pred             hh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCcccccch--hhHHH---------
Confidence            52    2333    2456999999999999999999999999999988 999999988643211  11110         


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHH
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAEL  181 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~l  181 (203)
                        .+.. +.++.++|+||||+++...
T Consensus       193 --~vle-r~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        193 --IDLE-RHYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             --HHHH-hHhcccccccceeEeehHH
Confidence              1222 4467899999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=1.6e-20  Score=133.00  Aligned_cols=125  Identities=18%  Similarity=0.156  Sum_probs=94.3

Q ss_pred             cCCCCCcEEEEEeccCccchhhh------------------------hHHHHHHHHHHhhcCCCCccchhhhccCCCcch
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVS------------------------SKRVFRELKMLCFFKHDNVLSALDILQPPHLDF   58 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   58 (203)
                      .+. +|+.||||+++........                        ......|.+.+.++.++++.....+....    
T Consensus        17 ~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~----   91 (190)
T cd05145          17 RTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK----   91 (190)
T ss_pred             EcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC----
Confidence            444 8999999999654211100                        12345789999999998875444333222    


Q ss_pred             hHHHHHHHhhhHHh-HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccC
Q psy16889         59 FQEIYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVE  136 (203)
Q Consensus        59 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~  136 (203)
                         .++||||++|. +.........++++++..++.|++.++.++|+ .|++|+||||+||+++ ++.++++|||.+...
T Consensus        92 ---~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~  167 (190)
T cd05145          92 ---NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             ---CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence               36999999874 33333344668899999999999999999999 9999999999999999 789999999999743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=5.9e-20  Score=129.31  Aligned_cols=170  Identities=18%  Similarity=0.083  Sum_probs=117.7

Q ss_pred             CCcEEEEEeccCccch--hhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC
Q psy16889          7 DGRRVALKKLPNVFQS--LVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH   82 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   82 (203)
                      .+.+++.+.+...-..  ......+.+|+++++++ +++++++++++.         ..+++|||+.| +|.....    
T Consensus        24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~lvmeyI~G~~L~~~~~----   90 (218)
T PRK12274         24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRHLDRSYLAGAAMYQRPP----   90 (218)
T ss_pred             CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEEEEEeeecCccHHhhhh----
Confidence            5667776666443221  11223577899999999 457888888751         23688999887 4543221    


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEecCCCeEEEeecCccccCCCCCCC----C--------cccccC
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDI-KPGNLLVNSNCILKICDFGLARVEEPDPNK----A--------MTQEVV  149 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di-~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~--------~~~~~~  149 (203)
                        .. ...++.|+..+++++|++|++|+|| ||.||+++.++.++++|||.+.........    .        ..-...
T Consensus        91 --~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y  167 (218)
T PRK12274         91 --RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMY  167 (218)
T ss_pred             --hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhc
Confidence              11 2457889999999999999999999 799999999999999999999743322110    0        001123


Q ss_pred             CcccccceeeecccCCC-cchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        150 TQYYRAPEILMGARHYS-AAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ++.+++|+...-....+ ...++++.|+-+|.++|++.|+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        168 CPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            66677776544322233 56799999999999999999976543

>KOG1166|consensus

Probab=99.80  E-value=5.9e-20  Score=152.93  Aligned_cols=169  Identities=20%  Similarity=0.247  Sum_probs=130.4

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcC---CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK---HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHL   83 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~   83 (203)
                      |+.||+|+-+....     -.+.=-.+++.+|+   -+.|..+.+.+...     ..-++|+||.+ |+|++.+...+.+
T Consensus       722 ~~~~alK~e~P~~~-----WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m  791 (974)
T KOG1166|consen  722 GKLVALKVEKPPNP-----WEFYICLQVMERLKPQMLPSIMHISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVM  791 (974)
T ss_pred             CcEEEEEeecCCCc-----eeeeehHHHHHhhchhhhcchHHHHHHHccC-----CcceeeeeccccccHHHhhccCCCC
Confidence            99999999754322     12222233444444   23455555544433     23458999998 8999999988889


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-------CCCeEEEeecCccccCC-CCCCCCcccccCCccccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-------SNCILKICDFGLARVEE-PDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-------~~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~~~~~a  155 (203)
                      ++.-+..+..|++..++.||..+||||||||+|+++.       ....++|+|||.+.-.. .+........++|-.+-.
T Consensus       792 ~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C  871 (974)
T KOG1166|consen  792 DEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDC  871 (974)
T ss_pred             CchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchh
Confidence            9999999999999999999999999999999999995       23468999999987332 333445666788888999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcc
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRIL  187 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  187 (203)
                      +|...| ++|+++.|.|+|+.+++.||.|+.-
T Consensus       872 ~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  872 IEMREG-RPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             HHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999888 7799999999999999999999653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=2.1e-20  Score=137.82  Aligned_cols=188  Identities=24%  Similarity=0.309  Sum_probs=111.6

Q ss_pred             CcCCCCCcEEEEEeccCc-cchhhhhHHHHHHHHHHhhcCC----------CCccchhhhccCC--------Cc---ch-
Q psy16889          2 VTDPRDGRRVALKKLPNV-FQSLVSSKRVFRELKMLCFFKH----------DNVLSALDILQPP--------HL---DF-   58 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~~----------~~i~~~~~~~~~~--------~~---~~-   58 (203)
                      |+|..||+++++|++... ..+....+.+.+|.-....+.+          -.++-..+.....        ..   .+ 
T Consensus        31 v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~  110 (288)
T PF14531_consen   31 VTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYW  110 (288)
T ss_dssp             EEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEE
T ss_pred             EEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccce
Confidence            678999999999998332 2344456677777666655432          1222222221111        00   00 


Q ss_pred             hHHHHHHHhhhHHhHHHHHh---CCCC----CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecC
Q psy16889         59 FQEIYVITELLQSDLHKIIV---SPQH----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG  131 (203)
Q Consensus        59 ~~~~~lv~e~~~~~l~~~~~---~~~~----~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~  131 (203)
                      ....+++++-+.++|.+.+.   ....    ........+..|+++.+++||+.|++|+||+|+|++++.+|.++|.||+
T Consensus       111 v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  111 VLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             eehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChH
Confidence            00123455555555544432   1111    2222334455899999999999999999999999999999999999998


Q ss_pred             ccccCCCCCCCCcccccCCcccccceeeecc-------cCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        132 LARVEEPDPNKAMTQEVVTQYYRAPEILMGA-------RHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .....+....    ....+..|.+||.....       -.++.+.|.|+||+++|.|++++.||....+
T Consensus       191 ~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  191 SLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             GEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             HHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            8765433211    12335668889866442       2367889999999999999999999986543

>KOG0195|consensus

Probab=99.77  E-value=2.2e-19  Score=128.95  Aligned_cols=181  Identities=21%  Similarity=0.319  Sum_probs=137.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC--C
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH--L   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~   83 (203)
                      .|..++.|++.-...+..-...|.+|.-.++.+.||||+++++.+..+     ..+.++..|++ |+|...+.....  .
T Consensus       212 qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvv  286 (448)
T KOG0195|consen  212 QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVV  286 (448)
T ss_pred             cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEE
Confidence            345567777744333444445678899999999999999999999988     67788999998 789888875443  7


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEe--ecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKIC--DFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +..++.+++..++.+++|||+..  |..--+....+++|++...++.  |--.+        .........+.|++||.+
T Consensus       287 d~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--------fqe~gr~y~pawmspeal  358 (448)
T KOG0195|consen  287 DHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--------FQEVGRAYSPAWMSPEAL  358 (448)
T ss_pred             ecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--------eeccccccCcccCCHHHH
Confidence            78899999999999999999875  5556788899999987665543  32111        222333447789999998


Q ss_pred             ecccCC--CcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHY--SAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~--~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ......  -.++|.|||++++||+-|.+.||.+.++-+.=.+|
T Consensus       359 qrkped~n~raadmwsfaillwel~trevpfadlspmecgmki  401 (448)
T KOG0195|consen  359 QRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI  401 (448)
T ss_pred             hcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence            764322  34789999999999999999999999887654433

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=1.1e-18  Score=124.64  Aligned_cols=123  Identities=23%  Similarity=0.276  Sum_probs=92.8

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-----CCCCccchhhhccCCCcchhHH-HHHHHhhhH---HhHH
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-----KHDNVLSALDILQPPHLDFFQE-IYVITELLQ---SDLH   74 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~~~-~~lv~e~~~---~~l~   74 (203)
                      ++.++.. +||++....  ....+.+.+|+..++.+     .||||+++++++.++.+.  .. +.+|+||.+   ++|.
T Consensus        21 hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~--g~v~~~I~e~~G~~~~tL~   95 (210)
T PRK10345         21 HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT--GYVYDVIADFDGKPSITLT   95 (210)
T ss_pred             CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC--eEEEEEEecCCCCcchhHH
Confidence            5666666 699885421  22446688999999999     579999999999887532  22 236899854   6999


Q ss_pred             HHHhCCCCCChHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEecC----CCeEEEeecCccc
Q psy16889         75 KIIVSPQHLTSDHIKVFLYQILRGL-KYLHSARILHRDIKPGNLLVNS----NCILKICDFGLAR  134 (203)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~qi~~~l-~~lh~~~i~H~di~~~nil~~~----~~~~~l~d~~~~~  134 (203)
                      +++.. +.+++.  ..++.|++.++ +|||+++|+||||||+||+++.    ++.++|+|++.+.
T Consensus        96 ~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345         96 EFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             HHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            99866 346666  35678888777 9999999999999999999974    3379999954443

>KOG4158|consensus

Probab=99.75  E-value=3.2e-18  Score=128.75  Aligned_cols=151  Identities=21%  Similarity=0.316  Sum_probs=112.7

Q ss_pred             CCCCccchhhhccCCCcc----------------------hhHHHHHHHhhhHHhHHHHHhCCCCCChHHHHHHHHHHHH
Q psy16889         40 KHDNVLSALDILQPPHLD----------------------FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR   97 (203)
Q Consensus        40 ~~~~i~~~~~~~~~~~~~----------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~   97 (203)
                      +||||+++...|.++-..                      .-..+|+||..+..+|+.++-.+. .+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHH
Confidence            699999999876553110                      012368899999889998876643 566777889999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEec--CC--CeEEEeecCccccCCC-----CCCCCcccccCCcccccceeeecccC----
Q psy16889         98 GLKYLHSARILHRDIKPGNLLVN--SN--CILKICDFGLARVEEP-----DPNKAMTQEVVTQYYRAPEILMGARH----  164 (203)
Q Consensus        98 ~l~~lh~~~i~H~di~~~nil~~--~~--~~~~l~d~~~~~~~~~-----~~~~~~~~~~~~~~~~aPe~~~~~~~----  164 (203)
                      ++.+||++|+.|||+|.+||++.  ++  ..+.+.|||.+-....     +.....-...|+..-+|||+......    
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999985  22  3678999998853322     11222234456777899998754211    


Q ss_pred             -CCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        165 -YSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       165 -~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                       .-.++|.|+.|.+.||+++...||.+.
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~r  460 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKR  460 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCccccc
Confidence             123789999999999999999999873

>KOG0606|consensus

Probab=99.74  E-value=2.6e-18  Score=141.98  Aligned_cols=121  Identities=32%  Similarity=0.516  Sum_probs=98.4

Q ss_pred             hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---------
Q psy16889         72 DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---------  142 (203)
Q Consensus        72 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------  142 (203)
                      +-...+...++++.+.        +.+++|+|+-+|+|+|+||+|.+++.-|.+|+.|||++.........         
T Consensus       137 Dc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k  208 (1205)
T KOG0606|consen  137 DCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEK  208 (1205)
T ss_pred             hhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHH
Confidence            3333444445666544        78899999999999999999999999999999999988653322111         


Q ss_pred             -----CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        143 -----AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       143 -----~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                           .....+||+.|.|||++.. +.|+...|+|++|+++|+.+.|..||.+..+++++.+++
T Consensus       209 ~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi  271 (1205)
T KOG0606|consen  209 DTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  271 (1205)
T ss_pred             HHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence                 1134478999999999988 458999999999999999999999999999999988765

>KOG1033|consensus

Probab=99.73  E-value=1.7e-18  Score=133.81  Aligned_cols=120  Identities=32%  Similarity=0.525  Sum_probs=104.0

Q ss_pred             HHHHHHHhhhH-HhHHHHHhCC---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         60 QEIYVITELLQ-SDLHKIIVSP---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        60 ~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .++|+.|++|. ++|.+++...   ...+......+++|++.+++|   ++.+|+|++|.||++..+..+++.|||+.+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            57899999999 5899998743   347778889999999999999   9999999999999999999999999999875


Q ss_pred             CCCCC-----CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh
Q psy16889        136 EEPDP-----NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG  183 (203)
Q Consensus       136 ~~~~~-----~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~  183 (203)
                      .....     ....+...||..|++||.+.+ +.|+.++||||||.+++|++.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH
Confidence            44433     335566788999999999998 559999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=5e-18  Score=123.83  Aligned_cols=122  Identities=15%  Similarity=0.107  Sum_probs=91.2

Q ss_pred             CCCCCcEEEEEeccCccchhh----------------------hhHHHHHHHHHHhhcCCCC--ccchhhhccCCCcchh
Q psy16889          4 DPRDGRRVALKKLPNVFQSLV----------------------SSKRVFRELKMLCFFKHDN--VLSALDILQPPHLDFF   59 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~   59 (203)
                      +..+|+.||+|+++.......                      ....+..|++.++++.+.+  +++++.   ..     
T Consensus        50 ~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~---~~-----  121 (237)
T smart00090       50 FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIA---WR-----  121 (237)
T ss_pred             cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeE---ec-----
Confidence            567899999999864321100                      1123567999999997533  333333   12     


Q ss_pred             HHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         60 QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        60 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~-i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                       ..++||||++| ++.........+...++..++.|++.++++||+.| ++|+||||+||+++ ++.++++|||.+..
T Consensus       122 -~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      122 -RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             -CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence             23699999997 45444444456777778899999999999999999 99999999999999 88999999998864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.64  E-value=2.6e-16  Score=113.29  Aligned_cols=119  Identities=22%  Similarity=0.277  Sum_probs=92.9

Q ss_pred             CCcEEEEEeccCccch------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          7 DGRRVALKKLPNVFQS------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +|..+++|........      ......+.+|++.+..+.+++++....++.+.     ...+++|||++| +|.+.+..
T Consensus        18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~G~~L~~~~~~   92 (211)
T PRK14879         18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINS   92 (211)
T ss_pred             CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCCEEEEEEeCCcCHHHHHHh
Confidence            6788999986432211      11234577899999999999887666665554     345689999985 77777654


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ...    ....++.+++.++.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        93 ~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         93 NGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             ccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            332    7889999999999999999999999999999999 78999999999874

>KOG1023|consensus

Probab=99.63  E-value=7e-17  Score=126.54  Aligned_cols=151  Identities=32%  Similarity=0.418  Sum_probs=122.0

Q ss_pred             HhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCChHHHHHHHHHHHHHHHHHHhCCc-eecCC
Q psy16889         36 LCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARI-LHRDI  112 (203)
Q Consensus        36 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i-~H~di  112 (203)
                      |+.+.|.|+.++++.+.++     ...+.+.+||+ |+|.+.+.. .-.++.-....+++.++++++|+|...+ .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence            4678999999999999888     56778899998 799998876 3457777788899999999999997765 99999


Q ss_pred             CCCcEEecCCCeEEEeecCccccCCC-CCCCCcccccCCcccccceeeecccC------CCcchhHHHHHHHHHHHHhCC
Q psy16889        113 KPGNLLVNSNCILKICDFGLARVEEP-DPNKAMTQEVVTQYYRAPEILMGARH------YSAAVDVWSVGCIFAELLGRR  185 (203)
Q Consensus       113 ~~~nil~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~aPe~~~~~~~------~~~~~Di~slG~~l~~ll~g~  185 (203)
                      +..|++++....+|+.|||+...... ..............|.|||.+.+...      .+.+.|+||+|++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999875432 11112222223566999999887311      366799999999999999999


Q ss_pred             cccCCC
Q psy16889        186 ILFQAQ  191 (203)
Q Consensus       186 ~pf~~~  191 (203)
                      .||...
T Consensus       156 ~~~~~~  161 (484)
T KOG1023|consen  156 GPFDLR  161 (484)
T ss_pred             Cccccc
Confidence            999774

>KOG0590|consensus

Probab=99.61  E-value=4.4e-17  Score=132.54  Aligned_cols=182  Identities=27%  Similarity=0.382  Sum_probs=145.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHH-hCCC-C
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKII-VSPQ-H   82 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-~~~~-~   82 (203)
                      +...+++|.+.....+.........|..+.+.+. |+|++..++...+.     ...++.+++..| ++.... .... .
T Consensus        45 ~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~~  119 (601)
T KOG0590|consen   45 PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDSTG  119 (601)
T ss_pred             CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----cccccccCcccccccccccccCCccC
Confidence            3344666666544333334455556888888886 99999999998888     678889999764 777766 4444 6


Q ss_pred             CChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCC-eEEEeecCccccCCC--CCCCCcccccC-Ccccccce
Q psy16889         83 LTSDHIKVFLYQILRGLKYLH-SARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEP--DPNKAMTQEVV-TQYYRAPE  157 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~--~~~~~~~~~~~-~~~~~aPe  157 (203)
                      .+......++.|+..++.|+| ..++.|+|++|+|.+++..+ .++..|||+++.+..  ..........| ++.|.|||
T Consensus       120 ~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E  199 (601)
T KOG0590|consen  120 TSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPE  199 (601)
T ss_pred             CCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcc
Confidence            888899999999999999999 99999999999999999999 999999999986554  22334445567 89999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ...+.....+..|+||.|+++..+++|..||.....
T Consensus       200 ~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~  235 (601)
T KOG0590|consen  200 HLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSR  235 (601)
T ss_pred             cccchhhcCCCcccccccccccccccCCCCcccccc
Confidence            998866678899999999999999999999976543

>KOG1243|consensus

Probab=99.61  E-value=2.8e-15  Score=119.41  Aligned_cols=167  Identities=22%  Similarity=0.373  Sum_probs=124.9

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH   82 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~   82 (203)
                      ..+.++.+|.|........  ...+...+-+..++.++||+|+++++.+..+     ...|+|+|.+.. |..++..   
T Consensus        32 t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~P-l~~~lk~---  100 (690)
T KOG1243|consen   32 TRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVRP-LETVLKE---  100 (690)
T ss_pred             ceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeecccc-HHHHHHH---
Confidence            4467899999999865322  4456677888999999999999999999888     578899998763 2223322   


Q ss_pred             CChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         83 LTSDHIKVFLYQILRGLKYLH-SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      ++...+..-+.||+.||.+|| +.+++|+++..+.++++..|.++|.+|..+........ .......-..|..|+.+..
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence            237788889999999999997 77899999999999999999999999998864332221 1111122233666664433


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhC
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGR  184 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g  184 (203)
                      .   .-..|.|.||+++++++.|
T Consensus       180 s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 S---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c---ccchhhhhHHHHHHHHhCc
Confidence            1   1356999999999999998

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.61  E-value=6.1e-16  Score=110.33  Aligned_cols=117  Identities=22%  Similarity=0.305  Sum_probs=86.8

Q ss_pred             CCCcEEEEEeccCcc-ch-----hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          6 RDGRRVALKKLPNVF-QS-----LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      .+|.++++|...... ..     ......+.+|+++++.++++++.....+..+.     ...+++|||++| +|.+.+.
T Consensus        15 ~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~e~~~g~~l~~~~~   89 (199)
T TIGR03724        15 FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKTIVMEYIEGKPLKDVIE   89 (199)
T ss_pred             cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCEEEEEEECCccHHHHHh
Confidence            367889999864321 11     11235677899999999887654443333333     234689999985 7766654


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ....       .++.+++.++.++|+.+++|+|++|.||+++ ++.++++|||.+..
T Consensus        90 ~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        90 EGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             hcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            3221       7899999999999999999999999999999 78999999998874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=1.4e-15  Score=111.21  Aligned_cols=124  Identities=17%  Similarity=0.277  Sum_probs=90.0

Q ss_pred             CCcEEEEEeccCcc------c-----hhhhhHHHHHHHHHHhhcCCCCc--cchhhhccCCCcchhHHHHHHHhhhHH--
Q psy16889          7 DGRRVALKKLPNVF------Q-----SLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVITELLQS--   71 (203)
Q Consensus         7 ~~~~~~vK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~--   71 (203)
                      +|..++||.+....      .     +......+.+|++.+..++|+++  +..+++...... .....++++|+++|  
T Consensus        54 ~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~-~~~~~~lV~e~l~G~~  132 (239)
T PRK01723         54 PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG-LFYRADILIERIEGAR  132 (239)
T ss_pred             CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC-cceeeeEEEEecCCCC
Confidence            36788999884311      0     11234567889999999988875  556655433221 11223589999985  


Q ss_pred             hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccC
Q psy16889         72 DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE  136 (203)
Q Consensus        72 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~  136 (203)
                      +|.+.+.. .++++..    +.+++.++.+||+.|++|+||||.||+++.++.++++|||.+...
T Consensus       133 ~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        133 DLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             CHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            67776654 4566543    568999999999999999999999999998889999999988753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.55  E-value=8.6e-15  Score=104.38  Aligned_cols=115  Identities=23%  Similarity=0.233  Sum_probs=83.7

Q ss_pred             CCCcEEEEEeccCccchh--------------------hhhHHHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHH
Q psy16889          6 RDGRRVALKKLPNVFQSL--------------------VSSKRVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIY   63 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~   63 (203)
                      .+|+.|+||+++......                    ........|...+..+.+++  ++..++    .     ...+
T Consensus        37 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~-----~~~~  107 (198)
T cd05144          37 PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----W-----NRHA  107 (198)
T ss_pred             CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----c-----CCce
Confidence            379999999875422110                    01123567888888887764  333332    1     2347


Q ss_pred             HHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         64 VITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        64 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ++|||++| +|.....      ......++.+++.++.++|+.|++|+||+|+||+++.++.++++|||.+..
T Consensus       108 lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~  174 (198)
T cd05144         108 VVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS  174 (198)
T ss_pred             EEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence            89999986 4443321      134667889999999999999999999999999999999999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.54  E-value=5.5e-15  Score=120.09  Aligned_cols=97  Identities=23%  Similarity=0.340  Sum_probs=81.1

Q ss_pred             hHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh
Q psy16889         26 SKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS  104 (203)
Q Consensus        26 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~  104 (203)
                      .+.+.+|+++++.++|++++....+..+.     ...+++|||++| +|.+.+.        ....++.+++.++.+||+
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~  446 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK  446 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh
Confidence            35678899999999999988766655554     345689999985 7777654        457799999999999999


Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccccC
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARVE  136 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~  136 (203)
                      .+++|||+||+||++ .++.++++|||.+...
T Consensus       447 ~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        447 AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999999999 5779999999999753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.53  E-value=1.2e-14  Score=102.73  Aligned_cols=117  Identities=25%  Similarity=0.252  Sum_probs=78.9

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHH----------------------HHHHHHHhhcCCCC--ccchhhhccCCCcch
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRV----------------------FRELKMLCFFKHDN--VLSALDILQPPHLDF   58 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~   58 (203)
                      .+. +|+.|+||+++............                      ..|.+.+..+.+.+  +++.+..        
T Consensus        17 ~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~--------   87 (187)
T cd05119          17 LDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL--------   87 (187)
T ss_pred             ECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec--------
Confidence            444 79999999986533222221111                      24555555553332  2222221        


Q ss_pred             hHHHHHHHhhhHH-----hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCc
Q psy16889         59 FQEIYVITELLQS-----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGL  132 (203)
Q Consensus        59 ~~~~~lv~e~~~~-----~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~  132 (203)
                       ...+++|||+++     .......    . ..++..++.+++.++.++|. .+++|+||+|+||+++ ++.++++|||.
T Consensus        88 -~~~~lv~e~~~g~~~~~~~l~~~~----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~  160 (187)
T cd05119          88 -NRHVLVMEFIGGDGIPAPRLKDVR----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQ  160 (187)
T ss_pred             -CCCEEEEEEeCCCCccChhhhhhh----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcc
Confidence             124689999886     2222111    1 16788999999999999999 9999999999999999 88999999999


Q ss_pred             ccc
Q psy16889        133 ARV  135 (203)
Q Consensus       133 ~~~  135 (203)
                      +..
T Consensus       161 a~~  163 (187)
T cd05119         161 AVE  163 (187)
T ss_pred             ccc
Confidence            964

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.46  E-value=5.4e-14  Score=95.53  Aligned_cols=112  Identities=23%  Similarity=0.281  Sum_probs=89.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC--CCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH--DNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~   85 (203)
                      ++.+++|..+....    ...+.+|...++.+++  .++++++.+....     ...++++||+.+......      +.
T Consensus        21 ~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~------~~   85 (155)
T cd05120          21 DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLMEWIEGETLDEV------SE   85 (155)
T ss_pred             CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEEecCCeecccC------CH
Confidence            46889999854322    4568889999999976  4788888777665     467899999876322211      56


Q ss_pred             HHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSA---RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~---~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .....++.+++.+++.+|..   +++|+|++|.|+++++.+.++++||+.+.
T Consensus        86 ~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             HHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            67788899999999999985   69999999999999998999999999886

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=2.7e-13  Score=95.46  Aligned_cols=95  Identities=16%  Similarity=0.224  Sum_probs=71.7

Q ss_pred             HHHHHHhhcCC--CCccchhhhccCCCcchhHHHHHHHhhhHHh-HHHHHhCCCCCChHHHHHHHHHHHHHHHHH-HhCC
Q psy16889         31 RELKMLCFFKH--DNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYL-HSAR  106 (203)
Q Consensus        31 ~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~  106 (203)
                      +|++.|+++..  -+++.++++.         ..++||||++++ +.........+++++...+..+++.++..+ |+.|
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g  145 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN  145 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            79999999954  4566666541         235899999853 322222233466677788899999999988 8999


Q ss_pred             ceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        107 ILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       107 i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ++|||+++.||+++ ++.+.++|||.+..
T Consensus       146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~  173 (197)
T cd05146         146 LVHADLSEYNMLWH-DGKVWFIDVSQSVE  173 (197)
T ss_pred             eecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence            99999999999997 46899999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.42  E-value=7.6e-14  Score=109.93  Aligned_cols=179  Identities=26%  Similarity=0.317  Sum_probs=144.7

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~   82 (203)
                      ...++..+++|.-............-.+|+...++. .|++.++.+..+...     ...++-+|.+++++.++......
T Consensus       139 ~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~-----~~lfiqtE~~~~sl~~~~~~~~~  213 (524)
T KOG0601|consen  139 NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS-----GILFIQTELCGESLQSYCHTPCN  213 (524)
T ss_pred             cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC-----CcceeeeccccchhHHhhhcccc
Confidence            377889999998655555555555556677777777 789999988888877     67889999999999998887654


Q ss_pred             -CChHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCC----CcccccCCcc
Q psy16889         83 -LTSDHIKVFLYQILR----GLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNK----AMTQEVVTQY  152 (203)
Q Consensus        83 -~~~~~~~~~~~qi~~----~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~  152 (203)
                       +++..++..+.+...    |+..+|..+++|-|++|.|++...+ ...++.|||+..........    ......+...
T Consensus       214 ~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~  293 (524)
T KOG0601|consen  214 FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCI  293 (524)
T ss_pred             cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCce
Confidence             899999999999999    9999999999999999999999999 88999999998765544311    2233366788


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                      |++||...+.  ++..+|+|++|.++.+-.++..+..
T Consensus       294 Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  294 YAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             EeChhhhccc--cchHhhhcchhhhhHhhHhhccccc
Confidence            9999998873  6899999999999999887755543

>KOG1266|consensus

Probab=99.38  E-value=1.1e-13  Score=102.33  Aligned_cols=160  Identities=19%  Similarity=0.245  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC----CCCCChHHHHHHHHHHHHHHHH
Q psy16889         27 KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS----PQHLTSDHIKVFLYQILRGLKY  101 (203)
Q Consensus        27 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~  101 (203)
                      +....-+..+.++-|.|+++++.+|.+.+........++.||+. |++..+++.    ...+....+.+|+.||+.||.|
T Consensus       112 ek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~y  191 (458)
T KOG1266|consen  112 EKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSY  191 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhh
Confidence            34445666778888999999999998876544456778899998 687777753    4569999999999999999999


Q ss_pred             HHhCC--ceecCCCCCcEEecCCCeEEEeecC--ccc-cCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHH
Q psy16889        102 LHSAR--ILHRDIKPGNLLVNSNCILKICDFG--LAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC  176 (203)
Q Consensus       102 lh~~~--i~H~di~~~nil~~~~~~~~l~d~~--~~~-~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~  176 (203)
                      ||+..  ++|+++..+.+++..+|-+|+.---  ... ..............+.++|.+||.-...+ .+.++|||++|+
T Consensus       192 Lhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgm  270 (458)
T KOG1266|consen  192 LHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFGM  270 (458)
T ss_pred             hhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhhH
Confidence            99875  9999999999999988888764311  110 00000011112223466789998766544 577899999999


Q ss_pred             HHHHHHhCCcc
Q psy16889        177 IFAELLGRRIL  187 (203)
Q Consensus       177 ~l~~ll~g~~p  187 (203)
                      ...+|.-++.-
T Consensus       271 cAlemailEiq  281 (458)
T KOG1266|consen  271 CALEMAILEIQ  281 (458)
T ss_pred             HHHHHHHheec
Confidence            99999888765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.33  E-value=2.6e-12  Score=95.10  Aligned_cols=128  Identities=16%  Similarity=0.136  Sum_probs=90.8

Q ss_pred             CCcEEEEEeccCccchh---------hhhHHHHHHHHHHhhcCCCCccch--hhhccCCCcchhHHHHHHHhhhHH--hH
Q psy16889          7 DGRRVALKKLPNVFQSL---------VSSKRVFRELKMLCFFKHDNVLSA--LDILQPPHLDFFQEIYVITELLQS--DL   73 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~--~~~~~~~~~~~~~~~~lv~e~~~~--~l   73 (203)
                      .|+.|.||.........         .......+|.+.+.++..-+|...  +.+...........-++|+|++++  +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            56789999774432110         111246789998888855554433  444432211111345689999986  67


Q ss_pred             HHHHhC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------CCeEEEeecCccc
Q psy16889         74 HKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-------NCILKICDFGLAR  134 (203)
Q Consensus        74 ~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-------~~~~~l~d~~~~~  134 (203)
                      .+++..  ..+.++.....++.+++..+..||+.|++|+|++++||+++.       +..+.++||+.+.
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            777653  345667788899999999999999999999999999999975       4688999999885

>KOG3087|consensus

Probab=99.32  E-value=3.8e-12  Score=87.12  Aligned_cols=128  Identities=19%  Similarity=0.269  Sum_probs=91.7

Q ss_pred             CCCCcEEEEEeccC------ccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH--hHHHH
Q psy16889          5 PRDGRRVALKKLPN------VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS--DLHKI   76 (203)
Q Consensus         5 ~~~~~~~~vK~~~~------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~   76 (203)
                      ..+|+.++||.-..      .....-...+..+|++.+.++.--+|.-..-++.|.     ..-.++|||.+|  ++.++
T Consensus        27 ~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~~~~i~ME~~~g~~~vk~~  101 (229)
T KOG3087|consen   27 SFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----YGGQIYMEFIDGASTVKDF  101 (229)
T ss_pred             ccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----CCCeEEEEeccchhHHHHH
Confidence            45788888886522      122334456777899999998766654444445444     334588999987  77777


Q ss_pred             HhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCC
Q psy16889         77 IVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEE  137 (203)
Q Consensus        77 ~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~  137 (203)
                      +...  .....+....+++++-..+.-||.++++||||+.+||++..++   .+.++|||++....
T Consensus       102 i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen  102 ILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             HHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            6532  2233344478999999999999999999999999999997554   45899999987443

>KOG3741|consensus

Probab=99.32  E-value=1.2e-11  Score=96.68  Aligned_cols=174  Identities=16%  Similarity=0.213  Sum_probs=128.4

Q ss_pred             CCcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH--HhHHHHHh
Q psy16889          1 AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ--SDLHKIIV   78 (203)
Q Consensus         1 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~   78 (203)
                      +|++..+|..|++|++..  ...........-++.++++.|+|++++.+++....++. ..+.+|.+|++  ++|.+..-
T Consensus       294 k~~s~~DG~~YvLkRlhg--~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D-~SlvlvYDYyP~s~TL~d~~F  370 (655)
T KOG3741|consen  294 KATSNVDGNAYVLKRLHG--DRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGD-LSLVLVYDYYPSSPTLYDLYF  370 (655)
T ss_pred             eeeeccCCceeeeeeecc--ccccCcccchHHHHHHHHhccCceeehhhhhhhhccCc-ceEEEEEecCCCCchHHHHHc
Confidence            467889999999999933  12223334567789999999999999999998554443 35678889887  46766543


Q ss_pred             C---------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC
Q psy16889         79 S---------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA  143 (203)
Q Consensus        79 ~---------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  143 (203)
                      .               +...+|+.+|.++.|+..||.++|+.|+.-+-+.|.+|+++.+.++++...|........+.  
T Consensus       371 ~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--  448 (655)
T KOG3741|consen  371 ANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--  448 (655)
T ss_pred             cCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCCC--
Confidence            2               22378899999999999999999999999999999999999988999887776653332220  


Q ss_pred             cccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCc-ccCCCChHHH
Q psy16889        144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQ  196 (203)
Q Consensus       144 ~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~-pf~~~~~~~~  196 (203)
                                   +.+.+    ..+.|.-.||.++..|.||.. -+......+.
T Consensus       449 -------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s  485 (655)
T KOG3741|consen  449 -------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS  485 (655)
T ss_pred             -------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH
Confidence                         11212    246799999999999999943 3444444433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.32  E-value=2.2e-12  Score=88.44  Aligned_cols=115  Identities=20%  Similarity=0.291  Sum_probs=81.8

Q ss_pred             CcEEEEEeccCc------cchhhhhHHHHHHHHHHhhcCCCCc--cchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          8 GRRVALKKLPNV------FQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         8 ~~~~~vK~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      |.++++|.-...      .+..-...+-..|++++.+++--+|  +.++++.++.       ..++|||.+| .|.+.+.
T Consensus        19 g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-------~~I~me~I~G~~lkd~l~   91 (204)
T COG3642          19 GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-------GLIVMEYIEGELLKDALE   91 (204)
T ss_pred             CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-------CEEEEEEeCChhHHHHHH
Confidence            456777765221      1122234566689999999965554  4444444443       4589999998 4555665


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCC
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEE  137 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~  137 (203)
                      ..       ...++..+-..+.-||..|++|||++++||++... ++.++|||++....
T Consensus        92 ~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~s~  142 (204)
T COG3642          92 EA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEFSD  142 (204)
T ss_pred             hc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccccc
Confidence            53       25677888888999999999999999999999876 49999999997433

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.22  E-value=5.5e-12  Score=87.57  Aligned_cols=109  Identities=20%  Similarity=0.167  Sum_probs=76.5

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCc-cchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV-LSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~   84 (203)
                      .|+.|++|+......   .......|+..++.+.+.++ ++++....+.       .+++||+++| ++...        
T Consensus        20 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~-------~~lv~e~i~G~~l~~~--------   81 (170)
T cd05151          20 ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPET-------GVLITEFIEGSELLTE--------   81 (170)
T ss_pred             CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCCC-------CeEEEEecCCCccccc--------
Confidence            478899999754311   12345678888888855443 4444433221       2589999987 33221        


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARI-----LHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i-----~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .......+.+++.+++.||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        82 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          82 DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            11123467899999999999885     9999999999999 6689999999886

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.21  E-value=1.5e-11  Score=88.12  Aligned_cols=129  Identities=25%  Similarity=0.296  Sum_probs=93.4

Q ss_pred             CCCcEEEEEeccCcc-----chhhhhHHHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHHHHHhhhHH--hHHHH
Q psy16889          6 RDGRRVALKKLPNVF-----QSLVSSKRVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIYVITELLQS--DLHKI   76 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~   76 (203)
                      ..++.+.+|......     ..........+|.+.+..+..-+  +++.+.+........ ...++++|.+++  +|.+.
T Consensus        30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~  108 (206)
T PF06293_consen   30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDL  108 (206)
T ss_pred             ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHH
Confidence            345566666542211     11133456778888888885444  455555554433222 345788999986  68888


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCcccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARV  135 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~  135 (203)
                      +......+......++.+++..+..||+.|++|+|+++.||+++.++   .+.++||+.+..
T Consensus       109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            77655578888899999999999999999999999999999999887   899999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.19  E-value=2.3e-11  Score=96.34  Aligned_cols=73  Identities=22%  Similarity=0.299  Sum_probs=54.3

Q ss_pred             HHHHHhhhHH-hHHHHHhCC-CCCChHHHHHHHHHHHH-HHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCC
Q psy16889         62 IYVITELLQS-DLHKIIVSP-QHLTSDHIKVFLYQILR-GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEE  137 (203)
Q Consensus        62 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~qi~~-~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~  137 (203)
                      .+++|||++| ++.+..... ...   ....++.+++. .+..+|..|++|+|++|.||+++.++.++++|||++....
T Consensus       233 ~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       233 RVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            4699999986 555443211 112   23456666655 4678899999999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.18  E-value=9.8e-12  Score=99.94  Aligned_cols=68  Identities=21%  Similarity=0.410  Sum_probs=49.8

Q ss_pred             HHHHHhhhHH-hHHHH--HhCCC----CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeec
Q psy16889         62 IYVITELLQS-DLHKI--IVSPQ----HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDF  130 (203)
Q Consensus        62 ~~lv~e~~~~-~l~~~--~~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~  130 (203)
                      .++||||+.| .+.+.  +...+    .+.+..+..++.|++       ..|++|+|+||.||+++.++    .++++||
T Consensus       236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDF  308 (537)
T PRK04750        236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDF  308 (537)
T ss_pred             ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence            4599999986 55442  22222    244555555555554       58999999999999999887    9999999


Q ss_pred             CccccC
Q psy16889        131 GLARVE  136 (203)
Q Consensus       131 ~~~~~~  136 (203)
                      |.+...
T Consensus       309 Givg~l  314 (537)
T PRK04750        309 GIVGSL  314 (537)
T ss_pred             ceEEEC
Confidence            998644

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=3.1e-11  Score=84.67  Aligned_cols=98  Identities=24%  Similarity=0.279  Sum_probs=64.7

Q ss_pred             HHHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHHHHHhhhH--HhHHHHHhCCCCCChHHHHHHHHHHHHHHHH-
Q psy16889         27 KRVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIYVITELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKY-  101 (203)
Q Consensus        27 ~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~-  101 (203)
                      ....+|.+.|.++...+  +++++++..         ..+||||++  |.....+.. ..++.+....++.+++..+.. 
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~~---------~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYNR---------NVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEET---------TEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEeC---------CEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHH
Confidence            45668999999997664  566654432         248999999  632222221 112255667788888885554 


Q ss_pred             HHhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        102 LHSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       102 lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      +|+.|++|||+++.||+++++ .+.++|||.+..
T Consensus       123 ~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~  155 (188)
T PF01163_consen  123 LHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVD  155 (188)
T ss_dssp             HHCTTEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred             HHhcCceecCCChhhEEeecc-eEEEEecCccee
Confidence            689999999999999999987 999999998863

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606|consensus

Probab=99.13  E-value=7.1e-11  Score=98.89  Aligned_cols=142  Identities=28%  Similarity=0.381  Sum_probs=115.4

Q ss_pred             HHHHHHHhhhH-HhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCC
Q psy16889         60 QEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP  138 (203)
Q Consensus        60 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~  138 (203)
                      ...+++++|++ ++|...+..-+..+++-.+..+..+....++||...+.|+|++|.|.+...++..++.+|+.......
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            45789999997 48888887777888888888999999999999999999999999999999999999999873221110


Q ss_pred             C--------------------------CC----CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCccc
Q psy16889        139 D--------------------------PN----KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF  188 (203)
Q Consensus       139 ~--------------------------~~----~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  188 (203)
                      .                          ..    .......+++.|.+||...+.. ..+.+|+|+.|..+++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCC
Confidence            0                          00    0122336788999999999855 688899999999999999999999


Q ss_pred             CCCChHHHhhhhhc
Q psy16889        189 QAQSPVQQLGLITD  202 (203)
Q Consensus       189 ~~~~~~~~~~~i~~  202 (203)
                      +...+....+.|.+
T Consensus      1036 na~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 1036 NAETPQQIFENILN 1049 (1205)
T ss_pred             CCcchhhhhhcccc
Confidence            99999888877753

>KOG0601|consensus

Probab=99.07  E-value=4.4e-11  Score=94.58  Aligned_cols=174  Identities=22%  Similarity=0.220  Sum_probs=126.9

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   82 (203)
                      ..++..|++|...+......+...-..|+-+...+ .|.+++++...|...     ...|+-.||+.+ ++.........
T Consensus       288 ~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----r~~~ip~e~~~~~s~~l~~~~~~~  362 (524)
T KOG0601|consen  288 PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----RQGYIPLEFCEGGSSSLRSVTSQM  362 (524)
T ss_pred             CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----ccccCchhhhcCcchhhhhHHHHh
Confidence            46777888888866555555544555666666666 788889988888776     455688999974 44333344456


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCcccc-cceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYR-APEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~-aPe~~~  160 (203)
                      +.+...+....|++.++.++|+...+|+|++|+||++..+ +..++.||+..+......    .......++. .+|.+.
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~  438 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILL  438 (524)
T ss_pred             cCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec----ccccccccccccchhhc
Confidence            8889999999999999999999999999999999999876 777889998876311111    1111123344 256666


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRIL  187 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~p  187 (203)
                      ....+..+.|++|||.-+.+.+++.+.
T Consensus       439 e~~~~~~~~~~~sl~~~~~e~~~~~~l  465 (524)
T KOG0601|consen  439 EDYPHLSKADIFSLGLSVDEAITGSPL  465 (524)
T ss_pred             cccccccccccccccccccccccCccc
Confidence            657788999999999999998887544

>PRK09902 hypothetical protein; Provisional

Probab=99.06  E-value=3.6e-10  Score=79.99  Aligned_cols=128  Identities=13%  Similarity=0.157  Sum_probs=92.3

Q ss_pred             CCcEEEEEeccCccc-h---hhhhHHHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHHHHHhhhH--HhHHHHHh
Q psy16889          7 DGRRVALKKLPNVFQ-S---LVSSKRVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIYVITELLQ--SDLHKIIV   78 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~-~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~   78 (203)
                      .|+.+-+|.-.+... +   +.....+.+|...++++..-+  ++++. ++..........-++|+|-++  .+|.+++.
T Consensus        40 ~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~  118 (216)
T PRK09902         40 NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYA  118 (216)
T ss_pred             CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHh
Confidence            345688887742111 1   335567889999999995444  44444 222111111134568899888  48888876


Q ss_pred             CC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe--EEEeecCcccc
Q psy16889         79 SP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARV  135 (203)
Q Consensus        79 ~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~  135 (203)
                      ..  .+.++.....++.+++.++.-||+.|+.|+|+.+.||+++.++.  +.++||.-++.
T Consensus       119 ~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        119 QHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             cCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            53  45688888899999999999999999999999999999986666  99999988763

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.05  E-value=1.6e-09  Score=83.35  Aligned_cols=128  Identities=16%  Similarity=0.166  Sum_probs=97.2

Q ss_pred             HHHHHhhhHH--hHHHHHh------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcc
Q psy16889         62 IYVITELLQS--DLHKIIV------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA  133 (203)
Q Consensus        62 ~~lv~e~~~~--~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~  133 (203)
                      ..+.|..+.|  ....+..      ..+.+.+..+.+.+..++.+.+.||..|.+-||++++|+++.+++.+.|+|-...
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            4455666553  2333322      2345888999999999999999999999999999999999999999999986544


Q ss_pred             ccCCCCCCCCcccccCCcccccceeeec----ccCCCcchhHHHHHHHHHHHHhC-CcccCCC
Q psy16889        134 RVEEPDPNKAMTQEVVTQYYRAPEILMG----ARHYSAAVDVWSVGCIFAELLGR-RILFQAQ  191 (203)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~----~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~  191 (203)
                      ..-  .......+..|.+.|.+||...-    .-.-+..+|.|.||+++++++.| +.||.+-
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            321  33444556678899999997651    11236788999999999999876 9999873

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.99  E-value=5.6e-10  Score=80.71  Aligned_cols=123  Identities=23%  Similarity=0.361  Sum_probs=83.4

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCC--CccchhhhccCCCcchhHHHHHHHhhhHHh-HHHHHhCCCCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD--NVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSPQHLT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~   84 (203)
                      |+.+++|........ .....+..|.++++.+.+.  .+++++.+.......  ...++++|+++|. +..... ...++
T Consensus        22 g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~--~~~~~v~e~i~G~~l~~~~~-~~~~~   97 (223)
T cd05154          22 GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL--GTPFYVMERVDGRVLRDRLL-RPELS   97 (223)
T ss_pred             CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc--CCceEEEEEeCCEecCCCCC-CCCCC
Confidence            678999998543221 2345678899999999664  356666665543211  2456888888863 333221 13466


Q ss_pred             hHHHHHHHHHHHHHHHHHHh--------------------------------------------------------CCce
Q psy16889         85 SDHIKVFLYQILRGLKYLHS--------------------------------------------------------ARIL  108 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~--------------------------------------------------------~~i~  108 (203)
                      ++....++.+++.++..||+                                                        ..++
T Consensus        98 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  177 (223)
T cd05154          98 PEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLV  177 (223)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEE
Confidence            66666777777777776663                                                        2468


Q ss_pred             ecCCCCCcEEecC--CCeEEEeecCccc
Q psy16889        109 HRDIKPGNLLVNS--NCILKICDFGLAR  134 (203)
Q Consensus       109 H~di~~~nil~~~--~~~~~l~d~~~~~  134 (203)
                      |+|++|.||+++.  ++.+.++||+.+.
T Consensus       178 HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         178 HGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             ECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            9999999999998  6678999999886

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=5.4e-09  Score=74.43  Aligned_cols=120  Identities=19%  Similarity=0.258  Sum_probs=70.7

Q ss_pred             CCCcEEEEEeccCccchhhhh-------HHHHHHHHHHhhcCCCC---ccchhhhccCCCcchhHHHHHHHhhhHH-hHH
Q psy16889          6 RDGRRVALKKLPNVFQSLVSS-------KRVFRELKMLCFFKHDN---VLSALDILQPPHLDFFQEIYVITELLQS-DLH   74 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~-------~~~~~e~~~l~~l~~~~---i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   74 (203)
                      .+|+.+++|..+......+..       ....+++..+..++..+   ...++-+..-....+....+++|||++| .|.
T Consensus        52 i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~  131 (229)
T PF06176_consen   52 IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELN  131 (229)
T ss_pred             ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecc
Confidence            357888899885532221111       11223333333343333   2332322222222222334579999998 443


Q ss_pred             HHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         75 KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      +..    .+++    .+...+..++..+|+.|+.|||.+|.|++++++ .++++|++...
T Consensus       132 d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  132 DIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             cch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence            321    1222    244567778999999999999999999999865 59999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.71  E-value=3.5e-08  Score=72.02  Aligned_cols=97  Identities=20%  Similarity=0.192  Sum_probs=72.6

Q ss_pred             hhHHHHHHHHHHhhcCCC--CccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHH
Q psy16889         25 SSKRVFRELKMLCFFKHD--NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL  102 (203)
Q Consensus        25 ~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  102 (203)
                      ++....+|.+.|+++...  .+++.++.         ..-.+|||+..|..+..+    +++.+....++..|+..+..+
T Consensus       152 sRl~A~rEf~~L~~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~----r~~~en~~~il~~il~~~~~~  218 (304)
T COG0478         152 SRLAAEREFEALQRLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRL----RLDVENPDEILDKILEEVRKA  218 (304)
T ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCcccc---------ccceeeeehcccceeecc----cCcccCHHHHHHHHHHHHHHH
Confidence            345677899999999665  56665553         345699999998333222    224555666677777777777


Q ss_pred             HhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        103 HSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       103 h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      -..|++|||+++-||+++++|.+.++||-.+.
T Consensus       219 ~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         219 YRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             HHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            79999999999999999999999999998775

>KOG2137|consensus

Probab=98.63  E-value=5.2e-09  Score=84.57  Aligned_cols=100  Identities=26%  Similarity=0.441  Sum_probs=75.4

Q ss_pred             HHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC------CCc--ccccCCcccccceeeec
Q psy16889         91 FLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN------KAM--TQEVVTQYYRAPEILMG  161 (203)
Q Consensus        91 ~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~------~~~--~~~~~~~~~~aPe~~~~  161 (203)
                      =+.+.+.|+.++|+ .++||++|.|++|.++..+.+|+..|+.+........      ...  ........|.+||.+..
T Consensus       104 nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  104 NLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34456689999995 5899999999999999999999999998764333111      111  11122456999999988


Q ss_pred             ccCCCcchhHHHHHHHHHHHH-hCCcccCCC
Q psy16889        162 ARHYSAAVDVWSVGCIFAELL-GRRILFQAQ  191 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll-~g~~pf~~~  191 (203)
                       ...++.+|+||+|+++|.+. +|+.-+...
T Consensus       184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~  213 (700)
T KOG2137|consen  184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAAN  213 (700)
T ss_pred             -ccccccccceeeeeEEEEEecCCcchhhcc
Confidence             55789999999999999998 566666554

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.44  E-value=6.8e-07  Score=64.68  Aligned_cols=122  Identities=19%  Similarity=0.180  Sum_probs=78.3

Q ss_pred             CCCcEEEEEeccCccchhhh----------------------hHHHHHHHHHHhhcCCC--CccchhhhccCCCcchhHH
Q psy16889          6 RDGRRVALKKLPNVFQSLVS----------------------SKRVFRELKMLCFFKHD--NVLSALDILQPPHLDFFQE   61 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~----------------------~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~~~~   61 (203)
                      .++..+|+|++..+...-..                      .....+|+..|+++...  .+++.+.+.         .
T Consensus        70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~  140 (268)
T COG1718          70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR---------N  140 (268)
T ss_pred             CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec---------C
Confidence            46888999998543211111                      11233566666666333  233333322         2


Q ss_pred             HHHHHhhhHHh-HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCC
Q psy16889         62 IYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEE  137 (203)
Q Consensus        62 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~  137 (203)
                      ..++||+++.. ...-..+.-++..+++..+..+++..+.-|-. .++||+||+.-||++. ++.+.++|++.+....
T Consensus       141 nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            34889998853 11111222234444788888888888888776 8999999999999999 7899999999986433

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.23  E-value=2.7e-06  Score=61.90  Aligned_cols=28  Identities=29%  Similarity=0.350  Sum_probs=25.4

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++|+|++|.|+++++++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999887 9999999886

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035|consensus

Probab=98.16  E-value=2.7e-05  Score=67.30  Aligned_cols=162  Identities=19%  Similarity=0.254  Sum_probs=111.2

Q ss_pred             hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHH
Q psy16889         24 VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYL  102 (203)
Q Consensus        24 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  102 (203)
                      ..+....-|...+.+..|+|+..++.+.....+.. ....+..+++.+ ++...+..-+..+....+.+..++.+++.++
T Consensus       224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence            34455566888889999999999999876665443 355677788875 7888888888999999999999999999999


Q ss_pred             HhCCceecCCCCC---cEEecCCCeEEEe--ecCccccCCCCCCCCcccccCCcccccceeeeccc-CCCcchhHHHHHH
Q psy16889        103 HSARILHRDIKPG---NLLVNSNCILKIC--DFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR-HYSAAVDVWSVGC  176 (203)
Q Consensus       103 h~~~i~H~di~~~---nil~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~~Di~slG~  176 (203)
                      |+..+.|.-+..+   +--.+..+.....  ||+.+......  ........+..+.++|....+. ..+...|+|++|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~--~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN--EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCc--ccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            9986655555444   2223344444444  77766533222  2222223345577777666521 1233479999999


Q ss_pred             HHHHHHhCCccc
Q psy16889        177 IFAELLGRRILF  188 (203)
Q Consensus       177 ~l~~ll~g~~pf  188 (203)
                      ....+..|..+-
T Consensus       381 l~~~~~~~~~i~  392 (1351)
T KOG1035|consen  381 LLLQLSQGEDIS  392 (1351)
T ss_pred             HHhhhhhcCccc
Confidence            999998876553

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.15  E-value=3.4e-06  Score=62.10  Aligned_cols=29  Identities=21%  Similarity=0.250  Sum_probs=26.1

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++|+|+.|.|++++.++...++||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999987777899999875

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.09  E-value=7.7e-06  Score=66.06  Aligned_cols=72  Identities=24%  Similarity=0.432  Sum_probs=47.8

Q ss_pred             HHHHhhhHH-hHHHH--HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCC
Q psy16889         63 YVITELLQS-DLHKI--IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEE  137 (203)
Q Consensus        63 ~lv~e~~~~-~l~~~--~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~  137 (203)
                      .++|||+.| .+.+.  +.. ..++...+.....++.  +..+=..|.+|.|.+|.||+++.+|.+.+.|||......
T Consensus       242 VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         242 VLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             EEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            478999987 33333  222 3345333333222221  222334799999999999999999999999999986543

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.96  E-value=8.1e-06  Score=57.59  Aligned_cols=95  Identities=18%  Similarity=0.129  Sum_probs=74.2

Q ss_pred             HHHHHHhhcCC-CCccchhhhccCCCcchhHHHHHHHhhhH-HhHHH---HHhCCCCCChHHHHHHHHHHHHHHHHHHh-
Q psy16889         31 RELKMLCFFKH-DNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHK---IIVSPQHLTSDHIKVFLYQILRGLKYLHS-  104 (203)
Q Consensus        31 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~---~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-  104 (203)
                      .|.-+++.+++ ++++++++++.+-         +++|+.+ +++..   .+...-..+++.+.+++.+++..+.+++. 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~~---------~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~   78 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGRF---------YVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHG   78 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCCE---------EEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC
Confidence            47788888855 6899999988443         5677776 33321   11122346899999999999999999997 


Q ss_pred             --CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 --ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 --~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                        ..+.-.|++++|+-++.+++++++|.+...
T Consensus        79 ~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~  110 (188)
T PF12260_consen   79 PLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF  110 (188)
T ss_pred             CCCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence              458889999999999999999999998765

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.78  E-value=5.1e-05  Score=65.36  Aligned_cols=60  Identities=25%  Similarity=0.306  Sum_probs=37.7

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCc--cchhhhccCCCcchhHHHHHHHhhhHH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNV--LSALDILQPPHLDFFQEIYVITELLQS   71 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~   71 (203)
                      ..+++|+.+.... ......+.+|+++++.+. |+++  ++++.++.+...  ....|+|||+++|
T Consensus        66 ~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v--~G~~flVME~v~G  128 (822)
T PLN02876         66 KRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV--IGTAFYIMEYLEG  128 (822)
T ss_pred             eeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc--CCCceEEEEecCC
Confidence            4678887654311 122346778999999995 6664  666666655421  1346788888775

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.77  E-value=8e-05  Score=54.53  Aligned_cols=31  Identities=39%  Similarity=0.642  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+++|+|+++.|++++.++...++||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998765567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0576|consensus

Probab=97.71  E-value=1.4e-05  Score=65.07  Aligned_cols=149  Identities=17%  Similarity=0.107  Sum_probs=101.9

Q ss_pred             HHHHHHHHHHhhcCCCC-ccchhhhccCCCcchhHHHHHHHhhhHHh--HHHHHh-CCCCCChHHHHHHHHHHHHHHHHH
Q psy16889         27 KRVFRELKMLCFFKHDN-VLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIV-SPQHLTSDHIKVFLYQILRGLKYL  102 (203)
Q Consensus        27 ~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~l  102 (203)
                      ....-++++|.+.+||| .+..++-+..+     .+.+++++++++.  ...... ....+.+.+...+...-.++++++
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E-----~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l  352 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGE-----DYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAEL  352 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcc-----cccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccc
Confidence            44556888999999999 44444433333     6788999999853  211111 112355556667777888899999


Q ss_pred             HhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHH
Q psy16889        103 HSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL  182 (203)
Q Consensus       103 h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll  182 (203)
                      |+.--+|+|    ||+..+ +..+..+|+.........  ......+++.+++||+...+ .+....|.|++|.-..++.
T Consensus       353 ~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~a  424 (829)
T KOG0576|consen  353 HSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMA  424 (829)
T ss_pred             ccccccCcc----cccccc-cccccccccCCcccCccc--ccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcC
Confidence            988778888    666544 577888988876433222  34455778999999988874 4778889999997666666


Q ss_pred             hCCccc
Q psy16889        183 GRRILF  188 (203)
Q Consensus       183 ~g~~pf  188 (203)
                      -|-+|-
T Consensus       425 p~~pPr  430 (829)
T KOG0576|consen  425 PGLPPR  430 (829)
T ss_pred             CCCCCC
Confidence            666654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.51  E-value=0.001  Score=46.11  Aligned_cols=109  Identities=21%  Similarity=0.219  Sum_probs=70.7

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCcc-chhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVL-SALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~   84 (203)
                      .|..+++|+-+    .+..+..+..|++++..+...++- +++.+.         ..++.|||+.| .|.+.....   +
T Consensus        44 ~~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~me~i~G~~L~~~~~~~---~  107 (201)
T COG2112          44 RGGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIRMEYIDGRPLGKLEIGG---D  107 (201)
T ss_pred             cCceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhhhhhhcCcchhhhhhcc---c
Confidence            46688888863    345567789999999999776653 333333         23456999997 555543221   2


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCC-CcEEecCCCeEEEeecCcccc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKP-GNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~-~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+.    +..+++..--|-..||-|+.|+- ...++..++.+.++||..++.
T Consensus       108 rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         108 RKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             HHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            223    33344444446678999999974 444444555999999999874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.49  E-value=0.00027  Score=50.24  Aligned_cols=98  Identities=19%  Similarity=0.258  Sum_probs=63.8

Q ss_pred             HHHHHHHHHHhhcC------CCCccchhhhccCCCcchhHHHHHHHhhhH-------HhHHHHHhCCCCCChHHHHHHHH
Q psy16889         27 KRVFRELKMLCFFK------HDNVLSALDILQPPHLDFFQEIYVITELLQ-------SDLHKIIVSPQHLTSDHIKVFLY   93 (203)
Q Consensus        27 ~~~~~e~~~l~~l~------~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-------~~l~~~~~~~~~~~~~~~~~~~~   93 (203)
                      ....+|+.....+.      +.+|.++++..+++.+.     .+|+|...       .+|.+++.. +.+++ ..   ..
T Consensus        56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~-----Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~  125 (199)
T PF10707_consen   56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGL-----GLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQ  125 (199)
T ss_pred             HHHHHHHHHHHHHhhccCCcccccccEeEEEecCCce-----EEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HH
Confidence            44555665555554      77899999999887443     34555432       266776644 44655 33   33


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEecCC--C--eEEEee-cCccc
Q psy16889         94 QILRGLKYLHSARILHRDIKPGNLLVNSN--C--ILKICD-FGLAR  134 (203)
Q Consensus        94 qi~~~l~~lh~~~i~H~di~~~nil~~~~--~--~~~l~d-~~~~~  134 (203)
                      .+-...++|-+.+|+.+|++|+||++...  +  .+.++| ||...
T Consensus       126 ~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  126 ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             HHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            34455567789999999999999999632  2  577777 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1826|consensus

Probab=97.31  E-value=0.00029  Score=63.28  Aligned_cols=160  Identities=14%  Similarity=0.107  Sum_probs=109.4

Q ss_pred             hHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----CCCChHHHHHHHHHHHHHHH
Q psy16889         26 SKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----QHLTSDHIKVFLYQILRGLK  100 (203)
Q Consensus        26 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~  100 (203)
                      .+....|.+..+...|+++.....-..+...   ...+..++++. |.+.+.+.++    +...+.-+....++......
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence            3444556566677789988877776655443   45688899988 6888887653    23444444444444466666


Q ss_pred             HHHhCC-----ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHH
Q psy16889        101 YLHSAR-----ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG  175 (203)
Q Consensus       101 ~lh~~~-----i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG  175 (203)
                      -+|++.     -+|.++++.|.++..+.++++.++|+.+..... ........+++.|+.|+....- .++.++|+|.+|
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~i-k~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEI-KFTKRSDILRRS 1427 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHH-hhhhHHHHHHHH
Confidence            666442     689999999999999999999999998732222 1122223446667777766553 366779999999


Q ss_pred             HHHHHHHhCCcccCC
Q psy16889        176 CIFAELLGRRILFQA  190 (203)
Q Consensus       176 ~~l~~ll~g~~pf~~  190 (203)
                      +-+|...-|..||-.
T Consensus      1428 ~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             HHHHHHhcccHHHHH
Confidence            999999888888743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.31  E-value=0.00099  Score=50.78  Aligned_cols=31  Identities=29%  Similarity=0.584  Sum_probs=28.0

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccccC
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARVE  136 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~  136 (203)
                      .++|||+++.|+++++.+.+-++||+.+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            4899999999999999888999999998753

>KOG2270|consensus

Probab=97.18  E-value=0.00064  Score=52.58  Aligned_cols=122  Identities=20%  Similarity=0.250  Sum_probs=83.0

Q ss_pred             CCCCcEEEEEeccCccchhhhh------------------------HHHHHHHHHHhhcCCCCccchhhhccCCCcchhH
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSS------------------------KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ   60 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~------------------------~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~   60 (203)
                      ..+|..+|||+++.+...-.++                        -....|++.|++++..+|+..-.+..       .
T Consensus       165 ~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlL-------k  237 (520)
T KOG2270|consen  165 EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILL-------K  237 (520)
T ss_pred             cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceee-------e
Confidence            4688999999986643211111                        12346778888887777543333322       2


Q ss_pred             HHHHHHhhhHHh-HHHHHhCCCCCChHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         61 EIYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYL-HSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        61 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~qi~~~l~~l-h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      ...+||++++++ -..-....-.++...+..+-.|++..+.-| +..++||.||+=-|+++.. |.+.++|.+.+-
T Consensus       238 ~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  238 NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYIIDVSQSV  312 (520)
T ss_pred             cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEEEccccc
Confidence            346899999852 222233445688888888888888877765 4678999999999999864 589999998775

>KOG1235|consensus

Probab=97.08  E-value=0.00088  Score=54.46  Aligned_cols=84  Identities=23%  Similarity=0.254  Sum_probs=54.5

Q ss_pred             ccchhhhccCCCcchhHHHHHHHhhhHH----hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe
Q psy16889         44 VLSALDILQPPHLDFFQEIYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV  119 (203)
Q Consensus        44 i~~~~~~~~~~~~~~~~~~~lv~e~~~~----~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~  119 (203)
                      |++++..+...       -.++|||++|    ++ +.+.+. .++...+..-+.++..  +.+=..|.+|+|-+|.||++
T Consensus       266 VP~Vy~~~st~-------RVLtME~~~G~~i~Dl-~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv  334 (538)
T KOG1235|consen  266 VPKVYWDLSTK-------RVLTMEYVDGIKINDL-DAIDKR-GISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILV  334 (538)
T ss_pred             CCeehhhcCcc-------eEEEEEecCCccCCCH-HHHHHc-CCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEE
Confidence            66666555443       3589999997    33 334443 3555544443333322  12225679999999999999


Q ss_pred             cC----CCeEEEeecCccccCCC
Q psy16889        120 NS----NCILKICDFGLARVEEP  138 (203)
Q Consensus       120 ~~----~~~~~l~d~~~~~~~~~  138 (203)
                      ++    ++.+.+.|||+......
T Consensus       335 ~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  335 RPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ecCCCCCccEEEEcccccccccH
Confidence            84    66899999999875443

>KOG2268|consensus

Probab=96.90  E-value=0.0032  Score=48.11  Aligned_cols=93  Identities=15%  Similarity=0.224  Sum_probs=64.0

Q ss_pred             HHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh
Q psy16889         28 RVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS  104 (203)
Q Consensus        28 ~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~  104 (203)
                      ...+|+..|+.+....  +++.+++         ...++|||++.| .|.....      .+.+-.+...+...+.-|-.
T Consensus       156 aa~kEfafmkaL~e~gfpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~  220 (465)
T KOG2268|consen  156 AATKEFAFMKALYERGFPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLAN  220 (465)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCcccc---------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHH
Confidence            4556888888884322  4444443         345689998886 3333211      11233455556666777889


Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .|++|||..-=||++++++.++++||-.+..
T Consensus       221 ~GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  221 HGLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             cCceecccchheeEEecCCCEEEeechHhhc
Confidence            9999999999999999999999999987653

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.68  E-value=0.039  Score=43.54  Aligned_cols=29  Identities=24%  Similarity=0.461  Sum_probs=25.3

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      +.++|||++|.|||++++ ..+++|...+.
T Consensus       227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKND-STKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence            458999999999999976 68999988775

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.68  E-value=0.0079  Score=46.66  Aligned_cols=52  Identities=23%  Similarity=0.400  Sum_probs=44.6

Q ss_pred             CChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      -..+++..++.+.+..+.-+... ..-|||+...||+++ +|++.|+||-+++.
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            45677888888888888777754 688999999999999 99999999999984

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.56  E-value=0.0035  Score=45.76  Aligned_cols=30  Identities=27%  Similarity=0.448  Sum_probs=26.6

Q ss_pred             CCceecCCCCCcEEecC-CCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNS-NCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~-~~~~~l~d~~~~~  134 (203)
                      ..++|+|+.+.||+++. ++.+.++||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            35999999999999997 5789999998875

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.46  E-value=0.009  Score=45.55  Aligned_cols=29  Identities=21%  Similarity=0.317  Sum_probs=25.6

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .+++|||+++.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.41  E-value=0.0072  Score=45.94  Aligned_cols=30  Identities=30%  Similarity=0.439  Sum_probs=26.8

Q ss_pred             CceecCCCCCcEEecCC----CeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSN----CILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~----~~~~l~d~~~~~~  135 (203)
                      .++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            58999999999999974    8899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.39  E-value=0.0082  Score=45.81  Aligned_cols=30  Identities=27%  Similarity=0.534  Sum_probs=27.2

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .+++|+|+++.|++++.++...++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            689999999999999988767899999885

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=96.24  E-value=0.0095  Score=44.60  Aligned_cols=49  Identities=27%  Similarity=0.380  Sum_probs=37.4

Q ss_pred             HHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889         87 HIKVFLYQILRGLKYLHSA--RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~--~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+...+..+-.++...+..  -.+|+|+.|.|++.++.+.++|+||..+..
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444555555555555544  589999999999999989999999998864

>PRK05231 homoserine kinase; Provisional

Probab=96.20  E-value=0.014  Score=44.71  Aligned_cols=31  Identities=23%  Similarity=0.338  Sum_probs=26.4

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+++|+|++|.||+++.+....++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999999765568999998853

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.15  E-value=0.0036  Score=45.30  Aligned_cols=30  Identities=40%  Similarity=0.670  Sum_probs=21.1

Q ss_pred             CCceecCCCCCcEEec-CCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVN-SNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~-~~~~~~l~d~~~~~  134 (203)
                      ..++|+|+.|.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            4599999999999999 66677899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.14  E-value=0.012  Score=44.59  Aligned_cols=31  Identities=23%  Similarity=0.389  Sum_probs=27.1

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+++|+|++|.|++++.++.+.++||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4699999999999999887778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.99  E-value=0.0072  Score=42.51  Aligned_cols=29  Identities=31%  Similarity=0.499  Sum_probs=25.4

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      -.+|+|+.|.|+++++++ ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            469999999999998776 88999998864

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.89  E-value=0.018  Score=43.96  Aligned_cols=30  Identities=13%  Similarity=0.151  Sum_probs=27.7

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      +++|+|+.++|++++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999998999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.79  E-value=0.0095  Score=43.12  Aligned_cols=37  Identities=30%  Similarity=0.434  Sum_probs=32.1

Q ss_pred             HHHHHHHHh--CCceecCCCCCcEEecCCCeEEEeecCc
Q psy16889         96 LRGLKYLHS--ARILHRDIKPGNLLVNSNCILKICDFGL  132 (203)
Q Consensus        96 ~~~l~~lh~--~~i~H~di~~~nil~~~~~~~~l~d~~~  132 (203)
                      +++|..+|+  .+..|||..|+|||-|..|.+|+.|-+.
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            567788884  5799999999999999999999999654

The function of this family is unknown.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.78  E-value=0.0061  Score=43.82  Aligned_cols=29  Identities=38%  Similarity=0.694  Sum_probs=20.9

Q ss_pred             CceecCCCCCcEEe-cCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLV-NSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~-~~~~~~~l~d~~~~~  134 (203)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 788999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.65  E-value=0.01  Score=44.06  Aligned_cols=29  Identities=34%  Similarity=0.439  Sum_probs=25.8

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .++|+|+.|.||++++++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999876 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=95.65  E-value=0.037  Score=39.38  Aligned_cols=31  Identities=19%  Similarity=0.315  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEecCCC-----eEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNC-----ILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~-----~~~l~d~~~~~~  135 (203)
                      ..++|||+++.|++++.++     .+.++||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4689999999999998543     589999998863

subfamily of choline kinases

>PLN02236 choline kinase

Probab=95.38  E-value=0.025  Score=43.96  Aligned_cols=30  Identities=23%  Similarity=0.507  Sum_probs=26.2

Q ss_pred             CceecCCCCCcEEecC-CCeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNS-NCILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~-~~~~~l~d~~~~~~  135 (203)
                      .++|+|+++.||++++ ++.+.++||+.+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986 46899999998863

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.33  E-value=0.012  Score=42.86  Aligned_cols=52  Identities=13%  Similarity=0.047  Sum_probs=34.8

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQ   70 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   70 (203)
                      .+|.||+=.     ......+..|+.-|+.+   +--.+++++.+..+.     .+.|+|+||++
T Consensus        40 ~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~-----~~sylVle~L~   94 (286)
T COG3001          40 DPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGASR-----DHSYLVLEYLP   94 (286)
T ss_pred             cceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCC-----CeeEEEEeecc
Confidence            457888743     23455677788777777   335577777777666     56677888765

>KOG1093|consensus

Probab=95.29  E-value=0.011  Score=47.93  Aligned_cols=118  Identities=23%  Similarity=0.350  Sum_probs=74.4

Q ss_pred             HHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCC
Q psy16889         27 KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR  106 (203)
Q Consensus        27 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~  106 (203)
                      ..+..-...++.+.|++...++++-....    ....+|+|+++-++.+.+..+. .-.....              ..+
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~   87 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHG   87 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------ccc
Confidence            45566788999999999999999877665    3466899999988888876544 2111111              111


Q ss_pred             ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCc
Q psy16889        107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI  186 (203)
Q Consensus       107 i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~  186 (203)
                      +.|     .|++       +..| .++.        ...                 -+..+++||||+|.++.++.-|..
T Consensus        88 ~~~-----~~~~-------~~td-~~~t--------~~~-----------------~~~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   88 VLH-----LNII-------YITD-HFLT--------KYP-----------------SPIGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cce-----ehhh-------hccc-cccc--------cCC-----------------CCCCcchhhhhHHHHHHHHHHhhH
Confidence            111     1121       1222 0000        000                 011249999999999999999998


Q ss_pred             ccCCCChHHHhhhhh
Q psy16889        187 LFQAQSPVQQLGLIT  201 (203)
Q Consensus       187 pf~~~~~~~~~~~i~  201 (203)
                      .++.....+.+..|.
T Consensus       130 l~~~~~~s~~l~~i~  144 (725)
T KOG1093|consen  130 LEAELTESEYLEILL  144 (725)
T ss_pred             HHHHHHHHHHHHHHH
Confidence            888877666665554

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.00  E-value=0.045  Score=42.24  Aligned_cols=28  Identities=32%  Similarity=0.522  Sum_probs=25.3

Q ss_pred             ceecCCCCCcEEecCCCe-EEEeecCccc
Q psy16889        107 ILHRDIKPGNLLVNSNCI-LKICDFGLAR  134 (203)
Q Consensus       107 i~H~di~~~nil~~~~~~-~~l~d~~~~~  134 (203)
                      ++|+|+.|.|++++.+.. ..++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 8899999775

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.55  E-value=0.046  Score=42.22  Aligned_cols=51  Identities=25%  Similarity=0.390  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHHHHHHH----HhCCceecCCCCCcEEecCC------------------CeEEEeecCccccC
Q psy16889         86 DHIKVFLYQILRGLKYL----HSARILHRDIKPGNLLVNSN------------------CILKICDFGLARVE  136 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~l----h~~~i~H~di~~~nil~~~~------------------~~~~l~d~~~~~~~  136 (203)
                      +.++.++.|++...-..    -..+.+|-||||+||++-+.                  -..+|-||..++..
T Consensus       275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            34556667776654222    14579999999999998432                  23567777777643

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.41  E-value=0.08  Score=40.85  Aligned_cols=28  Identities=36%  Similarity=0.439  Sum_probs=24.1

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .+++|+|+.+.|++++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 3 57899999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=94.30  E-value=0.041  Score=41.41  Aligned_cols=30  Identities=27%  Similarity=0.622  Sum_probs=25.4

Q ss_pred             CceecCCCCCcEEecCCCe-EEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSNCI-LKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~-~~l~d~~~~~~  135 (203)
                      .++|+|++|.|++++.++. .-++||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.14  E-value=0.13  Score=39.87  Aligned_cols=29  Identities=31%  Similarity=0.502  Sum_probs=25.4

Q ss_pred             ceecCCCCCcEEecC-CCeEEEeecCcccc
Q psy16889        107 ILHRDIKPGNLLVNS-NCILKICDFGLARV  135 (203)
Q Consensus       107 i~H~di~~~nil~~~-~~~~~l~d~~~~~~  135 (203)
                      .+|+|+.+.||++++ ++.++++||+.+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999974 57899999998853

>PRK06148 hypothetical protein; Provisional

Probab=93.55  E-value=0.21  Score=44.58  Aligned_cols=30  Identities=33%  Similarity=0.548  Sum_probs=25.4

Q ss_pred             CCceecCCCCCcEEecCCC--eEE-EeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNC--ILK-ICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~--~~~-l~d~~~~~  134 (203)
                      .+++|+|+++.||+++.++  .+. ++|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            4799999999999999775  454 99999775

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=93.20  E-value=0.15  Score=36.42  Aligned_cols=100  Identities=21%  Similarity=0.181  Sum_probs=57.1

Q ss_pred             hHHHHHHHHHHhhcC---CCCc--cchhhhccCCCcchhHHHHHH-H--hhhHH-hHHHHHhCCCCCChHHHHHHHHHHH
Q psy16889         26 SKRVFRELKMLCFFK---HDNV--LSALDILQPPHLDFFQEIYVI-T--ELLQS-DLHKIIVSPQHLTSDHIKVFLYQIL   96 (203)
Q Consensus        26 ~~~~~~e~~~l~~l~---~~~i--~~~~~~~~~~~~~~~~~~~lv-~--e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~   96 (203)
                      .+.+..|.+...+++   +.++  +++++++.-...   ...-.. +  +...+ .....+....+-...-...-+.+|.
T Consensus        98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~---~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~  174 (207)
T PF13095_consen   98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTED---QQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQML  174 (207)
T ss_pred             cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchH---HHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHH
Confidence            346777888877774   4455  888888754421   111100 0  00000 0000011101111112344556788


Q ss_pred             HHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCcc
Q psy16889         97 RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA  133 (203)
Q Consensus        97 ~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~  133 (203)
                      +-+..+|+.||+-+|+++.|..     .-+|+|||.+
T Consensus       175 ~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  175 RDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            8889999999999999999998     5688899864

>PRK06149 hypothetical protein; Provisional

Probab=93.14  E-value=0.13  Score=45.72  Aligned_cols=31  Identities=23%  Similarity=0.290  Sum_probs=25.1

Q ss_pred             hCCceecCCCCCcEEecCCC--e---EEEeecCccc
Q psy16889        104 SARILHRDIKPGNLLVNSNC--I---LKICDFGLAR  134 (203)
Q Consensus       104 ~~~i~H~di~~~nil~~~~~--~---~~l~d~~~~~  134 (203)
                      ..+++|+|++++||+++.+.  .   ..++|||-+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            45799999999999998652  3   3799999764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=92.93  E-value=0.19  Score=38.02  Aligned_cols=29  Identities=31%  Similarity=0.432  Sum_probs=24.6

Q ss_pred             ceecCCCCCcEEecCC--C---eEEEeecCcccc
Q psy16889        107 ILHRDIKPGNLLVNSN--C---ILKICDFGLARV  135 (203)
Q Consensus       107 i~H~di~~~nil~~~~--~---~~~l~d~~~~~~  135 (203)
                      ++|||+++.|||+..+  |   .+.++||..++.
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~  250 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY  250 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeeccccccC
Confidence            8999999999999754  3   689999988863

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=92.72  E-value=0.11  Score=41.20  Aligned_cols=30  Identities=27%  Similarity=0.449  Sum_probs=25.8

Q ss_pred             hCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        104 SARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       104 ~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      ...++|||+++.||+++.+ .++++|+..+.
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            3469999999999999876 68999998775

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	203
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-56
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-56
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-53
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-53
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-53
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-53
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-53
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-53
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-53
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-53
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-53
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-53
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-53
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-53
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-52
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-52
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-52
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-52
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-52
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-52
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-52
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-52
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-52
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-52
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-52
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-52
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-52
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-52
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-52
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-52
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-52
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-52
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-52
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-52
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-52
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-52
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-52
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-52
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-52
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-52
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-52
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-52
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-52
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-52
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-52
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-52
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-52
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-52
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-52
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-52
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-52
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-52
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-51
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-51
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-51
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-51
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-51
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-51
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-51
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-51
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-51
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-51
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-51
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-51
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-51
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-51
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-51
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-51
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-51
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-51
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-51
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-51
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-51
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-51
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-51
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-51
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-51
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-50
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-50
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-50
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-50
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-50
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-50
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-50
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-49
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-48
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-48
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-48
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-48
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-47
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-47
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-46
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-46
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-45
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-44
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-41
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-40
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-40
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-40
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-39
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-39
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-39
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-39
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-39
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-39
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-39
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-39
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-39
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-39
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-39
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-39
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-39
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-39
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-39
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-39
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-39
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-38
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-38
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-38
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-38
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-38
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-38
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-38
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-38
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-38
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-38
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-38
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-38
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-37
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-37
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-36
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-36
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-36
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-36
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-36
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-36
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-36
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-36
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-36
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-36
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-36
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-36
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-36
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-36
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-35
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-35
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-35
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-35
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-35
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-35
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-35
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-35
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-35
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-35
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-35
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-35
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-35
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-35
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-35
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-35
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-35
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-35
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-35
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-35
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-35
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-35
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-35
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-35
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-35
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-34
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-33
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-32
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-32
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-32
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-32
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-32
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-32
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-32
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-32
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-31
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-31
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-31
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-31
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-30
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-29
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-29
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-29
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-29
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		8e-29
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-28
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-28
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-27
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-26
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-26
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-24
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-24
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-24
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-24
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-24
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-24
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-24
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-24
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-24
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-24
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-24
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-24
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-24
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-24
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-24
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-24
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-24
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-24
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-24
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-24
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-24
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-19
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-17
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-17
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-17
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-17
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-17
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-17
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-17
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-17
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-17
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-17
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-17
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-17
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-17
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-17
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-17
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-17
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-17
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-17
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-17
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-17
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-17
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-17
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-17
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-17
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-17
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-17
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-17
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-16
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-16
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-16
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-16
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-16
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-16
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-16
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-16
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		9e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-15
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-15
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-15
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-15
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-15
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-15
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		4e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-13
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-12
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-12
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-12
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-12
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-11
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-11
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-11
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-11
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-11
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-11
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		5e-11
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		8e-11
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		8e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		5e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-10
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		9e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-09
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-09
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-08
3soa_A	444	Full-Length Human Camkii Length = 444		4e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-08
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		7e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		8e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-08
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-07
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-07

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  215 bits (547), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 104/198 (52%), Positives = 148/198 (74%), Gaps = 6/198 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP--PHLDFFQEIYVI 65
           G++VA+KK+PN F  + ++KR  RELK+L  FKHDN+++  DIL+P  P+ +F + +YV+
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF-KSVYVV 137
Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +L++SDLH+II S Q LT +H++ FLYQ+LRGLKY+HSA+++HRD+KP NLLVN NC L
Sbjct: 138 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 197
Query: 126 KICDFGLARVEEPDPNKA---MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFG+AR     P +    MT+ V T++YRAPE+++    Y+ A+D+WSVGCIF E+L
Sbjct: 198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257
Query: 183 GRRILFQAQSPVQQLGLI 200
            RR LF  ++ V QL LI
Sbjct: 258 ARRQLFPGKNYVHQLQLI 275

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  214 bits (546), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 104/198 (52%), Positives = 148/198 (74%), Gaps = 6/198 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP--PHLDFFQEIYVI 65
           G++VA+KK+PN F  + ++KR  RELK+L  FKHDN+++  DIL+P  P+ +F + +YV+
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF-KSVYVV 138
Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +L++SDLH+II S Q LT +H++ FLYQ+LRGLKY+HSA+++HRD+KP NLLVN NC L
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCEL 198
Query: 126 KICDFGLARVEEPDPNKA---MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFG+AR     P +    MT+ V T++YRAPE+++    Y+ A+D+WSVGCIF E+L
Sbjct: 199 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258
Query: 183 GRRILFQAQSPVQQLGLI 200
            RR LF  ++ V QL LI
Sbjct: 259 ARRQLFPGKNYVHQLQLI 276

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  204 bits (520), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 103/201 (51%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++ A HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  203 bits (516), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  203 bits (516), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  203 bits (516), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 50  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 109
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 110 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 168
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 169 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 224
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 225 ELLTGRTLFPGTDHIDQLKLI 245

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  203 bits (516), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 46  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 106 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 165 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 221 ELLTGRTLFPGTDHIDQLKLI 241

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  202 bits (515), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 96  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 155 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLI 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  202 bits (515), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 120 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 179 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 235 ELLTGRTLFPGTDHIDQLKLI 255

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  202 bits (515), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 59  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 119 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 178 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 234 ELLTGRTLFPGTDHIDQLKLI 254

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  202 bits (515), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  202 bits (515), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 52  AAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 112 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 171 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 227 ELLTGRTLFPGTDHIDQLKLI 247

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  202 bits (514), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 107 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 166 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLI 242

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 9e-53,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 102 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 161 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 217 ELLTGRTLFPGTDHIDQLKLI 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 111 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 170 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 226 ELLTGRTLFPGTDHIDQLKLI 246

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 102 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 161 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 217 ELLTGRTLFPGTDHIDQLKLI 237

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 106 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 165 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 221 ELLTGRTLFPGTDHIDQLKLI 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 112 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 171 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 227 ELLTGRTLFPGTDHIDQLKLI 247

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 52  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 111
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 112 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 170
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 171 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 227 ELLTGRTLFPGTDHIDQLKLI 247

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 105 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 164 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 220 ELLTGRTLFPGTDHIDQLKLI 240

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 39  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 98
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 99  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 157
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 158 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 213
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 214 ELLTGRTLFPGTDHIDQLKLI 234

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 105 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 164 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 220 ELLTGRTLFPGTDHIDQLKLI 240

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 106 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 165 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 221 ELLTGRTLFPGTDHIDQLKLI 241

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  202 bits (514), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 102 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 161 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 217 ELLTGRTLFPGTDHIDQLKLI 237

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 123 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 182 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 238 ELLTGRTLFPGTDHIDQLKLI 258

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 37  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 96
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 97  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 156 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 212 ELLTGRTLFPGTDHIDQLKLI 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 59  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 118
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 119 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 177
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 178 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 234 ELLTGRTLFPGTDHIDQLKLI 254

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 60  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 120 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 179 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 235 ELLTGRTLFPGTDHIDQLKLI 255

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 36  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 96  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 155 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLI 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  202 bits (513), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 37  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 96
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 97  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 155
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 156 NEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 212 ELLTGRTLFPGTDHIDQLKLI 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  201 bits (512), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 38  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 97
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 98  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 156
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 157 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 212
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 213 ELLTGRTLFPGTDHIDQLKLI 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  201 bits (512), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 107 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR    +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 166 NEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLI 242

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  201 bits (512), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 107 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR    +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 166 NEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLI 242

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  201 bits (511), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 102/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 107 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR    +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 166 NEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLI 242

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  201 bits (511), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI D+GLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  201 bits (511), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 60  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 119
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 120 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 178
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  M   V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 179 NEDCELKILDFGLAR----HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 235 ELLTGRTLFPGTDHIDQLKLI 255

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  201 bits (510), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 100/201 (49%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I+   + LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 96  NDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 155 NEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLI 231

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  201 bits (510), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  M   V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  200 bits (509), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  M   V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  200 bits (509), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 36  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 96  NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 154
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    M   V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 155 NEDCELKILDFGLARHTDDE----MAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 211 ELLTGRTLFPGTDHIDQLKLI 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  200 bits (509), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 63  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 122
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 123 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 181
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  M   V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 182 NEDCELKILDFGLAR----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 238 ELLTGRTLFPGTDHIDQLKLI 258

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  199 bits (507), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI  FGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  199 bits (506), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI D GLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDAGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  199 bits (506), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  199 bits (506), Expect = 9e-52,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DF LAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 46  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 105
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 106 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 164
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 165 NEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 221 ELLTGRTLFPGTDHIDQLKLI 241

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI D GLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI D GLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 42  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 101
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 102 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 161 NEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 217 ELLTGRTLFPGTDHIDQLKLI 237

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  199 bits (505), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 100/201 (49%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 40  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 99
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I+ S Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 100 NDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 158
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGL R      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 159 NEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 215 ELLTGRTLFPGTDHIDQLKLI 235

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  198 bits (504), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 52  RVAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 111 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 169
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 170 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 230 FPGKHYLDQLNHI 242

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  198 bits (504), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 51  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 110
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 111 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 169
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 170 NEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 226 ELLTGRTLFPGTDHIDQLKLI 246

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  198 bits (504), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 50  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 109 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 167
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 168 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 228 FPGKHYLDQLNHI 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  198 bits (504), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 58  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 116
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 117 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 175
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 176 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 235
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 236 FPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  198 bits (504), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 50  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 109 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 167
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 168 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 228 FPGKHYLDQLNHI 240

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  198 bits (504), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 48  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 107 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 165
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 166 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 226 FPGKHYLDQLNHI 238

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 52  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 111 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 169
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 170 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 230 FPGKHYLDQLNHI 242

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 48  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 107 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 165
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 166 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 226 FPGKHYLDQLNHI 238

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 105 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 164 NEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 220 ELLTGRTLFPGTDHIDQLKLI 240

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 55  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 114 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 172
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 173 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 233 FPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 56  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 115 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 173
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 174 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 233
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 234 FPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 47  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 106 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 164
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 165 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 224
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 225 FPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 101/201 (50%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 45  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 104
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 105 NDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 163
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +  LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 164 NEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           ELL  R LF     + QL LI
Sbjct: 220 ELLTGRTLFPGTDHIDQLKLI 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  198 bits (503), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 70  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 128
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 129 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 187
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 188 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 248 FPGKHYLDQLNHI 260

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  197 bits (501), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++   QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 113 ETDLYKLLKC-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  197 bits (501), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 144/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA++K+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIRKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  196 bits (499), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 99/201 (49%), Positives = 135/201 (67%), Gaps = 6/201 (2%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D + G ++A+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F ++
Sbjct: 72  DVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDV 131
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I V  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL VN +
Sbjct: 132 YLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 190
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C LKI DFGLAR      +  MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 191 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL 246
Query: 183 GRRILFQAQSPVQQLGLITDL 203
             R LF     + QL  I  L
Sbjct: 247 TGRTLFPGTDHINQLQQIMRL 267

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  196 bits (499), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    + + V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  196 bits (499), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 55  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 114 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 172
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    + + V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 173 FGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 233 FPGKHYLDQLNHI 245

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  195 bits (495), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 52  RVAIKKI-SPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 111 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICD 169
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 170 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 230 FPGKHYLDQLNHI 242

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  194 bits (493), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 141/193 (73%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+++L  F+H+NV+   DIL+   L+  +++Y++ +L+
Sbjct: 70  RVAIKKI-SPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLM 128
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ S Q L++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+ C LKICD
Sbjct: 129 ETDLYKLLKS-QQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICD 187
Query: 130 FGLARVEEP--DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLAR+ +P  D    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 188 FGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 248 FPGKHYLDQLNHI 260

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  194 bits (493), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIKKI-SPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  194 bits (493), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 50  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 109 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 167
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 168 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 228 FPGKHYLDQLNHI 240

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  194 bits (493), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 50  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 109 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 167
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 168 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 228 FPGKHYLDQLNHI 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  194 bits (492), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 90/193 (46%), Positives = 143/193 (74%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 54  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 113 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 171
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 232 FPGKHYLDQLNHI 244

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  193 bits (491), Expect = 5e-50,   Method: Compositional matrix adjust.
 Identities = 91/193 (47%), Positives = 142/193 (73%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++T L+
Sbjct: 70  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 128
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
            +DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKICD
Sbjct: 129 GADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICD 187
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 188 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 248 FPGKHYLDQLNHI 260

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  190 bits (482), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 89/193 (46%), Positives = 142/193 (73%), Gaps = 4/193 (2%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +++Y++ +L+
Sbjct: 50  RVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICD 129
           ++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+   LKI D
Sbjct: 109 ETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXD 167
Query: 130 FGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
           FGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI AE+L  R +
Sbjct: 168 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227
Query: 188 FQAQSPVQQLGLI 200
           F  +  + QL  I
Sbjct: 228 FPGKHYLDQLNHI 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  188 bits (478), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 93/201 (46%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D R  ++VA+KKL   FQSL+ ++R +REL++L   KH+NV+  LD+  P   ++ F E+
Sbjct: 41  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 100
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I V  Q L+ +H++  +YQ+LRGLKY+HSA I+HRD+KP N+ VN +
Sbjct: 101 YLVTTLMGADLNNI-VKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 159
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           C L+I DFGLAR      ++ MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 160 CELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215
Query: 183 GRRILFQAQSPVQQLGLITDL 203
             + LF     + QL  I ++
Sbjct: 216 QGKALFPGSDYIDQLKRIMEV 236

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  187 bits (475), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 95/209 (45%), Positives = 138/209 (66%), Gaps = 11/209 (5%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           + T    G  VA+KK+   F   + + R  RE+K+L  FKH+N+++  +I +P   + F 
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+Y+I EL+Q+DLH++I S Q L+ DHI+ F+YQ LR +K LH + ++HRD+KP NLL+N
Sbjct: 88  EVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 121 SNCILKICDFGLARV--------EEPDPNKA-MTQEVVTQYYRAPEILMGARHYSAAVDV 171
           SNC LK+CDFGLAR+         EP   ++ MT+ V T++YRAPE+++ +  YS A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           WS GCI AEL  RR +F  +    QL LI
Sbjct: 207 WSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  187 bits (475), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 92/201 (45%), Positives = 137/201 (68%), Gaps = 6/201 (2%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D R  ++VA+KKL   FQSL+ ++R +REL++L   KH+NV+  LD+  P   ++ F E+
Sbjct: 49  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 108
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I+ S Q L+ +H++  +YQ+LRGLKY+HSA I+HRD+KP N+ VN +
Sbjct: 109 YLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 167
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             L+I DFGLAR      ++ MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 168 SELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 183 GRRILFQAQSPVQQLGLITDL 203
             + LF     + QL  I ++
Sbjct: 224 QGKALFPGSDYIDQLKRIMEV 244

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  187 bits (474), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 95/209 (45%), Positives = 138/209 (66%), Gaps = 11/209 (5%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           + T    G  VA+KK+   F   + + R  RE+K+L  FKH+N+++  +I +P   + F 
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+Y+I EL+Q+DLH++I S Q L+ DHI+ F+YQ LR +K LH + ++HRD+KP NLL+N
Sbjct: 88  EVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 121 SNCILKICDFGLARV--------EEPDPNKA-MTQEVVTQYYRAPEILMGARHYSAAVDV 171
           SNC LK+CDFGLAR+         EP   ++ MT+ V T++YRAPE+++ +  YS A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           WS GCI AEL  RR +F  +    QL LI
Sbjct: 207 WSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  185 bits (469), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 92/201 (45%), Positives = 136/201 (67%), Gaps = 6/201 (2%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEI 62
           D R  ++VA+KKL   FQSL+ ++R +REL++L   KH+NV+  LD+  P   ++ F E+
Sbjct: 49  DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEV 108
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++T L+ +DL+ I V  Q L+ +H++  +YQ+LRGLKY+HSA I+HRD+KP N+ VN +
Sbjct: 109 YLVTTLMGADLNNI-VKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNED 167
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             L+I DFGLAR      ++ MT  V T++YRAPEI++   HY+  VD+WSVGCI AELL
Sbjct: 168 SELRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 183 GRRILFQAQSPVQQLGLITDL 203
             + LF     + QL  I ++
Sbjct: 224 QGKALFPGSDYIDQLKRIMEV 244

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  184 bits (467), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 94/209 (44%), Positives = 137/209 (65%), Gaps = 11/209 (5%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           + T    G  VA+KK+   F   + + R  RE+K+L  FKH+N+++  +I +P   + F 
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+Y+I EL+Q+DLH++I S Q L+ DHI+ F+YQ LR +K LH + ++HRD+KP NLL+N
Sbjct: 88  EVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146
Query: 121 SNCILKICDFGLARV--------EEPDPNKA-MTQEVVTQYYRAPEILMGARHYSAAVDV 171
           SNC LK+CDFGLAR+         EP   ++ M + V T++YRAPE+++ +  YS A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           WS GCI AEL  RR +F  +    QL LI
Sbjct: 207 WSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  181 bits (460), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 90/201 (44%), Positives = 132/201 (65%), Gaps = 7/201 (3%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           +  D R G +VA+KKL   FQS + +KR +REL +L   +H+NV+  LD+  P   L  F
Sbjct: 60  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + Y++   +Q+DL KI+      + + I+  +YQ+L+GLKY+HSA ++HRD+KPGNL V
Sbjct: 120 YDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 177
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  VVT++YRAPE+++   HY+  VD+WSVGCI A
Sbjct: 178 NEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L  + LF+ +  + QL  I
Sbjct: 234 EMLTGKTLFKGKDYLDQLTQI 254

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  181 bits (458), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 90/201 (44%), Positives = 132/201 (65%), Gaps = 7/201 (3%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFF 59
           +  D R G +VA+KKL   FQS + +KR +REL +L   +H+NV+  LD+  P   L  F
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + Y++   +Q+DL KI+      + + I+  +YQ+L+GLKY+HSA ++HRD+KPGNL V
Sbjct: 102 YDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  VVT++YRAPE+++   HY+  VD+WSVGCI A
Sbjct: 160 NEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L  + LF+ +  + QL  I
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQI 236

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  177 bits (449), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 87/201 (43%), Positives = 130/201 (64%), Gaps = 6/201 (2%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           +  D R G +VA+KKL   FQS + +KR +REL++L   +H+NV+  LD+  P   LD F
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + Y++   + +DL K++   + L  D I+  +YQ+L+GL+Y+H+A I+HRD+KPGNL V
Sbjct: 103 TDFYLVMPFMGTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR      +  M   VVT++YRAPE+++    Y+  VD+WSVGCI A
Sbjct: 162 NEDCELKILDFGLAR----QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E++  + LF+    + QL  I
Sbjct: 218 EMITGKTLFKGSDHLDQLKEI 238

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  174 bits (440), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 90/206 (43%), Positives = 127/206 (61%), Gaps = 26/206 (12%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D  + R VA+KK+  VF+ L+  KR+ RE+ +L    HD+V+  LDI+ P  ++ F E+Y
Sbjct: 74  DKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E+  SD  K+  +P +LT  HIK  LY +L G+KY+HSA ILHRD+KP N LVN +C
Sbjct: 134 VVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC 193
Query: 124 ILKICDFGLARV---------------EEPDPN-----------KAMTQEVVTQYYRAPE 157
            +K+CDFGLAR                 E D N           + +T  VVT++YRAPE
Sbjct: 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253
Query: 158 ILMGARHYSAAVDVWSVGCIFAELLG 183
           +++   +Y+ A+DVWS+GCIFAELL 
Sbjct: 254 LILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  164 bits (416), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 122/201 (60%), Gaps = 21/201 (10%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D    + VA+KK+  +F+ L+  KR+ RE+ +L   K D ++   D++ P  L  F E+Y
Sbjct: 47  DKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           ++ E+  SDL K+  +P  LT +HIK  LY +L G  ++H + I+HRD+KP N L+N +C
Sbjct: 107 IVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC 166
Query: 124 ILKICDFGLARV----------------EEPDPN-----KAMTQEVVTQYYRAPEILMGA 162
            +K+CDFGLAR                 EEP P+     K +T  VVT++YRAPE+++  
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ 226
Query: 163 RHYSAAVDVWSVGCIFAELLG 183
            +Y+ ++D+WS GCIFAELL 
Sbjct: 227 ENYTKSIDIWSTGCIFAELLN 247

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/198 (43%), Positives = 128/198 (64%), Gaps = 10/198 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVIT 66
           G  VA+KKL   FQ+   +KR +REL +L    H N++S L++  P   L+ FQ++Y++ 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 67  ELLQSDLHKIIVSPQHLTSDH--IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           EL+ ++L ++I    H+  DH  +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C 
Sbjct: 109 ELMDANLCQVI----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 164
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           LKI DFGLAR      N  MT  VVT+YYRAPE+++G   Y+A VD+WSVGCI  EL+  
Sbjct: 165 LKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGM-GYAANVDIWSVGCIMGELVKG 221
Query: 185 RILFQAQSPVQQLGLITD 202
            ++FQ    + Q   + +
Sbjct: 222 CVIFQGTDHIDQWNKVIE 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  162 bits (410), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/198 (43%), Positives = 126/198 (63%), Gaps = 10/198 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVIT 66
           G  VA+KKL   FQ+   +KR +REL +L    H N++S L++  P   L+ FQ++Y++ 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 67  ELLQSDLHKIIVSPQHLTSDH--IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           EL+ ++L ++I    H+  DH  +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C 
Sbjct: 107 ELMDANLCQVI----HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 162
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           LKI DFGLAR      N  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  EL+  
Sbjct: 163 LKILDFGLART--ASTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKG 219
Query: 185 RILFQAQSPVQQLGLITD 202
            ++FQ    + Q   + +
Sbjct: 220 SVIFQGTDHIDQWNKVIE 237

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  160 bits (404), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 78/204 (38%), Positives = 119/204 (58%), Gaps = 24/204 (11%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D    + VA+KK+  +F+ L+  KR+ RE+ +L   K D ++   D++ P  L  F E+Y
Sbjct: 49  DKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELY 108
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           ++ E+  SDL K+  +P  LT  H+K  LY +L G K++H + I+HRD+KP N L+N +C
Sbjct: 109 IVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDC 168
Query: 124 ILKICDFGLARVEEPDPN------------------------KAMTQEVVTQYYRAPEIL 159
            +KICDFGLAR    D +                        K +T  VVT++YRAPE++
Sbjct: 169 SVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 228
Query: 160 MGARHYSAAVDVWSVGCIFAELLG 183
           +   +Y+ ++D+WS GCIFAELL 
Sbjct: 229 LLQENYTNSIDIWSTGCIFAELLN 252

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  M  EVVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLART--AGTSFMMEPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVCHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 123/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT EVVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLARTA--GTSFMMTPEVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 111 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 169 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 225
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 226 FPGRDYIDQWNKVIE 240

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 108
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 109 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 166
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 167 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 223
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 224 FPGRDYIDQWNKVIE 238

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 111 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 169 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 225
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 226 FPGRDYIDQWNKVIE 240

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 104 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 162 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 218
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 219 FPGRDYIDQWNKVIE 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 103 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 160
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 161 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 217
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 218 FPGRDYIDQWNKVIE 232

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 148 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 206 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 262
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 263 FPGRDYIDQWNKVIE 277

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 148 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 205
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 206 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 262
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 263 FPGRDYIDQWNKVIE 277

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  158 bits (399), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 82/195 (42%), Positives = 125/195 (64%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 104 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 162 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 218
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 219 FPGRDYIDQWNKVIE 233

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  157 bits (398), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  M  EVVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLART--AGTSFMMEPEVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 103
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 104 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 162 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKIL 218
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 219 FPGRDYIDQWNKVIE 233

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  157 bits (396), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 55  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 114
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 115 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 172
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 173 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDLWSVGCIMGEMVCHKIL 229
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 230 FPGRDYIDQWNKVIE 244

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  156 bits (395), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 80/195 (41%), Positives = 122/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  156 bits (395), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 103 LMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 160
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 161 LDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 217
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 218 FPGRDYIDQWNKVIE 232

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  155 bits (393), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 80/195 (41%), Positives = 122/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  155 bits (392), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 80/195 (41%), Positives = 122/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 111 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 169 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 225
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 226 FPGTDHIDQWNKVIE 240

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  155 bits (392), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 80/195 (41%), Positives = 122/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  155 bits (392), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLXQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  154 bits (390), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 81/195 (41%), Positives = 124/195 (63%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++  +IL
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKIL 224
Query: 188 FQAQSPVQQLGLITD 202
           F  +  + Q   + +
Sbjct: 225 FPGRDYIDQWNKVIE 239

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  154 bits (389), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  154 bits (388), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  153 bits (387), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 77/204 (37%), Positives = 128/204 (62%), Gaps = 15/204 (7%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP---------HLDFF 59
           +RVA+KK+  V     S K   RE+K++    HDN++   +IL P           L   
Sbjct: 37  KRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTEL 94
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             +Y++ E +++DL  ++     L  +H ++F+YQ+LRGLKY+HSA +LHRD+KP NL +
Sbjct: 95  NSVYIVQEYMETDLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI 153
Query: 120 NS-NCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           N+ + +LKI DFGLAR+ +P  +    +++ +VT++YR+P +L+   +Y+ A+D+W+ GC
Sbjct: 154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGC 213
Query: 177 IFAELLGRRILFQAQSPVQQLGLI 200
           IFAE+L  + LF     ++Q+ LI
Sbjct: 214 IFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  153 bits (386), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  152 bits (385), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 79/195 (40%), Positives = 121/195 (62%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 52  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 111
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+C LKI
Sbjct: 112 LMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 169
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  M   VVT+YYRAPE+++G   Y   VD+WSVGCI  E++   +L
Sbjct: 170 LDFGLARTA--GTSFMMVPFVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVL 226
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 227 FPGTDHIDQWNKVIE 241

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  151 bits (381), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 78/195 (40%), Positives = 120/195 (61%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVG I  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  151 bits (381), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 78/195 (40%), Positives = 120/195 (61%), Gaps = 6/195 (3%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQP-PHLDFFQEIYVITE 67
           R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ FQ++Y++ E
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           L+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V S+  LKI
Sbjct: 110 LMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKI 167
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVG I  E++   +L
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGVIMGEMIKGGVL 224
Query: 188 FQAQSPVQQLGLITD 202
           F     + Q   + +
Sbjct: 225 FPGTDHIDQWNKVIE 239

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 120/193 (62%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 89
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 90  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 148
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 149 IKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 207
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 208 RALFPGDSEIDQL 220

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 120/193 (62%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 89
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 90  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 148
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 149 IKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 207
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 208 RALFPGDSEIDQL 220

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  148 bits (374), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 83
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 84  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 142
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 143 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 202 RALFPGDSEIDQL 214

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  148 bits (373), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/193 (43%), Positives = 120/193 (62%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 86
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 87  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 145
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 146 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 205 RALFPGDSEIDQL 217

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  146 bits (368), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 117/203 (57%), Gaps = 19/203 (9%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           DGR V      N+       KRV RE+++L  F H N+L   DI          ++Y++T
Sbjct: 60  DGRTV------NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 67  ELLQSDL------HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EL+++DL       +I++SPQH     I+ F+Y IL GL  LH A ++HRD+ PGN+L+ 
Sbjct: 114 ELMRTDLAQVIHDQRIVISPQH-----IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N  + ICDF LAR +  D NK  T  V  ++YRAPE++M  + ++  VD+WS GC+ AE
Sbjct: 169 DNNDITICDFNLAREDTADANK--THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           +  R+ LF+  +   QL  I ++
Sbjct: 227 MFNRKALFRGSTFYNQLNKIVEV 249

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  146 bits (368), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 117/203 (57%), Gaps = 19/203 (9%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           DGR V      N+       KRV RE+++L  F H N+L   DI          ++Y++T
Sbjct: 60  DGRTV------NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113
Query: 67  ELLQSDL------HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           EL+++DL       +I++SPQH     I+ F+Y IL GL  LH A ++HRD+ PGN+L+ 
Sbjct: 114 ELMRTDLAQVIHDQRIVISPQH-----IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N  + ICDF LAR +  D NK  T  V  ++YRAPE++M  + ++  VD+WS GC+ AE
Sbjct: 169 DNNDITICDFNLAREDTADANK--THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 181 LLGRRILFQAQSPVQQLGLITDL 203
           +  R+ LF+  +   QL  I ++
Sbjct: 227 MFNRKALFRGSTFYNQLNKIVEV 249

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  146 bits (368), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 117/193 (60%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   +     ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  146 bits (368), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 83
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 84  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGA 142
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 143 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 202 RALFPGDSEIDQL 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K  +    LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  FLHQDL-KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 83
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 84  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 142
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 143 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 202 RALFPGDSEIDQL 214

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 84
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 85  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGA 143
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 144 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 203 RALFPGDSEIDQL 215

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 84
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 85  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 143
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 144 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 203 RALFPGDSEIDQL 215

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 83
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 84  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 142
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 143 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 202 RALFPGDSEIDQL 214

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  146 bits (368), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  FLSMDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 84
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 85  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 143
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 144 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 203 RALFPGDSEIDQL 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VAL K+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 28  GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VAL K+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 83
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 84  FLSMDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGA 142
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 143 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 202 RALFPGDSEIDQL 214

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K + +   LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  FLHQDLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  145 bits (367), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 86
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 87  FLHQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 145
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 146 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 205 RALFPGDSEIDQL 217

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 119/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 81
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            +  DL K  +    LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 82  HVHQDL-KTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 141 IKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 200 RALFPGDSEIDQL 212

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  145 bits (365), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 117/193 (60%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   +     ++Y++ E
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLYLVFE 82
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K  +    LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 83  FLHQDL-KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGA 141
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 142 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 201 RALFPGDSEIDQL 213

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 82/193 (42%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K  +    LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  FLSMDL-KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFG-VPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  144 bits (364), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 117/193 (60%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   +     ++Y++ E
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KLYLVFE 84
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            L  DL K  +    LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 85  FLSMDL-KDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 143
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 144 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 203 RALFPGDSEIDQL 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  144 bits (362), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 77/191 (40%), Positives = 118/191 (61%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VALK++    +         RE+ +L    H N++S +D++          + ++ E
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFE 99
Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            ++ DL K++  +   L    IK++LYQ+LRG+ + H  RILHRD+KP NLL+NS+  LK
Sbjct: 100 FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           + DFGLAR     P ++ T EVVT +YRAP++LMG++ YS +VD+WS+GCIFAE++  + 
Sbjct: 160 LADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 187 LFQAQSPVQQL 197
           LF   +   QL
Sbjct: 219 LFPGVTDDDQL 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  144 bits (362), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 77/191 (40%), Positives = 118/191 (61%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VALK++    +         RE+ +L    H N++S +D++          + ++ E
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFE 99
Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            ++ DL K++  +   L    IK++LYQ+LRG+ + H  RILHRD+KP NLL+NS+  LK
Sbjct: 100 FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALK 159
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           + DFGLAR     P ++ T EVVT +YRAP++LMG++ YS +VD+WS+GCIFAE++  + 
Sbjct: 160 LADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
Query: 187 LFQAQSPVQQL 197
           LF   +   QL
Sbjct: 219 LFPGVTDDDQL 229

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  143 bits (360), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 81/193 (41%), Positives = 118/193 (61%), Gaps = 10/193 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALKK+    ++        RE+ +L    H N++  LD++   H +   ++Y++ E
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI---HTE--NKLYLVFE 85
Query: 68  LLQSDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            +  DL K +     LT      IK +L+Q+L+GL + HS R+LHRD+KP NLL+N+   
Sbjct: 86  HVDQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+ DFGLAR     P +    EVVT +YRAPEIL+G ++YS AVD+WS+GCIFAE++ R
Sbjct: 145 IKLADFGLARAFGV-PVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 185 RILFQAQSPVQQL 197
           R LF   S + QL
Sbjct: 204 RALFPGDSEIDQL 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/218 (34%), Positives = 130/218 (59%), Gaps = 25/218 (11%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEI 62
           D R G  VA+KK+ + FQ+   ++R FRE+ +L     H+N+++ L++L+    D  +++
Sbjct: 30  DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---DNDRDV 86
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++ + +++DLH +I +   L   H +  +YQ+++ +KYLHS  +LHRD+KP N+L+N+ 
Sbjct: 87  YLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE 145
Query: 123 CILKICDFGLAR---------------VEE-----PDPNKAMTQEVVTQYYRAPEILMGA 162
           C +K+ DFGL+R               + E      D    +T  V T++YRAPEIL+G+
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205
Query: 163 RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             Y+  +D+WS+GCI  E+L  + +F   S + QL  I
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  136 bits (342), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 74/176 (42%), Positives = 104/176 (59%), Gaps = 7/176 (3%)
Query: 26  SKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH-LT 84
           ++   RE+K+L    H N++  LD            I ++ + +++DL  II      LT
Sbjct: 56  NRTALREIKLLQELSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLT 110
Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM 144
             HIK ++   L+GL+YLH   ILHRD+KP NLL++ N +LK+ DFGLA+     PN+A 
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAY 169
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             +VVT++YRAPE+L GAR Y   VD+W+VGCI AELL R       S + QL  I
Sbjct: 170 XHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 83/205 (40%), Positives = 119/205 (58%), Gaps = 8/205 (3%)
Query: 4   DPRDGRRVALK--KLPNVFQSL-VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           DP  G  VALK  ++PN  + L +S+ R    L+ L  F+H NV+  +D+      D   
Sbjct: 25  DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 84
Query: 61  EIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           ++ ++ E +  DL   +    P  L ++ IK  + Q LRGL +LH+  I+HRD+KP N+L
Sbjct: 85  KVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V S   +K+ DFGLAR+       A+   VVT +YRAPE+L+ +  Y+  VD+WSVGCIF
Sbjct: 145 VTSGGTVKLADFGLARIY--SYQMALAPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AE+  R+ LF   S   QLG I DL
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  134 bits (338), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/191 (40%), Positives = 107/191 (56%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   ALKK+    +         RE+ +L   KH N++   D++        + + ++ E
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFE 80
Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            L  DL K++ V    L S   K FL Q+L G+ Y H  R+LHRD+KP NLL+N    LK
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGLAR     P +  T EVVT +YRAP++LMG++ YS  +D+WSVGCIFAE++    
Sbjct: 141 IADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 187 LFQAQSPVQQL 197
           LF   S   QL
Sbjct: 200 LFPGVSEADQL 210

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  134 bits (337), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 78/191 (40%), Positives = 107/191 (56%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   ALKK+    +         RE+ +L   KH N++   D++        + + ++ E
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFE 80
Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            L  DL K++ V    L S   K FL Q+L G+ Y H  R+LHRD+KP NLL+N    LK
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGLAR     P +  T EVVT +YRAP++LMG++ YS  +D+WSVGCIFAE++    
Sbjct: 141 IADFGLARAFGI-PVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAP 199
Query: 187 LFQAQSPVQQL 197
           LF   S   QL
Sbjct: 200 LFPGVSEADQL 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  134 bits (337), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/205 (40%), Positives = 119/205 (58%), Gaps = 8/205 (3%)
Query: 4   DPRDGRRVALK--KLPNVFQSL-VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           DP  G  VALK  ++PN  + L +S+ R    L+ L  F+H NV+  +D+      D   
Sbjct: 25  DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 84
Query: 61  EIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           ++ ++ E +  DL   +    P  L ++ IK  + Q LRGL +LH+  I+HRD+KP N+L
Sbjct: 85  KVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V S   +K+ DFGLAR+       A+   VVT +YRAPE+L+ +  Y+  VD+WSVGCIF
Sbjct: 145 VTSGGTVKLADFGLARIY--SYQMALDPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AE+  R+ LF   S   QLG I DL
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  134 bits (337), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 77/191 (40%), Positives = 107/191 (56%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   ALKK+    +         RE+ +L   KH N++   D++        + + ++ E
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFE 80
Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            L  DL K++ V    L S   K FL Q+L G+ Y H  R+LHRD+KP NLL+N    LK
Sbjct: 81  HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELK 140
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGLAR     P +  T E+VT +YRAP++LMG++ YS  +D+WSVGCIFAE++    
Sbjct: 141 IADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 187 LFQAQSPVQQL 197
           LF   S   QL
Sbjct: 200 LFPGVSEADQL 210

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  133 bits (335), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 83/205 (40%), Positives = 119/205 (58%), Gaps = 8/205 (3%)
Query: 4   DPRDGRRVALK--KLPNVFQSL-VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           DP  G  VALK  ++PN  + L +S+ R    L+ L  F+H NV+  +D+      D   
Sbjct: 25  DPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 84
Query: 61  EIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           ++ ++ E +  DL   +    P  L ++ IK  + Q LRGL +LH+  I+HRD+KP N+L
Sbjct: 85  KVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENIL 144
Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V S   +K+ DFGLAR+       A+   VVT +YRAPE+L+ +  Y+  VD+WSVGCIF
Sbjct: 145 VTSGGTVKLADFGLARIY--SYQMALFPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIF 201
Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AE+  R+ LF   S   QLG I DL
Sbjct: 202 AEMFRRKPLFCGNSEADQLGKIFDL 226

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  133 bits (335), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 83/208 (39%), Positives = 118/208 (56%), Gaps = 11/208 (5%)
Query: 4   DPRDGRRVALK--KLPNVFQSL----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
           DP  G  VALK  ++PN         +S+ R    L+ L  F+H NV+  +D+      D
Sbjct: 30  DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD 89
Query: 58  FFQEIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
              ++ ++ E +  DL   +    P  L ++ IK  + Q LRGL +LH+  I+HRD+KP 
Sbjct: 90  REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+LV S   +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVG
Sbjct: 150 NILVTSGGTVKLADFGLARIYS--YQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVG 206
Query: 176 CIFAELLGRRILFQAQSPVQQLGLITDL 203
           CIFAE+  R+ LF   S   QLG I DL
Sbjct: 207 CIFAEMFRRKPLFCGNSEADQLGKIFDL 234

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  133 bits (334), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 120/202 (59%), Gaps = 13/202 (6%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VALK++    +    S  + RE+ ++   KH+N++   D++   +     ++ ++ E
Sbjct: 30  GVYVALKEVKLDSEEGTPSTAI-REISLMKELKHENIVRLYDVIHTEN-----KLTLVFE 83
Query: 68  LLQSDLHKIIVS------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            + +DL K + S      P+ L  + +K F +Q+L+GL + H  +ILHRD+KP NLL+N 
Sbjct: 84  FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              LK+ DFGLAR     P    + EVVT +YRAP++LMG+R YS ++D+WS GCI AE+
Sbjct: 144 RGQLKLGDFGLARAFG-IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202
Query: 182 LGRRILFQAQSPVQQLGLITDL 203
           +  + LF   +  +QL LI D+
Sbjct: 203 ITGKPLFPGTNDEEQLKLIFDI 224

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  130 bits (328), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 120/201 (59%), Gaps = 8/201 (3%)
Query: 8   GRRVALKKL---PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           GR VALK++          +S+ R    L+ L  F+H NV+   D+      D   ++ +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 65  ITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           + E +  DL   +  V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+LV S+
Sbjct: 97  VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 156
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCIFAE+ 
Sbjct: 157 GQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMF 213
Query: 183 GRRILFQAQSPVQQLGLITDL 203
            R+ LF+  S V QLG I D+
Sbjct: 214 RRKPLFRGSSDVDQLGKILDV 234

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  130 bits (328), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 120/201 (59%), Gaps = 8/201 (3%)
Query: 8   GRRVALKKL---PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           GR VALK++          +S+ R    L+ L  F+H NV+   D+      D   ++ +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 65  ITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           + E +  DL   +  V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+LV S+
Sbjct: 97  VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 156
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCIFAE+ 
Sbjct: 157 GQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMF 213
Query: 183 GRRILFQAQSPVQQLGLITDL 203
            R+ LF+  S V QLG I D+
Sbjct: 214 RRKPLFRGSSDVDQLGKILDV 234

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  130 bits (328), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 80/201 (39%), Positives = 120/201 (59%), Gaps = 8/201 (3%)
Query: 8   GRRVALKKL---PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           GR VALK++          +S+ R    L+ L  F+H NV+   D+      D   ++ +
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96
Query: 65  ITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           + E +  DL   +  V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+LV S+
Sbjct: 97  VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 156
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCIFAE+ 
Sbjct: 157 GQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMF 213
Query: 183 GRRILFQAQSPVQQLGLITDL 203
            R+ LF+  S V QLG I D+
Sbjct: 214 RRKPLFRGSSDVDQLGKILDV 234

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  130 bits (327), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 69/173 (39%), Positives = 103/173 (59%), Gaps = 7/173 (4%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH- 87
             RE+ +L   KH N+++  DI+        + + ++ E L  DL + +    ++ + H 
Sbjct: 47  AIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHN 101
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
           +K+FL+Q+LRGL Y H  ++LHRD+KP NLL+N    LK+ DFGLAR +   P K    E
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNE 160
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           VVT +YR P+IL+G+  YS  +D+W VGCIF E+   R LF   +  +QL  I
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  127 bits (319), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 68/172 (39%), Positives = 104/172 (60%), Gaps = 11/172 (6%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+ +L   +H N++    ++   H      +++I E  ++DL K +     ++   IK 
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNH-----RLHLIFEYAENDLKKYMDKNPDVSMRVIKS 136
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVN-----SNCILKICDFGLARVEEPDPNKAMT 145
           FLYQ++ G+ + HS R LHRD+KP NLL++        +LKI DFGLAR     P +  T
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQFT 195
Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            E++T +YR PEIL+G+RHYS +VD+WS+ CI+AE+L +  LF   S + QL
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  125 bits (315), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 110/191 (57%), Gaps = 7/191 (3%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+KK        +  K   RE+K+L   +H+N+++ L++ +       +  Y++ E
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLVFE 104
Query: 68  LL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +  + L  + + P  L    ++ +L+QI+ G+ + HS  I+HRDIKP N+LV+ + ++K
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK 164
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           +CDFG AR     P +    EV T++YRAPE+L+G   Y  AVDVW++GC+  E+     
Sbjct: 165 LCDFGFARTLAA-PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
Query: 187 LFQAQSPVQQL 197
           LF   S + QL
Sbjct: 224 LFPGDSDIDQL 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  123 bits (308), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 9/206 (4%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ---PPHLDFFQEI 62
           + G++VALKK+    +         RE+K+L   KH+NV++ ++I +    P+      I
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASI 100
Query: 63  YVITELLQSDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ +  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K  N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 122 NCILKICDFGLARV----EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           + +LK+ DFGLAR     +   PN+   + VVT +YR PE+L+G R Y   +D+W  GCI
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
            AE+  R  + Q  +   QL LI+ L
Sbjct: 220 MAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  123 bits (308), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 9/206 (4%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ---PPHLDFFQEI 62
           + G++VALKK+    +         RE+K+L   KH+NV++ ++I +    P+      I
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 63  YVITELLQSDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ +  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K  N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 122 NCILKICDFGLARV----EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           + +LK+ DFGLAR     +   PN+   + VVT +YR PE+L+G R Y   +D+W  GCI
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
            AE+  R  + Q  +   QL LI+ L
Sbjct: 220 MAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  123 bits (308), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 9/206 (4%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ---PPHLDFFQEI 62
           + G++VALKK+    +         RE+K+L   KH+NV++ ++I +    P+      I
Sbjct: 40  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 99
Query: 63  YVITELLQSDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ +  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K  N+L+  
Sbjct: 100 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 159
Query: 122 NCILKICDFGLARV----EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           + +LK+ DFGLAR     +   PN+   + VVT +YR PE+L+G R Y   +D+W  GCI
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYXNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCI 218
Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
            AE+  R  + Q  +   QL LI+ L
Sbjct: 219 MAEMWTRSPIMQGNTEQHQLALISQL 244

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  123 bits (308), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 114/206 (55%), Gaps = 9/206 (4%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ---PPHLDFFQEI 62
           + G++VALKK+    +         RE+K+L   KH+NV++ ++I +    P+      I
Sbjct: 41  KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 100
Query: 63  YVITELLQSDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ +  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K  N+L+  
Sbjct: 101 YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR 160
Query: 122 NCILKICDFGLARV----EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           + +LK+ DFGLAR     +   PN+   + VVT +YR PE+L+G R Y   +D+W  GCI
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCI 219
Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
            AE+  R  + Q  +   QL LI+ L
Sbjct: 220 MAEMWTRSPIMQGNTEQHQLALISQL 245

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  122 bits (307), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/174 (41%), Positives = 102/174 (58%), Gaps = 8/174 (4%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ-HLTSDH 87
             RE+ +L   KH N++   D+L   H D  +++ ++ E    DL K   S    L  + 
Sbjct: 48  ALREICLLKELKHKNIVRLHDVL---HSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEI 102
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
           +K FL+Q+L+GL + HS  +LHRD+KP NLL+N N  LK+ DFGLAR     P +  + E
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFG-IPVRCYSAE 161
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLI 200
           VVT +YR P++L GA+ YS ++D+WS GCIFAEL    R LF       QL  I
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRI 215

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  120 bits (302), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 72/174 (41%), Positives = 102/174 (58%), Gaps = 8/174 (4%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ-HLTSDH 87
             RE+ +L   KH N++   D+L   H D  +++ ++ E    DL K   S    L  + 
Sbjct: 48  ALREICLLKELKHKNIVRLHDVL---HSD--KKLTLVFEFCDQDLKKYFDSCNGDLDPEI 102
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
           +K FL+Q+L+GL + HS  +LHRD+KP NLL+N N  LK+ +FGLAR     P +  + E
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAE 161
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLI 200
           VVT +YR P++L GA+ YS ++D+WS GCIFAEL    R LF       QL  I
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  119 bits (298), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 112/196 (57%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP---HLDFFQEIYV 64
           G+ VA+KK        V  K   RE++ML   KH N+++ L++ +     HL F  E   
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF--EYCD 85
Query: 65  ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            T L + D ++  V P+HL    +K   +Q L+ + + H    +HRD+KP N+L+  + +
Sbjct: 86  HTVLHELDRYQRGV-PEHL----VKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +K+CDFG AR+    P+     EV T++YR+PE+L+G   Y   VDVW++GC+FAELL  
Sbjct: 141 IKLCDFGFARLLT-GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199
Query: 185 RILFQAQSPVQQLGLI 200
             L+  +S V QL LI
Sbjct: 200 VPLWPGKSDVDQLYLI 215

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 121/234 (51%), Gaps = 46/234 (19%)
Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL---------- 51
           V D   G+R ALKK+      L   +   REL ++    H N++  +D            
Sbjct: 26  VFDIESGKRFALKKV------LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79
Query: 52  -QPPH--------------------LDFFQEIY--VITELLQSDLHKI----IVSPQHLT 84
            QPP                     ++  Q  Y  VI E +   LHK+    I S + + 
Sbjct: 80  PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIP 139
Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKA 143
            + I +++YQ+ R + ++HS  I HRDIKP NLLVNS +  LK+CDFG A+  +  P++ 
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAK--KLIPSEP 197
Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
               + +++YRAPE+++GA  Y+ ++D+WS+GC+F EL+  + LF  ++ + QL
Sbjct: 198 SVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQL 251

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  113 bits (282), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 69/176 (39%), Positives = 100/176 (56%), Gaps = 18/176 (10%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV---------SPQ 81
           RE+ +L   KH NV+S   +    H D  ++++++ +  + DL  II           P 
Sbjct: 67  REIALLRELKHPNVISLQKVFLS-HAD--RKVWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARV-E 136
            L    +K  LYQIL G+ YLH+  +LHRD+KP N+LV         +KI D G AR+  
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 137 EP-DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            P  P   +   VVT +YRAPE+L+GARHY+ A+D+W++GCIFAELL    +F  +
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/203 (36%), Positives = 111/203 (54%), Gaps = 22/203 (10%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY--VI 65
           G  VA+KK   V Q      R  + ++ L    H N++              ++IY  V+
Sbjct: 48  GMSVAIKK---VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVV 104
Query: 66  TELLQSDLHKII-------VSPQHLTSDHIKVFLYQILRGLKYLH--SARILHRDIKPGN 116
            E +   LH+         V+P  +    IKVFL+Q++R +  LH  S  + HRDIKP N
Sbjct: 105 MEYVPDTLHRCCRNYYRRQVAPPPIL---IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN 161
Query: 117 LLVN-SNCILKICDFGLARVEEP-DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           +LVN ++  LK+CDFG A+   P +PN A    + ++YYRAPE++ G +HY+ AVD+WSV
Sbjct: 162 VLVNEADGTLKLCDFGSAKKLSPSEPNVAY---ICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 175 GCIFAELLGRRILFQAQSPVQQL 197
           GCIFAE++    +F+  +   QL
Sbjct: 219 GCIFAEMMLGEPIFRGDNSAGQL 241

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 211 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 189 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 136 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 195
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 196 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 251

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 129 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 188
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 189 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 244

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 145 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 204
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 205 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 260

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 125 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 184
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 185 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 240

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 122 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 181
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 182 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 237

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 121 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 180
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 181 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 236

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  108 bits (270), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 118 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 177
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 178 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 233

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 155 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 214
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 215 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 270

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 153 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 212
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 213 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 268

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 211 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 80/119 (67%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN      + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPN---VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 130 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 189
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 190 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 245

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 196 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 255
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 256 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 311

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  108 bits (269), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 53/119 (44%), Positives = 81/119 (68%), Gaps = 5/119 (4%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLAR-VEEP 138
           Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NLL++ +  +LK+CDFG A+ +   
Sbjct: 117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +PN +    + ++YYRAPE++ GA  Y++++DVWS GC+ AELL  + +F   S V QL
Sbjct: 177 EPNVSY---ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  105 bits (263), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 65/178 (36%), Positives = 102/178 (57%), Gaps = 18/178 (10%)
Query: 31  RELKMLCFFKHDNVL-------SALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL 83
           REL+++   KH NV+       S  D      L+   E YV   + ++  H   +  Q +
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLK-QTM 138
Query: 84  TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARV---EEPD 139
               IK+++YQ+LR L Y+HS  I HRDIKP NLL++  + +LK+ DFG A++    EP+
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
                   + ++YYRAPE++ GA +Y+  +D+WS GC+ AEL+  + LF  +S + QL
Sbjct: 199 -----VSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL 251

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G++VALK +   V        R+ RE+  L   +H +++   D+++        EI ++ 
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVI 87
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E   ++L   IV    ++    + F  QI+  ++Y H  +I+HRD+KP NLL++ +  +K
Sbjct: 88  EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 147
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGL+ +   D N   T    +  Y APE++ G  +    VDVWS G I   +L RR+
Sbjct: 148 IADFGLSNIMT-DGNFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 205
Query: 187 LFQAQS 192
            F  +S
Sbjct: 206 PFDDES 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G++VALK +   V        R+ RE+  L   +H +++   D+++        EI ++ 
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVI 83
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E   ++L   IV    ++    + F  QI+  ++Y H  +I+HRD+KP NLL++ +  +K
Sbjct: 84  EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 143
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGL+ +   D N   T    +  Y APE++ G  +    VDVWS G I   +L RR+
Sbjct: 144 IADFGLSNIMT-DGNFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 201
Query: 187 LFQAQS 192
            F  +S
Sbjct: 202 PFDDES 207

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G++VALK +   V        R+ RE+  L   +H +++   D+++        EI ++ 
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVI 93
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E   ++L   IV    ++    + F  QI+  ++Y H  +I+HRD+KP NLL++ +  +K
Sbjct: 94  EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGL+ +   D N   T    +  Y APE++ G  +    VDVWS G I   +L RR+
Sbjct: 154 IADFGLSNIMT-DGNFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 211
Query: 187 LFQAQS 192
            F  +S
Sbjct: 212 PFDDES 217

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 96/186 (51%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G++VALK +   V        R+ RE+  L   +H +++   D+++        EI ++ 
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVI 92
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E   ++L   IV    ++    + F  QI+  ++Y H  +I+HRD+KP NLL++ +  +K
Sbjct: 93  EYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVK 152
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGL+ +   D N   T    +  Y APE++ G  +    VDVWS G I   +L RR+
Sbjct: 153 IADFGLSNIMT-DGNFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL 210
Query: 187 LFQAQS 192
            F  +S
Sbjct: 211 PFDDES 216

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 86/164 (52%), Gaps = 7/164 (4%)
Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           RV RE+  L   +H +++   D++  P      +I ++ E    +L   IV  + +T D 
Sbjct: 55  RVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDE 109
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE 147
            + F  QI+  ++Y H  +I+HRD+KP NLL++ N  +KI DFGL+ +   D N   T  
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKTS- 167
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
             +  Y APE++ G  +    VDVWS G +   +L  R+ F  +
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 88  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 142
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 201 LQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 89  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 143
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 144 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 201
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 202 LQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 88  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 142
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 143 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 200
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 201 LQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 87  NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 141
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 142 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 199
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 200 LQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 87/147 (59%), Gaps = 8/147 (5%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
           N++  LDI++  H    +   +I E + +   K++     LT   I+ ++Y++L+ L Y 
Sbjct: 108 NIVKLLDIVRDQHS---KTPSLIFEYVNNTDFKVLYPT--LTDYDIRYYIYELLKALDYC 162
Query: 103 HSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           HS  I+HRD+KP N++++     L++ D+GLA  E   P K     V ++Y++ PE+L+ 
Sbjct: 163 HSQGIMHRDVKPHNVMIDHELRKLRLIDWGLA--EFYHPGKEYNVRVASRYFKGPELLVD 220
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILF 188
            + Y  ++D+WS+GC+FA ++ R+  F
Sbjct: 221 LQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 97/177 (54%), Gaps = 10/177 (5%)
Query: 24  VSSKRVFRELKMLCFFKHD-NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH 82
           V   ++ RE+K+L   +   N+++  DI++ P         V   +  +D  ++    Q 
Sbjct: 73  VKKNKIKREIKILENLRGGPNIITLADIVKDPVSR--TPALVFEHVNNTDFKQLY---QT 127
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPN 141
           LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   P 
Sbjct: 128 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYHPG 185
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 89/185 (48%), Gaps = 13/185 (7%)
Query: 12  ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF-QEIYVITELLQ 70
           A+K +     S  S+ ++  E+ +L    H N++   D  +     +   E Y   EL  
Sbjct: 66  AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKI 127
             +H++             V + Q+L G+ YLH   I+HRD+KP NLL+ S   + ++KI
Sbjct: 126 EIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL 187
            DFGL+ V E    K M + + T YY APE+L   + Y    DVWS+G I   LL     
Sbjct: 181 VDFGLSAVFE--NQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPP 236
Query: 188 FQAQS 192
           F  Q+
Sbjct: 237 FGGQT 241

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +IL+          Y++ EL    +L   I+  +  +   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+  G+ Y+H   I+HRD+KP N+L+ S   +C +KI DFGL+   +   N  M
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + T YY APE+L G   Y    DVWS G I   LL
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILL 216

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VALK + N  +    +    R L+ L     DN ++ + +L+  +  F   I +  ELL 
Sbjct: 125 VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--NFTFRNHICMTFELLS 182
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILK 126
            +L+++I     Q  +   ++ F + IL+ L  LH  RI+H D+KP N+L+       +K
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           + DFG +  E    ++ +   + +++YRAPE+++GAR Y   +D+WS+GCI AELL    
Sbjct: 243 VIDFGSSCYE----HQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 187 LFQAQSPVQQLGLITDL 203
           L   +    QL  + +L
Sbjct: 298 LLPGEDEGDQLACMIEL 314

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VALK + N  +    +    R L+ L     DN ++ + +L+  +  F   I +  ELL 
Sbjct: 125 VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--NFTFRNHICMTFELLS 182
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILK 126
            +L+++I     Q  +   ++ F + IL+ L  LH  RI+H D+KP N+L+       +K
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           + DFG +  E    ++ +   + +++YRAPE+++GAR Y   +D+WS+GCI AELL    
Sbjct: 243 VIDFGSSCYE----HQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 187 LFQAQSPVQQLGLITDL 203
           L   +    QL  + +L
Sbjct: 298 LLPGEDEGDQLACMIEL 314

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 84.3 bits (207), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VALK + N  +    +    R L+ L     DN ++ + +L+  +  F   I +  ELL 
Sbjct: 125 VALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--NFTFRNHICMTFELLS 182
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILK 126
            +L+++I     Q  +   ++ F + IL+ L  LH  RI+H D+KP N+L+       +K
Sbjct: 183 MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           + DFG +  E    ++ +   + +++YRAPE+++GAR Y   +D+WS+GCI AELL    
Sbjct: 243 VIDFGSSCYE----HQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYP 297
Query: 187 LFQAQSPVQQLGLITDL 203
           L   +    QL  + +L
Sbjct: 298 LLPGEDEGDQLACMIEL 314

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           T+   G++VA+KK+    +     + +F E+ ++  + HDNV+     +   +L    E+
Sbjct: 65  TEKHTGKQVAVKKMD--LRKQQRRELLFNEVVIMRDYHHDNVVD----MYSSYL-VGDEL 117
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V+ E L+      IV+   +  + I      +LR L YLH+  ++HRDIK  ++L+ S+
Sbjct: 118 WVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 177
Query: 123 CILKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             +K+ DFG  A+V +  P +     V T Y+ APE++     Y   VD+WS+G +  E+
Sbjct: 178 GRIKLSDFGFCAQVSKEVPKRKXL--VGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIEM 234
Query: 182 LGRRILFQAQSPVQQLGLITD 202
           +     +  + P+Q +  I D
Sbjct: 235 IDGEPPYFNEPPLQAMRRIRD 255

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N+L++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 86/151 (56%), Gaps = 6/151 (3%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSD 86
           ++V++E+ +L    H NV+  +++L  P+ D    +Y++ EL+       + + + L+ D
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEVPTLKPLSED 137
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
             + +   +++G++YLH  +I+HRDIKP NLLV  +  +KI DFG++  E    +  ++ 
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGSDALLSN 196
Query: 147 EVVTQYYRAPEILMGARH--YSAAVDVWSVG 175
            V T  + APE L   R      A+DVW++G
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMG 227

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +IL+          Y++ EL    +L   I+  +  +   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+  G+ Y+H   I+HRD+KP N+L+ S   +C +KI DFGL+   +   N  M
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + T YY APE+L G   Y    DVWS G I   LL
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILL 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +IL+          Y++ EL    +L   I+  +  +   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+  G+ Y+H   I+HRD+KP N+L+ S   +C +KI DFGL+   +   N  M
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKM 180
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + T YY APE+L G   Y    DVWS G I   LL
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILL 216

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 181
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 83.6 bits (205), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 182
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 182
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 183 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 41/119 (34%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA  E   
Sbjct: 131 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA--EFYH 188
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 189 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 247

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 94/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K +     +  S +++FRE++++    H N++   ++++       + +Y+I E
Sbjct: 37  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIME 91
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H  RI+HRD+K  NLL++++  +K
Sbjct: 92  YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK 151
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 152 IADFGFSN--EFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 209
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 210 PFDGQN 215

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y++L+ L Y HS  I+HRD+KP N++++     L++ D+GLA  E   
Sbjct: 127 QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA--EFYH 184
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ RR   F  Q    QL
Sbjct: 185 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQL 243

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 40/119 (33%), Positives = 71/119 (59%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  +  L++ D+GLA      
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 183
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ R+   F       QL
Sbjct: 184 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 242

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 72/119 (60%), Gaps = 4/119 (3%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPD 139
           Q LT   I+ ++Y++L+ L Y HS  I+HRD+KP N++++     L++ D+GLA  E   
Sbjct: 132 QILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLA--EFYH 189
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI-LFQAQSPVQQL 197
           P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A ++ RR   F  Q    QL
Sbjct: 190 PAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQL 248

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/141 (39%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +  T    T  Y APE+L    H S  VD
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGH-SFEVD 199
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 200 VWSIGCIMYTLLVGKPPFETS 220

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/141 (39%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 145
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +  T    T  Y APE+L    H S  VD
Sbjct: 146 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGH-SFEVD 203
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 204 VWSIGCIMYTLLVGKPPFETS 224

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/141 (39%), Positives = 78/141 (55%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 141
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +  T    T  Y APE+L    H S  VD
Sbjct: 142 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGH-SFEVD 199
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 200 VWSIGCIMYTLLVGKPPFETS 220

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/152 (36%), Positives = 84/152 (55%), Gaps = 16/152 (10%)
Query: 51  LQPPHL----DFFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGL 99
           L  PH+     FF++   +YV+ E+ +     +LHK     + +T    + F+ Q ++G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK---RRKAVTEPEARYFMRQTIQGV 155
Query: 100 KYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL 159
           +YLH+ R++HRD+K GNL +N +  +KI DFGLA   E D  +  T    T  Y APE+L
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVL 214
Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
               H S  VD+WS+GCI   LL  +  F+  
Sbjct: 215 CKKGH-SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K +     +  S +++FRE++++    H N++   ++++       + +Y+I E
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIME 94
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H  RI+HRD+K  NLL++++  +K
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK 154
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +        Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 155 IADFGFSN--EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 213 PFDGQN 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L    H S  VD
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGH-SFEVD 223
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 224 VWSIGCIMYTLLVGKPPFETS 244

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 163
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L    H S  VD
Sbjct: 164 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGH-SFEVD 221
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 222 VWSIGCIMYTLLVGKPPFETS 242

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 80.9 bits (198), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 12/141 (8%)
Query: 58  FFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           FF++   ++V+ EL +     +LHK     + LT    + +L QI+ G +YLH  R++HR
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           D+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L    H S  VD
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSKKGH-SFEVD 197
Query: 171 VWSVGCIFAELLGRRILFQAQ 191
           VWS+GCI   LL  +  F+  
Sbjct: 198 VWSIGCIMYTLLVGKPPFETS 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 16/152 (10%)
Query: 51  LQPPHL----DFFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGL 99
           L  PH+     FF++   +YV+ E+ +     +LHK     + +T    + F+ Q ++G+
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK---RRKAVTEPEARYFMRQTIQGV 139
Query: 100 KYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL 159
           +YLH+ R++HRD+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L
Sbjct: 140 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-KDLCGTPNYIAPEVL 198
Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
               H S  VD+WS+GCI   LL  +  F+  
Sbjct: 199 CKKGH-SFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 92/186 (49%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLVME 94
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++ +  +K
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIK 154
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 155 IADFGFSN--EFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 213 PFDGQN 218

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 16/152 (10%)
Query: 51  LQPPHL----DFFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGL 99
           L  PH+     FF++   +YV+ E+ +     +LHK     + +T    + F+ Q ++G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK---RRKAVTEPEARYFMRQTIQGV 155
Query: 100 KYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL 159
           +YLH+ R++HRD+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK-KDLCGTPNYIAPEVL 214
Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
               H S  VD+WS+GCI   LL  +  F+  
Sbjct: 215 CKKGH-SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 16/152 (10%)
Query: 51  LQPPHL----DFFQE---IYVITELLQS----DLHKIIVSPQHLTSDHIKVFLYQILRGL 99
           L  PH+     FF++   +YV+ E+ +     +LHK     + +T    + F+ Q ++G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK---RRKAVTEPEARYFMRQTIQGV 155
Query: 100 KYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL 159
           +YLH+ R++HRD+K GNL +N +  +KI DFGLA   E D  +       T  Y APE+L
Sbjct: 156 QYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL-CGTPNYIAPEVL 214
Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
               H S  VD+WS+GCI   LL  +  F+  
Sbjct: 215 CKKGH-SFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +  +   +     E+Y   EL        I+S +  +   
Sbjct: 73  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVD 127
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+L G+ Y+H  +I+HRD+KP NLL+ S   +  ++I DFGL+   E   +K M
Sbjct: 128 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKM 185
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             ++ T YY APE+L G   Y    DVWS G I   LL
Sbjct: 186 KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 221

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +  +   +     E+Y   EL        I+S +  +   
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVD 150
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+L G+ Y+H  +I+HRD+KP NLL+ S   +  ++I DFGL+   E   +K M
Sbjct: 151 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKM 208
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             ++ T YY APE+L G   Y    DVWS G I   LL
Sbjct: 209 KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 244

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.1 bits (196), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +  +   +     E+Y   EL        I+S +  +   
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVD 151
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+L G+ Y+H  +I+HRD+KP NLL+ S   +  ++I DFGL+   E   +K M
Sbjct: 152 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKM 209
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             ++ T YY APE+L G   Y    DVWS G I   LL
Sbjct: 210 KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 245

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.1 bits (196), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIK 89
            E+ +L   KH N+++  DI +         +Y+I +L+   +L   IV     T     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLL---VNSNCILKICDFGLARVEEPDPNKAMTQ 146
             ++Q+L  +KYLH   I+HRD+KP NLL   ++ +  + I DFGL+++E  DP   ++ 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLST 177
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
              T  Y APE+L   + YS AVD WS+G I
Sbjct: 178 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIK 89
            E+ +L   KH N+++  DI +         +Y+I +L+   +L   IV     T     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLL---VNSNCILKICDFGLARVEEPDPNKAMTQ 146
             ++Q+L  +KYLH   I+HRD+KP NLL   ++ +  + I DFGL+++E  DP   ++ 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLST 177
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
              T  Y APE+L   + YS AVD WS+G I
Sbjct: 178 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIK 89
            E+ +L   KH N+++  DI +         +Y+I +L+   +L   IV     T     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLL---VNSNCILKICDFGLARVEEPDPNKAMTQ 146
             ++Q+L  +KYLH   I+HRD+KP NLL   ++ +  + I DFGL+++E  DP   ++ 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLST 177
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
              T  Y APE+L   + YS AVD WS+G I
Sbjct: 178 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 207

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 23/177 (12%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTS 85
           KR  RE+       H N++S +D+ +    D +   Y++ E ++   L + I S   L+ 
Sbjct: 56  KRFEREVHNSSQLSHQNIVSMIDVDEED--DCY---YLVMEYIEGPTLSEYIESHGPLSV 110
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
           D    F  QIL G+K+ H  RI+HRDIKP N+L++SN  LKI DFG+A        KA++
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA--------KALS 162
Query: 146 QEVVTQY--------YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV 194
           +  +TQ         Y +PE   G        D++S+G +  E+L     F  ++ V
Sbjct: 163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIK 89
            E+ +L   KH N+++  DI +         +Y+I +L+   +L   IV     T     
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDAS 119
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLL---VNSNCILKICDFGLARVEEPDPNKAMTQ 146
             ++Q+L  +KYLH   I+HRD+KP NLL   ++ +  + I DFGL+++E  DP   ++ 
Sbjct: 120 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLST 177
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
              T  Y APE+L   + YS AVD WS+G I
Sbjct: 178 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 207

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 82  NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 169 VDVWSVGCIF 178
           VD WS+G I 
Sbjct: 200 VDCWSLGVIL 209

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQ-PPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           + RE+++L    H N++   +  +   +     E+Y   EL        I+S +  +   
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVD 133
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+L G+ Y+H  +I+HRD+KP NLL+ S   +  ++I DFGL+   E   +K M
Sbjct: 134 AARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKM 191
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             ++ T YY APE+L G   Y    DVWS G I   LL
Sbjct: 192 KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 227

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 82  NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 169 VDVWSVGCIF 178
           VD WS+G I 
Sbjct: 200 VDCWSLGVIL 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 82  NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 141
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 142 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 199
Query: 169 VDVWSVGCIF 178
           VD WS+G I 
Sbjct: 200 VDCWSLGVIL 209

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 88  NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 147
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 148 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 205
Query: 169 VDVWSVGCIF 178
           VD WS+G I 
Sbjct: 206 VDCWSLGVIL 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 81  NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 140
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 141 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 198
Query: 169 VDVWSVGCIF 178
           VD WS+G I 
Sbjct: 199 VDCWSLGVIL 208

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 91/188 (48%), Gaps = 9/188 (4%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL-QPPHLDFFQEIYVITEL 68
           R+A+K++P   +    S+ +  E+ +    KH N++  L    +   +  F E      L
Sbjct: 49  RIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKI 127
             S L +    P       I  +  QIL GLKYLH  +I+HRDIK  N+L+N+ + +LKI
Sbjct: 107 --SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKI 164
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL-MGARHYSAAVDVWSVGCIFAEL-LGRR 185
            DFG ++      N        T  Y APEI+  G R Y  A D+WS+GC   E+  G+ 
Sbjct: 165 SDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
Query: 186 ILFQAQSP 193
             ++   P
Sbjct: 224 PFYELGEP 231

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 21/194 (10%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV----- 64
           R+A+K++P   +    S+ +  E+ +    KH N++  L        + F +I++     
Sbjct: 35  RIAIKEIPE--RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE---NGFIKIFMEQVPG 89
Query: 65  --ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS- 121
             ++ LL+S        P       I  +  QIL GLKYLH  +I+HRDIK  N+L+N+ 
Sbjct: 90  GSLSALLRSKW-----GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY 144
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL-MGARHYSAAVDVWSVGCIFAE 180
           + +LKI DFG ++      N        T  Y APEI+  G R Y  A D+WS+GC   E
Sbjct: 145 SGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 203
Query: 181 L-LGRRILFQAQSP 193
           +  G+   ++   P
Sbjct: 204 MATGKPPFYELGEP 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR+VA+K +    +     + +F E+ ++  ++H NV+     +   +L   +E++V+ E
Sbjct: 70  GRQVAVKMMD--LRKQQRRELLFNEVVIMRDYQHFNVVE----MYKSYL-VGEELWVLME 122
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            LQ      IVS   L  + I      +L+ L YLH+  ++HRDIK  ++L+  +  +K+
Sbjct: 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A++ +  P +     V T Y+ APE++     Y+  VD+WS+G +  E++    
Sbjct: 183 SDFGFCAQISKDVPKRKXL--VGTPYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 187 LFQAQSPVQQLGLITD 202
            + + SPVQ +  + D
Sbjct: 240 PYFSDSPVQAMKRLRD 255

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 76/129 (58%), Gaps = 10/129 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 207 NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 266
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 267 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 169 VDVWSVGCI 177
           VD WS+G I
Sbjct: 325 VDCWSLGVI 333

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/129 (35%), Positives = 76/129 (58%), Gaps = 10/129 (7%)
Query: 57  DFF--QEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +FF  ++ Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+K
Sbjct: 221 NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLK 280
Query: 114 PGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAA 168
           P N+L++S   +C++KI DFG +++        M     T  Y APE+L  +G   Y+ A
Sbjct: 281 PENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 338
Query: 169 VDVWSVGCI 177
           VD WS+G I
Sbjct: 339 VDCWSLGVI 347

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 4   DPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D R+   VA+KK+  +  QS    + + +E++ L   +H N +         H  +    
Sbjct: 75  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y +     SDL ++   P  L    I    +  L+GL YLHS  ++HRD+K GN+L++  
Sbjct: 135 YCLGS--ASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAAVDVWSVGCIFAE 180
            ++K+ DFG A +  P         V T Y+ APE++  M    Y   VDVWS+G    E
Sbjct: 191 GLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
Query: 181 LLGRR 185
           L  R+
Sbjct: 246 LAERK 250

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 12/185 (6%)
Query: 4   DPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D R+   VA+KK+  +  QS    + + +E++ L   +H N +         H  +    
Sbjct: 36  DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y +     SDL ++   P  L    I    +  L+GL YLHS  ++HRD+K GN+L++  
Sbjct: 96  YCLGS--ASDLLEVHKKP--LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL--MGARHYSAAVDVWSVGCIFAE 180
            ++K+ DFG A +  P         V T Y+ APE++  M    Y   VDVWS+G    E
Sbjct: 152 GLVKLGDFGSASIMAP-----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 206
Query: 181 LLGRR 185
           L  R+
Sbjct: 207 LAERK 211

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 90/170 (52%), Gaps = 13/170 (7%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKII---VSPQH 82
           +RV  E+K+ C  KH ++L   +  +  +      +Y++ E+  + ++++ +   V P  
Sbjct: 56  QRVQNEVKIHCQLKHPSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKP-- 108
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            + +  + F++QI+ G+ YLHS  ILHRD+   NLL+  N  +KI DFGLA  +   P++
Sbjct: 109 FSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHE 167
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
                  T  Y +PEI   + H     DVWS+GC+F  LL  R  F   +
Sbjct: 168 KHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDT 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 78.2 bits (191), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTS 85
           + ++ E+ +L    H N++   D+ +          Y++TE  +  +L + I++      
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDE 145
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV-NSNCIL--KICDFGLARVEEPDPNK 142
                 + QIL G+ YLH   I+HRDIKP N+L+ N N +L  KI DFGL+     D   
Sbjct: 146 CDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-- 203
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +   + T YY APE+L   + Y+   DVWS G I   LL
Sbjct: 204 KLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILL 241

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 16/197 (8%)
Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V    DGR+  +K++     S    +   RE+ +L   KH N++         + + F+E
Sbjct: 43  VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ--------YRESFEE 94
Query: 62  ---IYVITELLQS-DLHKIIVSPQHL--TSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
              +Y++ +  +  DL K I + + +    D I  +  QI   LK++H  +ILHRDIK  
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ +  +  +++ DFG+ARV       A    + T YY +PEI    + Y+   D+W++G
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICEN-KPYNNKSDIWALG 212
Query: 176 CIFAELLGRRILFQAQS 192
           C+  EL   +  F+A S
Sbjct: 213 CVLYELCTLKHAFEAGS 229

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 94/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA++ +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      + +   +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFSN--EFTFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+K +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFS--NEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+K +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 73/134 (54%), Gaps = 6/134 (4%)
Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV- 119
            +++ ELL   +L + I   +H +       + +++  + ++H   ++HRD+KP NLL  
Sbjct: 81  TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140
Query: 120 --NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
             N N  +KI DFG AR++ PD N+ +     T +Y APE L+    Y  + D+WS+G I
Sbjct: 141 DENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVI 198
Query: 178 FAELLGRRILFQAQ 191
              +L  ++ FQ+ 
Sbjct: 199 LYTMLSGQVPFQSH 212

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 15/175 (8%)
Query: 8   GRRVALKKLPN-VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G+  A+K +P    +   SS  +  E+ +L   KH+N+++  DI + P+      +Y++ 
Sbjct: 47  GKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHENIVALEDIYESPN-----HLYLVM 99
Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---N 122
           +L+   +L   IV     T       + Q+L  + YLH   I+HRD+KP NLL  S    
Sbjct: 100 QLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEE 159
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
             + I DFGL+++E       M+    T  Y APE+L   + YS AVD WS+G I
Sbjct: 160 SKIMISDFGLSKME--GKGDVMSTACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 211

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+K +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 86
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 87  YASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 146
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 147 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 204
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 205 PFDGQN 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 41  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 93
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  + 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  T  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211
Query: 184 RRILFQAQSPVQQLGLI 200
               +  ++P++ L LI
Sbjct: 212 GEPPYLNENPLRALYLI 228

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 92/186 (49%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+K +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +        Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 93/186 (50%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA++ +     +  S +++FRE++++    H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETE-----KTLYLVME 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +     +  Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFSN--EFTFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIK 89
            E+ +L   KH+N+++  DI +          Y++ +L+   +L   I+     T     
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPNKAMTQ 146
           + + Q+L  +KYLH   I+HRD+KP NLL      N  + I DFGL+++E+   N  M+ 
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMST 166
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
              T  Y APE+L   + YS AVD WS+G I
Sbjct: 167 ACGTPGYVAPEVL-AQKPYSKAVDCWSIGVI 196

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 41  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 93
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  + 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  ++ V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSK-RSEMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211
Query: 184 RRILFQAQSPVQQLGLIT 201
               +  ++P++ L LI 
Sbjct: 212 GEPPYLNENPLRALYLIA 229

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 9/177 (5%)
Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L     +SL    ++ RE++ L  F+H +++    ++  P      +I+++ 
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMVM 95
Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           E +   +L   I     L     +    QIL G+ Y H   ++HRD+KP N+L++++   
Sbjct: 96  EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL+ +      + +     +  Y APE++ G  +    VD+WS G I   LL
Sbjct: 156 KIADFGLSNMMS--DGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALL 210

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 167
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T+   T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 168 TTSHNSLTEPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 211

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 14/165 (8%)
Query: 18  NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKI 76
            V +  V  K V  E+ +L    H N++   +I + P      EI ++ EL+   +L   
Sbjct: 84  KVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDR 138
Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLA 133
           IV   + +       + QIL  + YLH   I+HRD+KP NLL  +   +  LKI DFGL+
Sbjct: 139 IVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
Query: 134 RVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCI 177
           ++ E   ++ + + V  T  Y APEIL G   Y   VD+WSVG I
Sbjct: 199 KIVE---HQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGII 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 42  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 94
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HR+IK  N+L+  + 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDG 154
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  T  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 155 SVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 212
Query: 184 RRILFQAQSPVQQLGLIT 201
               +  ++P++ L LI 
Sbjct: 213 GEPPYLNENPLRALYLIA 230

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 41  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 93
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  + 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  +  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 154 SVKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211
Query: 184 RRILFQAQSPVQQLGLIT 201
               +  ++P++ L LI 
Sbjct: 212 GEPPYLNENPLRALYLIA 229

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 13/158 (8%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYVITELLQSDLHKIIVSPQHLTSDH 87
           + RE+++L    H N+    +  +   +     E+Y   EL        I+S +  +   
Sbjct: 73  LLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDE-----IISRKRFSEVD 127
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAM 144
               + Q+L G+ Y H  +I+HRD+KP NLL+ S   +  ++I DFGL+   E   +K  
Sbjct: 128 AARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKX 185
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             ++ T YY APE+L G   Y    DVWS G I   LL
Sbjct: 186 KDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILL 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD     +L    E++
Sbjct: 42  DVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD----SYL-VGDELW 94
Query: 64  VITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  + 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 154
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            +K+ DFG      P+ +K  +  V T Y+ APE++   + Y   VD+WS+G +  E++ 
Sbjct: 155 SVKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 212
Query: 184 RRILFQAQSPVQQLGLIT 201
               +  ++P++ L LI 
Sbjct: 213 GEPPYLNENPLRALYLIA 230

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 156 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 213
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 257

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 162 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 219
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 220 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 263

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 117 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 174
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 175 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 218

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 118 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 175
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 176 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 219

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 110 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 167
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 168 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 211

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 116 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 173
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 174 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 217

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 169
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 170 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 111 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 168
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 169 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 212

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 169
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 170 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 56/105 (53%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 126 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 183
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 184 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 227

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 90/186 (48%), Gaps = 8/186 (4%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+K +     +  S +++FRE+++     H N++   ++++       + +Y++ E
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETE-----KTLYLVXE 93
Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+         +    QI+  ++Y H   I+HRD+K  NLL++++  +K
Sbjct: 94  YASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIK 153
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFG +   E      +        Y APE+  G ++    VDVWS+G I   L+   +
Sbjct: 154 IADFGFSN--EFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 211
Query: 187 LFQAQS 192
            F  Q+
Sbjct: 212 PFDGQN 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           VT P  G   A+K L      +    R   E  +L    H  V+         H  F  E
Sbjct: 50  VTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL-------HYAFQTE 102
Query: 62  --IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
             +Y+I + L+  DL   +      T + +K +L ++  GL +LHS  I++RD+KP N+L
Sbjct: 103 GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENIL 162
Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           ++    +K+ DFGL++ E  D  K       T  Y APE++    H S + D WS G + 
Sbjct: 163 LDEEGHIKLTDFGLSK-EAIDHEKKAYSFCGTVEYMAPEVVNRQGH-SHSADWWSYGVLM 220
Query: 179 AELLGRRILFQAQSPVQQLGLI 200
            E+L   + FQ +   + + LI
Sbjct: 221 FEMLTGSLPFQGKDRKETMTLI 242

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 91/179 (50%), Gaps = 28/179 (15%)
Query: 25  SSKRVF-RELKMLCFFKHDNVLSALDIL-QPPHLDFFQEIYVITELLQSD-LHKIIVS-- 79
            ++R F +E+K++   +H NVL  + +L +   L+F      ITE ++   L  II S  
Sbjct: 49  ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF------ITEYIKGGTLRGIIKSMD 102
Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR----- 134
            Q+  S  +  F   I  G+ YLHS  I+HRD+   N LV  N  + + DFGLAR     
Sbjct: 103 SQYPWSQRVS-FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 135 ---------VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
                    +++PD  K  T  V   Y+ APE++ G R Y   VDV+S G +  E++GR
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTV-VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L     +SL    ++ RE++ L  F+H +++    ++  P  DFF    V+ 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM---VME 91
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +   +L   I     +     +    QIL  + Y H   ++HRD+KP N+L++++   K
Sbjct: 92  YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL+ +      + +     +  Y APE++ G  +    VD+WS G I   LL
Sbjct: 152 IADFGLSNMMS--DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +  S + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSASKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK+    +     + +F E+ ++  ++H+NV+   +           E++V+ E
Sbjct: 54  GKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVME 106
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  +K+
Sbjct: 107 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 166
Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++    
Sbjct: 167 SDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 223
Query: 187 LFQAQSPVQQLGLITD 202
            +  + P++ + +I D
Sbjct: 224 PYFNEPPLKAMKMIRD 239

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK+    +     + +F E+ ++  ++H+NV+   +           E++V+ E
Sbjct: 45  GKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVME 97
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  +K+
Sbjct: 98  FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157
Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++    
Sbjct: 158 SDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 187 LFQAQSPVQQLGLITD 202
            +  + P++ + +I D
Sbjct: 215 PYFNEPPLKAMKMIRD 230

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 7/176 (3%)
Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L     +SL    ++ RE++ L  F+H +++    ++  P  DFF    V+ 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM---VME 91
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +   +L   I     +     +    QIL  + Y H   ++HRD+KP N+L++++   K
Sbjct: 92  YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAK 151
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL+ +      + +     +  Y APE++ G  +    VD+WS G I   LL
Sbjct: 152 IADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK+    +     + +F E+ ++  ++H+NV+   +           E++V+ E
Sbjct: 56  GKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWVVME 108
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  +K+
Sbjct: 109 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 168
Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++    
Sbjct: 169 SDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 225
Query: 187 LFQAQSPVQQLGLITD 202
            +  + P++ + +I D
Sbjct: 226 PYFNEPPLKAMKMIRD 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK+    +     + +F E+ ++  ++H+NV+   +           E++V+ E
Sbjct: 49  GKLVAVKKMD--LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVME 101
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
            L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  +K+
Sbjct: 102 FLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKL 161
Query: 128 CDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
            DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++    
Sbjct: 162 SDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 218
Query: 187 LFQAQSPVQQLGLITD 202
            +  + P++ + +I D
Sbjct: 219 PYFNEPPLKAMKMIRD 234

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 8   GRRVALKKLPNVFQSLVSSKR---VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           G+ VA+KK+      L   +R   +F E+ ++  ++H+NV+   +           E++V
Sbjct: 99  GKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYN-----SYLVGDELWV 148
Query: 65  ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           + E L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  
Sbjct: 149 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 208
Query: 125 LKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +K+ DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++ 
Sbjct: 209 VKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVD 265
Query: 184 RRILFQAQSPVQQLGLITD 202
               +  + P++ + +I D
Sbjct: 266 GEPPYFNEPPLKAMKMIRD 284

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-------------NVLSALDILQP 53
           D R  A+KK+ +  + L +   +  E+ +L    H              N +  +  ++ 
Sbjct: 30  DSRYYAIKKIRHTEEKLST---ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86
Query: 54  PHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
               F Q  Y     L   +H   ++ Q    D       QIL  L Y+HS  I+HRD+K
Sbjct: 87  KSTLFIQMEYCENRTLYDLIHSENLNQQR---DEYWRLFRQILEALSYIHSQGIIHRDLK 143
Query: 114 PGNLLVNSNCILKICDFGLAR-------------VEEPDPNKAMTQEVVTQYYRAPEILM 160
           P N+ ++ +  +KI DFGLA+                P  +  +T  + T  Y A E+L 
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 161 GARHYSAAVDVWSVGCIFAELL 182
           G  HY+  +D++S+G IF E++
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 100/199 (50%), Gaps = 17/199 (8%)
Query: 8   GRRVALKKLPNVFQSLVSSKR---VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYV 64
           G+ VA+KK+      L   +R   +F E+ ++  ++H+NV+   +           E++V
Sbjct: 176 GKLVAVKKM-----DLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV 225
Query: 65  ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           + E L+      IV+   +  + I      +L+ L  LH+  ++HRDIK  ++L+  +  
Sbjct: 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR 285
Query: 125 LKICDFGL-ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +K+ DFG  A+V +  P +     V T Y+ APE L+    Y   VD+WS+G +  E++ 
Sbjct: 286 VKLSDFGFCAQVSKEVPRRKXL--VGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVD 342
Query: 184 RRILFQAQSPVQQLGLITD 202
               +  + P++ + +I D
Sbjct: 343 GEPPYFNEPPLKAMKMIRD 361

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 9/162 (5%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSD 86
           + VF+EL+++   +H  +++     Q    D F    V+  LL  DL   +    H   +
Sbjct: 60  RNVFKELQIMQGLEHPFLVNLWYSFQDEE-DMFM---VVDLLLGGDLRYHLQQNVHFKEE 115
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
            +K+F+ +++  L YL + RI+HRD+KP N+L++ +  + I DF +A +   +    +T 
Sbjct: 116 TVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITT 173
Query: 147 EVVTQYYRAPEILMGAR--HYSAAVDVWSVGCIFAELL-GRR 185
              T+ Y APE+    +   YS AVD WS+G    ELL GRR
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 32/202 (15%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-------------NVLSALDILQP 53
           D R  A+KK+ +  + L +   +  E+ +L    H              N +  +  ++ 
Sbjct: 30  DSRYYAIKKIRHTEEKLST---ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86
Query: 54  PHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
               F Q  Y     L   +H   ++ Q    D       QIL  L Y+HS  I+HRD+K
Sbjct: 87  KSTLFIQMEYCENGTLYDLIHSENLNQQR---DEYWRLFRQILEALSYIHSQGIIHRDLK 143
Query: 114 PGNLLVNSNCILKICDFGLAR-------------VEEPDPNKAMTQEVVTQYYRAPEILM 160
           P N+ ++ +  +KI DFGLA+                P  +  +T  + T  Y A E+L 
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 161 GARHYSAAVDVWSVGCIFAELL 182
           G  HY+  +D++S+G IF E++
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--QEIYVIT 66
            +VA+K++ N+ +   S   + +E++ +    H N++S        +  F    E++++ 
Sbjct: 36  EKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSY-------YTSFVVKDELWLVM 87
Query: 67  ELLQSD-----LHKIIVSPQH----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           +LL        +  I+   +H    L    I   L ++L GL+YLH    +HRD+K GN+
Sbjct: 88  KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 147
Query: 118 LVNSNCILKICDFG----LARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           L+  +  ++I DFG    LA   +   NK     V T  + APE++   R Y    D+WS
Sbjct: 148 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 207
Query: 174 VGCIFAELLGRRILFQAQSPVQQLGL 199
            G    EL      +    P++ L L
Sbjct: 208 FGITAIELATGAAPYHKYPPMKVLML 233

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--QEIYVIT 66
            +VA+K++ N+ +   S   + +E++ +    H N++S        +  F    E++++ 
Sbjct: 41  EKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSY-------YTSFVVKDELWLVM 92
Query: 67  ELLQSD-----LHKIIVSPQH----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           +LL        +  I+   +H    L    I   L ++L GL+YLH    +HRD+K GN+
Sbjct: 93  KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNI 152
Query: 118 LVNSNCILKICDFG----LARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           L+  +  ++I DFG    LA   +   NK     V T  + APE++   R Y    D+WS
Sbjct: 153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 212
Query: 174 VGCIFAELLGRRILFQAQSPVQQLGL 199
            G    EL      +    P++ L L
Sbjct: 213 FGITAIELATGAAPYHKYPPMKVLML 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 42  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 96
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 97  FLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 12/164 (7%)
Query: 32  ELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSPQ-HLTSDHIK 89
           E  ++  F H N++    ++       ++ + +ITE +++  L K +       +   + 
Sbjct: 96  EAGIMGQFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKDGEFSVLQLV 150
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE-- 147
             L  I  G+KYL +   +HRD+   N+LVNSN + K+ DFGL+RV E DP    T    
Sbjct: 151 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
            +   + APE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 211 KIPIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/133 (36%), Positives = 71/133 (53%), Gaps = 11/133 (8%)
Query: 57  DFFQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           +FF++    Y++ E+ +  +L   I+  Q  +     V + Q+L G  YLH   I+HRD+
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDL 130
Query: 113 KPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAV 169
           KP NLL+ S   + ++KI DFGL+   E      M + + T YY APE+L   + Y    
Sbjct: 131 KPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLR--KKYDEKC 186
Query: 170 DVWSVGCIFAELL 182
           DVWS G I   LL
Sbjct: 187 DVWSCGVILYILL 199

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 74/143 (51%), Gaps = 11/143 (7%)
Query: 57  DFFQE---IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           +FF++    Y++ E+ +  +L   I+  Q  +     V + Q+L G  YLH   I+HRD+
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDL 147
Query: 113 KPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAV 169
           KP NLL+ S   + ++KI DFGL+   E      M + + T YY APE+L   + Y    
Sbjct: 148 KPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLR--KKYDEKC 203
Query: 170 DVWSVGCIFAELLGRRILFQAQS 192
           DVWS G I   LL     F  Q+
Sbjct: 204 DVWSCGVILYILLCGYPPFGGQT 226

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 7/151 (4%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII--VSPQHLTSD 86
           V +E+++L   +H NV+  +D+L   + +  Q++Y++ E     + +++  V  +     
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC 109
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP-DPNKAMT 145
               +  Q++ GL+YLHS  I+H+DIKPGNLL+ +   LKI   G+A    P   +    
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 146 QEVVTQYYRAPEILMGARHYSA-AVDVWSVG 175
               +  ++ PEI  G   +S   VD+WS G
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAG 200

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 44  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 98
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 99  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 158
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 216

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T          I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A+  E
Sbjct: 156 QAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--E 213
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + ++T    T YY APE+L G   Y  + D WS+G I   LL
Sbjct: 214 TTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDXWSLGVIXYILL 257

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 70  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 124
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 46  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 100
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 101 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 160
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 218

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 37  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 91
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 92  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 151
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 45  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 99
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 100 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 159
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 42  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 96
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 97  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 38  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 92
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 93  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 152
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 210

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 57  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 111
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 39  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 93
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGLARV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G  VA+KKL +   S     R F RE+++L   +HDN++    +         + + +I 
Sbjct: 43  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIM 96
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           E L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   
Sbjct: 97  EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 156
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 57  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 111
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 112 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 171
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 229

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 196 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 12/180 (6%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G  VA+KKL +   S     R F RE+++L   +HDN++    +         + + +I 
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIM 92
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           E L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   
Sbjct: 93  EYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR 152
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSAXKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 42  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 96
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 97  YLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 156
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 82/154 (53%), Gaps = 14/154 (9%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLY 93
           +L + +H N+++  D+      D  + +YV+TEL++  +L   I+  +  +       L+
Sbjct: 69  LLRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF 123
Query: 94  QILRGLKYLHSARILHRDIKPGNLLV-----NSNCILKICDFGLARVEEPDPNKAMTQEV 148
            I + ++YLH+  ++HRD+KP N+L      N   I +ICDFG A+    +    MT   
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAENGLLMT-PC 181
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T  + APE+L   + Y AA D+WS+G +   +L
Sbjct: 182 YTANFVAPEVLE-RQGYDAACDIWSLGVLLYTML 214

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 192 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 113 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 173 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 214

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 193 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 193 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 136 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 196 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 237

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 138 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 198 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 239

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 193 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 110 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 170 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 211

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 171 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 212

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 3/141 (2%)
Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++Y+I + L+  DL   +      T + +K +L ++   L +LHS  I++RD+KP N+L+
Sbjct: 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           +    +K+ DFGL++ E  D  K       T  Y APE++   R ++ + D WS G +  
Sbjct: 160 DEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMF 217
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L   + FQ +   + + +I
Sbjct: 218 EMLTGTLPFQGKDRKETMTMI 238

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 112 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 172 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 213

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 133 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 193 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 234

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 117 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 177 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 218

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 195 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 236

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 65/121 (53%), Gaps = 2/121 (1%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L   +I   L +IL+GL YLHS R +HRDIK  N+L++
Sbjct: 91  KLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS 150
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               +K+ DFG+A  +  D        V T ++ APE++  +  Y    D+WS+G    E
Sbjct: 151 EQGDVKLADFGVAG-QLTDTQIKRNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIE 208
Query: 181 L 181
           L
Sbjct: 209 L 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 3/141 (2%)
Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++Y+I + L+  DL   +      T + +K +L ++   L +LHS  I++RD+KP N+L+
Sbjct: 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           +    +K+ DFGL++ E  D  K       T  Y APE++   R ++ + D WS G +  
Sbjct: 160 DEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMF 217
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L   + FQ +   + + +I
Sbjct: 218 EMLTGTLPFQGKDRKETMTMI 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 132 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 192 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 233

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H N+++  DI +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLA-RVEE 137
           LT D    FL QIL G+ YLHS RI H D+KP N+++    +    +K+ DFG+A ++E 
Sbjct: 112 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 171
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            +  K +     T  + APEI+          D+WS+G I   LL     F  ++  + L
Sbjct: 172 GNEFKNI---FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 227
Query: 198 GLIT 201
             I+
Sbjct: 228 TNIS 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 61/103 (59%), Gaps = 2/103 (1%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     
Sbjct: 140 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
           V T  Y +PE+L   +    + D+W++GCI  +L+     F+A
Sbjct: 200 VGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRA 241

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLY 93
           +L + +H N+++  D+      D  + +Y++TEL++  +L   I+  +  +       L+
Sbjct: 74  LLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 94  QILRGLKYLHSARILHRDIKPGNLLV-----NSNCILKICDFGLARVEEPDPNKAMTQEV 148
            I + ++YLHS  ++HRD+KP N+L      N  C L+ICDFG A+    +    MT   
Sbjct: 129 TIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMT-PC 186
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
            T  + APE+L   + Y    D+WS+G +   +L     F A  P
Sbjct: 187 YTANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGP 229

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 2/121 (1%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L    I   L +IL+GL YLHS + +HRDIK  N+L++
Sbjct: 99  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 158
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFG+A  +  D        V T ++ APE++  +  Y +  D+WS+G    E
Sbjct: 159 EHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIE 216
Query: 181 L 181
           L
Sbjct: 217 L 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 76/141 (53%), Gaps = 3/141 (2%)
Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++Y+I + L+  DL   +      T + +K +L ++   L +LHS  I++RD+KP N+L+
Sbjct: 101 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           +    +K+ DFGL++ E  D  K       T  Y APE++   R ++ + D WS G +  
Sbjct: 161 DEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMF 218
Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L   + FQ +   + + +I
Sbjct: 219 EMLTGTLPFQGKDRKETMTMI 239

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 84/165 (50%), Gaps = 15/165 (9%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLY 93
           +L + +H N+++  D+      D  + +Y++TEL++  +L   I+  +  +       L+
Sbjct: 74  LLRYGQHPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLH 128
Query: 94  QILRGLKYLHSARILHRDIKPGNLLV-----NSNCILKICDFGLARVEEPDPNKAMTQEV 148
            I + ++YLHS  ++HRD+KP N+L      N  C L+ICDFG A+    +    MT   
Sbjct: 129 TIGKTVEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMT-PC 186
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP 193
            T  + APE+L   + Y    D+WS+G +   +L     F A  P
Sbjct: 187 YTANFVAPEVLK-RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGP 229

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+LVNSN + K+ DFG++RV E DP  A T     
Sbjct: 136 MLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 195
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +   + APE +   R +++A DVWS G +  E++
Sbjct: 196 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H N+++  DI +        ++ +I EL+   +L   +   + 
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKES 125
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLA-RVEE 137
           LT D    FL QIL G+ YLHS RI H D+KP N+++    +    +K+ DFG+A ++E 
Sbjct: 126 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 185
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            +  K +     T  + APEI+          D+WS+G I   LL     F  ++  + L
Sbjct: 186 GNEFKNI---FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 241
Query: 198 GLIT 201
             I+
Sbjct: 242 TNIS 245

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 2/121 (1%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L    I   L +IL+GL YLHS + +HRDIK  N+L++
Sbjct: 79  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 138
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFG+A  +  D        V T ++ APE++  +  Y +  D+WS+G    E
Sbjct: 139 EHGEVKLADFGVAG-QLTDTQIKRNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIE 196
Query: 181 L 181
           L
Sbjct: 197 L 197

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 2/121 (1%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L    I   L +IL+GL YLHS + +HRDIK  N+L++
Sbjct: 79  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 138
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFG+A  +  D        V T ++ APE++  +  Y +  D+WS+G    E
Sbjct: 139 EHGEVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIE 196
Query: 181 L 181
           L
Sbjct: 197 L 197

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 66/121 (54%), Gaps = 2/121 (1%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++++I E L       ++ P  L    I   L +IL+GL YLHS + +HRDIK  N+L++
Sbjct: 94  KLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +K+ DFG+A  +  D        V T ++ APE++  +  Y +  D+WS+G    E
Sbjct: 154 EHGEVKLADFGVAG-QLTDTQIKRNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIE 211
Query: 181 L 181
           L
Sbjct: 212 L 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H N+++  DI +        ++ +I EL+   +L   +   + 
Sbjct: 50  VSREEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKES 104
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLA-RVEE 137
           LT D    FL QIL G+ YLHS RI H D+KP N+++    +    +K+ DFG+A ++E 
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            +  K +     T  + APEI+          D+WS+G I   LL     F  ++  + L
Sbjct: 165 GNEFKNI---FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL 220
Query: 198 GLIT 201
             I+
Sbjct: 221 TNIS 224

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+LVNSN + K+ DFG++RV E DP  A T     
Sbjct: 121 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 180
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +   + APE +   R +++A DVWS G +  E++
Sbjct: 181 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K + NV +   +++   + L+ L     ++    + +L+    +    I ++ E
Sbjct: 40  GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE--WFEHHGHICIVFE 97
Query: 68  LLQSDLHKIIVSPQHLTS--DHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNS--- 121
           LL    +  I     L    DHI+   YQI + + +LHS ++ H D+KP N+L V S   
Sbjct: 98  LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157
Query: 122 ---------------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
                          N  +K+ DFG A  +    ++  +  V T++YRAPE+++ A  +S
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYD----DEHHSTLVSTRHYRAPEVIL-ALGWS 212
Query: 167 AAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
              DVWS+GCI  E      +F      + L ++
Sbjct: 213 QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/127 (36%), Positives = 71/127 (55%), Gaps = 7/127 (5%)
Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           + +  ELL+   L +++     L  D    +L Q L GL+YLHS RILH D+K  N+L++
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 121 SNCI-LKICDFGLARVEEPD--PNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVG 175
           S+     +CDFG A   +PD      +T + +  T+ + APE+++G R   A VDVWS  
Sbjct: 220 SDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSC 278
Query: 176 CIFAELL 182
           C+   +L
Sbjct: 279 CMMLHML 285

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+LVNSN + K+ DFG++RV E DP  A T     
Sbjct: 115 MLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGK 174
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +   + APE +   R +++A DVWS G +  E++
Sbjct: 175 IPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 183 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVI 65
           DG+ +  K+L     +    + +  E+ +L   KH N++   D I+   +      +Y++
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN----TTLYIV 85
Query: 66  TELLQS-DLHKIIVSP----QHLTSDHIKVFLYQILRGLKYLH-----SARILHRDIKPG 115
            E  +  DL  +I       Q+L  + +   + Q+   LK  H        +LHRD+KP 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ ++    +K+ DFGLAR+   D + A T  V T YY +PE  M    Y+   D+WS+G
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPE-QMNRMSYNEKSDIWSLG 203
Query: 176 CIFAELLGRRILFQAQSPVQQLGLITD 202
           C+  EL      F A S  +  G I +
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 150 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 209
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 210 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 251

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 140 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 199
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 200 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 123 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 182
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 183 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/127 (36%), Positives = 71/127 (55%), Gaps = 7/127 (5%)
Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           + +  ELL+   L +++     L  D    +L Q L GL+YLHS RILH D+K  N+L++
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 121 SNCI-LKICDFGLARVEEPD--PNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVG 175
           S+     +CDFG A   +PD      +T + +  T+ + APE+++G R   A VDVWS  
Sbjct: 201 SDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG-RSCDAKVDVWSSC 259
Query: 176 CIFAELL 182
           C+   +L
Sbjct: 260 CMMLHML 266

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL RV E DP  A T     
Sbjct: 152 MLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + +PE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 212 IPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/187 (28%), Positives = 92/187 (49%), Gaps = 25/187 (13%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRV--FRELKMLCFFKHDNVLSALDILQPPHLDFFQ--EI 62
           DG  VALKK+  +F  + +  R    +E+ +L    H NV+         +  F +  E+
Sbjct: 56  DGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKY-------YASFIEDNEL 107
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDH-------IKVFLYQILRGLKYLHSARILHRDIKP 114
            ++ EL  + DL ++I   +H            +  +  Q+   L+++HS R++HRDIKP
Sbjct: 108 NIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164
Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            N+ + +  ++K+ D GL R        A +  V T YY +PE +     Y+   D+WS+
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIH-ENGYNFKSDIWSL 222
Query: 175 GCIFAEL 181
           GC+  E+
Sbjct: 223 GCLLYEM 229

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 24/177 (13%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V +E K+    KH N+++   + L+ P+L       ++ E  +      ++S + +  
Sbjct: 51  ENVRQEAKLFAMLKHPNIIALRGVCLKEPNL------CLVMEFARGGPLNRVLSGKRIPP 104
Query: 86  DHIKVFLYQILRGLKYLHSARI---LHRDIKPGNLLVN--------SNCILKICDFGLAR 134
           D +  +  QI RG+ YLH   I   +HRD+K  N+L+         SN ILKI DFGLAR
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 135 VEEPDPNKAMTQEVVTQY-YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA 190
               + ++         Y + APE++  A  +S   DVWS G +  ELL   + F+ 
Sbjct: 165 ----EWHRTTKMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 39  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 93
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HRD+   N+LV +   +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 32/202 (15%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-------------NVLSALDILQP 53
           D R  A+KK+ +  + L +   +  E+ +L    H              N +     ++ 
Sbjct: 30  DSRYYAIKKIRHTEEKLST---ILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKK 86
Query: 54  PHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
               F Q  Y     L   +H   ++ Q    D       QIL  L Y+HS  I+HR++K
Sbjct: 87  KSTLFIQXEYCENRTLYDLIHSENLNQQR---DEYWRLFRQILEALSYIHSQGIIHRNLK 143
Query: 114 PGNLLVNSNCILKICDFGLARVEE-------------PDPNKAMTQEVVTQYYRAPEILM 160
           P N+ ++ +  +KI DFGLA+                P  +  +T  + T  Y A E+L 
Sbjct: 144 PXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLD 203
Query: 161 GARHYSAAVDVWSVGCIFAELL 182
           G  HY+  +D +S+G IF E +
Sbjct: 204 GTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 19/192 (9%)
Query: 15  KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DL 73
           K  N  +S V  +++  E+++L    H N++   ++ +  H      +Y++ E  +  +L
Sbjct: 53  KTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMYIVMETCEGGEL 107
Query: 74  HKIIVSPQH----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL---VNSNCILK 126
            + IVS Q     L+  ++   + Q++  L Y HS  ++H+D+KP N+L    + +  +K
Sbjct: 108 LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIK 167
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           I DFGLA + + D +   T    T  Y APE+    R  +   D+WS G +   LL   +
Sbjct: 168 IIDFGLAELFKSDEHS--TNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCL 223
Query: 187 LFQAQS--PVQQ 196
            F   S   VQQ
Sbjct: 224 PFTGTSLEEVQQ 235

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 42/93 (45%), Positives = 56/93 (60%), Gaps = 8/93 (8%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           +LRGL YL    +I+HRD+KP N+LVNS   +K+CDFG++         +M    V T+ 
Sbjct: 123 VLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRS 178
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
           Y APE L G  HYS   D+WS+G    EL +GR
Sbjct: 179 YMAPERLQGT-HYSVQSDIWSMGLSLVELAVGR 210

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQ 94
           ++ +    N+   L   +PP +++  +I  + E             + +T   +    YQ
Sbjct: 119 IVAYASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQ 165
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYY 153
           + RG++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   +
Sbjct: 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE L   R Y+   DVWS G +  E+ 
Sbjct: 226 MAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 37/99 (37%), Positives = 55/99 (55%), Gaps = 2/99 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT D I   L   L+GL+YLH  R +HRDIK GN+L+N+    K+ DFG+A  +  D   
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAG-QLTDXMA 180
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
                + T ++ APE++     Y+   D+WS+G    E+
Sbjct: 181 KRNXVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEM 218

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 2/106 (1%)
Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V  + +T   +    YQ+ RG++YL S + +HRD+   N+LV  N ++KI DFGLAR + 
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             D  K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 74/138 (53%), Gaps = 11/138 (7%)
Query: 50  ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
           + + P ++ F E+     L    L ++I     L  D    +L Q L GL+YLH+ RILH
Sbjct: 119 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 110 RDIKPGNLLVNSNCI-LKICDFGLARVEEPD--PNKAMTQEVV--TQYYRAPEILMGARH 164
            D+K  N+L++S+     +CDFG A   +PD      +T + +  T+ + APE++MG + 
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 232
Query: 165 YSAAVDVWSVGCIFAELL 182
             A VD+WS  C+   +L
Sbjct: 233 CDAKVDIWSSCCMMLHML 250

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 87/185 (47%), Gaps = 16/185 (8%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
            + VA+K++    +S    K    EL+ L    H N++        P     +  Y    
Sbjct: 32  AKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVME--YAEGG 85
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR---ILHRDIKPGNLL-VNSNC 123
            L + LH     P + T+ H   +  Q  +G+ YLHS +   ++HRD+KP NLL V    
Sbjct: 86  SLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 144
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +LKICDFG A     D    MT    +  + APE+  G+ +YS   DV+S G I  E++ 
Sbjct: 145 VLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVIT 199
Query: 184 RRILF 188
           RR  F
Sbjct: 200 RRKPF 204

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 58/103 (56%), Gaps = 5/103 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE--V 148
            L  I  G+KYL     +HRD+   N+L+NSN + K+ DFGL+RV E DP  A T     
Sbjct: 129 MLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 188
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
           +   + APE +   R +++A DVWS G +  E++  G R  ++
Sbjct: 189 IPIRWTAPEAI-AFRKFTSASDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 10/137 (7%)
Query: 62  IYVITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y++ E +   D+   +      +  H + +  QI+   +YLHS  +++RD+KP NLL++
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 121 SNCILKICDFGLA-RVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
               +K+ DFG A RV      K  T  +  T  Y APEI++ ++ Y+ AVD W++G + 
Sbjct: 176 QQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLI 228
Query: 179 AELLGRRILFQAQSPVQ 195
            E+      F A  P+Q
Sbjct: 229 YEMAAGYPPFFADQPIQ 245

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/107 (37%), Positives = 57/107 (53%), Gaps = 1/107 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
           T  Y APE+L     ++  VDVWS G +   +L   + +   S   Q
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQ 215

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI------LQPPHLDFFQE 61
           G +VA+K+      S  + +R   E++++    H NV+SA ++      L P  L     
Sbjct: 40  GEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 98
Query: 62  IYVITELLQSDLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            Y        DL K +   ++   L    I+  L  I   L+YLH  RI+HRD+KP N++
Sbjct: 99  EYCEG----GDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 154
Query: 119 VN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           +       I KI D G A+  E D  +  T+ V T  Y APE+L   + Y+  VD WS G
Sbjct: 155 LQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFG 211
Query: 176 CI-FAELLGRRILFQAQSPVQQLGLITD 202
            + F  + G R       PVQ  G + +
Sbjct: 212 TLAFECITGFRPFLPNWQPVQWHGKVRE 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVI 65
           DG+ +  K+L     +    + +  E+ +L   KH N++   D I+   +      +Y++
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN----TTLYIV 85
Query: 66  TELLQS-DLHKIIVSP----QHLTSDHIKVFLYQILRGLKYLH-----SARILHRDIKPG 115
            E  +  DL  +I       Q+L  + +   + Q+   LK  H        +LHRD+KP 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ ++    +K+ DFGLAR+   D + A  + V T YY +PE  M    Y+   D+WS+G
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYMSPE-QMNRMSYNEKSDIWSLG 203
Query: 176 CIFAELLGRRILFQAQSPVQQLGLITD 202
           C+  EL      F A S  +  G I +
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 10/137 (7%)
Query: 62  IYVITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y++ E +   D+   +      +  H + +  QI+   +YLHS  +++RD+KP NLL++
Sbjct: 116 LYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 121 SNCILKICDFGLA-RVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
               +K+ DFG A RV      K  T  +  T  Y APEI++ ++ Y+ AVD W++G + 
Sbjct: 176 QQGYIKVADFGFAKRV------KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLI 228
Query: 179 AELLGRRILFQAQSPVQ 195
            E+      F A  P+Q
Sbjct: 229 YEMAAGYPPFFADQPIQ 245

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 74/138 (53%), Gaps = 11/138 (7%)
Query: 50  ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
           + + P ++ F E+     L    L ++I     L  D    +L Q L GL+YLH+ RILH
Sbjct: 133 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 187
Query: 110 RDIKPGNLLVNSNCI-LKICDFGLARVEEPD--PNKAMTQEVV--TQYYRAPEILMGARH 164
            D+K  N+L++S+     +CDFG A   +PD      +T + +  T+ + APE++MG + 
Sbjct: 188 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 246
Query: 165 YSAAVDVWSVGCIFAELL 182
             A VD+WS  C+   +L
Sbjct: 247 CDAKVDIWSSCCMMLHML 264

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI------LQPPHLDFFQE 61
           G +VA+K+      S  + +R   E++++    H NV+SA ++      L P  L     
Sbjct: 39  GEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97
Query: 62  IYVITELLQSDLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            Y        DL K +   ++   L    I+  L  I   L+YLH  RI+HRD+KP N++
Sbjct: 98  EYCEG----GDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 153
Query: 119 VN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           +       I KI D G A+  E D  +  T+ V T  Y APE+L   + Y+  VD WS G
Sbjct: 154 LQPGPQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLE-QKKYTVTVDYWSFG 210
Query: 176 CI-FAELLGRRILFQAQSPVQQLGLITD 202
            + F  + G R       PVQ  G + +
Sbjct: 211 TLAFECITGFRPFLPNWQPVQWHGKVRE 238

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 168 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 214
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 215 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 274
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 275 EALFD-RVYTHQSDVWSFGVLMWEIF 299

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/138 (33%), Positives = 74/138 (53%), Gaps = 11/138 (7%)
Query: 50  ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
           + + P ++ F E+     L    L ++I     L  D    +L Q L GL+YLH+ RILH
Sbjct: 135 VREGPWVNIFMEL-----LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 189
Query: 110 RDIKPGNLLVNSNCI-LKICDFGLARVEEPD--PNKAMTQEVV--TQYYRAPEILMGARH 164
            D+K  N+L++S+     +CDFG A   +PD      +T + +  T+ + APE++MG + 
Sbjct: 190 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 248
Query: 165 YSAAVDVWSVGCIFAELL 182
             A VD+WS  C+   +L
Sbjct: 249 CDAKVDIWSSCCMMLHML 266

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/185 (31%), Positives = 87/185 (47%), Gaps = 16/185 (8%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
            + VA+K++    +S    K    EL+ L    H N++        P     +  Y    
Sbjct: 31  AKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVME--YAEGG 84
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR---ILHRDIKPGNLL-VNSNC 123
            L + LH     P + T+ H   +  Q  +G+ YLHS +   ++HRD+KP NLL V    
Sbjct: 85  SLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT 143
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +LKICDFG A     D    MT    +  + APE+  G+ +YS   DV+S G I  E++ 
Sbjct: 144 VLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVIT 198
Query: 184 RRILF 188
           RR  F
Sbjct: 199 RRKPF 203

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQ 94
           ++ +    N+   L   +PP +++  +I  + E             + +T   +    YQ
Sbjct: 119 IVGYASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQ 165
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYY 153
           + RG++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   +
Sbjct: 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKW 225
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE L   R Y+   DVWS G +  E+ 
Sbjct: 226 MAPEALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFGLA RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 109 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 155
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 156 GMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 215
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 216 EALFD-RVYTHQSDVWSFGVLMWEIF 240

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 10/163 (6%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL-QSDLHKIIVSPQHLTSDHIK 89
           RE+++    +H N+L                +Y+I E   + +++K +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
            ++ ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCG 173
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 174 TLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 111 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 157
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 158 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 217
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 218 EALFD-RVYTHQSDVWSFGVLMWEIF 242

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 89/179 (49%), Gaps = 10/179 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G  VA+KKL +  +  +  +   RE+++L   +HDN++    +         + + +I E
Sbjct: 40  GEVVAVKKLQHSTEEHL--RDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIME 94
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            L     +  +       DHIK+  Y  QI +G++YL + R +HR++   N+LV +   +
Sbjct: 95  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRV 154
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGL +V   D      +E      ++ APE L  ++ +S A DVWS G +  EL 
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELF 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 114 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 160
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 161 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 220
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 221 EALFD-RVYTHQSDVWSFGVLMWEIF 245

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 108 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 59/95 (62%), Gaps = 12/95 (12%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLAR--VEEPDPNKAMTQEVV-T 150
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG++   ++E      M  E V T
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE------MANEFVGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
           + Y +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 RSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N ++KI DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 15/156 (9%)
Query: 35  MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLY 93
           +L + +H N+++  D+      D  + +YV+TEL +  +L   I+  +  +       L+
Sbjct: 69  LLRYGQHPNIITLKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLF 123
Query: 94  QILRGLKYLHSARILHRDIKPGNLLV-----NSNCILKICDFGLARVEEPDPNKAMTQEV 148
            I + ++YLH+  ++HRD+KP N+L      N   I +ICDFG A+    + N  +    
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESI-RICDFGFAKQLRAE-NGLLXTPC 181
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGC-IFAELLG 183
            T  + APE+L   + Y AA D+WS+G  ++  L G
Sbjct: 182 YTANFVAPEVLE-RQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +K+ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 64/114 (56%), Gaps = 7/114 (6%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV+     
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX 197
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
            A T E     Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 198 LAGTPE-----YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 10/163 (6%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL-QSDLHKIIVSPQHLTSDHIK 89
           RE+++    +H N+L                +Y+I E   + +++K +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPRGEVYKELQKLSKFDEQRTA 116
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
            ++ ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +      +
Sbjct: 117 TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTL 175
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
              Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 176 D--YLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +K+ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 1/103 (0%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV-EEPDPNKAMTQEVV 149
           F +Q++ G+ YLH   I HRDIKP NLL++    LKI DFGLA V    +  + + +   
Sbjct: 109 FFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 168
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
           T  Y APE+L     ++  VDVWS G +   +L   + +   S
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K + NV +   +++   + L+ L     ++    + +L+    +    I ++ E
Sbjct: 40  GRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE--WFEHHGHICIVFE 97
Query: 68  LLQSDLHKIIVSPQHLTS--DHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNS--- 121
           LL    +  I     L    DHI+   YQI + + +LHS ++ H D+KP N+L V S   
Sbjct: 98  LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157
Query: 122 ---------------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
                          N  +K+ DFG A  +    ++  +  V  ++YRAPE+++ A  +S
Sbjct: 158 EAYNPKIKRDERTLINPDIKVVDFGSATYD----DEHHSTLVXXRHYRAPEVIL-ALGWS 212
Query: 167 AAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
              DVWS+GCI  E      +F      + L ++
Sbjct: 213 QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-NVLSALDILQPPH-----LDFFQEI 62
           R VA+K L     +    + +  ELK+L    H  NV++ L     P      +  F + 
Sbjct: 49  RTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKF 107
Query: 63  YVITELLQSDLHKII---VSPQHLTSD-----HIKVFLYQILRGLKYLHSARILHRDIKP 114
             ++  L+S  ++ +   V+P+ L  D     H+  + +Q+ +G+++L S + +HRD+  
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWS 173
            N+L++   ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS
Sbjct: 168 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS 226
Query: 174 VGCIFAELL 182
            G +  E+ 
Sbjct: 227 FGVLLWEIF 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 55/94 (58%), Gaps = 3/94 (3%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-- 148
            L  +  G++YL     +HRD+   N+LV+SN + K+ DFGL+RV E DP+ A T     
Sbjct: 156 MLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +   + APE +   R +S+A DVWS G +  E+L
Sbjct: 216 IPIRWTAPEAI-AFRTFSSASDVWSFGVVMWEVL 248

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 17/207 (8%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVI 65
           DG+ +  K+L     +    + +  E+ +L   KH N++   D I+   +      +Y++
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN----TTLYIV 85
Query: 66  TELLQS-DLHKIIVSP----QHLTSDHIKVFLYQILRGLKYLH-----SARILHRDIKPG 115
            E  +  DL  +I       Q+L  + +   + Q+   LK  H        +LHRD+KP 
Sbjct: 86  MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPA 145
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ ++    +K+ DFGLAR+   D + A    V T YY +PE  M    Y+   D+WS+G
Sbjct: 146 NVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPE-QMNRMSYNEKSDIWSLG 203
Query: 176 CIFAELLGRRILFQAQSPVQQLGLITD 202
           C+  EL      F A S  +  G I +
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE 230

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 53/87 (60%), Gaps = 3/87 (3%)
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV--VTQYYRA 155
           G++YL     +HRD+   N+LV+SN + K+ DFGL+RV E DP+ A T     +   + A
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL 182
           PE +   R +S+A DVWS G +  E+L
Sbjct: 223 PEAI-AFRTFSSASDVWSFGVVMWEVL 248

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 78/146 (53%), Gaps = 11/146 (7%)
Query: 61  EIYVITELLQSDLHK----IIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPG 115
           ++++  EL+ + L K    +I   Q +  D +      I++ L++LHS   ++HRD+KP 
Sbjct: 80  DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL---MGARHYSAAVDVW 172
           N+L+N+   +K+CDFG++     D  K +  +   + Y APE +   +  + YS   D+W
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPERINPELNQKGYSVKSDIW 197
Query: 173 SVGCIFAELLGRRILFQA-QSPVQQL 197
           S+G    EL   R  + +  +P QQL
Sbjct: 198 SLGITMIELAILRFPYDSWGTPFQQL 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 15/146 (10%)
Query: 38  FFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILR 97
           +    N+   L   +PP +++  +I  + E             + +T   +    YQ+ R
Sbjct: 122 YASKGNLREYLRARRPPGMEYSYDINRVPE-------------EQMTFKDLVSCTYQLAR 168
Query: 98  GLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAP 156
           G++YL S + +HRD+   N+LV  N +++I DFGLAR +   D  K  T   +   + AP
Sbjct: 169 GMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAP 228
Query: 157 EILMGARHYSAAVDVWSVGCIFAELL 182
           E L   R Y+   DVWS G +  E+ 
Sbjct: 229 EALFD-RVYTHQSDVWSFGVLMWEIF 253

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT- 119
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ SN  LKI DFG + V  P   +  T    T
Sbjct: 120 ---ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRR--TTLCGT 173
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L     F+A +
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V  ++   DL+K       LT +H+  + +Q+ +G+++L S + +HRD+   N+L++  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 123 CILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 243
Query: 182 L 182
Sbjct: 244 F 244

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V  ++   DL+K       LT +H+  + +Q+ +G+++L S + +HRD+   N+L++  
Sbjct: 121 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 123 CILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 234
Query: 182 L 182
Sbjct: 235 F 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NL+++    +K+ DFG A RV      K  T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV------KGRT 196
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 197 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 205 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 244

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 65/115 (56%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +++ DFGLA RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 205 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 244

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/114 (33%), Positives = 63/114 (55%), Gaps = 7/114 (6%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV+     
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT 218
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
              T E     Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 219 LCGTPE-----YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 82/153 (53%), Gaps = 15/153 (9%)
Query: 61  EIYVITELLQSDLHK----IIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPG 115
           ++++  EL+ + L K    +I   Q +  D +      I++ L++LHS   ++HRD+KP 
Sbjct: 124 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 183
Query: 116 NLLVNSNCILKICDFGLAR--VEEPDPNKAMTQEVVTQYYRAPEIL---MGARHYSAAVD 170
           N+L+N+   +K+CDFG++   V+    + A T +   + Y APE +   +  + YS   D
Sbjct: 184 NVLINALGQVKMCDFGISGYLVD----SVAKTIDAGCKPYMAPERINPELNQKGYSVKSD 239
Query: 171 VWSVGCIFAELLGRRILFQA-QSPVQQLGLITD 202
           +WS+G    EL   R  + +  +P QQL  + +
Sbjct: 240 IWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 272

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEV 148
            L  I  G++YL     +HRD+   N+LVNSN + K+ DFGL+RV E DP      T   
Sbjct: 150 MLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +   + APE +   R +++A DVWS G +  E++
Sbjct: 210 IPVRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVM 242

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T+   T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TELCGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +A      T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAAL--CGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLXGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 124 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 177
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 178 KGRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +A      T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAAL--CGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 125 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV------ 178
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 179 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 232

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V  ++   DL+K       LT +H+  + +Q+ +G+++L S + +HRD+   N+L++  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 123 CILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 243
Query: 182 L 182
Sbjct: 244 F 244

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQ 245

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-NVLSALDILQPPH-----LDFFQEI 62
           R VA+K L     +    + +  ELK+L    H  NV++ L     P      +  F + 
Sbjct: 49  RTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKF 107
Query: 63  YVITELLQSDLHKII---VSPQHLTSD-----HIKVFLYQILRGLKYLHSARILHRDIKP 114
             ++  L+S  ++ +   V+P+ L  D     H+  + +Q+ +G+++L S + +HRD+  
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWS 173
            N+L++   ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS 226
Query: 174 VGCIFAELL 182
            G +  E+ 
Sbjct: 227 FGVLLWEIF 235

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 7   DGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           +GR  A+K L   +   L   +    E  ML    H  ++      Q       Q+I++I
Sbjct: 30  NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMI 84
Query: 66  TELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            + ++  +L  ++   Q   +   K +  ++   L+YLHS  I++RD+KP N+L++ N  
Sbjct: 85  MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           +KI DFG A+   PD    +     T  Y APE++   + Y+ ++D WS G +  E+L 
Sbjct: 145 IKITDFGFAKY-VPDVTYXLCG---TPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLA 198

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 235

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 231

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 131 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 184
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 185 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 9   RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-NVLSALDILQPPH-----LDFFQEI 62
           R VA+K L     +    + +  ELK+L    H  NV++ L     P      +  F + 
Sbjct: 49  RTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKF 107
Query: 63  YVITELLQSDLHKII---VSPQHLTSD-----HIKVFLYQILRGLKYLHSARILHRDIKP 114
             ++  L+S  ++ +   V+P+ L  D     H+  + +Q+ +G+++L S + +HRD+  
Sbjct: 108 GNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 167
Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWS 173
            N+L++   ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS
Sbjct: 168 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWS 226
Query: 174 VGCIFAELL 182
            G +  E+ 
Sbjct: 227 FGVLLWEIF 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 246 YYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIF 287

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 57/103 (55%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPD 139
           + L+S  +    YQ+ RG++YL S + +HRD+   N+LV  + ++KI DFGLAR +   D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             K  T   +   + APE L   R Y+   DVWS G +  E+ 
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 246

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 4/132 (3%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +V+  L   DL   I S           +  +I+ GL++LHS  I++RD+K  N+L++ 
Sbjct: 95  FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 154
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           +  +KI DFG+ +  E     A T E   T  Y APEIL+G + Y+ +VD WS G +  E
Sbjct: 155 DGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 211
Query: 181 LLGRRILFQAQS 192
           +L  +  F  Q 
Sbjct: 212 MLIGQSPFHGQD 223

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 188
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 189 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V RE+      +H N++   + IL P HL    E     EL +      I +    + 
Sbjct: 61  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYER-----ICNAGRFSE 115
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNKA 143
           D  + F  Q+L G+ Y HS +I HRD+K  N L++ +    LKICDFG ++         
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175
Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLGRRILFQAQSP 193
            T  V T  Y APE+L+   +     DVWS G  ++  L+G       + P
Sbjct: 176 ST--VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 192
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 193 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 137 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 190
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 191 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 240

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 135 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 188
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 189 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 212
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 213 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V  ++   DL+K       LT +H+  + +Q+ +G+++L S + +HRD+   N+L++  
Sbjct: 167 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 123 CILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 280
Query: 182 L 182
Sbjct: 281 F 281

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 143 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 196
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 197 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 163 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 216
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 217 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 119
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 120 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 173
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 7/121 (5%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +V  ++   DL+K       LT +H+  + +Q+ +G+++L S + +HRD+   N+L++  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 123 CILKICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            ++KICDFGLAR    DP+     +  +   + APE +   R Y+   DVWS G +  E+
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI 243
Query: 182 L 182
Sbjct: 244 F 244

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 39/111 (35%), Positives = 63/111 (56%), Gaps = 9/111 (8%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPNKAMT 145
           H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      K  T
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRT 195
Query: 146 QEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
             +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 196 WXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 255 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 294

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 248 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 287

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 114
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 115 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 168
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 169 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 209

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 257 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 250 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 289

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 112
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 113 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 166
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 167 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 196
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 197 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 201 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 240

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLAR    DP+ 
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 207 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 246

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 8/93 (8%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG++         +M    V T+ 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRS 230
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
           Y +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 231 YMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYIT- 119
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ SN  LKI DFG + V  P   +       T
Sbjct: 120 ---ELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTL--CGT 173
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L     F+A +
Sbjct: 174 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHT 214

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TXLCGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 120
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 121 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGT 174
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 120
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 121 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 174
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 175 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 116
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 117 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TDLCGT 170
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           R A KK+P  F   V   R  +E++++    H N++   +  +        +IY++ EL 
Sbjct: 36  RRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELC 88
Query: 70  QS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCIL 125
              +L + +V  +          +  +L  + Y H   + HRD+KP N L    + +  L
Sbjct: 89  TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL 148
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           K+ DFGLA      P K M  +V T YY +P++L G   Y    D WS G +   LL
Sbjct: 149 KLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLL 201

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           R A KK+P  F   V   R  +E++++    H N++   +  +        +IY++ EL 
Sbjct: 53  RRAAKKIPKYFVEDVD--RFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELC 105
Query: 70  QS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCIL 125
              +L + +V  +          +  +L  + Y H   + HRD+KP N L    + +  L
Sbjct: 106 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL 165
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           K+ DFGLA      P K M  +V T YY +P++L G   Y    D WS G +   LL
Sbjct: 166 KLIDFGLA--ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLL 218

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 169
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 169
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 169
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 169
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/92 (41%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 95  ILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +++GL YL    +I+HRD+KP N+LVNS   +K+CDFG   V     +      V T+ Y
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSY 169
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL-LGR 184
            +PE L G  HYS   D+WS+G    E+ +GR
Sbjct: 170 MSPERLQGT-HYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+     
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----T 129
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           ++ ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 130 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 186
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 187 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 227

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFREL-KMLCFFK----HDNVL---SALDILQPPH 55
           D   GR  ALK+L      L + +   R + + +CF K    H N++   SA  I +   
Sbjct: 49  DVGSGREYALKRL------LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102
Query: 56  LDFFQEIYVITELLQSDL---HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR--ILHR 110
                E  ++TEL +  L    K + S   L+ D +    YQ  R ++++H  +  I+HR
Sbjct: 103 DTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHR 162
Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPN-------KAMTQEVVTQ----YYRAPEIL 159
           D+K  NLL+++   +K+CDFG A      P+       +A+ +E +T+     YR PEI+
Sbjct: 163 DLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222
Query: 160 MGARHY--SAAVDVWSVGCIFAELLGRRILFQ 189
               ++      D+W++GCI   L  R+  F+
Sbjct: 223 DLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+     
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----T 138
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           ++ ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 195
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 196 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS +++HRDIKP NLL+ S   LKI DFG + V  P   +A      T
Sbjct: 116 ---ELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAAL--CGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 11/172 (6%)
Query: 26  SKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLT 84
           +  V RE+      +H N++   + IL P HL    E     EL +      I +    +
Sbjct: 59  AANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFS 113
Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNK 142
            D  + F  Q++ G+ Y H+ ++ HRD+K  N L++ +    LKICDFG ++        
Sbjct: 114 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 173
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLGRRILFQAQSP 193
             T  V T  Y APE+L+   +     DVWS G  ++  L+G       + P
Sbjct: 174 KST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V RE+      +H N++   + IL P HL    E     EL +      I +    + 
Sbjct: 59  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSE 113
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNKA 143
           D  + F  Q++ G+ Y H+ ++ HRD+K  N L++ +    LKICDFG ++         
Sbjct: 114 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 173
Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLGRRILFQAQSP 193
            T  V T  Y APE+L+   +     DVWS G  ++  L+G       + P
Sbjct: 174 ST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 222

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 2/95 (2%)
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
            I   L +IL+GL YLHS + +HRDIK  N+L++    +K+ DFG+A  +  D       
Sbjct: 121 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNT 179
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            V T ++ APE++  +  Y +  D+WS+G    EL
Sbjct: 180 FVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIEL 213

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NL+++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 120
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +  T    T
Sbjct: 121 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--TTLCGT 174
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE + G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 175 LDYLPPEXIEG-RXHDEKVDLWSLGVLCYEFLVGKPPFEANT 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 64/115 (55%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y APEI++ ++ Y+ AVD W++G +  ++      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQ 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 11/146 (7%)
Query: 61  EIYVITELLQSDLHK----IIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPG 115
           ++++  EL  + L K    +I   Q +  D +      I++ L++LHS   ++HRD+KP 
Sbjct: 107 DVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 166
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL---MGARHYSAAVDVW 172
           N+L+N+   +K CDFG++     D  K +  +   + Y APE +   +  + YS   D+W
Sbjct: 167 NVLINALGQVKXCDFGISGYLVDDVAKDI--DAGCKPYXAPERINPELNQKGYSVKSDIW 224
Query: 173 SVGCIFAELLGRRILFQA-QSPVQQL 197
           S+G    EL   R  + +  +P QQL
Sbjct: 225 SLGITXIELAILRFPYDSWGTPFQQL 250

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 116
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG +      P+   T    T
Sbjct: 117 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHA---PSSRRTTLSGT 170
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/114 (32%), Positives = 63/114 (55%), Gaps = 7/114 (6%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV+     
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX 197
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
              T E +     APEI++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 198 LCGTPEAL-----APEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 116 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXL--CGT 169
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 170 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXL--CGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 117
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 118 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXL--CGT 171
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 172 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 13/181 (7%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L P    + ++  +  +E+++L    H+N++    I      D    I +I 
Sbjct: 50  GEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHENIVKYKGICTE---DGGNGIKLIM 104
Query: 67  ELLQSDLHKIIVSPQHLTSDHIK---VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           E L S   K  + P++    ++K    +  QI +G+ YL S + +HRD+   N+LV S  
Sbjct: 105 EFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 163
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            +KI DFGL +  E D      ++      ++ APE LM ++ Y A+ DVWS G    EL
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIAS-DVWSFGVTLHEL 222
Query: 182 L 182
           L
Sbjct: 223 L 223

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   +++LHS  I HRD+KP NLL  S   + +LK+ DFG A+   
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--- 179
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                A+     T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 180 ETTQNALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 223

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q L  L YLH  +I+HRD+K GN+L   +  +K+ DFG++       N 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNT 186
Query: 143 AMTQE----VVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAEL 181
              Q     + T Y+ APE++M      R Y    DVWS+G    E+
Sbjct: 187 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 8/197 (4%)
Query: 4   DPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D RD R VA+K L  ++ +      R  RE +      H  +++  D  +          
Sbjct: 33  DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLP 91
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++++
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV---TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
              +K+ DFG+AR    D   ++TQ      T  Y +PE   G     A  DV+S+GC+ 
Sbjct: 152 TNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVL 209
Query: 179 AELLGRRILFQAQSPVQ 195
            E+L     F   SPV 
Sbjct: 210 YEVLTGEPPFTGDSPVS 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   +++LHS  I HRD+KP NLL  S   + +LK+ DFG A+   
Sbjct: 104 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--- 160
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                A+     T YY APE+L G   Y  + D+WS+G I   LL
Sbjct: 161 ETTQNALQTPCYTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILL 204

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 91/181 (50%), Gaps = 13/181 (7%)
Query: 8   GRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L P    + ++  +  +E+++L    H+N++    I      D    I +I 
Sbjct: 38  GEQVAVKSLKPESGGNHIADLK--KEIEILRNLYHENIVKYKGICTE---DGGNGIKLIM 92
Query: 67  ELLQSDLHKIIVSPQHLTSDHIK---VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           E L S   K  + P++    ++K    +  QI +G+ YL S + +HRD+   N+LV S  
Sbjct: 93  EFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 151
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            +KI DFGL +  E D      ++      ++ APE LM ++ Y A+ DVWS G    EL
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIAS-DVWSFGVTLHEL 210
Query: 182 L 182
           L
Sbjct: 211 L 211

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 60/103 (58%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + +T + +  + +Q+ RG+++L S + +HRD+   N+L++ N ++KICDFGLAR    +P
Sbjct: 194 EPITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNP 253
Query: 141 NKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +     +  +   + APE +   + YS   DVWS G +  E+ 
Sbjct: 254 DYVRKGDTRLPLKWMAPESIFD-KIYSTKSDVWSYGVLLWEIF 295

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q L  L YLH  +I+HRD+K GN+L   +  +K+ DFG++       N 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNT 186
Query: 143 AMTQE----VVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAEL 181
              Q     + T Y+ APE++M      R Y    DVWS+G    E+
Sbjct: 187 RXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 13/107 (12%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q L  L YLH  +I+HRD+K GN+L   +  +K+ DFG++       N 
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA-----KNT 186
Query: 143 AMTQE----VVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAEL 181
              Q     + T Y+ APE++M      R Y    DVWS+G    E+
Sbjct: 187 RXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 68/132 (51%), Gaps = 4/132 (3%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +V+  L   DL   I S           +  +I+ GL++LHS  I++RD+K  N+L++ 
Sbjct: 94  FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           +  +KI DFG+ +  E     A T     T  Y APEIL+G + Y+ +VD WS G +  E
Sbjct: 154 DGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 210
Query: 181 LLGRRILFQAQS 192
           +L  +  F  Q 
Sbjct: 211 MLIGQSPFHGQD 222

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI +FG + V  P   +  T    T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRR--TTLCGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 116
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 117 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTL--CGT 170
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 171 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 2/110 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 165
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q 
Sbjct: 166 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 85/196 (43%), Gaps = 6/196 (3%)
Query: 4   DPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D RD R VA+K L  ++ +      R  RE +      H  +++  D  +          
Sbjct: 33  DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLP 91
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+L+++
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
              +K+ DFG+AR      N       V  T  Y +PE   G     A  DV+S+GC+  
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLY 210
Query: 180 ELLGRRILFQAQSPVQ 195
           E+L     F   SPV 
Sbjct: 211 EVLTGEPPFTGDSPVS 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 161 TMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K + N    L  ++   R L+++   KHD  +    +    H  F   + ++ E+L 
Sbjct: 82  VAIKIIKNKKAFLNQAQIEVRLLELMN--KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNS--NCI 124
            +L+ ++ +   + ++ +  + F  Q+   L +L +    I+H D+KP N+L+ +     
Sbjct: 140 YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +KI DFG          + + Q + +++YR+PE+L+G   Y  A+D+WS+GCI  E+   
Sbjct: 200 IKIVDFG----SSCQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTG 254
Query: 185 RILFQAQSPVQQLGLITDL 203
             LF   + V Q+  I ++
Sbjct: 255 EPLFSGANEVDQMNKIVEV 273

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 105 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 163
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 164 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 61/118 (51%), Gaps = 2/118 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
            T +  + +  +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL + E      
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGA 160
Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 117
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI +FG + V  P   +  T    T
Sbjct: 118 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRR--TTLCGT 171
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 172 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 212

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K + N    L  ++   R L+++   KHD  +    +    H  F   + ++ E+L 
Sbjct: 63  VAIKIIKNKKAFLNQAQIEVRLLELMN--KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 120
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNS--NCI 124
            +L+ ++ +   + ++ +  + F  Q+   L +L +    I+H D+KP N+L+ +     
Sbjct: 121 YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 180
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +KI DFG          + + Q + +++YR+PE+L+G   Y  A+D+WS+GCI  E+   
Sbjct: 181 IKIVDFG----SSCQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTG 235
Query: 185 RILFQAQSPVQQLGLITDL 203
             LF   + V Q+  I ++
Sbjct: 236 EPLFSGANEVDQMNKIVEV 254

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 63/115 (54%), Gaps = 9/115 (7%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA-RVEEPDPN 141
            +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A RV      
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------ 191
Query: 142 KAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
           K  T  +  T  Y AP I++ ++ Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 192 KGRTWXLCGTPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 6/137 (4%)
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++++
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV---TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
              +K+ DFG+AR    D   ++TQ      T  Y +PE   G     A  DV+S+GC+ 
Sbjct: 152 TNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVL 209
Query: 179 AELLGRRILFQAQSPVQ 195
            E+L     F   SPV 
Sbjct: 210 YEVLTGEPPFTGDSPVS 226

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 6/137 (4%)
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++++
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV---TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
              +K+ DFG+AR    D   ++TQ      T  Y +PE   G     A  DV+S+GC+ 
Sbjct: 152 TNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVL 209
Query: 179 AELLGRRILFQAQSPVQ 195
            E+L     F   SPV 
Sbjct: 210 YEVLTGEPPFTGDSPVS 226

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+ +I  
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT- 118
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
              ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 119 ---ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--DDLCGT 172
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 173 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 6/137 (4%)
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++++
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV---TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
              +K+ DFG+AR    D   ++TQ      T  Y +PE   G     A  DV+S+GC+ 
Sbjct: 169 TNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVL 226
Query: 179 AELLGRRILFQAQSPVQ 195
            E+L     F   SPV 
Sbjct: 227 YEVLTGEPPFTGDSPVS 243

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K + N    L  ++   R L+++   KHD  +    +    H  F   + ++ E+L 
Sbjct: 82  VAIKIIKNKKAFLNQAQIEVRLLELMN--KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS 139
Query: 71  SDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNS--NCI 124
            +L+ ++ +   + ++ +  + F  Q+   L +L +    I+H D+KP N+L+ +     
Sbjct: 140 YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXA 199
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           +KI DFG          + + Q + +++YR+PE+L+G   Y  A+D+WS+GCI  E+   
Sbjct: 200 IKIVDFG----SSCQLGQRIYQXIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTG 254
Query: 185 RILFQAQSPVQQLGLITDL 203
             LF   + V Q+  I ++
Sbjct: 255 EPLFSGANEVDQMNKIVEV 273

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           R   +VALK + NV +   +++     LK +   + D     L +L     +F   + + 
Sbjct: 43  RGKSQVALKIIRNVGKYREAARLEINVLKKIK--EKDKENKFLCVLMSDWFNFHGHMCIA 100
Query: 66  TELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNS- 121
            ELL  +  + +     Q     H++   YQ+   L++LH  ++ H D+KP N+L VNS 
Sbjct: 101 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160
Query: 122 -----------------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH 164
                            N  +++ DFG A  +    ++  T  V T++YR PE+++    
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFD----HEHHTTIVATRHYRPPEVILELG- 215
Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           ++   DVWS+GCI  E      LFQ     + L ++  +
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           R   +VALK + NV +   +++     LK +   + D     L +L     +F   + + 
Sbjct: 52  RGKSQVALKIIRNVGKYREAARLEINVLKKIK--EKDKENKFLCVLMSDWFNFHGHMCIA 109
Query: 66  TELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNS- 121
            ELL  +  + +     Q     H++   YQ+   L++LH  ++ H D+KP N+L VNS 
Sbjct: 110 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 169
Query: 122 -----------------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH 164
                            N  +++ DFG A  +    ++  T  V T++YR PE+++    
Sbjct: 170 FETLYNEHKSCEEKSVKNTSIRVADFGSATFD----HEHHTTIVATRHYRPPEVILELG- 224
Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           ++   DVWS+GCI  E      LFQ     + L ++  +
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 263

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 27  KRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSD 86
           +++ RE ++    KH N++   D +      +     V   +   +L + IV+ ++ +  
Sbjct: 75  QKLEREARICRLLKHPNIVRLHDSISEEGFHYL----VFDLVTGGELFEDIVAREYYSEA 130
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNKA 143
                ++QIL  + ++H   I+HRD+KP NLL+ S C    +K+ DFGLA +E     +A
Sbjct: 131 DASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQA 189
Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                 T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 190 WFGFAGTPGYLSPEVLR-KDPYGKPVDIWACGVILYILL 227

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           R   +VALK + NV +   +++     LK +   + D     L +L     +F   + + 
Sbjct: 75  RGKSQVALKIIRNVGKYREAARLEINVLKKIK--EKDKENKFLCVLMSDWFNFHGHMCIA 132
Query: 66  TELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNS- 121
            ELL  +  + +     Q     H++   YQ+   L++LH  ++ H D+KP N+L VNS 
Sbjct: 133 FELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 192
Query: 122 -----------------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH 164
                            N  +++ DFG A  +    ++  T  V T++YR PE+++    
Sbjct: 193 FETLYNEHKSCEEKSVKNTSIRVADFGSATFD----HEHHTTIVATRHYRPPEVILELG- 247
Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           ++   DVWS+GCI  E      LFQ     + L ++  +
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 2/127 (1%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +VI  +   DL   +   + L  +H + +  +I   L YLH   I++RD+K  N+L++S
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 188
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              +K+ D+G+ + E   P    +    T  Y APEIL G   Y  +VD W++G +  E+
Sbjct: 189 EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEM 246
Query: 182 LGRRILF 188
           +  R  F
Sbjct: 247 MAGRSPF 253

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V RE+      +H N++   + IL P HL    E     EL +      I +    + 
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSE 114
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGL--ARVEEPDPN 141
           D  + F  Q++ G+ Y H+ ++ HRD+K  N L++ +    LKI DFG   A V    P 
Sbjct: 115 DEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPK 174
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLG 183
            A    V T  Y APE+L+   +     DVWS G  ++  L+G
Sbjct: 175 SA----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 14/181 (7%)
Query: 15  KLPN---VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF----QEIYVITE 67
           KLP    +F ++ + K  + E +   F    +++   D     HL+        + +ITE
Sbjct: 55  KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 114
Query: 68  LLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +++      +  +    T   +   L  I  G+KYL     +HRD+   N+LVNSN + 
Sbjct: 115 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVC 174
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQY----YRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R  E D +       +       + APE +   R +++A DVWS G +  E+
Sbjct: 175 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEV 233
Query: 182 L 182
           +
Sbjct: 234 M 234

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 9/106 (8%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  +I  GL+ LH  RI++RD+KP N+L++ +  ++I D GLA V  P+  + +   V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPE-GQTIKGRVGT 348
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
             Y APE++   R Y+ + D W++GC+  E++        QSP QQ
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA------GQSPFQQ 387

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 2/127 (1%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +VI  +   DL   +   + L  +H + +  +I   L YLH   I++RD+K  N+L++S
Sbjct: 86  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              +K+ D+G+ + E   P    +    T  Y APEIL G   Y  +VD W++G +  E+
Sbjct: 146 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEM 203
Query: 182 LGRRILF 188
           +  R  F
Sbjct: 204 MAGRSPF 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 2/127 (1%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +VI  +   DL   +   + L  +H + +  +I   L YLH   I++RD+K  N+L++S
Sbjct: 97  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 156
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              +K+ D+G+ + E   P    +    T  Y APEIL G   Y  +VD W++G +  E+
Sbjct: 157 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEM 214
Query: 182 LGRRILF 188
           +  R  F
Sbjct: 215 MAGRSPF 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 64.3 bits (155), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 2/127 (1%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +VI  +   DL   +   + L  +H + +  +I   L YLH   I++RD+K  N+L++S
Sbjct: 82  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 141
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
              +K+ D+G+ + E   P    +    T  Y APEIL G   Y  +VD W++G +  E+
Sbjct: 142 EGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEM 199
Query: 182 LGRRILF 188
           +  R  F
Sbjct: 200 MAGRSPF 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 8/162 (4%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKV 90
           RE+++    +H N+L            +    Y     +  +L K+    +  T+     
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA----T 138
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           ++ ++   L Y HS R++HRDIKP NLL+ S   LKI DFG + V  P   +       T
Sbjct: 139 YITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRR--DDLCGT 195
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             Y  PE++ G R +   VD+WS+G +  E L  +  F+A +
Sbjct: 196 LDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANT 236

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 35  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 85
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 86  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 139
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 140 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 198
Query: 181 L 181
           L
Sbjct: 199 L 199

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 98
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 99  SFLQ---VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 156 GLSRYMEDSTXXKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILIGELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 33  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 83
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 84  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 137
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 138 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 196
Query: 181 L 181
           L
Sbjct: 197 L 197

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE------EPIYIVTEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGCLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 46  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 103
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 104 SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 161 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 211

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 62/106 (58%), Gaps = 9/106 (8%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  +I  GL+ LH  RI++RD+KP N+L++ +  ++I D GLA V  P+  + +   V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPE-GQTIKGRVGT 348
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
             Y APE++   R Y+ + D W++GC+  E++        QSP QQ
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA------GQSPFQQ 387

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 87/195 (44%), Gaps = 8/195 (4%)
Query: 4   DPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           D RD R VA+K L  ++ +      R  RE +      H  +++  D  +          
Sbjct: 33  DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPLP 91
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++++
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV---TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
              +K+ DFG+AR    D   ++TQ      T  Y +PE   G     A  DV+S+GC+ 
Sbjct: 152 TNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVL 209
Query: 179 AELLGRRILFQAQSP 193
            E+L     F   SP
Sbjct: 210 YEVLTGEPPFTGDSP 224

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 98
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 99  SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 69  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 126
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 127 SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 183
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 184 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 98
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 99  SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 155
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 38  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 95
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 96  SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 152
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 203

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L    H NV++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI+          D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LITDL 203
            IT +
Sbjct: 229 NITSV 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 43  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 100
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 101 SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 157
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 158 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 44  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 101
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DF
Sbjct: 102 SFLQ---VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 158
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 159 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 209

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 109
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 167
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 205

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 109
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 167
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 94/193 (48%), Gaps = 32/193 (16%)
Query: 15  KLPNVFQSLVSSKRVFRELKMLCFFKHDNVL---------SALDILQPPHLDFFQEIYVI 65
           +LPN     ++ ++V RE+K L   +H  ++         +  + LQP     +  +Y+ 
Sbjct: 39  RLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY--LYIQ 93
Query: 66  TELLQSDLHKIIVSPQHLTSDH-----IKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            +L + +  K  ++ +    +      + +FL QI   +++LHS  ++HRD+KP N+   
Sbjct: 94  MQLCRKENLKDWMNGRCTIEERERSVCLHIFL-QIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 121 SNCILKICDFGLARVEEPDPNKAM-----------TQEVVTQYYRAPEILMGARHYSAAV 169
            + ++K+ DFGL    + D  +             T +V T+ Y +PE + G   YS  V
Sbjct: 153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKV 211
Query: 170 DVWSVGCIFAELL 182
           D++S+G I  ELL
Sbjct: 212 DIFSLGLILFELL 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L    H NV++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI +         D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LITDL 203
            IT +
Sbjct: 229 NITSV 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L    H NV++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI+          D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LITDL 203
            IT +
Sbjct: 229 NITSV 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 17/179 (9%)
Query: 30  FRELKMLCFFKHDN-VLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHI 88
            RE+ ++   +H N VL    + QPP+L    E Y+    L   LHK     Q L     
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKSGAREQ-LDERRR 139
Query: 89  KVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT- 145
               Y + +G+ YLH+    I+HR++K  NLLV+    +K+CDFGL+R+      KA T 
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL------KASTF 193
Query: 146 ----QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
                   T  + APE+L        + DV+S G I  EL   +  +   +P Q +  +
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPAFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L   +H NV++  ++ +        ++ +I EL+   +L   +   + 
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKES 110
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           LT +    FL QIL G+ YLHS +I H D+KP N+++    +    +KI DFGLA   + 
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KI 168
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           D          T  + APEI+          D+WS+G I
Sbjct: 169 DFGNEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVI 206

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L    H NV++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI+          D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LIT 201
            IT
Sbjct: 229 NIT 231

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 13/183 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           VS + + RE+ +L    H NV++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI+          D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LIT 201
            IT
Sbjct: 229 NIT 231

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 11/171 (6%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V RE+      +H N++   + IL P HL    E     EL +      I +    + 
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSE 114
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNKA 143
           D  + F  Q++ G+ Y H+ ++ HRD+K  N L++ +    LKIC FG ++         
Sbjct: 115 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK 174
Query: 144 MTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLGRRILFQAQSP 193
            T  V T  Y APE+L+   +     DVWS G  ++  L+G       + P
Sbjct: 175 ST--VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q+L  L +LHS RI+HRD+K GN+L+     +++ DFG++       N 
Sbjct: 106 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNL 160
Query: 143 AMTQE----VVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
              Q+    + T Y+ APE++M        Y    D+WS+G    E+
Sbjct: 161 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 210 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 260
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 373
Query: 181 L 181
           L
Sbjct: 374 L 374

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 65/126 (51%), Gaps = 5/126 (3%)
Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLL 118
           E+ ++ E L S   +  +       D  ++ LY  QI +G++YL S R +HRD+   N+L
Sbjct: 84  ELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNIL 143
Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGC 176
           V S   +KI DFGLA++   D +  + +E      ++ APE L     +S   DVWS G 
Sbjct: 144 VESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGV 202
Query: 177 IFAELL 182
           +  EL 
Sbjct: 203 VLYELF 208

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 41  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 91
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 92  NKGSLLDFLKGETGKYLRLPQLVDMSA------QIASGMAYVERMNYVHRDLRAANILVG 145
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 146 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 204
Query: 181 L 181
           L
Sbjct: 205 L 205

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 210 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 260
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 373
Query: 181 L 181
           L
Sbjct: 374 L 374

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD+   N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLAAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 1/93 (1%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           ++ YQ+   L YL S R +HRDI   N+LV+SN  +K+ DFGL+R  E       ++  +
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +   R +++A DVW  G    E+L
Sbjct: 555 PIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KI DFGLAR    DP+ 
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               +  +   + APE +   R Y+   DVWS G +  E+ 
Sbjct: 201 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 240

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 13/107 (12%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT   I+V   Q+L  L +LHS RI+HRD+K GN+L+     +++ DFG++       N 
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA-----KNL 168
Query: 143 AMTQE----VVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
              Q+    + T Y+ APE++M        Y    D+WS+G    E+
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   A K +     S    +++ RE ++    KH N++   D +      +     V   
Sbjct: 29  GHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYL----VFDL 84
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---I 124
           +   +L + IV+ ++ +       + QIL  + + H   ++HRD+KP NLL+ S C    
Sbjct: 85  VTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +K+ DFGLA +E     +A      T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 145 VKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR-KEAYGKPVDIWACGVILYILL 200

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 101
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 162 IGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 218

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 15/173 (8%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTS 85
           + V RE+      +H N++   + IL P HL    E     EL +      I +    + 
Sbjct: 60  ENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSE 114
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLAR--VEEPDPN 141
           D  + F  Q++ G+ Y H+ ++ HRD+K  N L++ +    LKIC FG ++  V    P 
Sbjct: 115 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPK 174
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG-CIFAELLGRRILFQAQSP 193
                 V T  Y APE+L+   +     DVWS G  ++  L+G       + P
Sbjct: 175 DT----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEP 223

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 41  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 91
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 92  NKGSLLDFLKGETGKYLRLPQLVDMSA------QIASGMAYVERMNYVHRDLRAANILVG 145
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 146 ENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 204
Query: 181 L 181
           L
Sbjct: 205 L 205

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 81/174 (46%), Gaps = 7/174 (4%)
Query: 30  FRELKMLCFFKHDN-VLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHI 88
            RE+ ++   +H N VL    + QPP+L    E Y+    L   LHK     Q L     
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE-YLSRGSLYRLLHKSGAREQ-LDERRR 139
Query: 89  KVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
               Y + +G+ YLH+    I+HRD+K  NLLV+    +K+CDFGL+R++          
Sbjct: 140 LSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-SXFLXSKX 198
Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
              T  + APE+L        + DV+S G I  EL   +  +   +P Q +  +
Sbjct: 199 AAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQPWGNLNPAQVVAAV 251

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 293 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 343
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 344 SKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 397
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 398 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 456
Query: 181 L 181
           L
Sbjct: 457 L 457

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 37  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 87
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 88  SKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 141
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 142 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 200
Query: 181 L 181
           L
Sbjct: 201 L 201

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 91
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 152 IGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 54/89 (60%), Gaps = 3/89 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI +G+ Y+HS +++HRD+KP N+ +     +KI DFGL    + D  +  T+   T  Y
Sbjct: 144 QITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRSKGTLRY 201
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +PE  + ++ Y   VD++++G I AELL
Sbjct: 202 MSPE-QISSQDYGKEVDLYALGLILAELL 229

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           +  T   +++++ +I+  L++LH   I++RDIK  N+L++SN  + + DFGL++    D 
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213
Query: 141 NKAMTQEVVTQYYRAPEILMGA-RHYSAAVDVWSVGCIFAELL 182
            +       T  Y AP+I+ G    +  AVD WS+G +  ELL
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 9/184 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           DP      AL  +  +  S    +R F RE+++L     D ++    +   P     Q +
Sbjct: 45  DPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QSL 101
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVN 120
            ++ E L S   +  +       D  ++ LY  QI +G++YL S R +HRD+   N+LV 
Sbjct: 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 161
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIF 178
           S   +KI DFGLA++   D +  + +E      ++ APE L     +S   DVWS G + 
Sbjct: 162 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVL 220
Query: 179 AELL 182
            EL 
Sbjct: 221 YELF 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 95
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 96  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 155
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 156 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 212

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 43  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 95
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 96  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 155
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 156 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 212

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 83/178 (46%), Gaps = 13/178 (7%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           +VA+K L       +S +    E +++   KHD ++    ++        + IY++TE +
Sbjct: 35  KVAIKTLK---PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE------EPIYIVTEYM 85
Query: 70  -QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +  L   +   +   L   ++     Q+  G+ Y+     +HRD++  N+LV +  I K
Sbjct: 86  NKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICK 145
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           I DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  EL+ +
Sbjct: 146 IADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTK 202

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 101
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 91
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 208

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 9/184 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           DP      AL  +  +  S    +R F RE+++L     D ++    +   P     Q +
Sbjct: 32  DPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QSL 88
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVN 120
            ++ E L S   +  +       D  ++ LY  QI +G++YL S R +HRD+   N+LV 
Sbjct: 89  RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIF 178
           S   +KI DFGLA++   D +  + +E      ++ APE L     +S   DVWS G + 
Sbjct: 149 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVL 207
Query: 179 AELL 182
            EL 
Sbjct: 208 YELF 211

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRV-FRELKMLCFFKHDNVLSALDIL--QPPHLD 57
           AV   ++  R+   K+ N ++ L  ++   FRE + +        ++AL        HL 
Sbjct: 91  AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLY 150
Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              + YV  +LL + L K       L  D  + ++ +++  +  +H    +HRDIKP N+
Sbjct: 151 LVMDYYVGGDLL-TLLSKF---EDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 206
Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM----GARHYSAAVDVWS 173
           L++ N  +++ DFG       D     +  V T  Y +PEIL     G   Y    D WS
Sbjct: 207 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 266
Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLITD 202
           +G    E+L     F A+S V+  G I +
Sbjct: 267 LGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 11/209 (5%)
Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRV-FRELKMLCFFKHDNVLSALDIL--QPPHLD 57
           AV   ++  R+   K+ N ++ L  ++   FRE + +        ++AL        HL 
Sbjct: 107 AVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLY 166
Query: 58  FFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              + YV  +LL + L K       L  D  + ++ +++  +  +H    +HRDIKP N+
Sbjct: 167 LVMDYYVGGDLL-TLLSKF---EDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNV 222
Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM----GARHYSAAVDVWS 173
           L++ N  +++ DFG       D     +  V T  Y +PEIL     G   Y    D WS
Sbjct: 223 LLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS 282
Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLITD 202
           +G    E+L     F A+S V+  G I +
Sbjct: 283 LGVCMYEMLYGETPFYAESLVETYGKIMN 311

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++TE  
Sbjct: 211 RVAIKTLK---PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVTEYM 261
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 262 SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 315
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGL R+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 316 ENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 374
Query: 181 L 181
           L
Sbjct: 375 L 375

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 9/184 (4%)
Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           DP      AL  +  +  S    +R F RE+++L     D ++    +   P     Q +
Sbjct: 33  DPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QSL 89
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLY--QILRGLKYLHSARILHRDIKPGNLLVN 120
            ++ E L S   +  +       D  ++ LY  QI +G++YL S R +HRD+   N+LV 
Sbjct: 90  RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE 149
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQ--YYRAPEILMGARHYSAAVDVWSVGCIF 178
           S   +KI DFGLA++   D +  + +E      ++ APE L     +S   DVWS G + 
Sbjct: 150 SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL-SDNIFSRQSDVWSFGVVL 208
Query: 179 AELL 182
            EL 
Sbjct: 209 YELF 212

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++ E  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVIEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHD----NVLSA--------LDIL 51
           +DG R+  A+K++   + S    +    EL++LC   H     N+L A        L I 
Sbjct: 38  KDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 96
Query: 52  QPPH---LDFFQEIYVITELLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSAR 106
             PH   LDF ++    + +L++D    I   +   L+S  +  F   + RG+ YL   +
Sbjct: 97  YAPHGNLLDFLRK----SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 152
Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
            +HRD+   N+LV  N + KI DFGL+R +E    K M +  V   + A E L     Y+
Sbjct: 153 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMAIESL-NYSVYT 209
Query: 167 AAVDVWSVGCIFAELL 182
              DVWS G +  E++
Sbjct: 210 TNSDVWSYGVLLWEIV 225

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 73/135 (54%), Gaps = 11/135 (8%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +++  +   DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 123 CILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             ++I D GLA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 182 LGRRILFQAQSPVQQ 196
           L      +  SP +Q
Sbjct: 385 L------RGHSPFRQ 393

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 73/135 (54%), Gaps = 11/135 (8%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +++  +   DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 123 CILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             ++I D GLA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 182 LGRRILFQAQSPVQQ 196
           L      +  SP +Q
Sbjct: 385 L------RGHSPFRQ 393

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 73/135 (54%), Gaps = 11/135 (8%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +++  +   DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 123 CILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             ++I D GLA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +L
Sbjct: 329 GHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384
Query: 182 LGRRILFQAQSPVQQ 196
           L      +  SP +Q
Sbjct: 385 L------RGHSPFRQ 393

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 73/135 (54%), Gaps = 11/135 (8%)
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +++  +   DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N+L++ +
Sbjct: 268 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 327
Query: 123 CILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             ++I D GLA    +  P+ +    V T  Y APE+L     Y ++ D +S+GC+  +L
Sbjct: 328 GHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 383
Query: 182 LGRRILFQAQSPVQQ 196
           L      +  SP +Q
Sbjct: 384 L------RGHSPFRQ 392

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 11  VALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L P+V     +     RE+  +    H N++    + L PP       + ++TEL
Sbjct: 39  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 91
Query: 69  --LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
             L S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  ++K
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 151
Query: 127 ICDFGLARVEEPDPNKAMTQE--VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           I DFGL R    + +  + QE   V   + APE L   R +S A D W  G    E+ 
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK-TRTFSHASDTWMFGVTLWEMF 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHD----NVLSA--------LDIL 51
           +DG R+  A+K++   + S    +    EL++LC   H     N+L A        L I 
Sbjct: 48  KDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106
Query: 52  QPPH---LDFFQEIYVITELLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSAR 106
             PH   LDF ++    + +L++D    I   +   L+S  +  F   + RG+ YL   +
Sbjct: 107 YAPHGNLLDFLRK----SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 162
Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
            +HRD+   N+LV  N + KI DFGL+R +E    K M +  V   + A E L     Y+
Sbjct: 163 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMAIESL-NYSVYT 219
Query: 167 AAVDVWSVGCIFAELL 182
              DVWS G +  E++
Sbjct: 220 TNSDVWSYGVLLWEIV 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
             R++ ++L  V ++      + R++       H ++++ +D  +     F     V   
Sbjct: 131 AERLSPEQLEEVREATRRETHILRQVA-----GHPHIITLIDSYESSSFMFL----VFDL 181
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKI 127
           + + +L   +     L+    +  +  +L  + +LH+  I+HRD+KP N+L++ N  +++
Sbjct: 182 MRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241
Query: 128 CDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL---MGARH--YSAAVDVWSVGCIFAELL 182
            DFG +   E  P + + +   T  Y APEIL   M   H  Y   VD+W+ G I   LL
Sbjct: 242 SDFGFSCHLE--PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 183 G 183
Sbjct: 300 A 300

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++ E  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVCEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 28/216 (12%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           R G RVALK + NV +   +++     L+ +     DN    + +      D+   + + 
Sbjct: 57  RGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFD--WFDYHGHMCIS 114
Query: 66  TELLQSDLHKIIVSPQHLTS--DHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNSN 122
            ELL       +    +L      ++   +Q+ + +K+LH  ++ H D+KP N+L VNS+
Sbjct: 115 FELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSD 174
Query: 123 ------------------CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH 164
                               +++ DFG A  +    ++  +  V T++YRAPE+++    
Sbjct: 175 YELTYNLEKKRDERSVKSTAVRVVDFGSATFD----HEHHSTIVSTRHYRAPEVILELG- 229
Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           +S   DVWS+GCI  E      LFQ     + L ++
Sbjct: 230 WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMM 265

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++ E  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVIEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGSLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++ E  
Sbjct: 44  RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVMEYM 94
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ ++ K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 95  SKGCLLDFLKGEMGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 148
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 149 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 207
Query: 181 L 181
           L
Sbjct: 208 L 208

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 20  FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS 79
           FQ L    R+ R+L+      H N++   D +Q     +     V   +   +L + IV+
Sbjct: 72  FQKLEREARICRKLQ------HPNIVRLHDSIQEESFHYL----VFDLVTGGELFEDIVA 121
Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVE 136
            +  +       + QIL  + Y HS  I+HR++KP NLL+ S      +K+ DFGLA   
Sbjct: 122 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 179
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           E + ++A      T  Y +PE+L     YS  VD+W+ G I   LL
Sbjct: 180 EVNDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILL 224

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 20  FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS 79
           FQ L    R+ R+L+      H N++   D +Q     +     V   +   +L + IV+
Sbjct: 48  FQKLEREARICRKLQ------HPNIVRLHDSIQEESFHYL----VFDLVTGGELFEDIVA 97
Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVE 136
            +  +       + QIL  + Y HS  I+HR++KP NLL+ S      +K+ DFGLA   
Sbjct: 98  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 155
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           E + ++A      T  Y +PE+L     YS  VD+W+ G I   LL
Sbjct: 156 EVNDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILL 200

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 20  FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS 79
           FQ L    R+ R+L+      H N++   D +Q     +     V   +   +L + IV+
Sbjct: 49  FQKLEREARICRKLQ------HPNIVRLHDSIQEESFHYL----VFDLVTGGELFEDIVA 98
Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVE 136
            +  +       + QIL  + Y HS  I+HR++KP NLL+ S      +K+ DFGLA   
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 156
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           E + ++A      T  Y +PE+L     YS  VD+W+ G I   LL
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILL 201

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIVSPQHLTS 85
           +  +E ++L  + H N++  + +         Q IY++ EL+Q    L  +      L  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
             +   +     G++YL S   +HRD+   N LV    +LKI DFG++R EE D   A +
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVXAAS 271
Query: 146 QEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             +  V   + APE L   R YS+  DVWS G +  E
Sbjct: 272 GGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWE 307

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K L   +      +    E  ++  F+H N++    ++          + ++TE ++
Sbjct: 45  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVVTNS-----MPVMILTEFME 98
Query: 71  SDLHK--IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
           +      + ++    T   +   L  I  G++YL     +HRD+   N+LVNSN + K+ 
Sbjct: 99  NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 158
Query: 129 DFGLAR-VEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           DFGL+R +EE   +   T  +  +    + APE +   R +++A D WS G +  E++
Sbjct: 159 DFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL-QSDLHKIIVSPQHLTSDHIK 89
           RE+++    +H N+L   +          + IY++ E   + +L+K +            
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHD-----RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
            F+ ++   L Y H  +++HRDIKP NLL+     LKI DFG + V  P   +       
Sbjct: 118 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXM--CG 174
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           T  Y  PE++ G  H    VD+W  G +  E L
Sbjct: 175 TLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFL 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 16/166 (9%)
Query: 20  FQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS 79
           FQ L    R+ R+L+      H N++   D +Q     +     V   +   +L + IV+
Sbjct: 49  FQKLEREARICRKLQ------HPNIVRLHDSIQEESFHYL----VFDLVTGGELFEDIVA 98
Query: 80  PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVE 136
            +  +       + QIL  + Y HS  I+HR++KP NLL+ S      +K+ DFGLA   
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-- 156
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           E + ++A      T  Y +PE+L     YS  VD+W+ G I   LL
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILL 201

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 69/153 (45%), Gaps = 10/153 (6%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL-QSDLHKIIVSPQHLTSDHIK 89
           RE+++    +H N+L   +          + IY++ E   + +L+K +            
Sbjct: 64  REIEIQSHLRHPNILRMYNYFHD-----RKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
            F+ ++   L Y H  +++HRDIKP NLL+     LKI DFG + V  P   +       
Sbjct: 119 TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXM--CG 175
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           T  Y  PE++ G  H    VD+W  G +  E L
Sbjct: 176 TLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFL 207

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 82/173 (47%), Gaps = 32/173 (18%)
Query: 58  FFQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
           ++  + +I E L   L++II    +     + IK++  +IL+ L YL    + H D+KP 
Sbjct: 107 YYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166
Query: 116 NLLVN-------------------------SNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           N+L++                          +  +K+ DFG A  +  D + ++   + T
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-DYHGSI---INT 222
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           + YRAPE+++    +  + D+WS GC+ AEL    +LF+    ++ L ++  +
Sbjct: 223 RQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 82/181 (45%), Gaps = 14/181 (7%)
Query: 15  KLPN---VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF----QEIYVITE 67
           KLP    +F ++ + K  + E +   F    +++   D     HL+        + +ITE
Sbjct: 29  KLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 88
Query: 68  LLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +++      +  +    T   +   L  I  G+KYL     +HR +   N+LVNSN + 
Sbjct: 89  FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVC 148
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQY----YRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R  E D +       +       + APE +   R +++A DVWS G +  E+
Sbjct: 149 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEV 207
Query: 182 L 182
           +
Sbjct: 208 M 208

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 62  IYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLL 118
           + ++ E+L  +L  +I   +H  +   ++K    Q+L GL Y+H    I+H DIKP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 119 VN-----SNCI-LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +       N I +KI D G A   +    +  T  + T+ YR+PE+L+GA  +    D+W
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAP-WGCGADIW 219
Query: 173 SVGCIFAELLGRRILFQ 189
           S  C+  EL+    LF+
Sbjct: 220 STACLIFELITGDFLFE 236

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
           LT + +  F YQ+ +G+++L     +HRD+   N+LV    ++KICDFGLAR    D N 
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 143 AMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +     +   + APE L     Y+   DVWS G +  E+ 
Sbjct: 229 VVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIF 268

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K L   +      +    E  ++  F+H N++    ++          + ++TE ++
Sbjct: 47  VAIKTLKGGYTER-QRREFLSEASIMGQFEHPNIIRLEGVVTNS-----MPVMILTEFME 100
Query: 71  SDLHK--IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
           +      + ++    T   +   L  I  G++YL     +HRD+   N+LVNSN + K+ 
Sbjct: 101 NGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVS 160
Query: 129 DFGLAR-VEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           DFGL+R +EE   +   T  +  +    + APE +   R +++A D WS G +  E++
Sbjct: 161 DFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 72/137 (52%), Gaps = 14/137 (10%)
Query: 62  IYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLL 118
           + ++ E+L  +L  +I   +H  +   ++K    Q+L GL Y+H    I+H DIKP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 119 VN-----SNCI-LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +       N I +KI D G A   +    +  T  + T+ YR+PE+L+GA  +    D+W
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAP-WGCGADIW 219
Query: 173 SVGCIFAELLGRRILFQ 189
           S  C+  EL+    LF+
Sbjct: 220 STACLIFELITGDFLFE 236

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 107 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 165
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 166 ATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 105 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 163
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 164 ATMKXFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 106 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 164
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 165 ATMKXFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 17/121 (14%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT-------- 145
           QI   +++LHS  ++HRD+KP N+    + ++K+ DFGL    + D  +           
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 146 ---QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
               +V T+ Y +PE + G  +YS  VD++S+G I  EL     L+   + ++++ +ITD
Sbjct: 232 THXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFEL-----LYSFSTQMERVRIITD 285
Query: 203 L 203
           +
Sbjct: 286 V 286

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 25/181 (13%)
Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE-- 67
           RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++ E  
Sbjct: 210 RVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYIVGEYM 260
Query: 68  -------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
                   L+ +  K +  PQ +          QI  G+ Y+     +HRD++  N+LV 
Sbjct: 261 SKGSLLDFLKGETGKYLRLPQLVD------MAAQIASGMAYVERMNYVHRDLRAANILVG 314
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            N + K+ DFGLAR+ E +   A         + APE  +  R ++   DVWS G +  E
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTE 373
Query: 181 L 181
           L
Sbjct: 374 L 374

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 11/203 (5%)
Query: 11  VALKKLPNVFQSLVSSK-RVFRELKMLCFFKHDNVLSALDILQPPHLDF-FQE---IYVI 65
           V LK    VF   + +K  + +  +  CF +  +VL   D      L + FQ+   +Y++
Sbjct: 93  VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV 152
Query: 66  TEL-LQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
            +  +  DL  ++      L  +  + +L +++  +  +H    +HRDIKP N+L++ N 
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM----GARHYSAAVDVWSVGCIFA 179
            +++ DFG       D     +  V T  Y +PEIL     G   Y    D WS+G    
Sbjct: 213 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 180 ELLGRRILFQAQSPVQQLGLITD 202
           E+L     F A+S V+  G I +
Sbjct: 273 EMLYGETPFYAESLVETYGKIMN 295

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIVSPQHLTS 85
           +  +E ++L  + H N++  + +         Q IY++ EL+Q    L  +      L  
Sbjct: 158 KFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRV 212
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
             +   +     G++YL S   +HRD+   N LV    +LKI DFG++R EE D   A +
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR-EEADGVYAAS 271
Query: 146 QEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
             +  V   + APE L   R YS+  DVWS G +  E
Sbjct: 272 GGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWE 307

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 60.8 bits (146), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)
Query: 37  CFFKHDNVLSAL--DILQPPHLDFFQE-IYVITELL-QSDLHKIIVSPQHLTSDHIKV-- 90
            F    NV+  L  D L   H    +E IY+ITE + +  L   + S +       K+  
Sbjct: 56  AFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID 115
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           F  QI  G+ ++     +HRD++  N+LV+++ + KI DFGLARV E +   A       
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 175
Query: 151 QYYRAPE-ILMGARHYSAAVDVWSVGCIFAELL 182
             + APE I  G+  ++   DVWS G +  E++
Sbjct: 176 IKWTAPEAINFGS--FTIKSDVWSFGILLMEIV 206

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 33  LKMLCFFKHDNVLSAL--DILQPPHLDFFQE-IYVITELL-QSDLHKIIVSPQHLTSDHI 88
           + +  F    NV+  L  D L   H    +E IY+ITE + +  L   + S +       
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 284
Query: 89  KV--FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
           K+  F  QI  G+ ++     +HRD++  N+LV+++ + KI DFGLARV E +   A   
Sbjct: 285 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 147 EVVTQYYRAPE-ILMGARHYSAAVDVWSVGCIFAELL 182
                 + APE I  G+  ++   DVWS G +  E++
Sbjct: 345 AKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIV 379

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 31/199 (15%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFREL---KMLCFFKHDNVLSALDILQPPHLDF---- 58
           +D +  ALKK     +SL+  KR F +    K+    K+D+  + L I+     ++    
Sbjct: 52  KDNKFYALKKYE---KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108
Query: 59  ------FQEIYVITELLQSDL-----HKIIVSPQHLTS----DHIKVFLYQILRGLKYLH 103
                 + E+Y+I E +++D          V  ++ T       IK  +  +L    Y+H
Sbjct: 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168
Query: 104 SAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA 162
           + + I HRD+KP N+L++ N  +K+ DFG +   E   +K +     T  +  PE     
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGES---EYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 163 RHYSAA-VDVWSVG-CIFA 179
             Y+ A VD+WS+G C++ 
Sbjct: 226 SSYNGAKVDIWSLGICLYV 244

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 9/177 (5%)
Query: 12  ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS 71
           A+K L  + + +   +   RE  ++    H NVL+ + I+ PP  +    + ++  +   
Sbjct: 53  AIKSLSRITE-MQQVEAFLREGLLMRGLNHPNVLALIGIMLPP--EGLPHV-LLPYMCHG 108
Query: 72  DLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           DL + I SPQ + T   +  F  Q+ RG++YL   + +HRD+   N +++ +  +K+ DF
Sbjct: 109 DLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF 168
Query: 131 GLARVEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           GLAR        ++ Q    +    + A E L   R ++   DVWS G +  ELL R
Sbjct: 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTR 224

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 30/188 (15%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYV 64
           +  +VA+K L       +S +    E  ++   +HD +  L A+   + P       IY+
Sbjct: 36  NSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEP-------IYI 85
Query: 65  ITE---------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
           ITE          L+SD    ++ P+ +       F  QI  G+ Y+     +HRD++  
Sbjct: 86  ITEYMAKGSLLDFLKSDEGGKVLLPKLID------FSAQIAEGMAYIERKNYIHRDLRAA 139
Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDVWSV 174
           N+LV+ + + KI DFGLARV E +   A         + APE I  G   ++   DVWS 
Sbjct: 140 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC--FTIKSDVWSF 197
Query: 175 GCIFAELL 182
           G +  E++
Sbjct: 198 GILLYEIV 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 112 VCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 172 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 198

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 306
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 307 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 364

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 65/144 (45%), Gaps = 3/144 (2%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +Y++ E +       ++S   +     K +  +++  L  +HS  ++HRD+KP N+L++ 
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK 209
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM---GARHYSAAVDVWSVGCIF 178
           +  LK+ DFG     +          V T  Y +PE+L    G  +Y    D WSVG   
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 269
Query: 179 AELLGRRILFQAQSPVQQLGLITD 202
            E+L     F A S V     I D
Sbjct: 270 FEMLVGDTPFYADSLVGTYSKIMD 293

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 78/149 (52%), Gaps = 27/149 (18%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV--------FLYQILRGLKYLHSARILHRDIK 113
           +Y+  EL   +L  ++ S ++++ +++K+         L QI  G+ +LHS +I+HRD+K
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 114 PGNLLVNS-------------NCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAPE 157
           P N+LV++             N  + I DFGL +  +         +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 158 ILMGA--RHYSAAVDVWSVGCIFAELLGR 184
           +L  +  R  + ++D++S+GC+F  +L +
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI  G+ Y+     +HRD++  N+LV  N + K+ DFGLAR+ E +   A         +
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAEL 181
            APE  +  R ++   DVWS G +  EL
Sbjct: 172 TAPEAALYGR-FTIKSDVWSFGILLTEL 198

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 3/119 (2%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            + D  + +  +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E     
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDG 303
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
             M     T  Y APE+L     Y  AVD W +G +  E++  R+ F  Q   +   LI
Sbjct: 304 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 27/196 (13%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHD----NVLSA--------LDIL 51
           +DG R+  A+K++   + S    +    EL++LC   H     N+L A        L I 
Sbjct: 45  KDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 103
Query: 52  QPPH---LDFFQEIYVITELLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSAR 106
             PH   LDF ++    + +L++D    I   +   L+S  +  F   + RG+ YL   +
Sbjct: 104 YAPHGNLLDFLRK----SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 159
Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
            +HR++   N+LV  N + KI DFGL+R +E    K M +  V   + A E L     Y+
Sbjct: 160 FIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--WMAIESL-NYSVYT 216
Query: 167 AAVDVWSVGCIFAELL 182
              DVWS G +  E++
Sbjct: 217 TNSDVWSYGVLLWEIV 232

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.1 bits (144), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 78/149 (52%), Gaps = 27/149 (18%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV--------FLYQILRGLKYLHSARILHRDIK 113
           +Y+  EL   +L  ++ S ++++ +++K+         L QI  G+ +LHS +I+HRD+K
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 114 PGNLLVNS-------------NCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAPE 157
           P N+LV++             N  + I DFGL +  +         +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 158 ILMGA--RHYSAAVDVWSVGCIFAELLGR 184
           +L  +  R  + ++D++S+GC+F  +L +
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-V 149
           F YQ+ +G+ +L S   +HRD+   N+L+    I KICDFGLAR  + D N  +     +
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +     Y+   DVWS G    EL 
Sbjct: 226 PVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 257

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 49/193 (25%)
Query: 37  CFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQIL 96
           CF K+D+V+ A+  L+  H  F        ++L S           L+   ++ ++  + 
Sbjct: 88  CFRKNDHVVIAMPYLE--HESFL-------DILNS-----------LSFQEVREYMLNLF 127
Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCI-LKICDFGLAR------------------VEE 137
           + LK +H   I+HRD+KP N L N       + DFGLA+                   E 
Sbjct: 128 KALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 138 PDPNK-----AMTQEVV----TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL-GRRIL 187
              NK     +  Q+V     T  +RAPE+L    + + A+D+WS G IF  LL GR   
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247
Query: 188 FQAQSPVQQLGLI 200
           ++A   +  L  I
Sbjct: 248 YKASDDLTALAQI 260

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 2/94 (2%)
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
           + +  +I   L YLHS  I++RD+KP N+L++S   + + DFGL + E  + N   +   
Sbjct: 142 RFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFC 200
Query: 149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            T  Y APE+L   + Y   VD W +G +  E+L
Sbjct: 201 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEML 233

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-V 149
           F YQ+ +G+ +L S   +HRD+   N+L+    I KICDFGLAR  + D N  +     +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +     Y+   DVWS G    EL 
Sbjct: 210 PVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 241

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  QI+ GL++LH   I++RD+KP N+L++ +  ++I D GLA VE             T
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGT 352
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             + APE+L+G   Y  +VD +++G    E++  R  F+A+ 
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-V 149
           F YQ+ +G+ +L S   +HRD+   N+L+    I KICDFGLAR  + D N  +     +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +     Y+   DVWS G    EL 
Sbjct: 228 PVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 259

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  QI+ GL++LH   I++RD+KP N+L++ +  ++I D GLA VE             T
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGT 352
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             + APE+L+G   Y  +VD +++G    E++  R  F+A+ 
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  QI+ GL++LH   I++RD+KP N+L++ +  ++I D GLA VE             T
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGT 352
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             + APE+L+G   Y  +VD +++G    E++  R  F+A+ 
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-V 149
           F YQ+ +G+ +L S   +HRD+   N+L+    I KICDFGLAR  + D N  +     +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +     Y+   DVWS G    EL 
Sbjct: 233 PVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 264

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 2/92 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +L +I   L +LH   I++RD+KP N+++N    +K+ DFGL +    D     T    T
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-CGT 184
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             Y APEILM + H + AVD WS+G +  ++L
Sbjct: 185 IEYMAPEILMRSGH-NRAVDWWSLGALMYDML 215

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 2/93 (2%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV-V 149
           F YQ+ +G+ +L S   +HRD+   N+L+    I KICDFGLAR  + D N  +     +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +     Y+   DVWS G    EL 
Sbjct: 233 PVKWMAPESIFNCV-YTFESDVWSYGIFLWELF 264

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 85/183 (46%), Gaps = 13/183 (7%)
Query: 24  VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH 82
           V  + + RE+ +L    H N+++  D+ +        ++ +I EL+   +L   +   + 
Sbjct: 57  VCREEIEREVSILRQVLHPNIITLHDVYENR-----TDVVLILELVSGGELFDFLAQKES 111
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI----LKICDFGLARVEEP 138
           L+ +    F+ QIL G+ YLH+ +I H D+KP N+++    I    +K+ DFGLA   E 
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EI 169
Query: 139 DPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLG 198
           +          T  + APEI+          D+WS+G I   LL     F   +  + L 
Sbjct: 170 EDGVEFKNIFGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228
Query: 199 LIT 201
            IT
Sbjct: 229 NIT 231

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K L +   +  + K   RE ++L   +H++++    +     ++    I V   +  
Sbjct: 46  VAVKTLKDASDN--ARKDFHREAELLTNLQHEHIVKFYGVC----VEGDPLIMVFEYMKH 99
Query: 71  SDLHKIIVS-------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            DL+K + +             P  LT   +     QI  G+ YL S   +HRD+   N 
Sbjct: 100 GDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 159
Query: 118 LVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           LV  N ++KI DFG++R V   D  +     ++   +  PE +M  R ++   DVWS+G 
Sbjct: 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGV 218
Query: 177 IFAELL--GRRILFQ 189
           +  E+   G++  +Q
Sbjct: 219 VLWEIFTYGKQPWYQ 233

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 58/102 (56%), Gaps = 2/102 (1%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVT 150
           +  QI+ GL++LH   I++RD+KP N+L++ +  ++I D GLA VE             T
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGT 352
Query: 151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             + APE+L+G   Y  +VD +++G    E++  R  F+A+ 
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 6/172 (3%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K   N     V  K +   L M   F H +++  + ++    +    E+  + EL +
Sbjct: 41  VAIKTCKNCTSDSVREKFLQEALTMR-QFDHPHIVKLIGVITENPVWIIMELCTLGEL-R 98
Query: 71  SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
           S L    V    L    + ++ YQ+   L YL S R +HRDI   N+LV++   +K+ DF
Sbjct: 99  SFLQ---VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDF 155
Query: 131 GLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           GL+R  E       ++  +   + APE +   R +++A DVW  G    E+L
Sbjct: 156 GLSRYMEDSTYYKASKGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 79/153 (51%), Gaps = 31/153 (20%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV--------FLYQILRGLKYLHSARILHRDIK 113
           +Y+  EL   +L  ++ S ++++ +++K+         L QI  G+ +LHS +I+HRD+K
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 114 PGNLLVNS-------------NCILKICDFGLARVEEPDPNKAMT---QEVVTQYYRAPE 157
           P N+LV++             N  + I DFGL +  +   +   T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 158 ILMGA------RHYSAAVDVWSVGCIFAELLGR 184
           +L  +      R  + ++D++S+GC+F  +L +
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198
Query: 177 IFAELL 182
           +  E++
Sbjct: 199 LLTEIV 204

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 89  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 148
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 149 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 207
Query: 177 IFAELL 182
           +  E++
Sbjct: 208 LLTEIV 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 1/93 (1%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV 149
           ++ YQ+   L YL S R +HRDI   N+LV++   +K+ DFGL+R  E       ++  +
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              + APE +   R +++A DVW  G    E+L
Sbjct: 555 PIKWMAPESI-NFRRFTSASDVWMFGVCMWEIL 586

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 81  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 140
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 141 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 199
Query: 177 IFAELL 182
           +  E++
Sbjct: 200 LLTEIV 205

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 54/89 (60%), Gaps = 3/89 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI +G+ Y+HS ++++RD+KP N+ +     +KI DFGL    + D  +  ++   T  Y
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK--GTLRY 187
Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            +PE  + ++ Y   VD++++G I AELL
Sbjct: 188 MSPE-QISSQDYGKEVDLYALGLILAELL 215

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNK--- 142
           I   + QI   L YLH+  I HRDIKP N L ++N    +K+ DFGL++      N    
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 143 AMTQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELL 182
            MT +  T Y+ APE+L      Y    D WS G +   LL
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 82  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 141
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 142 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 200
Query: 177 IFAELL 182
           +  E++
Sbjct: 201 LLTEIV 206

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 200

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 110 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 170 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 196

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 222

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198
Query: 177 IFAELL 182
           +  E++
Sbjct: 199 LLTEIV 204

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 132 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 191
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 192 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 218

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 88  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 147
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 148 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 206
Query: 177 IFAELL 182
           +  E++
Sbjct: 207 LLTEIV 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 41  HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLK 100
           H N++   D  +     F     V   + + +L   +     L+    +  +  +L  + 
Sbjct: 70  HPNIIQLKDTYETNTFFFL----VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 101 YLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL- 159
            LH   I+HRD+KP N+L++ +  +K+ DFG +   + DP + + +   T  Y APEI+ 
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYLAPEIIE 183
Query: 160 --MGARH--YSAAVDVWSVGCIFAELLG 183
             M   H  Y   VD+WS G I   LL 
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLA 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPECI-NYYKFSSKSDVWSFGVLMWE 220

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 86/184 (46%), Gaps = 12/184 (6%)
Query: 21  QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIV 78
           + +   + V  E+ ++    H N++   D  +  +     +I ++ E +       +II 
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEYVDGGELFDRIID 179
Query: 79  SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL-VNSNCI-LKICDFGLARVE 136
              +LT     +F+ QI  G++++H   ILH D+KP N+L VN +   +KI DFGLAR  
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
           +  P + +     T  + APE++      S   D+WSVG I   LL     F   +  + 
Sbjct: 240 K--PREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
Query: 197 LGLI 200
           L  I
Sbjct: 297 LNNI 300

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 112 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 172 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 198

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 86  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 145
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 146 ILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 204
Query: 177 IFAELL 182
           +  E++
Sbjct: 205 LLTEIV 210

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 115 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 174
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 175 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 201

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 1/88 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +  G+ YL  A ++HRD+   N LV  N ++K+ DFG+ R    D   + T       + 
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           +PE+   +R YS+  DVWS G +  E+ 
Sbjct: 173 SPEVFSFSR-YSSKSDVWSFGVLMWEVF 199

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 55/93 (59%), Gaps = 4/93 (4%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV- 149
           +L +I   L +LH   I++RD+KP N+++N    +K+ DFGL +  E   +  +T     
Sbjct: 126 YLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFCG 183
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           T  Y APEILM + H + AVD WS+G +  ++L
Sbjct: 184 TIEYMAPEILMRSGH-NRAVDWWSLGALMYDML 215

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 75  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 134
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 135 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 193
Query: 177 IFAELL 182
           +  E++
Sbjct: 194 LLTEIV 199

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198
Query: 177 IFAELL 182
           +  E++
Sbjct: 199 LLTEIV 204

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 26/186 (13%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           +  +VA+K L       +S +    E  ++   +HD ++    ++        + IY+IT
Sbjct: 35  NSTKVAVKTLK---PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-----EPIYIIT 86
Query: 67  EL---------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           E          L+SD    ++ P+ +       F  QI  G+ Y+     +HRD++  N+
Sbjct: 87  EFMAKGSLLDFLKSDEGGKVLLPKLID------FSAQIAEGMAYIERKNYIHRDLRAANV 140
Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE-ILMGARHYSAAVDVWSVGC 176
           LV+ + + KI DFGLARV E +   A         + APE I  G   ++   +VWS G 
Sbjct: 141 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC--FTIKSNVWSFGI 198
Query: 177 IFAELL 182
           +  E++
Sbjct: 199 LLYEIV 204

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 11/148 (7%)
Query: 41  HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLK 100
           H N++   D  +     F     V   + + +L   +     L+    +  +  +L  + 
Sbjct: 83  HPNIIQLKDTYETNTFFFL----VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 101 YLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL- 159
            LH   I+HRD+KP N+L++ +  +K+ DFG +   + DP + + +   T  Y APEI+ 
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYLAPEIIE 196
Query: 160 --MGARH--YSAAVDVWSVGCIFAELLG 183
             M   H  Y   VD+WS G I   LL 
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 86  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 145
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 146 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 204
Query: 177 IFAELL 182
           +  E++
Sbjct: 205 LLTEIV 210

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 85  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 144
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 145 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 203
Query: 177 IFAELL 182
           +  E++
Sbjct: 204 LLTEIV 209

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
            G+ +LH    +HRDIK  N+L++     KI DFGLAR  E      M   +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMA 203
Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL 182
           PE L G    +   D++S G +  E++
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEII 228

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +   + +S+  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWE 564

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPDPNKAMTQE 147
           +F  QI  G+ YLH+   +HRD+   N+L++++ ++KI DFGLA+   E  +  +     
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               ++ APE L   + Y A+ DVWS G    ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 3/110 (2%)
Query: 73  LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL 132
           L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 133 ARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           ++    D N  KA T       + APE +   + +S+  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWE 565

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 78/153 (50%), Gaps = 31/153 (20%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV--------FLYQILRGLKYLHSARILHRDIK 113
           +Y+  EL   +L  ++ S ++++ +++K+         L QI  G+ +LHS +I+HRD+K
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 114 PGNLLVNS-------------NCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAPE 157
           P N+LV++             N  + I DFGL +  +         +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 158 ILMGA------RHYSAAVDVWSVGCIFAELLGR 184
           +L  +      R  + ++D++S+GC+F  +L +
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 16/169 (9%)
Query: 25  SSKRVFRELKMLCFFKHDNVLS----ALDILQPPHLDFFQEIYVITELLQ----SDLHKI 76
             + + +E+ ML  + H   ++    A     PP +D   +++++ E       +DL K 
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD--DQLWLVMEFCGAGSVTDLIKN 120
Query: 77  IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE 136
                 L  + I     +ILRGL +LH  +++HRDIK  N+L+  N  +K+ DFG++   
Sbjct: 121 -TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARH----YSAAVDVWSVGCIFAEL 181
           +    +  T  + T Y+ APE++    +    Y    D+WS+G    E+
Sbjct: 180 DRTVGRRNTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 90  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 149
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 150 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 208
Query: 177 IFAELL 182
           +  E++
Sbjct: 209 LLTEIV 214

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 110
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 170
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 171 FTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 229
Query: 180 ELLGR 184
           EL+ R
Sbjct: 230 ELMTR 234

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 10/191 (5%)
Query: 9   RRVALKKLPNVFQSLVSSKRVF--RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           R+V   KL + F+ +  S   F   E  ++ F     V+      Q         +Y++ 
Sbjct: 99  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY-----LYMVM 153
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E +       ++S   +     + +  +++  L  +HS   +HRD+KP N+L++ +  LK
Sbjct: 154 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 213
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLG 183
           + DFG       +        V T  Y +PE+L    G  +Y    D WSVG    E+L 
Sbjct: 214 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273
Query: 184 RRILFQAQSPV 194
               F A S V
Sbjct: 274 GDTPFYADSLV 284

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 113 NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 168
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 287
Query: 180 ELLGR 184
           EL+ R
Sbjct: 288 ELMTR 292

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
            G+ +LH    +HRDIK  N+L++     KI DFGLAR  E      M   +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMA 203
Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL 182
           PE L G    +   D++S G +  E++
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEII 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 55  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 110
Query: 64  VITELLQSDLHKIIVSPQHL-TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 111 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 170
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 171 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 229
Query: 180 ELLGR 184
           EL+ R
Sbjct: 230 ELMTR 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 109
Query: 64  VITELLQSDLHKIIVSPQHL-TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 169
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 228
Query: 180 ELLGR 184
           EL+ R
Sbjct: 229 ELMTR 233

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 26/203 (12%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           +D   VA+K L +   +L + K   RE ++L   +H++++    +      D    I V 
Sbjct: 43  KDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCG----DGDPLIMVF 96
Query: 66  TELLQSDLHK----------IIVSPQ------HLTSDHIKVFLYQILRGLKYLHSARILH 109
             +   DL+K          I+V  Q       L    +     QI  G+ YL S   +H
Sbjct: 97  EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVH 156
Query: 110 RDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAA 168
           RD+   N LV +N ++KI DFG++R V   D  +     ++   +  PE +M  R ++  
Sbjct: 157 RDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTE 215
Query: 169 VDVWSVGCIFAELL--GRRILFQ 189
            DVWS G I  E+   G++  FQ
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQ 238

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 109
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 169
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 170 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 228
Query: 180 ELLGR 184
           EL+ R
Sbjct: 229 ELMTR 233

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 107
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 167
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 168 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 226
Query: 180 ELLGR 184
           EL+ R
Sbjct: 227 ELMTR 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 59  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 114
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++  
Sbjct: 115 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 174
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G +  
Sbjct: 175 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 233
Query: 180 ELLGR 184
           EL+ R
Sbjct: 234 ELMTR 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
            G+ +LH    +HRDIK  N+L++     KI DFGLAR  E      M   +V T  Y A
Sbjct: 138 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMA 197
Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL 182
           PE L G    +   D++S G +  E++
Sbjct: 198 PEALRG--EITPKSDIYSFGVVLLEII 222

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 10/191 (5%)
Query: 9   RRVALKKLPNVFQSLVSSKRVF--RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           R+V   KL + F+ +  S   F   E  ++ F     V+      Q         +Y++ 
Sbjct: 99  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY-----LYMVM 153
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E +       ++S   +     + +  +++  L  +HS   +HRD+KP N+L++ +  LK
Sbjct: 154 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 213
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLG 183
           + DFG       +        V T  Y +PE+L    G  +Y    D WSVG    E+L 
Sbjct: 214 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273
Query: 184 RRILFQAQSPV 194
               F A S V
Sbjct: 274 GDTPFYADSLV 284

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 10/191 (5%)
Query: 9   RRVALKKLPNVFQSLVSSKRVF--RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           R+V   KL + F+ +  S   F   E  ++ F     V+      Q         +Y++ 
Sbjct: 94  RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY-----LYMVM 148
Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E +       ++S   +     + +  +++  L  +HS   +HRD+KP N+L++ +  LK
Sbjct: 149 EYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLK 208
Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLG 183
           + DFG       +        V T  Y +PE+L    G  +Y    D WSVG    E+L 
Sbjct: 209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 184 RRILFQAQSPV 194
               F A S V
Sbjct: 269 GDTPFYADSLV 279

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 108
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 168
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 169 FTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 227
Query: 180 ELLGR 184
           EL+ R
Sbjct: 228 ELMTR 232

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 11/148 (7%)
Query: 41  HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLK 100
           H N++   D  +     F     V   + + +L   +     L+    +  +  +L  + 
Sbjct: 83  HPNIIQLKDTYETNTFFFL----VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 101 YLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL- 159
            LH   I+HRD+KP N+L++ +  +K+ DFG +   + DP + +     T  Y APEI+ 
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLRSVCGTPSYLAPEIIE 196
Query: 160 --MGARH--YSAAVDVWSVGCIFAELLG 183
             M   H  Y   VD+WS G I   LL 
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 74  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 187
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 97  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 153
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 210
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCGDIPFE 238

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 74  GVIRLLDWFERP--DSFVLILERMEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 187
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 90  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 203
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+  A K +     S    +++ RE ++    KH N++   D +      +     V   
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYL----VFDL 84
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCI 124
           +   +L + IV+ ++ +       + QIL  + + H   I+HRD+KP NLL+ S      
Sbjct: 85  VTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +K+ DFGLA +E     +A      T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 145 VKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR-KDPYGKPVDMWACGVILYILL 200

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 75  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 188
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 90  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 203
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 89  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 202
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 89  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 202
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HRD++  N
Sbjct: 80  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E     A         + APE +     ++   DVWS G 
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 198
Query: 177 IFAELL 182
           +  E++
Sbjct: 199 LLTEIV 204

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 75  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 188
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 90  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 203
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 109 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 166 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 222
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 117 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 230
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 102 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 215
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 73  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 129
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 186
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 103 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 216
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 102 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 215
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 102 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 215
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 70  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 183
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 75  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 188
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 103 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 216
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 103 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 216
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 102 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 158
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 159 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 215
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 103 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 159
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 160 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 216
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 70  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 183
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 7/112 (6%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ-EV 148
            +L++ + GLK  H   I HRDIK  N+L+ +N    I DFGLA   E   +   T  +V
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 149 VTQYYRAPEILMGARHYSA----AVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
            T+ Y APE+L GA ++       +D++++G +  EL  R     A  PV +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR--CTAADGPVDE 244

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 122 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 178
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 179 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 235
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 33  LKMLCFFKHDNVLSAL--DILQPPHLDFFQE-IYVITELL-QSDLHKIIVSPQHLTSDHI 88
           + +  F    NV+  L  D L   H    +E IY+ITE + +  L   + S +       
Sbjct: 219 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 278
Query: 89  KV--FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
           K+  F  QI  G+ ++     +HRD++  N+LV+++ + KI DFGLARV    P K    
Sbjct: 279 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK---- 334
Query: 147 EVVTQYYRAPE-ILMGARHYSAAVDVWSVGCIFAELL 182
                 + APE I  G+  ++   DVWS G +  E++
Sbjct: 335 ------WTAPEAINFGS--FTIKSDVWSFGILLMEIV 363

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 117 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 230
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 70  GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 183
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 9/178 (5%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+  A K +     S    +++ RE ++    KH N++   D +      +     V   
Sbjct: 29  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYL----VFDL 84
Query: 68  LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCI 124
           +   +L + IV+ ++ +       + QIL  + + H   I+HRD+KP NLL+ S      
Sbjct: 85  VTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAA 144
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +K+ DFGLA +E     +A      T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 145 VKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR-KDPYGKPVDMWACGVILYILL 200

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 43  NVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
            V+  LD  + P  D F  I    E +Q DL   I     L  +  + F +Q+L  +++ 
Sbjct: 117 GVIRLLDWFERP--DSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 103 HSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+  +LHRDIK  N+L++ N   LK+ DFG   + +   +   T    T+ Y  PE +  
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRY 230
Query: 162 ARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            R++  +  VWS+G +  +++   I F+
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPDPNKAMTQE 147
           +F  QI  G+ YLHS   +HR++   N+L++++ ++KI DFGLA+   E  +  +     
Sbjct: 121 LFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               ++ APE L   + Y A+ DVWS G    ELL
Sbjct: 181 DSPVFWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS 188
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 189 PPEVLMYSK-FSSKSDIWAFGVLMWEI 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPN 141
           LT   +  F +QI +G++YL   +++HRD+   N+LV     +KI DFGL+R V E D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              +Q  +   + A E L     Y+   DVWS G +  E++
Sbjct: 207 VKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV 246

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +  L+PP        Y++TE 
Sbjct: 60  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPP-------FYIVTEY 109
Query: 69  L-QSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + + +T+  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 110 MPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVV 169
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 170 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNTFSIKSDVWAFGVLLWEI 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 63/126 (50%), Gaps = 4/126 (3%)
Query: 60  QEIYVITELLQS-DLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           + IY+ITE +++  L   + +P    LT + +     QI  G+ ++     +HR+++  N
Sbjct: 76  EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAAN 135
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +LV+     KI DFGLAR+ E +   A         + APE +     ++   DVWS G 
Sbjct: 136 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGI 194
Query: 177 IFAELL 182
           +  E++
Sbjct: 195 LLTEIV 200

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS--DLHKIIVSPQHLTS 85
           +V  E+ +L   +H N++  LDI +  +  FFQ   ++ E   S  DL   I     L  
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDIFE--NQGFFQ---LVMEKHGSGLDLFAFIDRHPRLDE 129
Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMT 145
                   Q++  + YL    I+HRDIK  N+++  +  +K+ DFG A   E    K   
Sbjct: 130 PLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFY 187
Query: 146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               T  Y APE+LMG  +    +++WS+G     L+
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 72  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 127
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 128 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 187
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 188 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 246
Query: 180 ELLGR 184
           EL+ R
Sbjct: 247 ELMTR 251

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 13/180 (7%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVIT 66
           G+  A K +     S    +++ RE ++    KH N++   D I +  H       Y+I 
Sbjct: 47  GQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH------YLIF 100
Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---N 122
           +L+   +L + IV+ ++ +       + QIL  + + H   ++HRD+KP NLL+ S    
Sbjct: 101 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKG 160
Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
             +K+ DFGLA +E     +A      T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 161 AAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILL 218

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 109 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 169 PPEVLMYSK-FSSKSDIWAFGVLMWEI 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 113 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 172
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 173 PPEVLMYSK-FSSKSDIWAFGVLMWEI 198

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 149 KVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 203

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 53  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 108
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 109 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 168
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 169 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 227
Query: 180 ELLGR 184
           EL+ R
Sbjct: 228 ELMTR 232

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPN 141
           LT   +  F +QI +G++YL   +++HRD+   N+LV     +KI DFGL+R V E D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              +Q  +   + A E L     Y+   DVWS G +  E++
Sbjct: 207 VKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV 246

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 109
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 169
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 228
Query: 180 ELLGR 184
           EL+ R
Sbjct: 229 ELMTR 233

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQE 147
           ++ QIL  L+Y H   I+HRD+KP N+L+ S   +  +K+ DFG+A ++  +        
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAGGR 193
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           V T ++ APE++     Y   VDVW  G I   LL
Sbjct: 194 VGTPHFMAPEVVK-REPYGKPVDVWGCGVILFILL 227

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 173
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 174 PPEVLMYSK-FSSKSDIWAFGVLMWEI 199

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 46  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 101
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 102 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 161
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 162 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 220
Query: 180 ELLGR 184
           EL+ R
Sbjct: 221 ELMTR 225

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 156 KVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 210

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 73  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 128
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 129 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 188
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 189 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 247
Query: 180 ELLGR 184
           EL+ R
Sbjct: 248 ELMTR 252

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 57.0 bits (136), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 120 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 179
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 180 PPEVLMYSK-FSSKSDIWAFGVLMWEI 205

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 51  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 106
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 166
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 167 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 225
Query: 180 ELLGR 184
           EL+ R
Sbjct: 226 ELMTR 230

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 52  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 107
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 108 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 167
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 168 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 226
Query: 180 ELLGR 184
           EL+ R
Sbjct: 227 ELMTR 231

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 49  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 104
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 164
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 165 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 223
Query: 180 ELLGR 184
           EL+ R
Sbjct: 224 ELMTR 228

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 189 PPEVLMYSK-FSSKSDIWAFGVLMWEI 214

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 11/185 (5%)
Query: 6   RDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            DG+++  A+K L N    +    +   E  ++  F H NVLS L I           + 
Sbjct: 54  NDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE---GSPLV 109
Query: 64  VITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           V+  +   DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++  
Sbjct: 110 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK 169
Query: 123 CILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +K+ DFGLAR    +E       T   +   + A E L   + ++   DVWS G +  
Sbjct: 170 FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ-TQKFTTKSDVWSFGVLLW 228
Query: 180 ELLGR 184
           EL+ R
Sbjct: 229 ELMTR 233

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 189 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQ 268

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 27/87 (31%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           +   ++YL S + LHRD+   N LVN   ++K+ DFGL+R    D   +         + 
Sbjct: 114 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS 173
Query: 155 APEILMGARHYSAAVDVWSVGCIFAEL 181
            PE+LM ++ +S+  D+W+ G +  E+
Sbjct: 174 PPEVLMYSK-FSSKSDIWAFGVLMWEI 199

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 161 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQ 240

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 85  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 144
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 145 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 203
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 204 SDVWSLGCILYYMTYGKTPFQ 224

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  RG+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +  +  YS   DV++ G +  EL+
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 45  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 94
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 95  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 155 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 210

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 81  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 140
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 141 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 199
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 200 SDVWSLGCILYYMTYGKTPFQ 220

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 54  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 103
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 104 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 163
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 164 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 218

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 69  LQ-SDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           +   +L   +        + + V LY   QI   ++YL     +HRD+   N LV  N +
Sbjct: 96  MTYGNLLDYLRECNRQEVNAV-VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 154
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 155 VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 210

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 189 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 153 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 207

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 93  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 152
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 153 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 3/95 (3%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPDPNKAMTQE 147
           +F  QI  G+ YLH+   +HR++   N+L++++ ++KI DFGLA+   E  +  +     
Sbjct: 121 LFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               ++ APE L   + Y A+ DVWS G    ELL
Sbjct: 181 DSPVFWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 90
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 95
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 96  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 210

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 82  QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 141
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 142 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 201 SDVWSLGCILYYMTYGKTPFQ 221

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 3/87 (3%)
Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
            G+ +LH    +HRDIK  N+L++     KI DFGLAR  E          +V T  Y A
Sbjct: 135 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXA 194
Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL 182
           PE L G    +   D++S G +  E++
Sbjct: 195 PEALRG--EITPKSDIYSFGVVLLEII 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 91
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 92  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 151
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 152 KVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 206

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 53/101 (52%), Gaps = 2/101 (1%)
Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPN 141
           LT   +  F +QI +G++YL    ++HRD+   N+LV     +KI DFGL+R V E D  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              +Q  +   + A E L     Y+   DVWS G +  E++
Sbjct: 207 VKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIV 246

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 18/177 (10%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 43  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 92
Query: 69  LQ-SDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           +   +L   +        + + V LY   QI   ++YL     +HRD+   N LV  N +
Sbjct: 93  MTYGNLLDYLRECNRQEVNAV-VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 151
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 152 VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 207

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 2/90 (2%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           Q+  G+ YL   + +HRD+   N LV  N ++KI DFGL+R +   D  KA   + +   
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +  PE +   R Y+   DVW+ G +  E+ 
Sbjct: 242 WMPPESIFYNR-YTTESDVWAYGVVLWEIF 270

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN 141
            L S  +  +  QI +G+ YL   R++HRD+   N+LV S   +KI DFGLAR+ + D  
Sbjct: 115 RLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 142 K--AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +  A   +V  ++     IL   R ++   DVWS G    EL+
Sbjct: 175 EYHADGGKVPIKWMALESILR--RRFTHQSDVWSYGVTVWELM 215

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 24/203 (11%)
Query: 11  VALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL 69
           VA+K  P    QS  S + +F    M    KH+N+L  +   +    +   E+++IT   
Sbjct: 41  VAVKIFPLQDKQSWQSEREIFSTPGM----KHENLLQFI-AAEKRGSNLEVELWLITAFH 95
Query: 70  QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS-----------ARILHRDIKPGNLL 118
                   +    +T + +      + RGL YLH              I HRD K  N+L
Sbjct: 96  DKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVL 155
Query: 119 VNSNCILKICDFGLA-RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA----AVDVWS 173
           + S+    + DFGLA R E   P      +V T+ Y APE+L GA ++       +D+++
Sbjct: 156 LKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 215
Query: 174 VGCIFAELLGRRILFQAQSPVQQ 196
           +G +  EL+ R     A  PV +
Sbjct: 216 MGLVLWELVSR--CKAADGPVDE 236

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 88
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 149 KVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 203

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP-DPNKAMTQEVVTQY 152
           Q  +G+ YLH+  I+HRD+K  N+ ++    +KI DFGLA V+     ++ + Q   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     +S   DV+S G +  EL+
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 81/193 (41%), Gaps = 17/193 (8%)
Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLS----ALDILQPPHLDFFQEI 62
           DG   ALK++  +       +   RE  M   F H N+L      L      H  +    
Sbjct: 53  DGHFYALKRI--LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           +     L +++ ++      LT D I   L  I RGL+ +H+    HRD+KP N+L+   
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE 170
Query: 123 CILKICDFG---LARVEEPDPNKAMT-QEVVTQ----YYRAPEILMGARH--YSAAVDVW 172
               + D G    A +      +A+T Q+   Q     YRAPE+     H       DVW
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230
Query: 173 SVGCI-FAELLGR 184
           S+GC+ +A + G 
Sbjct: 231 SLGCVLYAMMFGE 243

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPDPNKAMTQE 147
           +F  QI  G+ YLH+   +HR +   N+L++++ ++KI DFGLA+   E  +  +     
Sbjct: 116 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               ++ APE L   + Y A+ DVWS G    ELL
Sbjct: 176 DSPVFWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 90  VFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPDPNKAMTQE 147
           +F  QI  G+ YLH+   +HR +   N+L++++ ++KI DFGLA+   E  +  +     
Sbjct: 115 LFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 174
Query: 148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               ++ APE L   + Y A+ DVWS G    ELL
Sbjct: 175 DSPVFWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 16/173 (9%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DL-HKIIVSPQHLTSD 86
           V +E+ +L   +H N+L   +  +       +E+ +I E +   D+  +I  S   L   
Sbjct: 48  VKKEISILNIARHRNILHLHESFES-----MEELVMIFEFISGLDIFERINTSAFELNER 102
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAM 144
            I  +++Q+   L++LHS  I H DI+P N++  +  +  +KI +FG AR  +P  N  +
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 145 TQEVVTQYYRAPEILMGARH--YSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
                   Y APE+    +H   S A D+WS+G +   LL     F A++  Q
Sbjct: 163 L--FTAPEYYAPEV---HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 101 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 160
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V T  Y  PE +  M +   +          
Sbjct: 161 -VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQ 240

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 41/228 (17%)
Query: 7   DGRRVALKKLPNVF-----QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           D R VA+K    VF     Q+ ++ K ++R    +   +HDN+   +   +    D   E
Sbjct: 35  DERPVAVK----VFSFANRQNFINEKNIYR----VPLMEHDNIARFIVGDERVTADGRME 86
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV--FLYQILRGLKYLHSA---------RILHR 110
             ++ E   +      +S    TSD +      + + RGL YLH+           I HR
Sbjct: 87  YLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHR 144
Query: 111 DIKPGNLLVNSNCILKICDFGLA------RVEEP-DPNKAMTQEVVTQYYRAPEILMGA- 162
           D+   N+LV ++    I DFGL+      R+  P + + A   EV T  Y APE+L GA 
Sbjct: 145 DLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV 204
Query: 163 --RHYSAA---VDVWSVGCIFAELLGR-RILFQAQS-PVQQLGLITDL 203
             R   +A   VD++++G I+ E+  R   LF  +S P  Q+   T++
Sbjct: 205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 26/190 (13%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE---I 62
           ++G+  A+K +    Q+  S  RVFRE++ L  ++     + L++++     FF++    
Sbjct: 36  QNGKEYAVKIIEK--QAGHSRSRVFREVETL--YQCQGNKNILELIE-----FFEDDTRF 86
Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y++ E LQ   +   I   +H         +  +   L +LH+  I HRD+KP N+L  S
Sbjct: 87  YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146
Query: 122 N---CILKICDFGLARVEE------PDPNKAMTQEVVTQYYRAPEILM----GARHYSAA 168
                 +KICDF L    +      P     +T    +  Y APE++      A  Y   
Sbjct: 147 PEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKR 206
Query: 169 VDVWSVGCIF 178
            D+WS+G + 
Sbjct: 207 CDLWSLGVVL 216

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 3/123 (2%)
Query: 62  IYVITELLQSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           IY++TE + +   L+ +    + L    +    Y +  G+ +L S + +HRD+   N LV
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137
Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           + +  +K+ DFG+ R    D   +         + APE+    + YS+  DVW+ G +  
Sbjct: 138 DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMW 196
Query: 180 ELL 182
           E+ 
Sbjct: 197 EVF 199

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+I E 
Sbjct: 39  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 88
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 89  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 148
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 149 KVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 203

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 12/141 (8%)
Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q IY++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+
Sbjct: 129 QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 188
Query: 120 NSNCILKICDFGLARVEEPDPNKAMT-QEVVTQYYRAPEIL--MGARHYSA--------A 168
             + +LK+ DFG+A   +PD    +   +V    Y  PE +  M +   +          
Sbjct: 189 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPK 247
Query: 169 VDVWSVGCIFAELLGRRILFQ 189
            DVWS+GCI   +   +  FQ
Sbjct: 248 SDVWSLGCILYYMTYGKTPFQ 268

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 18/177 (10%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+I E 
Sbjct: 42  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 91
Query: 69  LQ-SDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
           +   +L   +        + + V LY   QI   ++YL     +HRD+   N LV  N +
Sbjct: 92  MTYGNLLDYLRECNRQEVNAV-VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL 150
Query: 125 LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 VKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 43  NVLSALDILQPPHL----DFFQEIY---VITELLQSD--LHKIIVSPQHLTSDHIKVFLY 93
           N +S ++ L  P L    D F++ Y   +I E L       +I      ++   +  ++ 
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSN--CILKICDFGLARVEEPDPNKAMTQEVVTQ 151
           Q   GLK++H   I+H DIKP N++  +     +KI DFGLA    PD    +T    T 
Sbjct: 157 QACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATA 214
Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            + APEI+          D+W++G +   LL     F  +  ++ L
Sbjct: 215 EFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 259

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 13/161 (8%)
Query: 27  KRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT 84
           +++ RE ++    KH N++   D I +  H       Y+I +L+   +L + IV+ ++ +
Sbjct: 55  QKLEREARICRLLKHPNIVRLHDSISEEGHH------YLIFDLVTGGELFEDIVAREYYS 108
Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPN 141
                  + QIL  + + H   ++HR++KP NLL+ S      +K+ DFGLA +E     
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ 167
Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +A      T  Y +PE+L     Y   VD+W+ G I   LL
Sbjct: 168 QAWFGFAGTPGYLSPEVLR-KDPYGKPVDLWACGVILYILL 207

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH---LTSDH 87
           RE ++L    H N++    I +        ++ ++       L+ ++  P +   L    
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLL----VNSNCILKICDFGLARVEEPDPNKA 143
             + L  ++ G+ +L    I+HR+IKPGN++     +   + K+ DFG AR  E D  + 
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQ 171
Query: 144 MTQEVVTQYYRAPEILMGA-------RHYSAAVDVWSVGCIF 178
                 T+ Y  P++   A       + Y A VD+WS+G  F
Sbjct: 172 FVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 73  LHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
           LHK +V   + +   ++   L+Q+  G+KYL     +HRD+   N+L+ +    KI DFG
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 132 LARVEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           L++    D +   T     ++   + APE +   R +S+  DVWS G    E L
Sbjct: 156 LSKALGAD-DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEAL 207

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 18/162 (11%)
Query: 31  RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH---LTSDH 87
           RE ++L    H N++    I +        ++ ++       L+ ++  P +   L    
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 88  IKVFLYQILRGLKYLHSARILHRDIKPGNLL----VNSNCILKICDFGLARVEEPDPNKA 143
             + L  ++ G+ +L    I+HR+IKPGN++     +   + K+ DFG AR  E D  + 
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQ 171
Query: 144 MTQEVVTQYYRAPEILMGA-------RHYSAAVDVWSVGCIF 178
                 T+ Y  P++   A       + Y A VD+WS+G  F
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA V+         +++     
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIVSPQHLTSD 86
           V +E++ +   +H  +++  D  +  +     E+ +I E +       K+      ++ D
Sbjct: 201 VRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVMIYEFMSGGELFEKVADEHNKMSED 255
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAM 144
               ++ Q+ +GL ++H    +H D+KP N++  +  +  LK+ DFGL      DP +++
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPKQSV 313
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
                T  + APE+  G +      D+WSVG +   LL     F  ++  + L
Sbjct: 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 365

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 29  VFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSD--LHKIIVSPQHLTSD 86
           V +E++ +   +H  +++  D  +  +     E+ +I E +       K+      ++ D
Sbjct: 95  VRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMVMIYEFMSGGELFEKVADEHNKMSED 149
Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAM 144
               ++ Q+ +GL ++H    +H D+KP N++  +  +  LK+ DFGL      DP +++
Sbjct: 150 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL--TAHLDPKQSV 207
Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
                T  + APE+  G +      D+WSVG +   LL     F  ++  + L
Sbjct: 208 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 259

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  RG+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA  +         +++     
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +  +  YS   DV++ G +  EL+
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+I E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+I E 
Sbjct: 41  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 90
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HRD+   N LV  N ++
Sbjct: 91  MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 150
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 205

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 65/134 (48%), Gaps = 7/134 (5%)
Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y + E +   DL   I         H   +  +I  GL +L S  I++RD+K  N++++
Sbjct: 96  LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 155
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           S   +KI DFG+ +    D    +T +    T  Y APEI+   + Y  +VD W+ G + 
Sbjct: 156 SEGHIKIADFGMCKENIWD---GVTTKXFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLL 211
Query: 179 AELLGRRILFQAQS 192
            E+L  +  F+ + 
Sbjct: 212 YEMLAGQAPFEGED 225

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  RG+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA  +         +++     
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +  +  YS   DV++ G +  EL+
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 248 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 297
Query: 69  LQ-SDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +   +L   +   + Q +++  +     QI   ++YL     +HR++   N LV  N ++
Sbjct: 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 357
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 358 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 412

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+ITE 
Sbjct: 287 VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIITEF 336
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HR++   N LV  N ++
Sbjct: 337 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLV 396
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L   + +S   DVW+ G +  E+
Sbjct: 397 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 451

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 76/176 (43%), Gaps = 16/176 (9%)
Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL--QPPHLDFFQEIYVITEL 68
           VA+K L    +  +  +   +E  ++   KH N++  L +   +PP        Y+I E 
Sbjct: 46  VAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIIEF 95
Query: 69  LQSDLHKIIVSPQHLTSDHIKVFLY---QILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +        +   +    +  V LY   QI   ++YL     +HRD+   N LV  N ++
Sbjct: 96  MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 155
Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 156 KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEI 210

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 62/131 (47%), Gaps = 18/131 (13%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKV-----FLYQILRGLKYLHSARILHRDIKPGN 116
           I ++T+L+    H  ++   H   D+I       +  QI +G+ YL   R++HRD+   N
Sbjct: 91  IQLVTQLMP---HGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN 147
Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG-----ARHYSAAVDV 171
           +LV S   +KI DFGLAR+ E D      +E      + P   M       R ++   DV
Sbjct: 148 VLVKSPNHVKITDFGLARLLEGD-----EKEYNADGGKMPIKWMALECIHYRKFTHQSDV 202
Query: 172 WSVGCIFAELL 182
           WS G    EL+
Sbjct: 203 WSYGVTIWELM 213

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 78/181 (43%), Gaps = 55/181 (30%)
Query: 62  IYVITELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLL 118
           + ++ E+L   L K I+    Q L    +K  + Q+L+GL YLHS  +I+H DIKP N+L
Sbjct: 114 VCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENIL 173
Query: 119 V----------------------------------------------NSNCI-LKICDFG 131
           +                                              N++ I +KI D G
Sbjct: 174 MCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLG 233
Query: 132 LARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ 191
            A       +K  T+++ T+ YR+ E+L+GA  YS   D+WS  C+  EL     LF+  
Sbjct: 234 NACW----VHKHFTEDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPH 288
Query: 192 S 192
           S
Sbjct: 289 S 289

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 63/132 (47%), Gaps = 4/132 (3%)
Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +V+  +   DL   I   +       + +  +I+  L +LH   I++RD+K  N+L++ 
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159
Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               K+ DFG+ +  E   N   T     T  Y APEIL     Y  AVD W++G +  E
Sbjct: 160 EGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQ-EMLYGPAVDWWAMGVLLYE 216
Query: 181 LLGRRILFQAQS 192
           +L     F+A++
Sbjct: 217 MLCGHAPFEAEN 228

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 14/165 (8%)
Query: 37  CFFKHDNVLSALDILQPPHL----DFFQEI---YVITELLQS-DLHKIIVSPQHLTSDHI 88
           C      VL+ LD  +PP L      FQ +   Y + E +   DL   I           
Sbjct: 65  CTMVEKRVLALLD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA 122
Query: 89  KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEV 148
             +  +I  GL +LH   I++RD+K  N++++S   +KI DFG+ +    D     T+E 
Sbjct: 123 VFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD--GVTTREF 180
Query: 149 V-TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             T  Y APEI+   + Y  +VD W+ G +  E+L  +  F  + 
Sbjct: 181 CGTPDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K + N      +++    E  ++   +H N++  L ++    ++    +Y++TE
Sbjct: 44  GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTE 95
Query: 68  LL-QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            + +  L   + S     L  D +  F   +   ++YL     +HRD+   N+LV+ + +
Sbjct: 96  YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 155
Query: 125 LKICDFGLARVEEPDPNKAMTQEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            K+ DFGL +        + TQ+   +   + APE L   + +S   DVWS G +  E+
Sbjct: 156 AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEI 207

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 50/103 (48%), Gaps = 22/103 (21%)
Query: 91  FLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD----------- 139
           +  QI +G+ YL   R++HRD+   N+LV S   +KI DFGLAR+ E D           
Sbjct: 145 WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 204
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           P K M  E +  +Y         R ++   DVWS G    EL+
Sbjct: 205 PIKWMALECI--HY---------RKFTHQSDVWSYGVTIWELM 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K + N      +++    E  ++   +H N++  L ++    ++    +Y++TE
Sbjct: 216 GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTE 267
Query: 68  LL-QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            + +  L   + S     L  D +  F   +   ++YL     +HRD+   N+LV+ + +
Sbjct: 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327
Query: 125 LKICDFGLARVEEPDPNKAMTQEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            K+ DFGL +        + TQ+   +   + APE L   + +S   DVWS G +  E+
Sbjct: 328 AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEI 379

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K + N      +++    E  ++   +H N++  L ++    ++    +Y++TE
Sbjct: 29  GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTE 80
Query: 68  LL-QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            + +  L   + S     L  D +  F   +   ++YL     +HRD+   N+LV+ + +
Sbjct: 81  YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 140
Query: 125 LKICDFGLARVEEPDPNKAMTQEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            K+ DFGL +        + TQ+   +   + APE L   + +S   DVWS G +  E+
Sbjct: 141 AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEI 192

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 84/179 (46%), Gaps = 20/179 (11%)
Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K + N      +++    E  ++   +H N++  L ++    ++    +Y++TE
Sbjct: 35  GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVTE 86
Query: 68  LL-QSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI 124
            + +  L   + S     L  D +  F   +   ++YL     +HRD+   N+LV+ + +
Sbjct: 87  YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 146
Query: 125 LKICDFGLARVEEPDPNKAMTQEV--VTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
            K+ DFGL +        + TQ+   +   + APE L  A  +S   DVWS G +  E+
Sbjct: 147 AKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREA-AFSTKSDVWSFGILLWEI 198

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 4/195 (2%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           RDG +VALK+     +S    +    E++ L F +H +++S +      +       Y+ 
Sbjct: 61  RDGAKVALKR--RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
              L+  L+   +    ++ +          RGL YLH+  I+HRD+K  N+L++ N + 
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178
Query: 126 KICDFGLARV-EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR 184
           KI DFG+++   E D          T  Y  PE  +  R  +   DV+S G +  E+L  
Sbjct: 179 KITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCA 237
Query: 185 RILFQAQSPVQQLGL 199
           R       P + + L
Sbjct: 238 RSAIVQSLPREMVNL 252

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 62/146 (42%), Gaps = 23/146 (15%)
Query: 62  IYVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y+ TEL    L +   +    L    +  +L   L  L +LHS  ++H D+KP N+ + 
Sbjct: 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191
Query: 121 SNCILKICDFGL---------ARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDV 171
                K+ DFGL           V+E DP            Y APE+L G+  Y  A DV
Sbjct: 192 PRGRCKLGDFGLLVELGTAGAGEVQEGDPR-----------YMAPELLQGS--YGTAADV 238
Query: 172 WSVGCIFAELLGRRILFQAQSPVQQL 197
           +S+G    E+     L       QQL
Sbjct: 239 FSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 6/196 (3%)
Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           RDG +VALK+     +S    +    E++ L F +H +++S +      +       Y+ 
Sbjct: 61  RDGAKVALKR--RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
              L+  L+   +    ++ +          RGL YLH+  I+HRD+K  N+L++ N + 
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP 178
Query: 126 KICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           KI DFG+++ +  +  +     VV  T  Y  PE  +  R  +   DV+S G +  E+L 
Sbjct: 179 KITDFGISK-KGTELGQTHLXXVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLC 236
Query: 184 RRILFQAQSPVQQLGL 199
            R       P + + L
Sbjct: 237 ARSAIVQSLPREMVNL 252

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 147 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 206
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 207 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 247

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 174 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 88/189 (46%), Gaps = 21/189 (11%)
Query: 11  VALKKLPNVFQSLVSSKRV----FRELKMLCFFKHDNVLSALDILQPPHLDFF--QEIYV 64
           VALK L   F+S +  + V     RE+++     H N+L   +        F+  + IY+
Sbjct: 51  VALKVL---FKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNY-------FYDRRRIYL 100
Query: 65  ITELL-QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           I E   + +L+K +              + ++   L Y H  +++HRDIKP NLL+    
Sbjct: 101 ILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKG 160
Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
            LKI DFG + V  P   +       T  Y  PE++ G R ++  VD+W +G +  ELL 
Sbjct: 161 ELKIADFGWS-VHAPSLRRKTM--CGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELLV 216
Query: 184 RRILFQAQS 192
               F++ S
Sbjct: 217 GNPPFESAS 225

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           +Y + E +   DL   I         H   +  +I  GL +L S  I++RD+K  N++++
Sbjct: 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD 476
Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           S   +KI DFG+ +    D    +T +    T  Y APEI+   + Y  +VD W+ G + 
Sbjct: 477 SEGHIKIADFGMCKENIWD---GVTTKXFCGTPDYIAPEII-AYQPYGKSVDWWAFGVLL 532
Query: 179 AELLGRRILFQAQ 191
            E+L  +  F+ +
Sbjct: 533 YEMLAGQAPFEGE 545

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 173 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 213

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 123 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 183 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 173 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 138 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 198 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 238

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 119 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 179 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 176 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 173 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 180 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 173 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 180 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 173 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 114 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 174 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 175 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 176 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 216

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 176 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELM 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 120 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 180 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 116 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 176 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 107 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 167 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 115 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 175 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 117 NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 176
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 177 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 22  SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ 81
           +L + ++   E  ++    H +++  + I++        E+Y   EL     H +  +  
Sbjct: 65  TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKN 120
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDP 140
            L    + ++  QI + + YL S   +HRDI   N+LV S   +K+ DFGL+R +E+ D 
Sbjct: 121 SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 180
Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQAQS 192
            KA    +  + + +PE +   R ++ A DVW       E+L  G++  F  ++
Sbjct: 181 YKASVTRLPIK-WMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 232

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 22  SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ 81
           +L + ++   E  ++    H +++  + I++        E+Y   EL     H +  +  
Sbjct: 49  TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKN 104
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDP 140
            L    + ++  QI + + YL S   +HRDI   N+LV S   +K+ DFGL+R +E+ D 
Sbjct: 105 SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 164
Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQAQS 192
            KA    +  + + +PE +   R ++ A DVW       E+L  G++  F  ++
Sbjct: 165 YKASVTRLPIK-WMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 216

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 28/174 (16%)
Query: 28  RVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-----SDLHKIIVSPQ 81
           RVFRE++ML   + H NVL  ++  +    D F   Y++ E ++     S +HK     +
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFE--EEDRF---YLVFEKMRGGSILSHIHK----RR 106
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEE- 137
           H       V +  +   L +LH+  I HRD+KP N+L    N    +KICDFGL    + 
Sbjct: 107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKL 166
Query: 138 -PDPNKAMTQEVVT----QYYRAPEILMG----ARHYSAAVDVWSVGCIFAELL 182
             D +   T E++T      Y APE++      A  Y    D+WS+G I   LL
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 9/174 (5%)
Query: 22  SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ 81
           +L + ++   E  ++    H +++  + I++        E+Y   EL     H +  +  
Sbjct: 53  TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKN 108
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDP 140
            L    + ++  QI + + YL S   +HRDI   N+LV S   +K+ DFGL+R +E+ D 
Sbjct: 109 SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168
Query: 141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQAQS 192
            KA    +  + + +PE +   R ++ A DVW       E+L  G++  F  ++
Sbjct: 169 YKASVTRLPIK-WMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL++ + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + APE L     ++ + D+WS G +  E     I   A+ P Q L
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWE-----ITSLAEQPYQGL 236

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL++ + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + APE L     ++ + D+WS G +  E     I   A+ P Q L
Sbjct: 195 WMAPESLKDGV-FTTSSDMWSFGVVLWE-----ITSLAEQPYQGL 233

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQY 152
           +I  G+ YL++ + +HRD+   N +V  +  +KI DFG+ R + E D  +   + ++   
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           + APE L     ++ + D+WS G +  E     I   A+ P Q L
Sbjct: 198 WMAPESLKDGV-FTTSSDMWSFGVVLWE-----ITSLAEQPYQGL 236

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 57/114 (50%), Gaps = 6/114 (5%)
Query: 73  LHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
           LHK +V   + +   ++   L+Q+  G+KYL     +HR++   N+L+ +    KI DFG
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 132 LARVEEPDPNKAMTQEVVTQY---YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           L++    D +   T     ++   + APE +   R +S+  DVWS G    E L
Sbjct: 482 LSKALGAD-DSYYTARSAGKWPLKWYAPECI-NFRKFSSRSDVWSYGVTMWEAL 533

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 53/103 (51%), Gaps = 4/103 (3%)
Query: 82  HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARV--EEPD 139
           ++ S ++  +  QI  G+ YL   R++HRD+   N+LV +   +KI DFGLA++   E  
Sbjct: 110 NIGSQYLLNWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 169
Query: 140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              A   +V  ++     IL   R Y+   DVWS G    EL+
Sbjct: 170 EYHAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 210

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA  +         +++     
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 223

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA  +         +++     
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-Y 152
           Q  +G+ YLH+  I+HRD+K  N+ ++ +  +KI DFGLA  +         +++     
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 153 YRAPEI--LMGARHYSAAVDVWSVGCIFAELL 182
           + APE+  +     YS   DV++ G +  EL+
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 7   DGRRVALKK-LPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           D R VA+K+ LP  F       ++ RE       +H NV+      +      FQ  Y+ 
Sbjct: 47  DNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIRYFCTEKDRQ---FQ--YIA 96
Query: 66  TELLQSDLHKIIVSPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---N 120
            EL  + L + +      HL  + I   L Q   GL +LHS  I+HRD+KP N+L+   N
Sbjct: 97  IELCAATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155
Query: 121 SNCILK--ICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMG--ARHYSAAVDVWSV 174
           ++  +K  I DFGL +      +    +  V  T+ + APE+L      + +  VD++S 
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215
Query: 175 GCIF 178
           GC+F
Sbjct: 216 GCVF 219

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 49/179 (27%)
Query: 62  IYVITELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLL 118
           I ++ E+L   L K I+    Q L    +K  + Q+L+GL YLH+  RI+H DIKP N+L
Sbjct: 104 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 163
Query: 119 --VNSNCILKICDFG--LARVEEPDPN--------------------------------- 141
             VN   I ++        R   P P+                                 
Sbjct: 164 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 223
Query: 142 --------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
                   K  T+++ T+ YR+ E+L+G+  Y+   D+WS  C+  EL     LF+  S
Sbjct: 224 LGNACWVHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHS 281

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 75/183 (40%), Gaps = 57/183 (31%)
Query: 62  IYVITELLQSDLHKIIVSP--QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKP---- 114
           I ++ E+L   L K I+    Q L    +K  + Q+L+GL YLH+  RI+H DIKP    
Sbjct: 120 ICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179
Query: 115 --------------------------------------GNLLVN-------SNCILKICD 129
                                                 GN LVN           +KI D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239
Query: 130 FGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQ 189
            G A       +K  T+++ T+ YR+ E+L+G+  Y+   D+WS  C+  EL     LF+
Sbjct: 240 LGNACW----VHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFE 294
Query: 190 AQS 192
             S
Sbjct: 295 PHS 297

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 53/93 (56%), Gaps = 8/93 (8%)
Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCIL---KICDFGLARVEEPDPNKAMTQEVV- 149
           QIL G+ YLH   I+H D+KP N+L++S   L   KI DFG++R      +    +E++ 
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMG 195
Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           T  Y APEIL      + A D+W++G I   LL
Sbjct: 196 TPEYLAPEIL-NYDPITTATDMWNIGIIAYMLL 227

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 44/105 (41%), Gaps = 27/105 (25%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEE 137
           Q  T       +  I   ++YLHS  I HRD+KP NLL  S   N ILK+ DFG A    
Sbjct: 112 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---- 167
Query: 138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
               K  T E                 Y  + D+WS+G I   LL
Sbjct: 168 ----KETTGE----------------KYDKSCDMWSLGVIMYILL 192

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + L+S  +  F  Q+ +G+ +L S   +HRD+   N+L+ +  + KI DFGLAR    D 
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 141 NKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           N  +     +   + APE +     Y+   DVWS G +  E+ 
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 262

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V+P  L    +     Q+  G+ YL     +HRD+   N LV    ++KI DFG++R + 
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
             D  +   + ++   +  PE ++  R ++   DVWS G +  E+   G++  +Q
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 58/118 (49%), Gaps = 3/118 (2%)
Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           + +L++D    I +    T D +  F  Q+ +G+ +L S   +HRD+   N+L+ +  + 
Sbjct: 145 SRVLETDPAFAIANSTASTRDLLH-FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203
Query: 126 KICDFGLARVEEPDPNKAMTQEV-VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           KI DFGLAR    D N  +     +   + APE +     Y+   DVWS G +  E+ 
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIF 260

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 78  VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VE 136
           V+P  L    +     Q+  G+ YL     +HRD+   N LV    ++KI DFG++R + 
Sbjct: 127 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 186
Query: 137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL--GRRILFQ 189
             D  +   + ++   +  PE ++  R ++   DVWS G +  E+   G++  +Q
Sbjct: 187 STDYYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 240
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	203
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-113
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-112
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-111
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-110
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-109
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-109
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-108
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-107
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-106
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-106
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-103
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-102
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-91
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-86
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-84
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-84
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-84
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-77
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-74
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-72
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-71
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-71
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-71
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-71
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-71
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-70
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-70
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-70
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-70
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-69
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	8e-63
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-41
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-41
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-40
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-40
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-39
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-39
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-39
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-38
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-37
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-37
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-37
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-37
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-35
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-35
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-35
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-35
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-35
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-35
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-34
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-34
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-34
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-34
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-33
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-33
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-33
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-33
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-33
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-33
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-33
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	6e-33
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-33
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-33
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-33
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-32
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-32
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-32
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-32
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-32
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-32
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-30
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-30
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-30
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-30
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-28
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-28
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-28
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	7e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-21
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-20
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-19
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-19
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-17
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	7e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-16
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-16
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-16
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  325 bits (836), Expect = e-113
 Identities = 92/212 (43%), Positives = 135/212 (63%), Gaps = 11/212 (5%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           + T    G  VA+KK+   F   + + R  RE+K+L  FKH+N+++  +I +P   + F 
Sbjct: 29  SATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+Y+I EL+Q+DLH++I S Q L+ DHI+ F+YQ LR +K LH + ++HRD+KP NLL+N
Sbjct: 88  EVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

Query: 121 SNCILKICDFGLARVEEPDPNKA---------MTQEVVTQYYRAPEILMGARHYSAAVDV 171
           SNC LK+CDFGLAR+ +               M + V T++YRAPE+++ +  YS A+DV
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206

Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           WS GCI AEL  RR +F  +    QL LI  +
Sbjct: 207 WSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  323 bits (829), Expect = e-112
 Identities = 92/205 (44%), Positives = 148/205 (72%), Gaps = 4/205 (1%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +  D  +  RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  +
Sbjct: 45  SAYDNLNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++Y++ +L+++DL+K++ + QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N
Sbjct: 104 DVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

Query: 121 SNCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           + C LKICDFGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI 
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 222

Query: 179 AELLGRRILFQAQSPVQQLGLITDL 203
           AE+L  R +F  +  + QL  I  +
Sbjct: 223 AEMLSNRPIFPGKHYLDQLNHILGI 247

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  321 bits (824), Expect = e-111
 Identities = 74/208 (35%), Positives = 119/208 (57%), Gaps = 12/208 (5%)

Query: 6   RDGRRVALKKLP---------NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL 56
            +G  VA+K++          N+       KRV RE+++L  F H N+L   DI      
Sbjct: 44  SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE 103

Query: 57  DFFQEIYVITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
               ++Y++TEL+++DL ++I   +  ++  HI+ F+Y IL GL  LH A ++HRD+ PG
Sbjct: 104 PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPG 163

Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+L+  N  + ICDF LAR +  D N   T  V  ++YRAPE++M  + ++  VD+WS G
Sbjct: 164 NILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG 221

Query: 176 CIFAELLGRRILFQAQSPVQQLGLITDL 203
           C+ AE+  R+ LF+  +   QL  I ++
Sbjct: 222 CVMAEMFNRKALFRGSTFYNQLNKIVEV 249

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  319 bits (819), Expect = e-110
 Identities = 88/204 (43%), Positives = 133/204 (65%), Gaps = 6/204 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           +  D R G +VA+KKL   FQS + +KR +REL++L   +H+NV+  LD+  P   LD F
Sbjct: 43  SAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + Y++   + +DL K++   + L  D I+  +YQ+L+GL+Y+H+A I+HRD+KPGNL V
Sbjct: 103 TDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 161

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  VVT++YRAPE+++    Y+  VD+WSVGCI A
Sbjct: 162 NEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E++  + LF+    + QL  I  +
Sbjct: 218 EMITGKTLFKGSDHLDQLKEIMKV 241

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  316 bits (813), Expect = e-109
 Identities = 90/204 (44%), Positives = 133/204 (65%), Gaps = 7/204 (3%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           +  D R G +VA+KKL   FQS + +KR +REL +L   +H+NV+  LD+  P   L  F
Sbjct: 42  SAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + Y++   +Q+DL KI+      + + I+  +YQ+L+GLKY+HSA ++HRD+KPGNL V
Sbjct: 102 YDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV 159

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR  + +    MT  VVT++YRAPE+++   HY+  VD+WSVGCI A
Sbjct: 160 NEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E+L  + LF+ +  + QL  I  +
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKV 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  316 bits (811), Expect = e-109
 Identities = 102/204 (50%), Positives = 137/204 (67%), Gaps = 6/204 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P   L+ F
Sbjct: 47  AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            ++Y++T L+ +DL+ I+   Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL V
Sbjct: 107 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV 165

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N +C LKI DFGLAR    +    MT  V T++YRAPEI++   HY+  VD+WSVGCI A
Sbjct: 166 NEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           ELL  R LF     + QL LI  L
Sbjct: 222 ELLTGRTLFPGTDHIDQLKLILRL 245

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  315 bits (809), Expect = e-108
 Identities = 82/252 (32%), Positives = 128/252 (50%), Gaps = 49/252 (19%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
              D    + VA+KK+  +F+ L+  KR+ RE+ +L   K D ++   D++ P  L  F 
Sbjct: 44  LAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+Y++ E+  SDL K+  +P  LT +HIK  LY +L G  ++H + I+HRD+KP N L+N
Sbjct: 104 ELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN 163

Query: 121 SNCILKICDFGLARVEEPDPNKA---------------------MTQEVVTQYYRAPEIL 159
            +C +K+CDFGLAR    + +                       +T  VVT++YRAPE++
Sbjct: 164 QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI 223

Query: 160 MGARHYSAAVDVWSVGCIFAELL-----------GRRILFQAQSP--------------- 193
           +   +Y+ ++D+WS GCIFAELL            R  LF   S                
Sbjct: 224 LLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEK 283

Query: 194 --VQQLGLITDL 203
               QL +I ++
Sbjct: 284 SNRDQLNIIFNI 295

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  313 bits (804), Expect = e-107
 Identities = 91/233 (39%), Positives = 129/233 (55%), Gaps = 37/233 (15%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
              D  + R VA+KK+  VF+ L+  KR+ RE+ +L    HD+V+  LDI+ P  ++ F 
Sbjct: 71  EAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           E+YV+ E+  SD  K+  +P +LT  HIK  LY +L G+KY+HSA ILHRD+KP N LVN
Sbjct: 131 ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN 190

Query: 121 SNCILKICDFGLARV--------------------------EEPDPNKAMTQEVVTQYYR 154
            +C +K+CDFGLAR                              +  + +T  VVT++YR
Sbjct: 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR 250

Query: 155 APEILMGARHYSAAVDVWSVGCIFAELLG-----------RRILFQAQSPVQQ 196
           APE+++   +Y+ A+DVWS+GCIFAELL            R  LF   S    
Sbjct: 251 APELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPL 303

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  307 bits (789), Expect = e-106
 Identities = 78/215 (36%), Positives = 131/215 (60%), Gaps = 15/215 (6%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH----- 55
           +  D    +RVA+KK+  V     S K   RE+K++    HDN++   +IL P       
Sbjct: 29  SAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 56  ----LDFFQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRD 111
               L     +Y++ E +++DL  ++     L  +H ++F+YQ+LRGLKY+HSA +LHRD
Sbjct: 87  DVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145

Query: 112 IKPGNLLVNS-NCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAA 168
           +KP NL +N+ + +LKI DFGLAR+ +P  +    +++ +VT++YR+P +L+   +Y+ A
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKA 205

Query: 169 VDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           +D+W+ GCIFAE+L  + LF     ++Q+ LI + 
Sbjct: 206 IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  308 bits (792), Expect = e-106
 Identities = 74/224 (33%), Positives = 129/224 (57%), Gaps = 25/224 (11%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFF 59
              D R G  VA+KK+ + FQ+   ++R FRE+ +L     H+N+++ L++L+  +    
Sbjct: 27  KSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---D 83

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +++Y++ + +++DLH +I +   L   H +  +YQ+++ +KYLHS  +LHRD+KP N+L+
Sbjct: 84  RDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142

Query: 120 NSNCILKICDFGLARV--------------------EEPDPNKAMTQEVVTQYYRAPEIL 159
           N+ C +K+ DFGL+R                        D    +T  V T++YRAPEIL
Sbjct: 143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202

Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           +G+  Y+  +D+WS+GCI  E+L  + +F   S + QL  I  +
Sbjct: 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  301 bits (774), Expect = e-103
 Identities = 82/204 (40%), Positives = 123/204 (60%), Gaps = 6/204 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D    R VA+KKL   FQ+   +KR +REL ++    H N++  L++  P   L+ F
Sbjct: 43  AAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q++Y++ EL+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V
Sbjct: 103 QDVYIVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            S+C LKI DFGLAR         MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  
Sbjct: 161 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 217

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E++   +LF     + Q   + + 
Sbjct: 218 EMIKGGVLFPGTDHIDQWNKVIEQ 241

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  302 bits (774), Expect = e-102
 Identities = 84/204 (41%), Positives = 126/204 (61%), Gaps = 6/204 (2%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH-LDFF 59
           A  D    R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ F
Sbjct: 80  AAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           Q++Y++ EL+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V
Sbjct: 140 QDVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            S+C LKI DFGLAR         MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  
Sbjct: 198 KSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMG 254

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E++  +ILF  +  + Q   + + 
Sbjct: 255 EMVRHKILFPGRDYIDQWNKVIEQ 278

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  269 bits (691), Expect = 4e-91
 Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 14/210 (6%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
            +   G  VA+KK   V Q      R  + ++ L    H N++              ++I
Sbjct: 43  KEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99

Query: 63  Y--VITELLQSDLHKII----VSPQHLTSDHIKVFLYQILRGLKYLH--SARILHRDIKP 114
           Y  V+ E +   LH+                IKVFL+Q++R +  LH  S  + HRDIKP
Sbjct: 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKP 159

Query: 115 GNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
            N+LVN ++  LK+CDFG A+     P++     + ++YYRAPE++ G +HY+ AVD+WS
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKL--SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217

Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           VGCIFAE++    +F+  +   QL  I  +
Sbjct: 218 VGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  260 bits (667), Expect = 1e-86
 Identities = 64/207 (30%), Positives = 107/207 (51%), Gaps = 14/207 (6%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF-FQE 61
                G  VA+KK   V Q     +   REL+++    H N++                 
Sbjct: 74  KLCDSGELVAIKK---VLQD---KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127

Query: 62  IYVITELLQSDLHKII----VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           + ++ + +   ++++      + Q L   ++K+++YQ+ R L Y+HS  I HRDIKP NL
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 187

Query: 118 LVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           L++ +  +LK+CDFG A+             + ++YYRAPE++ GA  Y++++DVWS GC
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245

Query: 177 IFAELLGRRILFQAQSPVQQLGLITDL 203
           + AELL  + +F   S V QL  I  +
Sbjct: 246 VLAELLLGQPIFPGDSGVDQLVEIIKV 272

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  254 bits (650), Expect = 1e-84
 Identities = 68/239 (28%), Positives = 115/239 (48%), Gaps = 46/239 (19%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL----------- 51
            D   G+R ALKK+          +   REL ++    H N++  +D             
Sbjct: 27  FDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80

Query: 52  ----------------------QPPHLDFFQEIYVITELLQSDLHKII----VSPQHLTS 85
                                    +    + + VI E +   LHK++     S + +  
Sbjct: 81  QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPM 140

Query: 86  DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAM 144
           + I +++YQ+ R + ++HS  I HRDIKP NLLVNS    LK+CDFG A+     P++  
Sbjct: 141 NLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL--IPSEPS 198

Query: 145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
              + +++YRAPE+++GA  Y+ ++D+WS+GC+F EL+  + LF  ++ + QL  I  +
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQI 257

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  253 bits (648), Expect = 4e-84
 Identities = 64/204 (31%), Positives = 106/204 (51%), Gaps = 14/204 (6%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQEIYV 64
            +   VA+KK   V Q     +   REL+++   KH NV+                 + +
Sbjct: 62  VESDEVAIKK---VLQD---KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115

Query: 65  ITELLQSDLHKIIVS----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           + E +   +++         Q +    IK+++YQ+LR L Y+HS  I HRDIKP NLL++
Sbjct: 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD 175

Query: 121 SNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
               +LK+ DFG A++      +     + ++YYRAPE++ GA +Y+  +D+WS GC+ A
Sbjct: 176 PPSGVLKLIDFGSAKIL--IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           EL+  + LF  +S + QL  I  +
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKV 257

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  251 bits (642), Expect = 5e-84
 Identities = 56/203 (27%), Positives = 106/203 (52%), Gaps = 15/203 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEI 62
           +  +  +V +K L       V  K++ RE+K+L   +   N+++  DI++ P        
Sbjct: 57  NITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVS--RTPA 109

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS- 121
            V   +  +D  ++    Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++  
Sbjct: 110 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE 166

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +  L++ D+GLA      P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A +
Sbjct: 167 HRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASM 224

Query: 182 LGRRI-LFQAQSPVQQLGLITDL 203
           + R+   F       QL  I  +
Sbjct: 225 IFRKEPFFHGHDNYDQLVRIAKV 247

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  234 bits (599), Expect = 1e-77
 Identities = 63/194 (32%), Positives = 105/194 (54%), Gaps = 7/194 (3%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G+ VA+KK        V  K   RE++ML   KH N+++ L++ +         ++++ E
Sbjct: 28  GQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----RLHLVFE 82

Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                +   +    + +    +K   +Q L+ + + H    +HRD+KP N+L+  + ++K
Sbjct: 83  YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIK 142

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           +CDFG AR     P+     EV T++YR+PE+L+G   Y   VDVW++GC+FAELL    
Sbjct: 143 LCDFGFAR-LLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

Query: 187 LFQAQSPVQQLGLI 200
           L+  +S V QL LI
Sbjct: 202 LWPGKSDVDQLYLI 215

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  226 bits (579), Expect = 2e-74
 Identities = 67/194 (34%), Positives = 110/194 (56%), Gaps = 7/194 (3%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+KK        +  K   RE+K+L   +H+N+++ L++ +       +  Y++ E
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLVFE 104

Query: 68  LLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
            +   +   + + P  L    ++ +L+QI+ G+ + HS  I+HRDIKP N+LV+ + ++K
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVK 164

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRI 186
           +CDFG AR     P +    EV T++YRAPE+L+G   Y  AVDVW++GC+  E+     
Sbjct: 165 LCDFGFAR-TLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

Query: 187 LFQAQSPVQQLGLI 200
           LF   S + QL  I
Sbjct: 224 LFPGDSDIDQLYHI 237

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  222 bits (568), Expect = 1e-72
 Identities = 81/203 (39%), Positives = 114/203 (56%), Gaps = 14/203 (6%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDF 58
           D    + VA+KK+         +K        RE+K+L    H N++  LD         
Sbjct: 31  DKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---GHK- 84

Query: 59  FQEIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              I ++ + +++DL  II  +   LT  HIK ++   L+GL+YLH   ILHRD+KP NL
Sbjct: 85  -SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           L++ N +LK+ DFGLA+     PN+A T +VVT++YRAPE+L GAR Y   VD+W+VGCI
Sbjct: 144 LLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 202

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
            AELL R       S + QL  I
Sbjct: 203 LAELLLRVPFLPGDSDLDQLTRI 225

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  217 bits (556), Expect = 3e-71
 Identities = 79/205 (38%), Positives = 122/205 (59%), Gaps = 25/205 (12%)

Query: 6   RDGRRVALKKL---------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL 56
             GR VALK++         P    ++       RE+ +L    H N++S +D++     
Sbjct: 43  SQGRIVALKRIRLDAEDEGIP--STAI-------REISLLKELHHPNIVSLIDVIHSE-- 91

Query: 57  DFFQEIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
              + + ++ E ++ DL K++  +   L    IK++LYQ+LRG+ + H  RILHRD+KP 
Sbjct: 92  ---RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQ 148

Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           NLL+NS+  LK+ DFGLAR     P ++ T EVVT +YRAP++LMG++ YS +VD+WS+G
Sbjct: 149 NLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207

Query: 176 CIFAELLGRRILFQAQSPVQQLGLI 200
           CIFAE++  + LF   +   QL  I
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKI 232

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  216 bits (553), Expect = 4e-71
 Identities = 79/201 (39%), Positives = 108/201 (53%), Gaps = 17/201 (8%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             G   ALKK+      L            RE+ +L   KH N++   D++        +
Sbjct: 24  NYGETFALKKI-----RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----K 73

Query: 61  EIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            + ++ E L  DL K++ V    L S   K FL Q+L G+ Y H  R+LHRD+KP NLL+
Sbjct: 74  RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N    LKI DFGLAR     P +  T E+VT +YRAP++LMG++ YS  +D+WSVGCIFA
Sbjct: 134 NREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFA 192

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E++    LF   S   QL  I
Sbjct: 193 EMVNGTPLFPGVSEADQLMRI 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  218 bits (557), Expect = 5e-71
 Identities = 71/212 (33%), Positives = 115/212 (54%), Gaps = 17/212 (8%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDF 58
             + G++VALKK+      + + K  F     RE+K+L   KH+NV++ ++I +     +
Sbjct: 38  HRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 92

Query: 59  FQE---IYVITELLQSDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
            +    IY++ +  + DL  ++ +     T   IK  +  +L GL Y+H  +ILHRD+K 
Sbjct: 93  NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 152

Query: 115 GNLLVNSNCILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDV 171
            N+L+  + +LK+ DFGLAR   + +       T  VVT +YR PE+L+G R Y   +D+
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 212

Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           W  GCI AE+  R  + Q  +   QL LI+ L
Sbjct: 213 WGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  216 bits (553), Expect = 7e-71
 Identities = 81/210 (38%), Positives = 114/210 (54%), Gaps = 15/210 (7%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RE---LKMLCFFKHDNVLSALDILQPPH 55
           DP  G  VALK +     +             RE   L+ L  F+H NV+  +D+     
Sbjct: 30  DPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87

Query: 56  LDFFQEIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
            D   ++ ++ E +  DL   +    P  L ++ IK  + Q LRGL +LH+  I+HRD+K
Sbjct: 88  TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 147

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           P N+LV S   +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WS
Sbjct: 148 PENILVTSGGTVKLADFGLARIY--SYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWS 204

Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           VGCIFAE+  R+ LF   S   QLG I DL
Sbjct: 205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  216 bits (553), Expect = 1e-70
 Identities = 74/206 (35%), Positives = 112/206 (54%), Gaps = 24/206 (11%)

Query: 4   DPRDGRRVALKKL--------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH 55
                  VALK++        P    ++       RE+ +L   KH N+++  DI+   H
Sbjct: 23  SKLTDNLVALKEIRLEHEEGAP--CTAI-------REVSLLKDLKHANIVTLHDII---H 70

Query: 56  LDFFQEIYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
            +  + + ++ E L  DL + +      +   ++K+FL+Q+LRGL Y H  ++LHRD+KP
Sbjct: 71  TE--KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
            NLL+N    LK+ DFGLAR +   P K    EVVT +YR P+IL+G+  YS  +D+W V
Sbjct: 129 QNLLINERGELKLADFGLARAKS-IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGV 187

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLI 200
           GCIF E+   R LF   +  +QL  I
Sbjct: 188 GCIFYEMATGRPLFPGSTVEEQLHFI 213

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  216 bits (553), Expect = 2e-70
 Identities = 74/207 (35%), Positives = 115/207 (55%), Gaps = 21/207 (10%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-----RELKMLCFFKHDNVLSALDILQPPHLDF 58
           D      VA+K++      L   +        RE+ +L   +H N++    ++   H   
Sbjct: 55  DTVTNETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH--- 106

Query: 59  FQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
              +++I E  ++DL K +     ++   IK FLYQ++ G+ + HS R LHRD+KP NLL
Sbjct: 107 --RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164

Query: 119 VNSNC-----ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           ++ +      +LKI DFGLAR     P +  T E++T +YR PEIL+G+RHYS +VD+WS
Sbjct: 165 LSVSDASETPVLKIGDFGLARAFG-IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223

Query: 174 VGCIFAELLGRRILFQAQSPVQQLGLI 200
           + CI+AE+L +  LF   S + QL  I
Sbjct: 224 IACIWAEMLMKTPLFPGDSEIDQLFKI 250

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  215 bits (551), Expect = 2e-70
 Identities = 73/211 (34%), Positives = 118/211 (55%), Gaps = 29/211 (13%)

Query: 4   DPRDGRRVALKKL--------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH 55
           +   G  VALK++        P    ++       RE+ ++   KH+N++   D++    
Sbjct: 26  NKTTGVYVALKEVKLDSEEGTP--STAI-------REISLMKELKHENIVRLYDVIHTE- 75

Query: 56  LDFFQEIYVITELLQSDLHKII------VSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
                ++ ++ E + +DL K +       +P+ L  + +K F +Q+L+GL + H  +ILH
Sbjct: 76  ----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILH 131

Query: 110 RDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAV 169
           RD+KP NLL+N    LK+ DFGLAR     P    + EVVT +YRAP++LMG+R YS ++
Sbjct: 132 RDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190

Query: 170 DVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
           D+WS GCI AE++  + LF   +  +QL LI
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  214 bits (547), Expect = 4e-70
 Identities = 76/208 (36%), Positives = 110/208 (52%), Gaps = 26/208 (12%)

Query: 4   DPRDGRRVALKKL---------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP 54
           +      VALK++         P    +L       RE+ +L   KH N++   D+L   
Sbjct: 23  NRETHEIVALKRVRLDDDDEGVP--SSAL-------REICLLKELKHKNIVRLHDVLHSD 73

Query: 55  HLDFFQEIYVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
                +++ ++ E    DL K   S    L  + +K FL+Q+L+GL + HS  +LHRD+K
Sbjct: 74  -----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           P NLL+N N  LK+ +FGLAR     P +  + EVVT +YR P++L GA+ YS ++D+WS
Sbjct: 129 PQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS 187

Query: 174 VGCIFAELL-GRRILFQAQSPVQQLGLI 200
            GCIFAEL    R LF       QL  I
Sbjct: 188 AGCIFAELANAGRPLFPGNDVDDQLKRI 215

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  213 bits (546), Expect = 1e-69
 Identities = 80/206 (38%), Positives = 121/206 (58%), Gaps = 18/206 (8%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVF-----RE---LKMLCFFKHDNVLSALDILQPPHLDFF 59
           GR VALK++      + + +        RE   L+ L  F+H NV+   D+      D  
Sbjct: 37  GRFVALKRVR-----VQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91

Query: 60  QEIYVITELLQSDLHKII--VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            ++ ++ E +  DL   +  V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+
Sbjct: 92  TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNI 151

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           LV S+  +K+ DFGLAR+       A+T  VVT +YRAPE+L+ +  Y+  VD+WSVGCI
Sbjct: 152 LVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCI 208

Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
           FAE+  R+ LF+  S V QLG I D+
Sbjct: 209 FAEMFRRKPLFRGSSDVDQLGKILDV 234

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  199 bits (507), Expect = 8e-63
 Identities = 76/222 (34%), Positives = 110/222 (49%), Gaps = 33/222 (14%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D +D +  ALK+     +    S    RE+ +L   KH NV+S   +          +++
Sbjct: 44  DGKDDKDYALKQ----IEGTGISMSACREIALLRELKHPNVISLQKVFLSHADR---KVW 96

Query: 64  VITELLQSDLHKII---------VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           ++ +  + DL  II           P  L    +K  LYQIL G+ YLH+  +LHRD+KP
Sbjct: 97  LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKP 156

Query: 115 GNLLV----NSNCILKICDFGLARVEEPDPNKAMTQ---EVVTQYYRAPEILMGARHYSA 167
            N+LV         +KI D G AR+    P K +      VVT +YRAPE+L+GARHY+ 
Sbjct: 157 ANILVMGEGPERGRVKIADMGFARLFN-SPLKPLADLDPVVVTFWYRAPELLLGARHYTK 215

Query: 168 AVDVWSVGCIFAELLGRRILFQAQS---------PVQQLGLI 200
           A+D+W++GCIFAELL    +F  +             QL  I
Sbjct: 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (370), Expect = 5e-43
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V    DGR+  +K++     S    +   RE+ +L   KH N++         + + F+E
Sbjct: 43  VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ--------YRESFEE 94

Query: 62  ---IYVITELLQS-DLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
              +Y++ +  +  DL K I +        D I  +  QI   LK++H  +ILHRDIK  
Sbjct: 95  NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ 154

Query: 116 NLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           N+ +  +  +++ DFG+ARV       A    + T YY +PEI    + Y+   D+W++G
Sbjct: 155 NIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICEN-KPYNNKSDIWALG 212

Query: 176 CIFAELLGRRILFQAQSPVQQLGLI 200
           C+  EL   +  F+A S    +  I
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKI 237

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  145 bits (367), Expect = 7e-43
 Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 22/212 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ---EI 62
              +  A+K +        +      E+  L   +  +      I++    D+      I
Sbjct: 50  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD----KIIR--LYDYEITDQYI 103

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+   
Sbjct: 104 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 163

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARH----------YSAAVDV 171
            + K+ DFG+A   +PD    +    V T  Y  PE +                S   DV
Sbjct: 164 ML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222

Query: 172 WSVGCIFAELLGRRILFQA-QSPVQQLGLITD 202
           WS+GCI   +   +  FQ   + + +L  I D
Sbjct: 223 WSLGCILYYMTYGKTPFQQIINQISKLHAIID 254

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (365), Expect = 3e-42
 Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 22/212 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ---EI 62
              +  A+K +        +      E+  L   +  +      I++    D+      I
Sbjct: 31  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD----KIIR--LYDYEITDQYI 84

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+   
Sbjct: 85  YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 144

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARH----------YSAAVDV 171
            + K+ DFG+A   +PD    +    V T  Y  PE +                S   DV
Sbjct: 145 ML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203

Query: 172 WSVGCIFAELLGRRILFQA-QSPVQQLGLITD 202
           WS+GCI   +   +  FQ   + + +L  I D
Sbjct: 204 WSLGCILYYMTYGKTPFQQIINQISKLHAIID 235

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  140 bits (355), Expect = 2e-41
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 23/195 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV-----------LSALDI 50
                DG+   +K++        ++++  RE+K L    H N+                 
Sbjct: 30  AKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83

Query: 51  LQPPHLDFFQEIYVITELLQS-DLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSARI 107
            +       + +++  E      L + I     + L          QI +G+ Y+HS ++
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 143

Query: 108 LHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA 167
           ++RD+KP N+ +     +KI DFGL    + D  K       T  Y +PE +   + Y  
Sbjct: 144 INRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRS-KGTLRYMSPEQISS-QDYGK 200

Query: 168 AVDVWSVGCIFAELL 182
            VD++++G I AELL
Sbjct: 201 EVDLYALGLILAELL 215

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  142 bits (360), Expect = 3e-41
 Identities = 46/212 (21%), Positives = 81/212 (38%), Gaps = 22/212 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF---QEI 62
              +  A+K +        +      E+  L   +  +      I++    D+    Q I
Sbjct: 78  EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD----KIIR--LYDYEITDQYI 131

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           Y++ E    DL+  +   + +     K +   +L  +  +H   I+H D+KP N L+   
Sbjct: 132 YMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG 191

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGA----------RHYSAAVDV 171
            + K+ DFG+A   +PD    +    V    Y  PE +                S   DV
Sbjct: 192 ML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250

Query: 172 WSVGCIFAELLGRRILFQA-QSPVQQLGLITD 202
           WS+GCI   +   +  FQ   + + +L  I D
Sbjct: 251 WSLGCILYYMTYGKTPFQQIINQISKLHAIID 282

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (356), Expect = 3e-41
 Identities = 50/201 (24%), Positives = 77/201 (38%), Gaps = 17/201 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDILQPPHLDFFQ 60
           V    DGR  A+K+  + F+      R   E+       +H   +             ++
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR--------LEQAWE 127

Query: 61  E---IYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           E   +Y+ TEL    L +        L    +  +L   L  L +LHS  ++H D+KP N
Sbjct: 128 EGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPAN 187

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           + +      K+ DFGL              +     Y APE+L G+  Y  A DV+S+G 
Sbjct: 188 IFLGPRGRCKLGDFGLLVELG-TAGAGEV-QEGDPRYMAPELLQGS--YGTAADVFSLGL 243

Query: 177 IFAELLGRRILFQAQSPVQQL 197
              E+     L       QQL
Sbjct: 244 TILEVACNMELPHGGEGWQQL 264

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  138 bits (349), Expect = 2e-40
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 25/206 (12%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           +    DG+ +  K+L     +    + +  E+ +L   KH N++         + D   +
Sbjct: 25  IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR--------YYDRIID 76

Query: 62  -----IYVITELLQS-DLHKIIVSP----QHLTSDHIKVFLYQILRGLKYLHSAR----- 106
                +Y++ E  +  DL  +I       Q+L  + +   + Q+   LK  H        
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
           +LHRD+KP N+ ++    +K+ DFGLAR+   D + A T  V T YY +PE +     Y+
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNR-MSYN 194

Query: 167 AAVDVWSVGCIFAELLGRRILFQAQS 192
              D+WS+GC+  EL      F A S
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFS 220

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  138 bits (350), Expect = 2e-40
 Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 24/203 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV-------LSALDILQPP 54
             +  D    A+K++  +    ++ ++V RE+K L   +H  +       L      +  
Sbjct: 24  AKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82

Query: 55  HLDFFQEIYVITELLQS-DLHKII---VSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
                  +Y+  +L +  +L   +    + +            QI   +++LHS  ++HR
Sbjct: 83  PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142

Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-----------TQYYRAPEIL 159
           D+KP N+    + ++K+ DFGL    + D  +      +           T+ Y +PE +
Sbjct: 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI 202

Query: 160 MGARHYSAAVDVWSVGCIFAELL 182
            G   YS  VD++S+G I  ELL
Sbjct: 203 HG-NSYSHKVDIFSLGLILFELL 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (348), Expect = 5e-40
 Identities = 47/196 (23%), Positives = 74/196 (37%), Gaps = 18/196 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V    DG   ALK++          +   RE  M   F H N+L  +            E
Sbjct: 48  VEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHE 104

Query: 62  IYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
            +++        L +++ ++      LT D I   L  I RGL+ +H+    HRD+KP N
Sbjct: 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTN 164

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVV--------TQYYRAPEILMGARH--YS 166
           +L+       + D G           +     +        T  YRAPE+     H    
Sbjct: 165 ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVID 224

Query: 167 AAVDVWSVGCIFAELL 182
              DVWS+GC+   ++
Sbjct: 225 ERTDVWSLGCVLYAMM 240

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (347), Expect = 6e-40
 Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 21/190 (11%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   A+K   N+   L       RE ++L    H N++    I +           +I E
Sbjct: 34  GDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIME 89

Query: 68  LLQS-DLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---- 119
                 L+ ++  P +   L      + L  ++ G+ +L    I+HR+IKPGN++     
Sbjct: 90  FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-------RHYSAAVDVW 172
           +   + K+ DFG AR  E + ++       T+ Y  P++   A       + Y A VD+W
Sbjct: 150 DGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207

Query: 173 SVGCIFAELL 182
           S+G  F    
Sbjct: 208 SIGVTFYHAA 217

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  136 bits (344), Expect = 1e-39
 Identities = 51/204 (25%), Positives = 85/204 (41%), Gaps = 26/204 (12%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +  D R  A+KK+     +      +  E+ +L    H  V+                
Sbjct: 25  ARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81

Query: 62  --------IYVITELLQ-SDLHKIIVSPQHLTS-DHIKVFLYQILRGLKYLHSARILHRD 111
                   +++  E  +   L+ +I S       D       QIL  L Y+HS  I+HRD
Sbjct: 82  TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRD 141

Query: 112 IKPGNLLVNSNCILKICDFGLARVEE-------------PDPNKAMTQEVVTQYYRAPEI 158
           +KP N+ ++ +  +KI DFGLA+                P  +  +T  + T  Y A E+
Sbjct: 142 LKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201

Query: 159 LMGARHYSAAVDVWSVGCIFAELL 182
           L G  HY+  +D++S+G IF E++
Sbjct: 202 LDGTGHYNEKIDMYSLGIIFFEMI 225

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  137 bits (348), Expect = 4e-39
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 21/188 (11%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQEIYV 64
            D R VA+K++     S        RE+++L    +H NV+      +       Q  Y+
Sbjct: 46  FDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCTEKDR-----QFQYI 95

Query: 65  ITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---- 119
             EL  + L + +               L Q   GL +LHS  I+HRD+KP N+L+    
Sbjct: 96  AIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN 155

Query: 120 -NSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILMGA--RHYSAAVDVWSV 174
            +      I DFGL +      +     +    T+ + APE+L      + +  VD++S 
Sbjct: 156 AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSA 215

Query: 175 GCIFAELL 182
           GC+F  ++
Sbjct: 216 GCVFYYVI 223

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (353), Expect = 8e-39
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 13/203 (6%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ-PPHLDFFQEIYVIT 66
           G +VA+K+      S  + +R   E++++    H NV+SA ++      L       +  
Sbjct: 39  GEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAM 97

Query: 67  ELLQS-DLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           E  +  DL K +   ++   L    I+  L  I   L+YLH  RI+HRD+KP N+++   
Sbjct: 98  EYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG 157

Query: 123 C---ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
               I KI D G A+  E D  +  T+ V T  Y APE+L   + Y+  VD WS G +  
Sbjct: 158 PQRLIHKIIDLGYAK--ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAF 214

Query: 180 ELL-GRRILFQAQSPVQQLGLIT 201
           E + G R       PVQ  G + 
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVR 237

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  135 bits (342), Expect = 8e-39
 Identities = 32/225 (14%), Positives = 59/225 (26%), Gaps = 34/225 (15%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNV---------LSALDIL 51
           V D       ALK        S    +R+            ++          L   D +
Sbjct: 81  VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140

Query: 52  QPPHLDFFQE------------IYVITELLQSDL-------HKIIVSPQHLTSDHIKVFL 92
                  F +              ++      DL         + V         + +  
Sbjct: 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 93  YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQY 152
            Q++R    L S  ++H    P NL +  +  L + D                   V   
Sbjct: 201 AQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK----VGTRGPASSVPVT 256

Query: 153 YRAPEILMG-ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
           Y   E L      ++ A++ W +G     +    + F   +P  +
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  135 bits (342), Expect = 1e-38
 Identities = 46/190 (24%), Positives = 79/190 (41%), Gaps = 21/190 (11%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G   A+K   N+   L       RE ++L    H N++    I +           +I E
Sbjct: 34  GDLFAIKVFNNI-SFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR---HKVLIME 89

Query: 68  LLQS-DLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---- 119
                 L+ ++  P +   L      + L  ++ G+ +L    I+HR+IKPGN++     
Sbjct: 90  FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE 149

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-------RHYSAAVDVW 172
           +   + K+ DFG AR  E + ++       T+ Y  P++   A       + Y A VD+W
Sbjct: 150 DGQSVYKLTDFGAAR--ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW 207

Query: 173 SVGCIFAELL 182
           S+G  F    
Sbjct: 208 SIGVTFYHAA 217

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  133 bits (336), Expect = 2e-38
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSK---RVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
                DG  VALKK+      L+ +K      +E+ +L    H NV+         +   
Sbjct: 51  AACLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLNHPNVIK--------YYAS 100

Query: 59  FQE---IYVITELLQS-DLHKIIVS----PQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           F E   + ++ EL  + DL ++I       + +    +  +  Q+   L+++HS R++HR
Sbjct: 101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHR 160

Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           DIKP N+ + +  ++K+ D GL R        A +  V T YY +PE +     Y+   D
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHE-NGYNFKSD 218

Query: 171 VWSVGCIFAELLGRRILFQAQS 192
           +WS+GC+  E+   +  F    
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDK 240

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  135 bits (342), Expect = 3e-38
 Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 20/188 (10%)

Query: 2   VTDPRDGRRVALKKLP------NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH 55
             + +  ++VA++ +          +    +  V  E+++L    H  ++   +      
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213

Query: 56  LDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
                  Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+KP
Sbjct: 214 ------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 267

Query: 115 GNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH--YSAAV 169
            N+L++S   +C++KI DFG +++        M     T  Y APE+L+      Y+ AV
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 325

Query: 170 DVWSVGCI 177
           D WS+G I
Sbjct: 326 DCWSLGVI 333

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  131 bits (332), Expect = 2e-37
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 24/216 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFF- 59
             D   GR  ALK+L         ++ + +E+  M     H N++           +   
Sbjct: 47  AQDVGSGREYALKRLL--SNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104

Query: 60  --QEIYVITELLQSDLHKIIV---SPQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDI 112
              E  ++TEL +  L + +    S   L+ D +    YQ  R ++++H  +  I+HRD+
Sbjct: 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDL 164

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-----------TQYYRAPEI--L 159
           K  NLL+++   +K+CDFG A      P+ + + +             T  YR PEI  L
Sbjct: 165 KVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224

Query: 160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
                     D+W++GCI   L  R+  F+  + ++
Sbjct: 225 YSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  130 bits (330), Expect = 2e-37
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 15/195 (7%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVIT 66
           G  VA+K L              RE+ ++   +H N++  +    QPP+L       ++T
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL------SIVT 113

Query: 67  ELL-QSDLHKII---VSPQHLTSDHIKVFLYQILRGLKYLHS--ARILHRDIKPGNLLVN 120
           E L +  L++++    + + L         Y + +G+ YLH+    I+HR++K  NLLV+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               +K+CDFGL+R++             T  + APE+L      +   DV+S G I  E
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWE 231

Query: 181 LLGRRILFQAQSPVQ 195
           L   +  +   +P Q
Sbjct: 232 LATLQQPWGNLNPAQ 246

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  130 bits (329), Expect = 2e-37
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 17/197 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSK---RVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
           ++D       A K +P     L+      ++  E+ +     H +V+      +      
Sbjct: 34  ISDADTKEVFAGKIVPK--SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN---- 87

Query: 59  FQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              ++V+ EL +   L ++    + LT    + +L QI+ G +YLH  R++HRD+K GNL
Sbjct: 88  -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVG 175
            +N +  +KI DFGLA   E D  +      +  T  Y APE+L   + +S  VDVWS+G
Sbjct: 147 FLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK-KGHSFEVDVWSIG 202

Query: 176 CIFAELLGRRILFQAQS 192
           CI   LL  +  F+   
Sbjct: 203 CIMYTLLVGKPPFETSC 219

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  131 bits (331), Expect = 2e-37
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 17/197 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSK---RVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
           ++D       A K +P     L+      ++  E+ +     H +V+      +      
Sbjct: 60  ISDADTKEVFAGKIVPK--SLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN---- 113

Query: 59  FQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              ++V+ EL +   L ++    + LT    + +L QI+ G +YLH  R++HRD+K GNL
Sbjct: 114 -DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVG 175
            +N +  +KI DFGLA   E D  +      +  T  Y APE+L   + +S  VDVWS+G
Sbjct: 173 FLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVLSK-KGHSFEVDVWSIG 228

Query: 176 CIFAELLGRRILFQAQS 192
           CI   LL  +  F+   
Sbjct: 229 CIMYTLLVGKPPFETSC 245

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  130 bits (328), Expect = 5e-37
 Identities = 50/188 (26%), Positives = 91/188 (48%), Gaps = 20/188 (10%)

Query: 2   VTDPRDGRRVALKKLP------NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPH 55
             + +  ++VA+K +          +    +  V  E+++L    H  ++   +      
Sbjct: 29  AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88

Query: 56  LDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
                  Y++ EL++  +L   +V  + L     K++ YQ+L  ++YLH   I+HRD+KP
Sbjct: 89  ------YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 142

Query: 115 GNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA--RHYSAAV 169
            N+L++S   +C++KI DFG +++        M     T  Y APE+L+      Y+ AV
Sbjct: 143 ENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200

Query: 170 DVWSVGCI 177
           D WS+G I
Sbjct: 201 DCWSLGVI 208

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  129 bits (327), Expect = 4e-36
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-----NVLSALDILQPPHL 56
             D +  + VALK + N  +    +    R L+ L   K D     NV+  L+     + 
Sbjct: 116 AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR--KQDKDNTMNVIHMLE-----NF 168

Query: 57  DFFQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
            F   I +  ELL  +L+++I   +    +   ++ F + IL+ L  LH  RI+H D+KP
Sbjct: 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228

Query: 115 GNLLVNSN--CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
            N+L+       +K+ DFG +  E    ++ +   + +++YRAPE+++GAR Y   +D+W
Sbjct: 229 ENILLKQQGRSGIKVIDFGSSCYE----HQRVYTYIQSRFYRAPEVILGAR-YGMPIDMW 283

Query: 173 SVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           S+GCI AELL    L   +    QL  + +L
Sbjct: 284 SLGCILAELLTGYPLLPGEDEGDQLACMIEL 314

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (316), Expect = 1e-35
 Identities = 54/186 (29%), Positives = 91/186 (48%), Gaps = 14/186 (7%)

Query: 2   VTDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
                 G  VA+K +           +RV  E+K+ C  KH ++L   +  +        
Sbjct: 30  AESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----N 84

Query: 61  EIYVITELLQS-DLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            +Y++ E+  + ++++ + +  +  + +  + F++QI+ G+ YLHS  ILHRD+   NLL
Sbjct: 85  YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLL 144

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGC 176
           +  N  +KI DFGLA   +    K  T   +  T  Y +PEI      +    DVWS+GC
Sbjct: 145 LTRNMNIKIADFGLATQLKMPHEKHYT---LCGTPNYISPEIATR-SAHGLESDVWSLGC 200

Query: 177 IFAELL 182
           +F  LL
Sbjct: 201 MFYTLL 206

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  125 bits (317), Expect = 1e-35
 Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 11/191 (5%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ 70
           VA+K L     +    +    E+ +L   +H N+L  +     P L       ++T+  +
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIVTQWCE 102

Query: 71  -SDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
            S L+  + + +       +     Q  RG+ YLH+  I+HRD+K  N+ ++ +  +KI 
Sbjct: 103 GSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 162

Query: 129 DFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMG--ARHYSAAVDVWSVGCIFAELLGRR 185
           DFGLA  +          Q   +  + APE++    +  YS   DV++ G +  EL+  +
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

Query: 186 ILFQAQSPVQQ 196
           + +   +   Q
Sbjct: 223 LPYSNINNRDQ 233

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  125 bits (316), Expect = 1e-35
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 15/180 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                   R A KK+P     +    R  +E++++    H N++   +  +        +
Sbjct: 28  AVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----D 80

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           IY++ EL    +L + +V  +          +  +L  + Y H   + HRD+KP N L  
Sbjct: 81  IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFL 140

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +   +  LK+ DFGLA      P K M  +V T YY +P++L     Y    D WS G +
Sbjct: 141 TDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVM 196

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (316), Expect = 2e-35
 Identities = 39/224 (17%), Positives = 73/224 (32%), Gaps = 41/224 (18%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDILQPPHLDFFQ 60
                DG   A+K+        V  +   RE+       +H +V+         +   + 
Sbjct: 30  CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR--------YFSAWA 81

Query: 61  E---IYVITELLQ-SDLHKII----VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
           E   + +  E      L   I        +     +K  L Q+ RGL+Y+HS  ++H DI
Sbjct: 82  EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDI 141

Query: 113 KPGNLLVNSN-------------------CILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           KP N+ ++                      + KI D G         +    +E     +
Sbjct: 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SSPQVEE-GDSRF 196

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
            A E+L     +    D++++        G   L +      ++
Sbjct: 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  128 bits (323), Expect = 2e-35
 Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 40/209 (19%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQEIYV 64
             GR VA+K++   F  +        E+K+L     H NV+              + +Y+
Sbjct: 37  FQGRPVAVKRMLIDFCDIAL-----MEIKLLTESDDHPNVIRYYCSETTD-----RFLYI 86

Query: 65  ITELLQSDLHKIIVSPQ-------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
             EL   +L  ++ S              +    L QI  G+ +LHS +I+HRD+KP N+
Sbjct: 87  ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNI 146

Query: 118 LVNS-------------NCILKICDFGLARVEEPD---PNKAMTQEVVTQYYRAPEILMG 161
           LV++             N  + I DFGL +  +         +     T  +RAPE+L  
Sbjct: 147 LVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206

Query: 162 A------RHYSAAVDVWSVGCIFAELLGR 184
           +      R  + ++D++S+GC+F  +L +
Sbjct: 207 SNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  125 bits (316), Expect = 2e-35
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 27/206 (13%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDIL-QPPHLDFFQEIYVI 65
           G  + +K+L    +    ++R F +E+K++   +H NVL  + +L +   L        I
Sbjct: 35  GEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL------NFI 85

Query: 66  TELLQS-DLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           TE ++   L  II S            F   I  G+ YLHS  I+HRD+   N LV  N 
Sbjct: 86  TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK 145

Query: 124 ILKICDFGLARVEEPDPNKA-------------MTQEVVTQYYRAPEILMGARHYSAAVD 170
            + + DFGLAR+   +  +                  V   Y+ APE++ G R Y   VD
Sbjct: 146 NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVD 204

Query: 171 VWSVGCIFAELLGRRILFQAQSPVQQ 196
           V+S G +  E++GR        P   
Sbjct: 205 VFSFGIVLCEIIGRVNADPDYLPRTM 230

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  128 bits (323), Expect = 4e-35
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 13/195 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D       A+K +     S  S+ ++  E+ +L    H N++   D  +         
Sbjct: 56  CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N 110

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ E  +  +L   I+           V + Q+L G+ YLH   I+HRD+KP NLL+ 
Sbjct: 111 YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S   + ++KI DFGL+ V E    K M + + T YY APE+L   + Y    DVWS+G I
Sbjct: 171 SKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVI 226

Query: 178 FAELLGRRILFQAQS 192
              LL     F  Q+
Sbjct: 227 LFILLAGYPPFGGQT 241

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  124 bits (313), Expect = 4e-35
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 10/201 (4%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D      VA  +L +   +    +R   E +ML   +H N++   D  +       + I 
Sbjct: 47  DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIV 105

Query: 64  VITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS--ARILHRDIKPGNLLVN 120
           ++TEL+ S  L   +   + +    ++ +  QIL+GL++LH+    I+HRD+K  N+ + 
Sbjct: 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT 165

Query: 121 S-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
                +KI D GLA ++     KA+   + T  + APE  M    Y  +VDV++ G    
Sbjct: 166 GPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPE--MYEEKYDESVDVYAFGMCML 220

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+      +       Q+   
Sbjct: 221 EMATSEYPYSECQNAAQIYRR 241

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  127 bits (320), Expect = 8e-35
 Identities = 53/186 (28%), Positives = 89/186 (47%), Gaps = 14/186 (7%)

Query: 2   VTDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             D   G+  A+K +     +     + + RE+++L    H N++   +  +        
Sbjct: 45  CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG----- 99

Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             Y++ E+    +L   I+S +  +       + Q+L G+ Y+H  +I+HRD+KP NLL+
Sbjct: 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159

Query: 120 NS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
            S   +  ++I DFGL+   E   +K M  ++ T YY APE+L     Y    DVWS G 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAPEVLH--GTYDEKCDVWSTGV 215

Query: 177 IFAELL 182
           I   LL
Sbjct: 216 ILYILL 221

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  123 bits (310), Expect = 1e-34
 Identities = 41/192 (21%), Positives = 79/192 (41%), Gaps = 25/192 (13%)

Query: 2   VTDPRDGRRVALK-----KLPNVFQSLVSSKR--VFRE---LKMLCFFKHDNVLSALDIL 51
                  +  A+K        +     V   R    +E   L+ +    H N++   D  
Sbjct: 36  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS--GHPNIIQLKDTY 93

Query: 52  QPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           +          +++ +L++  +L   +     L+    +  +  +L  +  LH   I+HR
Sbjct: 94  ETNT-----FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHR 148

Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-----RHY 165
           D+KP N+L++ +  +K+ DFG +   +P   + + +   T  Y APEI+  +       Y
Sbjct: 149 DLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGY 206

Query: 166 SAAVDVWSVGCI 177
              VD+WS G I
Sbjct: 207 GKEVDMWSTGVI 218

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  122 bits (309), Expect = 1e-34
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 13/180 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D    +  A+K +         +  + RE+++L    H N++   +IL+         
Sbjct: 41  CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----S 95

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ EL    +L   I+  +  +       + Q+  G+ Y+H   I+HRD+KP N+L+ 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S   +C +KI DFGL+   + +    M   + T YY APE+L     Y    DVWS G I
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVI 211

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 1e-34
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 26/202 (12%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLS---ALDILQPPHLDFFQEIYVITE 67
           VA++ +     +    K   RE+      +H+NV+    A   + PPHL       +IT 
Sbjct: 58  VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA--CMSPPHL------AIITS 109

Query: 68  LLQ-SDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           L +   L+ ++      L  +  +    +I++G+ YLH+  ILH+D+K  N+  ++  + 
Sbjct: 110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKV- 168

Query: 126 KICDFGLARVE----EPDPNKAMTQEVVTQYYRAPEILMGAR--------HYSAAVDVWS 173
            I DFGL  +            +  +     + APEI+             +S   DV++
Sbjct: 169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA 228

Query: 174 VGCIFAELLGRRILFQAQSPVQ 195
           +G I+ EL  R   F+ Q    
Sbjct: 229 LGTIWYELHAREWPFKTQPAEA 250

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  123 bits (310), Expect = 2e-34
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 24/190 (12%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
            + VA+K++    +S    K    EL+ L    H N++        P       + ++ E
Sbjct: 31  AKDVAIKQI----ESESERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVME 79

Query: 68  LLQS-DLHKIIVS---PQHLTSDHIKVFLYQILRGLKYLHSAR---ILHRDIKPGNLLVN 120
             +   L+ ++       + T+ H   +  Q  +G+ YLHS +   ++HRD+KP NLL+ 
Sbjct: 80  YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV 139

Query: 121 SN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           +   +LKICDFG A          MT    +  + APE+  G  +YS   DV+S G I  
Sbjct: 140 AGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILW 194

Query: 180 ELLGRRILFQ 189
           E++ RR  F 
Sbjct: 195 EVITRRKPFD 204

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (309), Expect = 2e-34
 Identities = 55/180 (30%), Positives = 87/180 (48%), Gaps = 15/180 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V     G+  ALK +            +  E+ +L   KH+N+++  DI +         
Sbjct: 28  VKQRLTGKLFALKCIKK--SPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----H 80

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ +L+   +L   I+     T     + + Q+L  +KYLH   I+HRD+KP NLL  
Sbjct: 81  YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +   N  + I DFGL+++E+      M+    T  Y APE+L   + YS AVD WS+G I
Sbjct: 141 TPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVI 196

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  123 bits (310), Expect = 2e-34
 Identities = 47/248 (18%), Positives = 87/248 (35%), Gaps = 69/248 (27%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVL---------------- 45
             +  D    A+K++  +    ++ ++V RE+K L   +H  ++                
Sbjct: 25  AKNKVDDCNYAIKRIR-LPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83

Query: 46  -----------------------------SALDILQPPHLDFF-------QEIYVITELL 69
                                          +D     +             +Y+  +L 
Sbjct: 84  EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143

Query: 70  Q-SDLHKIIVSPQHLTS---DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           +  +L   +     L             QI   +++LHS  ++HRD+KP N+    + ++
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203

Query: 126 KICDFGLARV-----------EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           K+ DFGL                       T +V T+ Y +PE + G  +YS  VD++S+
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSL 262

Query: 175 GCIFAELL 182
           G I  ELL
Sbjct: 263 GLILFELL 270

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (317), Expect = 2e-34
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 13/185 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D    +  A+K +         +  + RE+++L    H N++   +IL+         
Sbjct: 41  CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS-----S 95

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ EL    +L   I+  +  +       + Q+  G+ Y+H   I+HRD+KP N+L+ 
Sbjct: 96  FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S   +C +KI DFGL+   + +    M   + T YY APE+L     Y    DVWS G I
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLR--GTYDEKCDVWSAGVI 211

Query: 178 FAELL 182
              LL
Sbjct: 212 LYILL 216

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  121 bits (306), Expect = 4e-34
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 12/180 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G   A K +     S    +++ RE ++    +H N++   D +Q         
Sbjct: 25  CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 79

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ +L+   +L + IV+ +  +       + QIL  + Y HS  I+HR++KP NLL+ 
Sbjct: 80  HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S      +K+ DFGLA       ++A      T  Y +PE+L     YS  VD+W+ G I
Sbjct: 140 SKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVI 196

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  121 bits (305), Expect = 7e-34
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 17/185 (9%)

Query: 2   VTDPRDGRRVALKKLP----NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
                 G+  A K +     +  +  VS + + RE+ +L   +H N+++  DI +     
Sbjct: 24  CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT-- 81

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++ +I EL+   +L   +   + LT D    FL QIL G+ YLHS RI H D+KP N
Sbjct: 82  ---DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138

Query: 117 LLVNS----NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +++      N  +K+ DFG+A     +          T  + APEI+          D+W
Sbjct: 139 IMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMW 195

Query: 173 SVGCI 177
           S+G I
Sbjct: 196 SIGVI 200

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  120 bits (303), Expect = 7e-34
 Identities = 38/196 (19%), Positives = 71/196 (36%), Gaps = 18/196 (9%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVIT 66
           G  + +K L     S   S+    E   L  F H NVL  L     PP         +IT
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP----TLIT 88

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKV--FLYQILRGLKYLHSAR--ILHRDIKPGNLLVNS 121
             +    L+ ++    +   D  +   F   + RG+ +LH+    I    +   +++++ 
Sbjct: 89  HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR--HYSAAVDVWSVGCIFA 179
           +   +I    +    +          +    + APE L          + D+WS   +  
Sbjct: 149 DMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202

Query: 180 ELLGRRILFQAQSPVQ 195
           EL+ R + F   S ++
Sbjct: 203 ELVTREVPFADLSNME 218

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (302), Expect = 2e-33
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 19/201 (9%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEI 62
           D  +  R+A+K++P   +    S+ +  E+ +    KH N++  L    +   +  F E 
Sbjct: 43  DLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME- 99

Query: 63  YV----ITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            V    ++ LL+S    +           I  +  QIL GLKYLH  +I+HRDIK  N+L
Sbjct: 100 QVPGGSLSALLRSKWGPL-----KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVL 154

Query: 119 VNS-NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPE-ILMGARHYSAAVDVWSVG 175
           +N+ + +LKI DFG ++          T     T  Y APE I  G R Y  A D+WS+G
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212

Query: 176 CIFAELL-GRRILFQAQSPVQ 195
           C   E+  G+   ++   P  
Sbjct: 213 CTIIEMATGKPPFYELGEPQA 233

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  121 bits (306), Expect = 2e-33
 Identities = 41/189 (21%), Positives = 82/189 (43%), Gaps = 20/189 (10%)

Query: 2   VTDPRDGRRVALK-----KLPNVFQSLVSSK-RVFRELK-MLCFFKHDNVLSALDILQPP 54
                 G   A+K           + L   +    RE   +     H ++++ +D  +  
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172

Query: 55  HLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
                  ++++ +L++  +L   +     L+    +  +  +L  + +LH+  I+HRD+K
Sbjct: 173 S-----FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLK 227

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-----RHYSAA 168
           P N+L++ N  +++ DFG +   EP   + + +   T  Y APEIL  +       Y   
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285

Query: 169 VDVWSVGCI 177
           VD+W+ G I
Sbjct: 286 VDLWACGVI 294

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  119 bits (300), Expect = 3e-33
 Identities = 40/206 (19%), Positives = 82/206 (39%), Gaps = 28/206 (13%)

Query: 6   RDGRRVALKKL----PNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFF 59
           +D   VA+K L          ++   + F RE+ ++    H N++    +   PP +   
Sbjct: 42  KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--- 98

Query: 60  QEIYVITELLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPG 115
                + E +   DL+  ++   H +        +  I  G++Y+ +    I+HRD++  
Sbjct: 99  -----VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSP 153

Query: 116 NLLV-----NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-RHYSAAV 169
           N+ +     N+    K+ DFGL++        +++  +    + APE +      Y+   
Sbjct: 154 NIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQWMAPETIGAEEESYTEKA 209

Query: 170 DVWSVGCIFAELLGRRILFQAQSPVQ 195
           D +S   I   +L     F   S  +
Sbjct: 210 DTYSFAMILYTILTGEGPFDEYSYGK 235

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  120 bits (304), Expect = 4e-33
 Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 55/236 (23%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFR-----ELKMLCFFKHDNVLSALDILQPPH--- 55
           D  +   VA+K        +V   +V+      E+K+L        ++  D  +      
Sbjct: 40  DMVNNTHVAMK--------IVRGDKVYTEAAEDEIKLL------QRVNDADNTKEDSMGA 85

Query: 56  ------LDFF-------QEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLK 100
                 LD F         + ++ E+L  +L  +I   +H  +   ++K    Q+L GL 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 145

Query: 101 YLHS-ARILHRDIKPGNLLVN------SNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           Y+H    I+H DIKP N+L+       +   +KI D G A       ++  T  + T+ Y
Sbjct: 146 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY----DEHYTNSIQTREY 201

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP------VQQLGLITDL 203
           R+PE+L+GA  +    D+WS  C+  EL+    LF+             +  I +L
Sbjct: 202 RSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  120 bits (302), Expect = 4e-33
 Identities = 53/190 (27%), Positives = 87/190 (45%), Gaps = 22/190 (11%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
           D + G + A+KK+      L   +    EL          ++     ++         + 
Sbjct: 79  DKQTGFQCAVKKVR-----LEVFRV--EELVACAGLSSPRIVPLYGAVREGP-----WVN 126

Query: 64  VITELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +  ELL+  S L ++I     L  D    +L Q L GL+YLH+ RILH D+K  N+L++S
Sbjct: 127 IFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185

Query: 122 N-CILKICDFGLA-RVEEPDPNKAMTQE---VVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +     +CDFG A  ++     K++        T+ + APE++MG     A VD+WS  C
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCC 244

Query: 177 IFAELL-GRR 185
           +   +L G  
Sbjct: 245 MMLHMLNGCH 254

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (309), Expect = 4e-33
 Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 24/196 (12%)

Query: 2   VTDPRDGRRVALKKLP-----------NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI 50
             +       A+K +            +        + ++ E+ +L    H N++   D+
Sbjct: 55  CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114

Query: 51  LQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
            +          Y++TE  +  +L + I++            + QIL G+ YLH   I+H
Sbjct: 115 FEDKK-----YFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVH 169

Query: 110 RDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
           RDIKP N+L+ +      +KI DFGL+     D    +   + T YY APE+L     Y+
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYN 225

Query: 167 AAVDVWSVGCIFAELL 182
              DVWS G I   LL
Sbjct: 226 EKCDVWSCGVIMYILL 241

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  120 bits (303), Expect = 5e-33
 Identities = 45/185 (24%), Positives = 81/185 (43%), Gaps = 17/185 (9%)

Query: 2   VTDPRDGRRVALK----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
             +   G   A K    +     +  V  + + RE+ +L    H N+++  D+ +     
Sbjct: 31  CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++ +I EL+   +L   +   + L+ +    F+ QIL G+ YLH+ +I H D+KP N
Sbjct: 89  ---DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145

Query: 117 LLVNS----NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +++         +K+ DFGLA     +          T  + APEI+          D+W
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMW 202

Query: 173 SVGCI 177
           S+G I
Sbjct: 203 SIGVI 207

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  120 bits (304), Expect = 5e-33
 Identities = 53/211 (25%), Positives = 102/211 (48%), Gaps = 23/211 (10%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-----NVLSALDILQPPHLDF 58
           D  +   VA+K + N    L  ++   R L+++   KHD      ++         H  F
Sbjct: 75  DRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMN--KHDTEMKYYIVHLKR-----HFMF 127

Query: 59  FQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHS--ARILHRDIKP 114
              + ++ E+L  +L+ ++ +     ++ +  + F  Q+   L +L +    I+H D+KP
Sbjct: 128 RNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP 187

Query: 115 GNLLV--NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
            N+L+       +KI DFG +        + + Q + +++YR+PE+L+G   Y  A+D+W
Sbjct: 188 ENILLCNPKRSAIKIVDFGSSCQL----GQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMW 242

Query: 173 SVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           S+GCI  E+     LF   + V Q+  I ++
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  119 bits (301), Expect = 6e-33
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 17/185 (9%)

Query: 2   VTDPRDGRRVALK----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
             +   G + A K    +     +  VS + + RE+ +L   +H NV++  ++ +     
Sbjct: 30  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 87

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++ +I EL+   +L   +   + LT +    FL QIL G+ YLHS +I H D+KP N
Sbjct: 88  ---DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144

Query: 117 LLVNS----NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +++         +KI DFGLA     D          T  + APEI+          D+W
Sbjct: 145 IMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMW 201

Query: 173 SVGCI 177
           S+G I
Sbjct: 202 SIGVI 206

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  120 bits (302), Expect = 6e-33
 Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 12/180 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G   A K +     S    +++ RE ++    +H N++   D +Q         
Sbjct: 48  CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 102

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ +L+   +L + IV+ +  +       + QIL  + Y HS  I+HR++KP NLL+ 
Sbjct: 103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S      +K+ DFGLA       ++A      T  Y +PE+L     YS  VD+W+ G I
Sbjct: 163 SKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVI 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  122 bits (308), Expect = 8e-33
 Identities = 42/180 (23%), Positives = 83/180 (46%), Gaps = 14/180 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           VT+   G   A K +          + V +E++ +   +H  +++  D  +  +     E
Sbjct: 176 VTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----E 228

Query: 62  IYVITELLQ-SDL-HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E +   +L  K+      ++ D    ++ Q+ +GL ++H    +H D+KP N++ 
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 288

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +  +  LK+ DFGL      DP +++     T  + APE+  G +      D+WSVG +
Sbjct: 289 TTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVL 345

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  118 bits (299), Expect = 8e-33
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 17/185 (9%)

Query: 2   VTDPRDGRRVALK----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
             +   G   A K    +     +  VS + + RE+ +L    H NV++  D+ +     
Sbjct: 31  CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-- 88

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++ +I EL+   +L   +   + L+ +    F+ QIL G+ YLH+ +I H D+KP N
Sbjct: 89  ---DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145

Query: 117 LLVNS----NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +++         +K+ DFGLA     +          T  + APEI+          D+W
Sbjct: 146 IMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMW 202

Query: 173 SVGCI 177
           S+G I
Sbjct: 203 SIGVI 207

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  117 bits (296), Expect = 1e-32
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 26/203 (12%)

Query: 8   GRRVALKKL-PNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYV 64
           G  VA+K    +  + +  +     +E K+    KH N+++   + L+ P+L       +
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL------CL 83

Query: 65  ITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS---ARILHRDIKPGNLLVN 120
           + E  +   L++++ S + +  D +  +  QI RG+ YLH      I+HRD+K  N+L+ 
Sbjct: 84  VMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142

Query: 121 --------SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
                   SN ILKI DFGLAR                  + APE++     +S   DVW
Sbjct: 143 QKVENGDLSNKILKITDFGLAREWH---RTTKMSAAGAYAWMAPEVIRA-SMFSKGSDVW 198

Query: 173 SVGCIFAELLGRRILFQAQSPVQ 195
           S G +  ELL   + F+    + 
Sbjct: 199 SYGVLLWELLTGEVPFRGIDGLA 221

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  117 bits (295), Expect = 2e-32
 Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 11/196 (5%)

Query: 2   VTDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             + +    +ALK L     +      ++ RE+++    +H N+L               
Sbjct: 28  AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T 82

Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            +Y+I E      +++ +             ++ ++   L Y HS R++HRDIKP NLL+
Sbjct: 83  RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            S   LKI DFG + V  P  ++       T  Y  PE++ G R +   VD+WS+G +  
Sbjct: 143 GSAGELKIADFGWS-VHAPS-SRRTDL-CGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCY 198

Query: 180 ELLGRRILFQAQSPVQ 195
           E L  +  F+A +  +
Sbjct: 199 EFLVGKPPFEANTYQE 214

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  117 bits (295), Expect = 2e-32
 Identities = 44/184 (23%), Positives = 86/184 (46%), Gaps = 18/184 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V +   G    +K +    +S V  +++  E+++L    H N++   ++ +  H      
Sbjct: 41  VEERSSGLERVIKTINKD-RSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----N 94

Query: 62  IYVITELLQSD--LHKII---VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           +Y++ E  +    L +I+      + L+  ++   + Q++  L Y HS  ++H+D+KP N
Sbjct: 95  MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPEN 154

Query: 117 LLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           +L      +  +KI DFGLA +     ++  T    T  Y APE+    R  +   D+WS
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELF--KSDEHSTNAAGTALYMAPEVF--KRDVTFKCDIWS 210

Query: 174 VGCI 177
            G +
Sbjct: 211 AGVV 214

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  118 bits (298), Expect = 2e-32
 Identities = 60/180 (33%), Positives = 83/180 (46%), Gaps = 16/180 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                  +  ALK L       V  K V  E+ +L    H N++   +I + P      E
Sbjct: 72  CKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----E 122

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           I ++ EL+   +L   IV   + +       + QIL  + YLH   I+HRD+KP NLL  
Sbjct: 123 ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +   +  LKI DFGL+++ E      M     T  Y APEIL G   Y   VD+WSVG I
Sbjct: 183 TPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGII 239

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  116 bits (294), Expect = 5e-32
 Identities = 43/180 (23%), Positives = 76/180 (42%), Gaps = 15/180 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +    +    K +            V +E+ +L   +H N+L   +  +        E
Sbjct: 24  CVETSSKKTYMAKFVK---VKGTDQVLVKKEISILNIARHRNILHLHESFESME-----E 75

Query: 62  IYVITELLQ-SDLH-KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E +   D+  +I  S   L    I  +++Q+   L++LHS  I H DI+P N++ 
Sbjct: 76  LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +  +  +KI +FG AR  +P              Y APE+       S A D+WS+G +
Sbjct: 136 QTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTL 192

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (296), Expect = 6e-32
 Identities = 41/180 (22%), Positives = 78/180 (43%), Gaps = 14/180 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +   GR    K +       +    V  E+ ++    H  +++  D  +  +     E
Sbjct: 70  CVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----E 122

Query: 62  IYVITELLQ-SDLH-KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E L   +L  +I      ++   +  ++ Q   GLK++H   I+H DIKP N++ 
Sbjct: 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 182

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +     +KI DFGLA     +P++ +     T  + APEI+          D+W++G +
Sbjct: 183 ETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVL 239

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  118 bits (298), Expect = 7e-32
 Identities = 46/180 (25%), Positives = 80/180 (44%), Gaps = 11/180 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G+  A   +     S    +++ RE ++    KH N++   D +          
Sbjct: 30  CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG-----H 84

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y+I +L+   +L + IV+ ++ +       + QIL  + + H   ++HR++KP NLL+ 
Sbjct: 85  HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144

Query: 121 S---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           S      +K+ DFGLA   E    +A      T  Y +PE+L     Y   VD+W+ G I
Sbjct: 145 SKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVI 202

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  116 bits (293), Expect = 2e-31
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 14/180 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +   G ++A K +    + +   + V  E+ ++    H N++   D  +  +     +
Sbjct: 108 CEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----D 160

Query: 62  IYVITELLQ-SDLH-KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           I ++ E +   +L  +II    +LT     +F+ QI  G++++H   ILH D+KP N+L 
Sbjct: 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +     +KI DFGLAR     P + +     T  + APE++      S   D+WSVG I
Sbjct: 221 VNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVI 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (287), Expect = 4e-31
 Identities = 50/212 (23%), Positives = 76/212 (35%), Gaps = 34/212 (16%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLS--ALDILQPPHLDFFQEIYVI 65
           G  VA+K           S     EL      +H+N+L   A D+          ++++I
Sbjct: 31  GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST---QLWLI 84

Query: 66  TEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR--------ILHRDI 112
           T       L   L    +         +++ L  I  GL +LH           I HRD+
Sbjct: 85  THYHEMGSLYDYLQLTTLDTVSC----LRIVL-SIASGLAHLHIEIFGTQGKPAIAHRDL 139

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAPEILMGA-----RH 164
           K  N+LV  N    I D GLA +     N+        V T+ Y APE+L          
Sbjct: 140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199

Query: 165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
               VD+W+ G +  E+  R +        + 
Sbjct: 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  114 bits (287), Expect = 5e-31
 Identities = 48/210 (22%), Positives = 78/210 (37%), Gaps = 30/210 (14%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           G +VA+K       +  +S     E+      +H+N+L  +          + ++Y+IT+
Sbjct: 60  GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYLITD 115

Query: 68  L-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR--------ILHRDIKP 114
                 L   L    +  + +         Y  + GL +LH+          I HRD+K 
Sbjct: 116 YHENGSLYDYLKSTTLDAKSMLK-----LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAPEILMGA-----RHYS 166
            N+LV  N    I D GLA     D N+        V T+ Y  PE+L  +         
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230

Query: 167 AAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
              D++S G I  E+  R +        Q 
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQL 260

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  114 bits (286), Expect = 2e-30
 Identities = 30/233 (12%), Positives = 73/233 (31%), Gaps = 34/233 (14%)

Query: 2   VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFK----------HDNVLSALDI 50
            TD   G    +       +    + K++  E+  L   +          H   +   D+
Sbjct: 97  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156

Query: 51  LQPPHLDFFQEI------------YVITELLQSDLHKIIVSPQHLTSDHIKV-------F 91
           ++ P       +            + +   +QS+L          +S H  +        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 92  LYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ 151
             Q++R L  LH   ++H  ++P +++++    + +  F     +       + +     
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276

Query: 152 YYRAPEILMGARH----YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
              A  +L   +H     + A D W++G     +    +     + +     I
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  112 bits (283), Expect = 3e-30
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 19/182 (10%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
                     A+K +        S +    E+++L  + +H N+++  D+          
Sbjct: 41  CIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHPNIITLKDVYDDGK----- 89

Query: 61  EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            +YV+TEL++  +L   I+  +  +       L+ I + ++YLH+  ++HRD+KP N+L 
Sbjct: 90  YVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILY 149

Query: 120 NSN----CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
                    ++ICDFG A+    + N  +     T  + APE+L   + Y AA D+WS+G
Sbjct: 150 VDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLG 207

Query: 176 CI 177
            +
Sbjct: 208 VL 209

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (281), Expect = 4e-30
 Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 15/183 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD-NVLSALDILQPPHLDFFQ 60
                 G+  A K L    +       +  E+ +L   K    V++  ++ +        
Sbjct: 48  CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS----- 102

Query: 61  EIYVITELLQ-SDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           EI +I E     ++  + +    + ++ + +   + QIL G+ YLH   I+H D+KP N+
Sbjct: 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNI 162

Query: 118 LVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L++S      +KI DFG++R         + + + T  Y APEIL      + A D+W++
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEILNY-DPITTATDMWNI 219

Query: 175 GCI 177
           G I
Sbjct: 220 GII 222

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  112 bits (283), Expect = 4e-30
 Identities = 48/237 (20%), Positives = 97/237 (40%), Gaps = 55/237 (23%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFR-----ELKMLCFFKHD-----NVLSALDILQP 53
              + +  A+K        +V + + +      E  +L   ++D     N++        
Sbjct: 56  HIDNKKYYAVK--------VVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHG---- 103

Query: 54  PHLDFFQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRD 111
               ++  + +I E L   L++II    +     + IK++  +IL+ L YL    + H D
Sbjct: 104 -KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTD 162

Query: 112 IKPGNLLVNSN-------------------------CILKICDFGLARVEEPDPNKAMTQ 146
           +KP N+L++                             +K+ DFG A  +    +     
Sbjct: 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK----SDYHGS 218

Query: 147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
            + T+ YRAPE+++    +  + D+WS GC+ AEL    +LF+    ++ L ++  +
Sbjct: 219 IINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  112 bits (281), Expect = 4e-30
 Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 19/183 (10%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
               R G++ ALK L +       S +  +E+          +++  LD+ +  H    +
Sbjct: 48  CFHRRTGQKCALKLLYD-------SPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99

Query: 61  EIYVITELLQ--SDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            + +I E ++      +I     Q  T       +  I   +++LHS  I HRD+KP NL
Sbjct: 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159

Query: 118 LVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L  S   + +LK+ DFG A+    +    +     T YY APE+L G   Y  + D+WS+
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYVAPEVL-GPEKYDKSCDMWSL 215

Query: 175 GCI 177
           G I
Sbjct: 216 GVI 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  112 bits (281), Expect = 5e-30
 Identities = 47/231 (20%), Positives = 77/231 (33%), Gaps = 55/231 (23%)

Query: 2   VTDPRDGRRVALK---KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
             + +     A+K   K      +    +R+  E++++    H N+    ++ +      
Sbjct: 45  AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ--- 101

Query: 59  FQEIYVITELLQ-SDLHKIIVSPQH----------------------------------- 82
              I ++ EL     L   +                                        
Sbjct: 102 --YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159

Query: 83  -----LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARV 135
                     I   + QI   L YLH+  I HRDIKP N L ++  +  +K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 136 ---EEPDPNKAMTQEVVTQYYRAPEILMGA-RHYSAAVDVWSVGCIFAELL 182
                      MT +  T Y+ APE+L      Y    D WS G +   LL
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (281), Expect = 5e-30
 Identities = 45/189 (23%), Positives = 86/189 (45%), Gaps = 22/189 (11%)

Query: 2   VTDPRDGRRVALK-----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL 56
             +   G++ A+K     K  +     +S++ + RE  +    KH +++  L+       
Sbjct: 43  CINRETGQQFAVKIVDVAKFTS--SPGLSTEDLKREASICHMLKHPHIVELLETYSSDG- 99

Query: 57  DFFQEIYVITELLQ-SDL-HKII---VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRD 111
                +Y++ E +  +DL  +I+    +    +      ++ QIL  L+Y H   I+HRD
Sbjct: 100 ----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRD 155

Query: 112 IKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAA 168
           +KP  +L+ S   +  +K+  FG+A ++  +        V T ++ APE++     Y   
Sbjct: 156 VKPHCVLLASKENSAPVKLGGFGVA-IQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKP 213

Query: 169 VDVWSVGCI 177
           VDVW  G I
Sbjct: 214 VDVWGCGVI 222

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  111 bits (280), Expect = 8e-30
 Identities = 39/170 (22%), Positives = 74/170 (43%), Gaps = 26/170 (15%)

Query: 55  HLDFFQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDI 112
             +F   + +  ELL  +  + +           H++   YQ+   L++LH  ++ H D+
Sbjct: 90  WFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDL 149

Query: 113 KPGNLLVNSN-------------------CILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           KP N+L  ++                     +++ DFG A  +    ++  T  V T++Y
Sbjct: 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD----HEHHTTIVATRHY 205

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           R PE+++    ++   DVWS+GCI  E      LFQ     + L ++  +
Sbjct: 206 RPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  111 bits (280), Expect = 8e-30
 Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 50/230 (21%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFR-----ELKMLCFF-KHD-----NVLSALDILQPP 54
             GR VA+K        +V +   +      E+++L      D       +  L+     
Sbjct: 38  AGGRHVAVK--------IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE----- 84

Query: 55  HLDFFQEIYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDI 112
             +    I ++ ELL    +  I          DHI+   YQI + + +LHS ++ H D+
Sbjct: 85  WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDL 144

Query: 113 KPGNLLVNSN-------------------CILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           KP N+L   +                     +K+ DFG A  +    ++  +  V T++Y
Sbjct: 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD----DEHHSTLVSTRHY 200

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITDL 203
           RAPE+++    +S   DVWS+GCI  E      +F      + L ++  +
Sbjct: 201 RAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  109 bits (275), Expect = 1e-29
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 11/190 (5%)

Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
              +ALK L  +  +      ++ RE+++    +H N+L   +          + IY++ 
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----KRIYLML 93

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           E     +L+K +             F+ ++   L Y H  +++HRDIKP NLL+     L
Sbjct: 94  EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGEL 153

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRR 185
           KI DFG + V  P   +  T    T  Y  PE++ G + +   VD+W  G +  E L   
Sbjct: 154 KIADFGWS-VHAPS-LRRRTM-CGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGM 209

Query: 186 ILFQAQSPVQ 195
             F + S  +
Sbjct: 210 PPFDSPSHTE 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  110 bits (277), Expect = 2e-29
 Identities = 43/179 (24%), Positives = 73/179 (40%), Gaps = 15/179 (8%)

Query: 7   DGRRVALKKLP------NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             + V +K +       + +       +V  E+ +L   +H N++  LDI +        
Sbjct: 48  KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG----- 102

Query: 61  EIYVITELLQS--DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
              ++ E   S  DL   I     L          Q++  + YL    I+HRDIK  N++
Sbjct: 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV 162

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +  +  +K+ DFG A   E            T  Y APE+LMG  +    +++WS+G  
Sbjct: 163 IAEDFTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVT 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  109 bits (274), Expect = 3e-29
 Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 22/191 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQ 60
             +    +  A+K +    Q      RVFRE++ML   + H NVL  ++  +        
Sbjct: 32  CINLITSQEYAVKIIEK--QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED----- 84

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             Y++ E ++   +   I   +H       V +  +   L +LH+  I HRD+KP N+L 
Sbjct: 85  RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILC 144

Query: 120 NS---NCILKICDFGLARVEEPD------PNKAMTQEVVTQYYRAPEILMG----ARHYS 166
                   +KICDF L    + +          +     +  Y APE++      A  Y 
Sbjct: 145 EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204

Query: 167 AAVDVWSVGCI 177
              D+WS+G I
Sbjct: 205 KRCDLWSLGVI 215

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  110 bits (277), Expect = 5e-29
 Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 18/183 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
           + + R   + ALK L +         +  RE+++     +  +++  +D+ +  +    +
Sbjct: 81  IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRK 132

Query: 61  EIYVITELLQ--SDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            + ++ E L       +I     Q  T       +  I   ++YLHS  I HRD+KP NL
Sbjct: 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 192

Query: 118 LVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L  S   N ILK+ DFG A+  E   + ++T    T YY APE+L G   Y  + D+WS+
Sbjct: 193 LYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCDMWSL 249

Query: 175 GCI 177
           G I
Sbjct: 250 GVI 252

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  108 bits (273), Expect = 5e-29
 Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 12/156 (7%)

Query: 27  KRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLT 84
               +E+  L   + H N++   ++            +++ ELL   +L + I   +H +
Sbjct: 50  ANTQKEITALKLCEGHPNIVKLHEVFHDQL-----HTFLVMELLNGGELFERIKKKKHFS 104

Query: 85  SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPN 141
                  + +++  + ++H   ++HRD+KP NLL      N  +KI DFG AR++ PD N
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-N 163

Query: 142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           + +     T +Y APE+L     Y  + D+WS+G I
Sbjct: 164 QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVI 198

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (274), Expect = 7e-29
 Identities = 30/199 (15%), Positives = 69/199 (34%), Gaps = 30/199 (15%)

Query: 4   DPRDGRRVALKKL--PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           D ++ ++  LK     N ++         + ++ L        +            F   
Sbjct: 91  DAKNKQKFVLKVQKPANPWEF----YIGTQLMERLKPSMQHMFMKFYSAHL-----FQNG 141

Query: 62  IYVITELL-QSDLHKIIVSPQHLTS-----DHIKVFLYQILRGLKYLHSARILHRDIKPG 115
             ++ EL     L   I   ++          +  F  ++L  ++ +H   I+H DIKP 
Sbjct: 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201

Query: 116 NLLVNSNCI-----------LKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGAR 163
           N ++ +  +           L + D G +  ++        T +  T  ++  E+L   +
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-K 260

Query: 164 HYSAAVDVWSVGCIFAELL 182
            ++  +D + V      +L
Sbjct: 261 PWNYQIDYFGVAATVYCML 279

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  109 bits (273), Expect = 9e-29
 Identities = 45/217 (20%), Positives = 81/217 (37%), Gaps = 34/217 (15%)

Query: 7   DGRRVALKKL---------------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL 51
           D +  ALKK                 +             EL+++   K++  L+   I+
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 52  QPPHLDFFQEIYVITE---------LLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
                    E+Y+I E           +            +    IK  +  +L    Y+
Sbjct: 113 TNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167

Query: 103 HSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG 161
           H+ + I HRD+KP N+L++ N  +K+ DFG +       +K +     T  +  PE    
Sbjct: 168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKGSRGTYEFMPPEFFSN 224

Query: 162 ARHYS-AAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
              Y+ A VD+WS+G     +    + F  +  + +L
Sbjct: 225 ESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  108 bits (271), Expect = 1e-28
 Identities = 56/188 (29%), Positives = 92/188 (48%), Gaps = 27/188 (14%)

Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
            ++VALK +   + +      RV RE+  L   +H +++   D++  P      +I ++ 
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMVI 88

Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
           E    +L   IV  + +T D  + F  QI+  ++Y H  +I+HRD+KP NLL++ N  +K
Sbjct: 89  EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVK 148

Query: 127 ICDFGLARVEEPD---------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           I DFGL+ +             PN           Y APE++ G  +    VDVWS G +
Sbjct: 149 IADFGLSNIMTDGNFLKTSCGSPN-----------YAAPEVINGKLYAGPEVDVWSCGIV 197

Query: 178 -FAELLGR 184
            +  L+GR
Sbjct: 198 LYVMLVGR 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  107 bits (270), Expect = 2e-28
 Identities = 45/171 (26%), Positives = 86/171 (50%), Gaps = 8/171 (4%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITE 67
           GR VA+K +     +  S +++FRE++++    H N++   ++++       + +Y+I E
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIME 94

Query: 68  LLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                ++   +V+   +     +    QI+  ++Y H  RI+HRD+K  NLL++++  +K
Sbjct: 95  YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIK 154

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           I DFG +          +        Y APE+  G ++    VDVWS+G I
Sbjct: 155 IADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVI 203

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  106 bits (268), Expect = 2e-28
 Identities = 48/161 (29%), Positives = 93/161 (57%), Gaps = 9/161 (5%)

Query: 28  RVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTSD 86
           +V++E+ +L    H NV+  +++L  P+ D    +Y++ EL+    + ++  + + L+ D
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNED---HLYMVFELVNQGPVMEV-PTLKPLSED 137

Query: 87  HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ 146
             + +   +++G++YLH  +I+HRDIKP NLLV  +  +KI DFG++   +   +  ++ 
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLSN 196

Query: 147 EVVTQYYRAPEILMGARH-YS-AAVDVWSVGCI-FAELLGR 184
            V T  + APE L   R  +S  A+DVW++G   +  + G+
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (268), Expect = 2e-28
 Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 12/190 (6%)

Query: 3   TDPRDGRRVALKKLP--NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
            D     R A+K L    + +       V +E+++L   +H NV+  +D+L        Q
Sbjct: 25  LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---Q 81

Query: 61  EIYVITELL---QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           ++Y++ E       ++   +   +         +  Q++ GL+YLHS  I+H+DIKPGNL
Sbjct: 82  KMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140

Query: 118 LVNSNCILKICDFGLARVEEP-DPNKAMTQEVVTQYYRAPEILMGARHYS-AAVDVWSVG 175
           L+ +   LKI   G+A    P   +        +  ++ PEI  G   +S   VD+WS G
Sbjct: 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG 200

Query: 176 CI-FAELLGR 184
              +    G 
Sbjct: 201 VTLYNITTGL 210

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (275), Expect = 4e-28
 Identities = 42/200 (21%), Positives = 75/200 (37%), Gaps = 27/200 (13%)

Query: 3   TDPR-DGRRVALKKLPN----VFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
            D   +GR V LK L +      Q          E + L    H +++   + ++     
Sbjct: 100 LDRNVNGRPVVLKGLVHSGDAEAQ-----AMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
                Y++ E +    L +     Q L       +L +IL  L YLHS  +++ D+KP N
Sbjct: 155 GDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQE---VVTQYYRAPEILMGARHYSAAVDVWS 173
           +++    + K+ D G            +        T  ++APEI+      + A D+++
Sbjct: 213 IMLTEEQL-KLIDLGAVS--------RINSFGYLYGTPGFQAPEIVRT--GPTVATDIYT 261

Query: 174 VGCIFAELLGRRILFQAQSP 193
           VG   A L         +  
Sbjct: 262 VGRTLAALTLDLPTRNGRYV 281

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  106 bits (267), Expect = 4e-28
 Identities = 44/211 (20%), Positives = 78/211 (36%), Gaps = 30/211 (14%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
            G  VA+K           S     E+      +H+N+L  +          + ++++++
Sbjct: 64  RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA-DNKDNGTWTQLWLVS 119

Query: 67  EL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR--------ILHRDIK 113
           +      L   L++  V+ + +              GL +LH           I HRD+K
Sbjct: 120 DYHEHGSLFDYLNRYTVTVEGMIK-----LALSTASGLAHLHMEIVGTQGKPAIAHRDLK 174

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAPEILMGA-----RHY 165
             N+LV  N    I D GLA   +   +    A    V T+ Y APE+L  +        
Sbjct: 175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 234

Query: 166 SAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
               D++++G +F E+  R  +       Q 
Sbjct: 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (268), Expect = 5e-28
 Identities = 31/239 (12%), Positives = 74/239 (30%), Gaps = 45/239 (18%)

Query: 2   VTDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFK----------HDNVLSALDI 50
            TD   G    +            + K++  E+  L   +          H   +   D+
Sbjct: 92  ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151

Query: 51  LQPPHLDFFQE------------IYVITELLQSDLHKII------VSPQHLTSDHIKVFL 92
           ++ P                    + +   +QS+L           S       H ++ L
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 93  -YQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ 151
             Q++R L  LH   ++H  ++P +++++    + +  F          + A     V++
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSR 266

Query: 152 YYRAPEIL----------MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            +  PE+                 + + D W++G +   +    +     + +     I
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  105 bits (264), Expect = 5e-28
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 28/189 (14%)

Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L     +SL    ++ RE++ L  F+H +++    ++  P      + +++ 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT-----DFFMVM 90

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           E +   +L   I     +     +    QIL  + Y H   ++HRD+KP N+L++++   
Sbjct: 91  EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA 150

Query: 126 KICDFGLARVEEPD---------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           KI DFGL+ +             PN           Y APE++ G  +    VD+WS G 
Sbjct: 151 KIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVISGRLYAGPEVDIWSCGV 199

Query: 177 I-FAELLGR 184
           I +A L G 
Sbjct: 200 ILYALLCGT 208

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  103 bits (260), Expect = 3e-27
 Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 19/183 (10%)

Query: 6   RDGRRVALKKLP----NVFQSLVSSKRVFRE---LKML-CFFKHDNVLSALDILQPPHLD 57
            D  +VA+K +P      +  L  S     E   L  +     H  V+  LD  +     
Sbjct: 54  TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ--- 110

Query: 58  FFQEIYVITELLQS--DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
             +   ++ E      DL   I     L     + F  Q++  +++ HS  ++HRDIK  
Sbjct: 111 --EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDE 168

Query: 116 NLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           N+L++      K+ DFG   +     ++  T    T+ Y  PE +   ++++    VWS+
Sbjct: 169 NILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSL 225

Query: 175 GCI 177
           G +
Sbjct: 226 GIL 228

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  103 bits (259), Expect = 5e-27
 Identities = 58/214 (27%), Positives = 84/214 (39%), Gaps = 33/214 (15%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLS--ALDILQPPHLDFFQEIY 63
                VA+K  P        S +   E+  L   KH+N+L     +  +   +D   +++
Sbjct: 45  LLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEK-RGTSVD--VDLW 98

Query: 64  VITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA----------RIL 108
           +IT       L   L   +VS   L           + RGL YLH             I 
Sbjct: 99  LITAFHEKGSLSDFLKANVVSWNELCH-----IAETMARGLAYLHEDIPGLKDGHKPAIS 153

Query: 109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGA----R 163
           HRDIK  N+L+ +N    I DFGLA   E   +   T   V T+ Y APE+L GA    R
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213

Query: 164 HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
                +D++++G +  EL  R            L
Sbjct: 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  102 bits (257), Expect = 8e-27
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCF-FKHDNVLS---ALDILQPPHLD 57
           +     G+ +A+K++     S    KR+  +L +          ++   A          
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTFYGA---------- 74

Query: 58  FFQE--IYVITEL----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHR 110
            F+E  +++  EL    L     ++I   Q +  D +      I++ L++LHS   ++HR
Sbjct: 75  LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR 134

Query: 111 DIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR---HYSA 167
           D+KP N+L+N+   +K+CDFG++       + A   +   + Y APE +        YS 
Sbjct: 135 DVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192

Query: 168 AVDVWSVGCIFAEL-LGRRILFQAQSPVQQLGLI 200
             D+WS+G    EL + R       +P QQL  +
Sbjct: 193 KSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  101 bits (255), Expect = 1e-26
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 19/185 (10%)

Query: 8   GRRVALK-----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
              VA+K     +  +        + + +E+ +     H+NV+      +          
Sbjct: 32  EEAVAVKIVDMKRAVDC------PENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80

Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y+  E     +L   I     +     + F +Q++ G+ YLH   I HRDIKP NLL++ 
Sbjct: 81  YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCI-FA 179
              LKI DFGLA V   +  + +  ++  T  Y APE+L     ++  VDVWS G +  A
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 180 ELLGR 184
            L G 
Sbjct: 201 MLAGE 205

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (257), Expect = 1e-26
 Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 27/211 (12%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           D R VA+K       +   +    + +  +   +HDN+   +   +    D   E  ++ 
Sbjct: 35  DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA---------RILHRDIKPGN 116
           E   +  L K +           ++    + RGL YLH+           I HRD+   N
Sbjct: 92  EYYPNGSLXKYLSLHTSDWVSSCRLAH-SVTRGLAYLHTELPRGDHYKPAISHRDLNSRN 150

Query: 117 LLVNSNCILKICDFGLARVEEPDP-------NKAMTQEVVTQYYRAPEILMGA------R 163
           +LV ++    I DFGL+     +        + A   EV T  Y APE+L GA       
Sbjct: 151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210

Query: 164 HYSAAVDVWSVGCIFAELLGRRILFQAQSPV 194
                VD++++G I+ E+  R         V
Sbjct: 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESV 241

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  103 bits (259), Expect = 3e-26
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 28/189 (14%)

Query: 8   GRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
           G +VA+K L     +SL    ++ RE++ L  F+H +++    ++  P      +I+++ 
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMVM 95

Query: 67  ELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           E +   +L   I     L     +    QIL G+ Y H   ++HRD+KP N+L++++   
Sbjct: 96  EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA 155

Query: 126 KICDFGLARVEEPD---------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           KI DFGL+ +             PN           Y APE++ G  +    VD+WS G 
Sbjct: 156 KIADFGLSNMMSDGEFLRTSCGSPN-----------YAAPEVISGRLYAGPEVDIWSSGV 204

Query: 177 I-FAELLGR 184
           I +A L G 
Sbjct: 205 ILYALLCGT 213

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  102 bits (255), Expect = 3e-26
 Identities = 48/184 (26%), Positives = 85/184 (46%), Gaps = 16/184 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V+    G  +A K +  +        ++ REL++L       ++            F+ +
Sbjct: 52  VSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHECNSPYIVGFYGA-------FYSD 103

Query: 62  --IYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR-ILHRDIKPGNL 117
             I +  E +    L +++     +    +      +++GL YL     I+HRD+KP N+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           LVNS   +K+CDFG++   +   + A +  V T+ Y +PE L G  HYS   D+WS+G  
Sbjct: 164 LVNSRGEIKLCDFGVSG--QLIDSMANSF-VGTRSYMSPERLQGT-HYSVQSDIWSMGLS 219

Query: 178 FAEL 181
             E+
Sbjct: 220 LVEM 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  101 bits (253), Expect = 4e-26
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 6   RDGRRVALKKLP----NVFQSLVSSKRVFRELKMLCFFKHD--NVLSALDILQPPHLDFF 59
            D   VA+K +     + +  L +  RV  E+ +L         V+  LD  + P     
Sbjct: 66  SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP----- 120

Query: 60  QEIYVITELLQS--DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
               +I E  +   DL   I     L  +  + F +Q+L  +++ H+  +LHRDIK  N+
Sbjct: 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180

Query: 118 LVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           L++ N   LK+ DFG   +     +   T    T+ Y  PE +   R++  +  VWS+G 
Sbjct: 181 LIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237

Query: 177 I 177
           +
Sbjct: 238 L 238

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  101 bits (253), Expect = 4e-26
 Identities = 51/185 (27%), Positives = 81/185 (43%), Gaps = 19/185 (10%)

Query: 8   GRRVALK-----KLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
              VA+K     +  +        + + +E+ +     H+NV+      +          
Sbjct: 32  EEAVAVKIVDMKRAVDC------PENIKKEICINKMLNHENVVKFYGHRREG-----NIQ 80

Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           Y+  E     +L   I     +     + F +Q++ G+ YLH   I HRDIKP NLL++ 
Sbjct: 81  YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCI-FA 179
              LKI DFGLA V   +  + +  ++  T  Y APE+L     ++  VDVWS G +  A
Sbjct: 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTA 200

Query: 180 ELLGR 184
            L G 
Sbjct: 201 MLAGE 205

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (250), Expect = 1e-25
 Identities = 38/186 (20%), Positives = 79/186 (42%), Gaps = 22/186 (11%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
           +     G+ +A+K++          K++  +L ++        ++         +   F+
Sbjct: 41  MVHKPSGQIMAVKRIR-STVDEKEQKQLLMDLDVVMRSSDCPYIVQF-------YGALFR 92

Query: 61  E--IYVITEL----LQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSAR-ILHRDI 112
           E   ++  EL           +  V    +  + +       ++ L +L     I+HRDI
Sbjct: 93  EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI 152

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH---YSAAV 169
           KP N+L++ +  +K+CDFG++   +   + A T++   + Y APE +  +     Y    
Sbjct: 153 KPSNILLDRSGNIKLCDFGISG--QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210

Query: 170 DVWSVG 175
           DVWS+G
Sbjct: 211 DVWSLG 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  100 bits (251), Expect = 1e-25
 Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 32/195 (16%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
            D      VA+K +    +     + V RE+      +H N++   +++  P       +
Sbjct: 40  RDKLTKELVAVKYIE---RGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 91

Query: 63  YVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            +I E     +L++ I +    + D  + F  Q+L G+ Y HS +I HRD+K  N L++ 
Sbjct: 92  AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151

Query: 122 NCI--LKICDFGLARVEEPD---------PNKAMTQEVVTQYYRAPEILMGARHYSAAVD 170
           +    LKICDFG ++              P            Y APE+L+   +     D
Sbjct: 152 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----------YIAPEVLLRQEYDGKIAD 200

Query: 171 VWSVGCI-FAELLGR 184
           VWS G   +  L+G 
Sbjct: 201 VWSCGVTLYVMLVGA 215

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 99.3 bits (248), Expect = 2e-25
 Identities = 52/188 (27%), Positives = 87/188 (46%), Gaps = 23/188 (12%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--Q 60
                  +VA+K++ N+ +   S   + +E++ +    H N++S           F    
Sbjct: 35  YCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-------SFVVKD 86

Query: 61  EIYVITELLQ----SDLHKIIVS-----PQHLTSDHIKVFLYQILRGLKYLHSARILHRD 111
           E++++ +LL      D+ K IV+        L    I   L ++L GL+YLH    +HRD
Sbjct: 87  ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146

Query: 112 IKPGNLLVNSNCILKICDFG----LARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSA 167
           +K GN+L+  +  ++I DFG    LA   +   NK     V T  + APE++   R Y  
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDF 206

Query: 168 AVDVWSVG 175
             D+WS G
Sbjct: 207 KADIWSFG 214

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (250), Expect = 2e-25
 Identities = 37/190 (19%), Positives = 69/190 (36%), Gaps = 23/190 (12%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF---QEI 62
             G  V ++++     S      +  EL +   F H N++        P+   F    E+
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV--------PYRATFIADNEL 101

Query: 63  YVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           +V+T  +      DL         +    I   L  +L+ L Y+H    +HR +K  ++L
Sbjct: 102 WVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHIL 160

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQE------VVTQYYRAPEILMGARH-YSAAVDV 171
           ++ +  + +              +           V    + +PE+L      Y A  D+
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220

Query: 172 WSVGCIFAEL 181
           +SVG    EL
Sbjct: 221 YSVGITACEL 230

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.5 bits (246), Expect = 3e-25
 Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 10/196 (5%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D     +VA+K +    +    + + F RE+       H N++S +D+ +         
Sbjct: 31  EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC----- 85

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ E ++   L + I S   L+ D    F  QIL G+K+ H  RI+HRDIKP N+L++
Sbjct: 86  YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           SN  LKI DFG+A+    + +   T  V+ T  Y +PE   G        D++S+G +  
Sbjct: 146 SNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLY 203

Query: 180 ELLGRRILFQAQSPVQ 195
           E+L     F  ++ V 
Sbjct: 204 EMLVGEPPFNGETAVS 219

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 98.5 bits (246), Expect = 3e-25
 Identities = 48/179 (26%), Positives = 88/179 (49%), Gaps = 21/179 (11%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--Q 60
            D   G+ VA++++    Q       +  E+ ++   K+ N+++ LD        +    
Sbjct: 40  MDVATGQEVAIRQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLD-------SYLVGD 90

Query: 61  EIYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           E++V+ E L     +D    +V+   +    I     + L+ L++LHS +++HRDIK  N
Sbjct: 91  ELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 146

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           +L+  +  +K+ DFG      P+ +K  T  V T Y+ APE++     Y   VD+WS+G
Sbjct: 147 ILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKA-YGPKVDIWSLG 203

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 98.6 bits (246), Expect = 4e-25
 Identities = 51/179 (28%), Positives = 88/179 (49%), Gaps = 21/179 (11%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--Q 60
            +   GR+VA+K +    Q       +F E+ ++  ++H NV+            +   +
Sbjct: 65  REKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRDYQHFNVVEMYK-------SYLVGE 115

Query: 61  EIYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           E++V+ E LQ    +D    IVS   L  + I      +L+ L YLH+  ++HRDIK  +
Sbjct: 116 ELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           +L+  +  +K+ DFG       D  K  +  V T Y+ APE++  +  Y+  VD+WS+G
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRSL-YATEVDIWSLG 228

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.6 bits (246), Expect = 4e-25
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 11/154 (7%)

Query: 58  FFQE--IYVITELLQSDLHKII-VSPQHLTSDHIKVFLYQILRGLKYLHSAR-ILHRDIK 113
           F     +++  EL+ +   K+       +    +      I++ L YL     ++HRD+K
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK 152

Query: 114 PGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR----HYSAAV 169
           P N+L++    +K+CDFG++       +KA  +      Y APE +         Y    
Sbjct: 153 PSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210

Query: 170 DVWSVGCIFAEL-LGRRILFQAQSPVQQLGLITD 202
           DVWS+G    EL  G+      ++  + L  +  
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 97.7 bits (244), Expect = 9e-25
 Identities = 55/198 (27%), Positives = 88/198 (44%), Gaps = 8/198 (4%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D RD R VA+K L        S    F RE +      H  +++  D  +         
Sbjct: 32  RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA-ETPAGPL 90

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N++++
Sbjct: 91  PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQ--EVV-TQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +   +K+ DFG+AR    D   ++TQ   V+ T  Y +PE   G     A  DV+S+GC+
Sbjct: 151 ATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCV 208

Query: 178 FAELLGRRILFQAQSPVQ 195
             E+L     F   SPV 
Sbjct: 209 LYEVLTGEPPFTGDSPVS 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 96.7 bits (241), Expect = 2e-24
 Identities = 47/178 (26%), Positives = 83/178 (46%), Gaps = 17/178 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G+ VA+K++P         + + +E+ ++      +V+               +
Sbjct: 48  AIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKNT-----D 98

Query: 62  IYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           ++++ E       SD+ ++      LT D I   L   L+GL+YLH  R +HRDIK GN+
Sbjct: 99  LWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           L+N+    K+ DFG+A        K  T  + T ++ APE++     Y+   D+WS+G
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEIG-YNCVADIWSLG 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 1e-23
 Identities = 44/182 (24%), Positives = 80/182 (43%), Gaps = 15/182 (8%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEI 62
             + G+  A+K +          K+    LK      H N+ +     ++        ++
Sbjct: 45  HVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS--HHRNIATYYGAFIKKNPPGMDDQL 102

Query: 63  YVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           +++ E       +DL K       L  + I     +ILRGL +LH  +++HRDIK  N+L
Sbjct: 103 WLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVL 161

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARH----YSAAVDVWS 173
           +  N  +K+ DFG++   +    +  T   + T Y+ APE++    +    Y    D+WS
Sbjct: 162 LTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWS 219

Query: 174 VG 175
           +G
Sbjct: 220 LG 221

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 93.1 bits (232), Expect = 4e-23
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 41/183 (22%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K+L     +   + +    E  ++    + +V   L I L          + +IT+L
Sbjct: 47  VAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQL 97

Query: 69  -----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                L   + +      ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +  
Sbjct: 98  MPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDVW 172
            +KI DFGLA++   +           + Y            A E ++  R Y+   DVW
Sbjct: 155 HVKITDFGLAKLLGAE----------EKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVW 203

Query: 173 SVG 175
           S G
Sbjct: 204 SYG 206

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 92.8 bits (231), Expect = 4e-23
 Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 20/178 (11%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--QE 61
           D R  + VA+K + ++ ++    + + +E+ +L       V             +    +
Sbjct: 43  DNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-------SYLKDTK 94

Query: 62  IYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           +++I E L      DL +    P  L    I   L +IL+GL YLHS + +HRDIK  N+
Sbjct: 95  LWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           L++ +  +K+ DFG+A        K  T  V T ++ APE++  +  Y +  D+WS+G
Sbjct: 151 LLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSA-YDSKADIWSLG 206

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 92.4 bits (230), Expect = 6e-23
 Identities = 42/183 (22%), Positives = 79/183 (43%), Gaps = 22/183 (12%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF--Q 60
            +   G   A K +    +  +       E+++L    H  ++  L         ++   
Sbjct: 39  KNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKLLG-------AYYHDG 89

Query: 61  EIYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           +++++ E         +   +     LT   I+V   Q+L  L +LHS RI+HRD+K GN
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN 147

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR----HYSAAVDVW 172
           +L+     +++ DFG++        K  +  + T Y+ APE++M        Y    D+W
Sbjct: 148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IGTPYWMAPEVVMCETMKDTPYDYKADIW 206

Query: 173 SVG 175
           S+G
Sbjct: 207 SLG 209

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 92.8 bits (231), Expect = 7e-23
 Identities = 55/193 (28%), Positives = 84/193 (43%), Gaps = 32/193 (16%)

Query: 5   PRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
              G  VA+K+L     S    +R F RE+++L     D ++    +   P     Q + 
Sbjct: 49  DNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QSLR 102

Query: 64  VITELLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++ E L S  L   +      L +  + ++  QI +G++YL S R +HRD+   N+LV S
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 162

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAV 169
              +KI DFGLA++   D +          YY             APE L     +S   
Sbjct: 163 EAHVKIADFGLAKLLPLDKD----------YYVVREPGQSPIFWYAPESLS-DNIFSRQS 211

Query: 170 DVWSVGCIFAELL 182
           DVWS G +  EL 
Sbjct: 212 DVWSFGVVLYELF 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.2 bits (227), Expect = 1e-22
 Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 32/195 (16%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                G  VA+KKL     S     R F RE+++L   +HDN++    +         + 
Sbjct: 34  LQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RN 87

Query: 62  IYVITELLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E L    L   +    + +    +  +  QI +G++YL + R +HRD+   N+LV
Sbjct: 88  LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 147

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSA 167
            +   +KI DFGL +V   D            +++            APE L     +S 
Sbjct: 148 ENENRVKIGDFGLTKVLPQDKE----------FFKVKEPGESPIFWYAPESLT-ESKFSV 196

Query: 168 AVDVWSVGCIFAELL 182
           A DVWS G +  EL 
Sbjct: 197 ASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 91.7 bits (228), Expect = 1e-22
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 32/195 (16%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                G  VA+KKL     S     R F RE+++L   +HDN++    +         + 
Sbjct: 65  LQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RN 118

Query: 62  IYVITELLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E L    L   +    + +    +  +  QI +G++YL + R +HRD+   N+LV
Sbjct: 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV 178

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSA 167
            +   +KI DFGL +V   D            YY+            APE L     +S 
Sbjct: 179 ENENRVKIGDFGLTKVLPQDKE----------YYKVKEPGESPIFWYAPESLT-ESKFSV 227

Query: 168 AVDVWSVGCIFAELL 182
           A DVWS G +  EL 
Sbjct: 228 ASDVWSFGVVLYELF 242

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.7 bits (228), Expect = 2e-22
 Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 18/179 (10%)

Query: 3   TDPRDGRRVALKKLP-NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D R+   VA+KK+  +  QS    + + +E++ L   +H N +         H      
Sbjct: 74  RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128

Query: 62  IYVITELLQ---SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            +++ E      SDL  + V  + L    I    +  L+GL YLHS  ++HRD+K GN+L
Sbjct: 129 AWLVMEYCLGSASDL--LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 186

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR--HYSAAVDVWSVG 175
           ++   ++K+ DFG A         A +  V T Y+ APE+++      Y   VDVWS+G
Sbjct: 187 LSEPGLVKLGDFGSA----SIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 90.8 bits (226), Expect = 2e-22
 Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 33/211 (15%)

Query: 5   PRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
              G +VA+K L    +S  +      +E+++L    H+N++    I           I 
Sbjct: 47  DNTGEQVAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GNGIK 101

Query: 64  VITELLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +I E L S  L + +  +   +       +  QI +G+ YL S + +HRD+   N+LV S
Sbjct: 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAV 169
              +KI DFGL +  E D            YY             APE LM    +  A 
Sbjct: 162 EHQVKIGDFGLTKAIETDKE----------YYTVKDDRDSPVFWYAPECLM-QSKFYIAS 210

Query: 170 DVWSVGCIFAEL--LGRRILFQAQSPVQQLG 198
           DVWS G    EL              ++ +G
Sbjct: 211 DVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 91.9 bits (228), Expect = 3e-22
 Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 81/256 (31%)

Query: 4   DPRDGRRVALKKLPNVFQSLVS-SKRVFRELKMLCFFKHDNVLSALDILQPPH------L 56
           D +  + VA+K    V +S    ++    E+++L   K    +   D   P        L
Sbjct: 58  DIQGKKFVAMK----VVKSAEHYTETALDEIRLL---KS---VRNSDPNDPNREMVVQLL 107

Query: 57  DFFQE-------IYVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHS-AR 106
           D F+        I ++ E+L   L K I+   +  L    +K  + Q+L+GL YLH+  R
Sbjct: 108 DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167

Query: 107 ILHRDIKPGNLLVN---------------------------------------------- 120
           I+H DIKP N+L++                                              
Sbjct: 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227

Query: 121 ---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
                  +KI D G A       +K  T+++ T+ YR+ E+L+G+  Y+   D+WS  C+
Sbjct: 228 KNAEKLKVKIADLGNAC----WVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACM 282

Query: 178 FAELLGRRILFQAQSP 193
             EL     LF+  S 
Sbjct: 283 AFELATGDYLFEPHSG 298

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.4 bits (225), Expect = 4e-22
 Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 18/198 (9%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D    R VALK +     S    +    RE +     +  +V+   D         F E
Sbjct: 54  EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD---------FGE 104

Query: 62  I----YVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
           I    YV   L+   DL  ++     L        + QI   L   H+A   HRD+KP N
Sbjct: 105 IDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPEN 164

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVG 175
           +LV+++    + DFG+A     D         V T YY APE      H +   D++++ 
Sbjct: 165 ILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALT 222

Query: 176 CIFAELLGRRILFQAQSP 193
           C+  E L     +Q    
Sbjct: 223 CVLYECLTGSPPYQGDQL 240

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.8 bits (228), Expect = 5e-22
 Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 20/184 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIY 63
           +    VA+K L    +  +  +   +E  ++   KH N+  L  +   +PP        Y
Sbjct: 243 KYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FY 292

Query: 64  VITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           +ITE      L   L +   + Q +++  +     QI   ++YL     +HR++   N L
Sbjct: 293 IITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           V  N ++K+ DFGL+R+   D   A         + APE L     +S   DVW+ G + 
Sbjct: 351 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLL 409

Query: 179 AELL 182
            E+ 
Sbjct: 410 WEIA 413

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 90.1 bits (224), Expect = 6e-22
 Identities = 32/184 (17%), Positives = 65/184 (35%), Gaps = 43/184 (23%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           V +K + +       S +     +  +    H +++  L +            + ++T+ 
Sbjct: 45  VCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-------LQLVTQY 95

Query: 69  -----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                L   + +       L    +  +  QI +G+ YL    ++HR++   N+L+ S  
Sbjct: 96  LPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS 152

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDV 171
            +++ DFG+A +  PD                           A E +     Y+   DV
Sbjct: 153 QVQVADFGVADLLPPD-----------DKQLLYSEAKTPIKWMALESIH-FGKYTHQSDV 200

Query: 172 WSVG 175
           WS G
Sbjct: 201 WSYG 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 89.6 bits (223), Expect = 7e-22
 Identities = 43/195 (22%), Positives = 74/195 (37%), Gaps = 33/195 (16%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
              +     +VA+K +     S    +    E   +  F H NV+  L +          
Sbjct: 55  LKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114

Query: 61  EIYVITEL-----LQSDL--HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
           +  VI        L + L   ++   P+H+    +  F+  I  G++YL +   LHRD+ 
Sbjct: 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLA 174

Query: 114 PGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILM 160
             N ++  +  + + DFGL++ +   D            YYR            A E L 
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGD------------YYRQGRIAKMPVKWIAIESLA 222

Query: 161 GARHYSAAVDVWSVG 175
             R Y++  DVW+ G
Sbjct: 223 -DRVYTSKSDVWAFG 236

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 88.8 bits (221), Expect = 1e-21
 Identities = 41/179 (22%), Positives = 74/179 (41%), Gaps = 32/179 (17%)

Query: 11  VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITELL 69
           VA+K L N          +  E  ++    +  ++  + I              ++ E+ 
Sbjct: 47  VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-------WMLVMEMA 99

Query: 70  QS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKIC 128
           +   L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ +    KI 
Sbjct: 100 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159

Query: 129 DFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSVG 175
           DFGL++    D N          YY+            APE +     +S+  DVWS G
Sbjct: 160 DFGLSKALRADEN----------YYKAQTHGKWPVKWYAPECIN-YYKFSSKSDVWSFG 207

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 90.6 bits (225), Expect = 1e-21
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYV 64
               RVA+K L       +S +   +E +++   +H+ ++     + + P       IY+
Sbjct: 206 NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYI 255

Query: 65  ITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +TE      L   L     + ++L    +     QI  G+ Y+     +HRD++  N+LV
Sbjct: 256 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 313

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             N + K+ DFGLAR+ E +   A         + APE  +    ++   DVWS G +  
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLT 372

Query: 180 ELL 182
           EL 
Sbjct: 373 ELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.1 bits (226), Expect = 1e-21
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 19/183 (10%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYV 64
               RVA+K L       +S +   +E +++   +H+ ++     + + P       IY+
Sbjct: 289 NGTTRVAIKTLK---PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-------IYI 338

Query: 65  ITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +TE      L   L     + ++L    +     QI  G+ Y+     +HRD++  N+LV
Sbjct: 339 VTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 396

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             N + K+ DFGLAR+ E +   A         + APE  +    ++   DVWS G +  
Sbjct: 397 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLT 455

Query: 180 ELL 182
           EL 
Sbjct: 456 ELT 458

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.9 bits (221), Expect = 1e-21
 Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 34/187 (18%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           +VA+K L     +    +   RE   +  F H +V   + + L+           VI   
Sbjct: 53  KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPF 112

Query: 69  -----LQSDL--HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
                L + L   +I  +P +L    +  F+  I  G++YL S   +HRD+   N ++  
Sbjct: 113 MKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172

Query: 122 NCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAA 168
           +  + + DFGL+R +   D            YYR            A E L     Y+  
Sbjct: 173 DMTVCVADFGLSRKIYSGD------------YYRQGCASKLPVKWLALESLA-DNLYTVH 219

Query: 169 VDVWSVG 175
            DVW+ G
Sbjct: 220 SDVWAFG 226

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 88.5 bits (220), Expect = 2e-21
 Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 39/183 (21%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
           + + R   + ALK L +         +  RE+++     +  +++  +D+ +  +    +
Sbjct: 37  IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRK 88

Query: 61  EIYVITELLQ-SDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            + ++ E L   +L   I     Q  T       +  I   ++YLHS  I HRD+KP NL
Sbjct: 89  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 148

Query: 118 LVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L  S   N ILK+ DFG                       A E       Y  + D+WS+
Sbjct: 149 LYTSKRPNAILKLTDFGF----------------------AKETT--GEKYDKSCDMWSL 184

Query: 175 GCI 177
           G I
Sbjct: 185 GVI 187

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.5 bits (220), Expect = 2e-21
 Identities = 43/187 (22%), Positives = 77/187 (41%), Gaps = 31/187 (16%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           T+   G  VA+K L     +    +  + +E+ +L    H++++      +         
Sbjct: 55  TNDGTGEMVAVKALKA--DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---AS 109

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           + ++ E +    L   +     +    + +F  QI  G+ YLH+   +HRD+   N+L++
Sbjct: 110 LQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD 168

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAA 168
           ++ ++KI DFGLA+                 YYR            APE L     +  A
Sbjct: 169 NDRLVKIGDFGLAKAVPEGHE----------YYRVREDGDSPVFWYAPECLK-EYKFYYA 217

Query: 169 VDVWSVG 175
            DVWS G
Sbjct: 218 SDVWSFG 224

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.5 bits (220), Expect = 2e-21
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 41/183 (22%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K+L     +   + +    E  ++    + +V   L I L          + +IT+L
Sbjct: 47  VAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-------VQLITQL 97

Query: 69  -----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                L   + +      ++ S ++  +  QI +G+ YL   R++HRD+   N+LV +  
Sbjct: 98  MPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ 154

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDVW 172
            +KI DFGLA++   +           + Y            A E ++  R Y+   DVW
Sbjct: 155 HVKITDFGLAKLLGAE----------EKEYHAEGGKVPIKWMALESIL-HRIYTHQSDVW 203

Query: 173 SVG 175
           S G
Sbjct: 204 SYG 206

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 86.9 bits (216), Expect = 5e-21
 Identities = 50/184 (27%), Positives = 74/184 (40%), Gaps = 40/184 (21%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L     S   +   F RE+  +    H N++    + L PP       + ++TEL
Sbjct: 49  VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-------MKMVTEL 101

Query: 69  -----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                L   L K      H     +  +  Q+  G+ YL S R +HRD+   NLL+ +  
Sbjct: 102 APLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD 158

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDV 171
           ++KI DFGL R    + +          +Y             APE L   R +S A D 
Sbjct: 159 LVKIGDFGLMRALPQNDD----------HYVMQEHRKVPFAWCAPESLK-TRTFSHASDT 207

Query: 172 WSVG 175
           W  G
Sbjct: 208 WMFG 211

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 86.9 bits (216), Expect = 6e-21
 Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 46/186 (24%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVIT 66
            VA+K L    +        F +E  ++   KH N+  L  +   +PP        Y+IT
Sbjct: 40  TVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-------FYIIT 88

Query: 67  EL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           E      L   L +   + Q +++  +     QI   ++YL     +HRD+   N LV  
Sbjct: 89  EFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAV 169
           N ++K+ DFGL+R+   D             Y             APE L     +S   
Sbjct: 147 NHLVKVADFGLSRLMTGD------------TYTAHAGAKFPIKWTAPESLA-YNKFSIKS 193

Query: 170 DVWSVG 175
           DVW+ G
Sbjct: 194 DVWAFG 199

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 7e-21
 Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 43/188 (22%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIY 63
               +VA+K L    +    S   F  E  ++   +H  ++    +  Q P       IY
Sbjct: 35  NGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEP-------IY 83

Query: 64  VITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           +ITE      L   L     S   LT + +     QI  G+ ++     +HRD++  N+L
Sbjct: 84  IITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSA 167
           V+     KI DFGLAR+ E +           +Y             APE +     ++ 
Sbjct: 142 VSDTLSCKIADFGLARLIEDN-----------EYTAREGAKFPIKWTAPEAIN-YGTFTI 189

Query: 168 AVDVWSVG 175
             DVWS G
Sbjct: 190 KSDVWSFG 197

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.9 bits (216), Expect = 1e-20
 Identities = 48/190 (25%), Positives = 69/190 (36%), Gaps = 44/190 (23%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEI 62
            D   VA+K            K  F +E ++L  + H N+  L  +   + P       I
Sbjct: 137 ADNTLVAVKSCRE--TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-------I 187

Query: 63  YVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           Y++ EL       + L         L    +   +     G++YL S   +HRD+   N 
Sbjct: 188 YIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC 244

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHY 165
           LV    +LKI DFG++R E               Y              APE L     Y
Sbjct: 245 LVTEKNVLKISDFGMSREEADG-----------VYAASGGLRQVPVKWTAPEALN-YGRY 292

Query: 166 SAAVDVWSVG 175
           S+  DVWS G
Sbjct: 293 SSESDVWSFG 302

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.7 bits (213), Expect = 1e-20
 Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 47/201 (23%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEI 62
           +    VA+K +         S+  F +E + +    H  +     +   + P       I
Sbjct: 30  KGQYDVAVKMIKE----GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-------I 78

Query: 63  YVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
           Y++TE      L + L       + L    +    Y +  G+ +L S + +HRD+   N 
Sbjct: 79  YIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYS 166
           LV+ +  +K+ DFG+ R    D           QY             APE+      YS
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDD-----------QYVSSVGTKFPVKWSAPEVFH-YFKYS 183

Query: 167 AAVDVWSVGCIFAEL--LGRR 185
           +  DVW+ G +  E+  LG+ 
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.1 bits (214), Expect = 2e-20
 Identities = 34/90 (37%), Positives = 55/90 (61%), Gaps = 2/90 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQY 152
           +I+  L+YLH   I+HRD+KP N+L+N +  ++I DFG A+V  P+  +A     V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           Y +PE+L        + D+W++GCI  +L+
Sbjct: 198 YVSPELLTEKSA-CKSSDLWALGCIIYQLV 226

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 85.4 bits (212), Expect = 2e-20
 Identities = 40/181 (22%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L     +  +      RE +++    +  ++  + +            + ++ E+
Sbjct: 40  VAIKVLKQ--GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-------LMLVMEM 90

Query: 69  LQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                LHK ++   + +   ++   L+Q+  G+KYL     +HRD+   N+L+ +    K
Sbjct: 91  AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK 150

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSV 174
           I DFGL++    D +          YY             APE +   R +S+  DVWS 
Sbjct: 151 ISDFGLSKALGADDS----------YYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSY 199

Query: 175 G 175
           G
Sbjct: 200 G 200

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 84.6 bits (210), Expect = 3e-20
 Identities = 43/189 (22%), Positives = 71/189 (37%), Gaps = 45/189 (23%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEI 62
            +  +VA+K +         S+  F  E +++    H  +  L  + + Q P       I
Sbjct: 30  LNKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-------I 78

Query: 63  YVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            ++TE      L   L           ++ +      +  G+ YL  A ++HRD+   N 
Sbjct: 79  CLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYS 166
           LV  N ++K+ DFG+ R    D           QY             +PE+      YS
Sbjct: 136 LVGENQVIKVSDFGMTRFVLDD-----------QYTSSTGTKFPVKWASPEVFS-FSRYS 183

Query: 167 AAVDVWSVG 175
           +  DVWS G
Sbjct: 184 SKSDVWSFG 192

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 84.6 bits (210), Expect = 4e-20
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 39/186 (20%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEI 62
           R    VA+K +         S+  F  E K++    H+ +  L  +   Q P       I
Sbjct: 46  RGQYDVAIKMIKEG----SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-------I 94

Query: 63  YVITELLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++ITE + +  L   +   +H   +  +      +   ++YL S + LHRD+   N LVN
Sbjct: 95  FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 154

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAV 169
              ++K+ DFGL+R    D           +Y              PE+LM    +S+  
Sbjct: 155 DQGVVKVSDFGLSRYVLDD-----------EYTSSVGSKFPVRWSPPEVLM-YSKFSSKS 202

Query: 170 DVWSVG 175
           D+W+ G
Sbjct: 203 DIWAFG 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 84.2 bits (209), Expect = 5e-20
 Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 36/181 (19%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITE 67
            VA+K   N      S +  F +E   +  F H +++  + +  + P       +++I E
Sbjct: 45  AVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITENP-------VWIIME 95

Query: 68  LLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           L    +L   + V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +
Sbjct: 96  LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 155

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDVWSV 174
           K+ DFGL+R  E              YY+           APE +   R +++A DVW  
Sbjct: 156 KLGDFGLSRYMEDS-----------TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMF 203

Query: 175 G 175
           G
Sbjct: 204 G 204

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.8 bits (208), Expect = 6e-20
 Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 38/182 (20%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYV 64
           G +VA+K +    ++  +++    E  ++   +H N++  L ++   +         +Y+
Sbjct: 44  GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-------LYI 92

Query: 65  ITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +TE      L   L         L  D +  F   +   ++YL     +HRD+   N+LV
Sbjct: 93  VTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 150

Query: 120 NSNCILKICDFGLARVEEPD------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           + + + K+ DFGL +           P K            APE L   + +S   DVWS
Sbjct: 151 SEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----------APEALR-EKKFSTKSDVWS 199

Query: 174 VG 175
            G
Sbjct: 200 FG 201

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 84.2 bits (209), Expect = 6e-20
 Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 36/181 (19%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITE 67
            VA+K         + +K  F  E  ++    H +++  + I  + P        ++I E
Sbjct: 42  NVAVKTCKK--DCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-------TWIIME 92

Query: 68  LLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           L    +L   +   ++ L    + ++  QI + + YL S   +HRDI   N+LV S   +
Sbjct: 93  LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECV 152

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDVWSV 174
           K+ DFGL+R  E +            YY+           +PE +   R ++ A DVW  
Sbjct: 153 KLGDFGLSRYIEDE-----------DYYKASVTRLPIKWMSPESIN-FRRFTTASDVWMF 200

Query: 175 G 175
            
Sbjct: 201 A 201

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.9 bits (208), Expect = 9e-20
 Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 43/187 (22%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI---LQPPHLDFFQEIYVI 65
             A+K L  +          F  E  ++  F H NVLS L I    +           V+
Sbjct: 55  HCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS-------PLVV 105

Query: 66  TELLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
              ++  DL   I +  H  T   +  F  Q+ +G+KYL S + +HRD+   N +++   
Sbjct: 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF 165

Query: 124 ILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR--------------APEILMGARHYSAA 168
            +K+ DFGLAR + + +            YY               A E L   + ++  
Sbjct: 166 TVKVADFGLARDMYDKE------------YYSVHNKTGAKLPVKWMALESLQ-TQKFTTK 212

Query: 169 VDVWSVG 175
            DVWS G
Sbjct: 213 SDVWSFG 219

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.3 bits (211), Expect = 1e-19
 Identities = 39/148 (26%), Positives = 76/148 (51%), Gaps = 11/148 (7%)

Query: 43  NVLSALDILQPP---HLDF-FQ---EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQ 94
            +LS +     P    + + F    ++  I +L+   DLH  +      +   ++ +  +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 95  ILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR 154
           I+ GL+++H+  +++RD+KP N+L++ +  ++I D GLA   +    K     V T  Y 
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYM 357

Query: 155 APEILMGARHYSAAVDVWSVGCIFAELL 182
           APE+L     Y ++ D +S+GC+  +LL
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL 385

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 84.8 bits (210), Expect = 1e-19
 Identities = 45/188 (23%), Positives = 74/188 (39%), Gaps = 43/188 (22%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIY 63
               +VA+K +    +    S   F  E  ++   +HD ++    +  + P       IY
Sbjct: 210 NKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-------IY 258

Query: 64  VITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           +ITE      L   L              +  F  QI  G+ ++     +HRD++  N+L
Sbjct: 259 IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSA 167
           V+++ + KI DFGLARV E +           +Y             APE +     ++ 
Sbjct: 317 VSASLVCKIADFGLARVIEDN-----------EYTAREGAKFPIKWTAPEAIN-FGSFTI 364

Query: 168 AVDVWSVG 175
             DVWS G
Sbjct: 365 KSDVWSFG 372

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.0 bits (210), Expect = 1e-19
 Identities = 36/181 (19%), Positives = 72/181 (39%), Gaps = 36/181 (19%)

Query: 11  VALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITEL 68
           VA+K L     +  +      RE +++    +  ++  + +            + ++ E+
Sbjct: 366 VAIKVLKQ--GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-------LMLVMEM 416

Query: 69  LQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILK 126
                    ++   + +   ++   L+Q+  G+KYL     +HR++   N+L+ +    K
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476

Query: 127 ICDFGLARVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSV 174
           I DFGL++    D +          YY             APE +   R +S+  DVWS 
Sbjct: 477 ISDFGLSKALGADDS----------YYTARSAGKWPLKWYAPECIN-FRKFSSRSDVWSY 525

Query: 175 G 175
           G
Sbjct: 526 G 526

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 83.6 bits (207), Expect = 3e-19
 Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 38/182 (20%)

Query: 8   GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYV 64
           G +VA+K +    ++  +++    E  ++   +H N++  L ++   +         +Y+
Sbjct: 216 GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-------LYI 264

Query: 65  ITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +TE      L   L         L  D +  F   +   ++YL     +HRD+   N+LV
Sbjct: 265 VTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 322

Query: 120 NSNCILKICDFGLARVEEPD------PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWS 173
           + + + K+ DFGL +           P K            APE L   + +S   DVWS
Sbjct: 323 SEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----------APEALR-EKKFSTKSDVWS 371

Query: 174 VG 175
            G
Sbjct: 372 FG 373

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 84.1 bits (208), Expect = 3e-19
 Identities = 50/181 (27%), Positives = 80/181 (44%), Gaps = 36/181 (19%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI-LQPPHLDFFQEIYVITE 67
            VA+K   N      S +  F +E   +  F H +++  + +  + P       +++I E
Sbjct: 420 AVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVITENP-------VWIIME 470

Query: 68  LLQS-DLHK-IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
           L    +L   + V    L    + ++ YQ+   L YL S R +HRDI   N+LV+SN  +
Sbjct: 471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCV 530

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDVWSV 174
           K+ DFGL+R  E              YY+           APE +   R +++A DVW  
Sbjct: 531 KLGDFGLSRYMEDS-----------TYYKASKGKLPIKWMAPESIN-FRRFTSASDVWMF 578

Query: 175 G 175
           G
Sbjct: 579 G 579

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.9 bits (205), Expect = 4e-19
 Identities = 44/184 (23%), Positives = 74/184 (40%), Gaps = 37/184 (20%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI---LQPPHLDFFQEIYVI 65
             A+K L  +          F  E  ++  F H NVLS L I    +           V+
Sbjct: 119 HCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS-------PLVV 169

Query: 66  TELLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
              ++  DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N +++   
Sbjct: 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF 229

Query: 124 ILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR-----------APEILMGARHYSAAVDV 171
            +K+ DFGLAR + + + +           +            A E L   + ++   DV
Sbjct: 230 TVKVADFGLARDMYDKEFDS---------VHNKTGAKLPVKWMALESLQ-TQKFTTKSDV 279

Query: 172 WSVG 175
           WS G
Sbjct: 280 WSFG 283

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.8 bits (205), Expect = 4e-19
 Identities = 58/188 (30%), Positives = 82/188 (43%), Gaps = 25/188 (13%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVIT 66
            VA+K L          +R F  E  ++  F H N+  L  +     P       + ++T
Sbjct: 75  SVAIKTLKV--GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP-------VMIVT 125

Query: 67  EL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           E      L S L K        T   +   L  I  G+KYL     +HRD+   N+L+NS
Sbjct: 126 EYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR--APEILMGARHYSAAVDVWSVGCIFA 179
           N + K+ DFGL RV E DP  A T        R  +PE +   R +++A DVWS G +  
Sbjct: 183 NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA-YRKFTSASDVWSYGIVLW 241

Query: 180 EL--LGRR 185
           E+   G R
Sbjct: 242 EVMSYGER 249

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 5e-19
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 43/196 (21%)

Query: 1   AVTDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI---LQPPHL 56
            +   ++  + A+K L  + +        F RE  ++    H NVL+ + I    +    
Sbjct: 42  YIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGL-- 97

Query: 57  DFFQEIYVITELLQS-DLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
                 +V+   +   DL + I SPQ   T   +  F  Q+ RG++YL   + +HRD+  
Sbjct: 98  -----PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAA 152

Query: 115 GNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR--------------APEIL 159
            N +++ +  +K+ DFGLAR + + +            YY               A E L
Sbjct: 153 RNCMLDESFTVKVADFGLARDILDRE------------YYSVQQHRHARLPVKWTALESL 200

Query: 160 MGARHYSAAVDVWSVG 175
                ++   DVWS G
Sbjct: 201 Q-TYRFTTKSDVWSFG 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 82.9 bits (205), Expect = 7e-19
 Identities = 31/89 (34%), Positives = 52/89 (58%), Gaps = 2/89 (2%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           QI+ GL++LH   I++RD+KP N+L++ +  ++I D GLA VE             T  +
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGF 355

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE+L+G   Y  +VD +++G    E++
Sbjct: 356 MAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 82.4 bits (204), Expect = 8e-19
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)

Query: 59  FQ---EIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
           FQ   +++++ +LL   DL   +    H   + +K+F+ +++  L YL + RI+HRD+KP
Sbjct: 84  FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKP 143

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM--GARHYSAAVDVW 172
            N+L++ +  + I DF +A          +T    T+ Y APE+        YS AVD W
Sbjct: 144 DNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWW 201

Query: 173 SVGCIFAELL-GRR 185
           S+G    ELL GRR
Sbjct: 202 SLGVTAYELLRGRR 215

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 81.6 bits (202), Expect = 9e-19
 Identities = 55/188 (29%), Positives = 81/188 (43%), Gaps = 25/188 (13%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVIT 66
            VA+K L          +R F  E  ++  F H N+  L  +               ++T
Sbjct: 79  PVAIKALKA--GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL-------AMIVT 129

Query: 67  EL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           E      L + L          T   +   L  +  G++YL     +HRD+   N+LV+S
Sbjct: 130 EYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR--APEILMGARHYSAAVDVWSVGCIFA 179
           N + K+ DFGL+RV E DP+ A T        R  APE +   R +S+A DVWS G +  
Sbjct: 187 NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA-FRTFSSASDVWSFGVVMW 245

Query: 180 EL--LGRR 185
           E+   G R
Sbjct: 246 EVLAYGER 253

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 81.2 bits (201), Expect = 1e-18
 Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 41/203 (20%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNV--LSALDILQPPHLDFF 59
           +  +    VA+K L          +  F  E  ++  F H N+  L  +     P     
Sbjct: 68  SSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP----- 120

Query: 60  QEIYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKP 114
             + +ITE      L   L +        +   +   L  I  G+KYL +   +HRD+  
Sbjct: 121 --MMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175

Query: 115 GNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR----------APEILMGARH 164
            N+LVNSN + K+ DFGL+RV E DP           Y            APE +   R 
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPE--------ATYTTSGGKIPIRWTAPEAIS-YRK 226

Query: 165 YSAAVDVWSVGCIFAEL--LGRR 185
           +++A DVWS G +  E+   G R
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGER 249

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 79.6 bits (197), Expect = 3e-18
 Identities = 28/187 (14%), Positives = 57/187 (30%), Gaps = 44/187 (23%)

Query: 10  RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNV--LSALDILQPPHLDFFQEIYVITE 67
            V LK L         S+  F    M+    H ++     + +             ++ E
Sbjct: 42  EVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQE 92

Query: 68  L-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS- 121
                 L + L K   +   +          Q+   + +L    ++H ++   N+L+   
Sbjct: 93  FVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149

Query: 122 -------NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------APEILMGARHYSAA 168
                     +K+ D G++    P               +       PE +   ++ + A
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLA 198

Query: 169 VDVWSVG 175
            D WS G
Sbjct: 199 TDKWSFG 205

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 80.6 bits (199), Expect = 4e-18
 Identities = 33/89 (37%), Positives = 55/89 (61%), Gaps = 3/89 (3%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           +I  GL+ LH  RI++RD+KP N+L++ +  ++I D GLA V  P+      + V T  Y
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGR-VGTVGY 351

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL 182
            APE++   R Y+ + D W++GC+  E++
Sbjct: 352 MAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 79.0 bits (195), Expect = 1e-17
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 4/124 (3%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
             L  +  + +L +++  +  +H    +HRDIKP N+L++ N  +++ DFG       D 
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 229

Query: 141 NKAMTQEVVTQYYRAPEILM----GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ 196
               +  V T  Y +PEIL     G   Y    D WS+G    E+L     F A+S V+ 
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289

Query: 197 LGLI 200
            G I
Sbjct: 290 YGKI 293

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.7 bits (192), Expect = 2e-17
 Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 53/177 (29%)

Query: 31  RELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYVITELLQS-DLH------------ 74
           RE ++L   +H +++    +    +P        + ++ E ++  DL+            
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRP--------LLMVFEYMRHGDLNRFLRSHGPDAKL 143

Query: 75  ---KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG 131
                 V+P  L    +     Q+  G+ YL     +HRD+   N LV    ++KI DFG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203

Query: 132 LAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSVG 175
           ++R +   D            YYR             PE ++  R ++   DVWS G
Sbjct: 204 MSRDIYSTD------------YYRVGGRTMLPIRWMPPESIL-YRKFTTESDVWSFG 247

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.3 bits (191), Expect = 2e-17
 Identities = 45/193 (23%), Positives = 73/193 (37%), Gaps = 49/193 (25%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVIT 66
           RVA+K +          +  F  E  ++  F   +V+  L +     P         VI 
Sbjct: 57  RVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-------TLVIM 107

Query: 67  EL---------LQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPG 115
           EL         L+S    +  +P     +   +     +I  G+ YL++ + +HRD+   
Sbjct: 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 167

Query: 116 NLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGA 162
           N +V  +  +KI DFG+ R + E D            YYR            +PE L   
Sbjct: 168 NCMVAEDFTVKIGDFGMTRDIYETD------------YYRKGGKGLLPVRWMSPESLK-D 214

Query: 163 RHYSAAVDVWSVG 175
             ++   DVWS G
Sbjct: 215 GVFTTYSDVWSFG 227

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 77.8 bits (192), Expect = 3e-17
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 6/126 (4%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + + ++  + +L +I+  +  +H    +HRDIKP N+L++    +++ DFG       D 
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG 216

Query: 141 NKAMTQEVVTQYYRAPEILMG------ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV 194
                  V T  Y +PEIL           Y    D W++G    E+   +  F A S  
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276

Query: 195 QQLGLI 200
           +  G I
Sbjct: 277 ETYGKI 282

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.9 bits (190), Expect = 3e-17
 Identities = 45/199 (22%), Positives = 69/199 (34%), Gaps = 57/199 (28%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDFFQEIYVI 65
             A+K++           R F  EL++LC    H N+++ L     +         +Y+ 
Sbjct: 54  DAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-------LYLA 104

Query: 66  TEL-----------------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARIL 108
            E                            +   L+S  +  F   + RG+ YL   + +
Sbjct: 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 164

Query: 109 HRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR------------AP 156
           HRD+   N+LV  N + KI DFGL+R +E               Y             A 
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSRGQE--------------VYVKKTMGRLPVRWMAI 210

Query: 157 EILMGARHYSAAVDVWSVG 175
           E L     Y+   DVWS G
Sbjct: 211 ESLN-YSVYTTNSDVWSYG 228

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.4 bits (191), Expect = 4e-17
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 3/118 (2%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
             +     + +  +++  L  +HS   +HRD+KP N+L++ +  LK+ DFG       + 
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 141 NKAMTQEVVTQYYRAPEILM---GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
                  V T  Y +PE+L    G  +Y    D WSVG    E+L     F A S V 
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.5 bits (189), Expect = 5e-17
 Identities = 46/200 (23%), Positives = 81/200 (40%), Gaps = 58/200 (29%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVIT 66
            VA+K L +     +++++ F RE ++L   +H++++    +     P       + ++ 
Sbjct: 47  LVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-------LIMVF 96

Query: 67  ELLQS-DLH----------------KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILH 109
           E ++  DL+                +   +   L    +     QI  G+ YL S   +H
Sbjct: 97  EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVH 156

Query: 110 RDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------AP 156
           RD+   N LV +N ++KI DFG++R V   D            YYR             P
Sbjct: 157 RDLATRNCLVGANLLVKIGDFGMSRDVYSTD------------YYRVGGHTMLPIRWMPP 204

Query: 157 E-ILMGARHYSAAVDVWSVG 175
           E I+     ++   DVWS G
Sbjct: 205 ESIMYRK--FTTESDVWSFG 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.5 bits (189), Expect = 5e-17
 Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 59/202 (29%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSAL----DILQPPHLDFFQEIY 63
            VA+K L        S  R    ELK+L     H NV++ L        P        + 
Sbjct: 59  TVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP--------LM 108

Query: 64  VITEL-----LQSDL------------HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR 106
           VI E      L + L                +    LT +H+  + +Q+ +G+++L S +
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR----------- 154
            +HRD+   N+L++   ++KICDFGLAR + +               Y            
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP------------DYVRKGDARLPLKW 216

Query: 155 -APEILMGARHYSAAVDVWSVG 175
            APE +   R Y+   DVWS G
Sbjct: 217 MAPETIFD-RVYTIQSDVWSFG 237

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.4 bits (189), Expect = 5e-17
 Identities = 34/91 (37%), Positives = 47/91 (51%), Gaps = 4/91 (4%)

Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
            G+ +LH    +HRDIK  N+L++     KI DFGLAR  E      MT  +V T  Y A
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203

Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL-GRR 185
           PE L G    +   D++S G +  E++ G  
Sbjct: 204 PEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.2 bits (188), Expect = 7e-17
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 54/198 (27%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDFFQEIYVI 65
           +VA+K L +   +    K     ELK++    +H+N+++ L       P       + VI
Sbjct: 78  KVAVKMLKS--TAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-------VLVI 128

Query: 66  TEL-----LQSDL----------HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHR 110
           TE      L + L              ++    ++  +  F  Q+ +G+ +L S   +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188

Query: 111 DIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APE 157
           D+   N+L+ +  + KI DFGLAR +                 Y             APE
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDS------------NYIVKGNARLPVKWMAPE 236

Query: 158 ILMGARHYSAAVDVWSVG 175
            +     Y+   DVWS G
Sbjct: 237 SIFDCV-YTVQSDVWSYG 253

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 54/206 (26%), Positives = 83/206 (40%), Gaps = 56/206 (27%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDFF 59
            P++   VA+K L +   +          E++M+    KH N+++ L       P     
Sbjct: 63  KPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP----- 115

Query: 60  QEIYVITEL-----------------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYL 102
             +YVI E                  ++       V  + +T   +    YQ+ RG++YL
Sbjct: 116 --LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173

Query: 103 HSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------- 154
            S + +HRD+   N+LV  N ++KI DFGLAR +   D            YY+       
Sbjct: 174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID------------YYKKTTNGRL 221

Query: 155 -----APEILMGARHYSAAVDVWSVG 175
                APE L   R Y+   DVWS G
Sbjct: 222 PVKWMAPEALFD-RVYTHQSDVWSFG 246

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 75.8 bits (187), Expect = 1e-16
 Identities = 35/108 (32%), Positives = 60/108 (55%), Gaps = 11/108 (10%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           +  T   +++++ +I+  L++LH   I++RDIK  N+L++SN  + + DFGL++    D 
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 213

Query: 141 NKAM-----TQEVVTQYYRAPEILMGARH-YSAAVDVWSVGCIFAELL 182
            +       T E     Y AP+I+ G    +  AVD WS+G +  ELL
Sbjct: 214 TERAYDFCGTIE-----YMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 75.9 bits (187), Expect = 1e-16
 Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 56/207 (27%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDF 58
             P++   VA+K L +              E++M+    KH N+++ L       P    
Sbjct: 108 DKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP---- 161

Query: 59  FQEIYVITEL-----------------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKY 101
              +YVI E                  ++       V  + +T   +    YQ+ RG++Y
Sbjct: 162 ---LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218

Query: 102 LHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------ 154
           L S + +HRD+   N+LV  N ++KI DFGLAR +   D            YY+      
Sbjct: 219 LASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID------------YYKKTTNGR 266

Query: 155 ------APEILMGARHYSAAVDVWSVG 175
                 APE L   R Y+   DVWS G
Sbjct: 267 LPVKWMAPEALFD-RVYTHQSDVWSFG 292

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.9 bits (185), Expect = 2e-16
 Identities = 42/178 (23%), Positives = 63/178 (35%), Gaps = 54/178 (30%)

Query: 31  RELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYVITELLQS-DLHK----------- 75
            E  +    +H NV+  L ++   QP        + +I       DLH+           
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQP--------LSMIFSYCSHGDLHEFLVMRSPHSDV 112

Query: 76  -----IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDF 130
                       L        + QI  G++YL S  ++H+D+   N+LV     +KI D 
Sbjct: 113 GSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 172

Query: 131 GLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSVG 175
           GL R V   D            YY+            APE +M    +S   D+WS G
Sbjct: 173 GLFREVYAAD------------YYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYG 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 40/186 (21%), Positives = 67/186 (36%), Gaps = 62/186 (33%)

Query: 31  RELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYVITELLQS-DLHK----------- 75
           RE  ++  F + N++  L +    +P        + ++ E +   DL++           
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKP--------MCLLFEYMAYGDLNEFLRSMSPHTVC 150

Query: 76  -------------IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
                            P  L+         Q+  G+ YL   + +HRD+   N LV  N
Sbjct: 151 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 210

Query: 123 CILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAV 169
            ++KI DFGL+R +   D            YY+             PE +   R Y+   
Sbjct: 211 MVVKIADFGLSRNIYSAD------------YYKADGNDAIPIRWMPPESIFYNR-YTTES 257

Query: 170 DVWSVG 175
           DVW+ G
Sbjct: 258 DVWAYG 263

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 74.6 bits (184), Expect = 3e-16
 Identities = 50/202 (24%), Positives = 76/202 (37%), Gaps = 58/202 (28%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDFFQEIYVI 65
            VA+K L     + ++ +     ELK+L     H N+++ L    +  P         VI
Sbjct: 55  TVAVKMLKP--SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP-------TLVI 105

Query: 66  TEL-----LQSDL--------------HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR 106
           TE      L + L                +      L  + +  F YQ+ +G+ +L S  
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR----------- 154
            +HRD+   N+L+    I KICDFGLAR ++                Y            
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDS------------NYVVKGNARLPVKW 213

Query: 155 -APEILMGARHYSAAVDVWSVG 175
            APE +     Y+   DVWS G
Sbjct: 214 MAPESIFN-CVYTFESDVWSYG 234

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 3e-16
 Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 56/205 (27%)

Query: 5   PRDGRRVALKKLPNVFQSLVSSKRVF-RELKMLC-FFKHDNVLSALDI--LQPPHLDFFQ 60
           P    +VA+K L +   +          E++M+    KH N+++ L       P      
Sbjct: 98  PNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP------ 149

Query: 61  EIYVITEL-----------------LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLH 103
            +YVI E                  L+   +      + L+S  +    YQ+ RG++YL 
Sbjct: 150 -LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 208

Query: 104 SARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR-------- 154
           S + +HRD+   N+LV  + ++KI DFGLAR +   D            YY+        
Sbjct: 209 SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID------------YYKKTTNGRLP 256

Query: 155 ----APEILMGARHYSAAVDVWSVG 175
               APE L   R Y+   DVWS G
Sbjct: 257 VKWMAPEALFD-RIYTHQSDVWSFG 280

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 74.4 bits (183), Expect = 4e-16
 Identities = 45/194 (23%), Positives = 68/194 (35%), Gaps = 51/194 (26%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDIL---QPPHLDFFQEIYVI 65
           +VA+K LP V       +  F  E  ++  F H N++  + +     P         +++
Sbjct: 103 QVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--------RFIL 152

Query: 66  TELLQS-DLH-------KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            EL+   DL             P  L    +      I  G +YL     +HRDI   N 
Sbjct: 153 LELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNC 212

Query: 118 LVN---SNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMG 161
           L+       + KI DFG+AR +                YYR             PE  M 
Sbjct: 213 LLTCPGPGRVAKIGDFGMARDIYRAG------------YYRKGGCAMLPVKWMPPEAFM- 259

Query: 162 ARHYSAAVDVWSVG 175
              +++  D WS G
Sbjct: 260 EGIFTSKTDTWSFG 273

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.1 bits (183), Expect = 4e-16
 Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           ++   L +LHS  I++RD+KP N+L++    +K+ DFGL++       KA     T E  
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE-- 191

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APE++   R ++ + D WS G +  E+L
Sbjct: 192 ---YMAPEVVNR-RGHTQSADWWSFGVLMFEML 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.2 bits (183), Expect = 5e-16
 Identities = 35/117 (29%), Positives = 60/117 (51%), Gaps = 9/117 (7%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
              +  H + +  QI+   +YLHS  +++RD+KP NLL++    +++ DFG A+      
Sbjct: 136 GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGR 194

Query: 141 NKAM--TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ 195
              +  T E       APEI++  + Y+ AVD W++G +  E+      F A  P+Q
Sbjct: 195 TWTLCGTPE-----ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.9 bits (182), Expect = 5e-16
 Identities = 45/193 (23%), Positives = 68/193 (35%), Gaps = 49/193 (25%)

Query: 10  RVALKKLPNVFQSLVSSKRVF-RELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVIT 66
           +VA+K LP V       +  F  E  ++  F H N++  + +     P        +++ 
Sbjct: 62  QVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-------RFILM 112

Query: 67  ELLQS-DLHK-------IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           EL+   DL             P  L    +      I  G +YL     +HRDI   N L
Sbjct: 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172

Query: 119 VN---SNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGA 162
           +       + KI DFG+AR +                YYR             PE  M  
Sbjct: 173 LTCPGPGRVAKIGDFGMARDIYRAS------------YYRKGGCAMLPVKWMPPEAFMEG 220

Query: 163 RHYSAAVDVWSVG 175
             +++  D WS G
Sbjct: 221 I-FTSKTDTWSFG 232

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 73.4 bits (181), Expect = 7e-16
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I+  L+YLHS  +++RDIK  NL+++ +  +KI DFGL +    D         T E  
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-- 170

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APE+L     Y  AVD W +G +  E++
Sbjct: 171 ---YLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 73.4 bits (181), Expect = 7e-16
 Identities = 42/185 (22%), Positives = 62/185 (33%), Gaps = 60/185 (32%)

Query: 31  RELKMLCFFKHDNVLSALDI--LQPPHLDFFQEIYVITEL-----LQS------------ 71
            E  +L    H +V+          P       + +I E      L+             
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGP-------LLLIVEYAKYGSLRGFLRESRKVGPGY 127

Query: 72  --------DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                            + LT   +  F +QI +G++YL   +++HRD+   N+LV    
Sbjct: 128 LGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187

Query: 124 ILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVD 170
            +KI DFGL+R V E D             Y             A E L     Y+   D
Sbjct: 188 KMKISDFGLSRDVYEED------------SYVKRSQGRIPVKWMAIESLF-DHIYTTQSD 234

Query: 171 VWSVG 175
           VWS G
Sbjct: 235 VWSFG 239

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 73.3 bits (181), Expect = 7e-16
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I   L +LH   I++RD+KP N+++N    +K+ DFGL +    D         T E  
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE-- 186

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APEILM    ++ AVD WS+G +  ++L
Sbjct: 187 ---YMAPEILMR-SGHNRAVDWWSLGALMYDML 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.6 bits (181), Expect = 1e-15
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 94  QILRGLKYLHSAR-ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQY 152
           +I+  L YLHS + +++RD+K  NL+++ +  +KI DFGL + E       M     T  
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314

Query: 153 YRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           Y APE+L     Y  AVD W +G +  E++
Sbjct: 315 YLAPEVLED-NDYGRAVDWWGLGVVMYEMM 343

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.0 bits (180), Expect = 1e-15
 Identities = 34/93 (36%), Positives = 55/93 (59%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I+ GL++LHS  I++RD+K  N+L++ +  +KI DFG+ +       K      T +  
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPD-- 183

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APEIL+G + Y+ +VD WS G +  E+L
Sbjct: 184 ---YIAPEILLG-QKYNHSVDWWSFGVLLYEML 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 72.3 bits (178), Expect = 2e-15
 Identities = 32/93 (34%), Positives = 48/93 (51%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I   L YLHS  I++RD+KP N+L++S   + + DFGL +      +       T E  
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE-- 204

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APE+L   + Y   VD W +G +  E+L
Sbjct: 205 ---YLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 9/91 (9%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM--TQEVVTQ 151
           ++   L+YLHS  I++RD+KP N+L++ N  +KI DFG A+   PD    +  T +    
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-YVPDVTYTLCGTPD---- 168

Query: 152 YYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            Y APE++    + + ++D WS G +  E+L
Sbjct: 169 -YIAPEVVSTKPY-NKSIDWWSFGILIYEML 197

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 3e-15
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 2/100 (2%)

Query: 83  LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK 142
               H   +  +I  GL +L S  I++RD+K  N++++S   +KI DFG+ + E      
Sbjct: 439 FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGV 497

Query: 143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
                  T  Y APEI+   + Y  +VD W+ G +  E+L
Sbjct: 498 TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 536

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 48/185 (25%), Positives = 69/185 (37%), Gaps = 60/185 (32%)

Query: 31  RELKMLC-FFKHDNVLSALDI--LQPPHLDFFQEIYVITEL-----LQSDLHK------- 75
            ELKM+     H+N+++ L    L  P       IY+I E      L + L         
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGP-------IYLIFEYCCYGDLLNYLRSKREKFSE 149

Query: 76  ------------IIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
                              LT + +  F YQ+ +G+++L     +HRD+   N+LV    
Sbjct: 150 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 209

Query: 124 ILKICDFGLAR-VEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVD 170
           ++KICDFGLAR +                 Y             APE L     Y+   D
Sbjct: 210 VVKICDFGLARDIMSDS------------NYVVRGNARLPVKWMAPESLF-EGIYTIKSD 256

Query: 171 VWSVG 175
           VWS G
Sbjct: 257 VWSYG 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 3e-15
 Identities = 33/114 (28%), Positives = 53/114 (46%), Gaps = 24/114 (21%)

Query: 74  HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLA 133
               +    LT +H+  + +Q+ +G+++L S + +HRD+   N+L++   ++KICDFGLA
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 134 RVEEPDPNKAMTQEVVTQYYR------------APEILMGARHYSAAVDVWSVG 175
           R    D             Y             APE +   R Y+   DVWS G
Sbjct: 241 RDIYKD-----------PDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 282

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 3e-15
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I+  L +LH   I++RD+K  N+L++     K+ DFG+ +    +         T +  
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPD-- 189

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APEIL     Y  AVD W++G +  E+L
Sbjct: 190 ---YIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.5 bits (176), Expect = 4e-15
 Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 10/106 (9%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + L  +H + +  +I   L YLH   I++RD+K  N+L++S   +K+ D+G+ +      
Sbjct: 105 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

Query: 141 NKAM----TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +       T       Y APEIL G   Y  +VD W++G +  E++
Sbjct: 165 DTTSTFCGTPN-----YIAPEILRG-EDYGFSVDWWALGVLMFEMM 204

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 5e-15
 Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 10/106 (9%)

Query: 81  QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP 140
           + L  +H + +  +I   L YLH   I++RD+K  N+L++S   +K+ D+G+ +      
Sbjct: 148 RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207

Query: 141 NKAM----TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
           +       T       Y APEIL G   Y  +VD W++G +  E++
Sbjct: 208 DTTSTFCGTPN-----YIAPEILRG-EDYGFSVDWWALGVLMFEMM 247

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.3 bits (173), Expect = 9e-15
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM----TQEVV 149
           +I  GL +L S  I++RD+K  N++++S   +KI DFG+ +    D         T +  
Sbjct: 129 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD-- 186

Query: 150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
              Y APEI+   + Y  +VD W+ G +  E+L
Sbjct: 187 ---YIAPEIIAY-QPYGKSVDWWAFGVLLYEML 215

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 4e-14
 Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 5/110 (4%)

Query: 97  RGLKYLH---SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY 153
           RGL YLH     +I+HRD+K  N+L++      + DFGLA++ +       T    T  +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201

Query: 154 RAPEILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD 202
            APE L      S   DV+  G +  EL+ G+R    A+       ++ D
Sbjct: 202 IAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 66.7 bits (163), Expect = 1e-13
 Identities = 23/200 (11%), Positives = 46/200 (23%), Gaps = 38/200 (19%)

Query: 3   TDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            D    R+VAL  + P         +        L       V   LD++          
Sbjct: 51  LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG----- 105

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             V+ E ++   L ++  +    +       +  +       H A +      P  + V+
Sbjct: 106 GLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS 163

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  + +                                      +   D+  +G     
Sbjct: 164 IDGDVVLAYPA---------------------TMPDA--------NPQDDIRGIGASLYA 194

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           LL  R           L   
Sbjct: 195 LLVNRWPLPEAGVRSGLAPA 214

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 64.5 bits (158), Expect = 1e-12
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 3/102 (2%)

Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRA 155
           RGL YLH+  I+HRD+K  N+L++ N + KI DFG+++         ++  V  T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYID 209

Query: 156 PEILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQ 196
           PE  +     +   DV+S G +  E+L  R  + Q+      
Sbjct: 210 PEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 6e-09
 Identities = 21/75 (28%), Positives = 36/75 (48%), Gaps = 4/75 (5%)

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV--- 119
           +++ E L  DL KI           +     ++L  L+Y+H    +H DIK  NLL+   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 120 NSNCILKICDFGLAR 134
           N +  + + D+GL+ 
Sbjct: 188 NPD-QVYLADYGLSY 201

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 52.6 bits (125), Expect = 2e-08
 Identities = 19/139 (13%), Positives = 45/139 (32%), Gaps = 20/139 (14%)

Query: 60  QEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLL 118
            +++++ E     +    +  +  +    K  L+Q+   L    ++ R  HRD+  GN+L
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE--ILMGARHYSAAVDVWSVGC 176
           +    + K+      +                     P   + +    Y+ +        
Sbjct: 195 LKKTSLKKLHYTLNGK-----------------SSTIPSCGLQVSIIDYTLSRLERDGIV 237

Query: 177 IFAELLGRRILFQAQSPVQ 195
           +F ++     LF      Q
Sbjct: 238 VFCDVSMDEDLFTGDGDYQ 256

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.5 bits (126), Expect = 2e-08
 Identities = 29/144 (20%), Positives = 52/144 (36%), Gaps = 13/144 (9%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
                     +K  P+    L +  + ++        +       L  L  P        
Sbjct: 60  ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119

Query: 63  --------YVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
                   ++I +   SDL KI  +  +  +   +     +IL  L+Y+H    +H DIK
Sbjct: 120 DKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179

Query: 114 PGNLLV---NSNCILKICDFGLAR 134
             NLL+   N + +  + D+GLA 
Sbjct: 180 ASNLLLNYKNPDQVY-LVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.5 bits (121), Expect = 7e-08
 Identities = 15/46 (32%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLV-----NSNCILKICDFGLAR 134
           Q++  ++Y+HS  +++RD+KP N L+      +  ++ I DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 1e-07
 Identities = 9/43 (20%), Positives = 20/43 (46%), Gaps = 2/43 (4%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLV--NSNCILKICDFGLAR 134
           ++L  L++LH    +H ++   N+ V       + +  +G A 
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 3e-07
 Identities = 15/47 (31%), Positives = 29/47 (61%), Gaps = 7/47 (14%)

Query: 94  QILRGLKYLHSARILHRDIKPGNLLV------NSNCILKICDFGLAR 134
           Q+L  ++ +H   +++RDIKP N L+      N+N ++ + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.7 bits (114), Expect = 6e-07
 Identities = 21/76 (27%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 63  YVITELLQSDL-HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV-- 119
            ++ ELL   L        +  +   + +   Q++  ++Y+HS   +HRD+KP N L+  
Sbjct: 81  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 120 -NSNCILKICDFGLAR 134
                ++ I DFGLA+
Sbjct: 141 GKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 22/76 (28%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 63  YVITELLQSDL-HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV-- 119
            ++ +LL   L        + L+   + +   Q++  ++++HS   LHRDIKP N L+  
Sbjct: 79  VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 120 -NSNCILKICDFGLAR 134
                 + I DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	203
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.98
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.51
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.99
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.98
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.72
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.6
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.6
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.31
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.21
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.08
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.53
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.12
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.08
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	94.54
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.62
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	93.47
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	93.37
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.07
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.61
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.74
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.83
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.47
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	87.73
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	87.13
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	85.77

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.3e-53  Score=311.96  Aligned_cols=193  Identities=28%  Similarity=0.503  Sum_probs=159.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++.... .....+.+.+|++++++++||||+++++++.++     ..+|+||||++|+|.+.+...
T Consensus        32 ~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~  106 (275)
T 3hyh_A           32 AYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQR  106 (275)
T ss_dssp             EECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHS
T ss_pred             EEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHc
Confidence            57889999999999965433 333456788999999999999999999999988     567899999999999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....  ........||+.|+|||++.
T Consensus       107 ~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~~GT~~Y~APE~~~  184 (275)
T 3hyh_A          107 DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVIS  184 (275)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------------CTTSCHHHHS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--CCccCCeeECcccCChhhhc
Confidence            8999999999999999999999999999999999999999999999999999975432  22334568999999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|||||||++|+|++|+.||.+.+..+.++.|.
T Consensus       185 ~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~  225 (275)
T 3hyh_A          185 GKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS  225 (275)
T ss_dssp             SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            85545789999999999999999999999998888777764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.1e-53  Score=317.74  Aligned_cols=195  Identities=25%  Similarity=0.390  Sum_probs=172.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||||+++... ......+.+.+|++++++++||||+++++++.++     ..+|+||||+. |+|.+++..
T Consensus        51 a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~  125 (311)
T 4aw0_A           51 ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRK  125 (311)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH
T ss_pred             EEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHH
Confidence            5788999999999996432 2334567789999999999999999999999988     67889999998 499999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.++|.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ........+||+.|+|||+
T Consensus       126 ~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEv  205 (311)
T 4aw0_A          126 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL  205 (311)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHH
Confidence            889999999999999999999999999999999999999999999999999999865432 2233455689999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+ +.|+.++|+|||||++|+|++|++||.+.+..+++.+|.+
T Consensus       206 l~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~  248 (311)
T 4aw0_A          206 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK  248 (311)
T ss_dssp             HHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             HcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            987 5689999999999999999999999999999888888764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-52  Score=318.76  Aligned_cols=194  Identities=28%  Similarity=0.457  Sum_probs=169.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |+++.+|+.||||+++....+....+.+.+|++++++++||||+++++++.++     ..+|+|||||+ |+|.+++.. 
T Consensus        43 a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~  117 (350)
T 4b9d_A           43 VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQ  117 (350)
T ss_dssp             EEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHT
T ss_pred             EEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHc
Confidence            57889999999999976555566678899999999999999999999999987     67889999998 599999863 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||+
T Consensus       118 ~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~  196 (350)
T 4b9d_A          118 KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIGTPYYLSPEI  196 (350)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHSCCTTCCHHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-cccccccCCCccccCHHH
Confidence             356899999999999999999999999999999999999999999999999999754321 112234578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+ +.|+.++|||||||++|+|++|++||.+.+..+++.+|.+
T Consensus       197 l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  239 (350)
T 4b9d_A          197 CEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS  239 (350)
T ss_dssp             HTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             HCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence            987 5689999999999999999999999999999888887753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-51  Score=313.57  Aligned_cols=190  Identities=25%  Similarity=0.473  Sum_probs=166.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |+++.+|+.||||++...  .....+.+.+|++++++++||||+++++++.++     ..+|+||||++| +|.+++.. 
T Consensus        93 a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-  164 (346)
T 4fih_A           93 ATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-  164 (346)
T ss_dssp             EEETTTCCEEEEEEEEGG--GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-
T ss_pred             EEECCCCCEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-
Confidence            578899999999999643  334456788999999999999999999999988     678899999985 88887764 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.
T Consensus       165 ~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          165 TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcccccccCcCcCCHHHHC
Confidence            57999999999999999999999999999999999999999999999999999854432 23345568999999999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..|+.++|||||||++|+|++|++||.+.+..+.+..|.
T Consensus       244 ~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~  283 (346)
T 4fih_A          244 R-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  283 (346)
T ss_dssp             T-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            7 568999999999999999999999999999888887764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.9e-52  Score=312.32  Aligned_cols=192  Identities=25%  Similarity=0.381  Sum_probs=162.4

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      +..+|+.||||+++...........+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+++...+.
T Consensus        48 ~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~  122 (304)
T 3ubd_A           48 GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVM  122 (304)
T ss_dssp             STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCC
T ss_pred             CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCC
Confidence            456899999999976544445566788999999999999999999999987     67889999998 599999988889


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++.++..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+ 
T Consensus       123 l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GT~~YmAPE~~~~-  200 (304)
T 3ubd_A          123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFCGTVEYMAPEVVNR-  200 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCCCCGGGCCHHHHHT-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-CccccccccCcccCCHHHhcc-
Confidence            999999999999999999999999999999999999999999999999999753322 233345689999999999987 


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        163 RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.++.++|+|||||++|+|++|++||.+.+..+++.+|.+
T Consensus       201 ~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~  240 (304)
T 3ubd_A          201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK  240 (304)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence            5689999999999999999999999999999988887753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-50  Score=311.47  Aligned_cols=201  Identities=51%  Similarity=0.874  Sum_probs=173.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++...........+.+|+++++.++||||+++++++..... .....+|+||||++|+|.+.+...
T Consensus        73 a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~  152 (398)
T 4b99_A           73 ARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS  152 (398)
T ss_dssp             EEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSS
T ss_pred             EEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhc
Confidence            6788999999999997665556666788899999999999999999998765421 111457899999999999999998


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC---CCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD---PNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++.++..++.||+.||+|||++||+||||||+||+++.++.+|++|||+++.....   .........||+.|+|||
T Consensus       153 ~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APE  232 (398)
T 4b99_A          153 QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPE  232 (398)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHH
Confidence            99999999999999999999999999999999999999999999999999999754332   223345668999999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.+...++.++||||+||++|+|++|++||.+.+..+++..|.+
T Consensus       233 v~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~  277 (398)
T 4b99_A          233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM  277 (398)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             HhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            988866789999999999999999999999999999999888753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=314.57  Aligned_cols=190  Identities=25%  Similarity=0.473  Sum_probs=166.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |+++.+|+.||||++...  .....+.+.+|+.++++++||||+++++++.++     ..+|+|||||+| +|.+++.. 
T Consensus       170 a~~~~tg~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-  241 (423)
T 4fie_A          170 ATVRSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-  241 (423)
T ss_dssp             EEETTTCCEEEEEEEEST--TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-
T ss_pred             EEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-
Confidence            578899999999999643  334456788999999999999999999999988     578899999985 88887754 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++...... ........||+.|+|||++.
T Consensus       242 ~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          242 TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCBCCCEECTTTCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-CccccccccCcCcCCHHHHC
Confidence            56999999999999999999999999999999999999999999999999999754432 23345568999999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..|+.++|||||||++|+|++|++||.+.+..+.+..|.
T Consensus       321 ~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~  360 (423)
T 4fie_A          321 R-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR  360 (423)
T ss_dssp             T-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence            7 558999999999999999999999999999888887764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-50  Score=298.87  Aligned_cols=188  Identities=24%  Similarity=0.348  Sum_probs=160.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||+|.+..........+.+.+|++++++++||||+++++++.+..... ..+|+||||++ |+|.+++...
T Consensus        45 a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~-~~~~lvmEy~~gg~L~~~l~~~  123 (290)
T 3fpq_A           45 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRF  123 (290)
T ss_dssp             EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE-EEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC-cEEEEEEeCCCCCCHHHHHHhc
Confidence            568899999999999765555666778999999999999999999999986521100 35789999998 5999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..+..++.|++.||+|||+++  |+||||||+|||++ .++.+||+|||+++....   .......||+.|+|||
T Consensus       124 ~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~---~~~~~~~GTp~YmAPE  200 (290)
T 3fpq_A          124 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPE  200 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC---CccCCcccCccccCHH
Confidence            89999999999999999999999998  99999999999998 478999999999975332   2334558999999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      ++.+  .++.++|||||||++|+|+||++||.+.....
T Consensus       201 ~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~  236 (290)
T 3fpq_A          201 MYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAA  236 (290)
T ss_dssp             GGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred             HcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH
Confidence            8865  48999999999999999999999998765443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-50  Score=307.40  Aligned_cols=187  Identities=28%  Similarity=0.376  Sum_probs=158.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++...       ...+|+.++++++||||+++++++.++     ..+|+||||++ |+|.+++...
T Consensus        77 a~~~~~g~~vAiK~i~~~~-------~~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~  144 (336)
T 4g3f_A           77 MKDKQTGFQCAVKKVRLEV-------FRVEELVACAGLSSPRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQM  144 (336)
T ss_dssp             EEETTTCCEEEEEEEETTT-------CCTHHHHTTTTCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHH
T ss_pred             EEECCCCCEEEEEEECHHH-------hHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHc
Confidence            5788999999999996421       124699999999999999999999887     67889999998 5999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCC----CcccccCCccccc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNK----AMTQEVVTQYYRA  155 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~a  155 (203)
                      +++++.++..++.|++.||+|||++||+||||||+|||++.+| .+||+|||+++........    ......||+.|+|
T Consensus       145 ~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmA  224 (336)
T 4g3f_A          145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA  224 (336)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccC
Confidence            8999999999999999999999999999999999999999887 5999999999854432211    1223468999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||++.+ +.++.++|||||||++|+|++|++||.+.+..+++.+|.
T Consensus       225 PE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  269 (336)
T 4g3f_A          225 PEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA  269 (336)
T ss_dssp             HHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH
T ss_pred             HHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            999987 568999999999999999999999999887766666554

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-49  Score=297.90  Aligned_cols=190  Identities=26%  Similarity=0.409  Sum_probs=160.6

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+|..||||+++..  +....+.+.+|++++++++||||+++++++.++     ...++||||++ |+|.+++...  
T Consensus        39 ~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~  111 (299)
T 4asz_A           39 PEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGP  111 (299)
T ss_dssp             ----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSH
T ss_pred             cCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCc
Confidence            3467899999999753  344567899999999999999999999999887     56789999998 6999988642  


Q ss_pred             -----------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccccc
Q psy16889         81 -----------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEV  148 (203)
Q Consensus        81 -----------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  148 (203)
                                 ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....... .......
T Consensus       112 ~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~  191 (299)
T 4asz_A          112 DAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM  191 (299)
T ss_dssp             HHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEE
T ss_pred             ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCcee
Confidence                       4699999999999999999999999999999999999999999999999999974432222 2223346


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ||+.|+|||++.+ +.++.++||||||+++|||+| |+.||.+.+..+++..|.
T Consensus       192 gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          192 LPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             ECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            7899999999987 568999999999999999998 899999999888887764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-48  Score=296.25  Aligned_cols=190  Identities=23%  Similarity=0.394  Sum_probs=155.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+|+.||||+++..  +....+.+.+|++++++++||||+++++++.++     ..+++||||++ |+|.+++...  
T Consensus        67 ~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~  139 (329)
T 4aoj_A           67 PEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGP  139 (329)
T ss_dssp             C---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSC
T ss_pred             cCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCc
Confidence            4568999999999653  444567899999999999999999999999887     56789999998 5999988643  


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  146 (203)
                                   +++++.++..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++...... ......
T Consensus       140 ~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~  219 (329)
T 4aoj_A          140 DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR  219 (329)
T ss_dssp             C-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------
T ss_pred             ccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCc
Confidence                         469999999999999999999999999999999999999999999999999997543322 223344


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..||+.|+|||++.+ ..++.++||||||+++|||+| |+.||.+.+..+.+..|.
T Consensus       220 ~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  274 (329)
T 4aoj_A          220 TMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT  274 (329)
T ss_dssp             CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred             ccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            578999999999987 558999999999999999998 899999999888887764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=290.35  Aligned_cols=185  Identities=24%  Similarity=0.335  Sum_probs=153.1

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~   86 (203)
                      ..||||+++....+....+.+.+|++++++++||||+++++++.++      .+++||||++ |+|.+++.. .+++++.
T Consensus        59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~~~iVmEy~~gGsL~~~l~~~~~~l~~~  132 (307)
T 3omv_A           59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------NLAIVTQWCEGSSLYKHLHVQETKFQMF  132 (307)
T ss_dssp             SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEEECCSSCBHHHHHHTSCCCCCHH
T ss_pred             CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------eEEEEEEcCCCCCHHHHHhhcCCCCCHH
Confidence            4699999976555666778899999999999999999999988654      3579999998 699999865 4679999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccceeeecc--c
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEILMGA--R  163 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~~--~  163 (203)
                      ++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..... .........||+.|+|||++.+.  .
T Consensus       133 ~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~  212 (307)
T 3omv_A          133 QLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN  212 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSC
T ss_pred             HHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCC
Confidence            99999999999999999999999999999999999999999999999754332 22334556889999999998642  3


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      .++.++||||||+++|||+||+.||.+.++...+..
T Consensus       213 ~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~  248 (307)
T 3omv_A          213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF  248 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH
T ss_pred             CCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            589999999999999999999999998766554433

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.5e-48  Score=292.45  Aligned_cols=191  Identities=24%  Similarity=0.351  Sum_probs=160.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+++.||||+++.. ......+.+.+|+.++++++||||+++++++.++     ..+++||||++ |+|.+++...  
T Consensus        52 ~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~  125 (308)
T 4gt4_A           52 PGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSP  125 (308)
T ss_dssp             ----CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCS
T ss_pred             cCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCc
Confidence            4567889999999653 2334457799999999999999999999999887     56789999998 6999998542  


Q ss_pred             --------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcc
Q psy16889         81 --------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMT  145 (203)
Q Consensus        81 --------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~  145 (203)
                                    ..+++.++..++.|++.|++|||+++++||||||+||+++.++.+||+|||+++..... ......
T Consensus       126 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~  205 (308)
T 4gt4_A          126 HSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG  205 (308)
T ss_dssp             SCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSS
T ss_pred             cccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEec
Confidence                          35899999999999999999999999999999999999999999999999999744322 222334


Q ss_pred             cccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       146 ~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ...||+.|+|||++.+ +.++.++||||||+++|||+| |+.||.+.+..+++..|.
T Consensus       206 ~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~  261 (308)
T 4gt4_A          206 NSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR  261 (308)
T ss_dssp             SSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred             ccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            5578999999999987 559999999999999999998 899999999988887764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.8e-46  Score=279.74  Aligned_cols=185  Identities=26%  Similarity=0.413  Sum_probs=144.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcch-------hHHHHHHHhhhH-HhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF-------FQEIYVITELLQ-SDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-------~~~~~lv~e~~~-~~l   73 (203)
                      |+++.+|+.||||+++... .....+.+.+|++++++++||||+++++++.+.....       ..++|++|||+. |+|
T Consensus        24 a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L  102 (299)
T 4g31_A           24 AKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL  102 (299)
T ss_dssp             EEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCH
T ss_pred             EEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcH
Confidence            5788999999999996432 3344567889999999999999999999987653210       013579999998 599


Q ss_pred             HHHHhCCCC---CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC---------
Q psy16889         74 HKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---------  141 (203)
Q Consensus        74 ~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---------  141 (203)
                      .+++...+.   .++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.......         
T Consensus       103 ~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~  182 (299)
T 4g31_A          103 KDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP  182 (299)
T ss_dssp             HHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-----------------
T ss_pred             HHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccc
Confidence            999887654   44566889999999999999999999999999999999999999999999975443211         


Q ss_pred             --CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        142 --KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       142 --~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                        .......||+.|+|||++.+ +.|+.++|||||||++|+|++   ||.+.
T Consensus       183 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~  230 (299)
T 4g31_A          183 AYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ  230 (299)
T ss_dssp             ---------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred             cccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCc
Confidence              12234579999999999987 568999999999999999996   77653

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5e-46  Score=301.37  Aligned_cols=183  Identities=22%  Similarity=0.356  Sum_probs=155.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHH---HHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVF---RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |+++.+|+.||||+++.... .........   .++.+++.++||||+++++++.++     ..+|+||||+. |+|.++
T Consensus       208 a~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~  282 (689)
T 3v5w_A          208 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYH  282 (689)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHH
T ss_pred             EEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHH
Confidence            57889999999999954322 112222333   346677788999999999999998     67889999998 599999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......   .....+||+.|+||
T Consensus       283 l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~---~~~t~~GTp~YmAP  359 (689)
T 3v5w_A          283 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP  359 (689)
T ss_dssp             HHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---CCCSCCSCGGGCCH
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC---CCCCccCCcCccCH
Confidence            988889999999999999999999999999999999999999999999999999999754332   23445899999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.+...|+.++|+|||||++|+|++|++||.+.+
T Consensus       360 Evl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             HHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999765568999999999999999999999997643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-45  Score=281.54  Aligned_cols=186  Identities=27%  Similarity=0.455  Sum_probs=154.1

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      ..+++.||+|.+...    .....+.+|+++++.+ +||||+++++++.++     ..+|+||||++ ++|.+.+.   .
T Consensus        46 ~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~~---~  113 (361)
T 4f9c_A           46 VGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDILN---S  113 (361)
T ss_dssp             TSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHHT---T
T ss_pred             CCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHHc---C
Confidence            457889999998542    2345678899999998 799999999999887     67889999998 58988873   5


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCC--------------------
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPN--------------------  141 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~--------------------  141 (203)
                      +++.+++.++.|++.||+|||++||+||||||+||+++.+ +.+||+|||+++.......                    
T Consensus       114 l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (361)
T 4f9c_A          114 LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC  193 (361)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999876 8999999999974332211                    


Q ss_pred             -------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCccc-CCCChHHHhhhhhc
Q psy16889        142 -------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILF-QAQSPVQQLGLITD  202 (203)
Q Consensus       142 -------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~i~~  202 (203)
                             .......||+.|+|||++.+...++.++|+||+||++|+|++|+.|| .+.+..+++.+|.+
T Consensus       194 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~  262 (361)
T 4f9c_A          194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMT  262 (361)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Confidence                   12234578999999999987666899999999999999999999997 55667777777653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.6e-45  Score=281.64  Aligned_cols=186  Identities=28%  Similarity=0.490  Sum_probs=153.6

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC-CCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC---
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH-DNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS---   79 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---   79 (203)
                      ..+++.||||.++... .....+.+.+|++++++++| |||+++++++..+.    ..+++|||||+ |+|.+++..   
T Consensus        91 ~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~  165 (353)
T 4ase_A           91 TATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRN  165 (353)
T ss_dssp             TTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGG
T ss_pred             ccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhccc
Confidence            3456789999996542 33445678899999999965 89999999986643    34679999998 699998853   


Q ss_pred             -------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcc
Q psy16889         80 -------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMT  145 (203)
Q Consensus        80 -------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~  145 (203)
                                   ...+++.++..++.|++.|++|||+++++||||||+||+++.++.+||+|||+++....... ....
T Consensus       166 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~  245 (353)
T 4ase_A          166 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  245 (353)
T ss_dssp             GBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEET
T ss_pred             ccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeec
Confidence                         24589999999999999999999999999999999999999999999999999985443322 2334


Q ss_pred             cccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHH
Q psy16889        146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQ  196 (203)
Q Consensus       146 ~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  196 (203)
                      ...||+.|+|||++.+ +.++.++|||||||++|||+| |+.||.+.+..+.
T Consensus       246 ~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~  296 (353)
T 4ase_A          246 DARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  296 (353)
T ss_dssp             TEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             cccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            4567899999999987 569999999999999999998 8999988764333

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-45  Score=295.56  Aligned_cols=191  Identities=23%  Similarity=0.404  Sum_probs=166.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |+++.+|+.||+|++...  .....+.+.+|+++|+.++||||+++++++.++     ..+|++|||+. |+|.+++.. 
T Consensus       176 ~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~  248 (573)
T 3uto_A          176 VTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADE  248 (573)
T ss_dssp             EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCT
T ss_pred             EEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHh
Confidence            568899999999999653  233456788999999999999999999999988     67889999998 599998864 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC--CeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN--CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .+.+++.++..++.||+.||+|||++||+||||||+||+++.+  +.+||+|||++.....  ........||+.|+|||
T Consensus       249 ~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--~~~~~~~~GT~~y~APE  326 (573)
T 3uto_A          249 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPE  326 (573)
T ss_dssp             TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT--TSEEEEECSSGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC--CCceeeeEECccccCHH
Confidence            4689999999999999999999999999999999999999854  8999999999986543  23334557899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.+ +.|+.++|+|||||++|+|++|++||.+.+..+.+.+|.+
T Consensus       327 v~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~  370 (573)
T 3uto_A          327 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS  370 (573)
T ss_dssp             HHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred             HhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHh
Confidence            9988 5689999999999999999999999999999888887754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.7e-43  Score=269.38  Aligned_cols=193  Identities=25%  Similarity=0.466  Sum_probs=168.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++.....+....+.+.+|+++++.++||||+++++++.++     ...++||||+. ++|.+++...
T Consensus        34 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  108 (328)
T 3fe3_A           34 ARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAH  108 (328)
T ss_dssp             EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHH
T ss_pred             EEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHc
Confidence            56788999999999976555556677888999999999999999999999887     56789999997 5999998877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......  .......|++.|+|||++.
T Consensus       109 ~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~  186 (328)
T 3fe3_A          109 GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQ  186 (328)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGTTSSSGGGCCHHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--CccccccCCcceeCccccc
Confidence            88999999999999999999999999999999999999999999999999999754322  2334557899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +....+.++|+||||+++|+|++|+.||.+.+..+....+.
T Consensus       187 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  227 (328)
T 3fe3_A          187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL  227 (328)
T ss_dssp             TCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            85544689999999999999999999999988877766653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.4e-43  Score=265.43  Aligned_cols=180  Identities=23%  Similarity=0.319  Sum_probs=140.1

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLT   84 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~   84 (203)
                      .+|+.||||+++..   .........|+..+.+++||||+++++++.++.... ..+|+||||++ |+|.+++.. ..++
T Consensus        24 ~~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~-~~~~lV~Ey~~~gsL~~~l~~-~~l~   98 (303)
T 3hmm_A           24 WRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNR-YTVT   98 (303)
T ss_dssp             ETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS-EEEEEEEECCTTCBHHHHHHH-CCBC
T ss_pred             ECCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc-eEEEEEecCCCCCcHHHHHHh-CCCC
Confidence            36899999998542   112223345677778899999999999987653211 24689999998 599998865 4689


Q ss_pred             hHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCccc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSA--------RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYY  153 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~--------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~  153 (203)
                      ++.+..++.|++.||+|||++        +|+||||||+|||++.++.+||+|||+++........   ......||+.|
T Consensus        99 ~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~y  178 (303)
T 3hmm_A           99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccc
Confidence            999999999999999999987        9999999999999999999999999998754332221   22345789999


Q ss_pred             ccceeeeccc-----CCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        154 RAPEILMGAR-----HYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       154 ~aPe~~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +|||++.+..     .++.++|||||||++|||+||.+||..
T Consensus       179 mAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             cCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence            9999987531     356789999999999999999877643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-42  Score=268.09  Aligned_cols=197  Identities=37%  Similarity=0.720  Sum_probs=165.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++............+.+|+.+++.+. ||||+++++++..+..   ..+|+||||++++|...+.. 
T Consensus        28 ~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~-  103 (388)
T 3oz6_A           28 SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---RDVYLVFDYMETDLHAVIRA-  103 (388)
T ss_dssp             EEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---SCEEEEEECCSEEHHHHHHH-
T ss_pred             EEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---CEEEEEecccCcCHHHHHHc-
Confidence            567899999999999766556667778889999999996 9999999999876532   35689999999999888765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC--------------------C
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD--------------------P  140 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~--------------------~  140 (203)
                      +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.....                    .
T Consensus       104 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (388)
T 3oz6_A          104 NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD  183 (388)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccc
Confidence            57999999999999999999999999999999999999999999999999999754321                    1


Q ss_pred             CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        141 NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       141 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ........||+.|+|||++.+...++.++|+|||||++|+|++|++||.+.+..+.+..|.+
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  245 (388)
T 3oz6_A          184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG  245 (388)
T ss_dssp             ------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            11234457899999999998766689999999999999999999999999998888877753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.8e-42  Score=262.69  Aligned_cols=193  Identities=26%  Similarity=0.388  Sum_probs=165.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |+++.+|+.||+|+++.... .....+.+.+|.++++.++||||+++++++.+.     ..+++||||+.| +|...+..
T Consensus        24 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~   98 (337)
T 1o6l_A           24 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHh
Confidence            46778999999999954322 334556788999999999999999999999887     567899999985 89888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||++
T Consensus        99 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~  177 (337)
T 1o6l_A           99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcccccccChhhCChhhh
Confidence            788999999999999999999999999999999999999999999999999999743322 2233455789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       178 ~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  218 (337)
T 1o6l_A          178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             SS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            87 458999999999999999999999999988777766553

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-42  Score=271.20  Aligned_cols=191  Identities=48%  Similarity=0.860  Sum_probs=156.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |+++.+|+.||||++............+.+|+.+++.++||||+++++++..........+|+|||+++++|.+.+....
T Consensus        72 ~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~  151 (458)
T 3rp9_A           72 AYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV  151 (458)
T ss_dssp             EEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSC
T ss_pred             EEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCC
Confidence            56788999999999976655666677899999999999999999999998665433224578999999999999999888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--------------------
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--------------------  141 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------------  141 (203)
                      .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........                    
T Consensus       152 ~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (458)
T 3rp9_A          152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP  231 (458)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC--------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccccccccccc
Confidence            999999999999999999999999999999999999999999999999999975432211                    


Q ss_pred             ------CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-----------CCcccCCCC
Q psy16889        142 ------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-----------RRILFQAQS  192 (203)
Q Consensus       142 ------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-----------g~~pf~~~~  192 (203)
                            .......||+.|+|||++.....++.++|||||||++|+|++           |+++|.+.+
T Consensus       232 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~  299 (458)
T 3rp9_A          232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS  299 (458)
T ss_dssp             -------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred             ccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence                  123445779999999987655668999999999999999998           788887754

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=266.26  Aligned_cols=193  Identities=23%  Similarity=0.354  Sum_probs=162.5

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |+++.+|+.||||+++... ......+.+..|.++++.+ +||||+++++++.+.     ..+|+||||+. ++|..++.
T Consensus        42 ~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~  116 (353)
T 3txo_A           42 ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQ  116 (353)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             EEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            4678899999999996432 2334556788899999988 799999999999887     56789999998 49999888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       117 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  195 (353)
T 3txo_A          117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEI  195 (353)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------CCGGGCCHHH
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-CccccccCCCcCeEChhh
Confidence            8788999999999999999999999999999999999999999999999999999743322 233345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       196 ~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  237 (353)
T 3txo_A          196 LQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL  237 (353)
T ss_dssp             HHH-HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCC-CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987 458999999999999999999999999999888887765

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-41  Score=262.13  Aligned_cols=192  Identities=28%  Similarity=0.380  Sum_probs=165.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.++.+|+.||+|++..........+.+.+|+++++.++||||+++++++.++     ...++||||+.+ +|.+.+...
T Consensus        48 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~  122 (362)
T 2bdw_A           48 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAR  122 (362)
T ss_dssp             EEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTC
T ss_pred             EEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHc
Confidence            46788999999999976545555667889999999999999999999999887     567899999985 999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN---CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++.++..++.|++.||+|||++|++||||||+||+++.+   +.++|+|||++......  .......|++.|+|||
T Consensus       123 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE  200 (362)
T 2bdw_A          123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE  200 (362)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--CSCCCSCSCTTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--cccccCCCCccccCHH
Confidence            889999999999999999999999999999999999999864   45999999999754422  2334457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++|+||||+++|+|++|.+||.+.+..+...+|.
T Consensus       201 ~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~  243 (362)
T 2bdw_A          201 VLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK  243 (362)
T ss_dssp             HHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9887 458999999999999999999999999888777666553

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-42  Score=270.60  Aligned_cols=195  Identities=24%  Similarity=0.334  Sum_probs=166.4

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      ++++.+|+.||+|+++... ......+.+.+|..+++.++||||+++++++.++     ..+|+||||+. |+|.+++..
T Consensus        93 ~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~  167 (437)
T 4aw2_A           93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSK  167 (437)
T ss_dssp             EEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHT
T ss_pred             EEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHH
Confidence            4567889999999995422 1223345588999999999999999999999987     56789999996 599999886


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...............||+.|+|||+
T Consensus       168 ~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~  247 (437)
T 4aw2_A          168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI  247 (437)
T ss_dssp             TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHH
Confidence             5789999999999999999999999999999999999999999999999999997554443334445578999999999


Q ss_pred             eec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +..    ...++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       248 l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             HHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             HhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            872    3457899999999999999999999999999888887765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-41  Score=258.31  Aligned_cols=193  Identities=37%  Similarity=0.635  Sum_probs=164.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-   80 (203)
                      |.++.+|+.||+|+++... .....+.+.+|++++++++||||+++++++.++     ...++||||++++|.+++... 
T Consensus        24 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~   97 (317)
T 2pmi_A           24 GLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRT   97 (317)
T ss_dssp             EECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHH
T ss_pred             EEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhcc
Confidence            5678899999999996432 233446788999999999999999999999887     567899999999888877532 


Q ss_pred             -----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         81 -----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        81 -----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                           ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...... ........+++.|+|
T Consensus        98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~a  176 (317)
T 2pmi_A           98 VGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRA  176 (317)
T ss_dssp             SSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC-CCCCCCCCSCCTTCC
T ss_pred             ccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC-cccCCCCcccccccC
Confidence                 45999999999999999999999999999999999999999999999999999754332 222334467899999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||++.+...++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       177 PE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  222 (317)
T 2pmi_A          177 PDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF  222 (317)
T ss_dssp             HHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             chHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999875668999999999999999999999999998888777664

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-41  Score=269.47  Aligned_cols=196  Identities=42%  Similarity=0.769  Sum_probs=163.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |++..+|+.||||++............+.+|+.+++.++||||+++++++..... .....+|+||||+++++.+.+.. 
T Consensus        81 a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~-  159 (464)
T 3ttj_A           81 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-  159 (464)
T ss_dssp             EEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS-
T ss_pred             EEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh-
Confidence            5678899999999997665566667788899999999999999999999876532 11134689999999988887754 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....  ........||+.|+|||++.
T Consensus       160 -~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~  236 (464)
T 3ttj_A          160 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL  236 (464)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------CCCC----CCCTTCCHHHHT
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC--CcccCCCcccccccCHHHHc
Confidence             499999999999999999999999999999999999999999999999999975432  22344557899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      + ..++.++|+|||||++|+|++|++||.+.+..+++..|.+
T Consensus       237 ~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~  277 (464)
T 3ttj_A          237 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  277 (464)
T ss_dssp             T-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             C-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8 4689999999999999999999999999998888877753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-41  Score=261.62  Aligned_cols=192  Identities=27%  Similarity=0.423  Sum_probs=165.3

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |.++.+|+.||+|+++......    ...+.+.+|+.++++++||||+++++++.+.     ..+++||||+. ++|.++
T Consensus        31 ~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~  105 (361)
T 2yab_A           31 CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-----TDVVLILELVSGGELFDF  105 (361)
T ss_dssp             EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHH
T ss_pred             EEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHH
Confidence            5678899999999996532221    1346788999999999999999999999887     56789999996 699999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      +...+.+++..+..++.|++.||+|||++|++||||||+||+++.++    .++|+|||++......  .......||+.
T Consensus       106 l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~gt~~  183 (361)
T 2yab_A          106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPE  183 (361)
T ss_dssp             HTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT--CCCCCCCSCGG
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC--CccccCCCCcc
Confidence            98888999999999999999999999999999999999999998776    7999999999754432  23344578999


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |+|||++.+ ..++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       184 y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~  231 (361)
T 2yab_A          184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (361)
T ss_dssp             GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             EECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999877 558999999999999999999999999988888777664

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=8.4e-42  Score=256.48  Aligned_cols=190  Identities=30%  Similarity=0.408  Sum_probs=157.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +.+..+|+.||+|.+.... ......+.+.+|+..+++++||||+++++++.++     ...+++|||+++ +|.+++..
T Consensus        30 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~  104 (294)
T 4eqm_A           30 AEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIES  104 (294)
T ss_dssp             EEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHH
T ss_pred             EEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHh
Confidence            4677899999999984432 2344556788999999999999999999999877     567899999975 99999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++++..++.++.|++.+|++||++|++||||||+||+++.++.++|+|||.+...............|++.|+|||.+
T Consensus       105 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (294)
T 4eqm_A          105 HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA  184 (294)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHh
Confidence            78899999999999999999999999999999999999999999999999999976544433334445689999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+..
T Consensus       185 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          185 KG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             HT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             cC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            87 55789999999999999999999999988765543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-42  Score=263.51  Aligned_cols=188  Identities=29%  Similarity=0.496  Sum_probs=160.6

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.++     ...++||||++|+|.+++...
T Consensus        28 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~  102 (336)
T 3h4j_B           28 ATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEK  102 (336)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHH
T ss_pred             EEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHc
Confidence            56788999999999854322 223345788999999999999999999999887     457899999999999998888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++......  .......|++.|+|||++.
T Consensus       103 ~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~~~~gt~~y~aPE~~~  180 (336)
T 3h4j_B          103 KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVIN  180 (336)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTCCCTTSTTTSCGGGSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccccccCCcCcCCHHHHc
Confidence            88999999999999999999999999999999999999999999999999999754332  2334457899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      +....++++|+||||+++|+|++|+.||.+....+.
T Consensus       181 ~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~  216 (336)
T 3h4j_B          181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL  216 (336)
T ss_dssp             CSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC
T ss_pred             CCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH
Confidence            755457899999999999999999999987654443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=267.11  Aligned_cols=193  Identities=25%  Similarity=0.349  Sum_probs=168.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.++.+|+.||+|++.....+....+.+.+|+++++.++||||+++++++.++     ...++||||+. ++|.+.+...
T Consensus        30 ~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~  104 (444)
T 3soa_A           30 CVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAR  104 (444)
T ss_dssp             EEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHC
T ss_pred             EEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHc
Confidence            56788999999999976555666677889999999999999999999999887     56789999998 4999998888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++.++..++.|++.||+|||++|++||||||+||+++   .++.++|+|||++...... ........||+.|+|||
T Consensus       105 ~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~~gt~~Y~APE  183 (444)
T 3soa_A          105 EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE  183 (444)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-CCBCCCSCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-CceeecccCCcccCCHH
Confidence            8899999999999999999999999999999999999998   4578999999999754432 23334557899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++||||||+++|+|++|.+||.+.+..+.+.+|.
T Consensus       184 ~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~  226 (444)
T 3soa_A          184 VLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK  226 (444)
T ss_dssp             HHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence            9877 458999999999999999999999999988877776654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.9e-41  Score=256.43  Aligned_cols=190  Identities=41%  Similarity=0.696  Sum_probs=158.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-QHLT   84 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~   84 (203)
                      .+|+.||+|+++...........+.+|++++++++||||+++++++.++     ...++||||++++|.+.+... ..++
T Consensus        43 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~  117 (311)
T 3niz_A           43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQ  117 (311)
T ss_dssp             TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCC
T ss_pred             CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCC
Confidence            3589999999965544444556788999999999999999999999877     567899999999888887754 5699


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........+++.|+|||++.+...
T Consensus       118 ~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~  196 (311)
T 3niz_A          118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVVTLWYRAPDVLMGSKK  196 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC---CCCCCCTTCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cccccCCcccCCcCCHHHhcCCCC
Confidence            9999999999999999999999999999999999999999999999999754322 223344467899999999887666


Q ss_pred             CCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|+|++|+.||.+....+.+..|.
T Consensus       197 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  233 (311)
T 3niz_A          197 YSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF  233 (311)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred             CCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            8999999999999999999999999888777766654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.6e-41  Score=254.55  Aligned_cols=194  Identities=36%  Similarity=0.585  Sum_probs=164.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~   80 (203)
                      |.+..+|+.||+|+++...........+.+|+.++++++||||+++++++.++     ...++||||+++++.+.+. ..
T Consensus        21 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   95 (292)
T 3o0g_A           21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCN   95 (292)
T ss_dssp             EEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTT
T ss_pred             EEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCC
Confidence            56788999999999976555555567788999999999999999999999877     5678999999988777665 46


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........+|+.|+|||++.
T Consensus        96 ~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~  174 (292)
T 3o0g_A           96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCCSCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccccCCccccCCcChHHHc
Confidence            78999999999999999999999999999999999999999999999999999754322 23334457789999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcc-cCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRIL-FQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|..| |.+.+..+.+..|.
T Consensus       175 ~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~  216 (292)
T 3o0g_A          175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF  216 (292)
T ss_dssp             TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred             CCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence            766689999999999999999987666 77777777766654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-41  Score=255.00  Aligned_cols=190  Identities=40%  Similarity=0.643  Sum_probs=160.1

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-CCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-PQHLT   84 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~   84 (203)
                      .+|+.||+|++..........+.+.+|++++++++||||+++++++.++     ...+++||+++++|.+.+.. .+.++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~   98 (288)
T 1ob3_A           24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLE   98 (288)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCC
T ss_pred             CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCC
Confidence            5789999999966544444557788999999999999999999999887     56789999999999988875 46799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........+++.|+|||++.+...
T Consensus        99 ~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~  177 (288)
T 1ob3_A           99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKK  177 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccccccccccccccCchheeCCCC
Confidence            9999999999999999999999999999999999999999999999998754322 222334467899999999977566


Q ss_pred             CCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       178 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  214 (288)
T 1ob3_A          178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (288)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            8999999999999999999999999988877776653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=268.43  Aligned_cols=195  Identities=22%  Similarity=0.304  Sum_probs=165.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||||+++... ......+.+.+|..++..++||||+++++++.+.     ..+|+||||+. |+|.+++..
T Consensus        80 ~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~  154 (412)
T 2vd5_A           80 VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSK  154 (412)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHh
Confidence            4567899999999995422 2333456688999999999999999999999987     56789999996 699998876


Q ss_pred             C-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 P-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      . ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...............||+.|+|||+
T Consensus       155 ~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~  234 (412)
T 2vd5_A          155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI  234 (412)
T ss_dssp             HSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHH
Confidence            4 479999999999999999999999999999999999999999999999999997554433323344578999999999


Q ss_pred             eec------ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMG------ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +..      ...++.++|+||||+++|+|++|+.||.+.+..+...+|.
T Consensus       235 l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~  283 (412)
T 2vd5_A          235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV  283 (412)
T ss_dssp             HHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             HhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            873      2457899999999999999999999999998888877765

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-42  Score=268.01  Aligned_cols=194  Identities=24%  Similarity=0.365  Sum_probs=164.6

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||+|+++... ......+.+.+|..+++.++||||+++++++.++     ..+|+||||+. |+|.+.+..
T Consensus        88 ~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~  162 (410)
T 3v8s_A           88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN  162 (410)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH
T ss_pred             EEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc
Confidence            4677899999999985422 2233455688999999999999999999999987     56789999996 588887764


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...............||+.|+|||++
T Consensus       163 -~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l  241 (410)
T 3v8s_A          163 -YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL  241 (410)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHh
Confidence             4699999999999999999999999999999999999999999999999999975544333334456789999999999


Q ss_pred             ecccC---CCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARH---YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~---~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+...   ++.++|+||||+++|+|++|+.||.+.+..+...+|.
T Consensus       242 ~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  286 (410)
T 3v8s_A          242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM  286 (410)
T ss_dssp             HTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             hccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence            76331   6789999999999999999999999999888887775

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=258.13  Aligned_cols=190  Identities=26%  Similarity=0.440  Sum_probs=164.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||+|+++.... .....+.+.+|..+++.++||||+++++++.+.     ..+|+||||+. ++|.+++..
T Consensus        25 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~   99 (318)
T 1fot_A           25 IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRK   99 (318)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHH
Confidence            46778999999999954322 223456788899999999999999999999887     56789999998 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||++.....    ......||+.|+|||++
T Consensus       100 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~  175 (318)
T 1fot_A          100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVV  175 (318)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----ccccccCCccccCHhHh
Confidence            88899999999999999999999999999999999999999999999999999975432    22344789999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       176 ~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  216 (318)
T 1fot_A          176 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL  216 (318)
T ss_dssp             TT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            87 558999999999999999999999999988877776664

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-41  Score=266.06  Aligned_cols=183  Identities=42%  Similarity=0.826  Sum_probs=155.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |++..+|+.||||++............+.+|+.+++.++||||+++++++..........+|+|||+++++|.+.+....
T Consensus        45 a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~  124 (432)
T 3n9x_A           45 AYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI  124 (432)
T ss_dssp             EEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSC
T ss_pred             EEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccC
Confidence            56788999999999977656666677899999999999999999999998776433324578999999999999999888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--------------------
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--------------------  141 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--------------------  141 (203)
                      .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++........                    
T Consensus       125 ~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (432)
T 3n9x_A          125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL  204 (432)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccch
Confidence            899999999999999999999999999999999999999999999999999985443221                    


Q ss_pred             -CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhC
Q psy16889        142 -KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR  184 (203)
Q Consensus       142 -~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g  184 (203)
                       .......||+.|+|||++.....++.++|+|||||++|+|++|
T Consensus       205 ~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g  248 (432)
T 3n9x_A          205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM  248 (432)
T ss_dssp             ------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence             1235567899999999876556789999999999999999983

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-41  Score=259.10  Aligned_cols=195  Identities=44%  Similarity=0.809  Sum_probs=166.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++.....+......+.+|+++++.++||||+++++++...... ....+|+|||+++++|.+.+.. 
T Consensus        44 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-  122 (367)
T 1cm8_A           44 AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-  122 (367)
T ss_dssp             EEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-
T ss_pred             EEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-
Confidence            56788999999999966555555667888999999999999999999998765321 1124579999998888888765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....    ......+|+.|+|||++.
T Consensus       123 ~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~  198 (367)
T 1cm8_A          123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL  198 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----ccCcCcCCCCcCCHHHHh
Confidence            5799999999999999999999999999999999999999999999999999985432    234456789999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+|||||++|+|++|++||.+.+..+.+..|.
T Consensus       199 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~  239 (367)
T 1cm8_A          199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM  239 (367)
T ss_dssp             TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            75668999999999999999999999999998888877765

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.5e-42  Score=260.21  Aligned_cols=194  Identities=37%  Similarity=0.621  Sum_probs=157.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |.+..+|+.||||+++...........+.+|++++++++||||+++++++.++     ...++||||++++|.+++...+
T Consensus        53 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~  127 (329)
T 3gbz_A           53 AIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNP  127 (329)
T ss_dssp             EEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCT
T ss_pred             EEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcC
Confidence            46788999999999976544555556778999999999999999999999887     5678999999999999998888


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-----CCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-----SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .+++..++.++.|++.||++||++|++||||||+||+++     .++.++|+|||.+...... ........+++.|+||
T Consensus       128 ~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aP  206 (329)
T 3gbz_A          128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEIITLWYRPP  206 (329)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC------------CCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-ccccCCCcCCccccCH
Confidence            899999999999999999999999999999999999994     4556999999999754322 2233444668899999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |++.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       207 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  251 (329)
T 3gbz_A          207 EILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF  251 (329)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHH
Confidence            999876668999999999999999999999999998888777664

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.9e-41  Score=259.53  Aligned_cols=193  Identities=25%  Similarity=0.380  Sum_probs=164.4

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||||+++.... .....+.+..|.++++.+ +||||+++++++.+.     ..+|+||||+. |+|.+++.
T Consensus        36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~  110 (345)
T 1xjd_A           36 AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQ  110 (345)
T ss_dssp             EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHH
T ss_pred             EEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            46778999999999964321 233456677899988877 999999999999887     56789999997 59999988


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       111 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  189 (345)
T 1xjd_A          111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEI  189 (345)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHH
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCcccCCCCCcccCChhh
Confidence            7788999999999999999999999999999999999999999999999999999743222 223345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       190 ~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  231 (345)
T 1xjd_A          190 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  231 (345)
T ss_dssp             HTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            987 458999999999999999999999999988887776664

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-41  Score=260.29  Aligned_cols=190  Identities=24%  Similarity=0.384  Sum_probs=164.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||||+++... ......+.+.+|+++++.++||||+++++++.++     ..+|+||||+. ++|.+++..
T Consensus        60 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~  134 (350)
T 1rdq_E           60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRR  134 (350)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHH
Confidence            4677899999999985432 2334556788999999999999999999999887     56789999997 599999887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+......    .....||+.|+|||++
T Consensus       135 ~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~gt~~y~aPE~~  210 (350)
T 1rdq_E          135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEII  210 (350)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCEECGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----cccccCCccccCHHHh
Confidence            788999999999999999999999999999999999999999999999999999754322    2344779999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       211 ~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  251 (350)
T 1rdq_E          211 LS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             TT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence            87 458999999999999999999999999988888777664

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-41  Score=260.17  Aligned_cols=193  Identities=23%  Similarity=0.311  Sum_probs=165.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||||+++.... .....+.+..|..+++.+ +||+|+++++++.+.     ...|+||||+. |+|.+++.
T Consensus        39 ~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~  113 (353)
T 2i0e_A           39 SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQ  113 (353)
T ss_dssp             EEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             EEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHH
Confidence            45678899999999964322 334456788899999888 899999999999887     56789999997 59999988


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       114 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  192 (353)
T 2i0e_A          114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEI  192 (353)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-CcccccccCCccccChhh
Confidence            7788999999999999999999999999999999999999999999999999999743222 223345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+..+.|.
T Consensus       193 ~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  234 (353)
T 2i0e_A          193 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM  234 (353)
T ss_dssp             HTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             hcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            987 558999999999999999999999999998888777764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.4e-41  Score=251.67  Aligned_cols=189  Identities=26%  Similarity=0.485  Sum_probs=160.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++...  .....+.+.+|+.+++.++||||+++++++.++     ...++||||+. ++|.+++.. 
T Consensus        39 ~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-  110 (297)
T 3fxz_A           39 AMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-  110 (297)
T ss_dssp             EEBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-
T ss_pred             EEECCCCcEEEEEEeecc--cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhh-
Confidence            567889999999998543  233456788999999999999999999999877     56789999996 588887765 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....... .......|++.|+|||++.
T Consensus       111 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~  189 (297)
T 3fxz_A          111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMVGTPYWMAPEVVT  189 (297)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCGGGCCHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccCCccCCcCccChhhhc
Confidence            469999999999999999999999999999999999999999999999999987544332 2334457899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.++...+..+
T Consensus       190 ~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  228 (297)
T 3fxz_A          190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI  228 (297)
T ss_dssp             C-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7 45899999999999999999999999988776655443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-40  Score=255.86  Aligned_cols=200  Identities=34%  Similarity=0.612  Sum_probs=166.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcch---hHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF---FQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~   78 (203)
                      |++..+|+.||||++............+.+|+++++.++||||+++++++.+....+   ....++||||+++++...+.
T Consensus        36 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~  115 (351)
T 3mi9_A           36 ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS  115 (351)
T ss_dssp             EEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHH
T ss_pred             EEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHh
Confidence            467789999999999665444445567889999999999999999999987753211   12467999999998888776


Q ss_pred             CC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC---CCCCcccccCCcccc
Q psy16889         79 SP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD---PNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~  154 (203)
                      .. ..+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+......   .........+++.|+
T Consensus       116 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~  195 (351)
T 3mi9_A          116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR  195 (351)
T ss_dssp             CTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGC
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCcc
Confidence            54 67999999999999999999999999999999999999999999999999998754322   122334456799999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..|.
T Consensus       196 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          196 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             CHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999876668999999999999999999999999998888777664

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=253.20  Aligned_cols=192  Identities=28%  Similarity=0.419  Sum_probs=163.7

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |.+..+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.+.     ...++||||+. ++|.++
T Consensus        30 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~  104 (326)
T 2y0a_A           30 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDF  104 (326)
T ss_dssp             EEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHH
T ss_pred             EEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHH
Confidence            5677899999999995432221    2356788999999999999999999999887     56789999997 599999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      +...+.+++.+++.++.|++.||+|||++|++||||||+||+++.++    .++|+|||.+......  .......|++.
T Consensus       105 l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~  182 (326)
T 2y0a_A          105 LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPE  182 (326)
T ss_dssp             HTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT--SCCCCCCSCTT
T ss_pred             HHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC--CccccccCCcC
Confidence            98888899999999999999999999999999999999999998877    8999999999754322  22334568999


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus       183 y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~  230 (326)
T 2y0a_A          183 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS  230 (326)
T ss_dssp             TCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             cCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence            999999876 558999999999999999999999999888777766553

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9e-41  Score=252.26  Aligned_cols=197  Identities=39%  Similarity=0.604  Sum_probs=162.0

Q ss_pred             CcCCCCCcEEEEEeccCccc---hhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ---SLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |++..+|+.||||++.....   .........+|+++++.+   +||||+++++++...........++++|+++++|.+
T Consensus        28 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~  107 (308)
T 3g33_A           28 ARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT  107 (308)
T ss_dssp             EECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHH
T ss_pred             EEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHH
Confidence            56789999999999853221   111234566777777666   499999999998776433223568999999999999


Q ss_pred             HHhCCCC--CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         76 IIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        76 ~~~~~~~--~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      ++.....  +++.+++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+.....  ........+|+.|
T Consensus       108 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y  185 (308)
T 3g33_A          108 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWY  185 (308)
T ss_dssp             HHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT--CCCSGGGGCCCSS
T ss_pred             HHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC--CcccCCccccccc
Confidence            9886544  99999999999999999999999999999999999999999999999999975432  2233455779999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +|||++.+ ..++.++|+||||+++|+|++|++||.+.+..+.+.+|.
T Consensus       186 ~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          186 RAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             CCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             cCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999987 458999999999999999999999999999888887764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=258.07  Aligned_cols=183  Identities=27%  Similarity=0.469  Sum_probs=157.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++... ........+.+|+++++.++||||+++++++.+.     ...++||||+. |+|..++..
T Consensus        34 ~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~  108 (384)
T 4fr4_A           34 VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQ  108 (384)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHT
T ss_pred             EEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHh
Confidence            4678899999999985432 2334456788999999999999999999999987     56789999997 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....  ........||+.|+|||++
T Consensus       109 ~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~~~~~gt~~Y~aPE~~  186 (384)
T 4fr4_A          109 NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITTMAGTKPYMAPEMF  186 (384)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--TCCBCCCCSCGGGCCGGGT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--CCceeccCCCccccCCeee
Confidence            88999999999999999999999999999999999999999999999999999975432  2333455789999999998


Q ss_pred             ecc--cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        160 MGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       160 ~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+.  ..++.++|+||||+++|+|++|+.||...
T Consensus       187 ~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  220 (384)
T 4fr4_A          187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR  220 (384)
T ss_dssp             CCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             ccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence            742  34788999999999999999999999754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-40  Score=255.34  Aligned_cols=182  Identities=24%  Similarity=0.380  Sum_probs=156.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |+++.+|+.||+|+++.... .....+.+.+|..+++++ +||||+++++++.++     ..+|+||||+. ++|.+++.
T Consensus        28 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~  102 (345)
T 3a8x_A           28 VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQ  102 (345)
T ss_dssp             EEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHH
T ss_pred             EEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            46778999999999965332 334556788899999988 899999999999887     56789999997 59998888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       103 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  181 (345)
T 3a8x_A          103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEI  181 (345)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCCBCCCCSCGGGCCHHH
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-CCcccccCCCccccCccc
Confidence            7788999999999999999999999999999999999999999999999999999743222 223345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||..
T Consensus       182 ~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          182 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             HTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCC-CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence            987 4589999999999999999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.1e-41  Score=259.62  Aligned_cols=182  Identities=24%  Similarity=0.394  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      |+++.+|+.||+|+++.... .....+.+..|..+++++ +||||+++++++.++     ..+++||||+.+ +|...+.
T Consensus        71 ~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~  145 (396)
T 4dc2_A           71 VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQ  145 (396)
T ss_dssp             EEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHH
T ss_pred             EEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHH
Confidence            46778999999999965322 334456788899999887 899999999999887     567899999985 8988888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++..... .........||+.|+|||+
T Consensus       146 ~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~~~~~~gt~~Y~aPE~  224 (396)
T 4dc2_A          146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEI  224 (396)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCCBCCCCBCGGGCCHHH
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-CCCccccccCCcccCCchh
Confidence            778899999999999999999999999999999999999999999999999999974322 2233445578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +.+ ..++.++|+||||+++|+|++|++||..
T Consensus       225 l~~-~~~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          225 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             HTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             hcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            987 5589999999999999999999999964

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=250.67  Aligned_cols=194  Identities=33%  Similarity=0.616  Sum_probs=160.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.||+|++..........+.+.+|++++++++||||+++++++.+.     ...++||||+++ +|.......
T Consensus        22 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~   96 (311)
T 4agu_A           22 CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQ   96 (311)
T ss_dssp             EEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTS
T ss_pred             EEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhh
Confidence            46778899999999966555555567788999999999999999999999877     567799999996 666777777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+...... ........+++.|+|||++.
T Consensus        97 ~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~  175 (311)
T 4agu_A           97 RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVATRWYRSPELLV  175 (311)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------------GGGCCHHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc-ccccCCCcCCccccChHHHh
Confidence            88999999999999999999999999999999999999999999999999999754432 22233446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       176 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  216 (311)
T 4agu_A          176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR  216 (311)
T ss_dssp             TCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            76668999999999999999999999999988877766543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-40  Score=252.58  Aligned_cols=191  Identities=26%  Similarity=0.370  Sum_probs=153.0

Q ss_pred             CCCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          4 DPRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +..+|+.||+|+++....  .......+.+|+++++.++||||+++++++.+.     ..+++||||+. ++|.+++...
T Consensus        41 ~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  115 (327)
T 3a62_A           41 GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLERE  115 (327)
T ss_dssp             STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHH
T ss_pred             cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhC
Confidence            357899999999965422  233455678899999999999999999999887     56789999997 5899988877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........|++.|+|||++.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~  194 (327)
T 3a62_A          116 GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEILM  194 (327)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------CTTSSCCTTSCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC-CccccccCCCcCccCHhhCc
Confidence            88999999999999999999999999999999999999999999999999998643222 22233446799999999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       195 ~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  234 (327)
T 3a62_A          195 R-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL  234 (327)
T ss_dssp             T-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             C-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            7 458999999999999999999999999988877776654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-41  Score=259.77  Aligned_cols=193  Identities=23%  Similarity=0.348  Sum_probs=155.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHH-HhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKM-LCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      |+++.+|+.||||+++.... .......+..|..+ ++.++||||+++++++.+.     ..+|+||||+.| +|.+++.
T Consensus        57 ~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~  131 (373)
T 2r5t_A           57 ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQ  131 (373)
T ss_dssp             EEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             EEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHH
Confidence            46778999999999955322 23344556667766 5778999999999999887     567899999984 9999888


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       132 ~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  210 (373)
T 2r5t_A          132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NSTTSTFCGTPEYLAPEV  210 (373)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-CCCCCSBSCCCCCCCHHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-CCccccccCCccccCHHH
Confidence            7788999999999999999999999999999999999999999999999999998743222 223345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       211 ~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~  252 (373)
T 2r5t_A          211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL  252 (373)
T ss_dssp             HTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred             hCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            987 558999999999999999999999999988888777664

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-40  Score=257.62  Aligned_cols=196  Identities=51%  Similarity=0.884  Sum_probs=154.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++.....+......+.+|+++++.++||||+++++++..... ......++++|+++++|.+.+.. 
T Consensus        48 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-  126 (367)
T 2fst_X           48 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-  126 (367)
T ss_dssp             EEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------
T ss_pred             EEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-
Confidence            4678899999999997655555667788899999999999999999999876422 11134678999998888877655 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....    ......+|+.|+|||++.
T Consensus       127 ~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~  202 (367)
T 2fst_X          127 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD----EMTGYVATRWYRAPEIML  202 (367)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------------------CCCTTCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc----cCCCcCcCcCccChHHHc
Confidence            6799999999999999999999999999999999999999999999999999975332    233456789999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +...++.++|+|||||++|+|++|+.||.+.+..+.+..|.+
T Consensus       203 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          203 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             TCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            756689999999999999999999999999998888776653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-40  Score=264.23  Aligned_cols=193  Identities=27%  Similarity=0.475  Sum_probs=165.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||+++.... .....+.+.+|+.+++.++||||+++++++.+.     ...++||||+. ++|.+++..
T Consensus        35 a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~  109 (476)
T 2y94_A           35 GKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICK  109 (476)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTS
T ss_pred             EEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHh
Confidence            45778999999999954322 223456788999999999999999999999887     56789999996 699999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++......  .......|++.|+|||++
T Consensus       110 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~  187 (476)
T 2y94_A          110 NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVI  187 (476)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCBCCCCSCSTTCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccccccCCCcCeEChhhc
Confidence            889999999999999999999999999999999999999999999999999999754332  223445789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+....+.++|+||||+++|+|++|+.||.+....+....|.
T Consensus       188 ~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~  229 (476)
T 2y94_A          188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC  229 (476)
T ss_dssp             TTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred             cCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence            875545789999999999999999999999887777666554

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-40  Score=257.94  Aligned_cols=193  Identities=19%  Similarity=0.277  Sum_probs=161.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.++.+|+.||||+++.........+.+.+|+.+++.++||||+++++++.++     ...++||||+. ++|.+++...
T Consensus        46 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  120 (389)
T 3gni_B           46 ARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTH  120 (389)
T ss_dssp             EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHT
T ss_pred             EEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhh
Confidence            56778999999999976545555667888999999999999999999999887     56789999998 5888887654


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC------CCCCcccccCCcc
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD------PNKAMTQEVVTQY  152 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~  152 (203)
                        +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+......      .........|++.
T Consensus       121 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~  200 (389)
T 3gni_B          121 FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP  200 (389)
T ss_dssp             CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGG
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccccc
Confidence              67999999999999999999999999999999999999999999999999987532111      1112223367888


Q ss_pred             cccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        153 YRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       153 ~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |+|||++.+. ..++.++|+||||+++|+|++|+.||.+.+..+.+..
T Consensus       201 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  248 (389)
T 3gni_B          201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE  248 (389)
T ss_dssp             GSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH
T ss_pred             ccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999874 4588999999999999999999999988766555543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=252.42  Aligned_cols=189  Identities=25%  Similarity=0.373  Sum_probs=162.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.|++|.+...   ....+.+.+|+++++.++||||+++++++.+.     ...+++|||+++ +|.+.+...
T Consensus        24 ~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~   95 (321)
T 1tki_A           24 CVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTS   95 (321)
T ss_dssp             EEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSS
T ss_pred             EEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhc
Confidence            567889999999998642   23445688999999999999999999999887     567899999985 999988765


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                       ..+++.++..++.|++.||+|||++|++||||||+||+++.  ++.++++|||.+......  .......+++.|+|||
T Consensus        96 ~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE  173 (321)
T 1tki_A           96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPE  173 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--CEEEEEESCGGGSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--CccccccCChhhcCcH
Confidence             47999999999999999999999999999999999999987  789999999999754332  2334456799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..|.
T Consensus       174 ~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  216 (321)
T 1tki_A          174 VHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM  216 (321)
T ss_dssp             HHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             HhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            9987 447899999999999999999999999988877776654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-40  Score=252.46  Aligned_cols=194  Identities=41%  Similarity=0.672  Sum_probs=162.0

Q ss_pred             CcCCCCCcEEEEEeccCccch---hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS---LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      +.+..+|+.||||+++.....   ......+.+|+++++.++||||+++++++.+.     ...++|+||++++|...+.
T Consensus        29 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~  103 (346)
T 1ua2_A           29 ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIK  103 (346)
T ss_dssp             EECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHT
T ss_pred             EEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHH
Confidence            567889999999999643222   12235678999999999999999999999877     5678999999999988887


Q ss_pred             CC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         79 SP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        79 ~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+...... ........+++.|+|||
T Consensus       104 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE  182 (346)
T 1ua2_A          104 DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPE  182 (346)
T ss_dssp             TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCCSCCCCTTCCHH
T ss_pred             hcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-cccCCcccccccccCch
Confidence            54 46999999999999999999999999999999999999999999999999999754332 22334457799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+...++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       183 ~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~  226 (346)
T 1ua2_A          183 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF  226 (346)
T ss_dssp             HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99775668999999999999999999999999998888777664

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3e-40  Score=255.49  Aligned_cols=195  Identities=41%  Similarity=0.744  Sum_probs=157.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |++..+|+.||||++............+.+|+.+++.++||||+++++++...... .....++||||++++|.+.+.  
T Consensus        44 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--  121 (371)
T 2xrw_A           44 AYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--  121 (371)
T ss_dssp             EEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--
T ss_pred             EEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--
Confidence            46788999999999976545555667788999999999999999999998766321 112568999999999888876  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+......  .......+++.|+|||++.
T Consensus       122 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~  199 (371)
T 2xrw_A          122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL  199 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------------------CTTCCHHHHT
T ss_pred             hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--cccCCceecCCccCHHHhc
Confidence            35899999999999999999999999999999999999999999999999999754322  2233456789999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       200 ~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  239 (371)
T 2xrw_A          200 G-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  239 (371)
T ss_dssp             T-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             C-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            7 458999999999999999999999999998877776664

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.6e-40  Score=254.43  Aligned_cols=198  Identities=46%  Similarity=0.883  Sum_probs=166.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |.+..+|+.||||++... ......+.+.+|++++++++||||+++++++...........++++|+++++|.+.+.. +
T Consensus        46 ~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~  123 (364)
T 3qyz_A           46 AYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-Q  123 (364)
T ss_dssp             EEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-C
T ss_pred             EEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-C
Confidence            467889999999999643 23344567889999999999999999999987654332235689999999999888765 4


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.........  ......||+.|+|||++
T Consensus       124 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  203 (364)
T 3qyz_A          124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM  203 (364)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHh
Confidence            6999999999999999999999999999999999999999999999999999754432211  22445789999999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+...++.++|+||||+++|+|++|++||.+.+..+.+..|.
T Consensus       204 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          204 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             HTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             cCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            766668999999999999999999999999998888777664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.4e-40  Score=250.38  Aligned_cols=194  Identities=35%  Similarity=0.653  Sum_probs=160.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.||||++..........+.+.+|++++++++||||+++++++.+.     ...++||||+++ .|.......
T Consensus        44 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~  118 (331)
T 4aaa_A           44 CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFP  118 (331)
T ss_dssp             EEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHST
T ss_pred             EEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhc
Confidence            46778899999999866544555566788999999999999999999999877     567899999996 555555667


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...... ........+++.|+|||++.
T Consensus       119 ~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~t~~y~aPE~~~  197 (331)
T 4aaa_A          119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPELLV  197 (331)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------CCCCCTTCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC-ccccCCCcCCccccCccccc
Confidence            78999999999999999999999999999999999999999999999999999754332 22233446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       198 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  238 (331)
T 4aaa_A          198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM  238 (331)
T ss_dssp             TCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            76568999999999999999999999999998877766553

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=255.02  Aligned_cols=193  Identities=37%  Similarity=0.631  Sum_probs=156.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      +.+..+|+.||+|+++... .......+.+|+++++.++||||+++++++.++     ...++||||++++|.+++.. .
T Consensus        21 ~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~   94 (324)
T 3mtl_A           21 GKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCG   94 (324)
T ss_dssp             EEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTT
T ss_pred             EEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcC
Confidence            4677899999999996432 222223455799999999999999999999877     56789999999999888775 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+...... ........+++.|+|||++.
T Consensus        95 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aPE~~~  173 (324)
T 3mtl_A           95 NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPDILL  173 (324)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------------CGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-ccccccccCcccccChhhhc
Confidence            56999999999999999999999999999999999999999999999999998744322 22334446789999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       174 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  214 (324)
T 3mtl_A          174 GSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIF  214 (324)
T ss_dssp             TCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            76668999999999999999999999999999888777664

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.9e-40  Score=247.34  Aligned_cols=187  Identities=26%  Similarity=0.445  Sum_probs=152.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC---
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH---   82 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---   82 (203)
                      +|+.||||++..........+.+.+|++++++++||||+++++++.+.     ...++||||+.+ +|.+++...+.   
T Consensus        59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  133 (309)
T 3p86_A           59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQ  133 (309)
T ss_dssp             TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHH
T ss_pred             CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCC
Confidence            688999999976555556667889999999999999999999999887     557899999985 99998887654   


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +++..++.++.|++.||++||++|  ++||||||+||+++.++.++|+|||.+...... ........|++.|+|||++.
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~~gt~~y~aPE~~~  212 (309)
T 3p86_A          134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSSKSAAGTPEWMAPEVLR  212 (309)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC------------------CCTTSCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-ccccccCCCCccccChhhhc
Confidence            999999999999999999999999  999999999999999999999999998743322 22234457799999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       213 ~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~  251 (309)
T 3p86_A          213 D-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV  251 (309)
T ss_dssp             T-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7 45799999999999999999999999998877766554

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-40  Score=251.59  Aligned_cols=196  Identities=26%  Similarity=0.377  Sum_probs=155.7

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||+++.... .......+.+|++++++++||||+++++++....... ...++||||++ ++|.+++..
T Consensus        31 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~  109 (311)
T 3ork_A           31 ARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHT  109 (311)
T ss_dssp             EEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE-EEEEEEEECCCEEEHHHHHHH
T ss_pred             EEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC-cccEEEEecCCCCCHHHHHHh
Confidence            46788999999999965432 3344567889999999999999999999987653210 13479999997 599999887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe  157 (203)
                      .+.+++.+++.++.|++.+|+|||++|++|+||||+||+++.++.++|+|||.+........  .......|++.|+|||
T Consensus       110 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  189 (311)
T 3ork_A          110 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE  189 (311)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHH
Confidence            78899999999999999999999999999999999999999999999999999975433221  2223346799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+.+..+...+
T Consensus       190 ~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  230 (311)
T 3ork_A          190 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ  230 (311)
T ss_dssp             HHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             HhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9987 4589999999999999999999999998887665543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-39  Score=252.30  Aligned_cols=194  Identities=46%  Similarity=0.823  Sum_probs=161.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++.....+......+.+|+.+++.++||||+++++++...... .....+++|||++++|.+.+.  
T Consensus        61 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--  138 (371)
T 4exu_A           61 AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--  138 (371)
T ss_dssp             EEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--
T ss_pred             EEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--
Confidence            56788999999999976555555667888999999999999999999999876432 111237999999999888764  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.....    ......+++.|+|||++.
T Consensus       139 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~  214 (371)
T 4exu_A          139 MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL  214 (371)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------------CTTCCCTTSCHHHHS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc----CcCCcccCccccCHHHhc
Confidence            3599999999999999999999999999999999999999999999999999974432    223446789999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+.+|.
T Consensus       215 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  255 (371)
T 4exu_A          215 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  255 (371)
T ss_dssp             CCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            75668999999999999999999999999998887777664

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.6e-40  Score=248.09  Aligned_cols=189  Identities=28%  Similarity=0.482  Sum_probs=159.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +++..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...     ...+++|||+.+ +|.+++.. 
T Consensus        64 a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-  135 (321)
T 2c30_A           64 AREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-  135 (321)
T ss_dssp             EEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-
T ss_pred             EEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-
Confidence            456779999999998543  233456788999999999999999999999877     567899999975 77776654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..+..++.|++.||++||+.|++||||||+||+++.++.++|+|||.+....... .......|++.|+|||++.
T Consensus       136 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~  214 (321)
T 2c30_A          136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVIS  214 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhc
Confidence            579999999999999999999999999999999999999999999999999987544322 2234457899999999997


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       215 ~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~  253 (321)
T 2c30_A          215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL  253 (321)
T ss_dssp             T-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7 45889999999999999999999999988777666554

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.5e-40  Score=262.14  Aligned_cols=191  Identities=28%  Similarity=0.542  Sum_probs=162.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.||||++............+.+|++++++++||||+++++++.+.     ...++||||+. ++|.+.+...
T Consensus        41 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~  115 (486)
T 3mwu_A           41 CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKR  115 (486)
T ss_dssp             EEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhc
Confidence            56778999999999965434444567788999999999999999999999887     56789999997 5898888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..+..++.|++.||.|||++|++||||||+||+++   .++.++|+|||++......  .......||+.|+|||
T Consensus       116 ~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE  193 (486)
T 3mwu_A          116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE  193 (486)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC------CCTTGGGGCCGG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--CccCCCcCCCCCCCHH
Confidence            8899999999999999999999999999999999999995   4567999999999754332  2334457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+  .++.++|+||||+++|+|++|++||.+.+..+.+..|.
T Consensus       194 ~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  235 (486)
T 3mwu_A          194 VLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE  235 (486)
T ss_dssp             GGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9876  38999999999999999999999999998887776654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-40  Score=269.78  Aligned_cols=194  Identities=23%  Similarity=0.313  Sum_probs=167.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||||+++... ......+.+..|.+++..+ +||+|+++++++.+.     ..+|+||||+. |+|.+++.
T Consensus       360 ~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~  434 (674)
T 3pfq_A          360 SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQ  434 (674)
T ss_dssp             EEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHH
T ss_pred             EEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHH
Confidence            4577899999999996432 2344566788899999988 899999999999887     56789999998 59999988


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       435 ~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~~~~~GT~~Y~APE~  513 (674)
T 3pfq_A          435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGTPDYIAPEI  513 (674)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCCBCCCCSCSSSCCHHH
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC-CcccccccCCCcccCHhh
Confidence            8788999999999999999999999999999999999999999999999999999743322 223445578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+ ..++.++|+||||+++|+|++|++||.+.+..++++.|.+
T Consensus       514 l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  556 (674)
T 3pfq_A          514 IAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME  556 (674)
T ss_dssp             HTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS
T ss_pred             hcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            977 5589999999999999999999999999998888887754

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-39  Score=243.74  Aligned_cols=191  Identities=28%  Similarity=0.379  Sum_probs=163.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.|++|++.....+....+.+.+|++++++++||||+++++++.++     ...++++||+.+ +|.+.+...
T Consensus        25 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~   99 (284)
T 3kk8_A           25 CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAR   99 (284)
T ss_dssp             EEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhc
Confidence            46778999999999966545555667888999999999999999999999877     456789999975 888888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe---EEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..+..++.|++.+|++||++|++|+||+|+||+++.++.   ++|+|||.+......  .......+++.|+|||
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE  177 (284)
T 3kk8_A          100 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE  177 (284)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--CBCCCSCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--ccccCCCCCcCCcCch
Confidence            88999999999999999999999999999999999999986655   999999999754332  2233456799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+....+....+
T Consensus       178 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  219 (284)
T 3kk8_A          178 VLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI  219 (284)
T ss_dssp             HHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH
Confidence            9987 45799999999999999999999999888877666554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-40  Score=262.35  Aligned_cols=193  Identities=26%  Similarity=0.387  Sum_probs=154.3

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.||||+++... ........+.+|+.+++.++||||+++++++.+.     ..+++||||+++ +|...+..
T Consensus       167 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  241 (446)
T 4ejn_A          167 VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSR  241 (446)
T ss_dssp             EEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHH
T ss_pred             EEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHh
Confidence            4678899999999995432 1333455677899999999999999999999887     567899999985 89888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++...... ........||+.|+|||+
T Consensus       242 ~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  320 (446)
T 4ejn_A          242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCGTPEYLAPEV  320 (446)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------CCSSSCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC-CcccccccCCccccCHhh
Confidence            7889999999999999999999998 99999999999999999999999999998743222 233345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||.+.+..+....|.
T Consensus       321 ~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~  362 (446)
T 4ejn_A          321 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL  362 (446)
T ss_dssp             HHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            977 558999999999999999999999999988777766653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-39  Score=249.56  Aligned_cols=189  Identities=28%  Similarity=0.447  Sum_probs=160.0

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~   79 (203)
                      |++..+|+.||||++.... ......+.+.+|++++++++||||+++++++.++     ...++||||+.|++.+.+. .
T Consensus        73 a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~  147 (348)
T 1u5q_A           73 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVH  147 (348)
T ss_dssp             EEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHH
T ss_pred             EEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHh
Confidence            4577899999999996432 2344556788999999999999999999999877     5678999999998888775 4


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.....     .....|++.|+|||++
T Consensus       148 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~~~~gt~~y~aPE~~  222 (348)
T 1u5q_A          148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVI  222 (348)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CCcccCCcceeCHhhh
Confidence            56799999999999999999999999999999999999999999999999999875432     2334679999999998


Q ss_pred             ec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+  ...++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       223 ~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             HTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            53  345789999999999999999999999887766655443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-40  Score=251.55  Aligned_cols=186  Identities=27%  Similarity=0.399  Sum_probs=155.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.++     ...+++|||+.+ +|.+.+...
T Consensus        26 ~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   99 (323)
T 3tki_A           26 AVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPD   99 (323)
T ss_dssp             EEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTT
T ss_pred             EEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhc
Confidence            4677899999999985432 222346688999999999999999999999887     566799999975 899988888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+....... ........|++.|+|||++
T Consensus       100 ~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  179 (323)
T 3tki_A          100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL  179 (323)
T ss_dssp             TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHh
Confidence            889999999999999999999999999999999999999999999999999997433221 2223345789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+...++.++|+||||+++|+|++|+.||.....
T Consensus       180 ~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             ccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence            8755457789999999999999999999987554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-39  Score=246.70  Aligned_cols=192  Identities=28%  Similarity=0.430  Sum_probs=163.6

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |.+..+|+.||+|++.......    ...+.+.+|+.++++++||||+++++++.+.     ...+++|||+. ++|.++
T Consensus        31 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~  105 (321)
T 2a2a_A           31 CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-----TDVVLILELVSGGELFDF  105 (321)
T ss_dssp             EEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHH
T ss_pred             EEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEEEEEEEcCCCCcHHHH
Confidence            5677899999999995432221    1356788999999999999999999999877     56789999996 599999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      +...+.+++..++.++.|++.||++||++|++|+||+|+||+++.++    .++|+|||.+......  .......+++.
T Consensus       106 l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~  183 (321)
T 2a2a_A          106 LAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPE  183 (321)
T ss_dssp             HHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT--CCCCCCCSCGG
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcc--ccccccCCCCC
Confidence            98888899999999999999999999999999999999999999887    7999999999754432  22234467999


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus       184 y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  231 (321)
T 2a2a_A          184 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT  231 (321)
T ss_dssp             GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             ccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            999999877 558999999999999999999999999988777766554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-39  Score=249.56  Aligned_cols=188  Identities=28%  Similarity=0.464  Sum_probs=157.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP---   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---   80 (203)
                      .++..||||+++.. ......+.+.+|+++++++ +||||+++++++.+.     ..+|+||||+.+ +|.+++...   
T Consensus       111 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~  184 (370)
T 2psq_A          111 KEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPP  184 (370)
T ss_dssp             TCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC
T ss_pred             CcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCc
Confidence            56778999999654 2344567789999999999 899999999999887     567899999985 998888643   


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                   ..+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ .....
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  264 (370)
T 2psq_A          185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN  264 (370)
T ss_dssp             -----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTT
T ss_pred             cccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccC
Confidence                         3489999999999999999999999999999999999999999999999999975443222 22333


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..+++.|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       265 ~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          265 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             TTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            456788999999987 558999999999999999999 99999988776666544

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-40  Score=246.10  Aligned_cols=194  Identities=26%  Similarity=0.459  Sum_probs=154.9

Q ss_pred             CcCCCCCcEEEEEeccCccch------------------------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS------------------------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD   57 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   57 (203)
                      |.+..+|+.||||++......                        ....+.+.+|++++++++||||+++++++.+... 
T Consensus        32 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-  110 (298)
T 2zv2_A           32 AYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE-  110 (298)
T ss_dssp             EEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSS-
T ss_pred             EEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCC-
Confidence            467889999999998543211                        1224668899999999999999999999886432 


Q ss_pred             hhHHHHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccC
Q psy16889         58 FFQEIYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVE  136 (203)
Q Consensus        58 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~  136 (203)
                        ...+++|||+++ +|.+. ...+.+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+...
T Consensus       111 --~~~~lv~e~~~~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  187 (298)
T 2zv2_A          111 --DHLYMVFELVNQGPVMEV-PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF  187 (298)
T ss_dssp             --SEEEEEEECCTTCBSCCS-SCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             --CEEEEEEecCCCCcHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccc
Confidence              456899999985 55553 44567999999999999999999999999999999999999999999999999999754


Q ss_pred             CCCCCCCcccccCCcccccceeeecccC--CCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        137 EPDPNKAMTQEVVTQYYRAPEILMGARH--YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .... .......|++.|+|||++.+...  ++.++|+||||+++|+|++|+.||.+.........+
T Consensus       188 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~  252 (298)
T 2zv2_A          188 KGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI  252 (298)
T ss_dssp             SSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHH
Confidence            4322 22234578999999999876432  367899999999999999999999887765554443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=252.09  Aligned_cols=190  Identities=27%  Similarity=0.430  Sum_probs=161.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |.+..+|+.||+|+++..  .....+.+.+|++++++++||||+++++++.+.     ...++||||++ ++|.+.+.. 
T Consensus       108 a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~  180 (373)
T 2x4f_A          108 CEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDE  180 (373)
T ss_dssp             EEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHT
T ss_pred             EEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhc
Confidence            456789999999999653  224556788999999999999999999999887     56789999997 488777754 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe--cCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV--NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ...+++..++.++.|++.||+|||++|++||||||+||++  +.++.++|+|||++......  .......|++.|+|||
T Consensus       181 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE  258 (373)
T 2x4f_A          181 SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPE  258 (373)
T ss_dssp             GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--CBCCCCCSSCTTCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--cccccccCCCcEeChh
Confidence            4569999999999999999999999999999999999999  56789999999999754432  2233446899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       259 ~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~  301 (373)
T 2x4f_A          259 VVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL  301 (373)
T ss_dssp             HHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             hccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9876 558999999999999999999999999988887776654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=252.80  Aligned_cols=190  Identities=24%  Similarity=0.404  Sum_probs=161.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.++.+|+.||+|++....  ......+.+|+++++.++||||+++++++.+.     ...++||||+. ++|.+.+...
T Consensus        70 ~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~  142 (387)
T 1kob_A           70 CVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAE  142 (387)
T ss_dssp             EEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCT
T ss_pred             EEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhh
Confidence            5678899999999996532  23445788999999999999999999999887     56789999997 5999888754


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                       ..+++.++..++.|++.||+|||++|++||||||+||+++.  .+.++|+|||++......  .......+|+.|+|||
T Consensus       143 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gt~~y~aPE  220 (387)
T 1kob_A          143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE  220 (387)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--cceeeeccCCCccCch
Confidence             47999999999999999999999999999999999999974  467999999999754432  2223446799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++|+||||+++|+|++|..||.+.+..+.+..+.
T Consensus       221 ~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~  263 (387)
T 1kob_A          221 IVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK  263 (387)
T ss_dssp             HHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred             hccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9887 558999999999999999999999999988777766553

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.3e-40  Score=250.85  Aligned_cols=182  Identities=19%  Similarity=0.249  Sum_probs=155.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.||||+++..    ...+.+.+|+++++++ +||||+++++++.+.     ...++||||++++|.+++.. 
T Consensus        28 ~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~   98 (330)
T 2izr_A           28 GKNLYTNEYVAIKLEPMK----SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLC   98 (330)
T ss_dssp             EEETTTTEEEEEEEEETT----CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT
T ss_pred             EEECCCCcEEEEEEeccc----cchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHc
Confidence            456789999999998543    2234688999999999 999999999999887     56789999997799988875 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe-----EEEeecCccccCCCCCCC------Cccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI-----LKICDFGLARVEEPDPNK------AMTQEV  148 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~------~~~~~~  148 (203)
                      .+.+++..++.++.|++.||++||++|++||||||+||+++.++.     ++|+|||.+.........      ......
T Consensus        99 ~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~  178 (330)
T 2izr_A           99 DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT  178 (330)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCC
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcC
Confidence            468999999999999999999999999999999999999998887     999999999754332221      124557


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+.
T Consensus       179 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~  222 (330)
T 2izr_A          179 GTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKA  222 (330)
T ss_dssp             SCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence            8999999999987 5589999999999999999999999988543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-39  Score=247.13  Aligned_cols=179  Identities=26%  Similarity=0.525  Sum_probs=136.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.++.+|+.||||++..     .......+|+..++.+. ||||+++++++.++     ...++||||+.+ +|.+++..
T Consensus        30 ~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~   99 (325)
T 3kn6_A           30 CVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKK   99 (325)
T ss_dssp             EEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHh
Confidence            56788999999999853     23456778999999996 99999999999887     567899999975 99999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .+.+++.++..++.|++.+|+|||++|++||||||+||+++.++   .++|+|||.+...... ........+++.|+||
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~t~~y~aP  178 (325)
T 3kn6_A          100 KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAP  178 (325)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcccccCCCcCccCH
Confidence            88999999999999999999999999999999999999998665   8999999999754332 2233445678999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       179 E~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          179 ELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             ------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             HHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence            99987 458999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-40  Score=251.44  Aligned_cols=184  Identities=26%  Similarity=0.400  Sum_probs=152.9

Q ss_pred             CcCCCCCcEEEEEeccCccch---hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS---LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      |.++.+|+.||||++......   ....+.+.+|+++++.++||||+++++++.++     ..+++||||+. ++|.+.+
T Consensus        43 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l  117 (351)
T 3c0i_A           43 CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEI  117 (351)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHH
T ss_pred             EEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHH
Confidence            567889999999998532111   12356788999999999999999999999887     56789999998 5787665


Q ss_pred             hC----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe---EEEeecCccccCCCCCCCCcccccCC
Q psy16889         78 VS----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLARVEEPDPNKAMTQEVVT  150 (203)
Q Consensus        78 ~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~  150 (203)
                      ..    ...+++..++.++.|++.||+|||++|++||||||+||+++.++.   ++|+|||.+...... ........||
T Consensus       118 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~-~~~~~~~~gt  196 (351)
T 3c0i_A          118 VKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGT  196 (351)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTT-SCBCCCCCSC
T ss_pred             HHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCC-CeeecCCcCC
Confidence            42    346999999999999999999999999999999999999986654   999999999754432 2223445789


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       197 ~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (351)
T 3c0i_A          197 PHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTK  237 (351)
T ss_dssp             GGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred             cCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence            99999999987 458999999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-39  Score=260.06  Aligned_cols=183  Identities=23%  Similarity=0.352  Sum_probs=156.1

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||||++..... .....+.+..|.+++++++||||+++++++.+.     ..+|+||||+. ++|.+++..
T Consensus       204 a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~  278 (543)
T 3c4z_A          204 CQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYN  278 (543)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHT
T ss_pred             EEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHH
Confidence            46778999999999954322 223456788999999999999999999999887     56789999998 588888765


Q ss_pred             ----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         80 ----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        80 ----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                          ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....... .......||+.|+|
T Consensus       279 ~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~GT~~Y~A  357 (543)
T 3c4z_A          279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMA  357 (543)
T ss_dssp             SSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-CCBCCCCSCTTTSC
T ss_pred             hhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC-cccccccCCccccC
Confidence                3469999999999999999999999999999999999999999999999999997543322 22234478999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ||++.+ ..++.++|+||||+++|+|++|++||.+.
T Consensus       358 PE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             HHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             hhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            999987 55899999999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=248.43  Aligned_cols=194  Identities=46%  Similarity=0.821  Sum_probs=160.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |.++.+|+.||||++.....+......+.+|+.+++.++||||+++++++...... .....+++||+++++|.+.+.. 
T Consensus        43 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-  121 (353)
T 3coi_A           43 AIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL-  121 (353)
T ss_dssp             EEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS-
T ss_pred             EEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcC-
Confidence            56788999999999976555555567788999999999999999999998876431 1113478999999888776643 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       .+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.....    ......+++.|+|||++.
T Consensus       122 -~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          122 -KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------------CCSBCCSCHHHHS
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC----CccccccCcCcCCHHHHh
Confidence             599999999999999999999999999999999999999999999999999875332    223446788999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       197 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~  237 (353)
T 3coi_A          197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL  237 (353)
T ss_dssp             CCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHH
T ss_pred             CcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            75668999999999999999999999999988877766654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-39  Score=260.48  Aligned_cols=191  Identities=29%  Similarity=0.524  Sum_probs=165.0

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||||++..... .....+.+.+|++++++++||||+++++++.+.     ...++|+||+. ++|.+.+..
T Consensus        45 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~  119 (484)
T 3nyv_A           45 CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIIS  119 (484)
T ss_dssp             EEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHT
T ss_pred             EEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHh
Confidence            46788999999999854322 344567789999999999999999999999887     56789999997 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||++   +.++.++|+|||++......  .......||+.|+||
T Consensus       120 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aP  197 (484)
T 3nyv_A          120 RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAP  197 (484)
T ss_dssp             CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC--CSHHHHTTGGGTCCH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc--cccccCCCCccccCc
Confidence            8899999999999999999999999999999999999999   46789999999999754432  233445789999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |++.+  .++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       198 E~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  240 (484)
T 3nyv_A          198 EVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE  240 (484)
T ss_dssp             HHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99876  48999999999999999999999999998888777654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.3e-39  Score=260.43  Aligned_cols=191  Identities=31%  Similarity=0.528  Sum_probs=162.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||+|+++...........+.+|+.+++.++||||+++++++.+.     ..+++||||+. ++|.+.+...
T Consensus        56 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~  130 (494)
T 3lij_A           56 CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHR  130 (494)
T ss_dssp             EEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHc
Confidence            56788999999999976544555567889999999999999999999999887     56789999998 4898888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN---CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ..+++..+..++.|++.||+|||++|++||||||+||+++..   +.++|+|||++......  .......||+.|+|||
T Consensus       131 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE  208 (494)
T 3lij_A          131 MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE  208 (494)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--BCBCCCCSCTTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--ccccccCCCcCeeCHH
Confidence            889999999999999999999999999999999999999754   45999999998754432  2334457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+  .++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       209 ~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  250 (494)
T 3lij_A          209 VLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE  250 (494)
T ss_dssp             HHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            8864  48999999999999999999999999998887776654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.8e-40  Score=254.02  Aligned_cols=182  Identities=27%  Similarity=0.424  Sum_probs=144.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |++..+|+.||||++....   ...+.+.+|+..++.++||||+++++++.++     ...++||||+. ++|.+.+...
T Consensus        39 ~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  110 (361)
T 3uc3_A           39 MRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNA  110 (361)
T ss_dssp             EEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhc
Confidence            4677899999999996432   2335678999999999999999999999887     56789999997 5999988877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe--EEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      +.+++..++.++.|++.||+|||++|++||||||+||+++.++.  ++|+|||.+.....  ........||+.|+|||+
T Consensus       111 ~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~  188 (361)
T 3uc3_A          111 GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEV  188 (361)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------------CTTSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--cCCCCCCcCCCCcCChhh
Confidence            88999999999999999999999999999999999999987665  99999999873222  222334468999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      +.+....+.++|+||||+++|+|++|+.||.+...
T Consensus       189 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~  223 (361)
T 3uc3_A          189 LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE  223 (361)
T ss_dssp             HHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred             hcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence            98754334458999999999999999999987543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=244.00  Aligned_cols=182  Identities=31%  Similarity=0.482  Sum_probs=154.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+|+.|++|.+..  .+....+.+.+|++++++++||||+++++++.++     ...++||||+.+ +|.+++.. 
T Consensus        29 ~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  101 (310)
T 3s95_A           29 VTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSM  101 (310)
T ss_dssp             EEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHC
T ss_pred             EEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhc
Confidence            56778999999998854  3445567888999999999999999999999877     567789999985 99988875 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-------------Cccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-------------AMTQ  146 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~  146 (203)
                      .+.+++.++..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.........             ....
T Consensus       102 ~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (310)
T 3s95_A          102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT  181 (310)
T ss_dssp             CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccc
Confidence            577999999999999999999999999999999999999999999999999999754332211             1114


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ..||+.|+|||++.+ ..++.++|+||||+++|+|++|..||...
T Consensus       182 ~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          182 VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             CCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence            468999999999987 56899999999999999999999998764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-39  Score=253.07  Aligned_cols=192  Identities=35%  Similarity=0.660  Sum_probs=156.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc------------------------
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD------------------------   57 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~------------------------   57 (203)
                      |.+..+|+.||||++...      .....+|+++++.++||||+++++++......                        
T Consensus        26 a~~~~~~~~vAiK~~~~~------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   99 (383)
T 3eb0_A           26 VFDIESGKRFALKKVLQD------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNH   99 (383)
T ss_dssp             EEETTTCCEEEEEEEECC------TTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------------------
T ss_pred             EEECCCCCEEEEEEEecC------cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccc
Confidence            567889999999998542      12234799999999999999999988543210                        


Q ss_pred             ---------hhHHHHHHHhhhHHhHHHHH----hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCC
Q psy16889         58 ---------FFQEIYVITELLQSDLHKII----VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNC  123 (203)
Q Consensus        58 ---------~~~~~~lv~e~~~~~l~~~~----~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~  123 (203)
                               ...+.++||||++++|.+.+    ...+.+++..++.++.|++.||+|||++|++||||||+||+++ .++
T Consensus       100 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~  179 (383)
T 3eb0_A          100 HKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN  179 (383)
T ss_dssp             ----------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTT
T ss_pred             cccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCC
Confidence                     00236789999998665554    4567899999999999999999999999999999999999998 688


Q ss_pred             eEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       124 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .++|+|||.+......  .......+++.|+|||++.+...++.++|+||+|+++|+|++|++||.+.+..+.+..|.
T Consensus       180 ~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  255 (383)
T 3eb0_A          180 TLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRII  255 (383)
T ss_dssp             EEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999754332  233344678899999998876668999999999999999999999999999888887765

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.3e-39  Score=247.83  Aligned_cols=197  Identities=46%  Similarity=0.832  Sum_probs=161.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      +.+..+|+.||||++... ........+.+|++++++++||||+++++++...........++++|+++++|.+.+.. +
T Consensus        30 ~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~  107 (353)
T 2b9h_A           30 ATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-Q  107 (353)
T ss_dssp             EEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-C
T ss_pred             EEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-c
Confidence            456788999999999643 23344567789999999999999999999877653322245689999999999888765 5


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---------CcccccCCcc
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---------AMTQEVVTQY  152 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~  152 (203)
                      .+++..+..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.........         ......|++.
T Consensus       108 ~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~  187 (353)
T 2b9h_A          108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW  187 (353)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccccc
Confidence            6999999999999999999999999999999999999999999999999998754422111         1223467889


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |+|||++.+...++.++|+||||+++|+|++|++||.+.+..+.+..+
T Consensus       188 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  235 (353)
T 2b9h_A          188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI  235 (353)
T ss_dssp             GCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            999998876566899999999999999999999999998876666554

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.1e-39  Score=248.25  Aligned_cols=193  Identities=38%  Similarity=0.704  Sum_probs=153.0

Q ss_pred             CCcEEEEEeccCccch---------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH
Q psy16889          7 DGRRVALKKLPNVFQS---------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII   77 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   77 (203)
                      +|+.||||++......         ....+.+.+|++++++++||||+++++++...........++||||++++|.+.+
T Consensus        45 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~  124 (362)
T 3pg1_A           45 EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI  124 (362)
T ss_dssp             TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHH
T ss_pred             CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHH
Confidence            4999999998543221         1223678899999999999999999999854332211456899999999998888


Q ss_pred             hCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         78 VSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        78 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      ... ..+++..+..++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......  .......+++.|+||
T Consensus       125 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aP  202 (362)
T 3pg1_A          125 HDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAP  202 (362)
T ss_dssp             HCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC-----------------CGGGCCH
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc--cccceecccceecCc
Confidence            754 47999999999999999999999999999999999999999999999999999743322  223344678889999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |++.+...++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus       203 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  247 (362)
T 3pg1_A          203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV  247 (362)
T ss_dssp             HHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998875668999999999999999999999999998888777664

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=244.86  Aligned_cols=185  Identities=25%  Similarity=0.443  Sum_probs=153.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.||||+++... .....+.+.+|++++++++||||+++++++.....   ...++||||+. ++|.+++...
T Consensus        28 ~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~  103 (319)
T 4euu_A           28 GRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEP  103 (319)
T ss_dssp             EEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEEECCTTCBHHHHHHSG
T ss_pred             EEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEEEEEeCCCCCCHHHHHHHh
Confidence            4677889999999996532 22345677899999999999999999999876642   24579999997 5898888764


Q ss_pred             C---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         81 Q---HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV----NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        81 ~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .   .+++.+++.++.|++.||++||++|++||||||+||++    +.++.++|+|||.+......  .......+++.|
T Consensus       104 ~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y  181 (319)
T 4euu_A          104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEY  181 (319)
T ss_dssp             GGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT--CCBCCCCSCGGG
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC--CceeecccCCCc
Confidence            3   39999999999999999999999999999999999999    77788999999999754432  222344679999


Q ss_pred             ccceeeec-------ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        154 RAPEILMG-------ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       154 ~aPe~~~~-------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +|||++..       ...++.++|+||||+++|+|++|+.||....
T Consensus       182 ~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             CCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             cCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99998862       2457899999999999999999999997543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=244.59  Aligned_cols=189  Identities=25%  Similarity=0.416  Sum_probs=155.6

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-QHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~   83 (203)
                      ..+..||||+++.. ......+.+.+|+.++++++||||+++++++.++     ...++||||+.+ +|.+++... +.+
T Consensus        75 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  148 (325)
T 3kul_A           75 QRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQF  148 (325)
T ss_dssp             SCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCS
T ss_pred             CCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCC
Confidence            34456999999653 2334556788999999999999999999999876     567899999975 999988654 679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeec
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~  161 (203)
                      ++.++..++.|++.||++||++|++||||||+||+++.++.++|+|||.+.........  ......+++.|+|||++.+
T Consensus       149 ~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  228 (325)
T 3kul_A          149 TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF  228 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC
Confidence            99999999999999999999999999999999999999999999999999855433222  2223344678999999976


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                       ..++.++|+||||+++|+|++ |+.||.+....+....+.
T Consensus       229 -~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  268 (325)
T 3kul_A          229 -RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE  268 (325)
T ss_dssp             -CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred             -CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence             458999999999999999998 999999988877766553

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-39  Score=243.94  Aligned_cols=188  Identities=26%  Similarity=0.359  Sum_probs=149.8

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      +.+..+|+.|++|++..... .....+.+.+|+.++++++||||+++++++.++     ...++++|++.+ +|.+++..
T Consensus        53 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  127 (309)
T 2h34_A           53 AEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRR  127 (309)
T ss_dssp             EEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHH
T ss_pred             EEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHh
Confidence            45678899999999965433 233356788999999999999999999999877     567899999985 99998887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+...............+++.|.|||.+
T Consensus       128 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~  207 (309)
T 2h34_A          128 QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF  207 (309)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGT
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHH
Confidence            78899999999999999999999999999999999999999999999999999875544333333455678999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+.....
T Consensus       208 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (309)
T 2h34_A          208 SE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSV  242 (309)
T ss_dssp             CC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred             cC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence            87 457899999999999999999999998876543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-39  Score=254.75  Aligned_cols=192  Identities=32%  Similarity=0.543  Sum_probs=154.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHH---
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKII---   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~---   77 (203)
                      |.+..+|+.||||++...      .....+|+++++.++||||+++++++...... ...++++||||+++++.+.+   
T Consensus        73 ~~~~~~~~~vaiK~~~~~------~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~  146 (420)
T 1j1b_A           73 AKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY  146 (420)
T ss_dssp             EEETTTCCEEEEEEEECC------TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHH
T ss_pred             EEECCCCcEEEEEEeccc------chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHH
Confidence            457788999999998542      12234799999999999999999987542110 11345789999997665544   


Q ss_pred             -hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-CeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         78 -VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        78 -~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                       .....+++..++.++.|++.||+|||++|++||||||+||+++.+ +.+||+|||++......  .......+++.|+|
T Consensus       147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~t~~y~a  224 (420)
T 1j1b_A          147 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRA  224 (420)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCTTSCC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC--CCceeeeeCCCcCC
Confidence             346789999999999999999999999999999999999999955 67899999999754322  22234467899999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||++.+...++.++|||||||++|+|++|++||.+.+..+.+..|.
T Consensus       225 PE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~  270 (420)
T 1j1b_A          225 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  270 (420)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999775568999999999999999999999999998887776664

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-39  Score=261.91  Aligned_cols=183  Identities=25%  Similarity=0.366  Sum_probs=156.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||||++..... .....+.+.+|+++++.++||||+++++++.+.     ..+|+||||+. |+|.+++..
T Consensus       203 a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~  277 (576)
T 2acx_A          203 CQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYH  277 (576)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHS
T ss_pred             EEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHh
Confidence            45778999999999954322 233456678999999999999999999999887     56789999997 599888876


Q ss_pred             CC--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .+  .+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++......  .......||+.|+|||
T Consensus       278 ~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~--~~~~~~~GT~~Y~APE  355 (576)
T 2acx_A          278 MGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRVGTVGYMAPE  355 (576)
T ss_dssp             SSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--CCEECCCSCGGGCCHH
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC--ccccccCCCccccCHH
Confidence            44  4999999999999999999999999999999999999999999999999999754322  2233457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       356 vl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          356 VVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             HHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             HHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence            9987 458999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-39  Score=246.92  Aligned_cols=187  Identities=25%  Similarity=0.457  Sum_probs=159.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-----CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-----HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~   76 (203)
                      |.+..+|+.||||+++..   .........|+++++.++     ||||+++++++...     ...++|||+++++|.++
T Consensus        54 ~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~  125 (360)
T 3llt_A           54 CQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEI  125 (360)
T ss_dssp             EEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHH
T ss_pred             EEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----CeeEEEEcCCCCCHHHH
Confidence            467789999999999642   233455677999999986     99999999999877     56789999998899998


Q ss_pred             HhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------------------------CCeEEEee
Q psy16889         77 IVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-------------------------NCILKICD  129 (203)
Q Consensus        77 ~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-------------------------~~~~~l~d  129 (203)
                      +...  ..+++.+++.++.|++.||+|||++|++||||||+||+++.                         ++.++|+|
T Consensus       126 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D  205 (360)
T 3llt_A          126 ITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID  205 (360)
T ss_dssp             HHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECC
T ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEe
Confidence            8754  35999999999999999999999999999999999999975                         78899999


Q ss_pred             cCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        130 FGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||.+......    .....||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+.+..+.+..|.
T Consensus       206 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  272 (360)
T 3llt_A          206 FGCATFKSDY----HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMME  272 (360)
T ss_dssp             CTTCEETTSC----CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCceecCCC----CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence            9999753322    234467899999999987 458999999999999999999999999988887776654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-39  Score=239.04  Aligned_cols=189  Identities=28%  Similarity=0.469  Sum_probs=161.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..++..+++|.+...  .....+.+.+|++++++++||||+++++++.+.     ...+++|||+.+ +|.+.+...
T Consensus        28 ~~~~~~~~~~a~k~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~  100 (277)
T 3f3z_A           28 AVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHK  100 (277)
T ss_dssp             EEETTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEeCCCCcEEEEEeehhh--ccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHc
Confidence            457788999999998653  223456788999999999999999999999887     567899999974 898888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..++.++.|++.+|++||++|++|+||+|+||++   +.++.++++|||.+......  .......+++.|+|||
T Consensus       101 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE  178 (277)
T 3f3z_A          101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ  178 (277)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--SCBCCCCSCTTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--cchhccCCCCCccChH
Confidence            889999999999999999999999999999999999999   78889999999998754432  2334446799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ . ++.++|+||||+++|+|++|+.||......+....+.
T Consensus       179 ~~~~-~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  220 (277)
T 3f3z_A          179 VLEG-L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR  220 (277)
T ss_dssp             HHTT-C-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             Hhcc-c-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            8865 3 7899999999999999999999999988777665543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.1e-39  Score=238.29  Aligned_cols=186  Identities=22%  Similarity=0.398  Sum_probs=157.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~   84 (203)
                      +++.||+|++....   ...+.+.+|++++++++||||+++++++.++     ...+++|||+++ +|.+++.. .+.++
T Consensus        33 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~  104 (269)
T 4hcu_A           33 NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFA  104 (269)
T ss_dssp             TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCC
T ss_pred             CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccC
Confidence            57789999996532   2335688999999999999999999999887     456799999975 89888865 45699


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..++.++.|++.+|++||++|++|+||||+||+++.++.++++|||.+...............+++.|+|||.+.+ ..
T Consensus       105 ~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  183 (269)
T 4hcu_A          105 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR  183 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcC-CC
Confidence            99999999999999999999999999999999999999999999999997554333333344455778999999876 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|+|++ |+.||.+....+....+.
T Consensus       184 ~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~  221 (269)
T 4hcu_A          184 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  221 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh
Confidence            8999999999999999999 999999988877776654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.4e-39  Score=257.42  Aligned_cols=191  Identities=28%  Similarity=0.480  Sum_probs=162.2

Q ss_pred             CcCCCCCcEEEEEeccCccchh-----------hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL-----------VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ   70 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   70 (203)
                      |.++.+|+.||+|+++......           ...+.+.+|+.++++++||||+++++++.++     ..+++||||+.
T Consensus        55 ~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~  129 (504)
T 3q5i_A           55 CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-----KYFYLVTEFYE  129 (504)
T ss_dssp             EEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCT
T ss_pred             EEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEEEEEEecCC
Confidence            5678899999999996533221           2356788999999999999999999999887     56789999998


Q ss_pred             H-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCCCCCCCccc
Q psy16889         71 S-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNKAMTQ  146 (203)
Q Consensus        71 ~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~  146 (203)
                      + +|.+.+...+.+++..+..++.|++.||+|||++|++||||||+||+++.++   .++|+|||++......  .....
T Consensus       130 gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~  207 (504)
T 3q5i_A          130 GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRD  207 (504)
T ss_dssp             TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT--SCBCC
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC--Ccccc
Confidence            5 8988888778899999999999999999999999999999999999998775   6999999999754432  23344


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ..|++.|+|||++.+  .++.++|+||||+++|+|++|.+||.+.+..+.+..|.
T Consensus       208 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  260 (504)
T 3q5i_A          208 RLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE  260 (504)
T ss_dssp             CCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            578999999999864  47999999999999999999999999998888777664

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-40  Score=256.42  Aligned_cols=194  Identities=14%  Similarity=0.172  Sum_probs=146.7

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHH---HHHhhcCCCCccchhhhc-------cCCCc------------ch
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFREL---KMLCFFKHDNVLSALDIL-------QPPHL------------DF   58 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~---~~l~~l~~~~i~~~~~~~-------~~~~~------------~~   58 (203)
                      |++..+|+.||||+++... ......+.+.+|+   +.+++++||||+++++.+       .+++.            .+
T Consensus        92 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (377)
T 3byv_A           92 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW  171 (377)
T ss_dssp             EEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CE
T ss_pred             EEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceE
Confidence            5677899999999996432 2334557788999   555566899999999443       33211            01


Q ss_pred             hHHHHHHHhhhHHhHHHHHhCCCCCCh-------HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecC
Q psy16889         59 FQEIYVITELLQSDLHKIIVSPQHLTS-------DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG  131 (203)
Q Consensus        59 ~~~~~lv~e~~~~~l~~~~~~~~~~~~-------~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~  131 (203)
                      ....+++|||++|+|.+++...+.+++       ..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus       172 i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG  251 (377)
T 3byv_A          172 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE  251 (377)
T ss_dssp             EESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGG
T ss_pred             EEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEech
Confidence            113679999999999998876555555       8888899999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCcccccCCcccccceeeecc----------cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        132 LARVEEPDPNKAMTQEVVTQYYRAPEILMGA----------RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~----------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ++.....    ......| +.|+|||++.+.          ..++.++|+||||+++|+|++|+.||.+.........+
T Consensus       252 ~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~  325 (377)
T 3byv_A          252 HLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI  325 (377)
T ss_dssp             GCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG
T ss_pred             hheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh
Confidence            9974322    2334456 889999999874          25899999999999999999999999887655544443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.5e-39  Score=243.95  Aligned_cols=198  Identities=20%  Similarity=0.312  Sum_probs=145.5

Q ss_pred             cCCCCCc---EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcch-hHHHHHHHhhhHH-hHHHHH
Q psy16889          3 TDPRDGR---RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF-FQEIYVITELLQS-DLHKII   77 (203)
Q Consensus         3 ~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~   77 (203)
                      .+..+++   .||||+++.........+.+.+|++++++++||||+++++++....... ....++++||+.+ +|.+++
T Consensus        43 ~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  122 (323)
T 3qup_A           43 QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL  122 (323)
T ss_dssp             EC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHH
T ss_pred             EEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHH
Confidence            3455554   8999999765555566788999999999999999999999987763221 1122789999985 888777


Q ss_pred             hCC------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCC
Q psy16889         78 VSP------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVT  150 (203)
Q Consensus        78 ~~~------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~  150 (203)
                      ...      ..+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+........ .......++
T Consensus       123 ~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  202 (323)
T 3qup_A          123 LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP  202 (323)
T ss_dssp             HHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CC
T ss_pred             HhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCc
Confidence            432      2699999999999999999999999999999999999999999999999999975433221 222333457


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      +.|.|||.+.+ ..++.++|+||||+++|+|++ |+.||.+....+....+.
T Consensus       203 ~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          203 VKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             GGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             ccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            78999999887 458999999999999999999 999999888777665543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=247.17  Aligned_cols=182  Identities=25%  Similarity=0.348  Sum_probs=155.9

Q ss_pred             CcCCCCCcEEEEEeccCccch------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-H-hH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-S-DL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~-~l   73 (203)
                      |+++.+|+.||||+++.....      ......+.+|++++++++||||+++++++.+.     ...+++||++. | +|
T Consensus        43 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l  117 (335)
T 3dls_A           43 AVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDL  117 (335)
T ss_dssp             EEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTSCBH
T ss_pred             EEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-----CEEEEEEEeCCCCccH
Confidence            467889999999999654221      12445677899999999999999999999887     56778999886 4 89


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .+++...+.+++..++.++.|++.+|+|||++|++||||||+||+++.++.++|+|||.+......  .......|++.|
T Consensus       118 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y  195 (335)
T 3dls_A          118 FAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEY  195 (335)
T ss_dssp             HHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT--CCBCEECSCGGG
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC--CceeccCCCccc
Confidence            999998889999999999999999999999999999999999999999999999999999754432  223345679999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +|||++.+....+.++|+||||+++|+|++|+.||..
T Consensus       196 ~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             CCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9999998755458899999999999999999999976

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-39  Score=239.32  Aligned_cols=191  Identities=26%  Similarity=0.406  Sum_probs=159.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.|++|++..... .......+.+|+.++++++||||+++++++.+.     ...+++|||++ ++|.+.+..
T Consensus        28 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~  102 (279)
T 3fdn_A           28 AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQK  102 (279)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH
T ss_pred             EEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHh
Confidence            46778899999999854322 222345688999999999999999999999887     55789999998 588888887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+......   ......+++.|+|||.+
T Consensus       103 ~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~  179 (279)
T 3fdn_A          103 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTDLCGTLDYLPPEMI  179 (279)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----------CCCCTTCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cccccCCCCCccCHhHh
Confidence            788999999999999999999999999999999999999999999999999988543222   22344678999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||......+....+.
T Consensus       180 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  220 (279)
T 3fdn_A          180 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS  220 (279)
T ss_dssp             TT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence            77 557899999999999999999999999988777766553

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=247.00  Aligned_cols=182  Identities=35%  Similarity=0.478  Sum_probs=142.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+++.||||++...    ...+.+.+|++++++++||||+++++++.++     ...+++|||+. ++|.+.+...
T Consensus        72 ~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  142 (349)
T 2w4o_A           72 CKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEK  142 (349)
T ss_dssp             EEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTC
T ss_pred             EEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhc
Confidence            456788999999999643    2345677899999999999999999999887     56779999997 5999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++.++..++.|++.||++||++|++||||||+||+++.   ++.++|+|||.+......  .......|++.|+|||
T Consensus       143 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE  220 (349)
T 2w4o_A          143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPE  220 (349)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------------CGGGSCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--cccccccCCCCccCHH
Confidence            88999999999999999999999999999999999999975   889999999998754322  2223446799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+....+
T Consensus       221 ~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  257 (349)
T 2w4o_A          221 ILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ  257 (349)
T ss_dssp             HHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred             HhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence            9987 458999999999999999999999997765443

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-38  Score=243.25  Aligned_cols=192  Identities=30%  Similarity=0.433  Sum_probs=162.8

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.|++|++.... ......+.+.+|+.+++.++|+||+++++++.+.     ...+++|||+. ++|.+++..
T Consensus        60 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~  134 (335)
T 2owb_A           60 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKR  134 (335)
T ss_dssp             EEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhc
Confidence            4677889999999985432 2344567788999999999999999999999887     56789999998 588888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||++
T Consensus       135 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~  213 (335)
T 2owb_A          135 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKKVLCGTPNYIAPEVL  213 (335)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCCCSCCSSCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-ccccccCCCccccCHHHh
Confidence            7889999999999999999999999999999999999999999999999999997543222 223344678999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++|+.||......+....+
T Consensus       214 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  253 (335)
T 2owb_A          214 SK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  253 (335)
T ss_dssp             HT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            87 45789999999999999999999999987766655443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-38  Score=238.22  Aligned_cols=192  Identities=30%  Similarity=0.436  Sum_probs=162.4

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.|++|++.... ......+.+.+|+.+++.++||||+++++++.++     ...++++||++ ++|.+.+..
T Consensus        34 ~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~  108 (294)
T 2rku_A           34 ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKR  108 (294)
T ss_dssp             EEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHh
Confidence            4677889999999985432 2344567788999999999999999999999877     56789999998 588888877


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+...... ........+++.|.|||.+
T Consensus       109 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~  187 (294)
T 2rku_A          109 RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVL  187 (294)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST-TCCBCCCCSCCSSCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC-ccccccccCCCCcCCcchh
Confidence            788999999999999999999999999999999999999999999999999998754322 2223344678899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++|+.||......+....+
T Consensus       188 ~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  227 (294)
T 2rku_A          188 SK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI  227 (294)
T ss_dssp             TT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             cc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            77 45789999999999999999999999988766655443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=240.24  Aligned_cols=197  Identities=39%  Similarity=0.771  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc---------hhHHHHHHHhhhHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD---------FFQEIYVITELLQSD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~---------~~~~~~lv~e~~~~~   72 (203)
                      +.+..+|+.||+|++...  +....+.+.+|++++++++||||+++++++......         .....+++|||++++
T Consensus        30 ~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~  107 (320)
T 2i6l_A           30 AVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD  107 (320)
T ss_dssp             EEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEE
T ss_pred             EEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCC
Confidence            467788999999998643  344567788999999999999999999987543211         013567999999999


Q ss_pred             HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCC--CCCcccccC
Q psy16889         73 LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDP--NKAMTQEVV  149 (203)
Q Consensus        73 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~  149 (203)
                      |.+.+.. +++++..++.++.|++.||++||++|++|+||||+||+++ .++.++|+|||.+.......  ........+
T Consensus       108 L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  186 (320)
T 2i6l_A          108 LANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV  186 (320)
T ss_dssp             HHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGS
T ss_pred             HHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccc
Confidence            9988764 6799999999999999999999999999999999999997 56799999999997543321  122234456


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +..|.|||.+.+...++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus       187 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             CCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            8889999988765668999999999999999999999999988777666553

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.3e-39  Score=238.48  Aligned_cols=188  Identities=29%  Similarity=0.470  Sum_probs=137.6

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.|++|++..... .....+.+.+|+.++++++||||+++++++.+.     ...++++||++ ++|.+++..
T Consensus        30 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  104 (278)
T 3cok_A           30 AESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKN  104 (278)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHT
T ss_pred             EEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhh
Confidence            45678999999999954322 222346788999999999999999999999887     56789999997 588888876


Q ss_pred             C-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 P-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      . +.+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.
T Consensus       105 ~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~  183 (278)
T 3cok_A          105 RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-EKHYTLCGTPNYISPEI  183 (278)
T ss_dssp             CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---------------------
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC-CcceeccCCCCcCCcch
Confidence            4 679999999999999999999999999999999999999999999999999987543222 22233467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||......+.
T Consensus       184 ~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  220 (278)
T 3cok_A          184 ATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT  220 (278)
T ss_dssp             ---------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred             hcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence            887 4578999999999999999999999987654433

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=249.13  Aligned_cols=183  Identities=39%  Similarity=0.688  Sum_probs=144.5

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC----
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS----   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----   79 (203)
                      +..+++.||||++...    .....+.+|+.++++++||||+++++++.....   ...++||||++++|.+.+..    
T Consensus        44 ~~~~~~~vaiK~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~  116 (405)
T 3rgf_A           44 DGKDDKDYALKQIEGT----GISMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRAS  116 (405)
T ss_dssp             SSSCCCCEEEEECSSS----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT---TEEEEEEECCSEEHHHHHHHHHHH
T ss_pred             cCCCCeEEEEEEECCC----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC---CeEEEEEeCCCCCHHHHHHHhccc
Confidence            4468899999999643    223467899999999999999999999854322   45789999999888777642    


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCeEEEeecCccccCCCCCC--CCccccc
Q psy16889         80 -----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV----NSNCILKICDFGLARVEEPDPN--KAMTQEV  148 (203)
Q Consensus        80 -----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  148 (203)
                           ...+++..++.++.|++.||+|||++|++||||||+||++    +.++.++|+|||++........  .......
T Consensus       117 ~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  196 (405)
T 3rgf_A          117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV  196 (405)
T ss_dssp             C-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCce
Confidence                 1259999999999999999999999999999999999999    6778999999999975443211  2334457


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ||+.|+|||++.+...++.++|||||||++|+|++|++||.+...
T Consensus       197 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          197 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             ecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence            799999999998766689999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-38  Score=237.33  Aligned_cols=187  Identities=27%  Similarity=0.412  Sum_probs=145.0

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-CCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-QHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~   84 (203)
                      ++..|++|.++.. ......+.+.+|+..+++++||||+++++++.++      ..++||||+.+ +|.+++... ..++
T Consensus        42 ~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~  114 (281)
T 1mp8_A           42 PALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLD  114 (281)
T ss_dssp             CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------SCEEEEECCTTEEHHHHHHHTTTTSC
T ss_pred             CceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC------ccEEEEecCCCCCHHHHHHhcCCCCC
Confidence            4567999998653 2344567788999999999999999999998543      35689999985 898888744 4799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...............+++.|+|||++.+ ..
T Consensus       115 ~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  193 (281)
T 1mp8_A          115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RR  193 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhccc-CC
Confidence            99999999999999999999999999999999999999999999999997554433333334455778999999876 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|+|++ |..||.+....+.+..+.
T Consensus       194 ~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~  231 (281)
T 1mp8_A          194 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  231 (281)
T ss_dssp             CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH
Confidence            8999999999999999996 999999887777665553

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-38  Score=239.72  Aligned_cols=194  Identities=21%  Similarity=0.322  Sum_probs=149.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh------
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV------   78 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------   78 (203)
                      .+++.||+|+++.........+.+.+|+.++++++||||+++++++.+.........++++||+.+ +|.+++.      
T Consensus        60 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~  139 (313)
T 3brb_A           60 GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET  139 (313)
T ss_dssp             SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTT
T ss_pred             CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhc
Confidence            467789999997654555666788999999999999999999999887644322345789999984 8888873      


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccce
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPE  157 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe  157 (203)
                      ....+++..++.++.|++.||.+||++|++||||||+||+++.++.++|+|||.+........ .......+++.|.|||
T Consensus       140 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  219 (313)
T 3brb_A          140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE  219 (313)
T ss_dssp             SCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHH
T ss_pred             CCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCch
Confidence            346799999999999999999999999999999999999999999999999999875433221 2223335577899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       220 ~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          220 SLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             HHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             hhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            9987 558999999999999999999 89999988776665544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-38  Score=241.00  Aligned_cols=189  Identities=24%  Similarity=0.387  Sum_probs=157.4

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--   81 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--   81 (203)
                      ..+++.|++|+++.. ......+.+.+|++++++++||||+++++++.+.     ...+++|||+. ++|.+++....  
T Consensus        50 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  123 (314)
T 2ivs_A           50 RAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKV  123 (314)
T ss_dssp             CSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTS
T ss_pred             ccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhc
Confidence            456789999999653 2344567788999999999999999999999887     56789999998 58988886433  


Q ss_pred             ----------------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC
Q psy16889         82 ----------------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD  139 (203)
Q Consensus        82 ----------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~  139 (203)
                                            .+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......
T Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~  203 (314)
T 2ivs_A          124 GPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE  203 (314)
T ss_dssp             TTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTT
T ss_pred             cCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccccc
Confidence                                  3899999999999999999999999999999999999999999999999998754332


Q ss_pred             CC-CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        140 PN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       140 ~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .. .......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       204 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  265 (314)
T 2ivs_A          204 DSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL  265 (314)
T ss_dssp             SCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             ccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh
Confidence            22 12233455778999999877 457999999999999999999 99999988776665544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-39  Score=247.22  Aligned_cols=186  Identities=26%  Similarity=0.510  Sum_probs=153.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||||++....      ....+|++++.++ +||||+++++++.++     ...|+||||+. ++|.+.+..
T Consensus        41 ~~~~~~~~~~avK~~~~~~------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~  109 (342)
T 2qr7_A           41 CIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILR  109 (342)
T ss_dssp             EEETTTTEEEEEEEEETTT------CCCHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHT
T ss_pred             EEECCCCCEEEEEEEEccc------CChHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHH
Confidence            5678899999999995432      1234678888887 899999999999887     56789999997 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC----CeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN----CILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      .+.+++.++..++.|++.||+|||++|++||||||+||++..+    +.++|+|||.+....... .......+|+.|+|
T Consensus       110 ~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~a  188 (342)
T 2qr7_A          110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN-GLLMTPCYTANFVA  188 (342)
T ss_dssp             CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-CCBCCSSCCSSCCC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-CceeccCCCccccC
Confidence            8899999999999999999999999999999999999998543    359999999997543322 22334577999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC---ChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ---SPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~---~~~~~~~~i  200 (203)
                      ||++.+ ..++.++|+||||+++|+|++|..||.+.   ...+.+..|
T Consensus       189 PE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i  235 (342)
T 2qr7_A          189 PEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI  235 (342)
T ss_dssp             HHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH
T ss_pred             HHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH
Confidence            999887 44789999999999999999999999863   344444443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-38  Score=237.72  Aligned_cols=191  Identities=30%  Similarity=0.455  Sum_probs=158.8

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |.+..+|+.|++|++.......    ...+.+.+|+.++++++||||+++++++.+.     ...++++|++. ++|.++
T Consensus        24 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~   98 (283)
T 3bhy_A           24 CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-----TDVVLILELVSGGELFDF   98 (283)
T ss_dssp             EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHH
T ss_pred             EEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-----CeEEEEEeecCCCcHHHH
Confidence            4567889999999985432221    2356788999999999999999999999887     56789999996 699998


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      +...+.+++.++..++.|++.+|++||++|++|+||+|+||+++.++    .++|+|||.+......  .......+++.
T Consensus        99 l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~  176 (283)
T 3bhy_A           99 LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPE  176 (283)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC----------CCCGG
T ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCC--CcccccCCCcC
Confidence            88777899999999999999999999999999999999999998776    8999999998754332  22234467889


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+.+..+
T Consensus       177 y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  223 (283)
T 3bhy_A          177 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI  223 (283)
T ss_dssp             GCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             ccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence            999999876 45899999999999999999999999988877766554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-39  Score=241.94  Aligned_cols=181  Identities=26%  Similarity=0.314  Sum_probs=148.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      |.+..+|+.||||++...............|+..+.++ +|+||+++++++.+.     ...++|||+++++|.+.+.. 
T Consensus        76 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~  150 (311)
T 3p1a_A           76 VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAW  150 (311)
T ss_dssp             EEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHH
T ss_pred             EEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhc
Confidence            46778999999999866544445555556666666555 999999999999877     56789999999898888764 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..++.++.|++.||+|||+++++||||||+||+++.++.++|+|||++......  .......||+.|+|||++
T Consensus       151 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~  228 (311)
T 3p1a_A          151 GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAGEVQEGDPRYMAPELL  228 (311)
T ss_dssp             CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--------CCCCCGGGCCGGGG
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CCCcccCCCccccCHhHh
Confidence            456999999999999999999999999999999999999999999999999998754332  223344679999999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+  .++.++|+||||+++|+|++|..|+.+.
T Consensus       229 ~~--~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          229 QG--SYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             GT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             cC--CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            76  4899999999999999999996665543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-38  Score=237.72  Aligned_cols=187  Identities=22%  Similarity=0.409  Sum_probs=157.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      .++..|++|+++...   ...+.+.+|++++++++||||+++++++.+.     ...+++|||+. ++|.+++.. ...+
T Consensus        46 ~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  117 (283)
T 3gen_A           46 RGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRF  117 (283)
T ss_dssp             TTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCC
T ss_pred             cCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCC
Confidence            367789999996432   2335688999999999999999999999877     55789999997 589988876 5679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...............+++.|+|||.+.+ .
T Consensus       118 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  196 (283)
T 3gen_A          118 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S  196 (283)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhcc-C
Confidence            999999999999999999999999999999999999999999999999997554332233334455778999999887 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |+.||......+....+.
T Consensus       197 ~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~  235 (283)
T 3gen_A          197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA  235 (283)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh
Confidence            58999999999999999998 999999988777766554

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.2e-38  Score=240.23  Aligned_cols=189  Identities=31%  Similarity=0.481  Sum_probs=158.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.|++|+++...  ....+.+.+|+.++++++||||+++++++.+.     ...+++|||+. ++|.+.+...
T Consensus        28 ~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  100 (304)
T 2jam_A           28 VKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILER  100 (304)
T ss_dssp             EEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHc
Confidence            4567899999999996432  22345688999999999999999999999877     56789999997 5898888877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..+..++.|++.+|++||++|++|+||+|+||++   +.++.++++|||.+.....   .......+++.|+|||
T Consensus       101 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~y~aPE  177 (304)
T 2jam_A          101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYVAPE  177 (304)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---BTTHHHHSCCCBCCTT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---CccccccCCCCccChH
Confidence            889999999999999999999999999999999999999   6788999999999864322   2223446789999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.+....+....|.
T Consensus       178 ~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  220 (304)
T 2jam_A          178 VLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK  220 (304)
T ss_dssp             TBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             Hhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9987 558999999999999999999999999888777665553

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.6e-39  Score=236.65  Aligned_cols=186  Identities=22%  Similarity=0.388  Sum_probs=156.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~   83 (203)
                      .++..||+|+++...   ...+.+.+|++++++++||||+++++++.++     ...+++|||++ ++|.+++... ..+
T Consensus        30 ~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  101 (268)
T 3sxs_A           30 KGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGL  101 (268)
T ss_dssp             TTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGC
T ss_pred             cCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCC
Confidence            357789999996432   2345688999999999999999999999877     55789999997 5788887754 459


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...............+++.|+|||.+.+ .
T Consensus       102 ~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  180 (268)
T 3sxs_A          102 EPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY-F  180 (268)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH-S
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc-c
Confidence            999999999999999999999999999999999999999999999999997654443333344455778999999877 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|+|++ |+.||......+....+
T Consensus       181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  218 (268)
T 3sxs_A          181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV  218 (268)
T ss_dssp             EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH
Confidence            47899999999999999998 99999988877666544

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=244.65  Aligned_cols=189  Identities=28%  Similarity=0.460  Sum_probs=158.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC---
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP---   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---   80 (203)
                      .++..||||+++.. ........+.+|+++++++ +||||+++++++.++     ...++||||+.+ +|.+++...   
T Consensus        99 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~  172 (382)
T 3tt0_A           99 NRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPP  172 (382)
T ss_dssp             TCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCS
T ss_pred             ccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhccc
Confidence            45578999999654 3344557788999999999 999999999999887     557899999975 999888643   


Q ss_pred             -------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         81 -------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        81 -------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                   ..+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+........ .....
T Consensus       173 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~  252 (382)
T 3tt0_A          173 GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN  252 (382)
T ss_dssp             SSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTT
T ss_pred             ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccC
Confidence                         3599999999999999999999999999999999999999999999999999975443222 23334


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+....+.
T Consensus       253 ~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~  307 (382)
T 3tt0_A          253 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  307 (382)
T ss_dssp             CCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            455788999999987 558999999999999999999 999999988777766553

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.7e-38  Score=245.12  Aligned_cols=192  Identities=24%  Similarity=0.443  Sum_probs=160.5

Q ss_pred             CcCCCCCcEEEEEeccCccc------hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ------SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l   73 (203)
                      |++..+|+.||||+++....      .....+.+.+|+.+++++ +||||+++++++...     ...++||||+.+ +|
T Consensus       113 a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L  187 (365)
T 2y7j_A          113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS-----SFMFLVFDLMRKGEL  187 (365)
T ss_dssp             EEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-----SEEEEEECCCTTCBH
T ss_pred             EEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-----CEEEEEEEeCCCCcH
Confidence            45678899999999854321      112245677899999999 899999999999877     567899999985 89


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .+++.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++++|||++......  .......|++.|
T Consensus       188 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~--~~~~~~~gt~~y  265 (365)
T 2y7j_A          188 FDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGY  265 (365)
T ss_dssp             HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGGG
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC--cccccCCCCCCc
Confidence            998887778999999999999999999999999999999999999999999999999998754432  223445789999


Q ss_pred             ccceeeecc-----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        154 RAPEILMGA-----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       154 ~aPe~~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      +|||++.+.     ..++.++|+||||+++|+|++|+.||.+......+..+
T Consensus       266 ~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i  317 (365)
T 2y7j_A          266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI  317 (365)
T ss_dssp             CCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999988642     24788999999999999999999999988776666554

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-39  Score=247.48  Aligned_cols=191  Identities=23%  Similarity=0.373  Sum_probs=155.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+++.||||+++.. ........+.+|+.++++++||||+++++++.+.     ...++||||+. ++|.+++...  
T Consensus        97 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~  170 (367)
T 3l9p_A           97 NDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRP  170 (367)
T ss_dssp             ---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSC
T ss_pred             CCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhcc
Confidence            4568889999999653 2334455788899999999999999999999887     45679999996 5898887642  


Q ss_pred             -----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCC-CCCCCcccccCCc
Q psy16889         81 -----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEP-DPNKAMTQEVVTQ  151 (203)
Q Consensus        81 -----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~-~~~~~~~~~~~~~  151 (203)
                           ..+++.+++.++.|++.||+|||++|++||||||+||+++.++   .++|+|||++..... ..........+++
T Consensus       171 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~  250 (367)
T 3l9p_A          171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV  250 (367)
T ss_dssp             CSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCG
T ss_pred             ccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcc
Confidence                 3599999999999999999999999999999999999999554   599999999863221 1122233446688


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+.+..+.
T Consensus       251 ~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          251 KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             cEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            8999999877 458999999999999999998 999999988887776654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-38  Score=237.93  Aligned_cols=191  Identities=25%  Similarity=0.377  Sum_probs=161.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+++.|++|++..... .......+.+|+++++.++||||+++++++.+.     ...+++|||+. ++|.+.+..
T Consensus        33 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  107 (284)
T 2vgo_A           33 AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQK  107 (284)
T ss_dssp             EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH
T ss_pred             EEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHh
Confidence            45678899999999854322 222346788999999999999999999999887     56789999997 499998887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......   ......+++.|.|||++
T Consensus       108 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~  184 (284)
T 2vgo_A          108 HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMCGTLDYLPPEMI  184 (284)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CBCCCCSCGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---ccccccCCCCcCCHHHh
Confidence            778999999999999999999999999999999999999999999999999988643322   22344678899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ ..++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus       185 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  225 (284)
T 2vgo_A          185 EG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV  225 (284)
T ss_dssp             TT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence            87 457899999999999999999999999887776665543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-38  Score=242.78  Aligned_cols=192  Identities=25%  Similarity=0.374  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++...........+.+|+.+++.+ +||||+++++++.+.     ...++||||+.+ +|.+++..
T Consensus        48 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~  122 (327)
T 3lm5_A           48 CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLP  122 (327)
T ss_dssp             EEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSS
T ss_pred             EEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHH
Confidence            46788999999999976555555567888999999999 569999999999877     567899999985 88888754


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                        .+.+++.+++.++.|++.||++||++|++||||||+||+++.   ++.++|+|||.+......  .......+++.|+
T Consensus       123 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~--~~~~~~~gt~~y~  200 (327)
T 3lm5_A          123 ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEYL  200 (327)
T ss_dssp             CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----------CCCGGGC
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc--cccccccCCcCcc
Confidence              367999999999999999999999999999999999999987   789999999999754322  2223346799999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |||++.+ ..++.++|+||||+++|+|++|+.||.+....+....+.
T Consensus       201 aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~  246 (327)
T 3lm5_A          201 APEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS  246 (327)
T ss_dssp             CHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence            9999877 458999999999999999999999999988777665543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=243.39  Aligned_cols=189  Identities=23%  Similarity=0.346  Sum_probs=156.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----   80 (203)
                      .+++.||||+++... .....+.+.+|+.++++++||||+++++++.+.     ...+++|||+.+ +|.+++...    
T Consensus        75 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  148 (343)
T 1luf_A           75 EPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHT  148 (343)
T ss_dssp             SSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC--
T ss_pred             CCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCccc
Confidence            567899999996542 334456788999999999999999999999877     567899999985 898887642    


Q ss_pred             --------------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC
Q psy16889         81 --------------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP  140 (203)
Q Consensus        81 --------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~  140 (203)
                                          +.+++.+++.++.|++.+|++||++|++||||||+||+++.++.++|+|||.+.......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  228 (343)
T 1luf_A          149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD  228 (343)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred             ccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCc
Confidence                                579999999999999999999999999999999999999999999999999987433221


Q ss_pred             C-CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        141 N-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       141 ~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      . .......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+....+....+.
T Consensus       229 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  290 (343)
T 1luf_A          229 YYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR  290 (343)
T ss_dssp             CBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHh
Confidence            1 22233456888999999887 458999999999999999999 999999988777766553

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.6e-39  Score=239.29  Aligned_cols=183  Identities=24%  Similarity=0.386  Sum_probs=141.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh---
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV---   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---   78 (203)
                      |.+..+|+.||+|+++.........+.+.++...++.++||||+++++++.++     ...+++|||++++|.+.+.   
T Consensus        26 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~  100 (290)
T 3fme_A           26 MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVI  100 (290)
T ss_dssp             EEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHH
T ss_pred             EEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHH
Confidence            46778999999999976544544555566666778889999999999999877     4678999999987765543   


Q ss_pred             -CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 -SPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 -~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                       ..+.+++..++.++.|++.||++||++ |++|+||||+||+++.++.++|+|||.+......  .......+++.|+||
T Consensus       101 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aP  178 (290)
T 3fme_A          101 DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD--VAKDIDAGCKPYMAP  178 (290)
T ss_dssp             HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------------CCCCCCSCH
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc--ccccccCCCccccCh
Confidence             467899999999999999999999998 9999999999999999999999999998754332  222333678899999


Q ss_pred             eeee---cccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        157 EILM---GARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       157 e~~~---~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |++.   ....++.++|+||||+++|+|++|+.||...
T Consensus       179 E~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (290)
T 3fme_A          179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW  216 (290)
T ss_dssp             HHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred             hhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence            9973   3355889999999999999999999999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-38  Score=245.08  Aligned_cols=186  Identities=28%  Similarity=0.486  Sum_probs=153.8

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   81 (203)
                      +..+|+.||||+++.. ......+.+.+|+++++++ +||||+++++++.+.+    ...+++|||+.+ +|.+++....
T Consensus        48 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~  122 (359)
T 3vhe_A           48 KTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKR  122 (359)
T ss_dssp             STTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTT
T ss_pred             ccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhcc
Confidence            6778899999999653 2334456788999999999 8899999999988764    236789999984 8988887543


Q ss_pred             C------------------------------------------------------------------CChHHHHHHHHHH
Q psy16889         82 H------------------------------------------------------------------LTSDHIKVFLYQI   95 (203)
Q Consensus        82 ~------------------------------------------------------------------~~~~~~~~~~~qi   95 (203)
                      .                                                                  +++..++.++.|+
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql  202 (359)
T 3vhe_A          123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV  202 (359)
T ss_dssp             TSBCSCC------------------------------------------------------CTTTTCBCHHHHHHHHHHH
T ss_pred             ccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHH
Confidence            2                                                                  8999999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceeeecccCCCcchhHHHH
Q psy16889         96 LRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV  174 (203)
Q Consensus        96 ~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~sl  174 (203)
                      +.||+|||++|++||||||+||+++.++.++|+|||.+....... ........+++.|+|||++.+ ..++.++|+|||
T Consensus       203 ~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~sl  281 (359)
T 3vhe_A          203 AKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSF  281 (359)
T ss_dssp             HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHH
T ss_pred             HHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhH
Confidence            999999999999999999999999999999999999997543322 223344466888999999887 558999999999


Q ss_pred             HHHHHHHHh-CCcccCCCChHH
Q psy16889        175 GCIFAELLG-RRILFQAQSPVQ  195 (203)
Q Consensus       175 G~~l~~ll~-g~~pf~~~~~~~  195 (203)
                      |+++|+|++ |+.||.+....+
T Consensus       282 G~il~ellt~g~~p~~~~~~~~  303 (359)
T 3vhe_A          282 GVLLWEIFSLGASPYPGVKIDE  303 (359)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSH
T ss_pred             HHHHHHHHhcCCCCCCccchhH
Confidence            999999998 999998876433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8e-39  Score=237.95  Aligned_cols=192  Identities=26%  Similarity=0.457  Sum_probs=154.2

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.|+||+++.... .....+.+.+|++.++.++||||+++++++.+.     ...++++|++. ++|.+++..
T Consensus        30 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  104 (276)
T 2h6d_A           30 GEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICK  104 (276)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHH
T ss_pred             EEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhc
Confidence            45677899999999854322 233456788999999999999999999999887     56789999997 599999887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+......  .......+++.|.|||.+
T Consensus       105 ~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~  182 (276)
T 2h6d_A          105 HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVI  182 (276)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---------------CCTGGG
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--cceecccCCccccCHHHH
Confidence            788999999999999999999999999999999999999999999999999998754332  222344678899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+....+.++|+||||+++|+|++|+.||......+..+.+
T Consensus       183 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  223 (276)
T 2h6d_A          183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI  223 (276)
T ss_dssp             TTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            87543468999999999999999999999988776665554

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.9e-39  Score=239.34  Aligned_cols=190  Identities=24%  Similarity=0.364  Sum_probs=161.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.+..+++.|++|++...   ....+.+.+|++++++++||||+++++++.++     ...++|||++. ++|.+++.. 
T Consensus        32 ~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~  103 (288)
T 3kfa_A           32 GVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC  103 (288)
T ss_dssp             EEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHC
T ss_pred             eEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhc
Confidence            456778999999998642   33456788999999999999999999999887     45689999998 599988874 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...............+++.|.|||.
T Consensus       104 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          104 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHH
T ss_pred             ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhh
Confidence             3559999999999999999999999999999999999999999999999999998655444444444456778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++ |..||.+....+....+
T Consensus       184 ~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~  225 (288)
T 3kfa_A          184 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  225 (288)
T ss_dssp             HHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             hcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            987 458999999999999999999 99999987766655444

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.5e-38  Score=238.89  Aligned_cols=181  Identities=18%  Similarity=0.264  Sum_probs=153.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      +.+..+|+.||||+++..    ...+.+.+|++.++.+ +|++++++++++.+.     ...++++||++++|.+++...
T Consensus        29 ~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~   99 (298)
T 1csn_A           29 GTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLC   99 (298)
T ss_dssp             EEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT
T ss_pred             EEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHh
Confidence            456789999999998542    2345678899999999 899999999998776     567899999988999988754


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe-----EEEeecCccccCCCCCC------CCccccc
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI-----LKICDFGLARVEEPDPN------KAMTQEV  148 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~------~~~~~~~  148 (203)
                       ..+++..+..++.|++.||++||++|++||||||+||+++.++.     ++|+|||.+........      .......
T Consensus       100 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  179 (298)
T 1csn_A          100 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS  179 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCC
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCC
Confidence             46999999999999999999999999999999999999987765     99999999975443322      1234456


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       180 gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  222 (298)
T 1csn_A          180 GTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLK  222 (298)
T ss_dssp             SCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             CCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence            8999999999877 558999999999999999999999998843

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-38  Score=260.40  Aligned_cols=191  Identities=23%  Similarity=0.364  Sum_probs=158.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      +..+++.||||+++.........+.+.+|++++++++||||+++++++.++      ..++||||+. ++|.+++...+.
T Consensus       392 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~  465 (635)
T 4fl3_A          392 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNRH  465 (635)
T ss_dssp             CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCTT
T ss_pred             CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEEEccCCCCHHHHHhhCCC
Confidence            456788999999976545555567899999999999999999999998654      2468999998 589999988888


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~  160 (203)
                      +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........  .......+++.|+|||++.
T Consensus       466 l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~  545 (635)
T 4fl3_A          466 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  545 (635)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence            99999999999999999999999999999999999999999999999999975443221  2223334577899999997


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..++.++||||||+++|+|++ |+.||.+.+..+....+.
T Consensus       546 ~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~  586 (635)
T 4fl3_A          546 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  586 (635)
T ss_dssp             H-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             C-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            7 558999999999999999998 999999988877776653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.2e-38  Score=244.21  Aligned_cols=188  Identities=26%  Similarity=0.448  Sum_probs=147.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~   83 (203)
                      .++..||||.++... .....+.+.+|+.++++++||||+++++++.++     ...++||||+. ++|.+++... ..+
T Consensus        71 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~  144 (373)
T 2qol_A           71 KKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQF  144 (373)
T ss_dssp             SCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCS
T ss_pred             CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCC
Confidence            567889999996532 334566788999999999999999999999877     56789999997 5999998764 469


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC--cccccCCcccccceeeec
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~aPe~~~~  161 (203)
                      ++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+..........  .....++..|+|||++.+
T Consensus       145 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  224 (373)
T 2qol_A          145 TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY  224 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc
Confidence            999999999999999999999999999999999999999999999999997544332221  122234667999999887


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                       ..++.++|+||||+++|++++ |+.||.+.+..+....+
T Consensus       225 -~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i  263 (373)
T 2qol_A          225 -RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV  263 (373)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH
T ss_pred             -CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence             558999999999999999997 99999988877766554

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.4e-38  Score=246.24  Aligned_cols=183  Identities=24%  Similarity=0.355  Sum_probs=150.6

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC--CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK--HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      .+. +|+.||||++..........+.+.+|++++++++  ||||+++++++..+     ..+++|||+.+++|.+++...
T Consensus        76 ~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~  149 (390)
T 2zmd_A           76 LNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKK  149 (390)
T ss_dssp             ECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHC
T ss_pred             EcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhc
Confidence            344 4899999999665445556678899999999996  59999999998887     457899997778999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++.++..++.|++.||+|||++|++||||||+||+++ ++.+||+|||++........ .......||+.|+|||++
T Consensus       150 ~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          150 KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHh
Confidence            8899999999999999999999999999999999999995 57999999999975443221 123445789999999998


Q ss_pred             ec----------ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        160 MG----------ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       160 ~~----------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+          ...++.++||||||+++|+|++|+.||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             HCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             hhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            64          1357899999999999999999999998753

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.3e-39  Score=250.11  Aligned_cols=192  Identities=26%  Similarity=0.378  Sum_probs=157.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.||||.++.. ......+.+.+|++++++++||||+++++++.++     ...++||||++ ++|.+++...
T Consensus       133 ~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~  206 (377)
T 3cbl_A          133 GRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTE  206 (377)
T ss_dssp             EEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHH
T ss_pred             EEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhc
Confidence            346678999999998653 2334456788999999999999999999999877     45789999997 5898888754


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCc-ccccCCccccccee
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAM-TQEVVTQYYRAPEI  158 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~aPe~  158 (203)
                       ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........... ....++..|+|||+
T Consensus       207 ~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~  286 (377)
T 3cbl_A          207 GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA  286 (377)
T ss_dssp             GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhH
Confidence             4699999999999999999999999999999999999999999999999999875332211111 12234667999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++ |..||.+.+..+....+
T Consensus       287 ~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~  328 (377)
T 3cbl_A          287 LNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV  328 (377)
T ss_dssp             HHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred             hcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            876 448899999999999999998 99999998877665544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-38  Score=249.52  Aligned_cols=188  Identities=30%  Similarity=0.504  Sum_probs=158.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc------CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF------KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |.+..+|+.||||+++..   ......+.+|+++++.+      +|+||+++++++...     ...++++|+++++|.+
T Consensus       116 a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~  187 (429)
T 3kvw_A          116 AYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-----NHICMTFELLSMNLYE  187 (429)
T ss_dssp             EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-----TEEEEEECCCCCBHHH
T ss_pred             EEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-----CeEEEEEeccCCCHHH
Confidence            467889999999999653   22334566777777776      577999999999877     5678999999999998


Q ss_pred             HHhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe--EEEeecCccccCCCCCCCCcccccCCc
Q psy16889         76 IIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--LKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        76 ~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      .+...  ..+++..++.++.|++.||+|||+++++||||||+||+++.++.  ++|+|||++.....    ......+|+
T Consensus       188 ~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~----~~~~~~gt~  263 (429)
T 3kvw_A          188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQSR  263 (429)
T ss_dssp             HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC----CCCSSCSCG
T ss_pred             HHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC----cccccCCCC
Confidence            87754  45999999999999999999999999999999999999998887  99999999874332    223446789


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..|.+
T Consensus       264 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~  313 (429)
T 3kvw_A          264 FYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE  313 (429)
T ss_dssp             GGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999987 4589999999999999999999999999998888877653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-39  Score=246.47  Aligned_cols=195  Identities=25%  Similarity=0.373  Sum_probs=155.3

Q ss_pred             CcCCCCCcEEEEEeccCccc---hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ---SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      |.+..+++.||+|++.....   .....+.+.+|++++++++||||+++++++.+.     ...++||||+. ++|.+.+
T Consensus        45 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l  119 (345)
T 3hko_A           45 AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-----QYICLVMELCHGGHLLDKL  119 (345)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHE
T ss_pred             EEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-----CeEEEEEeCCCCCcHHHHH
Confidence            46788999999999854321   334567888999999999999999999999887     56789999997 5888877


Q ss_pred             hC----------------------------------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy16889         78 VS----------------------------------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL  117 (203)
Q Consensus        78 ~~----------------------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~ni  117 (203)
                      ..                                        ...+++..++.++.|++.+|++||+++++|+||||+||
T Consensus       120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  199 (345)
T 3hko_A          120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF  199 (345)
T ss_dssp             EEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhE
Confidence            41                                        11246788999999999999999999999999999999


Q ss_pred             EecCCC--eEEEeecCccccCCCC---CCCCcccccCCcccccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        118 LVNSNC--ILKICDFGLARVEEPD---PNKAMTQEVVTQYYRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       118 l~~~~~--~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +++.++  .++|+|||.+......   .........+++.|+|||++.+. ..++.++|+||||+++|+|++|+.||.+.
T Consensus       200 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  279 (345)
T 3hko_A          200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV  279 (345)
T ss_dssp             EESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            998766  8999999998743321   11223455789999999998642 45789999999999999999999999998


Q ss_pred             ChHHHhhhhh
Q psy16889        192 SPVQQLGLIT  201 (203)
Q Consensus       192 ~~~~~~~~i~  201 (203)
                      +..+...++.
T Consensus       280 ~~~~~~~~~~  289 (345)
T 3hko_A          280 NDADTISQVL  289 (345)
T ss_dssp             SHHHHHHHHH
T ss_pred             ChHHHHHHHH
Confidence            8777766553

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.8e-38  Score=253.78  Aligned_cols=190  Identities=24%  Similarity=0.360  Sum_probs=159.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      +.++.++..||||.++..   ....+.+.+|++++++++||||+++++++.+.     ...++||||+. ++|.+++.. 
T Consensus       239 ~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~  310 (495)
T 1opk_A          239 GVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC  310 (495)
T ss_dssp             EEEGGGTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHS
T ss_pred             EEEcCCCeEEEEEEecCc---ccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhc
Confidence            345667899999999643   22456789999999999999999999999877     56789999998 599998874 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++...............++..|+|||+
T Consensus       311 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~  390 (495)
T 1opk_A          311 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  390 (495)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHH
T ss_pred             CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhH
Confidence             3569999999999999999999999999999999999999999999999999998654333333334445678999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++|+||||+++|+|++ |..||.+.+..+..+.+
T Consensus       391 ~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~  432 (495)
T 1opk_A          391 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  432 (495)
T ss_dssp             HHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             Hhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            877 458999999999999999999 99999988776665544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=242.77  Aligned_cols=181  Identities=25%  Similarity=0.368  Sum_probs=149.4

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC--CCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH--DNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   83 (203)
                      .+++.||||+++.........+.+.+|+.++++++|  +||+++++++.++     ...++|||+.+++|.+++...+.+
T Consensus        31 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~  105 (343)
T 3dbq_A           31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSI  105 (343)
T ss_dssp             TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCC
T ss_pred             CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCC
Confidence            468899999997654555566788999999999976  9999999999887     567899998888999999988899


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceeeec-
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEILMG-  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~-  161 (203)
                      ++.++..++.|++.||+|||++|++||||||+||+++ ++.++|+|||++......... ......||+.|+|||++.+ 
T Consensus       106 ~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  184 (343)
T 3dbq_A          106 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  184 (343)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhc
Confidence            9999999999999999999999999999999999997 578999999999754432221 2334578999999999854 


Q ss_pred             ---------ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        162 ---------ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       162 ---------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                               ...++.++||||||+++|+|++|+.||....
T Consensus       185 ~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             C-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence                     2457889999999999999999999998743

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-38  Score=237.75  Aligned_cols=191  Identities=22%  Similarity=0.355  Sum_probs=156.4

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      .+..+++.|+||+++.........+.+.+|+++++.++||||+++++++..+      ..++++|++. ++|.+++...+
T Consensus        39 ~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~  112 (291)
T 1xbb_A           39 QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNR  112 (291)
T ss_dssp             ECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCT
T ss_pred             cCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCC------CcEEEEEeCCCCCHHHHHHhCc
Confidence            3467789999999976544555567899999999999999999999998433      4568999998 58999988878


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+.........  ......+++.|.|||.+
T Consensus       113 ~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  192 (291)
T 1xbb_A          113 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI  192 (291)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHh
Confidence            8999999999999999999999999999999999999999999999999998754433221  12223446789999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+
T Consensus       193 ~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~  233 (291)
T 1xbb_A          193 NY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML  233 (291)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             cc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            76 447889999999999999999 99999998877666554

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-38  Score=246.28  Aligned_cols=190  Identities=33%  Similarity=0.528  Sum_probs=151.7

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhHHhHHHHHh---
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQSDLHKIIV---   78 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~---   78 (203)
                      .+..+++ +++|.+....      ....+|+++++.++||||+++++++..... ....+.++||||+++++.+.+.   
T Consensus        60 ~~~~~~~-~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~  132 (394)
T 4e7w_A           60 KLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA  132 (394)
T ss_dssp             EETTTEE-EEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHH
T ss_pred             EECCCCe-EEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHH
Confidence            3445555 7888774321      122369999999999999999999854322 1113467999999976554433   


Q ss_pred             -CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 -SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 -~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                       ..+.+++..++.++.|++.||+|||++|++||||||+||+++ .++.+||+|||.+......  .......+++.|+||
T Consensus       133 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~--~~~~~~~~t~~y~aP  210 (394)
T 4e7w_A          133 KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG--EPNVSYICSRYYRAP  210 (394)
T ss_dssp             HTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSSCSCGGGCCH
T ss_pred             hhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC--CCCcccccCcCccCH
Confidence             467899999999999999999999999999999999999999 7899999999999754322  223344678999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |++.+...++.++|+|||||++|+|++|++||.+.+..+.+..|.
T Consensus       211 E~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~  255 (394)
T 4e7w_A          211 ELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEII  255 (394)
T ss_dssp             HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999876668999999999999999999999999999888777664

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=244.92  Aligned_cols=177  Identities=16%  Similarity=0.229  Sum_probs=146.1

Q ss_pred             cCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC---CCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          3 TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK---HDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         3 ~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      .+..+++.||||++...     ....+..|.+.++.++   |+||+++++++..+     ...++||||+. |+|.+++.
T Consensus        90 ~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~  159 (365)
T 3e7e_A           90 NDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAIN  159 (365)
T ss_dssp             ----CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHH
T ss_pred             cccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHH
Confidence            36788999999998643     3345667777777775   89999999999877     45679999998 68988876


Q ss_pred             -----CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----------CCeEEEeecCccccCC-CCCC
Q psy16889         79 -----SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-----------NCILKICDFGLARVEE-PDPN  141 (203)
Q Consensus        79 -----~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-----------~~~~~l~d~~~~~~~~-~~~~  141 (203)
                           ....+++..++.++.|++.||+|||++|++||||||+||+++.           ++.++|+|||++.... ....
T Consensus       160 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~  239 (365)
T 3e7e_A          160 LYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG  239 (365)
T ss_dssp             HHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTT
T ss_pred             HhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCC
Confidence                 3567999999999999999999999999999999999999998           8999999999996432 1223


Q ss_pred             CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       142 ~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      .......||+.|+|||++.+ ..++.++|+||||+++|+|++|+.||..
T Consensus       240 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             EEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            34455678999999999987 4589999999999999999999999854

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-39  Score=248.61  Aligned_cols=182  Identities=24%  Similarity=0.357  Sum_probs=152.1

Q ss_pred             CCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          5 PRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      ..+|+.||||+++....  .....+.+.+|+++++.+ +||||+++++++.+.     ...++||||+. ++|.+++...
T Consensus        79 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  153 (355)
T 1vzo_A           79 HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQR  153 (355)
T ss_dssp             TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHH
T ss_pred             CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHc
Confidence            46899999999864321  223445677899999999 799999999999877     56789999998 4999998877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||++...............||+.|+|||++.
T Consensus       154 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence            88999999999999999999999999999999999999999999999999999754433333334457899999999987


Q ss_pred             cc-cCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        161 GA-RHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       161 ~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +. ..++.++|+||||+++|+|++|+.||...
T Consensus       234 ~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             TCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             CCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            53 34688999999999999999999999754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-38  Score=235.67  Aligned_cols=188  Identities=26%  Similarity=0.453  Sum_probs=153.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      |.+..+|+.+++|++.... .....+.+.+|++++++++||||+++++++.+.     ...++||||+.+ +|.+.+.. 
T Consensus        41 ~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  114 (285)
T 3is5_A           41 VEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSA  114 (285)
T ss_dssp             EEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHH
T ss_pred             EEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhh
Confidence            4577899999999986532 333457788999999999999999999999877     567899999984 88777643 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                         ...+++..++.++.|++.||++||++|++|+||||+||+++   .++.++|+|||.+......  .......+++.|
T Consensus       115 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y  192 (285)
T 3is5_A          115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALY  192 (285)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------------CTTGGG
T ss_pred             hhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc--ccCcCcccccCc
Confidence               46799999999999999999999999999999999999994   5678999999999754332  223444678999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      +|||.+.+  .++.++|+||||+++|+|++|+.||.+.+..+....
T Consensus       193 ~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~  236 (285)
T 3is5_A          193 MAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK  236 (285)
T ss_dssp             CCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence            99998764  478999999999999999999999998876665544

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.1e-38  Score=235.58  Aligned_cols=186  Identities=27%  Similarity=0.399  Sum_probs=156.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.+..+|+.|++|++.... .....+.+.+|+.+++.++||||+++++++.++     ...++++||+++ +|.+++...
T Consensus        26 ~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~   99 (276)
T 2yex_A           26 AVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPD   99 (276)
T ss_dssp             EEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTT
T ss_pred             EEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhc
Confidence            4567899999999985432 223456788999999999999999999999877     566799999985 899988887


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..+..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+....... ........+++.|.|||.+
T Consensus       100 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  179 (276)
T 2yex_A          100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL  179 (276)
T ss_dssp             TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHH
Confidence            889999999999999999999999999999999999999999999999999987433221 1223344678899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+....+.++|+||||+++|+|++|+.||.....
T Consensus       180 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             TCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             hcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence            8755457789999999999999999999987553

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.9e-38  Score=240.19  Aligned_cols=184  Identities=27%  Similarity=0.433  Sum_probs=150.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||++...  .....+.+.+|+++++++ +||||+++++++.++     ...++||||+. ++|.+++..
T Consensus        32 ~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  104 (316)
T 2ac3_A           32 CINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHK  104 (316)
T ss_dssp             EECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhc
Confidence            567889999999999643  233456788999999985 899999999999887     56789999998 599999887


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe---EEEeecCccccCCCCC------CCCcccccCC
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLARVEEPDP------NKAMTQEVVT  150 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~------~~~~~~~~~~  150 (203)
                      .+.+++.++..++.|++.||++||++|++||||||+||+++.++.   ++|+|||.+.......      ........|+
T Consensus       105 ~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt  184 (316)
T 2ac3_A          105 RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS  184 (316)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCS
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCC
Confidence            788999999999999999999999999999999999999997765   9999999986433211      1122234579


Q ss_pred             cccccceeeec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        151 QYYRAPEILMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       151 ~~~~aPe~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +.|+|||++.+    ...++.++|+||||+++|+|++|+.||.+..
T Consensus       185 ~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             GGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             cCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence            99999999864    1347889999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.5e-38  Score=241.64  Aligned_cols=195  Identities=34%  Similarity=0.557  Sum_probs=158.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc--hhHHHHHHHhhhHHhHHHHH--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD--FFQEIYVITELLQSDLHKII--   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--~~~~~~lv~e~~~~~l~~~~--   77 (203)
                      +.+..+|+.||||++...   ........++++.++.++||||+++++++......  ...+.+++|||+++++...+  
T Consensus        42 ~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~  118 (360)
T 3e3p_A           42 GKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN  118 (360)
T ss_dssp             EEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHH
Confidence            457789999999988432   23344567788888999999999999998553211  11236789999998665443  


Q ss_pred             --hCCCCCChHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         78 --VSPQHLTSDHIKVFLYQILRGLKYLH--SARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        78 --~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                        .....+++..+..++.|++.+|.+||  ++|++||||||+||+++. ++.++|+|||.+......  .......+++.
T Consensus       119 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~  196 (360)
T 3e3p_A          119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS--EPNVAYICSRY  196 (360)
T ss_dssp             HHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT--SCCCSTTSCGG
T ss_pred             HhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC--CCcccccCCcc
Confidence              35678999999999999999999999  999999999999999996 899999999999754432  22334467899


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |+|||++.+...++.++|+||||+++|+|++|+.||.+.+..+.+..+.
T Consensus       197 y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  245 (360)
T 3e3p_A          197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV  245 (360)
T ss_dssp             GCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence            9999998776668999999999999999999999999998888777664

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5e-38  Score=236.75  Aligned_cols=196  Identities=27%  Similarity=0.421  Sum_probs=158.9

Q ss_pred             CcCCCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~   79 (203)
                      |.+..+|+.|++|+++....  .....+.+.+|++++++++||||+++++++.+...   ...+++|||+.+++.+.+..
T Consensus        24 ~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~  100 (305)
T 2wtk_C           24 VLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDS  100 (305)
T ss_dssp             EEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHH
T ss_pred             EEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC---CeEEEEehhccCCHHHHHHh
Confidence            56788999999999964322  12345678899999999999999999999854322   45689999999877776653


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccc
Q psy16889         80 --PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        80 --~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aP  156 (203)
                        .+.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++++|||.+...... .........+++.|.||
T Consensus       101 ~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  180 (305)
T 2wtk_C          101 VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP  180 (305)
T ss_dssp             STTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCH
T ss_pred             CcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcCh
Confidence              467999999999999999999999999999999999999999999999999999754332 12223345678999999


Q ss_pred             eeeeccc-CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        157 EILMGAR-HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       157 e~~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |++.+.. .++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       181 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  225 (305)
T 2wtk_C          181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI  225 (305)
T ss_dssp             HHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             hhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH
Confidence            9887632 2477999999999999999999999988877666554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.9e-38  Score=240.09  Aligned_cols=196  Identities=39%  Similarity=0.638  Sum_probs=157.5

Q ss_pred             cCC-CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          3 TDP-RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         3 ~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      .+. .+|+.||+|+++...........+.+|+.+++.+   +||||+++++++...........++++|+++++|.+++.
T Consensus        31 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~  110 (326)
T 1blx_A           31 RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD  110 (326)
T ss_dssp             EETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHH
T ss_pred             EecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHH
Confidence            443 6789999999965433333344566777777766   899999999988622111114678999999999998887


Q ss_pred             CC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 SP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      ..  +.+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......  .......+++.|+||
T Consensus       111 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aP  188 (326)
T 1blx_A          111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP  188 (326)
T ss_dssp             HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCH
T ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC--CCccccccccceeCH
Confidence            53  45999999999999999999999999999999999999999999999999998754321  223345678899999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |++.+ ..++.++|+||||+++|+|++|+.||.+....+.+..|.
T Consensus       189 E~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (326)
T 1blx_A          189 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  232 (326)
T ss_dssp             HHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            99887 458999999999999999999999999988877776654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.3e-38  Score=232.41  Aligned_cols=186  Identities=22%  Similarity=0.403  Sum_probs=156.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~   84 (203)
                      +++.|++|++.....   ..+.+.+|++++++++||||+++++++.++     ...+++||+++ ++|.+++.. .+.++
T Consensus        31 ~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~  102 (267)
T 3t9t_A           31 NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFA  102 (267)
T ss_dssp             TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCC
T ss_pred             CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCC
Confidence            678899999965322   335788999999999999999999999887     46789999997 589888875 36799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+...............++..|.|||++.+ ..
T Consensus       103 ~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  181 (267)
T 3t9t_A          103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR  181 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcC-CC
Confidence            99999999999999999999999999999999999999999999999987544322222334455778999999876 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++|+||||+++|+|++ |+.||......+....+.
T Consensus       182 ~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~  219 (267)
T 3t9t_A          182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  219 (267)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh
Confidence            8999999999999999999 899999988777666553

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.5e-38  Score=235.44  Aligned_cols=192  Identities=23%  Similarity=0.389  Sum_probs=160.3

Q ss_pred             CcCCCCCcEEEEEeccCccc-------hhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-Hh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-------SLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   72 (203)
                      |.+..+|+.||||+++....       .....+.+.+|+++++++. ||||+++++++.++     ...++++||+. ++
T Consensus        36 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~  110 (298)
T 1phk_A           36 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGE  110 (298)
T ss_dssp             EEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCB
T ss_pred             EEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC-----CeEEEEEeccCCCc
Confidence            46778999999999854321       1223456788999999995 99999999999877     56789999998 59


Q ss_pred             HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         73 LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        73 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      |.+++.....+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+......  .......+++.
T Consensus       111 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~  188 (298)
T 1phk_A          111 LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPS  188 (298)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGG
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC--cccccccCCcc
Confidence            9999887788999999999999999999999999999999999999999999999999998754332  22334467889


Q ss_pred             cccceeeec-----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        153 YRAPEILMG-----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       153 ~~aPe~~~~-----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      |.|||++.+     ...++.++|+||||+++|+|++|+.||...+..+....+
T Consensus       189 y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  241 (298)
T 1phk_A          189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI  241 (298)
T ss_dssp             GCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence            999998852     244788999999999999999999999888776665544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.7e-38  Score=234.79  Aligned_cols=181  Identities=21%  Similarity=0.317  Sum_probs=152.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.|++|+++...........+.+|+..+..+ +||||+++++++.++     ...+++|||+++ +|.+++..
T Consensus        30 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  104 (289)
T 1x8b_A           30 CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISE  104 (289)
T ss_dssp             EEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH
T ss_pred             EEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHh
Confidence            46778999999999976555555667788999999999 999999999999877     567899999975 99888765


Q ss_pred             C----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-------------------CeEEEeecCccccC
Q psy16889         80 P----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-------------------CILKICDFGLARVE  136 (203)
Q Consensus        80 ~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-------------------~~~~l~d~~~~~~~  136 (203)
                      .    +.+++.+++.++.|++.||++||++|++|+||||+||+++.+                   ..++++|||.+...
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~  184 (289)
T 1x8b_A          105 NYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI  184 (289)
T ss_dssp             HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEET
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccccccccc
Confidence            3    679999999999999999999999999999999999999844                   47899999998754


Q ss_pred             CCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        137 EPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       137 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ....     ...+++.|+|||++.+...++.++|+||||+++|+|++|.+|+....
T Consensus       185 ~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          185 SSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             TCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             CCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence            4322     23478899999999875566789999999999999999998876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6e-38  Score=237.06  Aligned_cols=185  Identities=29%  Similarity=0.430  Sum_probs=154.7

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~   81 (203)
                      +..+++.|++|+++... .....+.+.+|+.+++++ +||||+++++++.++     ...+++|||+.+ +|.+++....
T Consensus        49 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~  122 (313)
T 1t46_A           49 KSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKR  122 (313)
T ss_dssp             STTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTT
T ss_pred             ccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcc
Confidence            56788999999996542 233457788999999999 999999999999887     456899999975 9988876432


Q ss_pred             ------------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-
Q psy16889         82 ------------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-  142 (203)
Q Consensus        82 ------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  142 (203)
                                        .+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+......... 
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  202 (313)
T 1t46_A          123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV  202 (313)
T ss_dssp             TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE
T ss_pred             cccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccce
Confidence                              4899999999999999999999999999999999999999999999999999755433222 


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHH
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQ  195 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~  195 (203)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.....
T Consensus       203 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          203 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             eccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            2223345778999999877 458999999999999999998 999998866433

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-38  Score=240.74  Aligned_cols=185  Identities=29%  Similarity=0.433  Sum_probs=151.1

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-   81 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-   81 (203)
                      ..+++.||+|+++.. ......+.+.+|+.+++++ +||||+++++++.+.     ...+++|||+. ++|.+++.... 
T Consensus        72 ~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~  145 (344)
T 1rjb_A           72 TGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKRE  145 (344)
T ss_dssp             SSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTT
T ss_pred             CCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccc
Confidence            457788999999643 2334567889999999999 999999999999887     56789999997 49999887542 


Q ss_pred             ----------------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC
Q psy16889         82 ----------------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD  139 (203)
Q Consensus        82 ----------------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~  139 (203)
                                            .+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+......
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~  225 (344)
T 1rjb_A          146 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD  225 (344)
T ss_dssp             CC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGC
T ss_pred             cccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccC
Confidence                                  3799999999999999999999999999999999999999999999999999754332


Q ss_pred             CC-CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHH
Q psy16889        140 PN-KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQ  196 (203)
Q Consensus       140 ~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~  196 (203)
                      .. .......+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+......
T Consensus       226 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  283 (344)
T 1rjb_A          226 SNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  283 (344)
T ss_dssp             TTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             ccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence            22 12233455778999999877 558999999999999999998 9999988764433

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.3e-38  Score=236.06  Aligned_cols=190  Identities=29%  Similarity=0.546  Sum_probs=160.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.+..+|+.|++|++..........+.+.+|++++++++||||+++++++.+.     ...++++|++. ++|.+.+...
T Consensus        41 ~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  115 (287)
T 2wei_A           41 CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKR  115 (287)
T ss_dssp             EEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHH
T ss_pred             EEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhc
Confidence            45678999999999966545555667889999999999999999999999877     46779999997 5888888777


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC---CeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN---CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..++.++.|++.+|++||++|++|+||+|+||+++.+   +.++|+|||.+......  .......+++.|.|||
T Consensus       116 ~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE  193 (287)
T 2wei_A          116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE  193 (287)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--SSCSCHHHHHTTCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--CccccccCcccccChH
Confidence            789999999999999999999999999999999999999754   47999999998754332  2223335688899999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+.+  .++.++|+||||+++|+|++|+.||.+.+..+.+..+
T Consensus       194 ~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~  234 (287)
T 2wei_A          194 VLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV  234 (287)
T ss_dssp             HHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             HhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8876  3789999999999999999999999998877766654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.2e-38  Score=234.17  Aligned_cols=186  Identities=24%  Similarity=0.352  Sum_probs=157.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..++..|++|.+.....+....+.+.+|+.++++++||||+++++++....... ...++||||++ ++|.+++...
T Consensus        45 ~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  123 (290)
T 1t4h_A           45 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRF  123 (290)
T ss_dssp             EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC-EEEEEEEECCCSCBHHHHHHHH
T ss_pred             eEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC-ceEEEEEEecCCCCHHHHHHHc
Confidence            467789999999999765556666788999999999999999999999876532110 45689999997 5999998877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++..++.++.|++.+|++||+++  ++|+||+|+||+++ .++.++|+|||.+......   ......+++.|+|||
T Consensus       124 ~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE  200 (290)
T 1t4h_A          124 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMAPE  200 (290)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT---SBEESCSSCCCCCGG
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc---ccccccCCcCcCCHH
Confidence            88999999999999999999999999  99999999999998 7889999999999643322   223446789999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      ++.+  .++.++|+||||+++|+|++|+.||.+...
T Consensus       201 ~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  234 (290)
T 1t4h_A          201 MYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQN  234 (290)
T ss_dssp             GGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS
T ss_pred             HHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCc
Confidence            8865  379999999999999999999999987543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.2e-38  Score=238.99  Aligned_cols=180  Identities=27%  Similarity=0.412  Sum_probs=151.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      .+|+.||||.+...  .....+.+.+|+++++.++||||+++++++.+.     ...+++|||+. ++|.+++...    
T Consensus        61 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  133 (321)
T 2qkw_B           61 RDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPT  133 (321)
T ss_dssp             TTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCS
T ss_pred             CCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCc
Confidence            46899999998653  334566788999999999999999999999877     56789999998 4888887643    


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~  159 (203)
                      ..+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+....... ........|++.|+|||++
T Consensus       134 ~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  213 (321)
T 2qkw_B          134 MSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF  213 (321)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHh
Confidence            259999999999999999999999999999999999999999999999999987533222 2222334578899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.+..+
T Consensus       214 ~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~  246 (321)
T 2qkw_B          214 IK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLP  246 (321)
T ss_dssp             HH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred             cC-CCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence            77 4589999999999999999999999976543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5e-39  Score=239.38  Aligned_cols=194  Identities=28%  Similarity=0.443  Sum_probs=158.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+|+.|++|.+.....+....+.+.+|++++++++||||+++++++.+...   ...+++|||+++ +|.+++.. 
T Consensus        25 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~  101 (279)
T 2w5a_A           25 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKG  101 (279)
T ss_dssp             EEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG---TEEEEEEECCTTEEHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC---ceEEEEEeCCCCCCHHHHHHhh
Confidence            4577899999999997654555667789999999999999999999998754321   456899999975 88887753 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSAR-----ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                         ...+++..++.++.|++.+|++||+++     ++|+||+|+||+++.++.++|+|||.+....... .......+++
T Consensus       102 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~  180 (279)
T 2w5a_A          102 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKTFVGTP  180 (279)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C-HHHHHHHSCC
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc-ccccccCCCc
Confidence               345999999999999999999999999     9999999999999999999999999987543221 1122346788


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+
T Consensus       181 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          181 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             TTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence            9999999887 45899999999999999999999999998877666554

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=9.8e-38  Score=235.10  Aligned_cols=190  Identities=26%  Similarity=0.376  Sum_probs=159.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.|++|++.... .....+.+.+|+.+++.++||||+++++++.++     ...+++|||+++ +|.+++.. 
T Consensus        41 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-  113 (303)
T 3a7i_A           41 GIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-  113 (303)
T ss_dssp             EEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-
T ss_pred             EEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-
Confidence            4567899999999996432 233457788999999999999999999999877     567899999985 88887654 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|.|||++.
T Consensus       114 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~  192 (303)
T 3a7i_A          114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIK  192 (303)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCCCCSCGGGCCHHHHT
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCccCCCcCccCHHHHh
Confidence            679999999999999999999999999999999999999999999999999987543322 2223446788999999997


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++|+.||...........+
T Consensus       193 ~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  231 (303)
T 3a7i_A          193 Q-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI  231 (303)
T ss_dssp             T-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             c-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh
Confidence            7 45789999999999999999999999987776655443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.4e-38  Score=246.09  Aligned_cols=180  Identities=29%  Similarity=0.471  Sum_probs=142.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHh-hcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      ++++.+|+.||||++..       ...+.+|++++. ..+||||+++++++.....+ ...+|+||||+. |+|.+++..
T Consensus        81 ~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~-~~~~~lv~E~~~gg~L~~~l~~  152 (400)
T 1nxk_A           81 IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAG-RKCLLIVMECLDGGELFSRIQD  152 (400)
T ss_dssp             EEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT-EEEEEEEEECCCSEEHHHHHHC
T ss_pred             EEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccC-CcEEEEEEEeCCCCcHHHHHHH
Confidence            56788999999999853       234667888764 45999999999988641100 045789999997 599999886


Q ss_pred             CC--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 PQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 ~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .+  .+++.++..++.|++.||+|||++|++||||||+||+++.   ++.+||+|||++.....  ........||+.|+
T Consensus       153 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~--~~~~~~~~gt~~y~  230 (400)
T 1nxk_A          153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYV  230 (400)
T ss_dssp             C---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-------------CTTC
T ss_pred             hCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC--CCccccCCCCCCcc
Confidence            53  5999999999999999999999999999999999999997   78999999999975432  22234557799999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |||++.+ ..++.++||||||+++|+|++|+.||.+..
T Consensus       231 aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          231 APEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             CGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             CHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999876 558999999999999999999999997754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.4e-38  Score=233.13  Aligned_cols=187  Identities=23%  Similarity=0.361  Sum_probs=150.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      .++..|++|.+.... .....+.+.+|+.++++++||||+++++++.++.      .++++|++. ++|.+++.. ...+
T Consensus        38 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~~~  110 (281)
T 3cc6_A           38 GEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSL  110 (281)
T ss_dssp             CCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS------CEEEEECCTTCBHHHHHHHHTTTC
T ss_pred             CCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC------CEEEEecCCCCCHHHHHHhccccC
Confidence            455679999986542 3345677889999999999999999999987652      368999998 588888865 3569


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...............+++.|+|||++.+ .
T Consensus       111 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  189 (281)
T 3cc6_A          111 KVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-R  189 (281)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-C
Confidence            999999999999999999999999999999999999999999999999997554433333344456778999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|+|++ |+.||......+....+
T Consensus       190 ~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~  227 (281)
T 3cc6_A          190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL  227 (281)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH
T ss_pred             CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH
Confidence            58999999999999999998 99999876665555443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.5e-37  Score=237.23  Aligned_cols=188  Identities=28%  Similarity=0.463  Sum_probs=155.2

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC--
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ--   81 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--   81 (203)
                      .+++.||+|+++.. ......+.+.+|+++++++ +||||+++++++.+.     ...++||||+.+ +|.+++....  
T Consensus        65 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  138 (334)
T 2pvf_A           65 KEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPP  138 (334)
T ss_dssp             ---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCT
T ss_pred             ccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccc
Confidence            67889999999653 2334566788999999999 999999999999877     567899999985 9999887543  


Q ss_pred             --------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCccc
Q psy16889         82 --------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQ  146 (203)
Q Consensus        82 --------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  146 (203)
                                    .+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........ .....
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  218 (334)
T 2pvf_A          139 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN  218 (334)
T ss_dssp             TCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSC
T ss_pred             cccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence                          389999999999999999999999999999999999999999999999999975443222 12233


Q ss_pred             ccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        147 EVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..+++.|+|||++.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       219 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  272 (334)
T 2pvf_A          219 GRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  272 (334)
T ss_dssp             CCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence            355778999999876 457899999999999999999 99999988877666544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-38  Score=248.23  Aligned_cols=183  Identities=27%  Similarity=0.494  Sum_probs=144.4

Q ss_pred             CcCCCCCcEEEEEeccCccc------hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ------SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLH   74 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   74 (203)
                      |.+..+|+.||||++.....      .......+.+|++++++++||||+++++++..+      ..++||||+.+ +|.
T Consensus       154 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~lv~e~~~~g~L~  227 (419)
T 3i6u_A          154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE------DYYIVLELMEGGELF  227 (419)
T ss_dssp             EEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS------EEEEEEECCTTCBGG
T ss_pred             EEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC------ceEEEEEcCCCCcHH
Confidence            46788999999999854321      122234578999999999999999999998654      24689999974 898


Q ss_pred             HHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC---eEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         75 KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC---ILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      +.+...+.+++.+++.++.|++.||+|||++|++||||||+||+++.++   .++|+|||.+......  .......|++
T Consensus       228 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~  305 (419)
T 3i6u_A          228 DKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTP  305 (419)
T ss_dssp             GGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-------------C
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC--ccccccCCCC
Confidence            8888888999999999999999999999999999999999999997544   5999999999754322  2234457899


Q ss_pred             ccccceeeec--ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        152 YYRAPEILMG--ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       152 ~~~aPe~~~~--~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .|+|||++.+  ...++.++|+||||+++|+|++|+.||.+..
T Consensus       306 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             TTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             CccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            9999999853  3457889999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.2e-38  Score=248.75  Aligned_cols=185  Identities=25%  Similarity=0.427  Sum_probs=155.0

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~   83 (203)
                      ++..||||.++...   ...+.+.+|++++++++||||+++++++..+      ..++||||+. |+|.+++...  ..+
T Consensus       211 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~  281 (454)
T 1qcf_A          211 KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTKE------PIYIITEFMAKGSLLDFLKSDEGSKQ  281 (454)
T ss_dssp             TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEECCCTTCBHHHHHHSHHHHTC
T ss_pred             CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCC------ccEEEEeecCCCcHHHHHHhccCCCC
Confidence            47789999996432   3467789999999999999999999998643      4679999997 5999998754  368


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++...............++..|+|||++.. .
T Consensus       282 ~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  360 (454)
T 1qcf_A          282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-G  360 (454)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-C
Confidence            999999999999999999999999999999999999999999999999998544322222233345678999999976 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |+.||.+.+..+.+..+.
T Consensus       361 ~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  399 (454)
T 1qcf_A          361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE  399 (454)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            58999999999999999999 999999988877766553

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.8e-38  Score=238.60  Aligned_cols=177  Identities=25%  Similarity=0.342  Sum_probs=149.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----   80 (203)
                      .+|+.||||++..... ......+.+|+++++.++||||+++++++.++     ...+++|||+.+ +|.+++...    
T Consensus        52 ~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  125 (326)
T 3uim_A           52 ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQ  125 (326)
T ss_dssp             SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTC
T ss_pred             cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccC
Confidence            4689999999965422 22334688999999999999999999999877     456789999985 898888754    


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSA---RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      ..+++..+..++.|++.||++||++   |++||||||+||+++.++.++|+|||.+...............|++.|+|||
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (326)
T 3uim_A          126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPE  205 (326)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHH
Confidence            3499999999999999999999999   9999999999999999999999999999865544444444556899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                      ++.+ ..++.++|+||||+++|+|++|+.||.
T Consensus       206 ~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          206 YLST-GKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             HHHH-SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             Hhcc-CCCCccccchhHHHHHHHHHhCCCccc
Confidence            9877 447999999999999999999999995

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-37  Score=237.09  Aligned_cols=187  Identities=25%  Similarity=0.379  Sum_probs=150.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcch-----------------------
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF-----------------------   58 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-----------------------   58 (203)
                      |++..+|+.||||+++... .....+.+.+|++++++++||||+++++++.+.....                       
T Consensus        25 a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  103 (332)
T 3qd2_B           25 AKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS  103 (332)
T ss_dssp             EEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----------------
T ss_pred             EEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCC
Confidence            4677899999999996432 3345677899999999999999999999875543210                       


Q ss_pred             -----------------------------hHHHHHHHhhhHH-hHHHHHhCCCC---CChHHHHHHHHHHHHHHHHHHhC
Q psy16889         59 -----------------------------FQEIYVITELLQS-DLHKIIVSPQH---LTSDHIKVFLYQILRGLKYLHSA  105 (203)
Q Consensus        59 -----------------------------~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lh~~  105 (203)
                                                   ....+++|||+.+ +|.+++.....   .++..++.++.|++.||++||++
T Consensus       104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  183 (332)
T 3qd2_B          104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK  183 (332)
T ss_dssp             ----------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC
Confidence                                         0125789999985 89998876543   56667899999999999999999


Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-----------CCcccccCCcccccceeeecccCCCcchhHHHH
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-----------KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV  174 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-----------~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~sl  174 (203)
                      |++||||||+||+++.++.++|+|||.+........           .......||+.|+|||++.+ ..++.++|+|||
T Consensus       184 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~sl  262 (332)
T 3qd2_B          184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSL  262 (332)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC-CCCCTHHHHHHH
T ss_pred             CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC-CCCcchhhHHHH
Confidence            999999999999999999999999999975443321           22234468999999999987 458999999999


Q ss_pred             HHHHHHHHhCCcccCC
Q psy16889        175 GCIFAELLGRRILFQA  190 (203)
Q Consensus       175 G~~l~~ll~g~~pf~~  190 (203)
                      |+++|+|++|..|+..
T Consensus       263 G~il~el~~~~~~~~~  278 (332)
T 3qd2_B          263 GLILFELLYSFSTQME  278 (332)
T ss_dssp             HHHHHHHHSCCCCHHH
T ss_pred             HHHHHHHHHcCCChhH
Confidence            9999999999887643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=231.84  Aligned_cols=189  Identities=23%  Similarity=0.387  Sum_probs=155.8

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~   81 (203)
                      +..++..|++|+++.. ......+.+.+|++++++++||||+++++++..+      ..++++|++.+ +|.+++.. .+
T Consensus        33 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~  105 (287)
T 1u59_A           33 MRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKRE  105 (287)
T ss_dssp             ---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHTTCTT
T ss_pred             cCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC------CcEEEEEeCCCCCHHHHHHhCCc
Confidence            3457889999999654 2344567788999999999999999999998543      35789999985 89888864 45


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+.........  ......+++.|+|||++
T Consensus       106 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (287)
T 1u59_A          106 EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI  185 (287)
T ss_dssp             TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHh
Confidence            6999999999999999999999999999999999999999999999999999755433221  22333457889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       186 ~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i  226 (287)
T 1u59_A          186 NF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI  226 (287)
T ss_dssp             HH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred             cc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            76 457899999999999999998 99999988777666554

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.2e-38  Score=236.28  Aligned_cols=182  Identities=27%  Similarity=0.429  Sum_probs=147.7

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-C
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-Q   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~   81 (203)
                      +..+|+.||||++...  .....+.+.+|++++++++||||+++++++...+.   ...++||||+. ++|.+++... .
T Consensus        35 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  109 (295)
T 3ugc_A           35 QDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKE  109 (295)
T ss_dssp             CSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGG
T ss_pred             cCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhccc
Confidence            6789999999999653  34455678899999999999999999998765421   23679999997 5999988754 4


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..+..++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+........  .......++..|+|||.+
T Consensus       110 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          110 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHh
Confidence            599999999999999999999999999999999999999999999999999975433221  122333456779999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      .+ ..++.++|+||||+++|+|++|..||...
T Consensus       190 ~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~  220 (295)
T 3ugc_A          190 TE-SKFSVASDVWSFGVVLYELFTYIEKSKSP  220 (295)
T ss_dssp             HH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred             cC-CCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence            87 45899999999999999999999988653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=247.34  Aligned_cols=183  Identities=26%  Similarity=0.457  Sum_probs=151.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |++..+|+.||||+++... .....+.+.+|++++++++||||+++++++.+...   ...++||||+. ++|.+++...
T Consensus        28 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~  103 (396)
T 4eut_A           28 GRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEP  103 (396)
T ss_dssp             EEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEECCCTTEEHHHHTTSG
T ss_pred             EEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---CeeEEEEecCCCCCHHHHHHhh
Confidence            5678899999999996532 23345677899999999999999999999877642   24579999997 5898888754


Q ss_pred             C---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe----cCCCeEEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         81 Q---HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV----NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        81 ~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .   .+++..++.++.|++.||+|||++|++||||||+||++    +.++.++|+|||.+......  .......|++.|
T Consensus       104 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~--~~~~~~~gt~~y  181 (396)
T 4eut_A          104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEY  181 (396)
T ss_dssp             GGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG--GGSSCSSSCCTT
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC--CccccccCCccc
Confidence            3   39999999999999999999999999999999999999    77778999999999754332  223345679999


Q ss_pred             ccceeeecc-------cCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        154 RAPEILMGA-------RHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       154 ~aPe~~~~~-------~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +|||++.+.       ..++.++|+||||+++|+|++|+.||..
T Consensus       182 ~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             CCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred             cCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            999988641       3467899999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.1e-38  Score=238.93  Aligned_cols=190  Identities=20%  Similarity=0.308  Sum_probs=151.9

Q ss_pred             cCCCCCcE----EEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          3 TDPRDGRR----VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         3 ~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      .+..+|+.    |++|.+... ........+.+|+.++++++||||+++++++.++      ..++++||+. ++|.+++
T Consensus        33 ~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~------~~~~v~e~~~~~~L~~~l  105 (325)
T 3kex_A           33 VWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS------SLQLVTQYLPLGSLLDHV  105 (325)
T ss_dssp             EECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS------SEEEEEECCTTCBSHHHH
T ss_pred             EEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC------ccEEEEEeCCCCCHHHHH
Confidence            45556665    777776432 2233445677899999999999999999998654      3568899998 5898888


Q ss_pred             hCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCccccc
Q psy16889         78 VSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~a  155 (203)
                      ... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......... ......++..|+|
T Consensus       106 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~a  185 (325)
T 3kex_A          106 RQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA  185 (325)
T ss_dssp             HSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSC
T ss_pred             HHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccC
Confidence            764 67999999999999999999999999999999999999999999999999999865433222 2334456778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ||++.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       186 PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  230 (325)
T 3kex_A          186 LESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL  230 (325)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH
T ss_pred             hHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence            999987 458999999999999999999 99999987766655544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=234.27  Aligned_cols=185  Identities=25%  Similarity=0.458  Sum_probs=157.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~   79 (203)
                      +.+..+|+.|++|.++..    ...+.+.+|+.+++.++||||+++++++.+.     ...+++|||+++ +|.+++. .
T Consensus        48 ~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~  118 (314)
T 3com_A           48 AIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLR  118 (314)
T ss_dssp             EEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHH
T ss_pred             EEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhc
Confidence            456788999999998542    2456788999999999999999999999876     556899999985 8888876 4


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .......+++.|.|||.+
T Consensus       119 ~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~  197 (314)
T 3com_A          119 NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKRNTVIGTPFWMAPEVI  197 (314)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCBCCCCSCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-cccCccCCCCCccChhhc
Confidence            5679999999999999999999999999999999999999999999999999987543321 223344678899999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+ ..++.++|+||||+++|+|++|+.||.........
T Consensus       198 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  234 (314)
T 3com_A          198 QE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI  234 (314)
T ss_dssp             SS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             CC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            87 45789999999999999999999999887655443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-37  Score=231.53  Aligned_cols=185  Identities=25%  Similarity=0.443  Sum_probs=154.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--C
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--H   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~   82 (203)
                      .+++.|++|.+....   ...+.+.+|++++++++||||+++++++.++      ..+++|||+. ++|.+++....  .
T Consensus        35 ~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~  105 (279)
T 1qpc_A           35 NGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPSGIK  105 (279)
T ss_dssp             TTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHTTSHHHHT
T ss_pred             cCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------CcEEEEecCCCCCHHHHHhcCCCCC
Confidence            356789999986432   2356788999999999999999999998754      3578999997 59998887543  6


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++.++..++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+...............++..|.|||.+.+ 
T Consensus       106 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  184 (279)
T 1qpc_A          106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-  184 (279)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-
Confidence            9999999999999999999999999999999999999999999999999998654433333334455778999999876 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ..++.++|+||||+++|+|++ |+.||.+....+.+..+
T Consensus       185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  223 (279)
T 1qpc_A          185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL  223 (279)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence            457899999999999999999 99999998877766554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.9e-38  Score=237.74  Aligned_cols=190  Identities=26%  Similarity=0.439  Sum_probs=140.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV--   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--   78 (203)
                      +.+..+|+.||||++.... .....+.+.+|+..+++++||||+++++++...     ...+++|||+. ++|.+++.  
T Consensus        34 ~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  107 (303)
T 2vwi_A           34 AYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHI  107 (303)
T ss_dssp             EEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHH
Confidence            4567789999999986432 233456788999999999999999999999887     45678999997 48887765  


Q ss_pred             ------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC----CCCccccc
Q psy16889         79 ------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP----NKAMTQEV  148 (203)
Q Consensus        79 ------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~  148 (203)
                            ..+.+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......    ........
T Consensus       108 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  187 (303)
T 2vwi_A          108 VAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV  187 (303)
T ss_dssp             HHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccC
Confidence                  24569999999999999999999999999999999999999999999999999886443221    11223446


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      +++.|+|||++.+...++.++|+||||+++|+|++|+.||........+
T Consensus       188 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  236 (303)
T 2vwi_A          188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL  236 (303)
T ss_dssp             CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred             CCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH
Confidence            7889999999876455899999999999999999999999886654443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.8e-38  Score=238.37  Aligned_cols=191  Identities=26%  Similarity=0.414  Sum_probs=153.8

Q ss_pred             CcCCCCCcEE--EEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRRV--ALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~--~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      |.+..+|..+  ++|.++.. ......+.+.+|+++++++ +||||+++++++.+.     ...+++|||++ ++|.+++
T Consensus        44 ~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l  117 (327)
T 1fvr_A           44 ARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFL  117 (327)
T ss_dssp             EEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHH
T ss_pred             EEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----CceEEEEecCCCCCHHHHH
Confidence            3456677755  99988643 3334556788999999999 999999999999877     56789999997 4999988


Q ss_pred             hCCC----------------CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC
Q psy16889         78 VSPQ----------------HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        78 ~~~~----------------~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~  141 (203)
                      ...+                .+++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+......  
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~--  195 (327)
T 1fvr_A          118 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--  195 (327)
T ss_dssp             HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE--
T ss_pred             HhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc--
Confidence            7653                7999999999999999999999999999999999999999999999999998732221  


Q ss_pred             CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       142 ~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .......+++.|.|||.+.+ ..++.++|+||||+++|+|++ |+.||.+....+....+.
T Consensus       196 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  255 (327)
T 1fvr_A          196 VKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  255 (327)
T ss_dssp             CCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             ccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence            12233345778999999876 457899999999999999998 999999988777666553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.9e-38  Score=242.62  Aligned_cols=186  Identities=26%  Similarity=0.414  Sum_probs=157.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.||+|++... ......+.+.+|+.++++++||||+++++++.++     ...++||||+.+ +|.+++...
T Consensus        52 ~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  125 (360)
T 3eqc_A           52 VSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKA  125 (360)
T ss_dssp             EEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHH
T ss_pred             EEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHc
Confidence            457789999999999654 2344567788999999999999999999999877     567899999975 999998877


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..+..++.|++.+|++||++ |++|+||||+||+++.++.++|+|||.+.....   .......+++.|+|||++
T Consensus       126 ~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~gt~~y~aPE~~  202 (360)
T 3eqc_A          126 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL  202 (360)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HC----CCCCTTCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc---ccccCCCCCCCeECHHHH
Confidence            8899999999999999999999986 999999999999999999999999998863321   122334678899999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      .+ ..++.++|+||||+++|+|++|+.||......+..
T Consensus       203 ~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  239 (360)
T 3eqc_A          203 QG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE  239 (360)
T ss_dssp             TT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred             cC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            87 45899999999999999999999999987765543

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=237.67  Aligned_cols=192  Identities=27%  Similarity=0.424  Sum_probs=136.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCc---chhHHHHHHHhhhHHhHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHL---DFFQEIYVITELLQSDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~   77 (203)
                      +.+..+|+.||||++...  .......+.+|+..++++. ||||+++++++.....   ......++++||++|+|.+++
T Consensus        47 ~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l  124 (337)
T 3ll6_A           47 AQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL  124 (337)
T ss_dssp             EEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHH
T ss_pred             EEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHH
Confidence            456789999999988432  3344567889999999995 9999999998742211   011346899999999888776


Q ss_pred             h---CCCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC----------
Q psy16889         78 V---SPQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK----------  142 (203)
Q Consensus        78 ~---~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----------  142 (203)
                      .   ..+.+++.+++.++.|++.+|++||+++  ++|+||||+||+++.++.++|+|||.+.........          
T Consensus       125 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  204 (337)
T 3ll6_A          125 KKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV  204 (337)
T ss_dssp             HHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------
T ss_pred             HHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccc
Confidence            5   3567999999999999999999999999  999999999999999999999999999754432211          


Q ss_pred             -CcccccCCcccccceeee--cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        143 -AMTQEVVTQYYRAPEILM--GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       143 -~~~~~~~~~~~~aPe~~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                       ......+++.|+|||++.  ....++.++|+||||+++|+|++|+.||.......
T Consensus       205 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             -------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             hhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence             112345788999999984  23557889999999999999999999998765443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-37  Score=232.08  Aligned_cols=185  Identities=24%  Similarity=0.343  Sum_probs=142.7

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~   84 (203)
                      .+..+++|+++.........+.+.+|++++++++||||++++++...+      ..+++|||+. ++|.+.+.. ...++
T Consensus        45 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~  118 (289)
T 3og7_A           45 WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFE  118 (289)
T ss_dssp             SSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEEECCCEEEHHHHHTTC---CC
T ss_pred             EcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC------ccEEEEEecCCCcHHHHHhhccCCCC
Confidence            345699999976655666778899999999999999999999976543      3578999998 588888854 46799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC-CCCCcccccCCcccccceeeec--
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD-PNKAMTQEVVTQYYRAPEILMG--  161 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~aPe~~~~--  161 (203)
                      +.+++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+...... .........+++.|+|||.+..  
T Consensus       119 ~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  198 (289)
T 3og7_A          119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD  198 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC---
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccC
Confidence            9999999999999999999999999999999999999999999999998744321 1223334467899999998862  


Q ss_pred             ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ...++.++|+||||+++|+|++|+.||.+....+.+
T Consensus       199 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  234 (289)
T 3og7_A          199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  234 (289)
T ss_dssp             -CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH
Confidence            245788999999999999999999999886544433

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-37  Score=235.67  Aligned_cols=184  Identities=24%  Similarity=0.362  Sum_probs=151.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      +.+..+|+.||||+++.. ......+.+.+|++++++++||||+++++++.+.+.   ..++++|||+.+ +|.+++...
T Consensus        54 ~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~  129 (318)
T 3lxp_A           54 PTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASLQLVMEYVPLGSLRDYLPRH  129 (318)
T ss_dssp             SCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT---TEEEEEECCCTTCBHHHHGGGS
T ss_pred             cCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC---ceEEEEEecccCCcHHHHHhhC
Confidence            456779999999999654 334456778899999999999999999999987533   356799999985 888887654


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCccccccee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~  158 (203)
                       .+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+........  .......++..|+|||+
T Consensus       130 -~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~  208 (318)
T 3lxp_A          130 -SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC  208 (318)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHH
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHH
Confidence             499999999999999999999999999999999999999999999999999985543322  12233456778999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       209 ~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          209 LKE-YKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             HHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             hcC-CCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            987 44789999999999999999999999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-37  Score=235.13  Aligned_cols=187  Identities=27%  Similarity=0.440  Sum_probs=150.0

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~   85 (203)
                      +..|++|+++... .......+.+|++++++++||||+++++++.+.     ...++||||+.+ +|.+++.. .+.+++
T Consensus        73 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~  146 (333)
T 1mqb_A           73 EVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSV  146 (333)
T ss_dssp             EEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCH
T ss_pred             cccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCH
Confidence            4569999996532 334456788999999999999999999999876     567899999985 89888864 467999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      .+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.........  ......+++.|+|||++.+ .
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  225 (333)
T 1mqb_A          147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-R  225 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-C
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhccc-C
Confidence            999999999999999999999999999999999999999999999999754432221  1222344678999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |+.||.+.+..+.+..+.
T Consensus       226 ~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~  264 (333)
T 1mqb_A          226 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  264 (333)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence            58999999999999999998 999999888777766553

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-37  Score=237.38  Aligned_cols=190  Identities=25%  Similarity=0.375  Sum_probs=146.7

Q ss_pred             cCCCCCcE----EEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          3 TDPRDGRR----VALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         3 ~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      .+..+|+.    |++|.+... ........+.+|+.++++++||||+++++++.++.      .+++++++. ++|.+++
T Consensus        35 ~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~v~e~~~~g~L~~~l  107 (327)
T 3poz_A           35 LWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYV  107 (327)
T ss_dssp             EECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS------EEEEEECCTTCBHHHHH
T ss_pred             EEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC------eEEEEEecCCCcHHHHH
Confidence            34555654    577877542 23345567889999999999999999999998763      346778877 5888887


Q ss_pred             hC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccccc
Q psy16889         78 VS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~a  155 (203)
                      .. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+........ .......++..|+|
T Consensus       108 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  187 (327)
T 3poz_A          108 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  187 (327)
T ss_dssp             HHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSC
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccC
Confidence            65 56799999999999999999999999999999999999999999999999999975433222 22233355778999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ||++.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       188 PE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  232 (327)
T 3poz_A          188 LESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  232 (327)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             hHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH
Confidence            999987 558999999999999999999 99999988776655444

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.6e-37  Score=228.52  Aligned_cols=181  Identities=20%  Similarity=0.301  Sum_probs=149.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhh-----hhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLV-----SSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   75 (203)
                      +.+..+++.||+|++........     ..+.+.+|++++++++||||+++++++.+..       +++|||+. ++|.+
T Consensus        38 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------~lv~e~~~~~~L~~  110 (287)
T 4f0f_A           38 GRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-------RMVMEFVPCGDLYH  110 (287)
T ss_dssp             EEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-------EEEEECCTTCBHHH
T ss_pred             EEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-------eEEEEecCCCCHHH
Confidence            45778999999999854322211     1267889999999999999999999997662       48999998 68888


Q ss_pred             HHhC-CCCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCe-----EEEeecCccccCCCCCCCCcccc
Q psy16889         76 IIVS-PQHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCI-----LKICDFGLARVEEPDPNKAMTQE  147 (203)
Q Consensus        76 ~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~  147 (203)
                      .+.. ...+++..++.++.|++.+|++||++|  ++|+||||+||+++.++.     ++|+|||.+....    ......
T Consensus       111 ~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~  186 (287)
T 4f0f_A          111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGL  186 (287)
T ss_dssp             HHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS----SCEECC
T ss_pred             HHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccc----cccccc
Confidence            7764 457999999999999999999999999  999999999999987776     9999999987432    223445


Q ss_pred             cCCcccccceeeec-ccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        148 VVTQYYRAPEILMG-ARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       148 ~~~~~~~aPe~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+++.|.|||++.. ...++.++|+||||+++|+|++|+.||.....
T Consensus       187 ~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  233 (287)
T 4f0f_A          187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY  233 (287)
T ss_dssp             CCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             CCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence            67899999999843 24468899999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.9e-37  Score=228.27  Aligned_cols=183  Identities=28%  Similarity=0.438  Sum_probs=142.5

Q ss_pred             CCcEEEEEeccCccch--hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCC
Q psy16889          7 DGRRVALKKLPNVFQS--LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~   83 (203)
                      +|+.|+||+++.....  ....+.+.+|+++++.++||||+++++++.++     ...+++|||+.+ +|.+++. .+.+
T Consensus        29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~  102 (271)
T 3dtc_A           29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRI  102 (271)
T ss_dssp             TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCC
T ss_pred             cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCC
Confidence            4889999998543222  23356788999999999999999999999887     667899999974 7777664 5679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEecC--------CCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSAR---ILHRDIKPGNLLVNS--------NCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~~~nil~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      ++..++.++.|++.+|++||++|   ++||||||+||+++.        ++.++|+|||.+.......   .....+++.
T Consensus       103 ~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~  179 (271)
T 3dtc_A          103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYA  179 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------CCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc---ccCCCCccc
Confidence            99999999999999999999999   889999999999986        6789999999997543222   223467899


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |.|||.+.+ ..++.++|+||||+++|+|++|+.||.+.........
T Consensus       180 y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  225 (271)
T 3dtc_A          180 WMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG  225 (271)
T ss_dssp             GSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred             eeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence            999999887 4589999999999999999999999998776555433

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-37  Score=228.64  Aligned_cols=185  Identities=20%  Similarity=0.277  Sum_probs=154.7

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC--CC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ--HL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~   83 (203)
                      +|+.||||++.....+....+.+.+|+.++++++||||+++++++.++..   ...+++|||+.+ +|.+++...+  .+
T Consensus        32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~  108 (271)
T 3kmu_A           32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA---PHPTLITHWMPYGSLYNVLHEGTNFVV  108 (271)
T ss_dssp             TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS---SSCEEEEECCTTCBHHHHHHSCSSCCC
T ss_pred             CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC---CCeEeeecccCCCcHHHHHhhcccCCC
Confidence            48899999997655555666789999999999999999999999877633   356799999984 9999988754  59


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeec
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      ++.+++.++.|++.||++||+++  ++|+||||+||+++.++.+++.||+......      .....+++.|+|||.+.+
T Consensus       109 ~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~  182 (271)
T 3kmu_A          109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQK  182 (271)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS------CTTCBSCGGGSCHHHHHS
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec------ccCccCCccccChhhhcc
Confidence            99999999999999999999999  9999999999999999999999888765322      123366889999999886


Q ss_pred             ccC--CCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        162 ARH--YSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~--~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ...  ++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       183 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  223 (271)
T 3kmu_A          183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV  223 (271)
T ss_dssp             CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH
T ss_pred             CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH
Confidence            432  233799999999999999999999988776665443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-37  Score=233.79  Aligned_cols=182  Identities=28%  Similarity=0.387  Sum_probs=149.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-CCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-SPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~   81 (203)
                      +..+|+.||+|++.... .....+.+.+|+++++.++||||+++++++.+.+.   ...+++|||+.+ +|.+++. ..+
T Consensus        46 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  121 (302)
T 4e5w_A           46 GDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPKNKN  121 (302)
T ss_dssp             SSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTT
T ss_pred             cCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC---ceEEEEEEeCCCCcHHHHHHhccc
Confidence            67899999999996532 33445778899999999999999999999887643   235789999975 9999884 456


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+........  .......++..|.|||.+
T Consensus       122 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (302)
T 4e5w_A          122 KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL  201 (302)
T ss_dssp             TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred             cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeee
Confidence            799999999999999999999999999999999999999999999999999975543322  223344667789999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      .+ ..++.++|+||||+++|+|++|..|+..
T Consensus       202 ~~-~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          202 MQ-SKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             cC-CCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            77 4478999999999999999999998643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-37  Score=235.58  Aligned_cols=189  Identities=24%  Similarity=0.362  Sum_probs=155.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP----   80 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----   80 (203)
                      .+++.|++|.+... ........+.+|+++++.++||||+++++++.+.     ...+++|||+.+ +|.+++...    
T Consensus        53 ~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~  126 (322)
T 1p4o_A           53 EPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAM  126 (322)
T ss_dssp             EEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHH
T ss_pred             CCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhh
Confidence            56788999999653 2334456788999999999999999999999877     456789999974 888877531    


Q ss_pred             ------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccc
Q psy16889         81 ------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYY  153 (203)
Q Consensus        81 ------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  153 (203)
                            ..+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+........ .......+++.|
T Consensus       127 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  206 (322)
T 1p4o_A          127 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  206 (322)
T ss_dssp             HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGG
T ss_pred             ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCc
Confidence                  4579999999999999999999999999999999999999999999999999874332211 122233557889


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      +|||++.+ ..++.++|+||||+++|+|++ |+.||.+.+..+....+.
T Consensus       207 ~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          207 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             cChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            99999877 458999999999999999999 899999988777666543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.4e-37  Score=244.79  Aligned_cols=185  Identities=25%  Similarity=0.433  Sum_probs=149.1

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~   83 (203)
                      .+..||||+++...   ...+.+.+|++++++++||||+++++++.++      ..++||||+. ++|.+++..  ...+
T Consensus       207 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~~iv~e~~~~gsL~~~l~~~~~~~~  277 (452)
T 1fmk_A          207 GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGETGKYL  277 (452)
T ss_dssp             TTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEECCCTTCBHHHHHSHHHHTTC
T ss_pred             CCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCC------ceEEEehhhcCCCHHHHHHhcCCCCC
Confidence            34679999996432   2346788999999999999999999998763      3578999998 599998864  3569


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++...............++..|+|||++.+ .
T Consensus       278 ~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  356 (452)
T 1fmk_A          278 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G  356 (452)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhc-C
Confidence            999999999999999999999999999999999999999999999999997554333333333455778999999887 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |+.||.+....+.+..+.
T Consensus       357 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~  395 (452)
T 1fmk_A          357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  395 (452)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            58999999999999999999 999999988877766553

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-37  Score=251.59  Aligned_cols=188  Identities=23%  Similarity=0.396  Sum_probs=153.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~   83 (203)
                      .++..||||+++.. ......+.+.+|++++++++||||+++++++.++      ..++||||+.+ +|.+++.. ...+
T Consensus       361 ~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l  433 (613)
T 2ozo_A          361 KKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKREEI  433 (613)
T ss_dssp             SCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHTTCTTTS
T ss_pred             CCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------CeEEEEEeCCCCcHHHHHhhccCCC
Confidence            46678999999654 2334567899999999999999999999998764      35789999984 89988864 4569


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceeeec
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~  161 (203)
                      ++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++........  .......+++.|+|||++.+
T Consensus       434 ~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~  513 (613)
T 2ozo_A          434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF  513 (613)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC
Confidence            9999999999999999999999999999999999999999999999999975433221  11222234678999999976


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                       ..++.++||||||+++|+|++ |+.||.+.+..+.+..|.
T Consensus       514 -~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~  553 (613)
T 2ozo_A          514 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE  553 (613)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred             -CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence             558999999999999999998 999999988877776653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-36  Score=228.52  Aligned_cols=189  Identities=25%  Similarity=0.396  Sum_probs=153.1

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      .++..|++|.+... ......+.+.+|+.++++++||||+++++++.+...    ..++++|++. ++|.+++.. ...+
T Consensus        47 ~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~~v~e~~~~~~L~~~~~~~~~~~  121 (298)
T 3pls_A           47 QNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG----LPHVLLPYMCHGDLLQFIRSPQRNP  121 (298)
T ss_dssp             SCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS----CCEEEECCCTTCBHHHHHHCTTCCC
T ss_pred             Cceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC----CcEEEEecccCCCHHHHHhccccCC
Confidence            34558999998653 333456778899999999999999999999977642    3368899986 689998876 4679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC---CCCcccccCCcccccceeee
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ++.+++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+.......   ........+++.|.|||.+.
T Consensus       122 ~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (298)
T 3pls_A          122 TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ  201 (298)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhc
Confidence            999999999999999999999999999999999999999999999999997443221   12223445678899999997


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      + ..++.++|+||||+++|+|++ +.+||...+..+....+
T Consensus       202 ~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~  241 (298)
T 3pls_A          202 T-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL  241 (298)
T ss_dssp             T-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred             c-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence            7 458999999999999999999 56667776666555444

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.9e-37  Score=234.89  Aligned_cols=191  Identities=23%  Similarity=0.375  Sum_probs=152.9

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+|+.||||.++.. ........+.+|+.++++++||||+++++++.+.     ...+++|||+. ++|.+++...  
T Consensus        56 ~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~  129 (327)
T 2yfx_A           56 NDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRP  129 (327)
T ss_dssp             ----CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSC
T ss_pred             CCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcc
Confidence            4578899999999643 2334556788999999999999999999999887     45679999996 5898888743  


Q ss_pred             -----CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCC-CCCCcccccCCc
Q psy16889         81 -----QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPD-PNKAMTQEVVTQ  151 (203)
Q Consensus        81 -----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~  151 (203)
                           ..+++.+++.++.|++.||.+||++|++||||+|+||+++.   +..++|+|||.+...... .........+++
T Consensus       130 ~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  209 (327)
T 2yfx_A          130 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV  209 (327)
T ss_dssp             CSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCG
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCc
Confidence                 34899999999999999999999999999999999999984   446999999998633222 122233445688


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .|+|||++.+ ..++.++|+||||+++|+|++ |..||......+.+..+.
T Consensus       210 ~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  259 (327)
T 2yfx_A          210 KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  259 (327)
T ss_dssp             GGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             ceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence            8999999877 458999999999999999998 999999988777666543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-37  Score=234.13  Aligned_cols=184  Identities=29%  Similarity=0.502  Sum_probs=153.1

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~   81 (203)
                      +..+++.|+||+++... .......+.+|+.+++++ +||||+++++++....    ...++++||+. ++|.+++....
T Consensus        53 ~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~  127 (316)
T 2xir_A           53 KTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKR  127 (316)
T ss_dssp             STTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCT
T ss_pred             ccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcc
Confidence            46788999999996542 333456788999999999 7999999999987653    34678999998 49999887654


Q ss_pred             C----------------CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCc
Q psy16889         82 H----------------LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAM  144 (203)
Q Consensus        82 ~----------------~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~  144 (203)
                      .                +++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........ ...
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  207 (316)
T 2xir_A          128 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  207 (316)
T ss_dssp             TSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEE
T ss_pred             cccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceec
Confidence            3                89999999999999999999999999999999999999999999999999975443322 222


Q ss_pred             ccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCCh
Q psy16889        145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSP  193 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~  193 (203)
                      ....+++.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+...
T Consensus       208 ~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~  256 (316)
T 2xir_A          208 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  256 (316)
T ss_dssp             TTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence            33456788999999877 558999999999999999998 9999987653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.7e-37  Score=233.40  Aligned_cols=186  Identities=30%  Similarity=0.590  Sum_probs=152.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |++..+|+.||||++...     ..+.+.+|+.++++++ ||||+++++++.+...   ...+++|||+.+ +|.+.+. 
T Consensus        55 ~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~-  125 (330)
T 3nsz_A           55 AINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQLYQ-  125 (330)
T ss_dssp             EEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CCEEEEEECCCCCCHHHHGG-
T ss_pred             EEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---CceEEEEeccCchhHHHHHH-
Confidence            467889999999998642     3466889999999996 9999999999987432   356789999984 7777663 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                        .+++.++..++.|++.||++||++|++||||||+||+++.++ .++|+|||.+......  .......++..|.|||.
T Consensus       126 --~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~~~y~aPE~  201 (330)
T 3nsz_A          126 --TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPEL  201 (330)
T ss_dssp             --GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT--CCCCSCCSCGGGCCHHH
T ss_pred             --hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC--CccccccccccccChhh
Confidence              489999999999999999999999999999999999999776 8999999999754432  22344467889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccC-CCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQ-AQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~i  200 (203)
                      +.+...++.++|+||||+++|+|++|+.||. +....+.+..+
T Consensus       202 ~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~  244 (330)
T 3nsz_A          202 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI  244 (330)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred             hcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence            8875668999999999999999999999984 44455544443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-37  Score=233.58  Aligned_cols=182  Identities=20%  Similarity=0.276  Sum_probs=149.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~   80 (203)
                      +.+..+|+.||||++...    .....+.+|+.+++.++|++++..+..+....    ...+++||+++++|.+.+. ..
T Consensus        28 ~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~   99 (296)
T 4hgt_A           28 GTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCS   99 (296)
T ss_dssp             EEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTT
T ss_pred             EEEcCCCceEEEEeeccc----ccchHHHHHHHHHHHhcCCCCCCeeeeecCCC----CceEEEEEccCCCHHHHHHHhc
Confidence            457789999999987432    23345788999999999888777776654332    4567999999889998887 35


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCC------CCcccccCCc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPN------KAMTQEVVTQ  151 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~  151 (203)
                      +.+++.++..++.|++.||++||++|++||||||+||++   +.++.++|+|||.+........      .......+++
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~  179 (296)
T 4hgt_A          100 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA  179 (296)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCG
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCc
Confidence            679999999999999999999999999999999999999   7889999999999975443322      2233457799


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+
T Consensus       180 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 4hgt_A          180 RYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             GGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             cccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence            9999999887 458999999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-37  Score=244.58  Aligned_cols=181  Identities=23%  Similarity=0.448  Sum_probs=150.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC--CC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ--HL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~   83 (203)
                      +|+.||||+++..    ...+.+.+|++++++++||||+++++++.+..    ...++||||+. ++|.+++...+  .+
T Consensus       215 ~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~  286 (450)
T 1k9a_A          215 RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  286 (450)
T ss_dssp             TTEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTC
T ss_pred             cCCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCC
Confidence            4789999999653    24567899999999999999999999976653    24679999998 49999887543  37


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++......    .....++..|+|||++.+ .
T Consensus       287 ~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~-~  361 (450)
T 1k9a_A          287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-K  361 (450)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----------CCCTTTSCHHHHHS-S
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----ccCCCCCcceeCHHHhcC-C
Confidence            99999999999999999999999999999999999999999999999998743321    122245778999999987 5


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|+|++ |+.||.+.+..+....+
T Consensus       362 ~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i  399 (450)
T 1k9a_A          362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  399 (450)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            58999999999999999998 99999987766665544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.1e-37  Score=231.74  Aligned_cols=177  Identities=17%  Similarity=0.235  Sum_probs=147.0

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-CCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-HLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~   86 (203)
                      ..|++|++...  .....+.+.+|++++++++||||+++++++.++     ...+++|||+. ++|.+++...+ .+++.
T Consensus        41 ~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  113 (289)
T 4fvq_A           41 TEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINIL  113 (289)
T ss_dssp             EEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHH
T ss_pred             hhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHH
Confidence            57999998542  334557788999999999999999999999887     45679999998 59999887654 49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe--------EEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI--------LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .++.++.|++.||++||++|++||||||+||+++.++.        ++++|||.+.....     .....+++.|+|||+
T Consensus       114 ~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~  188 (289)
T 4fvq_A          114 WKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQERIPWVPPEC  188 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHH
T ss_pred             HHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC-----ccccCCcCcccCHHH
Confidence            99999999999999999999999999999999998876        99999999864321     123346788999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQL  197 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~  197 (203)
                      +.+...++.++|+||||+++|+|++ +.+||.........
T Consensus       189 ~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~  228 (289)
T 4fvq_A          189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL  228 (289)
T ss_dssp             HHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             hCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence            9875668999999999999999999 46666665554433

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-37  Score=240.52  Aligned_cols=183  Identities=19%  Similarity=0.174  Sum_probs=144.8

Q ss_pred             CCcEEEEEeccCccchh---------hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH
Q psy16889          7 DGRRVALKKLPNVFQSL---------VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII   77 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   77 (203)
                      .++.||||+++......         ........|+..++.++||||+++++++....... ...++||||++++|.+++
T Consensus        64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~-~~~~lv~e~~g~~L~~~~  142 (364)
T 3op5_A           64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGK-SYRFMIMDRFGSDLQKIY  142 (364)
T ss_dssp             TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTE-EEEEEEEECEEEEHHHHH
T ss_pred             cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCc-ceEEEEEeCCCCCHHHHH
Confidence            47899999985432111         11123344566677888999999999987642110 346899999977999988


Q ss_pred             hCC-CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCeEEEeecCccccCCCCCC------CCccccc
Q psy16889         78 VSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILKICDFGLARVEEPDPN------KAMTQEV  148 (203)
Q Consensus        78 ~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~------~~~~~~~  148 (203)
                      ... +.+++.+++.++.|++.||+|||++|++||||||+||+++  .++.++|+|||++........      .......
T Consensus       143 ~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  222 (364)
T 3op5_A          143 EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD  222 (364)
T ss_dssp             HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence            754 6799999999999999999999999999999999999999  889999999999975432211      1123345


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.
T Consensus       223 gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          223 GTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             CCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            8999999999987 45899999999999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-37  Score=241.46  Aligned_cols=182  Identities=31%  Similarity=0.501  Sum_probs=150.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC--------CCCccchhhhccCCCcchhHHHHHHHhhhHHhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK--------HDNVLSALDILQPPHLDFFQEIYVITELLQSDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l   73 (203)
                      |++..+|+.||||+++..   ....+.+.+|+++++.++        |+||+++++++....... ...++|||++++++
T Consensus        56 ~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~-~~~~lv~e~~~~~l  131 (397)
T 1wak_A           56 SWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG-THICMVFEVLGHHL  131 (397)
T ss_dssp             EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE-EEEEEEECCCCCBH
T ss_pred             EEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC-ceEEEEEeccCccH
Confidence            467889999999999642   234567788999999985        788999999887321100 46789999999888


Q ss_pred             HHHHhCC--CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCC---------------------------
Q psy16889         74 HKIIVSP--QHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNC---------------------------  123 (203)
Q Consensus        74 ~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~---------------------------  123 (203)
                      .+.+...  +.+++..++.++.|++.||+|||++ |++||||||+||+++.++                           
T Consensus       132 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (397)
T 1wak_A          132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS  211 (397)
T ss_dssp             HHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC----------------
T ss_pred             HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccc
Confidence            8777643  5699999999999999999999998 999999999999998775                           


Q ss_pred             ----------------------eEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHH
Q psy16889        124 ----------------------ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL  181 (203)
Q Consensus       124 ----------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~l  181 (203)
                                            .++|+|||.+......    .....+|+.|+|||++.+ ..++.++||||||+++|+|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el  286 (397)
T 1wak_A          212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFEL  286 (397)
T ss_dssp             -----CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHH
T ss_pred             cCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHH
Confidence                                  7999999999754322    334467999999999987 4589999999999999999


Q ss_pred             HhCCcccCCCC
Q psy16889        182 LGRRILFQAQS  192 (203)
Q Consensus       182 l~g~~pf~~~~  192 (203)
                      ++|+.||...+
T Consensus       287 ltg~~pf~~~~  297 (397)
T 1wak_A          287 ATGDYLFEPHS  297 (397)
T ss_dssp             HHSSCSCCCCC
T ss_pred             hhCCCCCCCCc
Confidence            99999998755

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-37  Score=231.88  Aligned_cols=182  Identities=20%  Similarity=0.276  Sum_probs=149.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh-CC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV-SP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~   80 (203)
                      +.+..+|+.||||++...    ...+.+.+|+.+++.++|+++++.+..+....    ...+++|||++++|.+++. ..
T Consensus        28 ~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~   99 (296)
T 3uzp_A           28 GTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCS   99 (296)
T ss_dssp             EEETTTTEEEEEEEEESC----SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTT
T ss_pred             EEEcCCCcEEEEEEecCC----cchhHHHHHHHHHHHhhcCCCCCccccccCCC----CceEEEEEecCCCHHHHHHhhc
Confidence            456789999999998543    23346889999999999888776666554332    4567999999879999887 45


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCC------CCcccccCCc
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPN------KAMTQEVVTQ  151 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~  151 (203)
                      +.+++..++.++.|++.||++||++|++||||||+||++   +.++.++|+|||.+........      .......+++
T Consensus       100 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (296)
T 3uzp_A          100 RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA  179 (296)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccccccc
Confidence            679999999999999999999999999999999999999   4788999999999875443322      1234457799


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       180 ~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          180 RYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence            9999999887 458999999999999999999999998743

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.2e-38  Score=239.63  Aligned_cols=182  Identities=18%  Similarity=0.165  Sum_probs=148.4

Q ss_pred             CCcEEEEEeccCccchh---------hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH
Q psy16889          7 DGRRVALKKLPNVFQSL---------VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII   77 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   77 (203)
                      ++..+++|+........         .....+.+|+..++.++||||+++++++.+..... ...+++|||++++|.+++
T Consensus        64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~-~~~~lv~e~~~~~L~~~l  142 (345)
T 2v62_A           64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGR-SYRFMVMERLGIDLQKIS  142 (345)
T ss_dssp             GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSC-EEEEEEEECEEEEHHHHC
T ss_pred             ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCC-cEEEEEEeccCCCHHHHH
Confidence            78899999986432111         12234667888999999999999999987621000 567899999977999998


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC--eEEEeecCccccCCCCC------CCCcccccC
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC--ILKICDFGLARVEEPDP------NKAMTQEVV  149 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~------~~~~~~~~~  149 (203)
                      ...+.+++.+++.++.|++.||+|||++|++||||||+||+++.++  .++|+|||.+.......      ........+
T Consensus       143 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  222 (345)
T 2v62_A          143 GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG  222 (345)
T ss_dssp             BGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCS
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCC
Confidence            8777899999999999999999999999999999999999999877  99999999997543211      112244577


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+
T Consensus       223 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          223 TIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             CTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             CccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999999999887 4589999999999999999999999965

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-37  Score=236.20  Aligned_cols=183  Identities=28%  Similarity=0.492  Sum_probs=149.0

Q ss_pred             CcCCCCCcEEEEEeccCccc------hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ------SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLH   74 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~   74 (203)
                      |.+..+|+.||||++.....      .......+.+|++++++++||||+++++++..+.      .+++|||+.+ +|.
T Consensus        29 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~lv~e~~~~~~L~  102 (322)
T 2ycf_A           29 AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED------YYIVLELMEGGELF  102 (322)
T ss_dssp             EEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS------EEEEEECCTTEETH
T ss_pred             EEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc------eEEEEecCCCCcHH
Confidence            46778999999999854321      1223345789999999999999999999987652      5789999974 999


Q ss_pred             HHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe---EEEeecCccccCCCCCCCCcccccCCc
Q psy16889         75 KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      +.+...+.+++..++.++.|++.||++||++|++|+||||+||+++.++.   ++|+|||.+......  .......+++
T Consensus       103 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~  180 (322)
T 2ycf_A          103 DKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTP  180 (322)
T ss_dssp             HHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC--HHHHHHHSCC
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccc--cccccccCCc
Confidence            99888889999999999999999999999999999999999999987654   999999999754321  1223346788


Q ss_pred             ccccceeee--cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        152 YYRAPEILM--GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       152 ~~~aPe~~~--~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .|+|||++.  +...++.++|+||||+++|+|++|..||....
T Consensus       181 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (322)
T 2ycf_A          181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  223 (322)
T ss_dssp             TTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred             CccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence            999999874  23457899999999999999999999997754

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.3e-38  Score=234.99  Aligned_cols=191  Identities=25%  Similarity=0.412  Sum_probs=153.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      +.+..+|+.|++|++...  .....+.+.+|+++++.++||||+++++++.++     ...++++||+++ +|.+++.. 
T Consensus        38 ~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~  110 (302)
T 2j7t_A           38 AKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLEL  110 (302)
T ss_dssp             EEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHH
T ss_pred             EEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhh
Confidence            456788999999998643  334557788999999999999999999999887     567899999985 77777654 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...... ........+++.|+|||++
T Consensus       111 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC-----CCGGGCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccccccccCChhhcCCeee
Confidence            567999999999999999999999999999999999999999999999999987421111 1112234678899999998


Q ss_pred             e----cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 M----GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~----~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .    ....++.++|+||||+++|+|++|+.||...+....+..+
T Consensus       190 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  234 (302)
T 2j7t_A          190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  234 (302)
T ss_dssp             HHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            4    2355789999999999999999999999988776655443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1e-37  Score=239.10  Aligned_cols=186  Identities=24%  Similarity=0.411  Sum_probs=155.2

Q ss_pred             CCcEEEEEeccCccchhhh---------------hHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH
Q psy16889          7 DGRRVALKKLPNVFQSLVS---------------SKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS   71 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~---------------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~   71 (203)
                      +|+.||||++.........               .+.+.+|++++++++||||+++++++.++     ...++||||+++
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~  127 (348)
T 2pml_X           53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMEN  127 (348)
T ss_dssp             TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS-----SEEEEEEECCTT
T ss_pred             CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEEeccCC
Confidence            7999999998543222111               17788999999999999999999999887     567899999986


Q ss_pred             -hHHHH------HhC--CCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC
Q psy16889         72 -DLHKI------IVS--PQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        72 -~l~~~------~~~--~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~  141 (203)
                       +|.++      +..  ...+++..++.++.|++.||++||+ +|++|+||+|+||+++.++.++|+|||.+......  
T Consensus       128 ~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  205 (348)
T 2pml_X          128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--  205 (348)
T ss_dssp             CBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--
T ss_pred             CcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--
Confidence             88887      555  5779999999999999999999999 99999999999999999999999999999754322  


Q ss_pred             CCcccccCCcccccceeeecccCCCc-chhHHHHHHHHHHHHhCCcccCCCCh-HHHhhhh
Q psy16889        142 KAMTQEVVTQYYRAPEILMGARHYSA-AVDVWSVGCIFAELLGRRILFQAQSP-VQQLGLI  200 (203)
Q Consensus       142 ~~~~~~~~~~~~~aPe~~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~-~~~~~~i  200 (203)
                       ......+++.|.|||++.+...++. ++|+||||+++|+|++|+.||..... .+....+
T Consensus       206 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i  265 (348)
T 2pml_X          206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI  265 (348)
T ss_dssp             -EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHH
T ss_pred             -cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence             3344567899999999987534555 99999999999999999999988766 5555444

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-37  Score=235.49  Aligned_cols=183  Identities=30%  Similarity=0.503  Sum_probs=154.2

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCC------ccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN------VLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV   78 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~   78 (203)
                      ..+|+.||||+++..   ....+.+.+|+++++.++|++      ++++++++.+.     ...++||||++++|.+++.
T Consensus        37 ~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~  108 (339)
T 1z57_A           37 KAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIK  108 (339)
T ss_dssp             TTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHH
T ss_pred             CCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHH
Confidence            568899999999643   234566788999999887654      89999988877     5678999999889999887


Q ss_pred             CCC--CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-------------------CCeEEEeecCccccCC
Q psy16889         79 SPQ--HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-------------------NCILKICDFGLARVEE  137 (203)
Q Consensus        79 ~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-------------------~~~~~l~d~~~~~~~~  137 (203)
                      ..+  ++++..+..++.|++.||++||++|++||||||+||+++.                   ++.++|+|||.+....
T Consensus       109 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~  188 (339)
T 1z57_A          109 ENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD  188 (339)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETT
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCc
Confidence            554  6899999999999999999999999999999999999987                   6679999999987533


Q ss_pred             CCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        138 PDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       138 ~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .    ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+..+.+..+
T Consensus       189 ~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  246 (339)
T 1z57_A          189 E----HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM  246 (339)
T ss_dssp             S----CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred             c----ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            2    2234467899999999987 45899999999999999999999999998877766554

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.2e-37  Score=230.71  Aligned_cols=180  Identities=24%  Similarity=0.370  Sum_probs=150.7

Q ss_pred             CCcEEEEEeccCcc--chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC---C
Q psy16889          7 DGRRVALKKLPNVF--QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS---P   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~   80 (203)
                      +|+.|++|++....  ......+.+.+|+.++++++||||+++++++.+.     ...+++|||+. ++|.+++..   .
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~  127 (307)
T 2nru_A           53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGT  127 (307)
T ss_dssp             SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGC
T ss_pred             CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCC
Confidence            68899999985432  2334466788999999999999999999999887     56789999996 588887763   4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~aPe~~  159 (203)
                      +++++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+......... ......|++.|+|||.+
T Consensus       128 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  207 (307)
T 2nru_A          128 PPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL  207 (307)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHh
Confidence            56999999999999999999999999999999999999999999999999998754432221 22334678999999988


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+ . ++.++|+||||+++|+|++|..||.....
T Consensus       208 ~~-~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          208 RG-E-ITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             TT-E-ECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             cC-C-CCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            75 3 68999999999999999999999987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5e-38  Score=243.00  Aligned_cols=187  Identities=15%  Similarity=0.125  Sum_probs=135.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhc--CCCCccchhhhcc-------CCCcc------------hh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFF--KHDNVLSALDILQ-------PPHLD------------FF   59 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~-------~~~~~------------~~   59 (203)
                      |.+..+|+.||||++..... .....+.+.+|+.+++.+  +||||++++..+.       .++..            ..
T Consensus        81 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~  160 (371)
T 3q60_A           81 VRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAV  160 (371)
T ss_dssp             EEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCE
T ss_pred             EEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCccccee
Confidence            46778999999999966433 444556677885555555  6999888664332       21110            00


Q ss_pred             HHHHHHHhhhHHhHHHHHhCC-CCCChHHH------HHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCc
Q psy16889         60 QEIYVITELLQSDLHKIIVSP-QHLTSDHI------KVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGL  132 (203)
Q Consensus        60 ~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~------~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~  132 (203)
                      ...++||||++++|.+++... ..+++..+      ..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~  240 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA  240 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecce
Confidence            236899999999999988753 34556666      67889999999999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCcccccCCcccccceeeec-ccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        133 ARVEEPDPNKAMTQEVVTQYYRAPEILMG-ARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +.....    ......+++.|+|||++.+ ...++.++|+||||+++|+|++|+.||.+..
T Consensus       241 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          241 LWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             EEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             eeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            985432    1113456789999999975 2358999999999999999999999998773

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.1e-37  Score=234.03  Aligned_cols=183  Identities=22%  Similarity=0.393  Sum_probs=133.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHH-HHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV--   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--   78 (203)
                      +.+..+|+.||||+++...... ....+..|.. +++.++||||+++++++.++     ...+++|||++++|.+.+.  
T Consensus        41 ~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~  114 (327)
T 3aln_A           41 MVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYV  114 (327)
T ss_dssp             EEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHH
T ss_pred             EEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHH
Confidence            4567899999999996543333 3334444544 77888999999999999887     4567999999988777665  


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                         ....+++..+..++.|++.+|.+||++ |++|+||+|+||+++.++.++|+|||.+......  .......+++.|+
T Consensus       115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~gt~~y~  192 (327)
T 3aln_A          115 YSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRDAGCRPYM  192 (327)
T ss_dssp             HHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------
T ss_pred             HhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc--cccccCCCCcccc
Confidence               257799999999999999999999999 9999999999999999999999999999754322  2223336788999


Q ss_pred             cceeee---cccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        155 APEILM---GARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       155 aPe~~~---~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |||++.   ....++.++|+||||+++|+|++|+.||.+..
T Consensus       193 aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (327)
T 3aln_A          193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN  233 (327)
T ss_dssp             -------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred             CceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            999984   22457899999999999999999999998743

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.4e-36  Score=228.24  Aligned_cols=188  Identities=24%  Similarity=0.356  Sum_probs=150.5

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-CCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-PQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~   84 (203)
                      ++..+++|.+... ......+.+.+|+.++++++||||+++++++....    ...+++|||+.+ +|.+++.. ...++
T Consensus        52 ~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~  126 (298)
T 3f66_A           52 KKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPT  126 (298)
T ss_dssp             -CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCCC
T ss_pred             ceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCCC
Confidence            3446899998653 33445677889999999999999999999865443    356789999986 99998875 45699


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC---CCCcccccCCcccccceeeec
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP---NKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      +..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+.......   ........+++.|+|||.+.+
T Consensus       127 ~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (298)
T 3f66_A          127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT  206 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcC
Confidence            99999999999999999999999999999999999999999999999997543321   112233455778999999977


Q ss_pred             ccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        162 ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 ~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                       ..++.++|+||||+++|+|++ |.+||.+.+..+....+
T Consensus       207 -~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~  245 (298)
T 3f66_A          207 -QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL  245 (298)
T ss_dssp             -CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred             -CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence             458999999999999999999 67788877665554433

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-37  Score=233.51  Aligned_cols=191  Identities=25%  Similarity=0.367  Sum_probs=147.8

Q ss_pred             CcCCCCCcEE----EEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRV----ALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~----~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      +.+..+|+.+    ++|.+... ......+.+.+|+.++++++||||+++++++.++.      .+++++++. ++|.++
T Consensus        34 ~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~------~~~v~~~~~~g~L~~~  106 (327)
T 3lzb_A           34 GLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDY  106 (327)
T ss_dssp             EEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS------EEEEECCCSSCBHHHH
T ss_pred             EEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC------ceEEEEecCCCcHHHH
Confidence            3455666655    66666432 23345677889999999999999999999998763      346777777 588888


Q ss_pred             HhC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccc
Q psy16889         77 IVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYR  154 (203)
Q Consensus        77 ~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~  154 (203)
                      +.. .+.+++..++.++.|++.||++||++|++||||||+||+++.++.++|+|||.+........ .......+++.|+
T Consensus       107 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~  186 (327)
T 3lzb_A          107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM  186 (327)
T ss_dssp             HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGS
T ss_pred             HHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCcccccc
Confidence            764 56799999999999999999999999999999999999999999999999999975433222 2223334577899


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      |||.+.+ ..++.++|+||||+++|+|++ |+.||.+....+....+
T Consensus       187 aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~  232 (327)
T 3lzb_A          187 ALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  232 (327)
T ss_dssp             CHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH
T ss_pred             CHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            9999987 558999999999999999999 99999988776665544

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-37  Score=232.93  Aligned_cols=194  Identities=23%  Similarity=0.378  Sum_probs=150.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcc-hhHHHHHHHhhhHH-hHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLD-FFQEIYVITELLQS-DLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~   78 (203)
                      +.+..+|+.|+||++...   ....+.+.+|+..++++ +||||+++++++...... .....+++|||+++ +|.+++.
T Consensus        43 ~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  119 (326)
T 2x7f_A           43 GRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK  119 (326)
T ss_dssp             EEETTTCCEEEEEEEECC---SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHH
T ss_pred             EEECCCCCeEEEEEEecC---cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHH
Confidence            456789999999998543   23456788999999999 899999999998764210 00356899999985 8988887


Q ss_pred             CC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         79 SP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        79 ~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      ..  ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|+||
T Consensus       120 ~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aP  198 (326)
T 2x7f_A          120 NTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAP  198 (326)
T ss_dssp             HSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--------------CCGGGCCH
T ss_pred             hcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc-cccccccCCccccCh
Confidence            53  579999999999999999999999999999999999999999999999999987543221 122334678999999


Q ss_pred             eeeec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhh
Q psy16889        157 EILMG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGL  199 (203)
Q Consensus       157 e~~~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~  199 (203)
                      |++..    ...++.++|+||||+++|+|++|+.||.+......+..
T Consensus       199 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             HHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             hhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99863    24578999999999999999999999988776655543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-37  Score=235.27  Aligned_cols=181  Identities=25%  Similarity=0.373  Sum_probs=149.1

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC------
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS------   79 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~------   79 (203)
                      ++.|++|.+.... .....+.+.+|+.+++++ +||||+++++++.++     ...+++|||+.+ +|.+++..      
T Consensus        76 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~  149 (333)
T 2i1m_A           76 VLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLE  149 (333)
T ss_dssp             CCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHS
T ss_pred             hhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhccccc
Confidence            3589999996542 334557788999999999 899999999999887     567899999974 88887753      


Q ss_pred             --------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCC
Q psy16889         80 --------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVT  150 (203)
Q Consensus        80 --------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~  150 (203)
                              ...+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+........ .......++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~  229 (333)
T 2i1m_A          150 TDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP  229 (333)
T ss_dssp             CC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEEC
T ss_pred             ccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCC
Confidence                    34689999999999999999999999999999999999999999999999999974432222 122333457


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHH
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQ  195 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~  195 (203)
                      +.|+|||++.+ ..++.++|+||||+++|+|++ |..||.+.....
T Consensus       230 ~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          230 VKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             GGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred             ccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence            78999999877 458999999999999999998 999998765433

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.3e-37  Score=231.28  Aligned_cols=191  Identities=20%  Similarity=0.346  Sum_probs=144.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-P   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~   80 (203)
                      |.+..+|+.||||++..........+.+.++..+++.++||||+++++++.++     ...+++|||+++.+...... .
T Consensus        44 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~  118 (318)
T 2dyl_A           44 MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQ  118 (318)
T ss_dssp             EEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHT
T ss_pred             EEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhc
Confidence            45678999999999966544444445555666678888999999999999887     46789999996555444432 5


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..+..++.|++.+|.+||++ |++|+||+|+||+++.++.++|+|||.+......  .......+++.|+|||++
T Consensus       119 ~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAGCAAYMAPERI  196 (318)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCTTCCHHHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--ccccccCCCccccChhhc
Confidence            6799999999999999999999995 9999999999999999999999999998644322  222344678899999998


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCC-ChHHHhhh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQ-SPVQQLGL  199 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~~  199 (203)
                      ..    ...++.++|+||||+++|+|++|+.||... ...+.+..
T Consensus       197 ~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  241 (318)
T 2dyl_A          197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK  241 (318)
T ss_dssp             C--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             ccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence            52    345788999999999999999999999874 34444433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.3e-37  Score=233.97  Aligned_cols=183  Identities=27%  Similarity=0.403  Sum_probs=153.1

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQ   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~   81 (203)
                      +..+|+.|+||++...  .....+.+.+|++++++++||||+++++++...+.   ...++||||++ ++|.+++.. .+
T Consensus        48 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  122 (327)
T 3lxl_A           48 GDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRA  122 (327)
T ss_dssp             SSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS---CEEEEEEECCTTCBHHHHHHHHGG
T ss_pred             CCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC---ceEEEEEeecCCCCHHHHHHhccc
Confidence            6789999999999653  33455678899999999999999999998865432   35679999996 589888875 45


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.+|++||++|++|+||||+||+++.++.++|+|||.+.........  ......++..|+|||++
T Consensus       123 ~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  202 (327)
T 3lxl_A          123 RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL  202 (327)
T ss_dssp             GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHh
Confidence            6999999999999999999999999999999999999999999999999999754433221  22344567889999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      .+ ..++.++|+||||+++|+|++|+.||....
T Consensus       203 ~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          203 SD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             cc-CCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            77 447899999999999999999999986643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-37  Score=237.31  Aligned_cols=186  Identities=24%  Similarity=0.347  Sum_probs=143.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-CCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-QHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~   85 (203)
                      +..|++|.++.. ......+.+.+|+.++++++||||+++++++....    ...+++|||+.+ +|.+++... ..+++
T Consensus       117 ~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~  191 (373)
T 3c1x_A          117 KIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTV  191 (373)
T ss_dssp             EEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCBH
T ss_pred             EEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCCH
Confidence            346899998643 33445678899999999999999999999865443    345789999985 999998764 56899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC---CCcccccCCcccccceeeecc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      .++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........   .......+++.|+|||++.+ 
T Consensus       192 ~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  270 (373)
T 3c1x_A          192 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-  270 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-
Confidence            99999999999999999999999999999999999999999999999974432211   12233355778999999887 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGL  199 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~  199 (203)
                      ..++.++|+||||+++|+|++ |.+||.+.+..+....
T Consensus       271 ~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~  308 (373)
T 3c1x_A          271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY  308 (373)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH
Confidence            558999999999999999999 7888987665554433

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=237.74  Aligned_cols=178  Identities=15%  Similarity=0.176  Sum_probs=143.7

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-----------chhHHHHHHHhhhHHhHHH
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-----------DFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----------~~~~~~~lv~e~~~~~l~~   75 (203)
                      +|+.||+|++...       +.+.+|++++++++||||+++++.+.....           ......++||||++++|.+
T Consensus        74 ~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~  146 (352)
T 2jii_A           74 QKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQS  146 (352)
T ss_dssp             ---CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHH
T ss_pred             cCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHH
Confidence            5899999998532       467899999999999999996654332110           0014568999999779999


Q ss_pred             HHhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC--eEEEeecCccccCCCCCC------CCcc
Q psy16889         76 IIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC--ILKICDFGLARVEEPDPN------KAMT  145 (203)
Q Consensus        76 ~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~--~~~l~d~~~~~~~~~~~~------~~~~  145 (203)
                      ++...  +.+++.+++.++.|++.||+|||++|++||||||+||+++.++  .++|+|||.+........      ....
T Consensus       147 ~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  226 (352)
T 2jii_A          147 ALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRS  226 (352)
T ss_dssp             HHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSC
T ss_pred             HHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccc
Confidence            98865  7899999999999999999999999999999999999999988  899999999975432211      1223


Q ss_pred             cccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        146 QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       146 ~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ...+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||....
T Consensus       227 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          227 PHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            4477899999999887 458999999999999999999999998764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.3e-37  Score=235.11  Aligned_cols=181  Identities=28%  Similarity=0.333  Sum_probs=146.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCCh
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLTS   85 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~   85 (203)
                      .|+.||||+++..   .........|+.++++++||||+++++++.+..... ..+++||||+.+ +|.+++.. ..+++
T Consensus        46 ~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~  120 (322)
T 3soc_A           46 LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD-VDLWLITAFHEKGSLSDFLKA-NVVSW  120 (322)
T ss_dssp             TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS-EEEEEEEECCTTCBHHHHHHH-CCBCH
T ss_pred             CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC-ceEEEEEecCCCCCHHHHHHh-cCCCH
Confidence            4789999998542   233445566899999999999999999987753210 235799999985 99988865 45999


Q ss_pred             HHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSA----------RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYR  154 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~----------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~  154 (203)
                      ..++.++.|++.||+|||+.          +++||||||+||+++.++.+||+|||.+....... ........||+.|+
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  200 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM  200 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCcccc
Confidence            99999999999999999999          99999999999999999999999999997544322 22233457799999


Q ss_pred             cceeeecc----cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        155 APEILMGA----RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       155 aPe~~~~~----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |||++.+.    ..++.++|+||||+++|+|++|+.||.+..
T Consensus       201 aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             CHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             CHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            99998763    235668899999999999999999997653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.9e-37  Score=230.84  Aligned_cols=183  Identities=27%  Similarity=0.469  Sum_probs=144.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-   78 (203)
                      +.+..+|+.||||+++... ......+.+.+|+.++++++||||+++++++.+.     ...++++||+.+ +|.+++. 
T Consensus        51 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~  125 (310)
T 2wqm_A           51 AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKH  125 (310)
T ss_dssp             EEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHH
T ss_pred             EEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHH
Confidence            4567889999999996422 2344567788999999999999999999999877     567799999985 8877765 


Q ss_pred             ---CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         79 ---SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        79 ---~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                         ....+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... .......+++.|.|
T Consensus       126 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~a  204 (310)
T 2wqm_A          126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMS  204 (310)
T ss_dssp             HHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------------------CCSSCC
T ss_pred             hcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-ccccccCCCeeEeC
Confidence               35679999999999999999999999999999999999999999999999999987543322 22233467889999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ||++.+ ..++.++|+||||+++|+|++|+.||.+.
T Consensus       205 PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          205 PERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             HHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             hHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            999877 45899999999999999999999999764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.8e-37  Score=237.17  Aligned_cols=188  Identities=26%  Similarity=0.468  Sum_probs=156.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CC-----CccchhhhccCCCcchhHHHHHHHhhhHHhHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HD-----NVLSALDILQPPHLDFFQEIYVITELLQSDLHK   75 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~   75 (203)
                      |.+..+|+.||||+++..   ......+..|+++++.++ |+     +++++++++...     ...++|||+++++|.+
T Consensus        73 ~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~  144 (382)
T 2vx3_A           73 AYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYD  144 (382)
T ss_dssp             EEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-----TEEEEEEECCCCBHHH
T ss_pred             EEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-----CceEEEEecCCCCHHH
Confidence            467889999999999642   233455677888888884 55     388888888776     5678999999999999


Q ss_pred             HHhCC--CCCChHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEec--CCCeEEEeecCccccCCCCCCCCcccccC
Q psy16889         76 IIVSP--QHLTSDHIKVFLYQILRGLKYLH--SARILHRDIKPGNLLVN--SNCILKICDFGLARVEEPDPNKAMTQEVV  149 (203)
Q Consensus        76 ~~~~~--~~~~~~~~~~~~~qi~~~l~~lh--~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  149 (203)
                      .+...  +.+++..+..++.|++.||.+||  +.|++||||||+||+++  .++.++|+|||.+......    .....+
T Consensus       145 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~  220 (382)
T 2vx3_A          145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQ  220 (382)
T ss_dssp             HHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC----CCSSCS
T ss_pred             HHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc----cccccC
Confidence            88754  56999999999999999999999  57999999999999995  4778999999999754322    234467


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.|+|||++.+ ..++.++|+||||+++|+|++|++||.+.+..+.+..|.+
T Consensus       221 t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          221 SRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             CGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            889999999987 4589999999999999999999999999998888877653

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=7.3e-37  Score=234.67  Aligned_cols=187  Identities=28%  Similarity=0.463  Sum_probs=154.2

Q ss_pred             CcCCCCC-cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCC------ccchhhhccCCCcchhHHHHHHHhhhHHhHH
Q psy16889          2 VTDPRDG-RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN------VLSALDILQPPHLDFFQEIYVITELLQSDLH   74 (203)
Q Consensus         2 ~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~   74 (203)
                      |.+..++ +.||+|+++..   ....+.+.+|+++++.++|++      ++.+.+++...     ...+++||++++++.
T Consensus        38 ~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~  109 (355)
T 2eu9_A           38 CLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-----GHMCIAFELLGKNTF  109 (355)
T ss_dssp             EEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-----TEEEEEEECCCCBHH
T ss_pred             EEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-----CeEEEEEeccCCChH
Confidence            3455666 68999999642   234566778999999997665      88888888776     567899999998888


Q ss_pred             HHHhCC--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe-------------------cCCCeEEEeecCcc
Q psy16889         75 KIIVSP--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV-------------------NSNCILKICDFGLA  133 (203)
Q Consensus        75 ~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~-------------------~~~~~~~l~d~~~~  133 (203)
                      +.+...  ..+++.+++.++.|++.||++||++|++||||||+||++                   +.++.++|+|||.+
T Consensus       110 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~  189 (355)
T 2eu9_A          110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA  189 (355)
T ss_dssp             HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTC
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcc
Confidence            877643  479999999999999999999999999999999999999                   56789999999999


Q ss_pred             ccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        134 RVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       134 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .....    ......+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+....+.+..+.
T Consensus       190 ~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (355)
T 2eu9_A          190 TFDHE----HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMME  252 (355)
T ss_dssp             EETTS----CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccc----cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            75332    2234467999999999987 458999999999999999999999999988777665543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.7e-37  Score=228.29  Aligned_cols=181  Identities=23%  Similarity=0.448  Sum_probs=145.2

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCC--CC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQ--HL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~   83 (203)
                      +|+.|+||+++..    ...+.+.+|++++++++||||+++++++.+..    ...++++||+.+ +|.+++...+  .+
T Consensus        43 ~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~  114 (278)
T 1byg_A           43 RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  114 (278)
T ss_dssp             TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             cCCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccC
Confidence            5889999998643    24567889999999999999999999876543    356799999985 8988887543  38


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..++.++.|++.+|++||++|++|+||+|+||+++.++.++|+|||.+......    .....+++.|.|||.+.+ .
T Consensus       115 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~-~  189 (278)
T 1byg_A          115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-K  189 (278)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCCCccccccCHHHhCC-C
Confidence            99999999999999999999999999999999999999999999999998743322    122345778999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      .++.++|+||||+++|+|++ |+.||......+....+
T Consensus       190 ~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  227 (278)
T 1byg_A          190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV  227 (278)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred             CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            58999999999999999998 99999987766655544

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.1e-37  Score=246.54  Aligned_cols=184  Identities=25%  Similarity=0.436  Sum_probs=153.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--CCCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--PQHLT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~   84 (203)
                      +..||||+++...   ...+.+.+|++++++++|+||+++++++.++      ..++||||+. ++|.+++..  ...++
T Consensus       291 ~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~l~  361 (535)
T 2h8h_A          291 TTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGETGKYLR  361 (535)
T ss_dssp             TEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEECCCTTEEHHHHHSHHHHTTCC
T ss_pred             CceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEeec------cceEeeehhcCCcHHHHHhhcCCCCCC
Confidence            4679999996532   2346788999999999999999999998763      3578999998 499998864  25699


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++...............++..|+|||++.+ ..
T Consensus       362 ~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~  440 (535)
T 2h8h_A          362 LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR  440 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhcc-CC
Confidence            99999999999999999999999999999999999999999999999997543321122233345678999999887 45


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++||||||+++|+|++ |+.||.+....+.+..+.
T Consensus       441 ~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~  478 (535)
T 2h8h_A          441 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  478 (535)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            8999999999999999999 999999988877776653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=227.82  Aligned_cols=183  Identities=31%  Similarity=0.461  Sum_probs=149.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      +.+..+|+.|+||.++..  .....+.+.+|+.+++.++||||+++++++.+.     ...++++|++. ++|.+++...
T Consensus        41 ~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~  113 (295)
T 2clq_A           41 GRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSK  113 (295)
T ss_dssp             EEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHT
T ss_pred             EEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhh
Confidence            456789999999998653  234456788999999999999999999999877     56778999996 5888887643


Q ss_pred             ---CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         81 ---QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        81 ---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                         ..+++..+..++.|++.||++||++|++|+||+|+||+++. ++.++|+|||.+....... .......+++.|.||
T Consensus       114 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aP  192 (295)
T 2clq_A          114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFTGTLQYMAP  192 (295)
T ss_dssp             TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCCCCCGGGCCH
T ss_pred             ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-CcccccCCCccccCh
Confidence               35779999999999999999999999999999999999987 8999999999987543321 222344678899999


Q ss_pred             eeeecc-cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        157 EILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       157 e~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |++.+. ..++.++|+||||+++|+|++|+.||....
T Consensus       193 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (295)
T 2clq_A          193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG  229 (295)
T ss_dssp             HHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred             hhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence            998753 237899999999999999999999997643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.4e-36  Score=246.65  Aligned_cols=188  Identities=27%  Similarity=0.414  Sum_probs=152.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~   83 (203)
                      ..+..|++|.++.. ......+.+.+|+.++++++||||+++++++.++      ..++||||+. ++|.+++... ..+
T Consensus       416 ~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~lv~E~~~~g~L~~~l~~~~~~l  488 (656)
T 2j0j_A          416 NPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKFSL  488 (656)
T ss_dssp             SCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHTTTTC
T ss_pred             CccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC------ceEEEEEcCCCCcHHHHHHhccCCC
Confidence            34667999998653 2334557788999999999999999999998544      3578999998 5999888743 469


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++...............+++.|+|||++.+ .
T Consensus       489 ~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~  567 (656)
T 2j0j_A          489 DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-R  567 (656)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC-C
Confidence            999999999999999999999999999999999999999999999999998654433333334455778999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |..||.+....+.+..+.
T Consensus       568 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~  606 (656)
T 2j0j_A          568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  606 (656)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            68999999999999999997 999999988877766553

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=229.44  Aligned_cols=181  Identities=27%  Similarity=0.418  Sum_probs=150.0

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC-C
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP-Q   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~   81 (203)
                      +..+|+.||||++...  .....+.+.+|++++++++||||+++++++.....   ...++++||+++ +|.+++... +
T Consensus        66 ~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~  140 (326)
T 2w1i_A           66 QDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKE  140 (326)
T ss_dssp             SSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTT
T ss_pred             cCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC---CceEEEEECCCCCCHHHHHHhccc
Confidence            6789999999999653  34455678899999999999999999998876532   356799999975 999988754 5


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.........  ......++..|.|||.+
T Consensus       141 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  220 (326)
T 2w1i_A          141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL  220 (326)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhh
Confidence            6999999999999999999999999999999999999999999999999999754433221  12233456779999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      .+ ..++.++|+||||+++|+|++|..||..
T Consensus       221 ~~-~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          221 TE-SKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             HH-CEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             cC-CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence            77 4478999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-36  Score=228.31  Aligned_cols=181  Identities=25%  Similarity=0.358  Sum_probs=147.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC--CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK--HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   83 (203)
                      .+|+.||||++..........+.+.+|++++++++  |+||+++++++.++     ...+++||+.+++|.+++...+.+
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~  124 (313)
T 3cek_A           50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSI  124 (313)
T ss_dssp             TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSC
T ss_pred             CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCC
Confidence            35889999999665455556778899999999996  59999999999887     467889997778999999888889


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCcccccceeeecc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      ++..++.++.|++.||++||++|++|+||+|+||++++ +.++|+|||.+........ .......+++.|+|||.+.+.
T Consensus       125 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (313)
T 3cek_A          125 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM  203 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhc
Confidence            99999999999999999999999999999999999965 8999999999975433221 122344678999999998641


Q ss_pred             ----------cCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        163 ----------RHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       163 ----------~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                                ..++.++|+||||+++|+|++|+.||....
T Consensus       204 ~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             C----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence                      357889999999999999999999997753

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=237.86  Aligned_cols=180  Identities=27%  Similarity=0.310  Sum_probs=142.3

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCC-C
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSP-Q   81 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~   81 (203)
                      ...+|+.||||++...     ......+|+++++.+ +||||+++++++.+.     ...|++||+++++|.+++... .
T Consensus        44 ~~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~  113 (432)
T 3p23_A           44 GMFDNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDF  113 (432)
T ss_dssp             EESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSC
T ss_pred             EEeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCC
Confidence            3468999999998542     223456899999999 899999999998877     567899999999999998764 3


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----CCeEEEeecCccccCCCCC--CCCcccccCCcccc
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-----NCILKICDFGLARVEEPDP--NKAMTQEVVTQYYR  154 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~  154 (203)
                      .+++..+..++.|++.||+|||++|++||||||+||+++.     ...++|+|||++.......  ........||+.|+
T Consensus       114 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~  193 (432)
T 3p23_A          114 AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI  193 (432)
T ss_dssp             CCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSC
T ss_pred             CccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCcc
Confidence            5677778899999999999999999999999999999953     2357899999997544321  12334457899999


Q ss_pred             cceeeec--ccCCCcchhHHHHHHHHHHHHh-CCcccCCCCh
Q psy16889        155 APEILMG--ARHYSAAVDVWSVGCIFAELLG-RRILFQAQSP  193 (203)
Q Consensus       155 aPe~~~~--~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~  193 (203)
                      |||++.+  ...++.++|||||||++|+|++ |..||.....
T Consensus       194 APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~  235 (432)
T 3p23_A          194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ  235 (432)
T ss_dssp             CGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT
T ss_pred             ChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH
Confidence            9999874  2446789999999999999999 9999976543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-36  Score=226.47  Aligned_cols=180  Identities=25%  Similarity=0.365  Sum_probs=148.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-----------chhHHHHHHHhhhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-----------DFFQEIYVITELLQ   70 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-----------~~~~~~~lv~e~~~   70 (203)
                      +.+..+|+.|++|+++..      .+.+.+|++++++++||||+++++++.....           .....++++|||++
T Consensus        30 ~~~~~~~~~vavK~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~  103 (284)
T 2a19_B           30 AKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD  103 (284)
T ss_dssp             EEETTTCCEEEEEEEECC------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCC
T ss_pred             EEEcCCCeEEEEEEeccc------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccC
Confidence            456778999999998642      2456789999999999999999998754110           00134689999998


Q ss_pred             H-hHHHHHhC--CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccc
Q psy16889         71 S-DLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQE  147 (203)
Q Consensus        71 ~-~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  147 (203)
                      + +|.+++..  ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.......  .....
T Consensus       104 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  181 (284)
T 2a19_B          104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRS  181 (284)
T ss_dssp             SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS--CCCCC
T ss_pred             CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc--ccccc
Confidence            5 99998864  3679999999999999999999999999999999999999999999999999987544322  22344


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      .+++.|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus       182 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          182 KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             CSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             CCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence            67899999999887 5589999999999999999999988754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-35  Score=240.93  Aligned_cols=187  Identities=28%  Similarity=0.376  Sum_probs=155.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc-chhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL-DFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +.+..+|+.||||+++.. ......+.+.+|++++++++||||+++++++..... ......++||||+. ++|.+++..
T Consensus        33 a~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~  111 (676)
T 3qa8_A           33 WIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ  111 (676)
T ss_dssp             CCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHS
T ss_pred             EEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHh
Confidence            567889999999998654 344556778899999999999999999998765211 01145689999996 599998876


Q ss_pred             CC---CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCe---EEEeecCccccCCCCCCCCcccccCCccc
Q psy16889         80 PQ---HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCI---LKICDFGLARVEEPDPNKAMTQEVVTQYY  153 (203)
Q Consensus        80 ~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  153 (203)
                      .+   .+++..++.++.|++.||+|||++|++||||+|+||+++.++.   ++|+|||.+......  .......+++.|
T Consensus       112 ~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~--~~~~~~~gt~~Y  189 (676)
T 3qa8_A          112 FENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQY  189 (676)
T ss_dssp             SSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC--CCCCCCCSCCTT
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc--cccccccCCccc
Confidence            43   6999999999999999999999999999999999999997664   899999999754432  223445779999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus       190 ~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          190 LAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             CSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             CChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            99999987 558999999999999999999999997653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-36  Score=238.40  Aligned_cols=179  Identities=28%  Similarity=0.435  Sum_probs=139.1

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~   82 (203)
                      +..+|+.||||++...     ..+.+.+|+++++++ +||||+++++++.++     ...+++||+++++|.+++...+.
T Consensus        35 ~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~  104 (434)
T 2rio_A           35 GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNV  104 (434)
T ss_dssp             EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC--
T ss_pred             EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCC
Confidence            3567999999998532     234567899999876 899999999999877     56789999999999999876543


Q ss_pred             C-------ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCC-------------CeEEEeecCccccCCCCCCC
Q psy16889         83 L-------TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN-------------CILKICDFGLARVEEPDPNK  142 (203)
Q Consensus        83 ~-------~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~-------------~~~~l~d~~~~~~~~~~~~~  142 (203)
                      .       ++..++.++.|++.||+|||++|++||||||+||+++.+             +.++|+|||++.........
T Consensus       105 ~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~  184 (434)
T 2rio_A          105 SDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS  184 (434)
T ss_dssp             ----------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----
T ss_pred             CchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCcc
Confidence            2       334567899999999999999999999999999999754             48999999999855433221


Q ss_pred             ---CcccccCCcccccceeeec------ccCCCcchhHHHHHHHHHHHHh-CCcccCCCC
Q psy16889        143 ---AMTQEVVTQYYRAPEILMG------ARHYSAAVDVWSVGCIFAELLG-RRILFQAQS  192 (203)
Q Consensus       143 ---~~~~~~~~~~~~aPe~~~~------~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~  192 (203)
                         ......||+.|+|||++.+      ...++.++|+|||||++|+|++ |+.||....
T Consensus       185 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             ----------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence               2234578999999999865      2457899999999999999998 999997654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-36  Score=225.94  Aligned_cols=186  Identities=26%  Similarity=0.383  Sum_probs=148.4

Q ss_pred             cEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCCh
Q psy16889          9 RRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTS   85 (203)
Q Consensus         9 ~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~   85 (203)
                      ..|++|+++.... .....+.+.+|++++++++||||+++++++.++.      .++++|++. ++|.+++.. .+.+++
T Consensus        47 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~v~e~~~~~~L~~~l~~~~~~~~~  120 (291)
T 1u46_A           47 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLL  120 (291)
T ss_dssp             EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS------CEEEEECCTTCBHHHHHHHHGGGSCH
T ss_pred             eEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC------ceeeEecccCCCHHHHHHhccCCcCH
Confidence            3689999865322 3345677889999999999999999999998763      468899998 588888765 366999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeeccc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.........  ......++..|+|||++.+ .
T Consensus       121 ~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~  199 (291)
T 1u46_A          121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-R  199 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-C
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcC-C
Confidence            999999999999999999999999999999999999999999999998754433221  2223345778999999876 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++|+||||+++|+|++ |+.||.+.+..+.+..+.
T Consensus       200 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            47899999999999999999 999999988777766553

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-36  Score=230.23  Aligned_cols=186  Identities=25%  Similarity=0.364  Sum_probs=149.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-   79 (203)
                      |.+..+|+.||||++..  ......+.+.+|+++++.++||||+++++++...... ....++++||+.+ +|.+++.. 
T Consensus        48 ~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~  124 (317)
T 2buj_A           48 VEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA-KHEAWLLLPFFKRGTLWNEIERL  124 (317)
T ss_dssp             EEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT-EEEEEEEEECCTTCBHHHHHHHH
T ss_pred             EEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC-CceeEEEEEeCCCCcHHHHHHHH
Confidence            45678999999999854  2334567788999999999999999999998632110 0356789999985 88777653 


Q ss_pred             ---CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--------Cccccc
Q psy16889         80 ---PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--------AMTQEV  148 (203)
Q Consensus        80 ---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~  148 (203)
                         ...+++.+++.++.|++.||++||++|++|+||||+||+++.++.++|+|||.+.........        ......
T Consensus       125 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  204 (317)
T 2buj_A          125 KDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR  204 (317)
T ss_dssp             HTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHH
T ss_pred             HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccccccccc
Confidence               577999999999999999999999999999999999999999999999999988643211110        012234


Q ss_pred             CCcccccceeeeccc--CCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        149 VTQYYRAPEILMGAR--HYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +++.|+|||++.+..  .++.++|+||||+++|+|++|+.||..
T Consensus       205 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             SCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             CCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            588899999987532  268899999999999999999999954

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=232.38  Aligned_cols=187  Identities=24%  Similarity=0.329  Sum_probs=151.0

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC-CCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ-HLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~   85 (203)
                      +..+++|++..........+.+.+|+.++++++||||+++++++.++     ...++++||+. ++|.+++...+ .+++
T Consensus        55 ~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~  129 (319)
T 2y4i_B           55 HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDV  129 (319)
T ss_dssp             SSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCS
T ss_pred             cCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCH
Confidence            34589999976544455566788899999999999999999999887     45779999997 58998887644 7999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCC----CCCCcccccCCcccccceeeec
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPD----PNKAMTQEVVTQYYRAPEILMG  161 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~aPe~~~~  161 (203)
                      ..++.++.|++.||++||++|++|+||+|+||+++ ++.++|+|||.+......    .........|++.|+|||.+.+
T Consensus       130 ~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  208 (319)
T 2y4i_B          130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ  208 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence            99999999999999999999999999999999998 679999999987643221    1122334457889999999874


Q ss_pred             --------ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        162 --------ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       162 --------~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                              ...++.++|+||||+++|+|++|+.||...........+
T Consensus       209 ~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             BSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence                    234788999999999999999999999988877666554

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.4e-37  Score=232.46  Aligned_cols=182  Identities=26%  Similarity=0.377  Sum_probs=152.2

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhcC--CCCccchhhhccCCCcchhHHHHHHHhhhH--HhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFFK--HDNVLSALDILQPPHLDFFQEIYVITELLQ--SDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l   73 (203)
                      +.+..+|+.||||++.......    ...+.+.+|+.++++++  |+||+++++++.++     ...++++|++.  ++|
T Consensus        62 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L  136 (320)
T 3a99_A           62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDL  136 (320)
T ss_dssp             EEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEH
T ss_pred             EEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-----CcEEEEEEcCCCCccH
Confidence            4567899999999995432221    23355778999999995  59999999999887     45678999986  689


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      .+++...+.+++..++.++.|++.||++||++|++||||||+||+++ .++.++|+|||.+......   ......+++.
T Consensus       137 ~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~  213 (320)
T 3a99_A          137 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRV  213 (320)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGG
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc---cccCCCCCcc
Confidence            99888778899999999999999999999999999999999999999 7899999999998754422   2234467899


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |+|||++.+....+.++|+||||+++|+|++|+.||...
T Consensus       214 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             GSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            999999887554578899999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.8e-36  Score=238.97  Aligned_cols=182  Identities=20%  Similarity=0.266  Sum_probs=147.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCC-ccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN-VLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      +.+..+|+.||||++...    .....+..|+++++.++|++ +..+..++...     ...+++|||++++|.+++.. 
T Consensus        26 a~~~~~~~~vAvK~~~~~----~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~   96 (483)
T 3sv0_A           26 GTNIQTNEEVAIKLENVK----TKHPQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFC   96 (483)
T ss_dssp             EEETTTCCEEEEEEEETT----CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT
T ss_pred             EEECCCCcEEEEEEeccc----cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhh
Confidence            456788999999987542    22345788999999997755 44444444444     45679999998899998873 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEe---cCCCeEEEeecCccccCCCCCC------CCcccccCC
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV---NSNCILKICDFGLARVEEPDPN------KAMTQEVVT  150 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~---~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~  150 (203)
                      .+.+++.+++.++.||+.+|+|||++|++||||||+||++   +.++.++|+|||++........      .......|+
T Consensus        97 ~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt  176 (483)
T 3sv0_A           97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT  176 (483)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSC
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCC
Confidence            5679999999999999999999999999999999999999   5888999999999975443322      122355789


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      +.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...
T Consensus       177 ~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          177 ARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             TTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence            99999999987 4589999999999999999999999987543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=223.10  Aligned_cols=169  Identities=31%  Similarity=0.505  Sum_probs=138.7

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCC---C
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQ---H   82 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~   82 (203)
                      .++.|++|.+...    ...+.+.+|++.+++++||||+++++++.+.       .++||||+. ++|.+++...+   .
T Consensus        30 ~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~   98 (307)
T 2eva_A           30 RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY   98 (307)
T ss_dssp             TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-------TEEEEECCTTCBHHHHHHCSSSEEC
T ss_pred             CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-------cEEEEEcCCCCCHHHHHhccCCCCc
Confidence            4788999998532    3456788999999999999999999988743       568999997 49999987654   4


Q ss_pred             CChHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEecCCCe-EEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHS---ARILHRDIKPGNLLVNSNCI-LKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~~~nil~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      +++..++.++.|++.+|++||+   +|++||||||+||+++.++. ++|+|||.+......    .....|++.|+|||+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~  174 (307)
T 2eva_A           99 YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEV  174 (307)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------------CCTTSSCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----cccCCCCCceEChhh
Confidence            7899999999999999999999   89999999999999998876 799999998743321    223357899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      +.+ ..++.++|+||||+++|+|++|+.||...
T Consensus       175 ~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          175 FEG-SNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             HTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             hCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            887 45899999999999999999999999764

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-36  Score=233.14  Aligned_cols=182  Identities=28%  Similarity=0.454  Sum_probs=147.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-----------CCCccchhhhccCCCcchhHHHHHHHhhhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-----------HDNVLSALDILQPPHLDFFQEIYVITELLQ   70 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   70 (203)
                      |.+..+|+.||||++...   ....+.+.+|+.++++++           |+||+++++++....... ...++++|+++
T Consensus        38 ~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~lv~e~~~  113 (373)
T 1q8y_A           38 AKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG-VHVVMVFEVLG  113 (373)
T ss_dssp             EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE-EEEEEEECCCC
T ss_pred             EEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC-ceEEEEEecCC
Confidence            467789999999999642   234456778999988886           889999999987642111 25679999998


Q ss_pred             HhHHHHHhC--CCCCChHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEec------CCCeEEEeecCccccCCCCCC
Q psy16889         71 SDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLVN------SNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        71 ~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~~~nil~~------~~~~~~l~d~~~~~~~~~~~~  141 (203)
                      ++|.+.+..  ...+++..+..++.|++.||++||++ |++||||||+||+++      ..+.++|+|||.+.....   
T Consensus       114 ~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~---  190 (373)
T 1q8y_A          114 ENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---  190 (373)
T ss_dssp             EEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---
T ss_pred             CCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC---
Confidence            899988874  35699999999999999999999998 999999999999995      344899999999975432   


Q ss_pred             CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       142 ~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                       ......+|+.|+|||++.+ ..++.++|+||||+++|+|++|+.||.+..
T Consensus       191 -~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          191 -HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             -CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             -CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence             2233467899999999987 458999999999999999999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-36  Score=228.55  Aligned_cols=182  Identities=24%  Similarity=0.338  Sum_probs=146.7

Q ss_pred             CcCCCCCcEEEEEeccCccchh----hhhHHHHHHHHHHhhc----CCCCccchhhhccCCCcchhHHHHHHHhh-hH-H
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----VSSKRVFRELKMLCFF----KHDNVLSALDILQPPHLDFFQEIYVITEL-LQ-S   71 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~~~~~~~~~~~~~~~~~~~lv~e~-~~-~   71 (203)
                      +.+..+|+.||||+++......    .....+.+|+..++++    +|+||+++++++.+.     ...++++|+ +. +
T Consensus        50 ~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~  124 (312)
T 2iwi_A           50 GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-----EGFMLVLERPLPAQ  124 (312)
T ss_dssp             EECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----------CEEEEECCSSEE
T ss_pred             EEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-----CeEEEEEEecCCCC
Confidence            4678899999999995532211    2334566789999888    899999999999877     567789998 44 6


Q ss_pred             hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCC
Q psy16889         72 DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVT  150 (203)
Q Consensus        72 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  150 (203)
                      +|.+++...+.+++..++.++.|++.+|++||++|++|+||+|+||+++ .++.++|+|||.+......   ......++
T Consensus       125 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~  201 (312)
T 2iwi_A          125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFDGT  201 (312)
T ss_dssp             EHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS---CBCCCCSC
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC---cccccCCc
Confidence            9999988778899999999999999999999999999999999999999 8899999999998754432   22344678


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      ..|.|||++.+....+.++|+||||+++|+|++|+.||...
T Consensus       202 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             TTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            89999999877554456899999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.9e-36  Score=225.37  Aligned_cols=179  Identities=28%  Similarity=0.435  Sum_probs=141.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCc--------chhHHHHHHHhhhH-Hh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHL--------DFFQEIYVITELLQ-SD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--------~~~~~~~lv~e~~~-~~   72 (203)
                      +.+..+|+.|+||+++.   .....+.+.+|+.++++++||||+++++++.+...        ......+++|||+. ++
T Consensus        25 ~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~  101 (303)
T 1zy4_A           25 ARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGT  101 (303)
T ss_dssp             EEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCB
T ss_pred             EEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCC
Confidence            45678999999999853   33455678899999999999999999998754321        00135689999997 59


Q ss_pred             HHHHHhC-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-----------
Q psy16889         73 LHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-----------  140 (203)
Q Consensus        73 l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-----------  140 (203)
                      |.+++.. ...+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+.......           
T Consensus       102 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  181 (303)
T 1zy4_A          102 LYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP  181 (303)
T ss_dssp             HHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------
T ss_pred             HHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhcccccccc
Confidence            9998874 4568899999999999999999999999999999999999999999999999987543221           


Q ss_pred             --CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh
Q psy16889        141 --NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG  183 (203)
Q Consensus       141 --~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~  183 (203)
                        ........+++.|+|||++.+...++.++|+||||+++|+|++
T Consensus       182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             ------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             ccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence              1222344678899999998875568999999999999999998

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.8e-36  Score=224.31  Aligned_cols=178  Identities=28%  Similarity=0.395  Sum_probs=140.6

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhh--cCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCF--FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~   83 (203)
                      +|+.||||++...     ....+..|.+++..  ++||||+++++++.+..... ...+++|||+.+ +|.+++.. ..+
T Consensus        30 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~  102 (301)
T 3q4u_A           30 QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS-TQLWLITHYHEMGSLYDYLQL-TTL  102 (301)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE-EEEEEEECCCTTCBHHHHHTT-CCB
T ss_pred             CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC-ceeEEehhhccCCCHHHHHhh-ccc
Confidence            6889999998542     23445556666665  79999999999865431110 346799999985 89988854 579


Q ss_pred             ChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcc
Q psy16889         84 TSDHIKVFLYQILRGLKYLH--------SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQY  152 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh--------~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~  152 (203)
                      ++..++.++.|++.||+|||        +.+++||||||+||+++.++.++|+|||.+.........   ......||+.
T Consensus       103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  182 (301)
T 3q4u_A          103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR  182 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccc
Confidence            99999999999999999999        999999999999999999999999999998643332221   1233477999


Q ss_pred             cccceeeeccc-----CCCcchhHHHHHHHHHHHHhC----------CcccCCC
Q psy16889        153 YRAPEILMGAR-----HYSAAVDVWSVGCIFAELLGR----------RILFQAQ  191 (203)
Q Consensus       153 ~~aPe~~~~~~-----~~~~~~Di~slG~~l~~ll~g----------~~pf~~~  191 (203)
                      |+|||++.+..     .++.++|+||||+++|+|++|          +.||...
T Consensus       183 y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             GCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             eeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99999988742     234689999999999999999          8888653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.7e-36  Score=227.39  Aligned_cols=182  Identities=29%  Similarity=0.425  Sum_probs=126.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.++.+|+.||||++...      .....+....++.++||||+++++++....... ...++||||+.+ +|.+++...
T Consensus        48 ~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~~  120 (336)
T 3fhr_A           48 CFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQER  120 (336)
T ss_dssp             EEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE-EEEEEEEECCTTEEHHHHHHTC
T ss_pred             EEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC-ceEEEEEeccCCCCHHHHHHhc
Confidence            567889999999998542      111223334466779999999999986521100 346899999985 999998765


Q ss_pred             --CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         81 --QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        81 --~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                        ..+++.+++.++.|++.||++||++|++||||||+||+++.   ++.++|+|||.+.....   .......+++.|+|
T Consensus       121 ~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~t~~y~a  197 (336)
T 3fhr_A          121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVA  197 (336)
T ss_dssp             -CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------------
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc---cccccCCCCcCccC
Confidence              36999999999999999999999999999999999999986   45599999999975432   22234466889999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                      ||++.+ ..++.++|+||||+++|+|++|+.||......
T Consensus       198 PE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (336)
T 3fhr_A          198 PEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ  235 (336)
T ss_dssp             -------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             hhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence            999876 44789999999999999999999999776543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2e-35  Score=231.34  Aligned_cols=194  Identities=14%  Similarity=0.142  Sum_probs=139.5

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCC-CCccchhhh---------c------------cCCCcch
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKH-DNVLSALDI---------L------------QPPHLDF   58 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~---------~------------~~~~~~~   58 (203)
                      |.|..+|+.||||+++... ......+.+.+|+.+++.++| .+...+..+         .            .......
T Consensus        97 a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (413)
T 3dzo_A           97 ATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMW  176 (413)
T ss_dssp             EEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------
T ss_pred             EEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCcccc
Confidence            5678899999999986322 233446778899999999977 333222222         1            1110000


Q ss_pred             hHHHHHHHhhhHHhHHHHHh-------CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecC
Q psy16889         59 FQEIYVITELLQSDLHKIIV-------SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFG  131 (203)
Q Consensus        59 ~~~~~lv~e~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~  131 (203)
                      ...++++++.+.++|.+++.       ..+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus       177 ~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG  256 (413)
T 3dzo_A          177 VLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE  256 (413)
T ss_dssp             CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGG
T ss_pred             ccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEecc
Confidence            01234455556666766653       23458888999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCcccccCCcccccceeee---------cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        132 LARVEEPDPNKAMTQEVVTQYYRAPEILM---------GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~---------~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      ++......    .....| +.|+|||++.         ....++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus       257 ~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~  329 (413)
T 3dzo_A          257 HLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI  329 (413)
T ss_dssp             GCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG
T ss_pred             ceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH
Confidence            98753322    334456 8899999983         2245788999999999999999999999887655444433

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.9e-36  Score=243.91  Aligned_cols=175  Identities=18%  Similarity=0.106  Sum_probs=129.9

Q ss_pred             CcCCCCCcEEEEEeccCcc--------chhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-
Q psy16889          2 VTDPRDGRRVALKKLPNVF--------QSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-   71 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-   71 (203)
                      ++....|+.|+||++....        ....+.+.+.+|+++|+++ .|+||++++++++++     ...||||||++| 
T Consensus       253 ~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-----~~~yLVMEyv~G~  327 (569)
T 4azs_A          253 SRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-----QSGWLVMEKLPGR  327 (569)
T ss_dssp             CEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-----SEEEEEEECCCSE
T ss_pred             cccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-----CEEEEEEecCCCC
Confidence            3445679999999995421        1234456789999999999 899999999999998     678999999996 


Q ss_pred             hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         72 DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        72 ~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                      +|.+.+...+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++..... ........||+
T Consensus       328 ~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-~~~~~t~vGTp  403 (569)
T 4azs_A          328 LLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-CSWPTNLVQSF  403 (569)
T ss_dssp             EHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHH
T ss_pred             cHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC-CccccCceech
Confidence            999999998888875   47899999999999999999999999999999999999999999754433 23334557899


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcc
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL  187 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  187 (203)
                      .|+|||++.+.  +...+|+||+|++.+++.++..|
T Consensus       404 ~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          404 FVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHC-------------------CCCCTTHHH
T ss_pred             hhccHHHhCCC--CCCcccccccccchhhhccccch
Confidence            99999999873  56789999999998777655444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=224.08  Aligned_cols=177  Identities=27%  Similarity=0.334  Sum_probs=133.7

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHH--HHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVF--RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      .+|+.||||+++..     ....+.  .|+..++.++||||+++++.+..........+++||||++ ++|.+++.... 
T Consensus        34 ~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-  107 (336)
T 3g2f_A           34 LDERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-  107 (336)
T ss_dssp             ETTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC-
T ss_pred             ECCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc-
Confidence            36889999998532     222333  3444455689999999997433211111134679999997 59998886543 


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEecCCCeEEEeecCccccCCCCC-------CCCccc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSA---------RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-------NKAMTQ  146 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~---------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~  146 (203)
                      .++..+..++.|++.||+|||++         |++||||||+||+++.++.++|+|||.+.......       ......
T Consensus       108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred             cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccccc
Confidence            58999999999999999999999         99999999999999999999999999997543221       112234


Q ss_pred             ccCCcccccceeeecc------cCCCcchhHHHHHHHHHHHHhCCccc
Q psy16889        147 EVVTQYYRAPEILMGA------RHYSAAVDVWSVGCIFAELLGRRILF  188 (203)
Q Consensus       147 ~~~~~~~~aPe~~~~~------~~~~~~~Di~slG~~l~~ll~g~~pf  188 (203)
                      ..||+.|+|||++.+.      ..++.++||||||+++|+|++|..||
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            4689999999998762      23567899999999999999996665

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.9e-34  Score=218.71  Aligned_cols=178  Identities=24%  Similarity=0.400  Sum_probs=144.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhh--cCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCF--FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~   83 (203)
                      +|+.||||+++..     ....+.+|.++++.  ++||||+++++++....... ...+++|||+.+ +|.+++.. ..+
T Consensus        64 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~  136 (342)
T 1b6c_B           64 RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNR-YTV  136 (342)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC-CCEEEEECCCTTCBHHHHHHH-CCB
T ss_pred             cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc-ceeEEEEeecCCCcHHHHHhc-cCc
Confidence            5889999998532     33556778888887  79999999999988764211 156799999985 99998865 469


Q ss_pred             ChHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcc
Q psy16889         84 TSDHIKVFLYQILRGLKYLH--------SARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQY  152 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh--------~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~  152 (203)
                      ++.+++.++.|++.+|++||        +.+++|+||||+||+++.++.++|+|||.+.........   ......+++.
T Consensus       137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~  216 (342)
T 1b6c_B          137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  216 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGG
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcc
Confidence            99999999999999999999        899999999999999999999999999998754333221   2344467899


Q ss_pred             cccceeeecccC-----CCcchhHHHHHHHHHHHHhC----------CcccCCC
Q psy16889        153 YRAPEILMGARH-----YSAAVDVWSVGCIFAELLGR----------RILFQAQ  191 (203)
Q Consensus       153 ~~aPe~~~~~~~-----~~~~~Di~slG~~l~~ll~g----------~~pf~~~  191 (203)
                      |+|||++.+...     ++.++|+||||+++|+|++|          +.||...
T Consensus       217 y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             GCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             cCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            999999876422     23689999999999999999          7888664

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-35  Score=241.48  Aligned_cols=177  Identities=23%  Similarity=0.301  Sum_probs=143.2

Q ss_pred             cCCC-CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          3 TDPR-DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         3 ~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      .+.. +|+.|+||++... ......+.+.+|++++++++||||+++++++...........|+||||++| +|.+.+.. 
T Consensus       100 ~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-  177 (681)
T 2pzi_A          100 LDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-  177 (681)
T ss_dssp             EEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-
T ss_pred             EEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-
Confidence            4444 7899999998643 233455678899999999999999999999887632111125899999985 77665544 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                       .+++.+++.++.|++.+|.|||++|++||||||+||+++.+ .+||+|||.+......     ....||+.|+|||++.
T Consensus       178 -~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~  250 (681)
T 2pzi_A          178 -KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVR  250 (681)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-----SCCCCCTTTSCTTHHH
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-----CccCCCccccCHHHHc
Confidence             79999999999999999999999999999999999999985 9999999999754332     3446799999999987


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      + . ++.++||||||+++|+|++|.+||.+
T Consensus       251 ~-~-~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          251 T-G-PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             H-C-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             C-C-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            6 3 48899999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-34  Score=216.72  Aligned_cols=176  Identities=28%  Similarity=0.408  Sum_probs=136.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhh--cCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCF--FKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~   83 (203)
                      +|+.||||++...     .......|.+++..  ++||||+++++++.+..... ...+++|||+.+ +|.+++.. ..+
T Consensus        59 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~  131 (337)
T 3mdy_A           59 RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW-TQLYLITDYHENGSLYDYLKS-TTL  131 (337)
T ss_dssp             TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG-CEEEEEECCCTTCBHHHHHHH-CCB
T ss_pred             CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC-CceEEEEeccCCCcHHHHhhc-cCC
Confidence            4889999998432     22334445555544  49999999999987654321 246799999985 99988865 469


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSA--------RILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQY  152 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~--------~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~  152 (203)
                      ++..++.++.|++.||++||++        |++||||||+||+++.++.++|+|||.+.........   ......|++.
T Consensus       132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  211 (337)
T 3mdy_A          132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR  211 (337)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence            9999999999999999999998        9999999999999999999999999998654332221   1234478999


Q ss_pred             cccceeeecccCCCc------chhHHHHHHHHHHHHhC----------CcccCC
Q psy16889        153 YRAPEILMGARHYSA------AVDVWSVGCIFAELLGR----------RILFQA  190 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~------~~Di~slG~~l~~ll~g----------~~pf~~  190 (203)
                      |+|||++.+.. ...      ++|+||||+++|+|++|          +.||..
T Consensus       212 y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          212 YMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             GCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99999987643 333      38999999999999999          777755

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-33  Score=211.45  Aligned_cols=157  Identities=13%  Similarity=0.071  Sum_probs=132.6

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +++..+|+.||||++..... .....+.+.+|+..+++++||||+++++++.++     ...|+||||+. ++|.+++..
T Consensus        50 a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~  124 (286)
T 3uqc_A           50 ALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADT  124 (286)
T ss_dssp             EEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTT
T ss_pred             EEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhc
Confidence            56778899999999965433 234457788999999999999999999999887     56789999997 588888754


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                       + ....++..++.|++.+|+|||++|++||||||+||+++.++.+++++++.                     .+    
T Consensus       125 -~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~---------------------~~----  177 (286)
T 3uqc_A          125 -S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT---------------------MP----  177 (286)
T ss_dssp             -C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------------------CT----
T ss_pred             -C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------------------cC----
Confidence             3 46667899999999999999999999999999999999999999874432                     22    


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                          .++.++|+||||+++|+|++|+.||.+.+..
T Consensus       178 ----~~~~~~Di~slG~il~elltg~~Pf~~~~~~  208 (286)
T 3uqc_A          178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVR  208 (286)
T ss_dssp             ----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred             ----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence                2688999999999999999999999886653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.9e-35  Score=221.99  Aligned_cols=175  Identities=17%  Similarity=0.160  Sum_probs=138.3

Q ss_pred             CCcEEEEEeccCccc------hhhhhHHHHHHHHHHhhcC--------------------------CCCccchhhhccCC
Q psy16889          7 DGRRVALKKLPNVFQ------SLVSSKRVFRELKMLCFFK--------------------------HDNVLSALDILQPP   54 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~--------------------------~~~i~~~~~~~~~~   54 (203)
                      +|+.||||+++....      .....+.+.+|+++++.++                          ||||+++++++.+.
T Consensus        42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~  121 (336)
T 2vuw_A           42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST  121 (336)
T ss_dssp             TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence            689999999965321      2223467888999988886                          77777888877651


Q ss_pred             Cc--------chhHHHHHHHhhhH-HhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCC-
Q psy16889         55 HL--------DFFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLH-SARILHRDIKPGNLLVNSNC-  123 (203)
Q Consensus        55 ~~--------~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~~~nil~~~~~-  123 (203)
                      ..        .....+++||||+. |++.+.+.. +.+++.+++.++.|++.||+||| ++|++||||||+||+++.++ 
T Consensus       122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~  200 (336)
T 2vuw_A          122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL  200 (336)
T ss_dssp             TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSC
T ss_pred             ccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCC
Confidence            00        00156789999986 456666544 67899999999999999999999 99999999999999999887 


Q ss_pred             -------------------eEEEeecCccccCCCCCCCCcccccCCcccccceeeecccCCCcchhHHHHHHH-HHHHHh
Q psy16889        124 -------------------ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI-FAELLG  183 (203)
Q Consensus       124 -------------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~-l~~ll~  183 (203)
                                         .+||+|||+++....      ....||+.|+|||++.+..  +.++|||||+++ .+++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~  272 (336)
T 2vuw_A          201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWG  272 (336)
T ss_dssp             SEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTT
T ss_pred             cceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCCC--ccceehhhhhCCCCccccc
Confidence                               899999999985432      2337799999999998743  889999998777 777888


Q ss_pred             CCcccCC
Q psy16889        184 RRILFQA  190 (203)
Q Consensus       184 g~~pf~~  190 (203)
                      |..||.+
T Consensus       273 g~~p~~~  279 (336)
T 2vuw_A          273 EYHPYSN  279 (336)
T ss_dssp             SCCTHHH
T ss_pred             ccCCCcc
Confidence            9999965

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.98  E-value=1.9e-33  Score=211.40  Aligned_cols=161  Identities=29%  Similarity=0.465  Sum_probs=130.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHH-hhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |.+..+|+.||+|+++.       .....+|++.+ +..+||||+++++++...... ....+++|||+.+ +|.+++..
T Consensus        37 ~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~  108 (299)
T 3m2w_A           37 IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAG-RKCLLIVMECLDGGELFSRIQD  108 (299)
T ss_dssp             EEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT-EEEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCC-CceEEEEEeecCCCcHHHHHHh
Confidence            46778999999999853       24566788877 556999999999988651000 0457899999975 99998875


Q ss_pred             C--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 P--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 ~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .  ..+++..++.++.|++.||++||++|++|+||||+||+++.   ++.++|+|||.+....                 
T Consensus       109 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------  171 (299)
T 3m2w_A          109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----------------  171 (299)
T ss_dssp             CTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------------
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------------
Confidence            4  36999999999999999999999999999999999999997   7889999999886321                 


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChH
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPV  194 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~  194 (203)
                            + ..++.++|+||||+++|+|++|+.||.+....
T Consensus       172 ------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  204 (299)
T 3m2w_A          172 ------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  204 (299)
T ss_dssp             ------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred             ------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence                  1 23678999999999999999999999775543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=2e-26  Score=185.52  Aligned_cols=169  Identities=19%  Similarity=0.216  Sum_probs=130.0

Q ss_pred             CCCcEEEEEeccCccc------hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          6 RDGRRVALKKLPNVFQ------SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      ..++.+++|.......      .....+.+.+|++++++++||||+++..+..+.     ...++||||++ ++|.+++.
T Consensus       357 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~  431 (540)
T 3en9_A          357 YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIE  431 (540)
T ss_dssp             CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHST
T ss_pred             ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHH
Confidence            3577889998633211      112245678999999999999999544444443     34589999997 69998876


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCC------cccccCCcc
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKA------MTQEVVTQY  152 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~------~~~~~~~~~  152 (203)
                      .        +..++.|++.+|+|||+++++||||||+||+++.  .+||+|||+++.........      .....||+.
T Consensus       432 ~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~  501 (540)
T 3en9_A          432 D--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHH  501 (540)
T ss_dssp             T--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCG
T ss_pred             H--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCC
Confidence            5        6789999999999999999999999999999999  99999999998654322111      124577999


Q ss_pred             cccceeeecc-cCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        153 YRAPEILMGA-RHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       153 ~~aPe~~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                      |+|||++... ..|+...|+||..+-..+-..++.+|.
T Consensus       502 y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          502 EKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             GGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            9999998751 236777899999998888887777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=3e-22  Score=149.13  Aligned_cols=115  Identities=18%  Similarity=0.179  Sum_probs=89.8

Q ss_pred             CcCCCCCcEEEEEeccCccchh----------------hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL----------------VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI   65 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   65 (203)
                      |.+ .+|+.||||+++....+.                .....+.+|++++++++  | +++.+++..      ...++|
T Consensus       109 ~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~------~~~~lv  178 (282)
T 1zar_A          109 CYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW------EGNAVL  178 (282)
T ss_dssp             EEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE------ETTEEE
T ss_pred             EEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec------cceEEE
Confidence            345 689999999995432111                23566889999999999  4 666665533      345899


Q ss_pred             HhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         66 TELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        66 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      |||++| +|.+ +.      ......++.|++.++++||++|++||||||+||+++ ++.++|+|||.+.
T Consensus       179 mE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          179 MELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             EECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             EEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            999975 7777 32      234567999999999999999999999999999999 9999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=6.7e-19  Score=129.48  Aligned_cols=119  Identities=17%  Similarity=0.168  Sum_probs=87.9

Q ss_pred             cCCCCCcE--EEEEeccCccchh----------------------hhhHHHHHHHHHHhhcCCCCc--cchhhhccCCCc
Q psy16889          3 TDPRDGRR--VALKKLPNVFQSL----------------------VSSKRVFRELKMLCFFKHDNV--LSALDILQPPHL   56 (203)
Q Consensus         3 ~~~~~~~~--~~vK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~~~   56 (203)
                      .+..+|+.  ||||+++......                      .....+.+|++.++.+.|+++  +.+++.      
T Consensus        67 ~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~------  140 (258)
T 1zth_A           67 DGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY------  140 (258)
T ss_dssp             EEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE------
T ss_pred             EEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc------
Confidence            34467888  9999875431110                      112357789999999988764  333321      


Q ss_pred             chhHHHHHHHhhhHH------hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEecCCCeEEEee
Q psy16889         57 DFFQEIYVITELLQS------DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLH-SARILHRDIKPGNLLVNSNCILKICD  129 (203)
Q Consensus        57 ~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~~~nil~~~~~~~~l~d  129 (203)
                         ...++||||+++      .|.+....   .++..+..++.|++.++.+|| +.|++||||||+||+++.  .++|+|
T Consensus       141 ---~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liD  212 (258)
T 1zth_A          141 ---MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFID  212 (258)
T ss_dssp             ---ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECC
T ss_pred             ---CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEE
Confidence               235689999952      56655332   346678899999999999999 999999999999999998  999999


Q ss_pred             cCcccc
Q psy16889        130 FGLARV  135 (203)
Q Consensus       130 ~~~~~~  135 (203)
                      ||++..
T Consensus       213 FG~a~~  218 (258)
T 1zth_A          213 MGQAVT  218 (258)
T ss_dssp             CTTCEE
T ss_pred             Cccccc
Confidence            999964

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.51  E-value=1.2e-15  Score=117.28  Aligned_cols=68  Identities=12%  Similarity=0.174  Sum_probs=54.7

Q ss_pred             HHHHHhhhHH-hHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----------eEEEeec
Q psy16889         62 IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----------ILKICDF  130 (203)
Q Consensus        62 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----------~~~l~d~  130 (203)
                      .++||||++| .|....      ..+....++.|++.++.+||+.|++||||||.|||++.++          .+.++||
T Consensus       186 ~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~  259 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXF  259 (397)
T ss_dssp             TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCC
T ss_pred             ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEe
Confidence            3589999986 443321      2234567889999999999999999999999999998776          3899999


Q ss_pred             Ccccc
Q psy16889        131 GLARV  135 (203)
Q Consensus       131 ~~~~~  135 (203)
                      +.+..
T Consensus       260 ~Q~V~  264 (397)
T 4gyi_A          260 PQMVS  264 (397)
T ss_dssp             TTCEE
T ss_pred             CCccc
Confidence            98753

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.21  E-value=3.6e-12  Score=93.55  Aligned_cols=116  Identities=14%  Similarity=0.137  Sum_probs=87.2

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~   84 (203)
                      .|+.+++|+.+....  .....+.+|++.++.+ .+..+++++++..+.     ...|++||+++| ++.+...     +
T Consensus        36 ~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~  103 (263)
T 3tm0_A           36 ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----D  103 (263)
T ss_dssp             SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----T
T ss_pred             CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----C
Confidence            368899999864211  2334688899999988 466788888887765     456789999997 5655421     2


Q ss_pred             hHHHHHHHHHHHHHHHHHHh-----------------------------------------------------------C
Q psy16889         85 SDHIKVFLYQILRGLKYLHS-----------------------------------------------------------A  105 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~-----------------------------------------------------------~  105 (203)
                      ......++.+++.++..||+                                                           .
T Consensus       104 ~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~  183 (263)
T 3tm0_A          104 EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL  183 (263)
T ss_dssp             TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCE
T ss_pred             cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCc
Confidence            23345788899999999998                                                           4


Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++|+|++|.||+++.+....++||+.+.
T Consensus       184 ~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             eEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence            48999999999999876556799998775

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=1.4e-11  Score=92.50  Aligned_cols=174  Identities=20%  Similarity=0.233  Sum_probs=101.7

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCC--ccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCCC
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDN--VLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHLT   84 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~   84 (203)
                      ..+++|+.+..    .....+.+|.+.++.+ .+..  +++++......  ......|+||++++| .+.....  ..++
T Consensus        41 ~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~~i~G~~l~~~~~--~~l~  112 (304)
T 3sg8_A           41 RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFTKIKGVPLTPLLL--NNLP  112 (304)
T ss_dssp             TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEECCCCEECCHHHH--HTSC
T ss_pred             CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEcccCCeECCcccc--ccCC
Confidence            46788886432    3456788899999888 3333  34444333222  111234667888876 3322111  2456


Q ss_pred             hHHHHHHHHHHHHHHHHHHh----------------------------------------------------------CC
Q psy16889         85 SDHIKVFLYQILRGLKYLHS----------------------------------------------------------AR  106 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~----------------------------------------------------------~~  106 (203)
                      .++...++.+++..+..||+                                                          ..
T Consensus       113 ~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~  192 (304)
T 3sg8_A          113 KQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPC  192 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCce
Confidence            66777777777777777775                                                          23


Q ss_pred             ceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCCcccccceeee---ccc-C---------CCcchhH
Q psy16889        107 ILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM---GAR-H---------YSAAVDV  171 (203)
Q Consensus       107 i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~---~~~-~---------~~~~~Di  171 (203)
                      ++|+|++|.||+++.  ...+.++||+.+........-...... . .-..|+...   ... .         .....+.
T Consensus       193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~-~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~  270 (304)
T 3sg8_A          193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED-D-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKY  270 (304)
T ss_dssp             EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT-T-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHH
T ss_pred             eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh-c-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHH
Confidence            699999999999997  456789999988643221100000000 0 001111110   000 0         1123589


Q ss_pred             HHHHHHHHHHHhCCcccCCCC
Q psy16889        172 WSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       172 ~slG~~l~~ll~g~~pf~~~~  192 (203)
                      |+++.++|.+.+|..+|-...
T Consensus       271 ~~l~~~~~~~~~g~~~~~~~g  291 (304)
T 3sg8_A          271 WSFEKIIYGKEYGYMDWYEEG  291 (304)
T ss_dssp             HHHHHHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHHHHHcCCHHHHHHH
Confidence            999999999999999985543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.99  E-value=2.6e-11  Score=88.65  Aligned_cols=111  Identities=15%  Similarity=0.177  Sum_probs=78.5

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCC--ccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDN--VLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   82 (203)
                      .+|+.+++|+.+..     ....+..|++.++.+.+.+  +++++.+..++     ...+++||+++| ++ . .   ..
T Consensus        42 ~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~---~~  106 (264)
T 1nd4_A           42 QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-S---SH  106 (264)
T ss_dssp             TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEECCSSEET-T-T---SC
T ss_pred             CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEEEEecCCccc-C-c---Cc
Confidence            45778999997542     2345778999999885444  55677776655     345788999987 44 3 1   11


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCC--------------------------------------------------------
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSAR--------------------------------------------------------  106 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~--------------------------------------------------------  106 (203)
                      .+   ...++.+++..+..||+..                                                        
T Consensus       107 ~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  183 (264)
T 1nd4_A          107 LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED  183 (264)
T ss_dssp             CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred             CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCC
Confidence            11   2356677777777777643                                                        


Q ss_pred             --ceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        107 --ILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       107 --i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                        ++|+|++|.||+++.++.+.++||+.+.
T Consensus       184 ~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          184 LVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence              9999999999999876556799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.97  E-value=1.8e-10  Score=88.36  Aligned_cols=123  Identities=17%  Similarity=0.270  Sum_probs=86.7

Q ss_pred             CcEEEEEecc--CccchhhhhHHHHHHHHHHhhcCC--CCccchhhhccCCCcchhHHHHHHHhhhHHh-HHHHHhCCCC
Q psy16889          8 GRRVALKKLP--NVFQSLVSSKRVFRELKMLCFFKH--DNVLSALDILQPPHLDFFQEIYVITELLQSD-LHKIIVSPQH   82 (203)
Q Consensus         8 ~~~~~vK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~   82 (203)
                      +..+++|+.+  ... .......+.+|+++++.+..  ..+++++.++.+...  ....|++||+++|. +.+  .....
T Consensus        61 ~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~vme~v~G~~l~~--~~~~~  135 (359)
T 3dxp_A           61 GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFYIMEFVSGRVLWD--QSLPG  135 (359)
T ss_dssp             SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEEEEECCCCBCCCC--TTCTT
T ss_pred             CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEEEEEecCCeecCC--Ccccc
Confidence            4678888876  321 11234567789999999964  457788877765421  13457899999873 222  11234


Q ss_pred             CChHHHHHHHHHHHHHHHHHHh----------------------------------------------------------
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHS----------------------------------------------------------  104 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~----------------------------------------------------------  104 (203)
                      +++.+...++.+++..|..||+                                                          
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            7888899999999999999997                                                          


Q ss_pred             CCceecCCCCCcEEecCCCe--EEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCI--LKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~--~~l~d~~~~~~  135 (203)
                      ..++|+|++|.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            35899999999999997653  68999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=1.4e-07  Score=69.18  Aligned_cols=117  Identities=15%  Similarity=0.238  Sum_probs=72.4

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQH   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~   82 (203)
                      ...+..+++|+-+.     .....+.+|...++.+. +--+++++.++.+.     ...+++||+++| ++.+....   
T Consensus        47 ~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~---  113 (272)
T 4gkh_A           47 KPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEE---  113 (272)
T ss_dssp             CTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHH---
T ss_pred             cCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCccccccccC---
Confidence            34567789998653     23456778999888883 33467777777665     344677777765 33222111   


Q ss_pred             CChHHHHHHHHHHHHHHHHHHh---------------------------------------------------C------
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHS---------------------------------------------------A------  105 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~---------------------------------------------------~------  105 (203)
                       .......+..++...+..||+                                                   .      
T Consensus       114 -~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  192 (272)
T 4gkh_A          114 -YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPD  192 (272)
T ss_dssp             -CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCC
T ss_pred             -CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCC
Confidence             111122333334444433332                                                   1      


Q ss_pred             -CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        106 -RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       106 -~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                       .++|+|+++.||+++.++..-++||+.+..
T Consensus       193 ~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          193 SVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence             268999999999999876677999998863

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.29  E-value=5.1e-07  Score=67.63  Aligned_cols=118  Identities=19%  Similarity=0.216  Sum_probs=69.2

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCC---CccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCCCCC
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHD---NVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSPQHL   83 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~   83 (203)
                      |+.+++|+.+.    ......+.+|.+.++.+.+.   .+++++.+.....    ...+++|++++| .+.....  ..+
T Consensus        39 g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~----g~~~~v~e~i~G~~l~~~~~--~~l  108 (306)
T 3tdw_A           39 NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD----GNPFVGYRKVQGQILGEDGM--AVL  108 (306)
T ss_dssp             TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT----SCEEEEEECCCSEECHHHHH--TTS
T ss_pred             CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC----CceEEEEeccCCeECchhhh--hhC
Confidence            56688888532    23456788999999999642   2555555543211    223467777665 2222110  122


Q ss_pred             ChHHHHHHHHHHHHHHHHHHh-----------------------------------------------------------
Q psy16889         84 TSDHIKVFLYQILRGLKYLHS-----------------------------------------------------------  104 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~-----------------------------------------------------------  104 (203)
                      +.++...++.++...+..||+                                                           
T Consensus       109 ~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~  188 (306)
T 3tdw_A          109 PDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRY  188 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCC
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccC
Confidence            333344444444444444432                                                           


Q ss_pred             -CCceecCCCCCcEEecC---CCeE-EEeecCcccc
Q psy16889        105 -ARILHRDIKPGNLLVNS---NCIL-KICDFGLARV  135 (203)
Q Consensus       105 -~~i~H~di~~~nil~~~---~~~~-~l~d~~~~~~  135 (203)
                       ..++|+|++|.|++++.   ++.+ .++||+.+..
T Consensus       189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence             24699999999999987   4554 8999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.72  E-value=7.9e-06  Score=62.31  Aligned_cols=31  Identities=19%  Similarity=0.329  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ..++|+|+++.||+++++..+.++||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.60  E-value=4.5e-05  Score=59.06  Aligned_cols=31  Identities=19%  Similarity=0.386  Sum_probs=26.3

Q ss_pred             hCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        104 SARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       104 ~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ...++|||+++.||+++.+ .+.++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            4579999999999999876 589999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.60  E-value=0.00046  Score=48.63  Aligned_cols=100  Identities=14%  Similarity=0.083  Sum_probs=65.3

Q ss_pred             hHHHHHh-CCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccC
Q psy16889         72 DLHKIIV-SPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV  149 (203)
Q Consensus        72 ~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  149 (203)
                      +|.+.+. .+.+++|+++|.++.|.+..|...-. ..-..+=+.|..|++..+|++.+.+ ..+.             ..
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~   99 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AG   99 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------cc
Confidence            5777776 45789999999999999999887632 2223444567889999999887664 1110             01


Q ss_pred             CcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcc
Q psy16889        150 TQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRIL  187 (203)
Q Consensus       150 ~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~p  187 (203)
                      ...+.+||....  ..+.+.=|||||+++|.-+--..|
T Consensus       100 ~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A          100 EPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCC
Confidence            223677876642  245677899999999999865555

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.21  E-value=0.00051  Score=51.06  Aligned_cols=29  Identities=21%  Similarity=0.209  Sum_probs=24.8

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .++|+|+.+.|++ ..++.+.++||+.+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5666889999998763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.08  E-value=0.00092  Score=50.28  Aligned_cols=31  Identities=23%  Similarity=0.363  Sum_probs=27.8

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ..++|+|+++.||+++.++.+.++||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            5799999999999998778899999998753

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.63  E-value=0.0018  Score=50.47  Aligned_cols=32  Identities=16%  Similarity=0.410  Sum_probs=28.1

Q ss_pred             HhCCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        103 HSARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       103 h~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      +...++|||++|.||+++.++ +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            467899999999999998776 99999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.53  E-value=0.0068  Score=45.53  Aligned_cols=32  Identities=28%  Similarity=0.405  Sum_probs=27.3

Q ss_pred             hCCceecCCCCCcEEecCC----CeEEEeecCcccc
Q psy16889        104 SARILHRDIKPGNLLVNSN----CILKICDFGLARV  135 (203)
Q Consensus       104 ~~~i~H~di~~~nil~~~~----~~~~l~d~~~~~~  135 (203)
                      ...++|||+++.||+++.+    +.+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3479999999999999874    6789999998864

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.36  E-value=0.016  Score=43.31  Aligned_cols=29  Identities=31%  Similarity=0.307  Sum_probs=25.0

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ..++|||+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 899999987753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.12  E-value=0.015  Score=43.99  Aligned_cols=31  Identities=29%  Similarity=0.422  Sum_probs=27.3

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ..++|+|+.+.|++++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999878899999987754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.08  E-value=0.0073  Score=45.07  Aligned_cols=30  Identities=23%  Similarity=0.360  Sum_probs=25.5

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .+++|+|+++.||+++.++...++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            368999999999999877556899998775

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=94.54  E-value=0.04  Score=41.96  Aligned_cols=28  Identities=25%  Similarity=0.631  Sum_probs=23.7

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++|+|+++.||+++.++ +.++||+.+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            589999999999998654 8999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.62  E-value=0.035  Score=43.84  Aligned_cols=15  Identities=20%  Similarity=0.379  Sum_probs=14.1

Q ss_pred             CceecCCCCCcEEec
Q psy16889        106 RILHRDIKPGNLLVN  120 (203)
Q Consensus       106 ~i~H~di~~~nil~~  120 (203)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            589999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=93.47  E-value=0.026  Score=44.11  Aligned_cols=29  Identities=31%  Similarity=0.502  Sum_probs=24.1

Q ss_pred             CceecCCCCCcEEecCC----------------------------CeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSN----------------------------CILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~----------------------------~~~~l~d~~~~~  134 (203)
                      .++|+|+.+.||+++.+                            +.+.++||+.+.
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~  306 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  306 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence            48999999999999875                            678999998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=93.37  E-value=0.038  Score=42.47  Aligned_cols=29  Identities=34%  Similarity=0.516  Sum_probs=26.0

Q ss_pred             CceecCCCCCcEEecCC----CeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSN----CILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~----~~~~l~d~~~~~  134 (203)
                      .++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            58999999999999876    789999999875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.61  E-value=0.06  Score=41.64  Aligned_cols=29  Identities=28%  Similarity=0.481  Sum_probs=24.7

Q ss_pred             ceecCCCCCcEEe------cCCCeEEEeecCcccc
Q psy16889        107 ILHRDIKPGNLLV------NSNCILKICDFGLARV  135 (203)
Q Consensus       107 i~H~di~~~nil~------~~~~~~~l~d~~~~~~  135 (203)
                      ++|+|+.+.||++      +++..+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      3466799999998753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.74  E-value=0.41  Score=33.70  Aligned_cols=52  Identities=23%  Similarity=0.127  Sum_probs=41.7

Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++..+.++++..++..... |...-+|--++|+|++++.++.+++.-.|...
T Consensus        81 ~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A           81 KTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             TSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECTTCCEEESCCEETT
T ss_pred             hcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence            47888999999888886651 23456888999999999999999998877653

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.83  E-value=0.4  Score=33.62  Aligned_cols=83  Identities=14%  Similarity=0.083  Sum_probs=58.6

Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..++..+.++++.+++...+++  ..-+|--++|+|++++.++.+++.-.|....                  ++|.   
T Consensus        76 k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~~p~i~~RGik~~------------------l~P~---  132 (215)
T 4ann_A           76 KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDGLPIAKTRGLQNV------------------VDPL---  132 (215)
T ss_dssp             GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTSCEEESCCEETTT------------------BSCC---
T ss_pred             HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCCCEEEEEccCccC------------------CCCC---
Confidence            3478889999999999877433  3458889999999999999999887765431                  1221   


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccC
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQ  189 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~  189 (203)
                         ..+...=+-..-|++..+++++..|.
T Consensus       133 ---~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          133 ---PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ---CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence               12233335566777788888877773

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.47  E-value=0.11  Score=40.47  Aligned_cols=28  Identities=21%  Similarity=0.471  Sum_probs=25.2

Q ss_pred             CceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        106 RILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       106 ~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .++|+|+.+.|++ +.++.+.++||..+.
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCC
Confidence            4899999999999 778899999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=87.73  E-value=0.21  Score=37.27  Aligned_cols=26  Identities=19%  Similarity=0.328  Sum_probs=23.0

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecC
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFG  131 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~  131 (203)
                      ..++|+|+.+.|++++.++ ..++|+.
T Consensus       207 ~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          207 PSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            3699999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=87.13  E-value=0.21  Score=36.54  Aligned_cols=34  Identities=21%  Similarity=0.113  Sum_probs=23.7

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK   40 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~   40 (203)
                      ..+|++|++|+.+...  ......+..|++.|+.+.
T Consensus        36 l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~   69 (288)
T 3f7w_A           36 LADGTPLFVKALPDDA--PALDGLFRAEALGLDWLG   69 (288)
T ss_dssp             ETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHT
T ss_pred             ECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHH
Confidence            3579999999875432  222345778999888884

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=85.77  E-value=0.25  Score=36.83  Aligned_cols=78  Identities=14%  Similarity=0.066  Sum_probs=53.8

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC---CCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK---HDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~   83 (203)
                      ++..+++|+.+..     ....+..|++.++.+.   ...+++++.+....     ...+++||+++|.         ..
T Consensus        58 ~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvme~l~G~---------~~  118 (312)
T 3jr1_A           58 EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLLEALNKS---------KN  118 (312)
T ss_dssp             SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEEECCCCC---------CC
T ss_pred             CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEEEeccCC---------CC
Confidence            4678889987532     3456788988888883   35677887776654     3467899998863         11


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARI  107 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i  107 (203)
                      +.    ....++...|+.||+.+.
T Consensus       119 ~~----~~~~~lG~~LA~LH~~~~  138 (312)
T 3jr1_A          119 KQ----SSFTIFAEKIAQLHQIQG  138 (312)
T ss_dssp             CT----THHHHHHHHHHHHHHCCC
T ss_pred             Cc----hhHHHHHHHHHHHHcCCC
Confidence            21    245678889999998753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	203
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-44
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-43
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-42
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-41
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-40
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-39
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-38
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-37
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-37
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-37
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-36
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-33
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-32
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-31
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-31
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-30
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-30
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-29
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-26
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 8e-46
 Identities = 93/204 (45%), Positives = 145/204 (71%), Gaps = 4/204 (1%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D  +  RVA+KK+ + F+     +R  RE+K+L  F+H+N++   DI++ P ++  ++
Sbjct: 27  AYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +Y++T L+ +DL+K++   QHL++DHI  FLYQILRGLKY+HSA +LHRD+KP NLL+N+
Sbjct: 86  VYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 144

Query: 122 NCILKICDFGLARVEEPDPNKA--MTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            C LKICDFGLARV +PD +    +T+ V T++YRAPEI++ ++ Y+ ++D+WSVGCI A
Sbjct: 145 TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 204

Query: 180 ELLGRRILFQAQSPVQQLGLITDL 203
           E+L  R +F  +  + QL  I  +
Sbjct: 205 EMLSNRPIFPGKHYLDQLNHILGI 228

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 9e-46
 Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 8/198 (4%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +      VA+K + ++ +++   + + +E+ +     H+NV+      +  +      
Sbjct: 24  AVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----I 77

Query: 62  IYVITELLQSDLH-KIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            Y+  E          I     +     + F +Q++ G+ YLH   I HRDIKP NLL++
Sbjct: 78  QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
               LKI DFGLA V   +  + +  ++  T  Y APE+L     ++  VDVWS G +  
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197

Query: 180 ELLGRRILFQAQSPVQQL 197
            +L   + +   S   Q 
Sbjct: 198 AMLAGELPWDQPSDSCQE 215

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 1e-45
 Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 11/201 (5%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             + +    +ALK L     +      ++ RE+++    +H N+L               
Sbjct: 25  AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----T 79

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
            +Y+I E      +++ +             ++ ++   L Y HS R++HRDIKP NLL+
Sbjct: 80  RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
            S   LKI DFG +      P+   T    T  Y  PE++ G R +   VD+WS+G +  
Sbjct: 140 GSAGELKIADFGWSVH---APSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCY 195

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E L  +  F+A +  +    I
Sbjct: 196 EFLVGKPPFEANTYQETYKRI 216

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 2e-45
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 14/203 (6%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             D R+   VA+KK+  +  QS    + + +E++ L   +H N +         H     
Sbjct: 34  ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH----- 88

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             +++ E    S    + V  + L    I    +  L+GL YLHS  ++HRD+K GN+L+
Sbjct: 89  TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH--YSAAVDVWSVGCI 177
           +   ++K+ DFG A +  P         V T Y+ APE+++      Y   VDVWS+G  
Sbjct: 149 SEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
             EL  R+      + +  L  I
Sbjct: 204 CIELAERKPPLFNMNAMSALYHI 226

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-45
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 9/199 (4%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D   G+ VA++++    Q     + +  E+ ++   K+ N+++ LD           E
Sbjct: 39  AMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DE 91

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++V+ E L       +V+   +    I     + L+ L++LHS +++HRDIK  N+L+  
Sbjct: 92  LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +  +K+ DFG      P+ +K  +  V T Y+ APE++   + Y   VD+WS+G +  E+
Sbjct: 152 DGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEM 209

Query: 182 LGRRILFQAQSPVQQLGLI 200
           +     +  ++P++ L LI
Sbjct: 210 IEGEPPYLNENPLRALYLI 228

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 4e-45
 Identities = 48/205 (23%), Positives = 88/205 (42%), Gaps = 14/205 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +       A K +    +  +  +    E+ +L    H N++  LD     +      
Sbjct: 31  AQNKETSVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDAFYYEN-----N 83

Query: 62  IYVITELLQ-SDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++++ E      +  +++  +  LT   I+V   Q L  L YLH  +I+HRD+K GN+L 
Sbjct: 84  LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF 143

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMG----ARHYSAAVDVWSVG 175
             +  +K+ DFG++  +     +     + T Y+ APE++M      R Y    DVWS+G
Sbjct: 144 TLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG 202

Query: 176 CIFAELLGRRILFQAQSPVQQLGLI 200
               E+          +P++ L  I
Sbjct: 203 ITLIEMAEIEPPHHELNPMRVLLKI 227

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 2e-44
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 12/201 (5%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V+    G  +A K + ++        ++ REL++L       ++               E
Sbjct: 25  VSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----E 78

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA-RILHRDIKPGNLLV 119
           I +  E +    L +++     +    +      +++GL YL    +I+HRD+KP N+LV
Sbjct: 79  ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV 138

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           NS   +K+CDFG++       +      V T+ Y +PE L G  HYS   D+WS+G    
Sbjct: 139 NSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLV 194

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+   R         +   + 
Sbjct: 195 EMAVGRYPIPPPDAKELELMF 215

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-43
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 7/209 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQ---PPHLDF 58
               + G++VALKK+    +         RE+K+L   KH+NV++ ++I +    P+   
Sbjct: 29  ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88

Query: 59  FQEIYVITELLQSDLHKI-IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              IY++ +  + DL  +        T   IK  +  +L GL Y+H  +ILHRD+K  N+
Sbjct: 89  KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANV 148

Query: 118 LVNSNCILKICDFGLAR---VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L+  + +LK+ DFGLAR   + +       T  VVT +YR PE+L+G R Y   +D+W  
Sbjct: 149 LITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 208

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLITDL 203
           GCI AE+  R  + Q  +   QL LI+ L
Sbjct: 209 GCIMAEMWTRSPIMQGNTEQHQLALISQL 237

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 3e-43
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 15/211 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           +    DG+ +  K+L     +    + +  E+ +L   KH N++   D +          
Sbjct: 23  IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 79

Query: 62  IYVITEL-----LQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLH-----SARILHRD 111
           +Y++ E      L S + K     Q+L  + +   + Q+   LK  H        +LHRD
Sbjct: 80  LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139

Query: 112 IKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDV 171
           +KP N+ ++    +K+ DFGLAR+   D + A      T YY +PE +     Y+   D+
Sbjct: 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNR-MSYNEKSDI 197

Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
           WS+GC+  EL      F A S  +  G I +
Sbjct: 198 WSLGCLLYELCALMPPFTAFSQKELAGKIRE 228

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 9e-43
 Identities = 81/206 (39%), Positives = 115/206 (55%), Gaps = 10/206 (4%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSS---KRVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
             D    + VA+KK+    +S       +   RE+K+L    H N++  LD         
Sbjct: 17  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--- 73

Query: 59  FQEIYVITELLQSDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
              I ++ + +++DL  II      LT  HIK ++   L+GL+YLH   ILHRD+KP NL
Sbjct: 74  --NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131

Query: 118 LVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           L++ N +LK+ DFGLA+     PN+A T +VVT++YRAPE+L GAR Y   VD+W+VGCI
Sbjct: 132 LLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI 190

Query: 178 FAELLGRRILFQAQSPVQQLGLITDL 203
            AELL R       S + QL  I + 
Sbjct: 191 LAELLLRVPFLPGDSDLDQLTRIFET 216

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-42
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 9/202 (4%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             +    R  A+K L             V RE  ++    H   +      Q        
Sbjct: 27  ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE----- 81

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           ++Y      +  +L K I           + +  +I+  L+YLH   I+HRD+KP N+L+
Sbjct: 82  KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 141

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQ-YYRAPEILMGARHYSAAVDVWSVGCIF 178
           N +  ++I DFG A+V  P+  +A     V    Y +PE+L   +    + D+W++GCI 
Sbjct: 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCII 200

Query: 179 AELLGRRILFQAQSPVQQLGLI 200
            +L+     F+A +       I
Sbjct: 201 YQLVAGLPPFRAGNEYLIFQKI 222

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 7e-42
 Identities = 88/200 (44%), Positives = 130/200 (65%), Gaps = 6/200 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQ 60
             D R G +VA+KKL   FQS + +KR +REL++L   +H+NV+  LD+  P   LD F 
Sbjct: 37  AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           + Y++   + +DL K++   + L  D I+  +YQ+L+GL+Y+H+A I+HRD+KPGNL VN
Sbjct: 97  DFYLVMPFMGTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 155

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +C LKI DFGLAR      +  MT  VVT++YRAPE+++    Y+  VD+WSVGCI AE
Sbjct: 156 EDCELKILDFGLARQ----ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 211

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           ++  + LF+    + QL  I
Sbjct: 212 MITGKTLFKGSDHLDQLKEI 231

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  140 bits (354), Expect = 3e-41
 Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 14/203 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           VT+   G   A K +    +S    + V +E++ +   +H  +++  D  +  +     E
Sbjct: 45  VTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----E 97

Query: 62  IYVITELLQ-SDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E +   +L + +      ++ D    ++ Q+ +GL ++H    +H D+KP N++ 
Sbjct: 98  MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF 157

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +  +  LK+ DFGL      DP +++     T  + APE+  G +      D+WSVG +
Sbjct: 158 TTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVL 214

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
              LL     F  ++  + L  +
Sbjct: 215 SYILLSGLSPFGGENDDETLRNV 237

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (350), Expect = 3e-41
 Identities = 74/195 (37%), Positives = 102/195 (52%), Gaps = 5/195 (2%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
             G   ALKK+    +         RE+ +L   KH N++   D++           ++ 
Sbjct: 24  NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83

Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
            +L       + V    L S   K FL Q+L G+ Y H  R+LHRD+KP NLL+N    L
Sbjct: 84  QDLK----KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL 139

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRR 185
           KI DFGLAR     P +  T E+VT +YRAP++LMG++ YS  +D+WSVGCIFAE++   
Sbjct: 140 KIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

Query: 186 ILFQAQSPVQQLGLI 200
            LF   S   QL  I
Sbjct: 199 PLFPGVSEADQLMRI 213

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 3e-41
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 11/200 (5%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           +    VA+K L     +    +    E+ +L   +H N+L  +     P L       ++
Sbjct: 28  KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL------AIV 81

Query: 66  TELLQ-SDLHKIIVSPQ-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           T+  + S L+  +   +       +     Q  +G+ YLH+  I+HRD+K  N+ ++ + 
Sbjct: 82  TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL 141

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMG--ARHYSAAVDVWSVGCIFAE 180
            +KI DFGLA V+         +++  +  + APE++       YS   DV++ G +  E
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           L+  ++ +   +   Q+  +
Sbjct: 202 LMTGQLPYSNINNRDQIIFM 221

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-41
 Identities = 81/201 (40%), Positives = 120/201 (59%), Gaps = 8/201 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +   G  VALKK+    ++        RE+ +L    H N++  LD++   +     +
Sbjct: 21  ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----K 75

Query: 62  IYVITELLQSDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +Y++ E L  DL K + +     +    IK +L+Q+L+GL + HS R+LHRD+KP NLL+
Sbjct: 76  LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 135

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           N+   +K+ DFGLAR     P +  T EVVT +YRAPEIL+G ++YS AVD+WS+GCIFA
Sbjct: 136 NTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 194

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E++ RR LF   S + QL  I
Sbjct: 195 EMVTRRALFPGDSEIDQLFRI 215

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  137 bits (347), Expect = 7e-41
 Identities = 46/215 (21%), Positives = 90/215 (41%), Gaps = 21/215 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSK-------RVFRELKMLC-FFKHDNVLSALDILQP 53
                  +  A+K +        S++          +E+ +L     H N++   D  + 
Sbjct: 22  CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81

Query: 54  PHLDFFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDI 112
                    +++ +L++  +L   +     L+    +  +  +L  +  LH   I+HRD+
Sbjct: 82  NT-----FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDL 136

Query: 113 KPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH-----YSA 167
           KP N+L++ +  +K+ DFG +   + DP + + +   T  Y APEI+  + +     Y  
Sbjct: 137 KPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGK 194

Query: 168 AVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD 202
            VD+WS G I   LL     F  +  +  L +I  
Sbjct: 195 EVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 3e-40
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 10/200 (5%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D      VA  +L +   +    +R   E +ML   +H N++   D  +   +   + 
Sbjct: 28  GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST-VKGKKC 86

Query: 62  IYVITELLQS-DLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA--RILHRDIKPGNLL 118
           I ++TEL+ S  L   +   + +    ++ +  QIL+GL++LH+    I+HRD+K  N+ 
Sbjct: 87  IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF 146

Query: 119 VNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           +      +KI D GLA ++     KA+   + T  + APE+      Y  +VDV++ G  
Sbjct: 147 ITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEMYEE--KYDESVDVYAFGMC 201

Query: 178 FAELLGRRILFQAQSPVQQL 197
             E+      +       Q+
Sbjct: 202 MLEMATSEYPYSECQNAAQI 221

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 3e-40
 Identities = 94/199 (47%), Positives = 121/199 (60%), Gaps = 4/199 (2%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D + G RVA+KKL   FQS++ +KR +REL++L   KH+NV+  LD+  P        
Sbjct: 37  AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
              +   L       IV  Q LT DH++  +YQILRGLKY+HSA I+HRD+KP NL VN 
Sbjct: 97  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +C LKI DFGLA       +  MT  V T++YRAPEI++   HY+  VD+WSVGCI AEL
Sbjct: 157 DCELKILDFGLA----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212

Query: 182 LGRRILFQAQSPVQQLGLI 200
           L  R LF     + QL LI
Sbjct: 213 LTGRTLFPGTDHIDQLKLI 231

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 6e-40
 Identities = 79/202 (39%), Positives = 116/202 (57%), Gaps = 8/202 (3%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRE---LKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
            GR VALK++              RE   L+ L  F+H NV+   D+      D   ++ 
Sbjct: 32  GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91

Query: 64  VITELLQSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++ E +  D   +   V    + ++ IK  ++Q+LRGL +LHS R++HRD+KP N+LV S
Sbjct: 92  LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 151

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           +  +K+ DFGLAR+       A+T  VVT +YRAPE+L+    Y+  VD+WSVGCIFAE+
Sbjct: 152 SGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEM 208

Query: 182 LGRRILFQAQSPVQQLGLITDL 203
             R+ LF+  S V QLG I D+
Sbjct: 209 FRRKPLFRGSSDVDQLGKILDV 230

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-39
 Identities = 72/203 (35%), Positives = 101/203 (49%), Gaps = 6/203 (2%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +      VALK++              RE+ +L   KH N++   D+L        + 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK----KL 76

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
             V     Q            L  + +K FL+Q+L+GL + HS  +LHRD+KP NLL+N 
Sbjct: 77  TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           N  LK+ +FGLAR     P +  + EVVT +YR P++L GA+ YS ++D+WS GCIFAEL
Sbjct: 137 NGELKLANFGLARAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

Query: 182 L-GRRILFQAQSPVQQLGLITDL 203
               R LF       QL  I  L
Sbjct: 196 ANAGRPLFPGNDVDDQLKRIFRL 218

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  136 bits (343), Expect = 2e-39
 Identities = 45/203 (22%), Positives = 87/203 (42%), Gaps = 14/203 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +   GR    K +       +    V  E+ ++    H  +++  D  +  +     E
Sbjct: 48  CVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----E 100

Query: 62  IYVITELLQ-SDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E L   +L   I +  + ++   +  ++ Q   GLK++H   I+H DIKP N++ 
Sbjct: 101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC 160

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +     +KI DFGLA     +P++ +     T  + APEI+          D+W++G +
Sbjct: 161 ETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVL 217

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
              LL     F  +  ++ L  +
Sbjct: 218 GYVLLSGLSPFAGEDDLETLQNV 240

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-38
 Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 14/208 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                 G  VA+KK+          +   REL+++    H N++              + 
Sbjct: 39  AKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92

Query: 62  -IYVITELLQ----SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
            + ++ + +             + Q L   ++K+++YQ+ R L Y+HS  I HRDIKP N
Sbjct: 93  YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 152

Query: 117 LLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVG 175
           LL++ +  +LK+CDFG A+  +    +     + ++YYRAPE++ GA  Y++++DVWS G
Sbjct: 153 LLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 210

Query: 176 CIFAELLGRRILFQAQSPVQQLGLITDL 203
           C+ AELL  + +F   S V QL  I  +
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKV 238

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (332), Expect = 2e-38
 Identities = 61/203 (30%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D R  + VA+K +            +  E+ +L   KH N+++  DI +         
Sbjct: 28  AEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GH 81

Query: 62  IYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV- 119
           +Y+I +L+   +L   IV     T       ++Q+L  +KYLH   I+HRD+KP NLL  
Sbjct: 82  LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYY 141

Query: 120 --NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
             + +  + I DFGL+++E  DP   ++    T  Y APE+L   + YS AVD WS+G I
Sbjct: 142 SLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVI 198

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
              LL     F  ++  +    I
Sbjct: 199 AYILLCGYPPFYDENDAKLFEQI 221

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (325), Expect = 1e-37
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 6/203 (2%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
             D R  R VA+K L  ++ +      R  RE +      H  +++  D  +        
Sbjct: 26  ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             Y++ E +    L  I+ +   +T       +    + L + H   I+HRD+KP N+++
Sbjct: 85  LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144

Query: 120 NSNCILKICDFGLAR--VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
           ++   +K+ DFG+AR   +  +        + T  Y +PE   G     A  DV+S+GC+
Sbjct: 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCV 203

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
             E+L     F   SPV      
Sbjct: 204 LYEVLTGEPPFTGDSPVSVAYQH 226

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-37
 Identities = 83/202 (41%), Positives = 126/202 (62%), Gaps = 6/202 (2%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPP-HLDFFQ 60
             D    R VA+KKL   FQ+   +KR +REL ++    H N++S L++  P   L+ FQ
Sbjct: 36  AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
           ++Y++ EL+ ++L ++I     L  + +   LYQ+L G+K+LHSA I+HRD+KP N++V 
Sbjct: 96  DVYLVMELMDANLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
           S+C LKI DFGLAR      +  MT  VVT+YYRAPE+++G   Y   VD+WSVGCI  E
Sbjct: 154 SDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGE 210

Query: 181 LLGRRILFQAQSPVQQLGLITD 202
           ++  +ILF  +  + Q   + +
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIE 232

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 3e-37
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 10/202 (4%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKML-CFFKHDNVLSALDILQPPHLDFF 59
               +  +  A+K L  +V       +    E ++L   ++H  +       Q       
Sbjct: 21  AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE---- 76

Query: 60  QEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
             ++ + E L   DL   I S           +  +I+ GL++LHS  I++RD+K  N+L
Sbjct: 77  -NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 135

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           ++ +  +KI DFG+ + E    +        T  Y APEIL+G + Y+ +VD WS G + 
Sbjct: 136 LDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLL 193

Query: 179 AELLGRRILFQAQSPVQQLGLI 200
            E+L  +  F  Q   +    I
Sbjct: 194 YEMLIGQSPFHGQDEEELFHSI 215

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 9e-37
 Identities = 43/201 (21%), Positives = 86/201 (42%), Gaps = 11/201 (5%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
             +  + VA+K L N          +  E  ++    +  ++  + I +           
Sbjct: 30  MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW------M 83

Query: 64  VITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           ++ E+ +   L+K +   +H+   +I   ++Q+  G+KYL  +  +HRD+   N+L+ + 
Sbjct: 84  LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143

Query: 123 CILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
              KI DFGL++    D N  KA T       + APE +     +S+  DVWS G +  E
Sbjct: 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWE 202

Query: 181 LL-GRRILFQAQSPVQQLGLI 200
                +  ++     +   ++
Sbjct: 203 AFSYGQKPYRGMKGSEVTAML 223

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-36
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 15/205 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             +    +    K +            V +E+ +L   +H N+L   +  +        E
Sbjct: 24  CVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESME-----E 75

Query: 62  IYVITELLQS-DLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           + +I E +   D+ + I +    L    I  +++Q+   L++LHS  I H DI+P N++ 
Sbjct: 76  LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY 135

Query: 120 NS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +  +  +KI +FG AR  +  P            Y APE+       S A D+WS+G +
Sbjct: 136 QTRRSSTIKIIEFGQAR--QLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTL 192

Query: 178 FAELLGRRILFQAQSPVQQLGLITD 202
              LL     F A++  Q +  I +
Sbjct: 193 VYVLLSGINPFLAETNQQIIENIMN 217

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 3e-36
 Identities = 45/198 (22%), Positives = 81/198 (40%), Gaps = 8/198 (4%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
               +VA+K L    Q  +S      E  ++   +H  ++    ++    +    E Y+ 
Sbjct: 35  NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITE-YME 90

Query: 66  TELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCIL 125
              L   L     S   LT + +     QI  G+ ++     +HRD++  N+LV+     
Sbjct: 91  NGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC 148

Query: 126 KICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL-GR 184
           KI DFGLAR+ E +   A         + APE +     ++   DVWS G +  E++   
Sbjct: 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHG 207

Query: 185 RILFQAQSPVQQLGLITD 202
           RI +   +  + +  +  
Sbjct: 208 RIPYPGMTNPEVIQNLER 225

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-36
 Identities = 45/199 (22%), Positives = 85/199 (42%), Gaps = 14/199 (7%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
               RVA+K L       +S +   +E +++   +H+ ++    ++        + IY++
Sbjct: 39  NGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV 89

Query: 66  TELLQ---SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
           TE +            + ++L    +     QI  G+ Y+     +HRD++  N+LV  N
Sbjct: 90  TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 149

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL 182
            + K+ DFGLAR+ E +   A         + APE  +    ++   DVWS G +  EL 
Sbjct: 150 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELT 208

Query: 183 -GRRILFQAQSPVQQLGLI 200
              R+ +      + L  +
Sbjct: 209 TKGRVPYPGMVNREVLDQV 227

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (317), Expect = 6e-36
 Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 15/205 (7%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
             +  +  +V +K L  V +     K++ RE+K+L       N+++  DI++ P      
Sbjct: 54  AINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTP- 107

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
              V   +  +D  ++    Q LT   I+ ++Y+IL+ L Y HS  I+HRD+KP N++++
Sbjct: 108 -ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163

Query: 121 S-NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
             +  L++ D+GLA      P +     V ++Y++ PE+L+  + Y  ++D+WS+GC+ A
Sbjct: 164 HEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221

Query: 180 ELL-GRRILFQAQSPVQQLGLITDL 203
            ++  +   F       QL  I  +
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKV 246

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  126 bits (318), Expect = 8e-36
 Identities = 42/204 (20%), Positives = 85/204 (41%), Gaps = 13/204 (6%)

Query: 2   VTDPRDGRRVALKKLP----NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
                 G+  A+K L      + Q    +      L ++       ++        P   
Sbjct: 23  CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 79

Query: 58  FFQEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++  I +L+   DLH  +      +   ++ +  +I+ GL+++H+  +++RD+KP N
Sbjct: 80  --DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 137

Query: 117 LLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +L++ +  ++I D GLA              V T  Y APE+L     Y ++ D +S+GC
Sbjct: 138 ILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC 194

Query: 177 IFAELLGRRILFQAQSPVQQLGLI 200
           +  +LL     F+      +  + 
Sbjct: 195 MLFKLLRGHSPFRQHKTKDKHEID 218

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-35
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 18/206 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELK-MLCFFKHDNVLSALDILQPPHLDFFQ 60
           + + R   + ALK L +         +  RE++      +  +++  +D+ +  +    +
Sbjct: 31  IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR-K 82

Query: 61  EIYVITELLQS-DLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
            + ++ E L   +L   I     Q  T       +  I   ++YLHS  I HRD+KP NL
Sbjct: 83  CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENL 142

Query: 118 LVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           L  S   N ILK+ DFG A+  E   + ++T    T YY APE+L     Y  + D+WS+
Sbjct: 143 LYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSL 199

Query: 175 GCIFAELLGRRILFQAQSPVQQLGLI 200
           G I   LL     F +   +     +
Sbjct: 200 GVIMYILLCGYPPFYSNHGLAISPGM 225

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 4e-35
 Identities = 42/194 (21%), Positives = 85/194 (43%), Gaps = 16/194 (8%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
            G +VA+K + N      +++    E  ++   +H N++  L ++    ++    +Y++T
Sbjct: 29  RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVI----VEEKGGLYIVT 80

Query: 67  ELLQ-SDLHKIIVS--PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           E +    L   + S     L  D +  F   +   ++YL     +HRD+   N+LV+ + 
Sbjct: 81  EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           + K+ DFGL +      +           + APE L   + +S   DVWS G +  E+  
Sbjct: 141 VAKVSDFGLTKEASSTQDTGKL----PVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYS 195

Query: 184 RRILFQAQSPVQQL 197
              +   + P++ +
Sbjct: 196 FGRVPYPRIPLKDV 209

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 7e-35
 Identities = 49/204 (24%), Positives = 88/204 (43%), Gaps = 17/204 (8%)

Query: 2   VTDPRDGRRVALKKLP----NVFQSLVSSKRVFRELKML--CFFKHDNVLSALDILQPPH 55
                D   VA+K +     + +  L +  RV  E+ +L         V+  LD  + P 
Sbjct: 23  GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82

Query: 56  LDFFQEIYVITELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIK 113
                   +I E  +   DL   I     L  +  + F +Q+L  +++ H+  +LHRDIK
Sbjct: 83  -----SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIK 137

Query: 114 PGNLLVNSN-CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
             N+L++ N   LK+ DFG   + +       T    T+ Y  PE +   R++  +  VW
Sbjct: 138 DENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVW 194

Query: 173 SVGCIFAELLGRRILFQAQSPVQQ 196
           S+G +  +++   I F+    + +
Sbjct: 195 SLGILLYDMVCGDIPFEHDEEIIR 218

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (309), Expect = 7e-35
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 12/201 (5%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           +    +GR  A+K L   +   L   +    E  ML    H  ++      Q       Q
Sbjct: 23  IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----Q 77

Query: 61  EIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
           +I++I + ++  +L  ++   Q   +   K +  ++   L+YLHS  I++RD+KP N+L+
Sbjct: 78  QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137

Query: 120 NSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
           + N  +KI DFG A+               T  Y APE++   + Y+ ++D WS G +  
Sbjct: 138 DKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIY 192

Query: 180 ELLGRRILFQAQSPVQQLGLI 200
           E+L     F   + ++    I
Sbjct: 193 EMLAGYTPFYDSNTMKTYEKI 213

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 9e-35
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 17/208 (8%)

Query: 2   VTDPRDGRRVALKKLPNVF----QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD 57
             +   G + A K +        +  VS + + RE+ +L   +H NV++  ++ +     
Sbjct: 29  CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 86

Query: 58  FFQEIYVITELLQSD-LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGN 116
              ++ +I EL+    L   +   + LT +    FL QIL G+ YLHS +I H D+KP N
Sbjct: 87  ---DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 143

Query: 117 LLVNSN----CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVW 172
           +++         +KI DFGLA   + D          T  + APEI+          D+W
Sbjct: 144 IMLLDRNVPKPRIKIIDFGLAH--KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMW 200

Query: 173 SVGCIFAELLGRRILFQAQSPVQQLGLI 200
           S+G I   LL     F   +  + L  +
Sbjct: 201 SIGVITYILLSGASPFLGDTKQETLANV 228

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 6e-34
 Identities = 45/200 (22%), Positives = 82/200 (41%), Gaps = 10/200 (5%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           V     G   A+K L       L   +    E ++L       ++     L+    D   
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK----LEFSFKDNSN 115

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
              V+  +   ++   +      +  H + +  QI+   +YLHS  +++RD+KP NLL++
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
               +++ DFG A+  +                 APEI++  + Y+ AVD W++G +  E
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLCGT----PEALAPEIILS-KGYNKAVDWWALGVLIYE 230

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           +      F A  P+Q    I
Sbjct: 231 MAAGYPPFFADQPIQIYEKI 250

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 1e-33
 Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 7/200 (3%)

Query: 2   VTDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQ 60
           V +   GR  A+K L   V  +         E ++L   +H  + +     Q      F 
Sbjct: 24  VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83

Query: 61  EIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             Y        +L   +   +  T +  + +  +I+  L+YLHS  +++RDIK  NL+++
Sbjct: 84  MEYA----NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAE 180
            +  +KI DFGL + E       M     T  Y APE+L     Y  AVD W +G +  E
Sbjct: 140 KDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYE 197

Query: 181 LLGRRILFQAQSPVQQLGLI 200
           ++  R+ F  Q   +   LI
Sbjct: 198 MMCGRLPFYNQDHERLFELI 217

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-33
 Identities = 41/200 (20%), Positives = 83/200 (41%), Gaps = 12/200 (6%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
           R    VA+K +    +  +S      E K++    H+ ++    +         + I++I
Sbjct: 26  RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII 77

Query: 66  TELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
           TE +     L+ +        +  +      +   ++YL S + LHRD+   N LVN   
Sbjct: 78  TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG 137

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELL- 182
           ++K+ DFGL+R    D   +         +  PE+LM    +S+  D+W+ G +  E+  
Sbjct: 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYS 196

Query: 183 GRRILFQAQSPVQQLGLITD 202
             ++ ++  +  +    I  
Sbjct: 197 LGKMPYERFTNSETAEHIAQ 216

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (297), Expect = 2e-33
 Identities = 42/196 (21%), Positives = 79/196 (40%), Gaps = 6/196 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
               +    VA+K L    +  +  +   +E  ++   KH N++  L +       +   
Sbjct: 36  GVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
            ++    L   L +   + Q +++  +     QI   ++YL     +HRD+   N LV  
Sbjct: 93  EFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 150

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           N ++K+ DFGL+R+   D   A         + APE L     +S   DVW+ G +  E+
Sbjct: 151 NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEI 209

Query: 182 LGRRILFQAQSPVQQL 197
               +       + Q+
Sbjct: 210 ATYGMSPYPGIDLSQV 225

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-32
 Identities = 52/204 (25%), Positives = 83/204 (40%), Gaps = 13/204 (6%)

Query: 3   TDPRDGRRVALKKL-PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
                   VA+K L P+V     +     RE+  +    H N++    ++  P +     
Sbjct: 31  APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM----- 85

Query: 62  IYVITELLQ--SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             ++TEL    S L ++     H     +  +  Q+  G+ YL S R +HRD+   NLL+
Sbjct: 86  -KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL 144

Query: 120 NSNCILKICDFGLARV--EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCI 177
            +  ++KI DFGL R   +  D         V   + APE L   R +S A D W  G  
Sbjct: 145 ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVT 203

Query: 178 FAELL-GRRILFQAQSPVQQLGLI 200
             E+    +  +   +  Q L  I
Sbjct: 204 LWEMFTYGQEPWIGLNGSQILHKI 227

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 2e-32
 Identities = 44/204 (21%), Positives = 87/204 (42%), Gaps = 13/204 (6%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
             +    VA+K L    +    ++ + RE +++    +  ++  + + Q   L       
Sbjct: 32  MRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL------M 84

Query: 64  VITELLQ-SDLHKIIVSP-QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           ++ E+     LHK +V   + +   ++   L+Q+  G+KYL     +HRD+   N+L+ +
Sbjct: 85  LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 144

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVV--TQYYRAPEILMGARHYSAAVDVWSVGCIFA 179
               KI DFGL++    D +    +        + APE +   R +S+  DVWS G    
Sbjct: 145 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMW 203

Query: 180 ELL-GRRILFQAQSPVQQLGLITD 202
           E L   +  ++     + +  I  
Sbjct: 204 EALSYGQKPYKKMKGPEVMAFIEQ 227

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-32
 Identities = 38/194 (19%), Positives = 80/194 (41%), Gaps = 11/194 (5%)

Query: 6   RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVI 65
            +  +VA+K +    +  +S +    E +++    H  ++    +           I ++
Sbjct: 27  LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLV 78

Query: 66  TELLQ-SDLHKIIVSPQHLTS-DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC 123
            E ++   L   + + + L + + +      +  G+ YL  A ++HRD+   N LV  N 
Sbjct: 79  FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ 138

Query: 124 ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG 183
           ++K+ DFG+ R    D   + T       + +PE+      YS+  DVWS G +  E+  
Sbjct: 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFS 197

Query: 184 RRILFQAQSPVQQL 197
              +        ++
Sbjct: 198 EGKIPYENRSNSEV 211

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-31
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 8/203 (3%)

Query: 2   VTDPRDGRRVALKKLP--NVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFF 59
           ++    G+  A+K L    + Q   +++    E ++L   +    L  L           
Sbjct: 46  ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY----AFQTE 101

Query: 60  QEIYVITELLQ-SDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
            ++++I + +   +L   +   +  T   +++++ +I+  L++LH   I++RDIK  N+L
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 161

Query: 119 VNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA-RHYSAAVDVWSVGCI 177
           ++SN  + + DFGL++    D  +       T  Y AP+I+ G    +  AVD WS+G +
Sbjct: 162 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVL 221

Query: 178 FAELLGRRILFQAQSPVQQLGLI 200
             ELL     F           I
Sbjct: 222 MYELLTGASPFTVDGEKNSQAEI 244

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  113 bits (284), Expect = 2e-31
 Identities = 38/211 (18%), Positives = 77/211 (36%), Gaps = 27/211 (12%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            T+  + ++VA+K  P         +  +R  K+L        +            F QE
Sbjct: 24  GTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNV----------YYFGQE 72

Query: 62  ---IYVITELLQSDLHKIIVS-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNL 117
                ++ +LL   L  ++    +  +   + +   Q+L  ++ +H   +++RDIKP N 
Sbjct: 73  GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132

Query: 118 LVNSNC-----ILKICDFGLARVEEPDPNKAMTQE------VVTQYYRAPEILMGARHYS 166
           L+         ++ + DFG+ +       K             T  Y +    +G R  S
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQS 191

Query: 167 AAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
              D+ ++G +F   L   + +Q        
Sbjct: 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNK 222

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (283), Expect = 3e-31
 Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 34/226 (15%)

Query: 4   DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIY 63
                  VA+K L     + +      RE  ++  F + N++  L +         + + 
Sbjct: 39  PYEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMC 92

Query: 64  VITELLQ-SDLHKII------------------------VSPQHLTSDHIKVFLYQILRG 98
           ++ E +   DL++ +                          P  L+         Q+  G
Sbjct: 93  LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAG 152

Query: 99  LKYLHSARILHRDIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPE 157
           + YL   + +HRD+   N LV  N ++KI DFGL+R +   D  KA   + +   +  PE
Sbjct: 153 MAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212

Query: 158 ILMGARHYSAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD 202
            +     Y+   DVW+ G +  E+       +   +  + +  + D
Sbjct: 213 SIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  112 bits (280), Expect = 8e-31
 Identities = 37/209 (17%), Positives = 71/209 (33%), Gaps = 19/209 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
            TD   G  VA+K      +      ++  E K+    +    +  +             
Sbjct: 26  GTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRW----CGAEGDY 77

Query: 62  IYVITELLQSDLHKI-IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
             ++ ELL   L  +     +  +   + +   Q++  ++Y+HS   +HRD+KP N L+ 
Sbjct: 78  NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137

Query: 121 S---NCILKICDFGLARVEEPDPNKAM------TQEVVTQYYRAPEILMGARHYSAAVDV 171
                 ++ I DFGLA+                     T  Y +    +G    S   D+
Sbjct: 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDL 196

Query: 172 WSVGCIFAELLGRRILFQAQSPVQQLGLI 200
            S+G +        + +Q      +    
Sbjct: 197 ESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 8e-31
 Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 14/205 (6%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
              +    VA+K L + + +    +    E  ++  F H NV+    ++          +
Sbjct: 49  LPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-----PV 102

Query: 63  YVITELLQSDLHKIIVSPQH--LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            +ITE +++      +       T   +   L  I  G+KYL     +HRD+   N+LVN
Sbjct: 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN 162

Query: 121 SNCILKICDFGLARVEEPDPNKAMTQEVV----TQYYRAPEILMGARHYSAAVDVWSVGC 176
           SN + K+ DFGL+R  E D +       +       + APE +   R +++A DVWS G 
Sbjct: 163 SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGI 221

Query: 177 IFAELLGR-RILFQAQSPVQQLGLI 200
           +  E++      +   +    +  I
Sbjct: 222 VMWEVMSYGERPYWDMTNQDVINAI 246

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-30
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 7/202 (3%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           ++       VA+K   N     V  ++  +E   +  F H +++  + ++    +    E
Sbjct: 29  MSPENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLIGVITENPVWIIME 87

Query: 62  IYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS 121
           +  + EL      +       L    + ++ YQ+   L YL S R +HRDI   N+LV+S
Sbjct: 88  LCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 143

Query: 122 NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
           N  +K+ DFGL+R  E       ++  +   + APE +   R +++A DVW  G    E+
Sbjct: 144 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEI 202

Query: 182 L-GRRILFQAQSPVQQLGLITD 202
           L      FQ       +G I +
Sbjct: 203 LMHGVKPFQGVKNNDVIGRIEN 224

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-30
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 11/199 (5%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
           +  +    VA+K L   +           E  ++  F H N++    ++        + +
Sbjct: 31  SSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPM 84

Query: 63  YVITELLQSDLHKIIV--SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN 120
            +ITE +++      +       +   +   L  I  G+KYL +   +HRD+   N+LVN
Sbjct: 85  MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 144

Query: 121 SNCILKICDFGLARVEEPDPNKAMT--QEVVTQYYRAPEILMGARHYSAAVDVWSVGCIF 178
           SN + K+ DFGL+RV E DP    T     +   + APE +   +  S A DVWS G + 
Sbjct: 145 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVM 203

Query: 179 AELLGRRILFQAQSPVQQL 197
            E++        +    ++
Sbjct: 204 WEVMTYGERPYWELSNHEV 222

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 3e-30
 Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 34/226 (15%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
           ++      +VA+K L     S    + +  ELKM+     H+N+++ L            
Sbjct: 61  ISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTLSG----- 114

Query: 61  EIYVITELL-QSDLHKIIVSPQH-----------------------LTSDHIKVFLYQIL 96
            IY+I E     DL   + S +                        LT + +  F YQ+ 
Sbjct: 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVA 174

Query: 97  RGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYYRA 155
           +G+++L     +HRD+   N+LV    ++KICDFGLAR    D N        +   + A
Sbjct: 175 KGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMA 234

Query: 156 PEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLI 200
           PE L     Y+   DVWS G +  E+       +           +
Sbjct: 235 PESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 4e-30
 Identities = 42/206 (20%), Positives = 80/206 (38%), Gaps = 20/206 (9%)

Query: 7   DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVIT 66
            G  VA+K   +       S     E+      +H+N+L  +      +  +  ++++++
Sbjct: 25  RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT-QLWLVS 80

Query: 67  ELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSA--------RILHRDIKPGNLL 118
           +  +       ++   +T + +         GL +LH           I HRD+K  N+L
Sbjct: 81  DYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 140

Query: 119 VNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYYRAPEILMGARH-----YSAAVD 170
           V  N    I D GLA   +   +    A    V T+ Y APE+L  + +          D
Sbjct: 141 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200

Query: 171 VWSVGCIFAELLGRRILFQAQSPVQQ 196
           ++++G +F E+  R  +       Q 
Sbjct: 201 IYAMGLVFWEIARRCSIGGIHEDYQL 226

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 6e-30
 Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 7/196 (3%)

Query: 3   TDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEI 62
              +    VA+K+L     S  ++K +  E  ++    + +V   L I     +    ++
Sbjct: 33  EGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQL 91

Query: 63  YVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSN 122
                LL            ++ S ++  +  QI +G+ YL   R++HRD+   N+LV + 
Sbjct: 92  MPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP 147

Query: 123 CILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYSAAVDVWSVGCIFAEL 181
             +KI DFGLA++   +  +   +       + A E ++  R Y+   DVWS G    EL
Sbjct: 148 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWEL 206

Query: 182 LGRRILFQAQSPVQQL 197
           +          P  ++
Sbjct: 207 MTFGSKPYDGIPASEI 222

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 4e-29
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 20/217 (9%)

Query: 2   VTDPRDGRR--VALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDF 58
               +DG R   A+K++   + S    +    EL++LC    H N+++ L   +     +
Sbjct: 29  ARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87

Query: 59  FQEIYVITELLQSDLHKIIV------------SPQHLTSDHIKVFLYQILRGLKYLHSAR 106
               Y     L   L K  V            +   L+S  +  F   + RG+ YL   +
Sbjct: 88  LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 147

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARHYS 166
            +HRD+   N+LV  N + KI DFGL+R    +     T   +   + A E L     Y+
Sbjct: 148 FIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPVRWMAIESLNY-SVYT 204

Query: 167 AAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD 202
              DVWS G +  E++      +   +  +    +  
Sbjct: 205 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 1e-27
 Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 20/214 (9%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           V       RVA+K + N   S+        E  ++  F   +V+  L ++        Q 
Sbjct: 44  VVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QP 97

Query: 62  IYVITELLQ-SDLHKIIVSPQH----------LTSDHIKVFLYQILRGLKYLHSARILHR 110
             VI EL+   DL   + S +            +   +     +I  G+ YL++ + +HR
Sbjct: 98  TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 157

Query: 111 DIKPGNLLVNSNCILKICDFGLAR-VEEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAV 169
           D+   N +V  +  +KI DFG+ R + E D  +   + ++   + +PE L     ++   
Sbjct: 158 DLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYS 216

Query: 170 DVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD 202
           DVWS G +  E+       +Q  S  Q L  + +
Sbjct: 217 DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 1e-27
 Identities = 50/218 (22%), Positives = 79/218 (36%), Gaps = 19/218 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQ 60
           +        VA+K L      L   + +  ELK+L     H N+++ L            
Sbjct: 47  LIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI 105

Query: 61  EIYVITELLQSDLHK--------------IIVSPQHLTSDHIKVFLYQILRGLKYLHSAR 106
             Y     L + L +              +      L  + +  F YQ+ +G+ +L S  
Sbjct: 106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN 165

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHY 165
            +HRD+   N+L+    I KICDFGLAR  + D N  +         + APE +     Y
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVY 224

Query: 166 SAAVDVWSVGCIFAELL-GRRILFQAQSPVQQLGLITD 202
           +   DVWS G    EL       +       +   +  
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-26
 Identities = 50/207 (24%), Positives = 85/207 (41%), Gaps = 12/207 (5%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
           + +       A+K L N    +    +   E  ++  F H NVLS L I     L     
Sbjct: 49  LDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI----CLRSEGS 103

Query: 62  IYVITELLQ-SDLHKIIVSPQH-LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLV 119
             V+   ++  DL   I +  H  T   +  F  Q+ +G+K+L S + +HRD+   N ++
Sbjct: 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML 163

Query: 120 NSNCILKICDFGLARV---EEPDPNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGC 176
           +    +K+ DFGLAR    +E D     T   +   + A E L   + ++   DVWS G 
Sbjct: 164 DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGV 222

Query: 177 IFAELL-GRRILFQAQSPVQQLGLITD 202
           +  EL+      +   +       +  
Sbjct: 223 LLWELMTRGAPPYPDVNTFDITVYLLQ 249

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-26
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 5   PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQEIY 63
           P    +VA+K L     +      +  E++M+    KH N+++ L             +Y
Sbjct: 42  PNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG-----PLY 95

Query: 64  VITELL-QSDLHKII----------------VSPQHLTSDHIKVFLYQILRGLKYLHSAR 106
           VI E   + +L + +                   + L+S  +    YQ+ RG++YL S +
Sbjct: 96  VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155

Query: 107 ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQ-EVVTQYYRAPEILMGARHY 165
            +HRD+   N+LV  + ++KI DFGLAR          T    +   + APE L   R Y
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIY 214

Query: 166 SAAVDVWSVGCIFAELLGRRILFQAQSPVQQL 197
           +   DVWS G +  E+           PV++L
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-26
 Identities = 48/212 (22%), Positives = 86/212 (40%), Gaps = 18/212 (8%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD--ILQPPHLDFF 59
           +      R VA+K L     +    + +  ELK+L    H   +  L     +P      
Sbjct: 37  IDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 95

Query: 60  QEIYVITELLQSDLHK------------IIVSPQHLTSDHIKVFLYQILRGLKYLHSARI 107
              +     L + L                +    LT +H+  + +Q+ +G+++L S + 
Sbjct: 96  IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC 155

Query: 108 LHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV-TQYYRAPEILMGARHYS 166
           +HRD+   N+L++   ++KICDFGLAR    DP+     +      + APE +   R Y+
Sbjct: 156 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYT 214

Query: 167 AAVDVWSVGCIFAELL-GRRILFQAQSPVQQL 197
              DVWS G +  E+       +      ++ 
Sbjct: 215 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 246

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 87.4 bits (215), Expect = 3e-21
 Identities = 43/210 (20%), Positives = 74/210 (35%), Gaps = 27/210 (12%)

Query: 2   VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQE 61
             D  +   VA+K +       V ++    E+K+L      +      +     L     
Sbjct: 32  AKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88

Query: 62  IYVITELL------------QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSAR-IL 108
                                          + +   ++K    Q+L GL Y+H    I+
Sbjct: 89  FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGII 148

Query: 109 HRDIKPGNLLVNSN------CILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA 162
           H DIKP N+L+           +KI D G A   +     ++      + YR+PE+L+G 
Sbjct: 149 HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT----REYRSPEVLLG- 203

Query: 163 RHYSAAVDVWSVGCIFAELLGRRILFQAQS 192
             +    D+WS  C+  EL+    LF+   
Sbjct: 204 APWGCGADIWSTACLIFELITGDFLFEPDE 233

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.8 bits (196), Expect = 2e-19
 Identities = 31/181 (17%), Positives = 52/181 (28%), Gaps = 27/181 (14%)

Query: 6   RDGRRVALKKL-------PNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF 58
                  +K           V +        F  L +         L  L  L  P +  
Sbjct: 22  EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81

Query: 59  FQEIYVITELLQSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLL 118
           ++   V+ EL+ +     +              L  IL  +   +   I+H D+   N+L
Sbjct: 82  WEGNAVLMELIDAKELYRVRVENPDE------VLDMILEEVAKFYHRGIVHGDLSQYNVL 135

Query: 119 VNSNCILKICDFGLARVEEPDPNK----AMTQEVVTQYYRAPEILMGARHYSAAVDVWSV 174
           V S   + I DF  + VE  +             +  Y+         R Y    D+ S 
Sbjct: 136 V-SEEGIWIIDFPQS-VEVGEEGWREILERDVRNIITYFS--------RTYRTEKDINSA 185

Query: 175 G 175
            
Sbjct: 186 I 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	203
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.81
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.18
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.2
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.32

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=295.17  Aligned_cols=192  Identities=26%  Similarity=0.401  Sum_probs=167.9

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||+|++..... .....+.+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+.+..
T Consensus        25 ~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~   99 (263)
T d2j4za1          25 AREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQK   99 (263)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhh
Confidence            56889999999999854322 333456788999999999999999999999988     56789999998 599999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....   .......||+.|+|||++
T Consensus       100 ~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~~~Gt~~Y~APE~~  176 (263)
T d2j4za1         100 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTTLCGTLDYLPPEMI  176 (263)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---CCCEETTEEGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---CcccccCCCCcccCHHHH
Confidence            88899999999999999999999999999999999999999999999999999975432   223445789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      .+ +.++.++|||||||++|+|++|+.||.+.+..+.+.+|.+
T Consensus       177 ~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  218 (263)
T d2j4za1         177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR  218 (263)
T ss_dssp             TT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             cC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            87 5689999999999999999999999999998888877653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=296.81  Aligned_cols=195  Identities=25%  Similarity=0.393  Sum_probs=166.9

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.++.+|+.||||+++... ......+.+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+++..
T Consensus        27 a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~  101 (288)
T d1uu3a_          27 ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRK  101 (288)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH
T ss_pred             EEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhc
Confidence            5678899999999985432 2334556788999999999999999999999887     56789999998 599998888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||++....... ........||+.|+|||+
T Consensus       102 ~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~  181 (288)
T d1uu3a_         102 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL  181 (288)
T ss_dssp             HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCcee
Confidence            8899999999999999999999999999999999999999999999999999998554322 223345578999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      +.+ +.++.++|||||||++|+|++|+.||.+.+..+++++|.+
T Consensus       182 ~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  224 (288)
T d1uu3a_         182 LTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK  224 (288)
T ss_dssp             HHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             ecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence            987 5589999999999999999999999999999888887754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=295.85  Aligned_cols=186  Identities=27%  Similarity=0.399  Sum_probs=157.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++... .....+.+.+|++++++++||||+++++++.++     ...|+||||+. |+|.+++...
T Consensus        24 ~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~   97 (271)
T d1nvra_          24 AVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPD   97 (271)
T ss_dssp             EEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTT
T ss_pred             EEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcC
Confidence            5788999999999996532 223446788999999999999999999999987     56789999998 4999999888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... ........||+.|+|||++
T Consensus        98 ~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~  177 (271)
T d1nvra_          98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL  177 (271)
T ss_dssp             TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHh
Confidence            899999999999999999999999999999999999999999999999999998543222 2234456789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+...++.++|||||||++|+|++|++||.....
T Consensus       178 ~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             HCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             cCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence            8755456789999999999999999999977654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=294.56  Aligned_cols=190  Identities=26%  Similarity=0.485  Sum_probs=164.0

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |.++.+|+.||||+++..  .....+.+.+|++++++++||||+++++++.++     ..+|+||||+.| +|.+.+.. 
T Consensus        39 a~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-  110 (293)
T d1yhwa1          39 AMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-  110 (293)
T ss_dssp             EEBTTTCCEEEEEEEEGG--GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-
T ss_pred             EEECCCCCEEEEEEEecc--cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-
Confidence            578899999999998643  233456788999999999999999999999887     567899999985 88776554 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... ........||+.|+|||++.
T Consensus       111 ~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVT  189 (293)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TCCBCCCCSCGGGCCHHHHS
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc-cccccccccCCCccChhhhc
Confidence            56999999999999999999999999999999999999999999999999999865433 22334557899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + +.++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus       190 ~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~  229 (293)
T d1yhwa1         190 R-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA  229 (293)
T ss_dssp             S-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             C-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            7 558999999999999999999999999988877766553

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=291.06  Aligned_cols=195  Identities=28%  Similarity=0.441  Sum_probs=156.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh--
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV--   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--   78 (203)
                      |+++.+|+.||||++.....+....+.+.+|++++++++||||+++++++.+...   ..+|+||||++ |+|.+++.  
T Consensus        23 ~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~ivmEy~~~g~L~~~i~~~   99 (269)
T d2java1          23 IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKG   99 (269)
T ss_dssp             EEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHH
T ss_pred             EEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEEEEEEecCCCCcHHHHHHhc
Confidence            5688999999999997665566667789999999999999999999999876432   34689999998 58888765  


Q ss_pred             --CCCCCChHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCc
Q psy16889         79 --SPQHLTSDHIKVFLYQILRGLKYLHSAR-----ILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQ  151 (203)
Q Consensus        79 --~~~~~~~~~~~~~~~qi~~~l~~lh~~~-----i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  151 (203)
                        ..+.+++..++.++.|++.||+|||+++     |+||||||+||+++.++.+||+|||++...... ........||+
T Consensus       100 ~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~-~~~~~~~~gt~  178 (269)
T d2java1         100 TKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTP  178 (269)
T ss_dssp             HHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC------------CCC
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC-CCccccCCCCc
Confidence              3567999999999999999999999876     999999999999999999999999999854432 22234457899


Q ss_pred             ccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        152 YYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       152 ~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+...+|.
T Consensus       179 ~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         179 YYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             SCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            9999999977 558999999999999999999999999998888877764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=295.12  Aligned_cols=193  Identities=26%  Similarity=0.388  Sum_probs=169.7

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||||+++... ......+.+.+|+.++++++||||+++++++.++     ..+|+||||+. |+|.+.+..
T Consensus        24 ~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~   98 (337)
T d1o6la_          24 VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSR   98 (337)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----cccccceeccCCCchhhhhhc
Confidence            5788999999999996532 2344567788999999999999999999999988     67889999998 589999888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.++++.++.++.|++.||+|||++|++||||||+||+++.+|.+||+|||++...... ........||+.|+|||++
T Consensus        99 ~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~~~~GT~~Y~aPE~~  177 (337)
T d1o6la_          99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEECGGGCCGGGG
T ss_pred             ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-CcccccceeCHHHhhhhhc
Confidence            889999999999999999999999999999999999999999999999999999754332 2334456889999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ +.++.++|+|||||++|+|++|++||.+.+..++.+.|.
T Consensus       178 ~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~  218 (337)
T d1o6la_         178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL  218 (337)
T ss_dssp             SS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence            88 558999999999999999999999999999888877664

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.8e-48  Score=289.18  Aligned_cols=190  Identities=28%  Similarity=0.437  Sum_probs=163.2

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |+++.+|+.||||+++... ......+.+.+|++++++++||||+++++++.++     ...|+||||+.+ ++......
T Consensus        34 a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~  108 (309)
T d1u5ra_          34 ARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVH  108 (309)
T ss_dssp             EEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHh
Confidence            5688999999999986533 3445567788999999999999999999999887     567899999985 56555566


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....     .....||+.|+|||++
T Consensus       109 ~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~~~GT~~Y~APE~~  183 (309)
T d1u5ra_         109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVI  183 (309)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCCCCSCGGGCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCccccCccccCHHHH
Confidence            78899999999999999999999999999999999999999999999999999975432     2344789999999998


Q ss_pred             ecc--cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGA--RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+.  ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus       184 ~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~  227 (309)
T d1u5ra_         184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA  227 (309)
T ss_dssp             TTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             hccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            642  357899999999999999999999999988877776654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-48  Score=291.05  Aligned_cols=191  Identities=31%  Similarity=0.493  Sum_probs=150.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |.++.+|+.||||+++..... .....+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+++...
T Consensus        28 ~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~  101 (307)
T d1a06a_          28 AEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEK  101 (307)
T ss_dssp             EEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTC
T ss_pred             EEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcc
Confidence            567889999999999654322 2345677899999999999999999999887     56789999998 6999999988


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++.++..++.|++.||+|||++|++||||||+||++.   .++.+|++|||++......  .......||+.|+|||
T Consensus       102 ~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~--~~~~~~~GT~~y~APE  179 (307)
T d1a06a_         102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPE  179 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------------CTTSCHH
T ss_pred             cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--CeeeeeeeCccccCcH
Confidence            8999999999999999999999999999999999999995   5789999999999754322  2334457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ +.++.++|||||||++|+|++|++||.+....+...+|.
T Consensus       180 ~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~  222 (307)
T d1a06a_         180 VLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL  222 (307)
T ss_dssp             HHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence            9987 568999999999999999999999999988888777665

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-49  Score=290.89  Aligned_cols=192  Identities=26%  Similarity=0.423  Sum_probs=163.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |+++.+|+.||||+++..  +....+.+.+|++++++++||||+++++++.++     ...++||||+. |+|.+++.. 
T Consensus        31 ~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~  103 (288)
T d2jfla1          31 AQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLEL  103 (288)
T ss_dssp             EEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHH
T ss_pred             EEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhc
Confidence            568899999999999643  344567788999999999999999999999887     56789999998 488887653 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||++...... ........||+.|+|||++
T Consensus       104 ~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~Gt~~y~APE~l  182 (288)
T d2jfla1         104 ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPEVV  182 (288)
T ss_dssp             TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHHTCCCSCCTTCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccccccccccccCCHHHH
Confidence            567999999999999999999999999999999999999999999999999998643221 1122345789999999998


Q ss_pred             ec----ccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MG----ARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~----~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ..    .+.++.++|||||||++|+|++|++||.+.++.+.+.+|.
T Consensus       183 ~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~  228 (288)
T d2jfla1         183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA  228 (288)
T ss_dssp             TTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH
T ss_pred             hhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            52    3457899999999999999999999999988888777664

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.7e-48  Score=290.63  Aligned_cols=190  Identities=26%  Similarity=0.440  Sum_probs=167.4

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |+++.+|+.||||+++... ......+.+.+|+.++++++||||+++++++.++     ..+|+||||+.| ++...+..
T Consensus        23 a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~   97 (316)
T d1fota_          23 IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRK   97 (316)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----CeeeeEeeecCCccccccccc
Confidence            5788999999999996432 2334567788999999999999999999999988     678899999985 88888888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      ...+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....    ......||+.|+|||++
T Consensus        98 ~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~l  173 (316)
T d1fota_          98 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVV  173 (316)
T ss_dssp             TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCCCSCTTTCCHHHH
T ss_pred             cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----ccccccCcccccCHHHH
Confidence            88899999999999999999999999999999999999999999999999999985432    23345789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ +.++.++|||||||++|+|++|+.||.+.+..+.+.+|.
T Consensus       174 ~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  214 (316)
T d1fota_         174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL  214 (316)
T ss_dssp             TT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH
Confidence            87 558999999999999999999999999999888887765

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=286.00  Aligned_cols=195  Identities=41%  Similarity=0.666  Sum_probs=163.0

Q ss_pred             CcCCCCCcEEEEEeccCccchh---hhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHH-H
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSL---VSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKI-I   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~-~   77 (203)
                      |+++.+|+.||||+++......   .....+.+|++++++++||||+++++++.++     ..+|+||||+.+++... .
T Consensus        17 ~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~   91 (299)
T d1ua2a_          17 ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIK   91 (299)
T ss_dssp             EECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHT
T ss_pred             EEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----CceeehhhhhcchHHhhhh
Confidence            6788999999999996533221   2245688999999999999999999999988     56789999999755444 4


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .....+++.++..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+...... ........||+.|+|||
T Consensus        92 ~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE  170 (299)
T d1ua2a_          92 DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPE  170 (299)
T ss_dssp             TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCCCCCSCCCCTTCCHH
T ss_pred             hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC-cccccceecChhhccHH
Confidence            45677999999999999999999999999999999999999999999999999999754433 23334457899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.+...++.++|||||||++|+|++|++||.+.++.+.+.+|.+
T Consensus       171 ~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~  215 (299)
T d1ua2a_         171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  215 (299)
T ss_dssp             HHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             HHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence            988766789999999999999999999999999999988887753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=282.64  Aligned_cols=188  Identities=24%  Similarity=0.348  Sum_probs=158.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||+|.+..........+.+.+|++++++++||||+++++++.+..... ..+|+||||++ |+|.+++...
T Consensus        28 ~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~-~~~~ivmE~~~~g~L~~~l~~~  106 (270)
T d1t4ha_          28 GLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRF  106 (270)
T ss_dssp             EEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC-EEEEEEEECCCSCBHHHHHHHH
T ss_pred             EEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC-CEEEEEEeCCCCCcHHHHHhcc
Confidence            567889999999999665445556778999999999999999999999986521110 35689999998 5999998888


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEec-CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSAR--ILHRDIKPGNLLVN-SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      +.+++++++.++.|++.||+|||+++  ++||||||+||+++ .++.+||+|||++.....   .......||+.|+|||
T Consensus       107 ~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~---~~~~~~~GT~~Y~aPE  183 (270)
T d1t4ha_         107 KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPE  183 (270)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBEESCSSCCCCCGG
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---CccCCcccCccccCHH
Confidence            88999999999999999999999998  99999999999997 578999999999975332   2234557899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHH
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQ  195 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  195 (203)
                      ++.+  .++.++|||||||++|+|++|+.||.+..+..
T Consensus       184 ~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~  219 (270)
T d1t4ha_         184 MYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAA  219 (270)
T ss_dssp             GGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred             HhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH
Confidence            8865  48999999999999999999999998765443

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-47  Score=290.56  Aligned_cols=191  Identities=24%  Similarity=0.399  Sum_probs=165.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++...  ......+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+.+...
T Consensus        48 a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~  120 (352)
T d1koba_          48 CVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAE  120 (352)
T ss_dssp             EEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCT
T ss_pred             EEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhc
Confidence            5788999999999986532  23456788999999999999999999999987     56789999998 5898877654


Q ss_pred             -CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec--CCCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 -QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN--SNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 -~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                       .++++.+++.++.||+.||+|||++|++||||||+|||++  .++.+||+|||++......  .......+++.|+|||
T Consensus       121 ~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~~~~~~gt~~y~aPE  198 (352)
T d1koba_         121 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE  198 (352)
T ss_dssp             TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SCEEEECSSGGGCCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--CceeeccCcccccCHH
Confidence             4699999999999999999999999999999999999998  5789999999999865432  3334557799999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+
T Consensus       199 ~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~  242 (352)
T d1koba_         199 IVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR  242 (352)
T ss_dssp             HHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred             HHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9987 5589999999999999999999999999998888877653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.5e-47  Score=290.12  Aligned_cols=190  Identities=23%  Similarity=0.405  Sum_probs=165.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~   79 (203)
                      |+++.+|+.||||++...  .....+.+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.+.+. .
T Consensus        45 ~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~  117 (350)
T d1koaa2          45 VTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADE  117 (350)
T ss_dssp             EEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCT
T ss_pred             EEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhh
Confidence            567899999999999653  233456788999999999999999999999887     67789999998 59999885 4


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      .+.+++.++..++.||+.||+|||++|++||||||+||+++.  ++.+||+|||++......  .......||+.|+|||
T Consensus       118 ~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~gT~~Y~aPE  195 (350)
T d1koaa2         118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPE  195 (350)
T ss_dssp             TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SCEEEECSCTTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--cccceecCcccccCHH
Confidence            567999999999999999999999999999999999999964  578999999999754432  3334557899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ +.++.++|||||||++|+|++|+.||.+.+..+.+.+|.
T Consensus       196 v~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~  238 (350)
T d1koaa2         196 VAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK  238 (350)
T ss_dssp             HHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9987 558999999999999999999999999999888887765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.2e-47  Score=290.62  Aligned_cols=190  Identities=24%  Similarity=0.384  Sum_probs=166.7

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+++.+|+.||||++.... ......+.+.+|+++++.++||||+++++++.+.     ...++++||+. |+|...+..
T Consensus        60 a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~  134 (350)
T d1rdqe_          60 VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRR  134 (350)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHH
T ss_pred             EEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cccccccccccccchhhhHhh
Confidence            5788999999999985432 2334556788999999999999999999999888     56789999998 488888888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....    ......||+.|+|||++
T Consensus       135 ~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~----~~~~~~Gt~~Y~APE~~  210 (350)
T d1rdqe_         135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEII  210 (350)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----CBCCCEECGGGCCHHHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----ccccccCccccCCHHHH
Confidence            78899999999999999999999999999999999999999999999999999985432    22345789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .+ +.++.++|||||||++|+|++|+.||.+.+....+.+|.
T Consensus       211 ~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~  251 (350)
T d1rdqe_         211 LS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV  251 (350)
T ss_dssp             TT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh
Confidence            87 558999999999999999999999999999888887764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=290.87  Aligned_cols=182  Identities=26%  Similarity=0.436  Sum_probs=157.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |+++.+|+.||+|+++... .....+.+.+|+.++++++||||+++++++.++     ..+|+||||+.| +|.+++...
T Consensus        25 ~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~   98 (322)
T d1s9ja_          25 VSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKA   98 (322)
T ss_dssp             EEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHH
T ss_pred             EEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhc
Confidence            5678999999999996542 334456788999999999999999999999988     567899999984 999998887


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      +.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.....   .......||+.|+|||++
T Consensus        99 ~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~GT~~Y~APEvl  175 (322)
T d1s9ja_          99 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERL  175 (322)
T ss_dssp             SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---HTC---CCSSCCCCHHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC---CccccccCCccccCchHH
Confidence            889999999999999999999997 5999999999999999999999999999874332   222345789999999999


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      .+ ..++.++||||+||++|+|++|+.||.+.+.
T Consensus       176 ~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         176 QG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             HC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             cC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            88 5689999999999999999999999987654

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-47  Score=282.11  Aligned_cols=193  Identities=28%  Similarity=0.412  Sum_probs=166.1

Q ss_pred             CcCCCCCcEEEEEeccCccc----hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ----SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |+++.+|+.||||+++....    .....+.+.+|++++++++||||+++++++.++     ..+|+||||++ |+|.++
T Consensus        29 ~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~  103 (293)
T d1jksa_          29 CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----TDVILILELVAGGELFDF  103 (293)
T ss_dssp             EEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHH
T ss_pred             EEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEEEEcCCCccccch
Confidence            56789999999999854322    222356788999999999999999999999988     56789999998 599999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC----eEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC----ILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      +...+.+++..++.++.|++.||+|||+++++||||||+||+++.++    .+|++|||++......  .......+++.
T Consensus       104 i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~--~~~~~~~~t~~  181 (293)
T d1jksa_         104 LAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPE  181 (293)
T ss_dssp             HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS--CBCSCCCCCGG
T ss_pred             hccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCC--ccccccCCCCc
Confidence            88878899999999999999999999999999999999999998766    5999999999754322  23344577899


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      |+|||++.+ +.++.++|||||||++|+|++|+.||.+.+..+.+..|.+
T Consensus       182 y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~  230 (293)
T d1jksa_         182 FVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA  230 (293)
T ss_dssp             GCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred             ccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence            999999987 5589999999999999999999999999998888877654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=280.09  Aligned_cols=191  Identities=22%  Similarity=0.355  Sum_probs=159.2

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCC
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQH   82 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~   82 (203)
                      +..+++.||||+++....+....+.+.+|++++++++||||+++++++.++      ..++||||++ |+|.+++.....
T Consensus        30 ~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~  103 (277)
T d1xbba_          30 MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVMEMAELGPLNKYLQQNRH  103 (277)
T ss_dssp             CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHHHCTT
T ss_pred             cCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEEEcCCCCcHHHHHhhccC
Confidence            456778999999976555555667899999999999999999999998654      2368999998 599999888888


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~  160 (203)
                      +++.++..++.|++.||+|||+++++||||||+||+++.++.++++|||+++........  ......||+.|+|||++.
T Consensus       104 l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~  183 (277)
T d1xbba_         104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  183 (277)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence            999999999999999999999999999999999999999999999999999754433222  223446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..++.++||||||+++|||++ |++||.+.+..++...|.
T Consensus       184 ~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~  224 (277)
T d1xbba_         184 Y-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE  224 (277)
T ss_dssp             H-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             C-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH
Confidence            7 458999999999999999997 899999998887776654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=276.08  Aligned_cols=184  Identities=24%  Similarity=0.347  Sum_probs=151.7

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~   85 (203)
                      +..||||+++....+....+.+.+|++++++++||||+++++++.++      .+++||||++ |+|.+++.. .+.+++
T Consensus        30 ~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~~~lv~Ey~~~g~L~~~l~~~~~~~~~  103 (276)
T d1uwha_          30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------QLAIVTQWCEGSSLYHHLHIIETKFEM  103 (276)
T ss_dssp             SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------SCEEEEECCCEEEHHHHHHTSCCCCCH
T ss_pred             CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------EEEEEEecCCCCCHHHHHhhccCCCCH
Confidence            44699999976555666778899999999999999999999987554      3579999998 699998864 467999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccccCCcccccceeeecc--
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQEVVTQYYRAPEILMGA--  162 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~--  162 (203)
                      .++..++.|++.||+|||+++++||||||+||+++.++.+||+|||++....... ........||+.|+|||++.+.  
T Consensus       104 ~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~  183 (276)
T d1uwha_         104 IKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK  183 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccC
Confidence            9999999999999999999999999999999999999999999999997544322 2233455789999999998642  


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQL  197 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  197 (203)
                      ..++.++||||||+++|||+||+.||.+.++...+
T Consensus       184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~  218 (276)
T d1uwha_         184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI  218 (276)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence            34789999999999999999999999987655544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=280.98  Aligned_cols=194  Identities=41%  Similarity=0.695  Sum_probs=163.8

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHh--C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIV--S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~   79 (203)
                      |.++.+|+.||||+++.........+.+.+|++++++++||||+++++++.++     ..+|+||||+.+++.+.+.  .
T Consensus        21 ~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~   95 (298)
T d1gz8a_          21 ARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASA   95 (298)
T ss_dssp             EEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTT
T ss_pred             EEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhhhc
Confidence            67889999999999965544445567889999999999999999999999988     6788999999987666553  3


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++.+++.++.|++.||+|||++||+||||||+||+++.++.+|++|||.+...... ........||+.|+|||++
T Consensus        96 ~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~apE~~  174 (298)
T d1gz8a_          96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL  174 (298)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCTTCCBCCCTTCCHHHH
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-cccceeecccceeeehhhh
Confidence            567999999999999999999999999999999999999999999999999999754432 3344455789999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      .....++.++|+||||+++|+|++|+.||.+.++.+.+.+|.
T Consensus       175 ~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~  216 (298)
T d1gz8a_         175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF  216 (298)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence            876667899999999999999999999999988887776653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=281.61  Aligned_cols=193  Identities=25%  Similarity=0.383  Sum_probs=166.1

Q ss_pred             CcCCCCCcEEEEEeccCcc-chhhhhHHHHHHHHHHh-hcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          2 VTDPRDGRRVALKKLPNVF-QSLVSSKRVFRELKMLC-FFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      |.++.+|+.||||+++... ......+.+..|..++. .++||||+++++++.++     ...|+||||+. |+|.+++.
T Consensus        21 ~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~   95 (320)
T d1xjda_          21 AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQ   95 (320)
T ss_dssp             EEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHH
T ss_pred             EEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhh
Confidence            5688999999999995432 23344556677777665 68999999999999988     56889999998 59999998


Q ss_pred             CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         79 SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        79 ~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      ..+.+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+...... ........||+.|+|||+
T Consensus        96 ~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~  174 (320)
T d1xjda_          96 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEI  174 (320)
T ss_dssp             HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCCSCGGGCCHHH
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cccccccCCCCCcCCHHH
Confidence            8888999999999999999999999999999999999999999999999999999754432 334455678999999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +.+ ..++.++|||||||++|+|++|+.||.+.+..+++..|.
T Consensus       175 ~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~  216 (320)
T d1xjda_         175 LLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR  216 (320)
T ss_dssp             HTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             HcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            987 558999999999999999999999999999888887764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-46  Score=277.81  Aligned_cols=190  Identities=24%  Similarity=0.372  Sum_probs=159.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-   79 (203)
                      |+++.+|+.||||+++..   ....+.+.+|++++++++||||+++++++.++     ...+++|||++ |+|.+++.. 
T Consensus        36 a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~  107 (287)
T d1opja_          36 GVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLREC  107 (287)
T ss_dssp             EEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHS
T ss_pred             EEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhc
Confidence            467788999999998643   23456789999999999999999999999887     56789999998 588888753 


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 -PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 -~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                       ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..............+++.|+|||+
T Consensus       108 ~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~  187 (287)
T d1opja_         108 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES  187 (287)
T ss_dssp             CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHH
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHH
Confidence             4679999999999999999999999999999999999999999999999999998655444444445567889999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcc-cCCCChHHHhhhh
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRIL-FQAQSPVQQLGLI  200 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i  200 (203)
                      +.+ ..++.++||||||+++|+|++|..| |.+.+..+..+.+
T Consensus       188 ~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i  229 (287)
T d1opja_         188 LAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL  229 (287)
T ss_dssp             HHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             HcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH
Confidence            887 5589999999999999999996554 5666655554443

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-46  Score=277.91  Aligned_cols=198  Identities=25%  Similarity=0.345  Sum_probs=159.6

Q ss_pred             CcCCCCCcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |.+..+|+.||||+++.... +....+.+.+|+++++.++||||+++++++....... ..+|+||||++ ++|...+..
T Consensus        26 a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~-~~~~lvmE~~~g~~L~~~~~~  104 (277)
T d1o6ya_          26 ARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHT  104 (277)
T ss_dssp             EEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS-EEEEEEEECCCEEEHHHHHHH
T ss_pred             EEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC-ceEEEEEECCCCCEehhhhcc
Confidence            57889999999999965433 3445567889999999999999999999987653211 24689999998 588888888


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC--CCCcccccCCcccccce
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP--NKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~aPe  157 (203)
                      .+++++.+++.++.|++.||+|||++|++||||||+||+++.++..+++|||.+.......  ........||+.|+|||
T Consensus       105 ~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE  184 (277)
T d1o6ya_         105 EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE  184 (277)
T ss_dssp             HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHH
Confidence            8899999999999999999999999999999999999999999999999999886433222  22344557899999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.+ ..+++++||||||+++|+|+||++||.+.++.+.+.++.
T Consensus       185 ~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~  227 (277)
T d1o6ya_         185 QARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV  227 (277)
T ss_dssp             HHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             HHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence            9877 568999999999999999999999999988877766553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-46  Score=274.93  Aligned_cols=193  Identities=23%  Similarity=0.391  Sum_probs=165.8

Q ss_pred             CcCCCCCcEEEEEeccCccch-------hhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhH-Hh
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS-------LVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQ-SD   72 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~   72 (203)
                      |+++.+|+.||||+++.....       ....+.+.+|+.++++++ ||||+++++++.++     ...|+||||++ |+
T Consensus        22 ~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-----~~~~ivmE~~~~g~   96 (277)
T d1phka_          22 CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-----TFFFLVFDLMKKGE   96 (277)
T ss_dssp             EEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEEEEEEECCTTCB
T ss_pred             EEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC-----cceEEEEEcCCCch
Confidence            577889999999998543221       223346788999999996 99999999999988     67889999998 59


Q ss_pred             HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         73 LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        73 l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      |.+++...+++++++++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+......  .......||+.
T Consensus        97 L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~  174 (277)
T d1phka_          97 LFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPS  174 (277)
T ss_dssp             HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--CCBCCCCSCGG
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC--CceeeeeccCC
Confidence            9999988889999999999999999999999999999999999999999999999999999865432  23344578999


Q ss_pred             cccceeeecc-----cCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        153 YRAPEILMGA-----RHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       153 ~~aPe~~~~~-----~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |.|||.+.+.     ..++.++||||+|+++|+|++|+.||.+.++.+.+++|.
T Consensus       175 y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~  228 (277)
T d1phka_         175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  228 (277)
T ss_dssp             GCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence            9999998642     346789999999999999999999999999888877665

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=273.50  Aligned_cols=189  Identities=23%  Similarity=0.396  Sum_probs=158.6

Q ss_pred             CCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCC
Q psy16889          5 PRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQH   82 (203)
Q Consensus         5 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~   82 (203)
                      ..++..||||+++.. ......+.+.+|++++++++||||+++++++.++      .+++||||++ |+|.+++.. .+.
T Consensus        33 ~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~~lvmE~~~~g~L~~~l~~~~~~  105 (285)
T d1u59a_          33 RKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ALMLVMEMAGGGPLHKFLVGKREE  105 (285)
T ss_dssp             --CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEEECCTTEEHHHHHTTCTTT
T ss_pred             CCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------eEEEEEEeCCCCcHHHHhhccccC
Confidence            345668999999654 3445567889999999999999999999998765      2579999998 589888764 467


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceeee
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~  160 (203)
                      +++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++.......  .......||+.|+|||++.
T Consensus       106 l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         106 IPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence            99999999999999999999999999999999999999999999999999985543322  2223445788999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      + +.++.++||||||+++|||+| |+.||.+.+..+.+..|.
T Consensus       186 ~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~  226 (285)
T d1u59a_         186 F-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE  226 (285)
T ss_dssp             H-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH
T ss_pred             C-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            7 458999999999999999998 899999988887777664

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=271.33  Aligned_cols=187  Identities=21%  Similarity=0.396  Sum_probs=148.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-CCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-QHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~   83 (203)
                      .+++.||||+++..   ....+.+.+|++++++++||||+++++++.++     ...++||||+. |+|.+++... ..+
T Consensus        27 ~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~   98 (263)
T d1sm2a_          27 LNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLF   98 (263)
T ss_dssp             TTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC
T ss_pred             CCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCC
Confidence            36778999999643   23346788999999999999999999999887     56789999998 5898887654 668


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      +++.+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++..............||+.|+|||++.+ .
T Consensus        99 ~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~  177 (263)
T d1sm2a_          99 AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-S  177 (263)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTT-C
T ss_pred             CHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcC-C
Confidence            999999999999999999999999999999999999999999999999997655444444445577899999999987 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++||||||+++|||+| |.+||...+..+.++.|.
T Consensus       178 ~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~  216 (263)
T d1sm2a_         178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS  216 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred             CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            58999999999999999998 578888888877776654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-45  Score=274.96  Aligned_cols=192  Identities=26%  Similarity=0.417  Sum_probs=149.6

Q ss_pred             cCCCCCc---EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh
Q psy16889          3 TDPRDGR---RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV   78 (203)
Q Consensus         3 ~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~   78 (203)
                      .++.+|+   .||||.+... .+....+.+.+|++++++++||||+++++++.++     ...++||||++ |+|.+++.
T Consensus        46 ~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~  119 (299)
T d1jpaa_          46 HLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLR  119 (299)
T ss_dssp             EECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHH
T ss_pred             EEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----CEEEEEEEecCCCcceeeec
Confidence            3444443   5889988653 2334556789999999999999999999999887     56789999998 58888777


Q ss_pred             C-CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC----CcccccCCccc
Q psy16889         79 S-PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK----AMTQEVVTQYY  153 (203)
Q Consensus        79 ~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~  153 (203)
                      . .+.+++.++..++.|+++||+|||+++++||||||+||+++.++.+||+|||+++........    ......+|+.|
T Consensus       120 ~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y  199 (299)
T d1jpaa_         120 QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW  199 (299)
T ss_dssp             TTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGG
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccc
Confidence            5 467999999999999999999999999999999999999999999999999999754432221    12233568899


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      +|||.+.+ +.++.++||||||+++|||+| |++||.+.+..+.+..|.
T Consensus       200 ~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~  247 (299)
T d1jpaa_         200 TAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE  247 (299)
T ss_dssp             SCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             cCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999887 568999999999999999998 899999999888877664

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=278.46  Aligned_cols=190  Identities=25%  Similarity=0.374  Sum_probs=163.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~   80 (203)
                      |+++.+|+.||||+++...   .+...+.+|++++++++||||+++++++.++     ..+|+||||++ ++|.+.+...
T Consensus        24 ~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~   95 (321)
T d1tkia_          24 CVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTS   95 (321)
T ss_dssp             EEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSS
T ss_pred             EEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhc
Confidence            5788999999999996532   2345678999999999999999999999987     67899999998 4999998865


Q ss_pred             C-CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC--CCeEEEeecCccccCCCCCCCCcccccCCcccccce
Q psy16889         81 Q-HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS--NCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPE  157 (203)
Q Consensus        81 ~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe  157 (203)
                      + .+++.+++.++.||+.||+|||++|++||||||+||+++.  ...++++|||.+.....  ........+++.|+|||
T Consensus        96 ~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~~~~~~~t~~y~ape  173 (321)
T d1tkia_          96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPE  173 (321)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCEEEEEESCGGGSCHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--CCcccccccccccccch
Confidence            4 7999999999999999999999999999999999999984  45899999999975432  22334456789999999


Q ss_pred             eeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        158 ILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       158 ~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ...+ ..++.++|||||||++|+|++|+.||.+.+..+.+.+|.+
T Consensus       174 ~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~  217 (321)
T d1tkia_         174 VHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN  217 (321)
T ss_dssp             HHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred             hccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            9887 4589999999999999999999999999999888887753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=6.7e-46  Score=283.72  Aligned_cols=184  Identities=22%  Similarity=0.357  Sum_probs=155.0

Q ss_pred             CcCCCCCcEEEEEeccCccch-hhhhHHHH---HHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS-LVSSKRVF---RELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKI   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   76 (203)
                      |+++.+|+.||||++...... ......+.   .++++++.++||||+++++++.++     ..+|+||||+. |+|.++
T Consensus        23 ~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~   97 (364)
T d1omwa3          23 CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYH   97 (364)
T ss_dssp             EEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHH
T ss_pred             EEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHH
Confidence            568899999999998543221 12222233   346777788999999999999988     56789999998 699999


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAP  156 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aP  156 (203)
                      +...+.+++.+++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++......   ......||+.|+||
T Consensus        98 l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~---~~~~~~GT~~y~AP  174 (364)
T d1omwa3          98 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP  174 (364)
T ss_dssp             HHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS---CCCSCCSCGGGCCH
T ss_pred             HHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC---cccccccccccchh
Confidence            988888999999999999999999999999999999999999999999999999999754332   23445789999999


Q ss_pred             eeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCCh
Q psy16889        157 EILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSP  193 (203)
Q Consensus       157 e~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~  193 (203)
                      |++.....++.++|||||||++|+|++|+.||.+.+.
T Consensus       175 E~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~  211 (364)
T d1omwa3         175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  211 (364)
T ss_dssp             HHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred             HHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence            9997656689999999999999999999999987654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-45  Score=268.53  Aligned_cols=186  Identities=25%  Similarity=0.438  Sum_probs=155.6

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QH   82 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~   82 (203)
                      ++++.||||+++..   ....+.+.+|++++++++||||+++++++.++      ..++||||+. |+|.+.+...  ..
T Consensus        35 ~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~iv~Ey~~~g~L~~~~~~~~~~~  105 (272)
T d1qpca_          35 NGHTKVAVKSLKQG---SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIYIITEYMENGSLVDFLKTPSGIK  105 (272)
T ss_dssp             TTTEEEEEEEECTT---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHTTSHHHHT
T ss_pred             CCCCEEEEEEEccC---cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeEEEEEeCCCCcHHHHHhhcCCCC
Confidence            36788999999643   23446789999999999999999999988654      3468999998 5888766543  35


Q ss_pred             CChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecc
Q psy16889         83 LTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        83 ~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++..............+++.|+|||++.+ 
T Consensus       106 l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-  184 (272)
T d1qpca_         106 LTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-  184 (272)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-
Confidence            9999999999999999999999999999999999999999999999999998655444444455577889999999886 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      +.++.++||||||+++|||+| |.+||...+..+.++.|.
T Consensus       185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~  224 (272)
T d1qpca_         185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE  224 (272)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            458999999999999999998 566777777777776654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=263.72  Aligned_cols=188  Identities=22%  Similarity=0.409  Sum_probs=161.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHL   83 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~   83 (203)
                      ++++.||||.++...   ...+.+.+|+.++++++||||+++++++.++     ..+++||||+. |++..++.. ...+
T Consensus        26 ~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~   97 (258)
T d1k2pa_          26 RGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRF   97 (258)
T ss_dssp             TTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCC
T ss_pred             CCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCC
Confidence            477899999996532   2345788999999999999999999999877     56789999997 678877654 4679


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||++...............+|+.|+|||.+.+ .
T Consensus        98 ~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~  176 (258)
T d1k2pa_          98 QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-S  176 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH-C
T ss_pred             cHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC-C
Confidence            999999999999999999999999999999999999999999999999997655444444455677899999999987 5


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhhc
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~~  202 (203)
                      .++.++||||||+++|||+| |+.||.+.+..++..+|.+
T Consensus       177 ~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~  216 (258)
T d1k2pa_         177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ  216 (258)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT
T ss_pred             CCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh
Confidence            58999999999999999998 8999999998888877653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.5e-44  Score=268.71  Aligned_cols=193  Identities=40%  Similarity=0.650  Sum_probs=161.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH-hCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII-VSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~~~   80 (203)
                      |.+ .+|+.||||+++....+....+.+.+|+.++++++||||+++++++.++     ...++++|++.+++...+ ...
T Consensus        21 ~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~   94 (286)
T d1ob3a_          21 AQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCE   94 (286)
T ss_dssp             EEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTST
T ss_pred             EEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhc
Confidence            344 4789999999976555555677899999999999999999999999988     567789999997555444 557


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+|++|||.+....... .......+++.|.|||.+.
T Consensus        95 ~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~y~~pE~~~  173 (286)
T d1ob3a_          95 GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLM  173 (286)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----------CCCTTCCHHHHT
T ss_pred             CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccceecccchhhhHHHHh
Confidence            889999999999999999999999999999999999999999999999999997544332 2333446788999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|+.||.+.++.+.+.+|.
T Consensus       174 ~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~  214 (286)
T d1ob3a_         174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF  214 (286)
T ss_dssp             TCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            77778999999999999999999999999998888877654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-45  Score=275.87  Aligned_cols=184  Identities=29%  Similarity=0.462  Sum_probs=151.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      |+|+.+|+.||||+++.       ...+.+|++++.++ +||||+++++++.+..... ..+|+|||||+ |+|.+++..
T Consensus        31 a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~-~~~~ivmEy~~gg~L~~~i~~  102 (335)
T d2ozaa1          31 IFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD  102 (335)
T ss_dssp             EEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE-EEEEEEEECCCSEEHHHHHHS
T ss_pred             EEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC-CEEEEEEECCCCCcHHHHHHh
Confidence            57889999999999853       24567899886655 8999999999986521100 45789999998 599999876


Q ss_pred             C--CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC---CCeEEEeecCccccCCCCCCCCcccccCCcccc
Q psy16889         80 P--QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS---NCILKICDFGLARVEEPDPNKAMTQEVVTQYYR  154 (203)
Q Consensus        80 ~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~  154 (203)
                      .  ..+++.+++.++.|++.||+|||++|++||||||+||+++.   .+.+|++|||++......  .......||+.|+
T Consensus       103 ~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--~~~~~~~gt~~y~  180 (335)
T d2ozaa1         103 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYV  180 (335)
T ss_dssp             CSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--CCCCCCSCCCSSC
T ss_pred             cCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC--CccccccCCcccC
Confidence            4  46999999999999999999999999999999999999985   457999999999754432  2334557899999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      |||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus       181 aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~  221 (335)
T d2ozaa1         181 APEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI  221 (335)
T ss_dssp             CCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred             CcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence            9999987 5589999999999999999999999987664443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=272.80  Aligned_cols=185  Identities=29%  Similarity=0.435  Sum_probs=151.3

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC------
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP------   80 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------   80 (203)
                      ..||+|.+... ........+.+|+.+++++ +||||+++++++.++     ...++||||++ |+|.+++...      
T Consensus        68 ~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~  141 (325)
T d1rjba_          68 IQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSE  141 (325)
T ss_dssp             EEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC--
T ss_pred             eEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcc
Confidence            46999998543 2334556788999999998 899999999999988     56789999998 5999988643      


Q ss_pred             -----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-
Q psy16889         81 -----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-  142 (203)
Q Consensus        81 -----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-  142 (203)
                                       +.+++.+++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++........ 
T Consensus       142 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  221 (325)
T d1rjba_         142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV  221 (325)
T ss_dssp             -------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSE
T ss_pred             hhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCcee
Confidence                             34899999999999999999999999999999999999999999999999999754433222 


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ......||+.|+|||++.+ +.++.++|||||||++|||+| |++||.+.+..+.+.++
T Consensus       222 ~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~  279 (325)
T d1rjba_         222 VRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL  279 (325)
T ss_dssp             EETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             eeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            2334567899999999887 558999999999999999997 89999987765555444

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-44  Score=271.60  Aligned_cols=195  Identities=44%  Similarity=0.808  Sum_probs=166.6

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |+|+.+|+.||||+++....+....+.+.+|++++++++||||+++++++...+.. ....+|+||||++.+|..... .
T Consensus        37 ~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~  115 (346)
T d1cm8a_          37 AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-H  115 (346)
T ss_dssp             EEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHH-H
T ss_pred             EEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHH-h
Confidence            57889999999999976555666677889999999999999999999998776421 113468999999777776654 4


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||.+.....    ..+...+++.|+|||++.
T Consensus       116 ~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~  191 (346)
T d1cm8a_         116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVIL  191 (346)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHH
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC----ccccccccccccCHHHHc
Confidence            6799999999999999999999999999999999999999999999999999985432    234557899999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++||||+||++|+|++|++||.+.+..+.+.++.
T Consensus       192 ~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~  232 (346)
T d1cm8a_         192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIM  232 (346)
T ss_dssp             TTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHH
Confidence            76668999999999999999999999999998877766553

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=270.74  Aligned_cols=198  Identities=40%  Similarity=0.660  Sum_probs=158.8

Q ss_pred             CcCCCC-CcEEEEEeccCccchhhhhHHHHHHHHHHhhc---CCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHH
Q psy16889          2 VTDPRD-GRRVALKKLPNVFQSLVSSKRVFRELKMLCFF---KHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKII   77 (203)
Q Consensus         2 ~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~   77 (203)
                      |+|.++ ++.||||+++...........+.+|+.+++.+   +||||+++++++...........++++|++.+++....
T Consensus        26 a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~  105 (305)
T d1blxa_          26 ARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL  105 (305)
T ss_dssp             EEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHH
T ss_pred             EEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhh
Confidence            456655 66799999965444444445566777777666   79999999999864322222467899999997544333


Q ss_pred             --hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         78 --VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        78 --~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                        .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++|||.+.....  ........||+.|+|
T Consensus       106 ~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~A  183 (305)
T d1blxa_         106 DKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRA  183 (305)
T ss_dssp             HHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG--GGGGCCCCCCCTTCC
T ss_pred             hhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc--cccCCCcccChhhcC
Confidence              3456799999999999999999999999999999999999999999999999999874322  234455678999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhhc
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLITD  202 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~~  202 (203)
                      ||++.+ ..++.++||||+||++|+|++|++||.+.++.+.+.+|.+
T Consensus       184 PE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~  229 (305)
T d1blxa_         184 PEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  229 (305)
T ss_dssp             HHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            999987 5689999999999999999999999999998888877653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-44  Score=263.14  Aligned_cols=187  Identities=27%  Similarity=0.419  Sum_probs=146.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-CCCCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-SPQHLT   84 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~   84 (203)
                      ++..||||.++.. ......+.+.+|++++++++||||+++++++.++      .+++||||+. |++.+++. ..+.++
T Consensus        34 ~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------~~~iv~E~~~~g~l~~~~~~~~~~l~  106 (273)
T d1mp8a_          34 PALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN------PVWIIMELCTLGELRSFLQVRKYSLD  106 (273)
T ss_dssp             CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS------SCEEEEECCTTEEHHHHHHHTTTTSC
T ss_pred             eeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------eEEEEEEeccCCcHHhhhhccCCCCC
Confidence            4567899998653 3444567789999999999999999999998654      4679999998 57777654 456799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeecccC
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      +..++.++.|++.||+|||+++++||||||+||+++.++.+|++|||++...............+|+.|+|||++.+ ..
T Consensus       107 ~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~  185 (273)
T d1mp8a_         107 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF-RR  185 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHH-CC
T ss_pred             HHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhcc-CC
Confidence            99999999999999999999999999999999999999999999999998654444444455567889999999987 55


Q ss_pred             CCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++||||||+++|||++ |.+||.+.+..+.+.+|.
T Consensus       186 ~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~  223 (273)
T d1mp8a_         186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE  223 (273)
T ss_dssp             CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            8999999999999999997 899999998888877664

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=270.11  Aligned_cols=197  Identities=47%  Similarity=0.877  Sum_probs=163.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhCCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVSPQ   81 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~   81 (203)
                      |+|+.+|+.||||+++.. ......+.+.+|++++++++||||+++++++..+.......++++++.++++|.+++.. .
T Consensus        27 ~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~  104 (345)
T d1pmea_          27 AYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-Q  104 (345)
T ss_dssp             EEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-C
T ss_pred             EEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-C
Confidence            578899999999999643 23445567889999999999999999999987664332234566777677899998865 4


Q ss_pred             CCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC--CCCcccccCCcccccceee
Q psy16889         82 HLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP--NKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        82 ~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......  ........|++.|+|||++
T Consensus       105 ~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l  184 (345)
T d1pmea_         105 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM  184 (345)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHh
Confidence            69999999999999999999999999999999999999999999999999987543322  1223445678999999998


Q ss_pred             ecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .....++.++|+||+|+++|+|++|+.||.+.+..+....+
T Consensus       185 ~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~  225 (345)
T d1pmea_         185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI  225 (345)
T ss_dssp             TTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             hcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH
Confidence            77667899999999999999999999999998877666554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-43  Score=265.02  Aligned_cols=200  Identities=34%  Similarity=0.605  Sum_probs=161.5

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcch---hHHHHHHHhhhHHhHHHHH-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDF---FQEIYVITELLQSDLHKII-   77 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~-   77 (203)
                      |+++.+|+.||||++............+.+|++++++++|||++++++++......+   ....+++||++++++.... 
T Consensus        29 a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~  108 (318)
T d3blha1          29 ARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS  108 (318)
T ss_dssp             EEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHT
T ss_pred             EEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhh
Confidence            678899999999999665555556677889999999999999999999886643221   1246789999986555444 


Q ss_pred             hCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC---CCCcccccCCcccc
Q psy16889         78 VSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP---NKAMTQEVVTQYYR  154 (203)
Q Consensus        78 ~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~  154 (203)
                      .....+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||++.......   ........||+.|+
T Consensus       109 ~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~  188 (318)
T d3blha1         109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR  188 (318)
T ss_dssp             CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGC
T ss_pred             hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHh
Confidence            456779999999999999999999999999999999999999999999999999997544322   12233446899999


Q ss_pred             cceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        155 APEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       155 aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      |||++.+...++.++||||+||++|+|++|++||.+..+.+.+.+|.
T Consensus       189 aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             CHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             hHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence            99999876678999999999999999999999999988888777664

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=265.83  Aligned_cols=182  Identities=27%  Similarity=0.386  Sum_probs=152.7

Q ss_pred             CcCCCCCcEEEEEeccCccch----hhhhHHHHHHHHHHhhcC--CCCccchhhhccCCCcchhHHHHHHHhhhH--HhH
Q psy16889          2 VTDPRDGRRVALKKLPNVFQS----LVSSKRVFRELKMLCFFK--HDNVLSALDILQPPHLDFFQEIYVITELLQ--SDL   73 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~l   73 (203)
                      |+++.+|+.||||+++.....    ......+.+|+.++++++  ||||+++++++.++     ...++|||++.  +++
T Consensus        23 a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l   97 (273)
T d1xwsa_          23 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----DSFVLILERPEPVQDL   97 (273)
T ss_dssp             EEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----SEEEEEEECCSSEEEH
T ss_pred             EEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-----CeEEEEEEeccCcchH
Confidence            578899999999998543221    122344678999999996  89999999999888     56789999986  377


Q ss_pred             HHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-CCeEEEeecCccccCCCCCCCCcccccCCcc
Q psy16889         74 HKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-NCILKICDFGLARVEEPDPNKAMTQEVVTQY  152 (203)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  152 (203)
                      .+.+...+.+++++++.++.|++.||+|||++|++||||||+||+++. ++.+|++|||.+.....   .......||+.
T Consensus        98 ~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~---~~~~~~~GT~~  174 (273)
T d1xwsa_          98 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRV  174 (273)
T ss_dssp             HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS---SCBCCCCSCGG
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc---ccccccccCCC
Confidence            788877788999999999999999999999999999999999999985 57999999999975432   23345578999


Q ss_pred             cccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCC
Q psy16889        153 YRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQ  191 (203)
Q Consensus       153 ~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  191 (203)
                      |+|||++.+...++.++|||||||++|+|++|+.||.+.
T Consensus       175 y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             GSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             cCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            999999987555677899999999999999999999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-43  Score=259.08  Aligned_cols=186  Identities=27%  Similarity=0.439  Sum_probs=146.7

Q ss_pred             cEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHh-CCCCCChH
Q psy16889          9 RRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIV-SPQHLTSD   86 (203)
Q Consensus         9 ~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~   86 (203)
                      ..||||+++... +......+.+|++++++++||||+++++++.+.     ...+++|||+.+ ++.+.+. ..+.+++.
T Consensus        37 ~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  110 (283)
T d1mqba_          37 VPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVL  110 (283)
T ss_dssp             EEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHH
T ss_pred             EEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHH
Confidence            579999996543 334456788999999999999999999999877     456789999985 6666554 45779999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC--CCcccccCCcccccceeeecccC
Q psy16889         87 HIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN--KAMTQEVVTQYYRAPEILMGARH  164 (203)
Q Consensus        87 ~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~  164 (203)
                      ++..++.|++.|++|||+++++||||||+||+++.++.+||+|||+++.......  .......||+.|+|||++.+ +.
T Consensus       111 ~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~  189 (283)
T d1mqba_         111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RK  189 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CC
T ss_pred             HHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CC
Confidence            9999999999999999999999999999999999999999999999975433222  12234467889999999887 56


Q ss_pred             CCcchhHHHHHHHHHHHHhC-CcccCCCChHHHhhhhh
Q psy16889        165 YSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLIT  201 (203)
Q Consensus       165 ~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  201 (203)
                      ++.++||||||+++|||+++ .+|+.+.+..+.+..+.
T Consensus       190 ~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~  227 (283)
T d1mqba_         190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN  227 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh
Confidence            89999999999999999985 66677777777666554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=268.65  Aligned_cols=192  Identities=32%  Similarity=0.533  Sum_probs=157.2

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHH----
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKI----   76 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~----   76 (203)
                      |+++.+|+.||||++....      ....+|++++++++||||+++++++...... ...++++||||+++++.+.    
T Consensus        39 a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~  112 (350)
T d1q5ka_          39 AKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY  112 (350)
T ss_dssp             EEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHH
T ss_pred             EEECCCCCEEEEEEECccc------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhh
Confidence            6788999999999995431      2234799999999999999999988543211 1135679999998754433    


Q ss_pred             HhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCccccc
Q psy16889         77 IVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRA  155 (203)
Q Consensus        77 ~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~a  155 (203)
                      ......+++.+++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......  .......|++.|.|
T Consensus       113 ~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~a  190 (350)
T d1q5ka_         113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--EPNVSYICSRYYRA  190 (350)
T ss_dssp             HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT--SCCCSCCSCTTSCC
T ss_pred             hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC--cccccccccccccC
Confidence            34567899999999999999999999999999999999999999765 8999999998754332  23344578999999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      ||.+.+...++.++||||+||++|+|++|++||.+.+..+.+..|.
T Consensus       191 PE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~  236 (350)
T d1q5ka_         191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII  236 (350)
T ss_dssp             HHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHH
T ss_pred             hHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHH
Confidence            9998876678999999999999999999999999999888887764

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=259.87  Aligned_cols=185  Identities=25%  Similarity=0.440  Sum_probs=147.2

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC--CCCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS--PQHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~   83 (203)
                      +++.||||+++...   ...+.+.+|+.++++++||||+++++++.++      ..++||||+.+ +|...+..  .+.+
T Consensus        40 ~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~lv~Ey~~~g~l~~~~~~~~~~~l  110 (285)
T d1fmka3          40 GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIYIVTEYMSKGSLLDFLKGETGKYL  110 (285)
T ss_dssp             TTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEECCCTTCBHHHHHSHHHHTTC
T ss_pred             CCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeEEEEEecCCCchhhhhhhcccccc
Confidence            44679999996432   2346789999999999999999999998654      34789999984 67766653  3579


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++.+++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..............+++.|+|||++.+ .
T Consensus       111 ~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~  189 (285)
T d1fmka3         111 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G  189 (285)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHH-C
T ss_pred             hHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhC-C
Confidence            999999999999999999999999999999999999999999999999998655444445555678999999999987 5


Q ss_pred             CCCcchhHHHHHHHHHHHHhC-CcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++||||||+++|||++| ++|+.+....+.+..|.
T Consensus       190 ~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~  228 (285)
T d1fmka3         190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE  228 (285)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH
T ss_pred             CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            589999999999999999985 66677777777777664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=263.71  Aligned_cols=190  Identities=25%  Similarity=0.373  Sum_probs=148.8

Q ss_pred             cCCCCCc----EEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          3 TDPRDGR----RVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         3 ~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      .+..+|+    +||+|.++.. .+....+.+.+|++++++++||||+++++++.++.      .+++++++. ++|.+.+
T Consensus        29 ~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~v~e~~~~~~l~~~~  101 (317)
T d1xkka_          29 LWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYV  101 (317)
T ss_dssp             EECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS------EEEEEECCTTCBHHHHH
T ss_pred             EEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC------eeEEEEeccCCcccccc
Confidence            3455555    5888887543 33345677899999999999999999999998763      235566665 6787766


Q ss_pred             h-CCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC-CcccccCCccccc
Q psy16889         78 V-SPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK-AMTQEVVTQYYRA  155 (203)
Q Consensus        78 ~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~a  155 (203)
                      . ....+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||++......... ......||+.|+|
T Consensus       102 ~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~A  181 (317)
T d1xkka_         102 REHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA  181 (317)
T ss_dssp             HHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSC
T ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccC
Confidence            5 4567999999999999999999999999999999999999999999999999999855433222 2334467899999


Q ss_pred             ceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        156 PEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       156 Pe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ||++.+ +.++.++||||||+++|||+| |++||.+.+..+....+
T Consensus       182 PE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i  226 (317)
T d1xkka_         182 LESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL  226 (317)
T ss_dssp             HHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred             hHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence            999987 568999999999999999998 89999998877766554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=263.28  Aligned_cols=195  Identities=42%  Similarity=0.758  Sum_probs=159.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |+|+.+|+.||||+++....+......+.+|+.++++++||||+++++++...+.. ....+|+||||+.+++.+.+.  
T Consensus        36 ~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--  113 (355)
T d2b1pa1          36 AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--  113 (355)
T ss_dssp             EEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--
T ss_pred             EEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--
Confidence            57889999999999977655666677889999999999999999999998755321 114678999999988877664  


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+.....  ........+|+.|+|||++.
T Consensus       114 ~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--~~~~~~~~~t~~y~aPE~l~  191 (355)
T d2b1pa1         114 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVIL  191 (355)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCTTCCHHHHT
T ss_pred             cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc--ccccccccccccccChhhhc
Confidence            4689999999999999999999999999999999999999999999999998874332  23334446789999999998


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      + ..+++++|+||+||++|+|++|++||.+.+....+.+|.
T Consensus       192 ~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~  231 (355)
T d2b1pa1         192 G-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI  231 (355)
T ss_dssp             T-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             C-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            7 568999999999999999999999999998888777664

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=256.61  Aligned_cols=187  Identities=26%  Similarity=0.379  Sum_probs=150.0

Q ss_pred             CcEEEEEeccCccc-hhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHh-CCCCCC
Q psy16889          8 GRRVALKKLPNVFQ-SLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIV-SPQHLT   84 (203)
Q Consensus         8 ~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~~~~   84 (203)
                      +..||||+++.... .....+.+.+|+.++++++||||+++++++.++      ..++|+||+. +++.+.+. ..+.++
T Consensus        36 ~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~------~~~lv~e~~~~~~l~~~~~~~~~~l~  109 (273)
T d1u46a_          36 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFL  109 (273)
T ss_dssp             EEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSC
T ss_pred             EEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec------chheeeeeecCcchhhhhhcccCCCC
Confidence            44789999855332 344556789999999999999999999999765      3468999998 57776655 346799


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC--CcccccCCcccccceeeecc
Q psy16889         85 SDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK--AMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~aPe~~~~~  162 (203)
                      +..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||+++........  ......++..|+|||++.+ 
T Consensus       110 ~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-  188 (273)
T d1u46a_         110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-  188 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-
T ss_pred             HHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-
Confidence            9999999999999999999999999999999999999999999999999865433222  2223355778999999987 


Q ss_pred             cCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      ..++.++||||||+++|||+| |+.||.+.+..+.+.+|.
T Consensus       189 ~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~  228 (273)
T d1u46a_         189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  228 (273)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH
Confidence            558999999999999999998 899999999888887764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-42  Score=254.68  Aligned_cols=193  Identities=35%  Similarity=0.555  Sum_probs=163.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~   80 (203)
                      |+|+.+|+.||||+++...........+.+|+.+++.++||||+++++++.++     ...+++++++.+ ++.......
T Consensus        21 ~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~   95 (292)
T d1unla_          21 AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCN   95 (292)
T ss_dssp             EEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTT
T ss_pred             EEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cceeEEeeeccccccccccccc
Confidence            67889999999999966555556678899999999999999999999999888     566788999885 666767778


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||.+...... ........+++.|.|||.+.
T Consensus        96 ~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~~~pe~~~  174 (292)
T d1unla_          96 GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLF  174 (292)
T ss_dssp             TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-CSCCCSCCSCGGGCCHHHHT
T ss_pred             cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-CccceeeccccchhhhhHhc
Confidence            89999999999999999999999999999999999999999999999999999854433 22333345677899999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcc-cCCCChHHHhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRIL-FQAQSPVQQLGLI  200 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~p-f~~~~~~~~~~~i  200 (203)
                      +...++.++|||||||++|+|++|+.| |.+.+..+.+.++
T Consensus       175 ~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~  215 (292)
T d1unla_         175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI  215 (292)
T ss_dssp             TCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred             cCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence            766679999999999999999999887 5666666666554

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-42  Score=257.78  Aligned_cols=191  Identities=23%  Similarity=0.342  Sum_probs=157.5

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--   80 (203)
                      +..+++.||||+++.. ......+.+.+|++++++++||||+++++++.+.     ...++++|++. |+|.+++...  
T Consensus        39 ~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~  112 (301)
T d1lufa_          39 PYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSP  112 (301)
T ss_dssp             TTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC
T ss_pred             cCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCc
Confidence            4567889999999653 2334456789999999999999999999999877     45678999997 5888776421  


Q ss_pred             ----------------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCC
Q psy16889         81 ----------------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEP  138 (203)
Q Consensus        81 ----------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~  138 (203)
                                            ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++.....
T Consensus       113 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~  192 (301)
T d1lufa_         113 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS  192 (301)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred             cccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccC
Confidence                                  2489999999999999999999999999999999999999999999999999874433


Q ss_pred             CC-CCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCChHHHhhhhh
Q psy16889        139 DP-NKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLIT  201 (203)
Q Consensus       139 ~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  201 (203)
                      .. ........+++.|+|||.+.+ ..++.++||||||+++|||++| .+||.+.++.+.+..+.
T Consensus       193 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~  256 (301)
T d1lufa_         193 ADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR  256 (301)
T ss_dssp             GGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             CccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHH
Confidence            22 223334567889999999987 5589999999999999999998 57899999888887764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-43  Score=265.06  Aligned_cols=192  Identities=23%  Similarity=0.342  Sum_probs=161.4

Q ss_pred             CCCCCcEEEEEeccCccc--hhhhhHHHHHHHHHHhhcCC-CCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC
Q psy16889          4 DPRDGRRVALKKLPNVFQ--SLVSSKRVFRELKMLCFFKH-DNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~   79 (203)
                      +..+|+.||||+++....  .....+.+.+|++++++++| |||+++++++.++     ..+++++||+. ++|.+.+..
T Consensus        48 ~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~  122 (322)
T d1vzoa_          48 GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQ  122 (322)
T ss_dssp             STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHH
T ss_pred             cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-----CceeeeeecccccHHHHHHHh
Confidence            467899999999965322  23345678899999999966 8999999999888     56788999998 599999988


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEIL  159 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~  159 (203)
                      .+.+++..+..++.|++.||+|+|++|++||||||+||+++.++.++|+|||.+...............|++.|.+||.+
T Consensus       123 ~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~  202 (322)
T d1vzoa_         123 RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV  202 (322)
T ss_dssp             HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred             cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHh
Confidence            88899999999999999999999999999999999999999999999999999976554444445566789999999998


Q ss_pred             eccc-CCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhh
Q psy16889        160 MGAR-HYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLI  200 (203)
Q Consensus       160 ~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i  200 (203)
                      .+.. .++.++|||||||++|+|++|+.||.+.+..+...+|
T Consensus       203 ~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i  244 (322)
T d1vzoa_         203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  244 (322)
T ss_dssp             TTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             hcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            7643 4688999999999999999999999887655554444

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-42  Score=260.94  Aligned_cols=195  Identities=51%  Similarity=0.884  Sum_probs=159.4

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcc-hhHHHHHHHhhhHHhHHHHHhCC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLD-FFQEIYVITELLQSDLHKIIVSP   80 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~   80 (203)
                      |+|+.+|+.||||+++....+....+.+.+|++++++++|||++++++++...... .....++++++.+++|.+++.. 
T Consensus        37 a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-  115 (348)
T d2gfsa1          37 AFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-  115 (348)
T ss_dssp             EEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-
T ss_pred             EEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-
Confidence            67889999999999976656666677888999999999999999999998654321 1123445555555789887754 


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeee
Q psy16889         81 QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILM  160 (203)
Q Consensus        81 ~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~  160 (203)
                      +.+++.+++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+....    .......|++.|+|||...
T Consensus       116 ~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~----~~~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         116 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIML  191 (348)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT----GGGSSSCHHHHTSCHHHHT
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC----cccccccccccccCchhhc
Confidence            579999999999999999999999999999999999999999999999999987432    2334456788999999988


Q ss_pred             cccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHHhhhhh
Q psy16889        161 GARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       161 ~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~i~  201 (203)
                      +...++.++|+||||+++|+|++|++||.+.+......+|.
T Consensus       192 ~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~  232 (348)
T d2gfsa1         192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  232 (348)
T ss_dssp             TCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            76667899999999999999999999999998887777664

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=253.41  Aligned_cols=182  Identities=23%  Similarity=0.448  Sum_probs=147.9

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC--CCC
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP--QHL   83 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~   83 (203)
                      +|+.||||+++..    ...+.+.+|++++++++||||+++++++.++.    ..+++||||++ |+|.+++...  ..+
T Consensus        29 ~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l  100 (262)
T d1byga_          29 RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVL  100 (262)
T ss_dssp             TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHC
T ss_pred             CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCC
Confidence            5789999999643    34567889999999999999999999886542    34689999998 5898887643  358


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccCCcccccceeeeccc
Q psy16889         84 TSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEILMGAR  163 (203)
Q Consensus        84 ~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~  163 (203)
                      ++..++.++.|++.|++|||+++++||||+|+||+++.++.++++|||.+......    .....+++.|+|||++.+ .
T Consensus       101 ~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~-~  175 (262)
T d1byga_         101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALRE-K  175 (262)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------CCTTTSCHHHHHH-C
T ss_pred             CHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----CccccccccCCChHHHhC-C
Confidence            99999999999999999999999999999999999999999999999999753322    223355788999999987 4


Q ss_pred             CCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        164 HYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       164 ~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .++.++||||||+++|||+| |++||...+..+....|.
T Consensus       176 ~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~  214 (262)
T d1byga_         176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE  214 (262)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT
T ss_pred             CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence            58999999999999999998 799999988887777664

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-41  Score=251.75  Aligned_cols=188  Identities=28%  Similarity=0.459  Sum_probs=157.3

Q ss_pred             CCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC----
Q psy16889          7 DGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP----   80 (203)
Q Consensus         7 ~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----   80 (203)
                      ++..||||+++... .......+.+|...+.++ +||||+++++++.++     ...++||||+. |+|.+++...    
T Consensus        44 ~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~  117 (299)
T d1fgka_          44 RVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPG  117 (299)
T ss_dssp             CEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC-
T ss_pred             CceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCc
Confidence            44579999996542 334456788888888888 899999999999887     56789999998 5888888643    


Q ss_pred             ------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCC-CCCcccc
Q psy16889         81 ------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDP-NKAMTQE  147 (203)
Q Consensus        81 ------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  147 (203)
                                  ..+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||.+....... .......
T Consensus       118 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  197 (299)
T d1fgka_         118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG  197 (299)
T ss_dssp             -----------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTS
T ss_pred             cccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccC
Confidence                        358999999999999999999999999999999999999999999999999998544332 2233445


Q ss_pred             cCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhhh
Q psy16889        148 VVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLIT  201 (203)
Q Consensus       148 ~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i~  201 (203)
                      .+++.|+|||.+.+ +.++.++||||||+++|+|++ |++||.+.+..+....+.
T Consensus       198 ~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~  251 (299)
T d1fgka_         198 RLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK  251 (299)
T ss_dssp             CCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             CCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHH
Confidence            67889999999987 569999999999999999997 799999988887776653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=254.26  Aligned_cols=188  Identities=28%  Similarity=0.490  Sum_probs=142.8

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC--
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS--   79 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--   79 (203)
                      +..+++.||||+++... .....+.+.+|...+.++ +|+||+.+++++..+.    ..++++|||++ |+|.+++..  
T Consensus        39 ~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~  113 (299)
T d1ywna1          39 KTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKR  113 (299)
T ss_dssp             SSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTG
T ss_pred             cccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhcc
Confidence            34577899999996532 233445667777777776 7899999999876653    34678999998 588888753  


Q ss_pred             --------------CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCc
Q psy16889         80 --------------PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAM  144 (203)
Q Consensus        80 --------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~  144 (203)
                                    ...+++.++..++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....... ...
T Consensus       114 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~  193 (299)
T d1ywna1         114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK  193 (299)
T ss_dssp             GGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCT
T ss_pred             ccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccccccc
Confidence                          23589999999999999999999999999999999999999999999999999975443322 233


Q ss_pred             ccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCChHHHh
Q psy16889        145 TQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQL  197 (203)
Q Consensus       145 ~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~  197 (203)
                      ....||+.|+|||++.+ +.++.++||||||+++|||++| .+||.+....+.+
T Consensus       194 ~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         194 GDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             TSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            44578999999999987 5589999999999999999986 6788876644433

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-41  Score=252.95  Aligned_cols=181  Identities=18%  Similarity=0.277  Sum_probs=151.7

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCC-CCccchhhhccCCCcchhHHHHHHHhhhHHhHHHHHhC-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKH-DNVLSALDILQPPHLDFFQEIYVITELLQSDLHKIIVS-   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-   79 (203)
                      |+++.+|+.||||+++..    .....+.+|++.++.++| +|++.+++++..+     ...++|||+++++|.+.+.. 
T Consensus        24 a~~~~~~~~vAvK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~   94 (293)
T d1csna_          24 GTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLC   94 (293)
T ss_dssp             EEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT
T ss_pred             EEECCCCCEEEEEEEccc----cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhh
Confidence            577899999999998543    233457788999999955 8999999998877     56788999999999888764 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecC-----CCeEEEeecCccccCCCCCC------CCccccc
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNS-----NCILKICDFGLARVEEPDPN------KAMTQEV  148 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~-----~~~~~l~d~~~~~~~~~~~~------~~~~~~~  148 (203)
                      ...+++.++..++.|++.+|++||++|++||||||+||+++.     ++.++++|||+++.......      .......
T Consensus        95 ~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~  174 (293)
T d1csna_          95 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS  174 (293)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCC
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceE
Confidence            457999999999999999999999999999999999999964     57899999999985433211      1233457


Q ss_pred             CCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        149 VTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       149 ~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      ||+.|+|||++.+ +.++.++|+||||+++|+|++|+.||.+..
T Consensus       175 GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~  217 (293)
T d1csna_         175 GTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLK  217 (293)
T ss_dssp             SCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             EchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence            8999999999987 568999999999999999999999998654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-41  Score=252.88  Aligned_cols=190  Identities=28%  Similarity=0.422  Sum_probs=157.7

Q ss_pred             CCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCC-
Q psy16889          4 DPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSP-   80 (203)
Q Consensus         4 ~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-   80 (203)
                      +..+++.||||+++.. ........+.+|+.+++++ +||||+++++++.++     ...+++|||++ |+|.+++... 
T Consensus        49 ~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~  122 (311)
T d1t46a_          49 KSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKR  122 (311)
T ss_dssp             STTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTT
T ss_pred             cCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhcc
Confidence            4578889999999654 2344556788999999999 799999999999887     56789999998 5887776532 


Q ss_pred             -----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-C
Q psy16889         81 -----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-K  142 (203)
Q Consensus        81 -----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~  142 (203)
                                       ..+++..+..++.|++.|++|||+++++||||||+||+++.++.++++|||.+........ .
T Consensus       123 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~  202 (311)
T d1t46a_         123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV  202 (311)
T ss_dssp             TTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSE
T ss_pred             ccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcce
Confidence                             3599999999999999999999999999999999999999999999999999985543322 3


Q ss_pred             CcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHh-CCcccCCCChHHHhhhh
Q psy16889        143 AMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLG-RRILFQAQSPVQQLGLI  200 (203)
Q Consensus       143 ~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~-g~~pf~~~~~~~~~~~i  200 (203)
                      ......+|+.|+|||++.+ ..++.++||||||+++|+|+| |.+||.+.+..+.+.++
T Consensus       203 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~  260 (311)
T d1t46a_         203 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (311)
T ss_dssp             ECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             EeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            3344577899999999987 568999999999999999998 67778777665555444

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-41  Score=252.94  Aligned_cols=191  Identities=26%  Similarity=0.407  Sum_probs=153.8

Q ss_pred             CcCCCCCcE--EEEEeccCccchhhhhHHHHHHHHHHhhc-CCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHH
Q psy16889          2 VTDPRDGRR--VALKKLPNVFQSLVSSKRVFRELKMLCFF-KHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKII   77 (203)
Q Consensus         2 ~~~~~~~~~--~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~   77 (203)
                      |+++.+|..  |+||.++.. ......+.+.+|+++++++ +||||+++++++.++     ...++||||++ |+|.+++
T Consensus        29 ~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l  102 (309)
T d1fvra_          29 ARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFL  102 (309)
T ss_dssp             EEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHH
T ss_pred             EEECCCCeEEEEEEEEECcc-cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHH
Confidence            345566664  677777432 2334567799999999999 799999999999887     56789999998 5898887


Q ss_pred             hCC----------------CCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC
Q psy16889         78 VSP----------------QHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN  141 (203)
Q Consensus        78 ~~~----------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~  141 (203)
                      ...                ..+++..+..++.|++.|+.|+|+++++||||||+||+++.++.+||+|||++....... 
T Consensus       103 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-  181 (309)
T d1fvra_         103 RKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-  181 (309)
T ss_dssp             HTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-
T ss_pred             hhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-
Confidence            543                569999999999999999999999999999999999999999999999999997443222 


Q ss_pred             CCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCChHHHhhhhh
Q psy16889        142 KAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLIT  201 (203)
Q Consensus       142 ~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  201 (203)
                       ......+|..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+..+.+..|.
T Consensus       182 -~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~  240 (309)
T d1fvra_         182 -KKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  240 (309)
T ss_dssp             -CC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             -cccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence             2223356889999999987 4589999999999999999996 57899988888877764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-41  Score=249.59  Aligned_cols=185  Identities=20%  Similarity=0.271  Sum_probs=147.1

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhh-hccCCCcchhHHHHHHHhhhHHhHHHHHh-C
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALD-ILQPPHLDFFQEIYVITELLQSDLHKIIV-S   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~   79 (203)
                      |++..+|+.||||++...    ...+.+..|+++++.++|++++..+. ++.++     ...++|||++++++...+. .
T Consensus        26 a~~~~~~~~vAvK~~~~~----~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~-----~~~~ivme~~~~~l~~~~~~~   96 (299)
T d1ckia_          26 GTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEG-----DYNVMVMELLGPSLEDLFNFC   96 (299)
T ss_dssp             EEETTTTEEEEEEEEESC----TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHT
T ss_pred             EEECCCCCEEEEEEEchh----ccCHHHHHHHHHHHHccCCCcccEEEEEEecC-----CEEEEEEEEcCCchhhhhhhc
Confidence            567889999999998543    22345788999999998777555544 44444     4567899999987776655 4


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEec---CCCeEEEeecCccccCCCCCC------CCcccccCC
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVN---SNCILKICDFGLARVEEPDPN------KAMTQEVVT  150 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~---~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~  150 (203)
                      .+.+++..+..++.|++.||+|||++|++||||||+||+++   .+..++++|||.+........      .......||
T Consensus        97 ~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt  176 (299)
T d1ckia_          97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT  176 (299)
T ss_dssp             TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCC
T ss_pred             cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCC
Confidence            56899999999999999999999999999999999999986   345799999999985443221      233455789


Q ss_pred             cccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCChHHH
Q psy16889        151 QYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQSPVQQ  196 (203)
Q Consensus       151 ~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~  196 (203)
                      +.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.
T Consensus       177 ~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~  221 (299)
T d1ckia_         177 ARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK  221 (299)
T ss_dssp             SSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----
T ss_pred             ccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHH
Confidence            99999999987 5589999999999999999999999987655443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-40  Score=246.16  Aligned_cols=185  Identities=25%  Similarity=0.350  Sum_probs=147.4

Q ss_pred             CcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-CCCCCh
Q psy16889          8 GRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-PQHLTS   85 (203)
Q Consensus         8 ~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~   85 (203)
                      ...||||.++.. .+....+.+.+|++++++++||||+++++++.+.+    ...++||||++ ++|.+++.. ....++
T Consensus        55 ~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~~  129 (311)
T d1r0pa_          55 KIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTV  129 (311)
T ss_dssp             CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCBH
T ss_pred             EEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccchH
Confidence            346899998643 34556678999999999999999999999876543    35679999999 478877764 456888


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCC---CcccccCCcccccceeeecc
Q psy16889         86 DHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNK---AMTQEVVTQYYRAPEILMGA  162 (203)
Q Consensus        86 ~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~aPe~~~~~  162 (203)
                      ..+..++.|++.||.|+|+.+++||||||+||+++.++.+||+|||+++........   ......||+.|+|||.+.+ 
T Consensus       130 ~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-  208 (311)
T d1r0pa_         130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-  208 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-
T ss_pred             HHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc-
Confidence            899999999999999999999999999999999999999999999999754433222   2233467889999999887 


Q ss_pred             cCCCcchhHHHHHHHHHHHHhCCcccCCC-ChHHHhh
Q psy16889        163 RHYSAAVDVWSVGCIFAELLGRRILFQAQ-SPVQQLG  198 (203)
Q Consensus       163 ~~~~~~~Di~slG~~l~~ll~g~~pf~~~-~~~~~~~  198 (203)
                      ..++.++||||||+++|||++|+.||... +..+...
T Consensus       209 ~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~  245 (311)
T d1r0pa_         209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV  245 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred             CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            45899999999999999999977766543 3433333

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-40  Score=247.79  Aligned_cols=189  Identities=24%  Similarity=0.360  Sum_probs=156.9

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhC-----
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVS-----   79 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----   79 (203)
                      .+++.||||+++.. ........+.+|++++++++||||+++++++..+     ...++||||+. |+|.+++..     
T Consensus        48 ~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~  121 (308)
T d1p4oa_          48 EPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAM  121 (308)
T ss_dssp             EEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHH
T ss_pred             CCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhccccc
Confidence            45678999999653 2444556788999999999999999999999877     45788999998 577776542     


Q ss_pred             -----CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC-CCcccccCCccc
Q psy16889         80 -----PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN-KAMTQEVVTQYY  153 (203)
Q Consensus        80 -----~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  153 (203)
                           ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++....... .......+++.|
T Consensus       122 ~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y  201 (308)
T d1p4oa_         122 ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW  201 (308)
T ss_dssp             HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGG
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceeccccc
Confidence                 13478999999999999999999999999999999999999999999999999974433222 223334678999


Q ss_pred             ccceeeecccCCCcchhHHHHHHHHHHHHhC-CcccCCCChHHHhhhhh
Q psy16889        154 RAPEILMGARHYSAAVDVWSVGCIFAELLGR-RILFQAQSPVQQLGLIT  201 (203)
Q Consensus       154 ~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~~~i~  201 (203)
                      +|||.+.+ ..++.++|+||||+++|||+|| ++||.+.+..+.+..|.
T Consensus       202 ~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~  249 (308)
T d1p4oa_         202 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  249 (308)
T ss_dssp             CCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999987 5588999999999999999998 68999998888887664

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-40  Score=249.61  Aligned_cols=178  Identities=30%  Similarity=0.604  Sum_probs=148.9

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-CCCccchhhhccCCCcchhHHHHHHHhhhHH-hHHHHHhC
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-HDNVLSALDILQPPHLDFFQEIYVITELLQS-DLHKIIVS   79 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~   79 (203)
                      |+++.+|+.||||+++..     ..+.+.+|+++++.++ ||||+++++++.....   ...++||||+.+ +|...   
T Consensus        54 a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~---  122 (328)
T d3bqca1          54 AINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQL---  122 (328)
T ss_dssp             EEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CSEEEEEECCCSCBGGGT---
T ss_pred             EEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC---CceeEEEeecCCCcHHHH---
Confidence            678899999999998643     3456889999999994 9999999999875532   356789999985 65543   


Q ss_pred             CCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCC-eEEEeecCccccCCCCCCCCcccccCCccccccee
Q psy16889         80 PQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNC-ILKICDFGLARVEEPDPNKAMTQEVVTQYYRAPEI  158 (203)
Q Consensus        80 ~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~aPe~  158 (203)
                      .+.+++.+++.++.||+.||+|||++||+||||||+||+++.++ .++++|||.+......  .......+|+.|+|||.
T Consensus       123 ~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~~~~~~t~~y~aPE~  200 (328)
T d3bqca1         123 YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPEL  200 (328)
T ss_dssp             TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCCCSCCSCGGGCCHHH
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--CcccccccCccccCccc
Confidence            35699999999999999999999999999999999999998654 6999999999754432  23344567899999999


Q ss_pred             eecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        159 LMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       159 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                      +.+...++.++|+||+||++|++++|+.||....
T Consensus       201 ~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~  234 (328)
T d3bqca1         201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  234 (328)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence            8886678999999999999999999999987654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=243.52  Aligned_cols=180  Identities=23%  Similarity=0.313  Sum_probs=140.8

Q ss_pred             CCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhhH-HhHHHHHhCCCCCC
Q psy16889          6 RDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELLQ-SDLHKIIVSPQHLT   84 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~   84 (203)
                      .+|+.||||+++..   .........|+..+++++||||+++++++.++.... ..+++||||+. |+|.+++... .++
T Consensus        24 ~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~-~l~   98 (303)
T d1vjya_          24 WRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRY-TVT   98 (303)
T ss_dssp             ETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS-EEEEEEEECCTTCBHHHHHHHC-CBC
T ss_pred             ECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc-eEEEEEEecccCCCHHHHHhcC-CCC
Confidence            46889999998542   122222334666677889999999999987654321 24679999998 5999988764 699


Q ss_pred             hHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEecCCCeEEEeecCccccCCCCCC---CCcccccCCccc
Q psy16889         85 SDHIKVFLYQILRGLKYLHS--------ARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPN---KAMTQEVVTQYY  153 (203)
Q Consensus        85 ~~~~~~~~~qi~~~l~~lh~--------~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~  153 (203)
                      +.+++.++.|++.+++++|+        +|++||||||+||+++.++.+||+|||++........   .......||+.|
T Consensus        99 ~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y  178 (303)
T d1vjya_          99 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCc
Confidence            99999999999999999996        5999999999999999999999999999875433322   133455789999


Q ss_pred             ccceeeeccc-----CCCcchhHHHHHHHHHHHHhCCcccCC
Q psy16889        154 RAPEILMGAR-----HYSAAVDVWSVGCIFAELLGRRILFQA  190 (203)
Q Consensus       154 ~aPe~~~~~~-----~~~~~~Di~slG~~l~~ll~g~~pf~~  190 (203)
                      +|||++.+..     .++.++||||||+++|||+||..||..
T Consensus       179 ~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             CChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            9999887532     246689999999999999999988754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=1.8e-33  Score=215.03  Aligned_cols=180  Identities=27%  Similarity=0.414  Sum_probs=135.3

Q ss_pred             CcCCCCCcEEEEEeccCccchhhhhHHHHHHHHHHhhcC-----------CCCccchhhhccCCCcchhHHHHHHHhhh-
Q psy16889          2 VTDPRDGRRVALKKLPNVFQSLVSSKRVFRELKMLCFFK-----------HDNVLSALDILQPPHLDFFQEIYVITELL-   69 (203)
Q Consensus         2 ~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-   69 (203)
                      |+++.+|+.||||+++..   ....+.+.+|+++++.++           |+||+++++++......   ..+++++++ 
T Consensus        32 ~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~---~~~~~~~~~~  105 (362)
T d1q8ya_          32 AKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN---GVHVVMVFEV  105 (362)
T ss_dssp             EEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT---EEEEEEEECC
T ss_pred             EEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc---ceeeeeeecc
Confidence            578899999999999643   223456778888888875           47788888887654221   122333333 


Q ss_pred             -HHh--HHHHHhCCCCCChHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEecCCC------eEEEeecCccccCCCC
Q psy16889         70 -QSD--LHKIIVSPQHLTSDHIKVFLYQILRGLKYLHS-ARILHRDIKPGNLLVNSNC------ILKICDFGLARVEEPD  139 (203)
Q Consensus        70 -~~~--l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~~~nil~~~~~------~~~l~d~~~~~~~~~~  139 (203)
                       .++  ..........+++..++.++.|++.|+++||+ .||+||||||+||+++.++      .++++|||.+..... 
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-  184 (362)
T d1q8ya_         106 LGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-  184 (362)
T ss_dssp             CCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-
T ss_pred             cccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-
Confidence             222  22333455779999999999999999999997 8999999999999998654      489999999874432 


Q ss_pred             CCCCcccccCCcccccceeeecccCCCcchhHHHHHHHHHHHHhCCcccCCCC
Q psy16889        140 PNKAMTQEVVTQYYRAPEILMGARHYSAAVDVWSVGCIFAELLGRRILFQAQS  192 (203)
Q Consensus       140 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  192 (203)
                         ......+++.|+|||++.+ ..++.++|+||+|+++++|++|+.||....
T Consensus       185 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         185 ---HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             ---CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             ---ccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence               2234467899999999887 558999999999999999999999997653

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.81  E-value=8.7e-22  Score=136.96  Aligned_cols=146  Identities=16%  Similarity=0.084  Sum_probs=100.0

Q ss_pred             CCCcEEEEEeccCccch----------------hhhhHHHHHHHHHHhhcCCCCccchhhhccCCCcchhHHHHHHHhhh
Q psy16889          6 RDGRRVALKKLPNVFQS----------------LVSSKRVFRELKMLCFFKHDNVLSALDILQPPHLDFFQEIYVITELL   69 (203)
Q Consensus         6 ~~~~~~~vK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~   69 (203)
                      .+|+.||||+++....+                .........|...+.++.|++++..+++..         .+++||++
T Consensus        22 ~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~---------~~lvme~~   92 (191)
T d1zara2          22 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG---------NAVLMELI   92 (191)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET---------TEEEEECC
T ss_pred             CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC---------CEEEEEee
Confidence            47899999987432111                112234456888999999999887775432         24788988


Q ss_pred             HHhHHHHHhCCCCCChHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEecCCCeEEEeecCccccCCCCCCCCcccccC
Q psy16889         70 QSDLHKIIVSPQHLTSDHIKVFLYQILRGLKYLHSARILHRDIKPGNLLVNSNCILKICDFGLARVEEPDPNKAMTQEVV  149 (203)
Q Consensus        70 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  149 (203)
                      ++...      ..+++..+..++.|++.++++||++|++||||||+||+++++ .++++|||.+.....+...       
T Consensus        93 ~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~-------  158 (191)
T d1zara2          93 DAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR-------  158 (191)
T ss_dssp             CCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH-------
T ss_pred             ccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH-------
Confidence            86322      125566678899999999999999999999999999999865 6899999998643322111       


Q ss_pred             Cccccc------ceeeecccCCCcchhHHHHHHHH
Q psy16889        150 TQYYRA------PEILMGARHYSAAVDVWSVGCIF  178 (203)
Q Consensus       150 ~~~~~a------Pe~~~~~~~~~~~~Di~slG~~l  178 (203)
                        .|+.      .+.+.  +.|+..+|+||+.--+
T Consensus       159 --~~l~rd~~~~~~~f~--r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         159 --EILERDVRNIITYFS--RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             --HHHHHHHHHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred             --HHHHHHHHHHHHHHc--CCCCCcccHHHHHHHH
Confidence              1111      11121  3478899999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.18  E-value=3.1e-07  Score=65.28  Aligned_cols=28  Identities=21%  Similarity=0.381  Sum_probs=24.6

Q ss_pred             ceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        107 ILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       107 i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      ++|+|+.|.||++++++...++||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCceEEEeechhcc
Confidence            7899999999999977666799999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.64  E-value=7.5e-06  Score=61.60  Aligned_cols=30  Identities=20%  Similarity=0.387  Sum_probs=25.9

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      ..++|||++|.|||++++ .++++||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            369999999999999876 489999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.62  E-value=4.1e-06  Score=59.02  Aligned_cols=28  Identities=21%  Similarity=0.247  Sum_probs=24.9

Q ss_pred             ceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        107 ILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       107 i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      ++|+|++|.||+++.+....++||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.89  E-value=0.00018  Score=53.92  Aligned_cols=28  Identities=32%  Similarity=0.564  Sum_probs=21.9

Q ss_pred             ceecCCCCCcEEec----------------------------CCCeEEEeecCccc
Q psy16889        107 ILHRDIKPGNLLVN----------------------------SNCILKICDFGLAR  134 (203)
Q Consensus       107 i~H~di~~~nil~~----------------------------~~~~~~l~d~~~~~  134 (203)
                      ++|+|+.+.||++.                            +++.++++||..+.
T Consensus       220 ~CHnDL~~~NiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~lID~EYa~  275 (395)
T d1nw1a_         220 FCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS  275 (395)
T ss_dssp             EECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred             EEecCCCcccEeeccccccccccccccccccccccccccccCCCCcEEEEeecccC
Confidence            68999999999984                            34678999998775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.20  E-value=0.0011  Score=47.71  Aligned_cols=30  Identities=23%  Similarity=0.360  Sum_probs=26.7

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLAR  134 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~  134 (203)
                      .|++|+|+.++|++++.+...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.32  E-value=0.013  Score=42.21  Aligned_cols=29  Identities=31%  Similarity=0.344  Sum_probs=23.5

Q ss_pred             CCceecCCCCCcEEecCCCeEEEeecCcccc
Q psy16889        105 ARILHRDIKPGNLLVNSNCILKICDFGLARV  135 (203)
Q Consensus       105 ~~i~H~di~~~nil~~~~~~~~l~d~~~~~~  135 (203)
                      .+++|+|+++.|++++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            368999999999999743  45899998863